<html lang="en"><head><!-- Shady DOM styles for custom-style --><!-- Shady DOM styles for dom-template --><!-- Shady DOM styles for dom-repeat --><!-- Shady DOM styles for array-selector --><!-- Shady DOM styles for dom-if --><!-- Shady DOM styles for state-modifier --><style scope="state-modifier">a[inherit].state-modifier {
  color: inherit;
}</style><!-- Shady DOM styles for browser-ui --><!-- Shady DOM styles for outlined-text-field --><style scope="outlined-text-field">outlined-text-field {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: column;
}

outlined-text-field span.outlined-text-field {
  display: flex;
  flex-direction: row;
  align-items: center;
}

outlined-text-field input.outlined-text-field {
  height: 40px;
  padding: 0 33px 0 16px;
  
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  flex-grow: 1;
}

outlined-text-field[orig] input.outlined-text-field {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-text-field[dense] input.outlined-text-field {
  height: 32px;
}

outlined-text-field[uppercase] input.outlined-text-field {
  text-transform: uppercase;
}

outlined-text-field:not([wizard-focused]):hover input.outlined-text-field {
  border-color: #737375;
  color: #414447;
}

outlined-text-field:not([wizard-focused]):focus-within input.outlined-text-field,outlined-text-field[wizard-focused] input.outlined-text-field {
  border-color: #3574e0;
  caret-color: #80a5f1;
}

outlined-text-field[wizard-focused] input.outlined-text-field {
  border-width: 2px;
}

outlined-text-field input.outlined-text-field::placeholder {
  color: #65686c;
}

outlined-text-field[uppercase] input.outlined-text-field::placeholder {
  text-transform: none;
}</style><!-- Shady DOM styles for mat-keyword-editor --><!-- Shady DOM styles for mat-chips-input --><!-- Shady DOM styles for mat-input-chip --><!-- Shady DOM styles for pat-dialog --><style scope="pat-dialog">pat-dialog {
  background: white;
  position: absolute;
  border-radius: 8px;
  
  box-shadow: 0 24px 38px 3px rgb(0 0 0 / 14%),
              0 9px 46px 8px rgb(0 0 0 / 12%),
              0 11px 15px -7px rgb(0 0 0 / 20%);
  z-index: 1;
  display: flex;
  flex-direction: column;
}

pat-dialog:not([open]) {
  display: none;
}</style><!-- Shady DOM styles for mat-tabs --><!-- Shady DOM styles for filter-chip --><style scope="filter-chip">filter-chip {
  align-items: center;
  background-color: #fff;
  border-color: #dadce0;
  border-radius: 8px;
  border-style: solid;
  border-width: 1px;
  color: #606368;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 32px;
  letter-spacing: 0.2px;
  padding: 0 16px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

filter-chip[disabled] {
  background-color: #e8e8e8;
  border-color: #e8e8e8;
  color: #a9abad;
  cursor: auto;
}

filter-chip svg.filter-chip {
  visibility: collapse;
  font-size: 18px;
  width: 0;
  height: 18px;
}

filter-chip[selected] svg.filter-chip {
  visibility: visible;
  margin: 0 8px;
  width: 18px;
}

filter-chip[selected] svg.filter-chip path.filter-chip {
  fill: #4577d1;
}

filter-chip:not([disabled]):hover {
  background-color: #f7f8f8;
  border-color: #d7d9dc;
  color: #454649;
}

filter-chip:not([disabled]):hover:active {
  background-color: #eff0f0;
  border-color: #d2d5d8;
  color: #222326;
}

filter-chip:not([disabled]):focus {
  background-color: #e7e8e8;
  border-color: #232528;
  color: #202124;
}

filter-chip:not([disabled])[selected] {
  background-color: #e9f0fd;
  border-color: #e9f0fd;
  color: #4577d1;
  padding-left: 0;
}

filter-chip:not([disabled]):focus[selected] {
  background-color: #d5e1fb;
  border-color: #d5e1fb;
  color: #2550a0;
}

filter-chip:not([disabled]):hover[selected] {
  box-shadow: rgba(0, 0, 0, 0.2) 0px 3px 1px -2px,
    rgba(0, 0, 0, 0.14) 0px 2px 2px 0px, rgba(0, 0, 0, 0.12) 0px 1px 5px 0px;
}

filter-chip:not([disabled]):hover:active[selected] {
  background-color: #abc8f2;
  border-color: #abc8f2;
  color: #2a54a3;
}</style><!-- Shady DOM styles for figure-callout --><!-- Shady DOM styles for mat-button --><style scope="mat-button-0">.mat-button-0 {
  ;
  align-items: center;
  border-radius: 4px;
  color: hsl(217 4% 39%); 
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: 0.2px;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
}

.mat-button-0[filled] {
  background-color: hsl(217 73% 54%); 
  color: white;
}

.mat-button-0[filled]:hover {
  background-color: hsl(217 60% 47%);
}

.mat-button-0[filled]:focus {
  background-color: hsl(217 59% 44%);
}

.mat-button-0[filled]:active {
  background-color: hsl(217 59% 45%);
}

.mat-button-0[filled][disabled] {
  background-color: hsl(217 2% 90%); 
  color: hsl(217 1% 65%);
}</style><!-- Shady DOM styles for search-term-wizard --><style scope="search-term-wizard">search-term-wizard:not([open]) {
  display: none;
}

search-term-wizard .header.search-term-wizard {
  border-bottom: 1px solid #e5e5e5;
  padding: 24px;
  padding-bottom: 0;
}

search-term-wizard .title.search-term-wizard {
  color: #3c4043;
  font-family: Google Sans,Roboto,Arial,sans-serif;
  font-size: 22px;
  user-select: none;
  margin: 0 48px;
}

search-term-wizard #panels.search-term-wizard > *.search-term-wizard:not([selected]) {
  display: none;
}</style><!-- Shady DOM styles for outlined-textarea --><style scope="outlined-textarea">outlined-textarea {
  display: flex;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  flex-direction: row;
  
  position: relative;
}

outlined-textarea span.outlined-textarea {
  display: flex;
  flex-direction: column;
  flex-grow: 1;
  justify-content: center;
}

outlined-textarea span.right-button-container.outlined-textarea {
  position: absolute;
  right: 0;
  height: 100%;
}

outlined-textarea textarea.outlined-textarea {
  padding: 16px 16px 0 16px;
  border-color: #b0b3b6;
  border-width: 1px;
  border-style: solid;
  border-radius: 8px;
  caret-color: #3c78e0;
  color: #6a6c71;
  font-size: 14px;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
  resize: none;
}

outlined-textarea[dense] textarea.outlined-textarea {
  padding: 8px;
}

outlined-textarea[has-icon] textarea.outlined-textarea {
  padding-right: 38px;
}

outlined-textarea[orig] textarea.outlined-textarea {
  border-color: #e5e5e5;
  
  border-radius: 0;
}

outlined-textarea:not([rows]) textarea.outlined-textarea {
  height: 40px;
}

outlined-textarea textarea.resizable.outlined-textarea {
  resize: vertical;
}

outlined-textarea textarea.outlined-textarea:focus,outlined-textarea[wizard-focused] textarea.outlined-textarea,outlined-textarea textarea.outlined-textarea:focus:hover {
  border-color: #3574e0 !important;
  
  outline: none !important;
}

outlined-textarea textarea.outlined-textarea:hover {
  border-color: #202124;
  color: #414447;
}

outlined-textarea.hasValue textarea.outlined-textarea {
  border-color: #888d91;
  color: #45474a;
}

outlined-textarea #helperText.outlined-textarea {
  color: #6a6c71;
  font-size: 12px;
  letter-spacing: 0.3px;
  margin-left: 17px;
  margin-top: 6px;
  user-select: none;
}

outlined-textarea:not([helper-text]) #helperText.outlined-textarea {
  display: none;
}

outlined-textarea[error] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
  color: #3d4043;
}

outlined-textarea textarea.outlined-textarea::placeholder {
  font-size: 14px;
  font-weight: 400;
}

outlined-textarea:not([error]):not([disabled]) textarea.outlined-textarea::placeholder {
  color: #6a6c71;
}

outlined-textarea[error] textarea.outlined-textarea::placeholder {
  color: #c84132;
}

outlined-textarea[error] #helperText.outlined-textarea {
  color: #cd5648;
}

outlined-textarea[error] textarea.outlined-textarea:focus {
  border-color: #c84031;
  border-width: 2px;
  outline: none !important;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover {
  border-color: #97231b;
}

outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover::placeholder,outlined-textarea[error]:not([disabled]) textarea.outlined-textarea:hover + #helperText.outlined-textarea {
  color: #a94945;
}

outlined-textarea[disabled] textarea.outlined-textarea {
  border-color: #e9e9e9;
  color: #b5b6b8;
}

outlined-textarea[disabled] #helperText.outlined-textarea {
  color: #c4c6c7;
}

outlined-textarea[error][disabled] {
  opacity: 50%;
}

outlined-textarea[error][disabled] textarea.outlined-textarea {
  border-color: #cb4b3d;
  caret-color: #ca493a;
}

outlined-textarea[error][disabled] #helperText.outlined-textarea,outlined-textarea[error][disabled] textarea.outlined-textarea {
  color: #a94945;
}

outlined-textarea[error][disabled] textarea.outlined-textarea::placeholder {
  color: #c84132;
}</style><!-- Shady DOM styles for chemistry-search-term-wizard --><style scope="chemistry-search-term-wizard">chemistry-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

chemistry-search-term-wizard .suggestions.chemistry-search-term-wizard {
  margin-top: 4px;
}

chemistry-search-term-wizard > span.chemistry-search-term-wizard svg.chemistry-search-term-wizard {
  margin-right: 24px;
}

chemistry-search-term-wizard path.chemistry-search-term-wizard {
  fill: #5f6368;
}

chemistry-search-term-wizard .help.chemistry-search-term-wizard {
  margin-left: 12px;
  margin-right: 0;
  cursor: pointer;
}

chemistry-search-term-wizard outlined-text-field.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard mat-button.chemistry-search-term-wizard {
  margin-left: 48px;
}

chemistry-search-term-wizard filter-chip.chemistry-search-term-wizard {
  margin-right: 4px;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard {
  flex-grow: 1;
}

chemistry-search-term-wizard outlined-text-field[batchMode].chemistry-search-term-wizard {
  display: none;
}

chemistry-search-term-wizard outlined-textarea.chemistry-search-term-wizard:not([batchMode]) {
  display: none;
}</style><!-- Shady DOM styles for text-search-term-wizard --><style scope="text-search-term-wizard">text-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
}

text-search-term-wizard > span.text-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

text-search-term-wizard > span.text-search-term-wizard svg.text-search-term-wizard {
  margin-right: 24px;
}

text-search-term-wizard path.text-search-term-wizard {
  fill: #5f6368;
}

text-search-term-wizard outlined-text-field.text-search-term-wizard {
  flex-grow: 1;
}

text-search-term-wizard mat-button.text-search-term-wizard {
  margin-left: 48px;
}

text-search-term-wizard filter-chip.text-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for classification-wizard --><style scope="classification-wizard">classification-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

classification-wizard > span.classification-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

classification-wizard .suggestions.classification-wizard {
  margin-top: 4px;
}

classification-wizard > span.classification-wizard svg.classification-wizard {
  margin-right: 24px;
}

classification-wizard path.classification-wizard {
  fill: #5f6368;
}

classification-wizard outlined-text-field.classification-wizard {
  flex-grow: 1;
}

classification-wizard mat-button.classification-wizard {
  margin-left: 48px;
}

classification-wizard filter-chip.classification-wizard {
  margin-right: 4px;
}

classification-wizard .no-matches.classification-wizard {
  margin-left: 64px;
}

classification-wizard .table-container.classification-wizard {
  max-height: 300px;
  overflow: scroll;
  margin-top: 8px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar {
  -webkit-appearance: none;
  width: 10px;
}

classification-wizard .table-container.classification-wizard::-webkit-scrollbar-thumb {
  border-radius: 5px;
  background-color: #5f636880;
  -webkit-box-shadow: 0 0 1px rgba(255,255,255,.5);
}

classification-wizard table.classification-wizard {
  margin-left: 51px;
  max-width: 575px;
}

classification-wizard tr.classification-wizard {
  margin-top: 4px;
}

classification-wizard tr.classification-wizard suggestive-chip.classification-wizard {
  margin-right: 8px;
}

classification-wizard #spinner.classification-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}</style><!-- Shady DOM styles for suggestive-chip --><!-- Shady DOM styles for mat-checkbox --><!-- Shady DOM styles for measure-search-term-wizard --><style scope="measure-search-term-wizard">measure-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

measure-search-term-wizard > span.measure-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

measure-search-term-wizard .suggestions.measure-search-term-wizard {
  margin-top: 4px;
}

measure-search-term-wizard > span.measure-search-term-wizard svg.measure-search-term-wizard {
  margin-right: 24px;
}

measure-search-term-wizard path.measure-search-term-wizard {
  fill: #5f6368;
}

measure-search-term-wizard outlined-text-field.measure-search-term-wizard {
  flex-grow: 1;
}

measure-search-term-wizard mat-button.measure-search-term-wizard {
  margin-left: 48px;
}

measure-search-term-wizard filter-chip.measure-search-term-wizard {
  margin-right: 4px;
}</style><!-- Shady DOM styles for numerical-search-term-wizard --><style scope="numerical-search-term-wizard">numerical-search-term-wizard {
  display: flex;
  flex-direction: column;
  padding: 24px;
  padding-top: 0;
  max-width: 674px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
  flex-wrap: wrap;
  margin-top: 16px;
}

numerical-search-term-wizard .suggestions.numerical-search-term-wizard {
  margin-top: 4px;
}

numerical-search-term-wizard > span.numerical-search-term-wizard svg.numerical-search-term-wizard {
  margin-right: 24px;
}

numerical-search-term-wizard path.numerical-search-term-wizard {
  fill: #5f6368;
}

numerical-search-term-wizard outlined-text-field.numerical-search-term-wizard,numerical-search-term-wizard outlined-textarea.numerical-search-term-wizard {
  flex-grow: 1;
}

numerical-search-term-wizard mat-button.numerical-search-term-wizard {
  margin-left: 48px;
}

numerical-search-term-wizard filter-chip.numerical-search-term-wizard {
  margin-right: 4px;
}

numerical-search-term-wizard #spinner.numerical-search-term-wizard {
  justify-content: space-around;
  margin-left: 48px;
  transform: scale(0.5);
}

numerical-search-term-wizard #suggestions.numerical-search-term-wizard {
  margin-left: 58px;
  display: flex;
  flex-direction: column;
  align-items: flex-start;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard {
  display: flex;
  flex-direction: row;
  align-items: center;
}

numerical-search-term-wizard .suggestion.numerical-search-term-wizard mat-checkbox.numerical-search-term-wizard {
  margin-right: 8px;
}</style><!-- Shady DOM styles for text-button --><style scope="text-button">text-button {
  align-items: center;
  border-radius: 4px;
  cursor: pointer;
  font-family: "Google Sans", Roboto, Arial, sans-serif;
  font-size: 14px;
  font-weight: 500;
  height: 36px;
  letter-spacing: .25px;
  margin: 6px 0;
  padding: 0 8px;
  user-select: none;
  display: inline-flex;
  white-space: nowrap;
  line-height: 36px;
  text-decoration: none;
  text-transform: none;
  color: #5f6368;
}

text-button:hover {
  background-color: #f8f9fa;
}

text-button:active {
  background-color: #d5e2fa;
}

text-button[selected] {
  background-color: #e8f0fe;
  color: #1967d2;
}

text-button[selected]:active {
  background-color: #d2e3fc;
}</style><!-- Shady DOM styles for mat-spinner --><!-- Shady DOM styles for requery-tile --><style scope="requery-tile">requery-tile {
  display: flex;
  justify-content: space-between;
  align-items: center;
  box-sizing: border-box;
  min-height: 40px;
  padding: 8px 12px 8px 8px;
  gap: 8px;

  border-radius: 16px;
  background: #f7f8f9;
  color: #1f1f1f;
}

requery-tile:hover {
  background: #d7d8d9;
}

requery-tile > [slot="image"] {
  flex-shrink: 0;

  border-radius: 8px;

  background: #fff;
}

.label.requery-tile {
  flex-grow: 999;

  font: 16px/20px "Google Sans", Roboto, Arial, sans-serif;
  font-weight: 500;
}

.search-icon.requery-tile {
  flex-shrink: 0;

  width: 24px;
  height: 24px;
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/search/default/24px.svg');
}</style><!-- Shady DOM styles for s-more-inline --><style scope="s-more-inline">s-more-inline {
  display: block;
  margin-top: 24px;
  padding: 16px;
  padding-top: 0;
  position: relative;

  line-height: 18px;
  text-overflow: ellipsis;
  white-space: nowrap;
  cursor: pointer;
}

hr.s-more-inline {
  background-color: #dadce0;
  margin-top: 18px;
  position: absolute;
  border: 0;
  height: 1px;
  left: 0;
  width: 100%;
}

.button.s-more-inline {
  display: flex;
  align-items: center;
  justify-content: center;

  position: relative; 
  margin: 0 auto;

  font: 400 14px Roboto, arial, sans-serif;
  height: 36px;
  width: 300px;
  border-radius: 18px;
  background-color: #f1f3f4;
}

.button.s-more-inline:hover {
  background-color: #d8d7dc;
}

.button.s-more-inline > [slot] {
  padding-right: 8px;
}

.expand.s-more-inline {
  display: inline-block;
  width: 20px;
  height: 20px;
}

.expand.less.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_less/default/20px.svg');
}

.expand.more.s-more-inline {
  background-image: url('https://fonts.gstatic.com/s/i/short-term/release/googlesymbols/expand_more/default/20px.svg');
}</style><!-- Shady DOM styles for workspace-ui-search --><!-- Shady DOM styles for keyword-wizard --><style scope="keyword-wizard">keyword-wizard {
  display: inline-block;
}

iron-icon.keyword-wizard {
  height: 20px;
    width: 20px;
    color: #999;
    cursor: pointer;
}

iron-icon[active].keyword-wizard {
  color: #4285f4 !important;
}

iron-icon.keyword-wizard:hover {
  color: #ccc;
}

#wizardIcon.keyword-wizard {
  padding-left: 1px;
    height: 16px;
    width: 16px;
    margin: 4px 1px 1px 1px;
}

#wizard.keyword-wizard {
  padding: 0;
    left: 0;
    top: 37px;
    position: absolute;
    background-color: white;
    z-index: 2;
    overflow: hidden;
}

.wizard-header.keyword-wizard {
  display: block;
    width: 100%;
    color: #737373;
    text-transform: uppercase;
    font-size: 13px;
    margin: 16px 0 6px 12px;
}

.filter-chips.keyword-wizard {
  margin-left: 20px;
}

.chip.keyword-wizard {
  background-color: #ebebeb;
    color: #6a6a6a;
    display: inline-block;
    font-size: 13px;
    font-family: inherit;
    border-radius: 12px;
    padding: 6px 12px;
}

.chip.keyword-wizard:hover {
  cursor: pointer;
}

.chip[selected].keyword-wizard {
  background-color: #4285f4;
    color: white;
}

.input-label.keyword-wizard {
  display: inline-block;
    font-size: 13px;
    font-family: inherit;
}

.keyword-input.keyword-wizard {
  display: inline-block;
    border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    padding: 3px;
}

.keyword-input.keyword-wizard::placeholder {
  font-style: italic;
}

.keyword-input.keyword-wizard:hover,.keyword-input.keyword-wizard:focus {
  border-color: #4284f4;
    border-width: 1px;
    outline: none;
}

.cpc-field.keyword-wizard {
  display: inline-block;
    margin: 6px 0 0 24px;
}

#checkboxCPC.keyword-wizard:hover {
  cursor: pointer;
}

.checkbox-label.keyword-wizard {
  font-size: 13px;
    font-style: italic;
    color: #737373;
}

.chemistry-field.keyword-wizard {
  display: block;
}

#inputChem.input-batch.keyword-wizard {
  height: 150px;
    border: 1px solid #dfe1e5;
    padding: 6px;
}

#inputChem.keyword-wizard {
  resize: none;
    height: 15px;
    vertical-align: text-top;
    font-size: 13px;
    font-family: inherit;
    padding: 2px;
}

.chem-type-label.keyword-wizard {
  display: inline;
    font-size: 13px;
    margin-left: 12px;
    margin-right: 4px;
}

#chemType.keyword-wizard {
  border-top: 0;
    border-left: 0;
    border-right: 0;
    border-bottom: 1px solid #dfe1e5;
    margin: 6px;
    padding: 2px;
    outline: none;
    font-family: inherit;
    font-size: 13px;
}

.import.keyword-wizard {
  font-size: 13px;
    font-family: inherit;
}

.import-text.keyword-wizard {
  vertical-align: middle;
    display: inline-block;
}

.import-button.keyword-wizard {
  margin: 6px 0 0 24px;
}

.import-button.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.import-button.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard {
  float: right;
    padding: 12px;
}

.wizard-buttons.keyword-wizard button.keyword-wizard {
  border: 0;
    border-radius: 4px;
    padding: 6px 12px;
    margin: 2px;
    font-family: inherit;
    background-color: #4284f4;
    color: white;
}

.wizard-buttons.keyword-wizard button.keyword-wizard:hover {
  cursor: pointer;
}

@media screen and (max-width: 700px) {
#wizard.keyword-wizard {
  width: 275px;
}

.chip.keyword-wizard {
  margin: 4px 2px;
}

.keyword-input.keyword-wizard {
  width: 82%;
      margin: 4px 12px 12px 24px;
}

.search-within.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 225px;
      margin: 12px 0 6px 0;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  display: none;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  margin-top: 6px;
}

#inputChem.keyword-wizard {
  width: 82%;
      padding: 2px;
      margin: 8px 12px 12px 24px;
}

#inputChem.input-batch.keyword-wizard {
  width: 220px;
      padding: 4px;
}

#chemType.keyword-wizard {
  width: 150px;
}

.import-text.keyword-wizard {
  margin: 6px 12px 6px 24px;
      width: 220px;
}

iron-icon.help-header.keyword-wizard {
  display: none;
}

}

@media screen and (min-width: 700px) {
#wizard.keyword-wizard {
  width: 540px;
}

.chip.keyword-wizard {
  margin: 0 2px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard {
  width: 240px;
      margin: 12px 16px 6px 6px;
}

.cpc-inputs.keyword-wizard {
  display: inline;
}

.find-patents.keyword-wizard .keyword-input.keyword-wizard {
  width: 53%;
      margin: 4px 10px;
}

.cpc-field.keyword-wizard .keyword-input.keyword-wizard::placeholder,#inputAnd.keyword-wizard::placeholder,#inputExact.keyword-wizard::placeholder,#inputOr.keyword-wizard::placeholder,#inputMinus.keyword-wizard::placeholder {
  color: white;
}

.find-patents.keyword-wizard .input-label.keyword-wizard {
  width: 35%;
      margin-left: 24px;
}

.search-by.keyword-wizard .keyword-input.keyword-wizard {
  width: 42%;
      margin: 6px 4px;
}

.search-by.keyword-wizard .input-label.keyword-wizard {
  width: 55px;
      margin-left: 24px;
}

#inputChem.keyword-wizard {
  width: 290px;
      margin: 2px 12px 2px 6px;
}

#inputChem.input-batch.keyword-wizard {
  width: 280px;
      padding: 6px;
}

.import-text.keyword-wizard {
  margin: 6px 12px;
      width: 415px;
}

#chemType.keyword-wizard {
  width: 105px;
}

iron-icon.keyword-wizard:hover.help-header {
  cursor: default;
}

iron-icon.help-header.keyword-wizard {
  height: 16px;
      padding: 0 2px 2px 2px;
      color: #a3a3a3;
}

.help.keyword-wizard p.keyword-wizard {
  margin: 0 0 8px 0
}

.help.keyword-wizard .q.keyword-wizard {
  font-family: monospace;
      color: #0b8043;
      white-space: nowrap;
}

.help.keyword-wizard {
  z-index: 4;
      position: absolute;
      right: 10px;
      padding: 12px;
      border-radius: 2px;
      border: 1px solid #e0e0e0;
      box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.2), 0 6px 10px 0 rgba(0, 0, 0, 0.3);
      background: white;
      font-size: 13px;
      line-height: 20px;
      width: 450px;
      max-height: 400px;
      overflow: auto;
}

#withinHelp.keyword-wizard {
  top: 75px;
}

#chemHelp.keyword-wizard {
  top: 0;
}

#searchBooleanHelp.keyword-wizard {
  top: 140px;
}

}</style><!-- Shady DOM styles for bottom-bar --><style scope="bottom-bar">.fixed.bottom-bar {
  display: block;
  position: fixed;
  height: 46px;
  bottom: 0;
}

.fixed[medium].bottom-bar {
  height: 280px;
}

.fixed[large].bottom-bar {
  height: 480px;
}

.shadow.bottom-bar {
  background: white;
  padding: 16px;
  border-radius: 8px 8px 0px 0px;
  box-shadow: 0px 8px 10px 1px rgba(0,0,0,.14), 0px 3px 14px 2px rgba(0,0,0,.12), 0px 5px 5px -3px rgba(0,0,0,.2);
}

.oneline.bottom-bar {
  white-space: nowrap;
  overflow: hidden;
  text-overflow: ellipsis;
  cursor: pointer;
}

.button.bottom-bar {
  cursor: pointer;
}

.buttonAlign.bottom-bar {
  margin-top: -4px;
}

.header.bottom-bar {
  height: 30px;
  font-family: 'Google Sans';
  font-size: 18px;
  padding-bottom: 8px;
}

.list.bottom-bar {
  overflow-y: auto;
  line-height: 20px;
}

.definition.bottom-bar {
  padding: 0px 0px 4px 0px;
  cursor: pointer;
}

[medium].bottom-bar .content.bottom-bar {
  height: 230px;
}

[large].bottom-bar .content.bottom-bar {
  height: 430px;
}

[medium].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 200px;
}

[large].bottom-bar .content.bottom-bar .list.bottom-bar {
  height: 400px;
}

[hidden].bottom-bar {
  display: none;
}

.label.bottom-bar {
  font-family: 'Google Sans';
  font-size: 12px;
  line-height: 16px;
  font-weight: 400;
  padding: 6px 0px 4px 0px;
  color: #1f1f1f;
}

[pad].bottom-bar {
  margin-left: 16px;
}

.layout.vertical.bottom-bar {
  display: flex;
  flex-direction: column;
}

.layout.horizontal.bottom-bar {
  display: flex;
  flex-direction: row;
}

.flex.bottom-bar {
  flex: 1;
  flex-basis: 0.000000001px;
}

.layout.start.bottom-bar {
  align-items: flex-start;
}

.layout.center.bottom-bar {
  align-items: center;
}

.layout.end.bottom-bar {
  align-items: flex-end;
}

.flex-2.bottom-bar {
  flex: 2;
}

.flex-3.bottom-bar {
  flex: 3;
}

.flex-4.bottom-bar {
  flex: 4;
}

.flex-5.bottom-bar {
  flex: 5;
}

.flex-6.bottom-bar {
  flex: 6;
}

.flex-7.bottom-bar {
  flex: 7;
}

.flex-8.bottom-bar {
  flex: 8;
}

.flex-9.bottom-bar {
  flex: 9;
}

.flex-10.bottom-bar {
  flex: 10;
}

.flex-11.bottom-bar {
  flex: 11;
}

.flex-12.bottom-bar {
  flex: 12;
}</style><!-- Shady DOM styles for landscape-link --><!-- Shady DOM styles for landscape-summary-box --><!-- Shady DOM styles for search-state --><!-- Shady DOM styles for iron-overlay-backdrop --><!-- Shady DOM styles for opaque-animation --><!-- Shady DOM styles for iron-dropdown --><!-- Shady DOM styles for iron-meta --><!-- Shady DOM styles for iron-icon --><style scope="iron-icon-0">.iron-icon-0 {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;-ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;-ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
        position: relative;

        vertical-align: middle;

        fill: currentcolor;
        stroke: none;

        width: 24px;
        height: 24px;;
}

.iron-icon-0[hidden] {
  display: none;
}</style><!-- Shady DOM styles for iron-iconset-svg --><!-- Shady DOM styles for iron-list --><!-- Shady DOM styles for paper-icon-item --><!-- Shady DOM styles for paper-item-body --><!-- Shady DOM styles for paper-item --><!-- Shady DOM styles for dropdown-menu --><!-- Shady DOM styles for chips-input --><!-- Shady DOM styles for input-chip --><!-- Shady DOM styles for keyword-editor --><!-- Shady DOM styles for paper-ripple --><!-- Shady DOM styles for paper-button --><!-- Shady DOM styles for date-editor --><!-- Shady DOM styles for metadata-editor --><!-- Shady DOM styles for restrict-editor --><!-- Shady DOM styles for overlay-tooltip --><style scope="overlay-tooltip">overlay-tooltip {
  display: none;
        color: #fff;
        background-color: #000;
        padding: 10px 12px;
        border-radius: 3px;
        font-size: 13px;
        font-weight: normal;
        line-height: normal;
        position: fixed;
        z-index: 100;
}

#arrow.overlay-tooltip {
  width: 0;
        height: 0;
        border-style: solid;
        border-width: 0 6px 8px 6px;
        border-color: transparent transparent #000 transparent;
        position: absolute;
        top: -8px;
        left: calc(50% - 6px);
}</style><!-- Shady DOM styles for query-renderer --><!-- Shady DOM styles for result-nav --><style scope="result-nav">result-nav {
  display: block;
        white-space: nowrap;
        padding: 0 30px;
        line-height: 30px;
        height: 30px;
        margin-top: 17px;
        font-weight: 500;
        font-size: 15px;
}

state-modifier.result-nav {
  color: #333;
}

state-modifier[disabled].result-nav {
  pointer-events: none;
        color: #ccc;
}</style><!-- Shady DOM styles for raw-html --><!-- Shady DOM styles for paper-material --><style scope="paper-material-0">.paper-material-0 {
  display: block;
        position: relative;
}

.paper-material-0[elevation="1"] {
  box-shadow: 0 2px 2px 0 rgba(0, 0, 0, 0.14),
                    0 1px 5px 0 rgba(0, 0, 0, 0.12),
                    0 3px 1px -2px rgba(0, 0, 0, 0.2);
}

.paper-material-0[elevation="2"] {
  box-shadow: 0 4px 5px 0 rgba(0, 0, 0, 0.14),
                    0 1px 10px 0 rgba(0, 0, 0, 0.12),
                    0 2px 4px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="3"] {
  box-shadow: 0 6px 10px 0 rgba(0, 0, 0, 0.14),
                    0 1px 18px 0 rgba(0, 0, 0, 0.12),
                    0 3px 5px -1px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="4"] {
  box-shadow: 0 8px 10px 1px rgba(0, 0, 0, 0.14),
                    0 3px 14px 2px rgba(0, 0, 0, 0.12),
                    0 5px 5px -3px rgba(0, 0, 0, 0.4);
}

.paper-material-0[elevation="5"] {
  box-shadow: 0 16px 24px 2px rgba(0, 0, 0, 0.14),
                    0  6px 30px 5px rgba(0, 0, 0, 0.12),
                    0  8px 10px -5px rgba(0, 0, 0, 0.4);
}

.paper-material-0[animated] {
  transition: box-shadow 0.28s cubic-bezier(0.4, 0, 0.2, 1);
}

.paper-material-0 {
  ;
}</style><!-- Shady DOM styles for search-box --><style scope="search-box">.layout.horizontal.search-box,.layout.vertical.search-box {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-box {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-box {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-box {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-box {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-box {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-box,.layout.center-center.search-box {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-box,.layout.center-center.search-box {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-box {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-box {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-box {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.inputbox.search-box {
  border: 1px solid #ccc;
        padding: 0 12px;
        background: white;
}

.inputbox[focused].search-box {
  border: 1px solid #4285f4 !important;
}

.inputbox.search-box:hover {
  border: 1px solid #999;
}

#searchInput.search-box {
  font-family: inherit;
        font-size: 16px;
        padding: 8px 0;
        outline: none;
        border-right: none;
        width: 100%;
        margin-right: 0;
        border: 0;
}

#searchButton.search-box {
  cursor: pointer;
        background-color: #4285f4;
        border: none;
        color: #fff;
        vertical-align: top;
        width: 70px;
        height: 37px;
        outline: none;
}

.suggest-bg.search-box {
  display: inline-block;
        min-width: 0;
        white-space: nowrap;
}

#suggestMenu.search-box {
  position: absolute;
        margin-top: 38px;
        width: 100%;
        background: white;
        z-index: 1;
}

#suggestMenu.search-box .row.search-box {
  font-size: 13px;
        line-height: 28px;
        white-space: nowrap;
        overflow: hidden;
        text-overflow: ellipsis;
        padding: 4px 2px;
        cursor: pointer;
}

.row[selected].search-box {
  background: rgba(0, 0, 0, 0.05);
}

.suggest-icon.search-box {
  height: 20px;
        width: 20px;
        padding: 0 12px 0 6px;
        transition: transform .15s linear;
        transform: scale(1);
}

.suggest-icon[hide].search-box {
  transform: scale(0);
}

#corpora.search-box {
  padding: 6px 0;
        user-select: none;
}

#corpora.search-box iron-icon.search-box {
  height: 20px;
        width: 20px;
        color: #ccc;
        cursor: pointer;
}

#corpora.search-box iron-icon[active].search-box {
  color: #4285f4 !important;
}

#corpora.search-box iron-icon.search-box:hover {
  color: #999;
}</style><!-- Shady DOM styles for iron-media-query --><!-- Shady DOM styles for paper-header-panel --><!-- Shady DOM styles for iron-a11y-announcer --><style scope="iron-a11y-announcer">iron-a11y-announcer {
  display: inline-block;
        position: fixed;
        clip: rect(0px,0px,0px,0px);
}</style><!-- Shady DOM styles for iron-autogrow-textarea --><!-- Shady DOM styles for iron-input --><!-- Shady DOM styles for paper-input-char-counter --><!-- Shady DOM styles for paper-input-container --><!-- Shady DOM styles for paper-input-error --><!-- Shady DOM styles for paper-input --><!-- Shady DOM styles for paper-textarea --><!-- Shady DOM styles for paper-toast --><style scope="paper-toast-0">.paper-toast-0 {
  display: block;
        position: fixed;
        background-color: #323232;
        color: #f1f1f1;
        min-height: 48px;
        min-width: 288px;
        padding: 16px 24px;
        box-sizing: border-box;
        box-shadow: 0 2px 5px 0 rgba(0, 0, 0, 0.26);
        border-radius: 2px;
        margin: 12px;
        font-size: 14px;
        cursor: default;
        -webkit-transition: -webkit-transform 0.3s, opacity 0.3s;
        transition: transform 0.3s, opacity 0.3s;
        opacity: 0;
        -webkit-transform: translateY(100px);
        transform: translateY(100px);font-family: 'Roboto', 'Noto', sans-serif;
        -webkit-font-smoothing: antialiased;
}

.paper-toast-0.capsule {
  border-radius: 24px;
}

.paper-toast-0.fit-bottom {
  width: 100%;
        min-width: 0;
        border-radius: 0;
        margin: 0;
}

.paper-toast-0.paper-toast-open {
  opacity: 1;
        -webkit-transform: translateY(0px);
        transform: translateY(0px);
}</style><!-- Shady DOM styles for paper-toolbar --><!-- Shady DOM styles for search-footer --><style scope="search-footer">#footer.search-footer {
  font-size: 13px;
        margin-top: 10px;
        background: #fafafa;
        padding: 20px 10px;
        align-items: center;
        border-top: 1px solid #ebebeb;
}

#footer.search-footer .links.search-footer > *.search-footer {
  display: inline-block;
        margin: 0 12px;
}

.layout.horizontal.search-footer,.layout.vertical.search-footer {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-footer {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-footer {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-footer {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-footer {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-footer {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-footer {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-footer {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-footer {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-footer {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-footer,.layout.center-center.search-footer {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-footer {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-footer {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-footer {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-footer,.layout.center-center.search-footer {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-footer {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-footer {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-footer {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-footer {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-footer {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-footer {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-footer {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-footer {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-footer {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-footer {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-footer {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-footer {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-footer {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-header --><style scope="search-header">search-header {
  display: block;
}

.lockup-logo.search-header,.lockup-text.search-header {
  display: inline-block;
}

.lockup-logo.search-header {
  width: 74px;
        height: 24px;
        background-image: url('https://www.gstatic.com/images/branding/googlelogo/1x/googlelogo_color_74x24dp.png');
        background-size: 74px 24px;
}

.lockup-text.search-header {
  font-family: "Product Sans", Arial, Helvetica, sans-serif;

        
        font-size: 22.1px;

        
        text-rendering: optimizeLegibility;

        
        position: relative;
        top: -6px;
        left: -5px;

        
        -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
}

.lockup-brand.search-header {
  opacity: 0.54;
}

@media (-webkit-min-device-pixel-ratio: 1.5), (min-resolution: 144dpi) {
.lockup-logo.search-header {
  background-image: url('https://www.gstatic.com/images/branding/googlelogo/2x/googlelogo_color_74x24dp.png');
}

.lockup-text.search-header {
  font-size: 21.3px;
          left: -7px;
}

}

header.search-header {
  background-color: #fafafa;
        border-bottom: 1px solid #ebebeb;
        color: #333;
        height: 60px;
        width: 100%;
        z-index: 1;
        display: block;
}

[latestStyle].search-header header.search-header {
  background-color: transparent;
}

.headerpad.search-header {
  margin-left: 16px;
}

[wide].search-header .headerpad.search-header {
  margin-left: 32px;
}

.leftheader.search-header {
  width: 322px;
}

header.search-header h1.search-header {
  display: none;
}

header.search-header h1.search-header state-modifier.search-header {
  color: #777;
        text-decoration: none;
        display: inline-block;
}

[wide].search-header header.search-header h1.search-header {
  box-sizing: border-box;
        margin: 0;
        padding: 20px 0 10px;
        font-size: 20px;
        font-weight: 400;
        white-space: nowrap;
        display: block;
}

search-box.search-header {
  height: 37px;
        padding: 0 16px;
        width: 900px;
        align-self: center;
}

.layout.horizontal.search-header,.layout.vertical.search-header {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-header {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-header {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-header {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-header {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-header {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-header {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-header {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-header {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-header {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-header,.layout.center-center.search-header {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-header {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-header {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-header {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-header,.layout.center-center.search-header {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-header {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-header {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-header {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-header {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-header {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-header {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-header {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-header {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-header {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-header {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-header {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-header {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-header {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}</style><!-- Shady DOM styles for search-ui --><style scope="search-ui-0">.search-ui-0 paper-button.search-ui {
  display: inline-block;
        text-align: center;
        font-family: inherit;
}

.search-ui-0 .layout.horizontal.search-ui,.search-ui-0 .layout.vertical.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.search-ui-0 .layout.inline.search-ui {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.search-ui-0 .layout.horizontal.search-ui {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.search-ui-0 .layout.vertical.search-ui {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.search-ui-0 .layout.wrap.search-ui {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.search-ui-0 .layout.no-wrap.search-ui {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .flex.search-ui {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.search-ui-0 .flex-auto.search-ui {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.search-ui-0 .flex-none.search-ui {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.search-ui-0 .layout.start.search-ui {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.search-ui-0 .layout.center.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.search-ui-0 .layout.end.search-ui {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.search-ui-0 .layout.baseline.search-ui {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.search-ui-0 .layout.start-justified.search-ui {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.search-ui-0 .layout.center-justified.search-ui,.search-ui-0 .layout.center-center.search-ui {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.search-ui-0 .layout.end-justified.search-ui {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.search-ui-0 .layout.around-justified.search-ui {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.search-ui-0 .layout.justified.search-ui {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.search-ui-0 .self-start.search-ui {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.search-ui-0 .self-center.search-ui {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.search-ui-0 .self-end.search-ui {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.search-ui-0 .self-stretch.search-ui {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.search-ui-0 .self-baseline.search-ui {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.search-ui-0 .layout.start-aligned.search-ui {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.search-ui-0 .layout.end-aligned.search-ui {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.search-ui-0 .layout.center-aligned.search-ui {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.search-ui-0 .layout.between-aligned.search-ui {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.search-ui-0 .layout.around-aligned.search-ui {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.search-ui-0 {
  display: block;
        min-width: 350px;
        height: 100%;
}

.search-ui-0 #content.search-ui {
  height: 100%;
}

.search-ui-0 #leftBarOverflow.search-ui {
  padding-right: 16px;
}

.search-ui-0 [wide].search-ui #leftBarOverflow.search-ui {
  overflow: auto;
}

.search-ui-0 #leftBar.search-ui {
  box-sizing: border-box;
        color: #666;
        font-size: 13px;
        padding: 16px 0 16px 16px;
        border-bottom: 1px solid #e5e5e5;
}

.search-ui-0 [wide].search-ui #leftBar.search-ui {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;

        -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
        position: relative;
        width: 350px;
        margin-bottom: 0;
        padding-bottom: 0;
        border-bottom: none;
}

@media print {
.search-ui-0 #leftBar.search-ui {
  display: none !important;
}

}

.search-ui-0 #leftBar.search-ui h3.search-ui {
  text-transform: uppercase;
        font-size: 13px;
        font-weight: normal;
        margin-top: 6px;
        margin-bottom: 6px;
        cursor: default;
        display: inline-block;
        color: #a3a3a3;
}

.search-ui-0 #closeButton.search-ui {
  position: absolute;
        right: 0;
}

.search-ui-0 #searchTermsHeader.search-ui {
  position: relative;
}

.search-ui-0 #searchTermsQ.search-ui iron-icon.search-ui {
  height: 16px;
        padding: 0 2px 2px 2px;
        color: #a3a3a3;
}

.search-ui-0 #searchTermsHeader.search-ui:hover iron-icon.search-ui {
  color: #4285f4;
}

.search-ui-0 #closeLeftBar.search-ui {
  height: 16px;
        width: 16px;
        padding: 0 0 8px 0;
        cursor: pointer;
}

.search-ui-0 #compactQuery.search-ui iron-icon.search-ui {
  height: 20px;
}

.search-ui-0 #backToResultsButton.search-ui {
  color: #fff;
        background: #4285f4;
        margin-top: 20px;
        text-align: center;
}

.search-ui-0 #main.search-ui {
  display: block;
        min-height: calc(100vh - 127px);
}

@media print {
.search-ui-0 [wide].search-ui main.search-ui {
  margin-left: 0;
}

}</style><!-- Shady DOM styles for import-list --><!-- Shady DOM styles for iron-request --><!-- Shady DOM styles for iron-ajax --><!-- Shady DOM styles for paper-dialog --><!-- Shady DOM styles for coverage-stats --><!-- Shady DOM styles for iron-image --><!-- Shady DOM styles for iron-selector --><!-- Shady DOM styles for paper-card --><!-- Shady DOM styles for paper-checkbox --><!-- Shady DOM styles for landing-page --><!-- Shady DOM styles for remote-fetch --><!-- Shady DOM styles for paper-spinner --><style scope="paper-spinner-0">.paper-spinner-0 {
  display: inline-block;
        position: relative;
        width: 28px;
        height: 28px;
}

.paper-spinner-0 #spinnerContainer.paper-spinner {
  width: 100%;
        height: 100%;

        
        direction: ltr;
}

.paper-spinner-0 #spinnerContainer.active.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite;
        animation: container-rotate-paper-spinner-0 1568ms linear infinite;
}

@-webkit-keyframes container-rotate-paper-spinner-0 {
to {
  -webkit-transform: rotate(360deg)
}

}

@keyframes container-rotate-paper-spinner-0 {
to {
  transform: rotate(360deg)
}

}

.paper-spinner-0 .spinner-layer.paper-spinner {
  position: absolute;
        width: 100%;
        height: 100%;
        opacity: 0;
        white-space: nowrap;
        color: #4285f4;
}

.paper-spinner-0 .layer-1.paper-spinner {
  color: #4285f4;
}

.paper-spinner-0 .layer-2.paper-spinner {
  color: #db4437;
}

.paper-spinner-0 .layer-3.paper-spinner {
  color: #f4b400;
}

.paper-spinner-0 .layer-4.paper-spinner {
  color: #0f9d58;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0;
        -webkit-animation-duration: 5332ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-name: fill-unfill-rotate-paper-spinner-0;
        animation-duration: 5332ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
        opacity: 1;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-1.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-1-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-2.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-2-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-3.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-3-fade-in-out-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .spinner-layer.layer-4.paper-spinner {
  -webkit-animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
        animation-name: fill-unfill-rotate-paper-spinner-0, layer-4-fade-in-out-paper-spinner-0;
}

@-webkit-keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  -webkit-transform: rotate(135deg)
}

25% {
  -webkit-transform: rotate(270deg)
}

37.5% {
  -webkit-transform: rotate(405deg)
}

50% {
  -webkit-transform: rotate(540deg)
}

62.5% {
  -webkit-transform: rotate(675deg)
}

75% {
  -webkit-transform: rotate(810deg)
}

87.5% {
  -webkit-transform: rotate(945deg)
}

to {
  -webkit-transform: rotate(1080deg)
}

}

@keyframes fill-unfill-rotate-paper-spinner-0 {
12.5% {
  transform: rotate(135deg)
}

25% {
  transform: rotate(270deg)
}

37.5% {
  transform: rotate(405deg)
}

50% {
  transform: rotate(540deg)
}

62.5% {
  transform: rotate(675deg)
}

75% {
  transform: rotate(810deg)
}

87.5% {
  transform: rotate(945deg)
}

to {
  transform: rotate(1080deg)
}

}

@-webkit-keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@keyframes layer-1-fade-in-out-paper-spinner-0 {
0% {
  opacity: 1
}

25% {
  opacity: 1
}

26% {
  opacity: 0
}

89% {
  opacity: 0
}

90% {
  opacity: 1
}

to {
  opacity: 1
}

}

@-webkit-keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-2-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

15% {
  opacity: 0
}

25% {
  opacity: 1
}

50% {
  opacity: 1
}

51% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@keyframes layer-3-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

40% {
  opacity: 0
}

50% {
  opacity: 1
}

75% {
  opacity: 1
}

76% {
  opacity: 0
}

to {
  opacity: 0
}

}

@-webkit-keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes layer-4-fade-in-out-paper-spinner-0 {
0% {
  opacity: 0
}

65% {
  opacity: 0
}

75% {
  opacity: 1
}

90% {
  opacity: 1
}

to {
  opacity: 0
}

}

.paper-spinner-0 .circle-clipper.paper-spinner {
  display: inline-block;
        position: relative;
        width: 50%;
        height: 100%;
        overflow: hidden;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after {
  left: 45%;
        width: 10%;
        border-top-style: solid;
}

.paper-spinner-0 .spinner-layer.paper-spinner::after,.paper-spinner-0 .circle-clipper.paper-spinner::after {
  content: '';
        box-sizing: border-box;
        position: absolute;
        top: 0;
        border-width: 3px;
        border-radius: 50%;
}

.paper-spinner-0 .circle-clipper.paper-spinner::after {
  bottom: 0;
        width: 200%;
        border-style: solid;
        border-bottom-color: transparent !important;
}

.paper-spinner-0 .circle-clipper.left.paper-spinner::after {
  left: 0;
        border-right-color: transparent !important;
        -webkit-transform: rotate(129deg);
        transform: rotate(129deg);
}

.paper-spinner-0 .circle-clipper.right.paper-spinner::after {
  left: -100%;
        border-left-color: transparent !important;
        -webkit-transform: rotate(-129deg);
        transform: rotate(-129deg);
}

.paper-spinner-0 .active.paper-spinner .gap-patch.paper-spinner::after,.paper-spinner-0 .active.paper-spinner .circle-clipper.paper-spinner::after {
  -webkit-animation-duration: 1333ms;
        -webkit-animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        -webkit-animation-iteration-count: infinite;
        animation-duration: 1333ms;
        animation-timing-function: cubic-bezier(0.4, 0.0, 0.2, 1);
        animation-iteration-count: infinite;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.left.paper-spinner::after {
  -webkit-animation-name: left-spin-paper-spinner-0;
        animation-name: left-spin-paper-spinner-0;
}

.paper-spinner-0 .active.paper-spinner .circle-clipper.right.paper-spinner::after {
  -webkit-animation-name: right-spin-paper-spinner-0;
        animation-name: right-spin-paper-spinner-0;
}

@-webkit-keyframes left-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(130deg)
}

50% {
  -webkit-transform: rotate(-5deg)
}

to {
  -webkit-transform: rotate(130deg)
}

}

@keyframes left-spin-paper-spinner-0 {
0% {
  transform: rotate(130deg)
}

50% {
  transform: rotate(-5deg)
}

to {
  transform: rotate(130deg)
}

}

@-webkit-keyframes right-spin-paper-spinner-0 {
0% {
  -webkit-transform: rotate(-130deg)
}

50% {
  -webkit-transform: rotate(5deg)
}

to {
  -webkit-transform: rotate(-130deg)
}

}

@keyframes right-spin-paper-spinner-0 {
0% {
  transform: rotate(-130deg)
}

50% {
  transform: rotate(5deg)
}

to {
  transform: rotate(-130deg)
}

}

.paper-spinner-0 #spinnerContainer.cooldown.paper-spinner {
  -webkit-animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
        animation: container-rotate-paper-spinner-0 1568ms linear infinite, fade-out-paper-spinner-0 400ms cubic-bezier(0.4, 0.0, 0.2, 1);
}

@-webkit-keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}

@keyframes fade-out-paper-spinner-0 {
0% {
  opacity: 1
}

to {
  opacity: 0
}

}</style><!-- Shady DOM styles for paper-spinner-lite --><!-- Shady DOM styles for concept-card --><!-- Shady DOM styles for concept-mention --><style scope="concept-mention">.block.concept-mention {
  display: block;
}

[hidden].concept-mention {
  display: none !important;
}

.invisible.concept-mention {
  visibility: hidden !important;
}

.relative.concept-mention {
  position: relative;
}

.fit.concept-mention {
  position: absolute;
        top: 0;
        right: 0;
        bottom: 0;
        left: 0;
}

body.fullbleed.concept-mention {
  margin: 0;
        height: 100vh;
}

.scroll.concept-mention {
  -webkit-overflow-scrolling: touch;
        overflow: auto;
}

.fixed-bottom.concept-mention,.fixed-left.concept-mention,.fixed-right.concept-mention,.fixed-top.concept-mention {
  position: fixed;
}

.fixed-top.concept-mention {
  top: 0;
        left: 0;
        right: 0;
}

.fixed-right.concept-mention {
  top: 0;
        right: 0;
        bottom: 0;
}

.fixed-bottom.concept-mention {
  right: 0;
        bottom: 0;
        left: 0;
}

.fixed-left.concept-mention {
  top: 0;
        bottom: 0;
        left: 0;
}

#target.concept-mention:hover {
  background-color: #e8f0fe;
}

#target[noicon].concept-mention {
  padding: 1px;
}

#target.concept-mention:hover[noicon] {
  border: 1px solid #e8f0fe;
        padding: 0;
}

#target.concept-mention {
  display: inline-block;
}

.inline-icon.concept-mention {
  cursor: pointer;
        height: 12px;
        width: 12px;
        padding-left: 4px;
        color: #5e6368;
}

concept-card.concept-mention {
  z-index: 1;
        position: absolute;
}</style><!-- Shady DOM styles for fterm-concept-card --><!-- Shady DOM styles for fterm-concept-mention --><!-- Shady DOM styles for paper-fab --><!-- Shady DOM styles for paper-icon-button --><!-- Shady DOM styles for paper-icon-button-light --><!-- Shady DOM styles for classification-tree --><style scope="classification-tree">.layout.horizontal.classification-tree,.layout.vertical.classification-tree {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.classification-tree {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.classification-tree {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.classification-tree {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.classification-tree {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.classification-tree {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.classification-tree,.layout.center-center.classification-tree {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.classification-tree {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.classification-tree {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.classification-tree {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

classification-tree {
  display: block;
        line-height: 20px;
}

.wrap.classification-tree {
  padding: 6px 12px;
}

.wrap.classification-tree:hover {
  background: #fafafa;
}

.description.classification-tree {
  padding-left: 4px;
}

iron-icon.classification-tree {
  color: #eaeaea;
}

.code[first].classification-tree {
  font-weight: 500;
}

.code[additional].classification-tree {
  font-style: italic;
}</style><!-- Shady DOM styles for classification-viewer --><style scope="classification-viewer">.table.classification-viewer {
  border: 1px solid #eaeaea;
        display: block;
}

.more.classification-viewer {
  padding: 6px 12px;
        cursor: pointer;
        font-style: italic;
        color: #aaa;
}

.more.classification-viewer:hover {
  background: #fafafa;
}

.chip.classification-viewer {
  display: inline-block;
        padding: 4px 6px;
        border-radius: 2px;
}

.chip[additional].classification-viewer {
  font-style: italic;
}</style><!-- Shady DOM styles for image-carousel --><!-- Shady DOM styles for image-viewer --><!-- Shady DOM styles for patent-result --><style scope="patent-result">#wrapper.patent-result {
  padding: 20px;
        max-width: 1050px;
        outline: 0;
}

.scroll-target.patent-result:before {
  display: block;
        content: '';
        visibility: hidden;
}

h1.patent-result {
  font-weight: 500;
        font-size: 20px;
        margin: 0 0 20px 0;
}

h3.patent-result {
  font-size: 15px;
        font-weight: 500;
        margin: 28px 0 18px 0;
}

dl.patent-result {
  line-height: 1.5;
        font-size: 0;
}

dt.patent-result,dd.patent-result {
  display: inline;
        font-size: 13px;
        margin: 0;
}

dt.patent-result {
  font-weight: 500;
        color: #000;
}

dt.patent-result::after {
  content: ': ';
}

dd.patent-result {
  color: #aaa;
}

dd.patent-result ~ dd.patent-result::before {
  content: ', ';
}

dt.patent-result + dd.patent-result::before {
  content: '';
}

dd.patent-result ~ dt.patent-result::before {
  display: block;
        content: '';
        margin-top: 8px;
}

dd.patent-result core-icon.patent-result {
  width: 14px;
        height: 14px;
        vertical-align: top;
        color: inherit;
}

.table.patent-result {
  display: table;
        border-collapse: collapse;
        border-spacing: 0;
        border: 1px solid #eaeaea;
        width: 100%;
        box-sizing: border-box;
}

.tr.patent-result {
  display: table-row;
        border-bottom: 1px solid #eaeaea;
}

.th.patent-result,.td.patent-result {
  display: table-cell;
        padding: 10px 12px;
}

.thead.patent-result {
  display: table-header-group;
}

.tbody.patent-result {
  display: table-row-group;
}

.th.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.td.patent-result {
  vertical-align: top;
}

.td.patent-result > p.patent-result {
  margin-top: 0;
}

.nowrap.patent-result {
  white-space: nowrap;
}

.knowledge-card.patent-result {
  border: 1px solid #e5e5e5;
        border-radius: 2px;
}

.knowledge-card.patent-result > header.patent-result {
  -webkit-font-smoothing: antialiased;
        -moz-osx-font-smoothing: grayscale;
        background: #4285f4;
        color: #fff;
        padding: 20px 12px;
}

.knowledge-card.patent-result > header.patent-result state-modifier.patent-result,.knowledge-card.patent-result > header.patent-result a.patent-result {
  color: inherit;
        margin: 0 12px 0 0;
        display: inline-block;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result,.knowledge-card.patent-result > header.patent-result .tagline.patent-result {
  margin: 0;
        font-weight: normal;
        padding-top: 4px;
}

.knowledge-card.patent-result > header.patent-result h2.patent-result {
  font-size: 20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result {
  background: #3367d6;
        padding: 10px 12px;
        margin: 20px -12px -20px;
}

.knowledge-card.patent-result .knowledge-card-action-bar.patent-result core-icon.patent-result {
  margin-right: 12px;
        width: 24px;
        height: 24px;
}

.knowledge-card.patent-result dl.patent-result {
  padding: 16px 12px;
}

.knowledge-card.patent-result hr.patent-result {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 0;
}

.main-link.patent-result {
  margin: 14px;
        font-weight: 500;
}

.footer.patent-result h3.patent-result state-modifier.patent-result,.footer.patent-result h3.patent-result a.patent-result {
  float: right;
        font-weight: 400;
        font-size: 13px;
        line-height: 24px;
}

.footer.patent-result dl.patent-result {
  margin-left: 30px;
}

.footer.patent-result > ul.patent-result > li.patent-result {
  margin-bottom: 8px;
}

h3.patent-result .righthead.patent-result {
  color: #aaa;
        font-weight: 400;
        font-size: 13px;
        cursor: help;
}

.tooltip-hint.patent-result {
  border-bottom: 1px dotted #ccc;
}

[marginRight].patent-result {
  margin-right: 60px;
}

.flex-width.patent-result {
  min-width: 0;
        word-break: break-word;
}

.responsive-table.patent-result {
  width: 100%;
        overflow-x: auto;
        overflow-y: hidden;
}

.layout.horizontal.patent-result,.layout.vertical.patent-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-result,.layout.center-center.patent-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-result,.layout.center-center.patent-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

.flex.patent-result,.flex-1.patent-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-2.patent-result {
  -ms-flex: 2;
        -webkit-flex: 2;
        flex: 2;
}

.flex-3.patent-result {
  -ms-flex: 3;
        -webkit-flex: 3;
        flex: 3;
}

.flex-4.patent-result {
  -ms-flex: 4;
        -webkit-flex: 4;
        flex: 4;
}

.flex-5.patent-result {
  -ms-flex: 5;
        -webkit-flex: 5;
        flex: 5;
}

.flex-6.patent-result {
  -ms-flex: 6;
        -webkit-flex: 6;
        flex: 6;
}

.flex-7.patent-result {
  -ms-flex: 7;
        -webkit-flex: 7;
        flex: 7;
}

.flex-8.patent-result {
  -ms-flex: 8;
        -webkit-flex: 8;
        flex: 8;
}

.flex-9.patent-result {
  -ms-flex: 9;
        -webkit-flex: 9;
        flex: 9;
}

.flex-10.patent-result {
  -ms-flex: 10;
        -webkit-flex: 10;
        flex: 10;
}

.flex-11.patent-result {
  -ms-flex: 11;
        -webkit-flex: 11;
        flex: 11;
}

.flex-12.patent-result {
  -ms-flex: 12;
        -webkit-flex: 12;
        flex: 12;
}

@media print {
#text.patent-result {
  flex-direction: column-reverse !important;
}

}

patent-result-ref-list.patent-result {
  width: 100%;
}

patent-result-ref-list.patent-result + patent-result-ref-list.patent-result {
  margin-left: 10px;
}

[narrow].patent-result {
  flex-direction: column-reverse !important;
}

.famheader.patent-result {
  text-align: left;
        white-space: nowrap;
        background-color: #fafafa;
        color: #757575;
}

.collapse.patent-result {
  color: #616161;
        font-size: 13px;
        cursor: pointer;
}

#imageDrag.patent-result {
  position: fixed;
        cursor: col-resize;
}

#imageDrag.patent-result div.patent-result {
  width: 4px;
        height: 100%;
        margin: 0 4px;
        background: #eee;
}

#imageDrag.patent-result:hover {
  background: #eee;
}

#imageDrag.patent-result:hover div.patent-result {
  background: #ccc;
}

.imageWrapper.patent-result {
  position: fixed;
        top: 60px;
        background: white;
        margin-left: 12px;
}

#notices.patent-result {
  padding: 20px;
}

#figures.patent-result {
  background: #efefef;
}

.headerButton.patent-result {
  color: #3c80f6;
        cursor: pointer;
        display: inline-block;
        padding: 0 14px;
        line-height: 27px;
}

.headerButton.patent-result iron-icon.patent-result {
  width: 16px;
        height: 16px;
}

.tr.conceptDomain.patent-result {
  display: table-row;
}

.responsive-grid.patent-result {
  display: grid;
        gap: 8px;
        grid-template-columns: none;
}</style><!-- Shady DOM styles for family-viewer --><!-- Shady DOM styles for app-row --><!-- Shady DOM styles for application-timeline --><style scope="application-timeline">.layout.horizontal.application-timeline,.layout.vertical.application-timeline {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.application-timeline {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.application-timeline {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.application-timeline {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.application-timeline {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.application-timeline {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.application-timeline,.layout.center-center.application-timeline {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.application-timeline {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.application-timeline {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.application-timeline {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.wrap.application-timeline {
  padding: 16px 12px;
}

.event.application-timeline {
  padding: 3px 0;
}

[date].application-timeline {
  color: #5f6368;
        font-size: 13px;
        padding: 3px 0;
        width: 70px;
        line-height: 16px;
}

[critical].application-timeline [date].application-timeline {
  color: #202124;
        font-weight: 500;
        line-height: 18px;
}

.line.application-timeline {
  margin: 9px 6px;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
}

.dot.application-timeline {
  margin: 3px 0;
        border-radius: 4px;
        background: #dadce0;
        width: 4px;
        height: 4px;
        display: inline-block;
}

[critical].application-timeline .line.application-timeline {
  background: #4285f4;
}

[current].application-timeline .line.application-timeline {
  background: #81c995;
}

[current][critical].application-timeline .line.application-timeline {
  background: #81c995;
}

.title.application-timeline {
  font-size: 13px;
        padding: 3px 0;
        line-height: 16px;
}

.title-text.application-timeline {
  color: #5f6368;
}

.description-item.application-timeline {
  font-size: 12px;
        padding: 6px 0;
        max-width: 300px;
}

#legal.application-timeline {
  height: 14px;
        width: 14px;
        padding: 0 3px 1px 3px;
        vertical-align: text-bottom;
}

#icon.application-timeline {
  height: 12px;
        width: 12px;
        padding: 0 3px 3px 3px;
        vertical-align: text-bottom;
}

.unknown.application-timeline {
  font-style: italic;
}

.not_active.application-timeline {
  text-decoration: line-through;
}

.active.application-timeline {
  font-weight: 500;
}

#cc[this].application-timeline {
  color: #202124 !important;
        text-decoration: underline;
}

#cc[this].not_active.application-timeline {
  text-decoration: line-through underline;
}

hr.application-timeline {
  border: none;
        height: 1px;
        background: #e5e5e5;
        margin: 10px 0 16px 0;
}

.header.application-timeline {
  font-size: 13px;
        line-height: 20px;
        font-weight: 500;
        color: #202124;
        padding-bottom: 8px;
}

.block.application-timeline {
  padding: 0 6px 0 0;
}

.year.application-timeline {
  color: #5f6368;
        font-size: 13px;
        font-weight: 500;
        padding: 3px 1px;
        width: 70px;
}

.expand.application-timeline {
  cursor: pointer;
        padding: 6px 0 3px 0;
}</style><!-- Shady DOM styles for patent-text --><style scope="patent-text">.layout.horizontal.patent-text,.layout.vertical.patent-text {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.patent-text {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.patent-text {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.patent-text {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.patent-text {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.patent-text {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.patent-text {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.patent-text {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.patent-text {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.patent-text {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.patent-text,.layout.center-center.patent-text {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.patent-text {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.patent-text {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.patent-text {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.patent-text,.layout.center-center.patent-text {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.patent-text {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.patent-text {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.patent-text {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.patent-text {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.patent-text {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.patent-text {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.patent-text {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.patent-text {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.patent-text {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.patent-text {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.patent-text {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.patent-text {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.patent-text {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

patent-text {
  display: block;
}

#text.patent-text {
  line-height: 20px;
        min-width: 0;
}

#margin.patent-text {
  width: 16px;
}

#createHighlight.patent-text {
  position: relative;
        width: 16px;
        height: 16px;
        cursor: pointer;
}

.notranslate.patent-text > .google-src-text.patent-text {
  display: none;
}

.notranslate.patent-text:hover,mark.patent-text {
  background-color: #fbfcae;
}

.description-paragraph.patent-text {
  margin-block-start: 1em;
        margin-block-end: 1em;
}

.claim-text.patent-text {
  margin: 14px 0 0 20px;
}

.claim-dependent.patent-text {
  margin-left: 40px;
        color: #888;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim-text.patent-text {
  height: 0;
        width: 0;
        visibility: hidden;
}

[hide-claims].patent-text .claim-dependent.patent-text .claim.patent-text:after {
  content: ""
}

.patent-full-image.patent-text {
  max-width: 100%;
        height: auto;
}

.small-patent-image.patent-text {
  display: inline;
}

ul.patent-text {
  padding: 0 0 0 50px;
}

li.patent-text {
  list-style-type: none;
        position: relative;
}

ol.claims.patent-text li.patent-text {
  list-style-type: decimal;
        font-weight: bold;
}

ol.claims.patent-text li.patent-text > *.patent-text {
  font-weight: normal;
}

li.patent-text > para-num.patent-text {
  position: absolute;
        left: -45px;
        color: #888;
}

mark.patent-text {
  background: #fff59d;
}

mark.searchText.patent-text {
  background: #80deea;
}

.searchTextHeader.patent-text {
  font-weight: 500;
}

pre.patent-text {
  white-space: pre-wrap;
}

heading.patent-text {
  display: block;
        font-weight: 500;
        font-size: 13px;
}

#comment.patent-text {
  width: 16px;
        height: 16px;
}

[has-search][no-results].patent-text {
  display: none;
}

.highlight.patent-text {
  background-color: #fef7e0;
}</style><!-- Shady DOM styles for para-num --><!-- Shady DOM styles for result-container --><style scope="result-container">paper-spinner.result-container {
  position: absolute;
        
        top: calc(50%  + 56px - 16px);
        left: calc(50% + 175px - 16px);
}</style><!-- Shady DOM styles for scholar-result --><!-- Shady DOM styles for search-result --><style scope="search-result">.layout.horizontal.search-result,.layout.vertical.search-result {
  display: -ms-flexbox;
        display: -webkit-flex;
        display: flex;
}

.layout.inline.search-result {
  display: -ms-inline-flexbox;
        display: -webkit-inline-flex;
        display: inline-flex;
}

.layout.horizontal.search-result {
  -ms-flex-direction: row;
        -webkit-flex-direction: row;
        flex-direction: row;
}

.layout.vertical.search-result {
  -ms-flex-direction: column;
        -webkit-flex-direction: column;
        flex-direction: column;
}

.layout.wrap.search-result {
  -ms-flex-wrap: wrap;
        -webkit-flex-wrap: wrap;
        flex-wrap: wrap;
}

.layout.no-wrap.search-result {
  -ms-flex-wrap: nowrap;
        -webkit-flex-wrap: nowrap;
        flex-wrap: nowrap;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.flex.search-result {
  -ms-flex: 1 1 0.000000001px;
        -webkit-flex: 1;
        flex: 1;
        -webkit-flex-basis: 0.000000001px;
        flex-basis: 0.000000001px;
}

.flex-auto.search-result {
  -ms-flex: 1 1 auto;
        -webkit-flex: 1 1 auto;
        flex: 1 1 auto;
}

.flex-none.search-result {
  -ms-flex: none;
        -webkit-flex: none;
        flex: none;
}

.layout.start.search-result {
  -ms-flex-align: start;
        -webkit-align-items: flex-start;
        align-items: flex-start;
}

.layout.center.search-result,.layout.center-center.search-result {
  -ms-flex-align: center;
        -webkit-align-items: center;
        align-items: center;
}

.layout.end.search-result {
  -ms-flex-align: end;
        -webkit-align-items: flex-end;
        align-items: flex-end;
}

.layout.baseline.search-result {
  -ms-flex-align: baseline;
        -webkit-align-items: baseline;
        align-items: baseline;
}

.layout.start-justified.search-result {
  -ms-flex-pack: start;
        -webkit-justify-content: flex-start;
        justify-content: flex-start;
}

.layout.center-justified.search-result,.layout.center-center.search-result {
  -ms-flex-pack: center;
        -webkit-justify-content: center;
        justify-content: center;
}

.layout.end-justified.search-result {
  -ms-flex-pack: end;
        -webkit-justify-content: flex-end;
        justify-content: flex-end;
}

.layout.around-justified.search-result {
  -ms-flex-pack: distribute;
        -webkit-justify-content: space-around;
        justify-content: space-around;
}

.layout.justified.search-result {
  -ms-flex-pack: justify;
        -webkit-justify-content: space-between;
        justify-content: space-between;
}

.self-start.search-result {
  -ms-align-self: flex-start;
        -webkit-align-self: flex-start;
        align-self: flex-start;
}

.self-center.search-result {
  -ms-align-self: center;
        -webkit-align-self: center;
        align-self: center;
}

.self-end.search-result {
  -ms-align-self: flex-end;
        -webkit-align-self: flex-end;
        align-self: flex-end;
}

.self-stretch.search-result {
  -ms-align-self: stretch;
        -webkit-align-self: stretch;
        align-self: stretch;
}

.self-baseline.search-result {
  -ms-align-self: baseline;
        -webkit-align-self: baseline;
        align-self: baseline;
}

.layout.start-aligned.search-result {
  -ms-flex-line-pack: start;  
        -ms-align-content: flex-start;
        -webkit-align-content: flex-start;
        align-content: flex-start;
}

.layout.end-aligned.search-result {
  -ms-flex-line-pack: end;  
        -ms-align-content: flex-end;
        -webkit-align-content: flex-end;
        align-content: flex-end;
}

.layout.center-aligned.search-result {
  -ms-flex-line-pack: center;  
        -ms-align-content: center;
        -webkit-align-content: center;
        align-content: center;
}

.layout.between-aligned.search-result {
  -ms-flex-line-pack: justify;  
        -ms-align-content: space-between;
        -webkit-align-content: space-between;
        align-content: space-between;
}

.layout.around-aligned.search-result {
  -ms-flex-line-pack: distribute;  
        -ms-align-content: space-around;
        -webkit-align-content: space-around;
        align-content: space-around;
}

search-result {
  display: block;
        font-size: 13px;
}

#mainContainer.search-result {
  min-height: calc(100vh - 127px);
        color: #333;
}

#compactQuery.search-result {
  padding: 18px 20px 10px 20px;
        cursor: pointer;
}

#compactQuery.search-result > span.search-result {
  padding: 0 14px 0 0;
}

#compactQuery.search-result iron-icon.search-result {
  padding-right: 6px;
        height: 16px;
        width: 16px;
}</style><!-- Shady DOM styles for webdoc-result --><!-- Shady DOM styles for iron-pages --><!-- Shady DOM styles for paper-tab --><!-- Shady DOM styles for paper-tabs --><!-- Shady DOM styles for debug-info --><!-- Shady DOM styles for search-paging --><!-- Shady DOM styles for search-result-item --><!-- Shady DOM styles for search-result-image --><!-- Shady DOM styles for search-result-entities --><!-- Shady DOM styles for search-result-measures --><!-- Shady DOM styles for search-results --><!-- Shady DOM styles for summary-box --><!-- Shady DOM styles for timeline-page --><!-- Shady DOM styles for iron-localstorage --><!-- Shady DOM styles for search-app --><style scope="search-app">search-app {
  display: block;
        height: 100%;
}

#toast.search-app {
  min-height: 64px;
        min-width: 742px;
}</style><style>body {transition: opacity ease-in 0.2s; } 
body[unresolved] {opacity: 0; display: block; overflow: hidden; position: relative; } 
</style>
    <title>TW321644B -  - Google Patents</title>

    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta charset="UTF-8">
    <meta name="referrer" content="origin-when-crossorigin">
    <link rel="canonical" href="https://patents.google.com/patent/TW321644B/en">
    
    <meta name="DC.type" content="patent">
    <meta name="DC.title" content="">
    <meta name="DC.date" content="1995-11-18" scheme="dateSubmitted">
    <meta name="DC.description" content="">
    <meta name="citation_patent_application_number" content="TW:084112259A">
    <meta name="citation_pdf_url" content="https://patentimages.storage.googleapis.com/f2/fc/cc/97eea82ed8e1e7/TW321644B.pdf">
    <meta name="citation_patent_number" content="TW:321644:B">
    <meta name="DC.date" content="1997-12-01" scheme="issue">
    <meta name="DC.contributor" content="Fiandor Roman Jose" scheme="inventor">
    <meta name="DC.contributor" content="Gargallo Viola Domingo" scheme="inventor">
    <meta name="DC.contributor" content="Glaxo Wellcome Sa" scheme="assignee">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,400italic,500,500italic,700">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Product+Sans">
    <link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Google+Sans:wght@400;500;700">

    <style>
      body { transition: none; }
    </style>

    <script src="https://apis.google.com/_/scs/abc-static/_/js/k=gapi.lb.en.IKZeRvoAYNY.O/m=client/rt=j/sv=1/d=1/ed=1/am=AAAQ/rs=AHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw/cb=gapi.loaded_0?le=scs" async=""></script><script>
      window.version = 'patent-search.search_20240531_RC00';

      function sendFeedback() {
        userfeedback.api.startFeedback({
          'productId': '713680',
          'bucket': 'patent-search-web',
          'productVersion': window.version,
        });
      }

      window.experiments = {};
      window.experiments.patentCountries = "ae,ag,al,am,ao,ap,ar,at,au,aw,az,ba,bb,bd,be,bf,bg,bh,bj,bn,bo,br,bw,bx,by,bz,ca,cf,cg,ch,ci,cl,cm,cn,co,cr,cs,cu,cy,cz,dd,de,dj,dk,dm,do,dz,ea,ec,ee,eg,em,ep,es,fi,fr,ga,gb,gc,gd,ge,gh,gm,gn,gq,gr,gt,gw,hk,hn,hr,hu,ib,id,ie,il,in,ir,is,it,jo,jp,ke,kg,kh,km,kn,kp,kr,kw,kz,la,lc,li,lk,lr,ls,lt,lu,lv,ly,ma,mc,md,me,mg,mk,ml,mn,mo,mr,mt,mw,mx,my,mz,na,ne,ng,ni,nl,no,nz,oa,om,pa,pe,pg,ph,pl,pt,py,qa,ro,rs,ru,rw,sa,sc,sd,se,sg,si,sk,sl,sm,sn,st,su,sv,sy,sz,td,tg,th,tj,tm,tn,tr,tt,tw,tz,ua,ug,us,uy,uz,vc,ve,vn,wo,yu,za,zm,zw";
      
      
      window.experiments.keywordWizard = true;
      
      
      
      window.experiments.definitions = true;

      window.Polymer = {
        dom: 'shady',
        lazyRegister: true,
      };
    </script>

    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/webcomponentsjs/webcomponents-lite.min.js"></script>
    <style>[hidden]:not([style-scope]):not(.style-scope) {
  display: none !important;
}

</style><style></style><style></style><style></style><style></style><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto:400,300,300italic,400italic,500,500italic,700,700italic"><link rel="stylesheet" href="https://fonts.googleapis.com/css?family=Roboto+Mono:400,700"><style></style><style></style><style>
  html, body {
    min-width: 100%;
    width: 100%;
    min-height: 100%;
    height: 100%;
  }

  body {
    background-color: #fff;
    font-family: 'Roboto', sans-serif;
    color: #333;
    margin: 0;
    padding: 0;
    /*
     * Turn off https://github.com/WICG/ScrollAnchoring/blob/master/explainer.md
     * https://memegen.googleplex.com/5230756293246976
     */
    overflow-anchor: none;
  }

  body h1, body h2, body h3 {
    -webkit-font-smoothing: antialiased;
    -moz-osx-font-smoothing: grayscale;
  }

  body a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  body a:visited {
    color: #3c80f6;
  }

  body a[open-result]:visited {
    color: #7e57c2;
  }

  /* For Firefox */
  a:link {
    color: #3c80f6;
    text-decoration: none;
  }

  a:visited {
    color: #3c80f6;
  }

  a[open-result]:visited {
    color: #7e57c2;
  }

  ::selection , body ::selection {
    background-color: #c6dafc;
    color: #333;
  }
</style><link rel="import" href="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.html">
  <style>[hidden] { display: none !important; }</style><script type="text/javascript" charset="UTF-8" src="https://apis.google.com/js/client.js" gapi_processed="true"></script></head>
  <body>
    <script src="//www.gstatic.com/patent-search/frontend/patent-search.search_20240531_RC00/scs/compiled_dir/search-app-vulcanized.js"></script><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span><span style="font-size: 13px; white-space: pre-wrap; display: inline-block; position: absolute; left: -99999px; top: -99999px; max-width: 217px;"></span>
    <search-app>
    
    <remote-fetch class="style-scope search-app"></remote-fetch>
    <search-state class="style-scope search-app"></search-state>
    <browser-ui class="style-scope search-app"></browser-ui>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    
      <search-result id="result" class="style-scope search-app">
    
    
    <search-ui mode="result" class="style-scope search-result x-scope search-ui-0">
    
    
    
    <div id="content" class="style-scope search-ui" wide="">
      <search-header show-search="" class="style-scope search-ui">
    
    
    <div class="style-scope search-header" wide="">
      <header class="style-scope search-header">
        <div class="layout horizontal headerpad style-scope search-header">
          <div class="layout horizontal leftheader style-scope search-header">
            <h1 class="style-scope search-header">
              <state-modifier inherit="" act="{&quot;type&quot;: &quot;HOME&quot;}" class="style-scope search-header"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                <div class="lockup style-scope search-header">
                  <span class="lockup-logo style-scope search-header"></span>
                  <span class="lockup-text style-scope search-header">
                    <span class="lockup-brand style-scope search-header">&nbsp;Patents</span>
                  </span>
                </div>
              </a></state-modifier>
            </h1>
          </div>
          
            <search-box class="style-scope search-header">
    
    <div class="layout horizontal style-scope search-box" style="position: relative;">
      <div class="inputbox flex layout horizontal style-scope search-box">
        <div class="suggest-bg flex style-scope search-box">
          <input name="q" id="searchInput" data-proto="SEARCH_INPUT" autocomplete="off" class="style-scope search-box">
        </div>
        <div id="corpora" class="style-scope search-box">
          <iron-icon icon="icons:lightbulb-outline" id="patentIcon" class="style-scope search-box x-scope iron-icon-0" active=""><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M9 21c0 .55.45 1 1 1h4c.55 0 1-.45 1-1v-1H9v1zm3-19C8.14 2 5 5.14 5 9c0 2.38 1.19 4.47 3 5.74V17c0 .55.45 1 1 1h6c.55 0 1-.45 1-1v-2.26c1.81-1.27 3-3.36 3-5.74 0-3.86-3.14-7-7-7zm2.85 11.1l-.85.6V16h-4v-2.3l-.85-.6C7.8 12.16 7 10.63 7 9c0-2.76 2.24-5 5-5s5 2.24 5 5c0 1.63-.8 3.16-2.15 4.1z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#patentIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include patents
    </div>
  </overlay-tooltip>
          <iron-icon icon="social:school" id="nplIcon" class="style-scope search-box x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M5 13.18v4L12 21l7-3.82v-4L12 17l-7-3.82zM12 3L1 9l11 6 9-4.91V17h2V9L12 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
          <overlay-tooltip positioning-target="#nplIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Include non-patent literature
    </div>
  </overlay-tooltip>
          <keyword-wizard id="wizardIcon" class="style-scope search-box">


<div id="wizardContainer" class="style-scope keyword-wizard">
  <iron-icon icon="image:tune" id="wizardIcon" class="style-scope keyword-wizard x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M3 17v2h6v-2H3zM3 5v2h10V5H3zm10 16v-2h8v-2h-8v-2h-2v6h2zM7 9v2H3v2h4v2h2V9H7zm14 4v-2H11v2h10zm-6-4h2V7h4V5h-4V3h-2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
  <paper-material elevation="2" id="wizard" class="style-scope keyword-wizard x-scope paper-material-0" hidden="">
    
    

    
    
    <div class="search-within style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Search within
        <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="within"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="withinHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search within the title, abstract, claims, or full patent document</b>: You can
          restrict your search to a specific field using field names.</p>
        <p class="style-scope keyword-wizard">Use <span class="q style-scope keyword-wizard">TI=</span> to search in the title, <span class="q style-scope keyword-wizard">AB=</span> for the
          abstract, <span class="q style-scope keyword-wizard">CL=</span> for the claims, or <span class="q style-scope keyword-wizard">TAC=</span> for
          all three. For example, <span class="q style-scope keyword-wizard">TI=(safety belt)</span>.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Search by Cooperative Patent Classifications (CPCs)</b>: These are commonly used to
          represent ideas in place of keywords, and can also be entered in a search term box. If
          you're searching for<span class="q style-scope keyword-wizard">seat belts</span>, you could also search for
          <span class="q style-scope keyword-wizard">B60R22/00</span> to retrieve documents that mention safety belts or body
          harnesses. <span class="q style-scope keyword-wizard">CPC=B60R22</span> will match documents with exactly this CPC,
          <span class="q style-scope keyword-wizard">CPC=B60R22/low</span> matches documents with this CPC or a child
          classification of this CPC.
        </p>
          <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="filter-chips style-scope keyword-wizard">
        <span class="chip style-scope keyword-wizard" id="title" selected="">Title</span>
        <span class="chip style-scope keyword-wizard" id="abstract" selected="">Abstract</span>
        <span class="chip style-scope keyword-wizard" id="claims" selected="">Claims</span>
        <span class="chip style-scope keyword-wizard" id="fullDoc" selected="">Full Document</span>
      </div>
      
      <div class="cpc-field style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputCPC" class="style-scope keyword-wizard">or CPC</label></span>
        <div class="cpc-inputs style-scope keyword-wizard">
          <input class="keyword-input style-scope keyword-wizard" id="inputCPC" placeholder="Or search with CPC">
          <input type="checkbox" id="childCPC" checked="" class="style-scope keyword-wizard">
          <label class="checkbox-label style-scope keyword-wizard" for="childCPC">
            Include child classifications
          </label>
        </div>
      </div>
    </div>
    
    <div class="find-patents style-scope keyword-wizard">
      <span class="wizard-header style-scope keyword-wizard">
        Find patents
        <iron-icon class="help-header style-scope keyword-wizard x-scope iron-icon-0" icon="icons:help-outline" id="searchBoolean"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </span>
      
      <div class="help style-scope keyword-wizard" id="searchBooleanHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Keywords and boolean syntax (USPTO or EPO format)</b>:
          <span class="q style-scope keyword-wizard">seat belt</span> searches these two words, or their plurals and close
          synonyms. <span class="q style-scope keyword-wizard">"seat belt"</span> searches this exact phrase, in order.
          <span class="q style-scope keyword-wizard">-seat -belt</span> searches for documents not containing either word.
        </p>
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">For searches using boolean logic</b>, the default operator is
          <span class="q style-scope keyword-wizard">AND</span> with left associativity. <i class="style-scope keyword-wizard">Note:</i> this means
          <span class="q style-scope keyword-wizard">safety OR seat belt</span> is searched as <span class="q style-scope keyword-wizard">(safety OR seat)
          AND belt</span>. Each word automatically includes plurals and close synonyms. Adjacent
          words that are implicitly ANDed together, such as <span class="q style-scope keyword-wizard">(safety belt)</span>,
          are treated as a phrase when generating synonyms.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputAnd" class="style-scope keyword-wizard">with ALL of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputAnd" placeholder="with ALL of the words">
      </div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputExact" class="style-scope keyword-wizard">with the EXACT PHRASE</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputExact" placeholder="with the EXACT PHRASE"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputOr" class="style-scope keyword-wizard">with AT LEAST ONE of the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputOr" placeholder="with AT LEAST ONE of the words"></div>
      <div class="style-scope keyword-wizard">
        <span class="input-label style-scope keyword-wizard"><label for="inputMinus" class="style-scope keyword-wizard">WITHOUT the words</label></span>
        <input class="keyword-input style-scope keyword-wizard" id="inputMinus" placeholder="WITHOUT the words"></div>
    </div>
    <div class="search-by style-scope keyword-wizard">
      <div class="wizard-header style-scope keyword-wizard">
          Search by
          <iron-icon icon="icons:help-outline" class="help-header style-scope keyword-wizard x-scope iron-icon-0" id="chem"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </div>
      
      <div class="help style-scope keyword-wizard" id="chemHelp" hidden="">
        <p class="style-scope keyword-wizard"><b class="style-scope keyword-wizard">Chemistry searches</b> match terms (trade names, IUPAC names, etc.
          extracted from the entire document, and processed from .MOL files.)
        </p>
        <p class="style-scope keyword-wizard">Substructure (use <span class="q style-scope keyword-wizard">SSS=</span>) and similarity (use
          <span class="q style-scope keyword-wizard">~</span>) searches are limited to one per search at the top-level
          <span class="q style-scope keyword-wizard">AND</span> condition. Exact searches can be used multiple times throughout
          the search query.
        </p>
        <p class="style-scope keyword-wizard">Searching by SMILES or InChi key requires no special syntax. To search by SMARTS, use
          <span class="q style-scope keyword-wizard">SMARTS=</span>.
        </p>
        <p class="style-scope keyword-wizard">To search for multiple molecules, select "Batch" in the "Type" menu. Enter multiple
          molecules separated by whitespace or by comma.
        </p>
        <a href="https://support.google.com/faqs/answer/7049475" target="_blank" class="style-scope keyword-wizard">Learn More</a>
      </div>
      
      <div class="chemistry-field style-scope keyword-wizard">
          <span class="input-label style-scope keyword-wizard"><label for="inputChem" class="style-scope keyword-wizard">Chemistry</label></span>
          <span class="chem-type-label style-scope keyword-wizard"><label for="chemType" hidden="" class="style-scope keyword-wizard">Type</label></span>
          <select id="chemType" class="style-scope keyword-wizard">
            <option value="identical" class="style-scope keyword-wizard">Identical</option>
            <option value="substructure" class="style-scope keyword-wizard">Substructure</option>
            <option value="smarts" class="style-scope keyword-wizard">SMARTS</option>
            <option value="similarity" class="style-scope keyword-wizard">Similarity</option>
            <option value="batch" class="style-scope keyword-wizard">Batch</option>
          </select>
          <textarea class="keyword-input style-scope keyword-wizard" id="inputChem" placeholder="Trade name, SMILES, InChiKey"></textarea>
      </div>
      <div class="import style-scope keyword-wizard">
        <div class="wizard-header style-scope keyword-wizard">
          Patent numbers
        </div>
        <span class="import-button style-scope keyword-wizard">
          <a href="https://patents.google.com/import" class="style-scope keyword-wizard"><button class="style-scope keyword-wizard">Import</button></a>
        </span>
        <p class="import-text style-scope keyword-wizard">
          Search specific patents by importing a CSV or list of patent publication or application numbers.
        </p>
      </div>
    </div>
    
    <div class="wizard-buttons style-scope keyword-wizard">
      <button type="reset" class="style-scope keyword-wizard">Close</button>
      <button type="button" autofocus="" class="style-scope keyword-wizard">Add</button>
    </div>
  
  </paper-material>
</div>
</keyword-wizard>
          <overlay-tooltip positioning-target="#wizardIcon" direction="bottom" class="style-scope search-box" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Display advanced search options
    </div>
  </overlay-tooltip>
        </div>
      </div>
      <paper-material id="suggestMenu" class="style-scope search-box x-scope paper-material-0" elevation="1" hidden="">
    
    

    
        <template is="dom-repeat" class="style-scope search-box"></template>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Sorry, we couldn't find this patent number.
        </div>
        <div class="row style-scope search-box" hidden="">
          <iron-icon class="suggest-icon style-scope search-box x-scope iron-icon-0" icon="error"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 2C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm1 15h-2v-2h2v2zm0-4h-2V7h2v6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> 
        </div>
      
  </paper-material>
      <button id="searchButton" class="style-scope search-box"><iron-icon class="style-scope search-box x-scope iron-icon-0" icon="search"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.5 14h-.79l-.28-.27C15.41 12.59 16 11.11 16 9.5 16 5.91 13.09 3 9.5 3S3 5.91 3 9.5 5.91 16 9.5 16c1.61 0 3.09-.59 4.23-1.57l.27.28v.79l5 4.99L20.49 19l-4.99-5zm-6 0C7.01 14 5 11.99 5 9.5S7.01 5 9.5 5 14 7.01 14 9.5 11.99 14 9.5 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></button>
    </div>
  </search-box>
          <template is="dom-if" class="style-scope search-header"></template>
          <div class="flex style-scope search-header"></div>
          
            <div id="header-container" class="style-scope search-header">
              <result-nav class="style-scope search-header">
    
    <div class="style-scope result-nav" hidden="">
      <state-modifier id="current" act="{&quot;type&quot;: &quot;BACK_TO_RESULTS&quot;}" inherit="" class="style-scope result-nav"><a id="link" href="#" class="style-scope state-modifier" inherit=""><span class="style-scope result-nav"></span> of
      <template is="dom-if" class="style-scope result-nav"></template>
      0<template is="dom-if" class="style-scope result-nav"></template></a></state-modifier>
      <state-modifier id="prevResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-left" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M15.41 7.41L14 6l-6 6 6 6 1.41-1.41L10.83 12z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier><state-modifier id="nextResult" inherit="" act="{&quot;type&quot;: &quot;NAV_RESULT&quot;, &quot;result&quot;: &quot;$id&quot;, &quot;page&quot;: $page}" class="style-scope result-nav" disabled=""><a id="link" href="#" class="style-scope state-modifier" inherit="">
        <iron-icon icon="chevron-right" class="style-scope result-nav x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M10 6L8.59 7.41 13.17 12l-4.58 4.59L10 18l6-6z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      </a></state-modifier>
      <overlay-tooltip positioning-target="#prevResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Previous result
    </div>
  </overlay-tooltip>
      <overlay-tooltip positioning-target="#nextResult" direction="bottom" arrow="" class="style-scope result-nav" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip"></div>
    <div class="style-scope overlay-tooltip">
      Next result
    </div>
  </overlay-tooltip>
    </div>
  </result-nav>
            </div>
          <template is="dom-if" class="style-scope search-header"></template>
        </div>
      </header>
    </div>
  </search-header>

      <div class="layout horizontal style-scope search-ui">
        <template is="dom-if" class="style-scope search-ui"></template>

        <div id="main" class="style-scope search-ui">
          <search-term-wizard class="style-scope search-ui"><pat-dialog open="" class="style-scope search-term-wizard">
  <span class="header style-scope search-term-wizard">
    <span class="title style-scope search-term-wizard">Search tools</span>
    <span id="language" class="style-scope search-term-wizard">
      <text-button id="textButton" selected="" class="style-scope search-term-wizard">Text
</text-button>
      <text-button id="classificationButton" class="style-scope search-term-wizard">Classification
</text-button>
      <text-button id="chemistryButton" class="style-scope search-term-wizard">Chemistry
</text-button>
      <text-button id="measureButton" class="style-scope search-term-wizard">Measure
</text-button>
      <text-button id="numbersButton" class="style-scope search-term-wizard">Numbers
</text-button>
    </span>
  </span>
  <span id="panels" class="style-scope search-term-wizard">
    <text-search-term-wizard id="textPanel" class="style-scope search-term-wizard" selected=""><span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Type a concept you want to search for here" class="style-scope text-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Type a concept you want to search for here">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="title" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Title</filter-chip>
  <filter-chip id="abstract" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Abstract</filter-chip>
  <filter-chip id="claims" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope text-search-term-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope text-search-term-wizard"></path>
  </svg>
  <filter-chip id="all" selected="" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
All</filter-chip>
  <filter-chip id="any" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Any</filter-chip>
  <filter-chip id="exact" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="not" class="style-scope text-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Not</filter-chip>
</span>
<span class="style-scope text-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope text-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope text-search-term-wizard">Add AND condition</span></mat-button></span></text-search-term-wizard>
    <classification-wizard id="classificationPanel" class="style-scope search-term-wizard"><span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope classification-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Enter a CPC here" uppercase="" class="style-scope classification-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Enter a CPC here">
  
</span>
</outlined-text-field>
</span>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<template is="dom-if" class="style-scope classification-wizard"></template>
<span class="style-scope classification-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope classification-wizard">
    <path d="M16 16.925q2.05 0 3.488-1.437Q20.925 14.05 20.925 12t-1.437-3.488Q18.05 7.075 16 7.075q-.625 0-1.2.15t-1.075.425q.7.925 1.087 2.025.388 1.1.388 2.325t-.388 2.325q-.387 1.1-1.087 2.025.5.275 1.075.425.575.15 1.2.15Zm-4-2.075q.45-.575.688-1.313.237-.737.237-1.537 0-.8-.237-1.538Q12.45 9.725 12 9.15q-.45.575-.688 1.312-.237.738-.237 1.538t.237 1.537q.238.738.688 1.313Zm-4 2.075q.625 0 1.2-.15t1.075-.425q-.7-.925-1.087-2.025Q8.8 13.225 8.8 12t.388-2.325q.387-1.1 1.087-2.025-.5-.275-1.075-.425-.575-.15-1.2-.15-2.05 0-3.487 1.437Q3.075 9.95 3.075 12t1.438 3.488Q5.95 16.925 8 16.925ZM8 19.2q-3 0-5.1-2.1Q.8 15 .8 12q0-3 2.1-5.1Q5 4.8 8 4.8q1.125 0 2.137.312 1.013.313 1.863.913.85-.6 1.863-.913Q14.875 4.8 16 4.8q3 0 5.1 2.1Q23.2 9 23.2 12q0 3-2.1 5.1-2.1 2.1-5.1 2.1-1.125 0-2.137-.313-1.013-.312-1.863-.912-.85.6-1.863.912Q9.125 19.2 8 19.2Z" class="style-scope classification-wizard"></path>
  </svg>
  <filter-chip id="notExact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These CPCs and their children
  </filter-chip>
  <filter-chip selected="" id="exact" class="style-scope classification-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>

    These exact CPCs
  </filter-chip>
</span>
<span class="style-scope classification-wizard">
  <mat-button id="button" filled="" class="style-scope classification-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope classification-wizard">Add AND condition</span></mat-button>
</span></classification-wizard>
    <chemistry-search-term-wizard id="chemistryPanel" class="style-scope search-term-wizard"><span class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="textField" placeholder="Trade name, SMILES, InChI Key" class="style-scope chemistry-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Trade name, SMILES, InChI Key">
  
</span>
</outlined-text-field>
  <outlined-textarea id="textArea" placeholder="Enter multiple SMILES or InChI Keys, one per line" rows="4" class="style-scope chemistry-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple SMILES or InChI Keys, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
  <a href="https://support.google.com/faqs/answer/7049475#zippy=%2Csearching-by-chemistry" target="_blank" class="style-scope chemistry-search-term-wizard">
    <svg class="help style-scope chemistry-search-term-wizard" xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49">
      <path d="M11.95 18q.525 0 .888-.363.362-.362.362-.887t-.362-.887q-.363-.363-.888-.363t-.888.363q-.362.362-.362.887t.362.887q.363.363.888.363Zm-.9-3.85h1.85q0-.825.188-1.3.187-.475 1.062-1.3.65-.65 1.025-1.238.375-.587.375-1.412 0-1.4-1.025-2.15T12.1 6q-1.425 0-2.312.75-.888.75-1.238 1.8l1.65.65q.125-.45.563-.975Q11.2 7.7 12.1 7.7q.8 0 1.2.437.4.438.4.963 0 .5-.3.937-.3.438-.75.813-1.1.975-1.35 1.475-.25.5-.25 1.825ZM12 22q-2.075 0-3.9-.788-1.825-.787-3.175-2.137-1.35-1.35-2.137-3.175Q2 14.075 2 12t.788-3.9q.787-1.825 2.137-3.175 1.35-1.35 3.175-2.138Q9.925 2 12 2t3.9.787q1.825.788 3.175 2.138 1.35 1.35 2.137 3.175Q22 9.925 22 12t-.788 3.9q-.787 1.825-2.137 3.175-1.35 1.35-3.175 2.137Q14.075 22 12 22Zm0-2q3.35 0 5.675-2.325Q20 15.35 20 12q0-3.35-2.325-5.675Q15.35 4 12 4 8.65 4 6.325 6.325 4 8.65 4 12q0 3.35 2.325 5.675Q8.65 20 12 20Zm0-8Z" class="style-scope chemistry-search-term-wizard"></path>
    </svg>
  </a>
</span>
<span id="chemQuantifiers" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M5 21.2q-1.4 0-2-1.25-.6-1.25.3-2.325l5.5-6.7V5.15h-.825q-.475 0-.8-.338Q6.85 4.475 6.85 4q0-.475.325-.813.325-.337.8-.337h8.05q.475 0 .8.337.325.338.325.813 0 .475-.325.812-.325.338-.8.338H15.2v5.775l5.5 6.7q.9 1.075.3 2.325-.6 1.25-2 1.25Zm2.15-3.275h9.7l-3.275-3.85h-3.15Zm-2 1h13.7l-5.925-7.2V5.15h-1.85v6.575Zm6.85-6.9Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="exact" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact</filter-chip>
  <filter-chip id="exactBatch" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Exact Batch</filter-chip>
  <filter-chip id="similar" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Similar</filter-chip>
  <filter-chip id="substructure" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure</filter-chip>
  <filter-chip id="smarts" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Substructure (SMARTS)</filter-chip>
</span>
<span id="location" class="style-scope chemistry-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope chemistry-search-term-wizard">
    <path d="M8 18.025h8v-2.1H8Zm0-4h8v-2.1H8ZM6.075 22.2q-.95 0-1.612-.662-.663-.663-.663-1.613V4.075q0-.95.663-1.613.662-.662 1.612-.662h8L20.2 7.925v12q0 .95-.662 1.613-.663.662-1.613.662Zm6.85-13.125v-5h-6.85v15.85h11.85V9.075Zm-6.85-5v5-5 15.85-15.85Z" class="style-scope chemistry-search-term-wizard"></path>
  </svg>
  <filter-chip id="fullDocuments" selected="" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Full documents</filter-chip>
  <filter-chip id="claims" class="style-scope chemistry-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Claims only</filter-chip>
</span>
<span class="style-scope chemistry-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope chemistry-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope chemistry-search-term-wizard">Add AND condition</span></mat-button>
</span>
</chemistry-search-term-wizard>
    <measure-search-term-wizard id="measurePanel" class="style-scope search-term-wizard"><span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M4.1 18.15q-.95 0-1.612-.663-.663-.662-.663-1.612v-7.75q0-.95.663-1.613Q3.15 5.85 4.1 5.85h15.8q.95 0 1.613.662.662.663.662 1.613v7.75q0 .95-.662 1.612-.663.663-1.613.663Zm0-2.275h15.8v-7.75H17V12h-2V8.125h-2V12h-2V8.125H9V12H7V8.125H4.1v7.75ZM7 12h2Zm4 0h2Zm4 0h2Zm-3 0Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="measureExpression" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="1.5 mm, 20 ft, 400-500 fahrenheit, 800 MHz, 0.01-100 mol">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope measure-search-term-wizard">
    <path d="M3.875 20.15V8.85h4.25v11.3Zm6 0V3.85h4.25v16.3Zm6 0v-7.3h4.25v7.3Z" class="style-scope measure-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="context" placeholder="activity, wavelength, embossing depth, absorption" class="style-scope measure-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="activity, wavelength, embossing depth, absorption">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope measure-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope measure-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope measure-search-term-wizard">Add AND condition</span></mat-button>
</span>
</measure-search-term-wizard>
    <numerical-search-term-wizard id="numericalPanel" class="style-scope search-term-wizard"><span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M3.85 15.275V13h10.3v2.275Zm0-4.275V8.725h16.3V11Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-textarea id="batch" placeholder="Enter multiple Patent Application and Publication Numbers, one per line" rows="4" class="style-scope numerical-search-term-wizard"><span class="style-scope outlined-textarea">
  <textarea id="textarea" autocomplete="off" autocorrect="off" spellcheck="false" tabindex="0" aria-disabled="false" wrap="soft" class="style-scope outlined-textarea" rows="4" placeholder="Enter multiple Patent Application and Publication Numbers, one per line">  </textarea>
  <div id="helperText" class="style-scope outlined-textarea"> </div>
</span>
<span class="right-button-container style-scope outlined-textarea">
  
</span>
</outlined-textarea>
</span>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<template is="dom-if" class="style-scope numerical-search-term-wizard"></template>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="m10.825 23.45-1.6-1.625L10.9 20.15H8q-.35.9-1.162 1.488-.813.587-1.838.587-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.025.588-1.837Q2.95 16.35 3.85 16V8q-.9-.35-1.487-1.163Q1.775 6.025 1.775 5q0-1.35.938-2.288Q3.65 1.775 5 1.775q1.025 0 1.838.587Q7.65 2.95 8 3.85h2.9L9.225 2.175l1.6-1.625L15.275 5l-4.45 4.45-1.6-1.625L10.9 6.15H8q-.25.65-.725 1.125T6.15 8v8q.65.25 1.125.725T8 17.85h2.9l-1.675-1.675 1.6-1.625 4.45 4.45ZM19 22.225q-1.35 0-2.287-.937-.938-.938-.938-2.288 0-1.05.588-1.863.587-.812 1.487-1.137V8q-.9-.325-1.487-1.137-.588-.813-.588-1.863 0-1.35.938-2.288.937-.937 2.287-.937 1.35 0 2.288.937.937.938.937 2.288 0 1.05-.587 1.863Q21.05 7.675 20.15 8v8q.9.35 1.488 1.163.587.812.587 1.837 0 1.35-.937 2.288-.938.937-2.288.937ZM5 19.95q.4 0 .675-.275T5.95 19q0-.4-.275-.675T5 18.05q-.4 0-.675.275T4.05 19q0 .4.275.675T5 19.95Zm14 0q.4 0 .675-.275T19.95 19q0-.4-.275-.675T19 18.05q-.4 0-.675.275T18.05 19q0 .4.275.675t.675.275Zm-14-14q.4 0 .675-.275T5.95 5q0-.4-.275-.675T5 4.05q-.4 0-.675.275T4.05 5q0 .4.275.675T5 5.95Zm14 0q.4 0 .675-.275T19.95 5q0-.4-.275-.675T19 4.05q-.4 0-.675.275T18.05 5q0 .4.275.675T19 5.95ZM5 19Zm14 0ZM5 5Zm14 0Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <filter-chip id="applicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Application Numbers</filter-chip>
  <filter-chip id="publicationNumbers" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Publication Numbers</filter-chip>
  <filter-chip id="either" selected="" class="style-scope numerical-search-term-wizard"><svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" preserveAspectRatio="none" class="style-scope filter-chip">
  <path d="M18.9 35.7 7.7 24.5 9.85 22.35 18.9 31.4 38.1 12.2 40.25 14.35Z" class="style-scope filter-chip"></path>
</svg>
Either</filter-chip>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M12 22.2q-2.1 0-3.962-.8-1.863-.8-3.25-2.175Q3.4 17.85 2.6 15.988 1.8 14.125 1.8 12t.8-3.988q.8-1.862 2.188-3.237Q6.175 3.4 8.038 2.6 9.9 1.8 12 1.8q2.125 0 3.988.8 1.862.8 3.237 2.175Q20.6 6.15 21.4 8.012q.8 1.863.8 3.988t-.8 3.988q-.8 1.862-2.175 3.237Q17.85 20.6 15.988 21.4q-1.863.8-3.988.8Zm-1-2.325v-1.95q-.8 0-1.387-.575-.588-.575-.588-1.4v-.975L4.275 10.2q-.075.45-.137.9-.063.45-.063.9 0 3 1.975 5.25T11 19.875Zm6.85-2.525q.5-.55.888-1.175.387-.625.65-1.313.262-.687.4-1.412.137-.725.137-1.45 0-2.425-1.338-4.438-1.337-2.012-3.612-2.887v.375q0 .825-.587 1.4-.588.575-1.388.575h-2v2q0 .4-.287.687-.288.288-.688.288h-2v2h5.95q.425 0 .713.287.287.288.287.688v2.975h1q.65 0 1.163.387.512.388.712 1.013Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryFilter" placeholder="Restrict search to these countries" class="style-scope numerical-search-term-wizard" value=""><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Restrict search to these countries">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <svg xmlns="http://www.w3.org/2000/svg" height="24" width="24" fill="#041E49" class="style-scope numerical-search-term-wizard">
    <path d="M2.85 18.225V15.95h6.3v2.275Zm0-5.075v-2.3h12.3v2.3Zm0-5.1V5.775h18.3V8.05Z" class="style-scope numerical-search-term-wizard"></path>
  </svg>
  <outlined-text-field id="countryOrder" placeholder="Prefer results from these countries in this order" class="style-scope numerical-search-term-wizard" value="US, EP, WO, JP, CN"><span class="style-scope outlined-text-field">
  <input id="input" spellcheck="false" autocomplete="off" class="style-scope outlined-text-field" aria-disabled="false" placeholder="Prefer results from these countries in this order">
  
</span>
</outlined-text-field>
</span>
<span class="style-scope numerical-search-term-wizard">
  <mat-button id="button" filled="" class="style-scope numerical-search-term-wizard x-scope mat-button-0" disabled=""><span slot="label" class="style-scope numerical-search-term-wizard">Add AND condition</span></mat-button>
</span>
</numerical-search-term-wizard>
  </span>

</pat-dialog>
</search-term-wizard>
          
      <div content="" class="style-scope search-result">
        <div id="mainContainer" class="vertical layout style-scope search-result">
          <template is="dom-if" class="style-scope search-result"></template>
          <result-container class="style-scope search-result">
    

    <paper-spinner class="style-scope result-container x-scope paper-spinner-0" aria-hidden="true" hidden=""><div id="spinnerContainer" class="  style-scope paper-spinner"><div class="spinner-layer layer-1 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-2 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-3 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div><div class="spinner-layer layer-4 style-scope paper-spinner"><div class="circle-clipper left style-scope paper-spinner"></div><div class="circle-clipper right style-scope paper-spinner"></div></div></div></paper-spinner>
    
      <patent-result class="style-scope result-container">
    
    
    <div class="layout horizontal style-scope patent-result">
      <div style="width: 1200px; height: auto; overflow: auto;" class="style-scope patent-result">
        <div id="wrapper" tabindex="0" class="style-scope patent-result">
          <result-tags class="style-scope patent-result"></result-tags>
          <h1 id="title" class="scroll-target style-scope patent-result">
            </h1>
          <div class="horizontal layout style-scope patent-result">
            
            <div class="flex-3 style-scope patent-result" style="margin-top:-20px;overflow:hidden;" marginright="">
              <section id="abstract" class="style-scope patent-result" hidden="">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Abstract</div>
                  <div class="righthead style-scope patent-result" hidden="">translated from </div>
                </h3>
                <patent-text name="abstract" class="style-scope patent-result">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"></section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <section id="classifications" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Classifications</div>
                  <div id="machineClassifiedWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">machine-classified</div>
                  <div id="machineClassifiedCPCWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">cpc-machine-classified</div>
                  <div id="machineClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-machine-classified</div>
                  <div class="style-scope patent-result" hidden="">&nbsp;</div>
                  <div id="familyClassifiedFtermWarning" class="righthead tooltip-hint style-scope patent-result" hidden="">fterm-family-classified</div>
                </h3>
                <overlay-tooltip positioning-target="#machineClassifiedWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedCPCWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The CPC classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#familyClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned based on a patent family member containing these classification codes.
    </div>
  </overlay-tooltip>
                <overlay-tooltip positioning-target="#machineClassifiedFtermWarning" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      The F-term classifications are assigned by a computer and are not a legal conclusion. <br class="style-scope patent-result"> Google has not performed a legal analysis and makes no representation as to the accuracy of the classifications listed.
    </div>
  </overlay-tooltip>
                <classification-viewer class="style-scope patent-result">
    
    <div class="table style-scope classification-viewer">
      
        <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D493/00"><a id="link" href="#" class="style-scope state-modifier">C07D493/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D493/02"><a id="link" href="#" class="style-scope state-modifier">C07D493/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" first="true" data-cpc="C07D493/04"><a id="link" href="#" class="style-scope state-modifier">C07D493/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Ortho-condensed systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
      <template is="dom-repeat" class="style-scope classification-viewer"></template>
      
      <div class="style-scope classification-viewer">
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/04"><a id="link" href="#" class="style-scope state-modifier">A61P31/04</a></state-modifier>
                  <span class="description style-scope classification-tree">Antibacterial agents</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A"><a id="link" href="#" class="style-scope state-modifier">A</a></state-modifier>
                  <span class="description style-scope classification-tree">HUMAN NECESSITIES</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61"><a id="link" href="#" class="style-scope state-modifier">A61</a></state-modifier>
                  <span class="description style-scope classification-tree">MEDICAL OR VETERINARY SCIENCE; HYGIENE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P"><a id="link" href="#" class="style-scope state-modifier">A61P</a></state-modifier>
                  <span class="description style-scope classification-tree">SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/00"><a id="link" href="#" class="style-scope state-modifier">A61P31/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="A61P31/10"><a id="link" href="#" class="style-scope state-modifier">A61P31/10</a></state-modifier>
                  <span class="description style-scope classification-tree">Antimycotics</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D"><a id="link" href="#" class="style-scope state-modifier">C07D</a></state-modifier>
                  <span class="description style-scope classification-tree">HETEROCYCLIC COMPOUNDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D311/00"><a id="link" href="#" class="style-scope state-modifier">C07D311/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07D311/02"><a id="link" href="#" class="style-scope state-modifier">C07D311/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07"><a id="link" href="#" class="style-scope state-modifier">C07</a></state-modifier>
                  <span class="description style-scope classification-tree">ORGANIC CHEMISTRY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H"><a id="link" href="#" class="style-scope state-modifier">C07H</a></state-modifier>
                  <span class="description style-scope classification-tree">SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/00"><a id="link" href="#" class="style-scope state-modifier">C07H15/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/20"><a id="link" href="#" class="style-scope state-modifier">C07H15/20</a></state-modifier>
                  <span class="description style-scope classification-tree">Carbocyclic rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C07H15/24"><a id="link" href="#" class="style-scope state-modifier">C07H15/24</a></state-modifier>
                  <span class="description style-scope classification-tree">Condensed ring systems having three or more rings</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/00"><a id="link" href="#" class="style-scope state-modifier">C12P17/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/02"><a id="link" href="#" class="style-scope state-modifier">C12P17/02</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxygen as only ring hetero atoms</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P17/06"><a id="link" href="#" class="style-scope state-modifier">C12P17/06</a></state-modifier>
                  <span class="description style-scope classification-tree">Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        
          <classification-tree class="style-scope classification-viewer">
    
    <div class="style-scope classification-tree">
      <div class="layout horizontal wrap style-scope classification-tree">
        <div class="flex style-scope classification-tree">
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C"><a id="link" href="#" class="style-scope state-modifier">C</a></state-modifier>
                  <span class="description style-scope classification-tree">CHEMISTRY; METALLURGY</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12"><a id="link" href="#" class="style-scope state-modifier">C12</a></state-modifier>
                  <span class="description style-scope classification-tree">BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P"><a id="link" href="#" class="style-scope state-modifier">C12P</a></state-modifier>
                  <span class="description style-scope classification-tree">FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree" hidden="">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/00"><a id="link" href="#" class="style-scope state-modifier">C12P19/00</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of compounds containing saccharide radicals</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          
            
              <div class="style-scope classification-tree">
                <concept-mention class="style-scope classification-tree">
    
    <span id="target" tabindex="0" aria-label="Details of concept" role="link" class="style-scope concept-mention">
      
        <iron-icon class="inline-icon style-scope concept-mention x-scope iron-icon-0" icon="icons:label"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M17.63 5.84C17.27 5.33 16.67 5 16 5L5 5.01C3.9 5.01 3 5.9 3 7v10c0 1.1.9 1.99 2 1.99L16 19c.67 0 1.27-.33 1.63-.84L22 12l-4.37-6.16z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
      <template is="dom-if" class="style-scope concept-mention"></template>
      
                  <state-modifier class="code style-scope classification-tree" act="{&quot;type&quot;: &quot;QUERY_ADD_CPC&quot;, &quot;cpc&quot;: &quot;$cpc&quot;}" data-cpc="C12P19/44"><a id="link" href="#" class="style-scope state-modifier">C12P19/44</a></state-modifier>
                  <span class="description style-scope classification-tree">Preparation of O-glycosides, e.g. glucosides</span>
                
      <template is="dom-if" restamp="" class="style-scope concept-mention"></template>
    </span>
  </concept-mention>
              </div>
            <template is="dom-if" class="style-scope classification-tree"></template>
            <template is="dom-if" class="style-scope classification-tree"></template>
          <template is="dom-repeat" class="style-scope classification-tree"></template>
        </div>
      </div>
    </div>
  </classification-tree>
        <template is="dom-repeat" class="style-scope classification-viewer"></template>
        <div class="more style-scope classification-viewer" style="" hidden="">View 6 more classifications</div>
        <div class="more style-scope classification-viewer">Hide more classifications</div>
      </div>
      <template is="dom-if" class="style-scope classification-viewer"></template>
    </div>
  </classification-viewer>
              </section>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              <template is="dom-if" class="style-scope patent-result"></template>
              
              
                <section class="style-scope patent-result">
                  <h3 class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Landscapes</div>
                  </h3>
                  <div class="responsive-grid style-scope patent-result">
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Chemical &amp; Material Sciences"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Chemical &amp; Material Sciences
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    
                      <landscape-link class="style-scope patent-result"><state-modifier act="{&quot;type&quot;:&quot;QUERY_SET_TERM&quot;,&quot;term&quot;:&quot;$term&quot;,&quot;origin&quot;:&quot;LANDSCAPE_LINK&quot;}" class="style-scope landscape-link" data-term="Organic Chemistry"><a id="link" href="#" class="style-scope state-modifier">
  <requery-tile class="area style-scope landscape-link">
<span class="label style-scope requery-tile">
    Organic Chemistry
  </span>
<span class="search-icon style-scope requery-tile"></span>
</requery-tile>
</a></state-modifier>
</landscape-link>
                    <template is="dom-repeat" class="style-scope patent-result"></template>
                  </div>
                  <s-more-inline class="style-scope patent-result"><hr aria-hidden="true" class="style-scope s-more-inline">

<div class="button style-scope s-more-inline">
  <span slot="expand_text" class="style-scope patent-result">Show more</span>
  <span class="expand more style-scope s-more-inline"></span>
</div>
<div class="button style-scope s-more-inline" hidden="">
  <span slot="collapse_text" class="style-scope patent-result">Show less</span>
  <span class="expand less style-scope s-more-inline"></span>
</div>
</s-more-inline>
                </section>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
            <div class="flex-2 style-scope patent-result">
              <section class="knowledge-card style-scope patent-result">
                <header class="style-scope patent-result">
                  <h2 id="pubnum" class="style-scope patent-result">TW321644B</h2>
                  <p class="tagline style-scope patent-result">Taiwan</p>
                  <overlay-tooltip positioning-target="#pubnum" direction="bottom" class="style-scope patent-result" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                    <div style="max-width: 300px;" class="style-scope patent-result">Granted Patent or patent of addition</div>
                  
    </div>
  </overlay-tooltip>

                  <div class="knowledge-card-action-bar style-scope patent-result">
                    <a target="_blank" class="style-scope patent-result" href="https://patentimages.storage.googleapis.com/f2/fc/cc/97eea82ed8e1e7/TW321644B.pdf"><iron-icon icon="description" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Download PDF</a>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_FIND_PRIOR_ART&quot;, &quot;keywords&quot;: $keywords, &quot;before&quot;: &quot;$before&quot;}" class="style-scope patent-result" data-keywords="[&quot;methyl&quot;,&quot;formula&quot;,&quot;compound&quot;,&quot;group&quot;,&quot;printed&quot;]" data-before="19941108"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="find-in-page" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 19.59V8l-6-6H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c.45 0 .85-.15 1.19-.4l-4.43-4.43c-.8.52-1.74.83-2.76.83-2.76 0-5-2.24-5-5s2.24-5 5-5 5 2.24 5 5c0 1.02-.31 1.96-.83 2.75L20 19.59zM9 13c0 1.66 1.34 3 3 3s3-1.34 3-3-1.34-3-3-3-3 1.34-3 3z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Find Prior Art
                    </a></state-modifier>
                    <state-modifier inherit="" act="{&quot;type&quot;: &quot;QUERY_SIMILAR_DOCUMENTS&quot;, &quot;id&quot;: &quot;$id&quot;}" class="style-scope patent-result" data-id="patent/TW321644B"><a id="link" href="#" class="style-scope state-modifier" inherit="">
                      <iron-icon icon="editor:functions" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M18 4H6v2l6.5 6L6 18v2h12v-3h-7l5-5-5-5h7z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon> Similar
                    </a></state-modifier>
                  </div>
                </header>

                <dl class="important-people style-scope patent-result">
                  
                    <dt class="style-scope patent-result">Other languages</dt>
                    <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW321644B/zh"><a id="link" href="#" class="style-scope state-modifier">Chinese</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>
                  
                  <dt class="style-scope patent-result">Inventor</dt>
                  <dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Fiandor Roman Jose"><a id="link" href="#" class="style-scope state-modifier">Fiandor Roman Jose</a></state-modifier></dd><dd class="style-scope patent-result"><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_INVENTOR&quot;, &quot;inventor&quot;: &quot;$inventor&quot;}" class="style-scope patent-result" data-inventor="Gargallo Viola Domingo"><a id="link" href="#" class="style-scope state-modifier">Gargallo Viola Domingo</a></state-modifier></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                  <template is="dom-if" class="style-scope patent-result"></template>

                  <template is="dom-if" class="style-scope patent-result"></template>
                </dl>

                <hr class="style-scope patent-result">

                <application-timeline class="style-scope patent-result">
    
    
    <div class="wrap style-scope application-timeline">
      <div class="header style-scope application-timeline">Worldwide applications</div>
      <div class="event style-scope application-timeline">
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1995</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DK0753001T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">DK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DK95938406T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/DE69512041T2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">DE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: DE69512041T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/MX9602563A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">MX</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: MX9602563A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AP614A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">AP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: APAP/P/1996/000824A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ZA959362B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">ZA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ZA959362A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CN1056849C/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CN</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CN95192028A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NZ296091A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">NZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NZ296091A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/WO1996014326A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">WO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PCT/EP1995/004331</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/SK88496A3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">SK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: SK884-96A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/SI0753001T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">SI</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: SI9530311T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EE9600117A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">EE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EE9600117A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/PE49696A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">PE</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: PE1995283875A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Application Discontinuation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/RU2152398C1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline">RU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: RU96115273/04A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/KR100391401B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">KR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: KR1019960703661A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5854280A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US08/669,441</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ATE184284T1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AT</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AT95938406T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/ES2137549T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">ES</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ES95938406T</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CA2179403A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">CA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CA002179403A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Abandoned</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HU218611B/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">HU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HU9701865A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0753001B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">EP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: EP95938406A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Expired - Lifetime</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/JPH09508144A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">JP</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: JP8515051A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BR9506473A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">BR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BR9506473A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AU704405B2/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">AU</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: AU39809/95A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: Ceased</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CZ202796A3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">CZ</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CZ962027A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-06</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/AR013815A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">AR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: ARP950100073A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-07</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/CO4520226A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">CO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: CO95052481A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-07</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/IL115905A0/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">IL</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: IL11590595A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-07</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/TW321644B/zh"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="active style-scope application-timeline" this="">TW</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: TW084112259A</div>
                <div class="style-scope application-timeline">Filing date: 1995-11-18</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1996</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/IS4352A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">IS</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: IS4352A</div>
                <div class="style-scope application-timeline">Filing date: 1996-06-10</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/OA10303A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">OA</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: OA60855A</div>
                <div class="style-scope application-timeline">Filing date: 1996-07-03</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/FI962773A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">FI</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: FI962773A</div>
                <div class="style-scope application-timeline">Filing date: 1996-07-05</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/BG62620B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">BG</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: BG100699A</div>
                <div class="style-scope application-timeline">Filing date: 1996-07-05</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/NO307092B1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">NO</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: NO962856A</div>
                <div class="style-scope application-timeline">Filing date: 1996-07-05</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1998</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/HK1004222A1/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">HK</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: HK98103335A</div>
                <div class="style-scope application-timeline">Filing date: 1998-04-21</div>
                <div class="style-scope application-timeline">Legal status: IP Right Cessation</div>
              
    </div>
  </overlay-tooltip>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/US5952334A/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="not_active style-scope application-timeline">US</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: US09/081,090</div>
                <div class="style-scope application-timeline">Filing date: 1998-05-19</div>
                <div class="style-scope application-timeline">Legal status: Expired - Fee Related</div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        
          <span class="block style-scope application-timeline">
            <span class="year style-scope application-timeline">1999</span>
            <span class="dot style-scope application-timeline"></span>
            
              <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/GR3031677T3/en"><a id="link" href="#" class="style-scope state-modifier">
                <span id="cc" class="unknown style-scope application-timeline">GR</span>
              </a></state-modifier>
              <overlay-tooltip positioning-target="#cc" direction="bottom" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
                <div class="style-scope application-timeline">Application number: GR990402767T</div>
                <div class="style-scope application-timeline">Filing date: 1999-10-27</div>
                <div class="style-scope application-timeline">Legal status: </div>
              
    </div>
  </overlay-tooltip>
            <template is="dom-repeat" class="style-scope application-timeline"></template>
          </span>
        <template is="dom-repeat" class="style-scope application-timeline"></template>
      </div>
      <hr class="style-scope application-timeline">
      <div class="header style-scope application-timeline">Application TW084112259A events <iron-icon id="legal" icon="icons:help-outline" class="style-scope application-timeline x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M11 18h2v-2h-2v2zm1-16C6.48 2 2 6.48 2 12s4.48 10 10 10 10-4.48 10-10S17.52 2 12 2zm0 18c-4.41 0-8-3.59-8-8s3.59-8 8-8 8 3.59 8 8-3.59 8-8 8zm0-14c-2.21 0-4 1.79-4 4h2c0-1.1.9-2 2-2s2 .9 2 2c0 2-3 1.75-3 5h2c0-2.25 3-2.5 3-5 0-2.21-1.79-4-4-4z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        <overlay-tooltip positioning-target="#legal" direction="right" class="style-scope application-timeline" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
          <div style="max-width: 300px;" class="style-scope application-timeline">
            A timeline of key events for this patent application, including priority claims, publications, legal status, reassignments, and litigation.<br class="style-scope application-timeline"><br class="style-scope application-timeline">
            Google has not performed a legal analysis and makes no representation as to the accuracy or completeness of the events listed.
          </div>
        
    </div>
  </overlay-tooltip>
      </div>
      <div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">1994-11-08</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0712859A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from EP94500173A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline"><div date="" class="external-priority style-scope application-timeline">1994-11-08</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/EP0711784A1/en"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Priority claimed from EP94500175A</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="filed style-scope application-timeline">1995-11-18</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;QUERY_SEARCH_ASSIGNEE&quot;, &quot;assignee&quot;: &quot;$assignee&quot;}" class="style-scope application-timeline" data-assignee="Glaxo Wellcome Sa"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Application filed by Glaxo Wellcome Sa</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="granted style-scope application-timeline">1997-12-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><span class="title-text style-scope application-timeline">Application granted</span><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><div class="event layout horizontal style-scope application-timeline" critical=""><div date="" class="publication style-scope application-timeline">1997-12-01</div><div class="line style-scope application-timeline"></div><div class="flex title style-scope application-timeline"><template is="dom-if" class="style-scope application-timeline"></template><state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope application-timeline" data-result="patent/TW321644B/zh"><a id="link" href="#" class="style-scope state-modifier"><span class="title-text style-scope application-timeline">Publication of TW321644B</span></a></state-modifier><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template><template is="dom-if" class="style-scope application-timeline"></template></div></div><template is="dom-repeat" strip-whitespace="" class="style-scope application-timeline"></template>
      <template is="dom-if" class="style-scope application-timeline"></template>
    </div>
  </application-timeline>
                <hr class="style-scope patent-result">

                <dl class="links style-scope patent-result">
                  <dt class="style-scope patent-result">Info</dt>

                  
                  <dd class="style-scope patent-result"><a href="#patentCitations" class="style-scope patent-result">Patent citations (4)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#citedBy" class="style-scope patent-result">Cited by (25)</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#similarDocuments" class="style-scope patent-result">Similar documents</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  
                  <dd class="style-scope patent-result"><a href="#relatedApplications" class="style-scope patent-result">Priority and Related Applications</a></dd>
                  <template is="dom-if" restamp="" class="style-scope patent-result"></template>

                  <dt class="style-scope patent-result">External links</dt>

                  <dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://worldwide.espacenet.com/publicationDetails/biblio?CC=TW&amp;NR=321644B&amp;KC=B&amp;FT=D">Espacenet</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://globaldossier.uspto.gov/#/result/publication/TW/321644/1">Global Dossier</a></dd><dd class="style-scope patent-result"><a target="_blank" class="style-scope patent-result" href="https://patents.stackexchange.com/questions/tagged/TW321644B">Discuss</a></dd><template is="dom-repeat" strip-whitespace="" class="style-scope patent-result"></template>
                </dl>
              </section>
            </div>
          </div>

          <div id="text" class="horizontal layout style-scope patent-result">
            <div class="flex flex-width style-scope patent-result" marginright="">
              <section id="description" class="style-scope patent-result">
                <h3 class="layout horizontal style-scope patent-result">
                  <div class="flex style-scope patent-result">Description</div>
                  <div class="righthead style-scope patent-result">translated from Chinese</div>
                </h3>
                <patent-text name="description" id="descriptionText" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><description mxw-id="PDES113585559" lang="EN" load-source="google" class="style-scope patent-text">
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">^^164 4 A7 B7 1 srdarjn )    1162,027nrrl 319681^22668!^2266( Helvetica Chimica Acta (INI)g_ (sordaricin)J6 2040292A zofimarin)  A) ()</span>^^ 164 4 A7 B7 5. Description of the invention (1 The present invention relates to a novel sodarin (srdarjn) derivative with antimycobacterial activity, as well as its preparation, buttock composition containing these compounds, and Its medical use, more specifically, its use in the prevention or treatment of diseases caused by Candida infections in mammals, including humans. British Patent No. 1,162,027 describes the cultivation of Mycobacterium faecalis The nrrl 3196 strain was prepared as an antibiotic 81 ^ 226'6. 8! ^ 2266 (hereinafter called sodarin) was reported to have inhibitory activity against the mycobacterium. The same research group also explained sodarin in Helvetica Chimica Acta (INI), g It is degraded into sordaricin. Published Japanese patent application J6 2040292A shows the preparation of zofimarin antibiotics. It is reported that zofimarin also has antimycobacterial activity. Sodarin, Sodarin Lixin and Zofimarin can be represented by the following formula (A) (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T      </span> 1T kneads the accurate shellfish by the center</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(I) OR OH HCL OCH,      % OROH 4- ^CNS ) A4210X297 ^1644 A7 B7 2 ) OR  9CCH=zCH-CH=eCHCH3 -yCH3   ch3      J) H0 0 CH.</span>(I) Where OR is OH HCL and OCH, then it is printed by Sodarin Cooperative.% OR is OH, it is Sodarin new; and 4-this paper is suitable for China National Standard (CNS) A4 specification 210X297mm) ^ 1644 A7 B7 V. Description of the invention (2) OR is. 9CCH = zCH-CH = eCHCH3 -yCH3   ch3 is Zofimaline. Although sodarin and zofimaline exhibited antimycobacterial activity, these two compounds had only moderate activity, and the tests of various mycobacteria showed a limited range of action. The inventors are equal to the latter group of novel candidiasis sodarin derivatives. These derivatives have excellent anti-candidiasis activity and a wider range of action. Yes, according to the first aspect of the present invention, the inventors provided the compound of formula (J) H0 0 CH.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(I)  z  tug  (21()&amp;gt;&amp;lt;297~ - ()</span>(I) Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs where z is a basic paper of tetrahydropyridine selected from the following formula from tug thread (21 () &amp;gt; &amp;lt; 297 public) ~-(please read first (Notes on the back then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> R2 R3</span>3. Description of the invention (R2 R3</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> </span>Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs </span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  R1Ci42 R CuC14 RR3c = , c = sC  - 3'8 CH2R7(R7c MWw RRCu^._4Ci 4 R5R6C = Qc = 8  3* 1 ; -6- CNS ) 4210X297 (}</span>And its pharmaceutically acceptable salts and solvates (such as hydrates) or metabolic instability derivatives, where R1 represents hydrogen, Nansu, Lu, Ci4 tiger or oxo, ruler 2 and R can be independent Represents hydrogen 'Cu alkyl or C14 alkoxyalkyl, or the carbon atom to which R and R3 are linked together represents c = , c = s or C cycloalkyl;-3'8 ruler represents hydrogen or CH2R7 (this Where R7 is hydrogen, radical, c MW group diagram, where w group or aryl group; R and R can independently represent hydrogen, Cu alkyl or (^ ._ 4 alkoxy Ci 4 alkyl, or R5 and R6 The carbon atoms that are commonly associated with it represent C = Q, c = 8 cycloalkyl;  3 *  represents zero or 1; -6--sheet scales are used in China National Standard (CNS) 4 specifications (210X297 mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7  B7__ 4)''  ' --- XYCR9R10(R9Rl Cl-6C.44C_4 R9RlC = 0C = Sc3 C = CHRllR11^ Y-y_CR2r3-X_Cr2r3_ -N = CR3_  _NR12_CR2R3_( CR2&amp;amp; 3 c =  R12C!_4CR13Rl3!Ci 6 YCH  R15C16C16 1212C1-3 Ci_4c36OCORW R18(^_4Ci 1 - 10C1_6CuR16R&amp;quot; R16c = c = CH2 ; R17CH2Ri9Ri9Cii4 OCOR20r2(^Ci4 wch2* ;  {} a) I)   p_ N- CNS ) A4210X297 A7 ^^1644 ______ 7 5 ) ( 0 I)  I)  I)I)      &amp;quot;C14     123 Cuc_64Ci_4  5 -6 -  &amp;quot;  R 1 C  r 1 3 8 - CNS )2IGX297)~~~ ---'~~ () </span>A7  B7__ V. Description of the invention (4)  ''  '--- X and Y can independently represent oxygen, sulfur or CR9R10 (here R9 and Rl can independently represent hydrogen, Cl-6 alkyl, C. 4 alkoxy or .4 alkoxy C] _4 alkyl, or R9 and Rl together with the carbon atom to which it represents C = 0, C = S, or c3 cycloalkyl or C = CHRll, here R11 represents hydrogen or ^ "alkyl); or when  or Y is oxygen and  is zero, -y_CR2r3 or -X_Cr2r3_ may represent -N = CR3_ or _NR12_CR2R3_ (here CR2 &amp; rule 3 is c =  , And R12 is C! _4 alkyl, CR13 acetyl, here Rl3! Ci 6 alkyl) or when Y is oxygen and  is zero,  can represent a CH group, this group is linked to the piper with a double bond On the furan ring; R15 represents hydrogen, Nansu, azido, C16 alkyl, hydroxy, C16 alkoxy (optionally substituted by 1 or 2 hydroxy or its ketal or 1 or 2 C1-3 alkoxy ), Aryl Ci_4 alkoxy, c36 alkenyloxy, OCORW group diagram (where R18 is an aryl group (^ _4 alkoxy or Ci 1-10 burning group containing one or two double bonds as needed) or C1_6 alkoxycarbonyl group Cu alkoxy group, and R16 represents hydrogen or R &amp;quot; and R16 together with the carbon atom associated with it represents c = Or c = CH2; R17 represents CH2Ri9, where Ri9 is hydrogen, hydroxy, Cii4 alkoxy or OCOR20 group, where r2 (^ Ci4 alkyl); and w represents an oxygen or sulfur atom or ch2 *; Printed by the Pui Pui Consumer Cooperative {please read the precautions on the back before filling in this page} and the dotted line of group (a) indicates that sometimes there is another bond; the compound of formula (I) is suitably pharmaceutically acceptable Salts include inorganic salts, such as hair metal salts (such as sodium and potassium salts) and ammonium salts and organic alkali salts. Suitable organic salts include amine salts such as trialkylamines (such as triethylamine), dioxane Amines (such as dicyclohexylamine) 'optionally substituted fluorenylamines (such as phenylfluorenylamine or p-bromobenzylamine), procaine, ethanolamine, diethanolamine, N-methylglucamine And three paper standards for the Chinese National Standard (CNS) A4 specifications (210X297mm) A7 ^^ 1644 ______ 7 5. Description of the invention (5) (methyl) methylamine salt, and amino acid salt ( (Such as lysine salt and spermine salt) 0 The compound of formula (I) referred to hereinafter includes this compound and its pharmaceutically acceptable salts. Pharmaceutically unacceptable salts can be used to prepare compounds of formula (I), which is another aspect of the present invention. Metabolically unstable compounds of formula (I) are compounds that are converted into compounds of formula (I) in vivo. Examples of such derivatives include metabolically unstable esters traditionally formed from free trait acids in the molecule. It is understood that 'this invention includes any individual isomers of the compound represented by formula ()' includes optical isomers and mixtures thereof, including all or part of racemic mixtures. The "alkyl" here refers to either the alkyl group itself or the alkyl portion of the C14 alkoxy group may be linear or branched. Suitable examples include methyl, ethyl, n-propyl, isopropyl , N-butyl, secondary butyl, tertiary butyl, n-hexyl, and n-octyl. The so-called "aryl" here, whether it is an aromatic body or part of a group, means phenyl or heteroaryl , Each optionally substituted by one or more (eg 1, 2 or 3) atoms or radicals selected from halogen, hydroxy, Cu alkyl, c] _6alkoxy 4Ci_4 alkoxycarbonyl. This heteroaryl The group may be a 5- or 6-membered heteroaryl ring containing one or more heteroatoms selected from nitrogen, oxygen, and sulfur. Examples of suitable heteroaryl groups include pyridyl, furyl, pyrenyl, and halo The term "halogen" means fluorine, gas, moth or moth. When R 1 is a brewed milk base 'representable' For example, C r 1 3 base ring, of which 8-the speed of the paper with the Zhongguanjia standard rate (CNS) to threaten (2IGX297 mm) ~~~ --- '~~ (Please read the precautions on the back before filling out this page) </span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  / 32j^644 at ___B7 6 ) R13 C3_8 XCR9R10R9R10 &amp;lt;^_4Ci_4CR9 R10 /c = 0 C^CHR11c = CH2XNHR11 YCR9R10R9Ch4 SCuRiCu R18Cii. c5 8_CH=zch- ch=echch3 R1516  2,3-2,3_ - R16Ri5 R1 R2Ci_4R3  c^_4 4Ci_4cr2r3 c=  c = sc3_8 R4Ci_4  R5R64 ^^7^1210)&amp;lt;29 ---------f -------Tr------( ()  321644 A7 B7 7)</span>1. Printed by the Employee Consumer Cooperative of the Central Bureau of Economics of the 1T Ministry of Economic Affairs / 32j ^ 644 at ___B7 5. Description of Invention (6) The definition of R13 is as described above. Examples of C3_8 cycloalkyl include cyclopentyl and cyclohexyl. Examples of X-based sleepy groups include oxygen, CR9R10, wherein R9 and R10 are each hydrogen, &amp;lt; ^ _ 4 alkoxy or Ci_4 alkyl, or CR9 R10 / represents c = 0 or C ^ CHR11 group, for example, c = CH2, Or X stands for NHR11. Suitable examples of the Y base diagram include oxygen or CR9R10, where R9 is hydrogen, Ch4 alkoxy SCu alkyl, and Ri is hydrogen or Cu alkyl. When R18 is an unsaturated Cioalkane group, it may particularly represent a linear or branched C5 8 alkyl group containing two double bonds, for example, _CH = zch-ch = echch3. When R15 is substituted with hydroxy or alkoxy (16 alkoxy, it can be, for example, '2,3-dihydroxypropoxy and acetone ketal derived from it, or 2,3_ dimethoxy -Propoxy. R16 is preferably a hydrogen atom, and Ri5 exists in a configuration. R1 may represent, for example, a hydrogen atom or a hydroxyl group. R2 may represent, for example, hydrogen or a Ci_4 alkyl group (for example, methyl), and R3 may Represents, for example, "gas" c ^ _4 alkyl (such as methyl, ethyl or n-propyl) or 4 alkyloxy Ci_4 alkyl (such as methoxyethyl), or cr2r3 may represent c =  'c = s Or c3_8 cycloalkyl (eg cyclopentyl). R4 can represent 'for example, methyl or Ci_4 alkoxymethyl (eg methoxymethyl). R5 and R6 can independently represent, for example, hydrogen or 4 alkyl (For example, methyl). This paper is from China ^^ 7 ^ 1210) &amp;lt; 29 II) --------- f- ------, Tr ------ ((Please read the precautions on the back before filling in this page) Printed 321644 A7 B7 by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (7)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R </span>R to</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">S6 R R (CR5R6)n X  0\ P R2 R3 5 V R 0 f Re  R2 R3</span>The ring system represented by S6 R R (CR5R6) n X  includes 0 \ P R2 R3 5 V R 0 into f Re  R2 R3</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R2 R2 R3</span>R2 R2 R3</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> </span>,  and</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R2 R3 R11N O  R1 5C_ 4 Ci-4 C1-4Ci_4C1-4 -Cid^_42,3- 2,3-C3_6 3-R15R16 c = oc = ch2 R17-  R15Cyc3_4 CR4(R4Ci_4 R17 w . 1) -10 - CNS ) 4210297 ()</span>R2 R3 R11NQO O Examples of specific R1 5 radicals printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs include halogens (such as fluorine), azide bases, C alkoxy, benzyloxy, benzyloxy Carbonyloxy, Ci-4 alkoxycarbonyloxy, and C1-4 alkoxy Ci_4 alkoxy (for example, methyl oxyethoxy), C1-4 alkoxycarbonyl-Cid alkoxy, (^ _4 alkylcarbonyloxy, 2,3-dihydroxypropoxy, and its acetone ketal, 2,3-dimethoxypropoxy, C3_6 alkenyloxy such as allyloxy or 3-methylene Propoxy or R15 and R16 and the carbon atom to which they are associated represent c = o or c = ch2. R17 can represent, for example, methyl or alkoxymethyl (eg methoxymethyl) or hydroxyl R15 preferably represents Cy alkoxy, c3_4 alkenyloxy, fluorenyloxy or CR4 (here R4 is Ci_4 alkyl), especially in the configuration. R17 preferably represents methyl. W It is better to represent oxygen.  The compound of the specific group of the present invention is the compound of formula (1). Z is as follows: -10-This paper scale is applicable to China National Standards (CNS) 4 specification (210  297 mm) (please first Note on the back Item and then fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">S21644 8 ) A7 B7</span>S21644 V. Description of the invention (8) A7 B7</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CK</span>CK</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CH R1A  R4  R2 R3 X^(CR5R6)nR VS 'Ar4  Xycr9r10 RlXCR9R10R9  ci-3 Cb*RioCR9Ri c = 0OCHR11CHR99 Ci4R2R3ci4 C_423 C = C = SR5R6  R1ri R1 RR3Cl P4 R5R6 .  ______ -11 - CNS ) 42107 (</span>CH R1, A , R4 or R2 R3 X ^ (CR5R6) nR VS 'Arren Ar4 Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economics where one of X and y is oxygen and the other is oxygen or cr9r10 based Ring. More particular in this group is that R1 is hydroxy or hydrogen; X is oxygen, or CR9R10 where R9 is hydrogen 'ci-3 alkoxy' Cb * alkyl and Rio is hydrogen, or CR9Ri represents c = 0, or OCHR11 group;  is oxygen or CHR9, wherein ruler 9 is only or Ci  4 alkyl, R2 and R3 each independently represent hydrogen, ci4 alkyl, such as methyl, propyl or C _4 alkoxy (such as Oxymethyl), or the carbon atoms to which Ruler 2 and Ruler 3 are commonly associated represent a cyclopentyl or C = O or C = S group; R5 and R6 are each preferably hydrogen. When R1 represents a carbonyl group or a mayoxy group, the ri group is preferably located on the axis configuration. However, R1 preferably represents a hydrogen atom. R and R3 may represent nitrogen or Cl, or Hyun  ji, respectively. P4 preferably represents methyl. R5 and R6 are each preferably hydrogen. .  preferably represents zero. ______ -11-This paper scale is applicable to the Chinese National Standard (CNS) 4 specification (210X persuades 7mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  9 &amp;lt; R3 X^jCRVjn  A7 B7 R2 R3  R2R3 CR R (R9R10X YCHC%  ()  R2 R3 &amp;gt;5  XY CR9R10(R9Rl4 CR9R10c = 0C = CH2 R2R3C14C0 |  1)Za) R1R4 R2R3Ci4 XCHR9R9Ci 4c = ()C = XCHYn23 )Zb)  12- CNS ) A4210X297 - </span> 1T  V. Description of the invention (9 &amp;lt; R3 X ^ jCRVjn  A7 B7 R2 R3 represents the ring system including where R2 and R3 are as defined above, and each Y is independently oxygen, or CR R (where R9 and R10 The definition is as mentioned above), the prerequisite is that at least X and Y are oxygen or CHC% rings. (Please read the notes on the back before filling this page) Printed R2 R3&gt; 5 The preferred ring in the ring system is that one of X and Y represents oxygen, and the other represents CR9R10 (wherein R9 and R10 each independently represent argon or 4 alkyl (such as methyl) or CR9R10 represents c = 0 or C = CH2 Base map) or both represent oxygen; R2 and R3 represent hydrogen, C14 alkyl or C0 group. | It is understood that the present invention covers a mixture of the above specific and preferred groups. Another specific group of compounds of the invention is Compound of formula (1), wherein Z is (a) group and R1 is hydrogen, R4 is methyl;  is zero, and R2 and R3 are hydrogen or Ci4 alkyl, and Y is oxygen or  is oxygen and X is a CHR9 group, wherein R9 is hydrogen or Ci 4 alkyl, c = (), C =, or X is CH, Y is oxygen, n is zero and ruler 2 and ruler 3 are hydrogen. Group compounds are compounds of formula (), where Z is (b) group 12- This paper scale is applicable to China National Gradient (CNS) A4 specification (210X297 mm) -Subscribe </span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">II 3 A7 ^ B7 10)</span>Ministry of Economic Affairs, Central Bureau of Industry and Commerce-Industrial and Consumer Cooperatives Printed II 3 Ru Ren A7 ^ B7 V. Description of invention (10)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(b) (w RHwRls Cl-4OCOR4R4c  C3-4C1414   [1R-(1 a ,3a/3 ,  ,, ,  , ,8a^ )]8a-[[ 1 S,7R,9R]-2,8-9--4---[3.4.0]-_7__ ]-4--4,4a5,6,7i7a8,8a.-7_-3-(l--l4--S--3a(lH)- [1R-(1 a3a044a/? ;7y? ,7aar8ay5 )]8a-[(2,6--3,4-0----]-4-- 4,4&amp;amp;5,6,7,73,8,8&amp;amp;--7--3-(1--1,4- 1 -s--3a(lH)- [1R-(1  ,3ay5  ,4ay5 ,  ,laa ,8a/? )] 8a-[[ 1 S,4R,7R,9R]-2,8--4,9---[3 4.0]--:7--- ]-4 --4,4a,5,6,7,7a8,8a --7-- 3- (1- -1;4--s--3a(lH)- . -13- ______ &amp;gt;&amp;quot;?TCNS ) M21GX297' ---------f - ------1T------^  ()  A7 B7 11 ) [lR-(la ,3a^  ,4a/? ,7/9 ,7a^ ,8a/5 ) ] 8 a - [ [ 1 S , 4 S , 6 R, 8 R]-2,7--4,6---[3.4.0]--7-- ]-4 --4,4a56,7,7a8,8a --7 -- 3-(1--l4 --s -- 3a(lH)- [1R-(1 a3a4a/57/?7aa8a]8a-[(2,3--6-- 4- 0---D -]_4_ -4,4a56,7,7a8,8a --7 -- 3- (1--1,4--s-M-3a(lH)- [1R-(1 a3a/?44a77aa ,8ay5 )]8a-[(2,3--6--4-0 --D -]-4_ -4,43,5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1--14--s--3a(lH)-   I)    (      ___ -14- CNS ) A4^210X297 ()</span>(b) and its pharmaceutically acceptable solvates (such as hydrates), where w is oxygen or sulfur, and RH is as defined above. More specifically, w is oxygen and Rls is a radical selected from Cl-4 alkoxy, benzyloxy or OCOR4 (where R4 is a C alkyl group, such as isopropyl or tertiary butyl), or C3- 4 alkenoxy, C14 alkoxy 1 yl 4 carbonyl alkoxy. According to the present invention, specific compounds include: [1R- (1 a, 3a / 3,  , , ,  , , 8a ^)] 8a-[[1 S, 7R, 9R] -2, 8.  Dioxo-9-methyl-4-methylene-cis-bicyclo [3.4.0] -non_7_yl_oxymethyl] -4-carboxamide-4,4a, 5, 6,7i, 7a, 8,8a. Octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-S-pyridine-3a (lH) -carboxylic acid ; [1R- (1 a, 3a0, 4, 4a / ?; 7y ?, 7aar, 8ay5)] 8a-[(2,6-dioxy-3,4-0-isopropylidene-Lu- -epiperanosyloxy) methyl] -4-carboxamide-4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octahydro-7-methyl-3- (1 -Methyl ethyl) -1,4- 1 methylene-s-pyda-3a (lH) -carboxylic acid; [1R- (1 , 3ay5 , 4ay5,  , laa, 8a /? )] 8a-[[1 S, 4R, 7R, 9R] -2,8-dioxo-4,9-dimethyl-cis-bicyclo [3  4.0] -non-: 7-yl-oxy -Methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1; 4- Methylene-s--pyridine-3a (lH) -carboxylic acid. -13- ______ &amp;gt; Zhongguanjia ladder for paper New Zealand &amp;quot;? TCNS) M threat (21GX297 Gong '------- --f- ------ 1T ------ ^  (Please read the notes on the back before filling this page) A7 B7 printed by the Central Bureau of Standards Staff Consumer Cooperative V. Invention description (11) [lR- (la, 3a ^ , 4a /?, 7/9, 7a ^, 8a / 5)] 8 a-[[1 S , 4 S, 6 R, 8 R] -2,7-dioxo-4,6-dimethyl-cis-bicyclo [3.4.0] -non-7-yl-oxy  methyl] -4 -Methyl-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-s- Indah-3a (lH) -tetioic acid; [1R- (1 a, 3a Lu, 4a / 5, 7 / ?, 7aa, 8a cold)] 8a-[(2,3-anhydro-6-de Oxygen-4-O-propyl-cold-D-piperanmannosyloxy) methyl] _4_carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7 -Methyl- 3- (1-methylethyl) -1,4-methylene-sM-da-3a (lH) -carboxylic acid; [1R- (1 a, 3a / ?, 4, 4a Lu, 7 Lu, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-4-0-methyl  Van-D-piperanmannosyloxy) methyl] -4 _Methyl-4,43,5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene- s-indap-3a (lH) -carboxylic acid; and its pharmaceutically acceptable salts and solvates (such as hydrates) or metabolic instability derivatives. The compound of formula (I) is a very effective fungicide for the treatment of animal infections including humans. For example, it can be used to treat various types of Candida (such as Candida albicans, Candida group (Pseudomonas glabrata), Candida tropicalis, Candida parapsilosis, and Candida pseudotropicalis), Cryptococcus neoformans, and Pneumocystis carinii Insects, various Aspergillus species (such as Aspergillus flavus and Aspergillus fumigatus), Coccidioides (such as Coccidioides), Paracoccidioides (such as Paracoccus brazii), and Histoplasma (such as capsules) Systemic infections caused by histoplasma) or genus Buds (such as dermatitis dermatitis). It can also be used to treat local infections caused by a variety of Candida, Trichoderma, Microsporum or Epidermophilia (such as Trichomonas esculenta, Crimson red bacteria, Microsporum canis or Trichophyton floccus), or caused by Mucosal infection caused by Candida albicans. ___ -14- This paper uses the Chinese National Standard (CNS) A4 ^ (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7  12) I) Geotrichum clavatum) Blastoschizomyces( BlastschizomyCes capitatus)  Scedosporium( Scedosporium apiosperum)  I) CryptoperidumTripanosrna    37C2448 MIC)   MI C . 1. 1 MF C99 9 %   I)  39 5 0 % -15- CNS )421x297 (} .. 1T. A7</span>A7 B7 Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (12) The compound of formula (I) can also be used for the treatment of various filamentous mycetes such as Geotrichum clavatum, Mycelia ( Such as B. gerbilii), Blastoschizomyces (such as BlastozochimyCes capitatus), spore mycelia (such as S. sclerotiorum) Scedosporium (such as Scedosporium apiosperum), Cladosporium (such as Scavenger spores) Infections caused by bottle-shaped yeast. The compound of formula (I) can also be used to treat infections caused by protozoa such as Toxoplasma gondii, Cryptoperidum, Leishmania, Tripanosna, Giardia trichomoniasis. The in vitro evaluation of the anti-smear activity of the compounds of the present invention is performed on liquid or solid media using a two-fold serial dilution technique of anti-smear bacteria. This technique measures the inhibition of anti-smear agents at 37  C after 24 to 48 hours The minimum inhibitory concentration (MIC) of the growth of Candida. In practice, clinically relevant pathogens, such as Candida albicans, are cultivated with a series of agar plates or broth microdilution series containing a double dilution of antimycobacterial agent. Then measure the growth of the candida in the agar dish or broth microdilution series and record the appropriate MI C value. The MF C value (that is, the minimum concentration of anti-mycobacteria that kills at least 99.9% of pathogens in the original liquid medium) will be determined by subculture of 0.01 and 0.1 microliter broth in the control cavity without drug. Pathogens grow in the recesses, and other soil fat dish recesses grow without pathogens. The in vivo evaluation of the compound of formula (I) is based on a series of different dosimetry in which administration (eg, subcutaneous administration, oral administration, intraperitoneal administration or intravenous administration) is inoculated with Candida albicans strains. Untreated mice died within 3 to 9 days, and the dose that prevented 50% of infected mice from dying was recorded. -15- Use the Chinese National Standard Rate (CNS) 84 specifications (21x297mm) (please read the precautions on the back before filling out this page). .  1T. A7</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> i)   CNS)            I) /         _________ -16- CNS ) A4210X297 ' () '. 11 </span>Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. The compound of formula (i) has antimycobacterial activity and can be used to treat various infections of human mycetes. Such infections include surface, skin, subcutaneous, and systemic fungal infections, such as respiratory infections, gastrointestinal infections, cardiovascular infections, urinary tract infections, central nervous system (CNS) infections, candidiasis, and candidal candidiasis Diseases (such as thrush and vaginal candidiasis) and skin infections caused by candidiasis, candidiasis of the skin and mucous membranes, skin candidiasis including addiction and white addiction infections, Hong Kong foot, paronychia, variegation Ringworm, red addiction, abrasion, mycobacterial alveolar'candidiasis vulvitis and otitis externa. It can also be used as a preventive agent to prevent systemic and local infections. When used as a preventative, it can be used as part of a selective bowel decontamination program to prevent infections that occur in immunocompromised patients (eg, AIDS patients, cancer patients undergoing chemotherapy, and organ transplant patients). In some diseases or iatrogenic conditions, it may be necessary to prevent the overgrowth of mycetes during antibiotic treatment. When used for treatment, the compound of the present invention can be administered as its raw material, but it is preferred to use its pharmaceutical formulation. Therefore, the present invention also provides pharmaceutical formulations containing the compound of formula (I) and pharmaceutically acceptable salts thereof, and one or more pharmaceutically acceptable carriers, and optionally containing other therapeutic and / or prophylactic ingredients. The term "acceptable" means compatible with other ingredients and not harmful to the recipient. The composition of the present invention includes a composition specially formulated for oral administration, buccal administration, injection administration, implantation administration, rectal administration, topical administration, administration via the eye or urogenital system, or suitable for inhalation or insufflation Into the composition in the form of administration. Tablets or capsules for oral administration may contain traditional excipients, such as binding agents, ________; _ -16- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) '(Please read the back of the first Matters needing attention and then fill out this page)  'Household., 11 Printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ss1644 A7 _______^B7 14)     crsscarmdlse sodium ;     /     P-       /  -17- CNS ) A4210X297 ---------f '------------^ () A7 ^^^______B7___ 15)             ()   Pur_ns )           -18- CNS ) A4210X297  A7 B7 16) /           O.OOi1000 001400 0.0015000.12 14  5  //    0  polienicsB(Amphotericin B) _ -19- CNS ) 4210297 ()   321644 A7 B7 17 ) (Nystatin)(B (Fluconazole))Intraconazole)_  (Ketoconazole)Miconazole) + (Clotrimazole) ZD-08070 (UK-109496))5- Pneumocandine)Echinocandine) Cilofungin)LY-303366L-733560 / IFN- r)1L-1 1L-21L-3  1L-8)[(G)-CSFM)-CSFGM)-CSF]defensines)  (Intraconazole)yFluconazole)  B(Amphoterican B)          m ^1)  (} I, - </span>Ss1644 A7 _______ ^ B7 5. Description of the invention (14) For example, (iv) gum arabic, gelatin, sorbitol, tragacanth, starch syrup or polyvinylpyrrolidone; fillers such as lactose, sugar, microcrystalline cellulose Cornmeal powder 'saccharin' or sorbitol; lubricants such as magnesium stearate, stearic acid, talc, polyethylene glycol or silicon dioxide; crashing agents such as potato starch or sodium starch glycolate, Or crostscarmdlose sodium; or a moisturizing agent, such as sodium lauryl sulfate. Lozenges, including chewable, dispersible or foamed lozenges, can be coated by methods known in the art. Liquid preparations for oral administration may be, for example, aqueous or oily suspensions, solutions, emulsions, syrups or elixirs, or they may be dry products formulated with water or other carriers before use. Such liquid preparations may contain traditional additives such as suspending agents, such as sorbitol syrup, methyl cellulose, glucose / syrup, gelatin, hydroxyethyl cellulose, carboxymethyl cellulose, aluminum stearate gel Or hydrogenated edible fats; emulsifiers such as lecithin, sorbitan monooleate or gum arabic; non-aqueous carriers (which may include edible oils), such as almond oil, fractionated coconut oil, oily Ester, propylene glycol or ethanol, and preservatives, such as methyl or propyl P-hydroxybenzoate or ascorbic acid. For buccal administration, the composition can be tablets or tongues made in the traditional way. The composition of the present invention can be formulated for administration by injection or continuous infusion. The formulations for injection can be prepared in unit dose form in ampoules or in a multi-dose container with preservatives. These compositions may be suspensions, solutions, or emulsions in oily or aqueous vehicles, and may contain formulating agents such as suspending agents, stabilizers, and / or dispersing agents. Alternatively, the active ingredient can be powdered and mixed with a suitable carrier before use, such as sterilized pyrogen-free water. -17- Use Chinese nursery standard (CNS) A4 specification (210X297mm) --------- f ' ------,  ------ ^ (please read the back first (Notes to fill out this page) A7 ^^^ ______ B7___ V. Description of the invention (15) When the composition of the present invention is administered by inhalation, it is filled with a propellant in a pressurized tank with a spray, such as two gas two Fluoromethane, trifluorofluoromethane, difluorotetrafluoroethane, carbon dioxide or other suitable gases are delivered or delivered by spray. In the case of pressurized spraying, the dosage unit can deliver a fixed dose through the valve. Alternatively, when the composition of the present invention is administered by inhalation, it may be in the form of a dry powder composition, for example, a mixture of the compound of the present invention and a suitable powder base, such as lactose or starch, or it may be a separate physical form modified drug. The powder composition can be prepared in a unit dosage form, such as a capsule or a gelatin cartridge, or a blister pack, which is administered with the aid of an inhaler or an insufflator. The composition can be prepared in the form of suppositories, for example, containing traditional suppository bases, or suppositories, containing, for example, traditional suppository bases. Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling in this page) This composition can be formulated into ointments, creams, gels, lotions, shampoos, powders (including spray powders) , Suppositories, tamponades, sprays, sprays, sprays, drops (such as eye, ear or nasal drops, or coatings (Pur_ns)) for topical administration. Ointments for the administration of eye clear are available Sterilized ingredients are prepared by sterilization. The coating can be made into an oil body for veterinary use, which contains organic solvents, and if necessary, use formulating agents such as stabilizers and co-solvents. Suppositories and suppositories for vaginal insertion can use traditional techniques Formulated, when appropriate, may contain a foaming carrier. Where appropriate, such compositions may also contain other active ingredients such as corticosteroids, antibiotics' or antiparasitic agents. Liquid preparations for intranasal delivery may be prepared as solutions or suspensions Liquid form, and may contain traditional excipients such as tonicity modifiers, such as vaporized sodium, glucose, or mannose; preservatives, such as vaporized benzalkonium chloride, ethylmercury sodium thiosalicylate. Ethyl alcohol; and others Ingredients such as suspending agent, buffering agent, and stability -18- This paper standard uses the Chinese National Standard (CNS) A4 specification (210X297 mm). The A7 B7 is printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy. V. Invention Instructions (16) Agents, dispersants and / or flavoring agents. Transdermal administration can be achieved by designing a suitable system to promote the absorption of active ingredients through the skin, and is generally composed of a formulation base, which is sealed in a plaster cloth that can be attached to the skin. The plaster cloth includes a backing film and a release liner. This system may contain absorption enhancers, such as alcohol, or enhance ion absorption by promoting ion electrophoresis. The composition of the present invention can also be formulated with long-acting formulations. Such long-acting formulations can be borrowed Implantation (for example, subcutaneous implantation or intramuscular implantation), or by intramuscular injection. Therefore, for example, the compound of the present invention can use suitable polymers or hydrophobic materials (such as acceptable emulsion in oil) or ions Exchange resin formulation, or make poorly soluble derivatives, such as poorly soluble salts. When the composition is made into dosage units, as the compound of the present invention is administered orally, One unit preferably contains from 0.001 mg to 1000 mg, more preferably from 0.01 to 400 mg of active ingredient. If it is used for the treatment of adults, the daily dose should be 0.001 mg to 5000 mg, most preferably 0.001 Mg to 2000 mg, this dose can be divided into 1 to 4 administrations, depending on the route of administration and the condition of the patient and the disease to be treated. This compound can be given by intravenous infusion at a dose of, for example, 50 mg / Kg / day of active ingredient. The treatment period depends on the reaction rate rather than any specified number of days. The compound of the present invention can also be used in combination with other therapeutic agents, so that the present invention provides the compound of the present invention and other therapeutic active agents in another aspect The compound 0 is based on the compound of the present invention and can be combined with one or more anti-mycobacterial agents, such as polienics derivatives (Amphotericin B (Amphotericin B), Nystatin _ -19- This paper scale is applicable to the Chinese National Standard (CNS ) 4 specification (210297mm) (Please read the precautions on the back before filling out this education)   321644 A7 B7 5. Description of the invention (17) (Nystatin) (lipotrope of amphotericin B)), pyrrole derivative( Fluconazole, Intraconazole, Ketoconazole, Miconazole, Clotrimazole ZD-08070 (UK-109496)), 5-Fluoridine Glycosides, Pneumocandine or Echinocandine derivatives such as cilofungin, LY-303366, L-733560 and / or one or more immunomodulators such as interferon (IFN-r ), Interleukin (1L-1, 1L-2, 1L-3 and 1L-8) and colony growth factor, [(G) -CSF, (M) -CSF and (GM) -CSF] and defensin ( defensines) combined use. Compounds particularly suitable for use with the compounds of the present invention include Intraconazole, Fluoride: Y :, Fluconazole, or Amphoterican B. When the compound of the present invention is administered in combination with another antimycobacterial agent, the compound of the present invention and another antimycobacterial agent may be administered at the maximum recommended dose or at a lower dose. The above-mentioned compound medicine can be used in the form of a pharmaceutical preparation, and the pharmaceutical preparation containing the above-mentioned compound drug and an acceptable carrier constitutes another aspect of the present invention. The components of these compound drugs can be administered sequentially or simultaneously with compound drug formulations. When the compound of the present invention and the second therapeutic agent are co-administered to treat the same disease, the dose of each compound may be different from that when the compound is used alone. Those skilled in this art will easily know the appropriate dosage. According to m of the present invention, the inventors provide a compound of formula (1) or a physiologically acceptable salt thereof or a pharmaceutical composition containing the compound of formula (1) or a physiologically acceptable salt thereof for treatment, in particular It is used to treat animals (especially humans) (please read the precautions on the back and then fill out this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">321644 18)  1)     I)     a)I)) </span>321644 Fifth, the invention description (18) of Mycobacterium infection. According to another aspect of the present invention, the inventors provided the use of the compound of formula (1) or a physiologically acceptable salt thereof for the manufacture of a medicament for the treatment of candida infections in humans or animals other than humans. According to another aspect of the present invention, the inventors, etc. provide a method of treating the body of a human or an animal other than human to overcome a mycobacterial disease, this method comprises administering to the body a therapeutically effective amount of a compound of formula (I) or a physiologically Accept the salt. Those skilled in the art will understand that the treatment referred to here includes the prevention and treatment of established diseases or infections. . The compound of the present invention can be prepared by the following method. The general method for (a) compound of formula (I) where plow is Z is (a) is based on</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">XH</span>XH</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(II) (R1R41)Rp YI)XCR^R1%  -21 - CNS ) A4210X297 {} -  A7 19) B7 4(A)-(la)Ri Rn&amp;amp; III)</span>(II) (where R1 and R4 are as defined in the above formula (1), Rp is a carboxyl protecting group, and  and Y are as defined in the above formula (I), but X or  cannot represent CR ^ R1% Ring system, and then remove the carboxyl protecting group. -21-This paper scale is remotely used in China National Standard (CNS) A4 specification (210X297 Gonglian) {Please read the precautions on the back before filling this page} -Subscribe to the Ministry of Economic Affairs Printed by the Central Bureau of Standards and Staff Consumer Cooperative A7 V. Description of invention (19) B7 Root 4 According to the first-specific embodiment of the manufacturing method (A), the compound of formula (la), where Ri to R are as defined by the above formula () n is zero, and  &amp;amp;  are all oxygen, the diol of formula (III) can be used</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">0H</span>0H</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">0H (III) (#'}  (R1R41)RP L)2CR2R3(l R2R3 )   R2R3Ci_.6Cu CR2R3c3_8in) RO)2CR2R3(R!Cl_6 p -p_  _I a) 22- CNS ) A4210X297 - A7 32U44 -- B7 20) X/J)  CR2R3c = 0c = s (III)  CR2R3c = SIII)    A)I)R1 R4I)R2R3^  CuCuCuCR5R6)n CR5R651)&amp;amp;n 111)  HalCR5R6CR2 = CHRl4(Rl4Ci 6 Hal 4 80CIV) -23- () ..  f CNS) A4710X297 \  321644</span>0H (III) (Please read the note # 'on the back before filling in this page) Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (where R1 and R4 are as defined in the above formula (1), RP is a carboxyl protecting group) to Chemical treatment (L) 2CR2R3 (where l is a suitable leaving group) treatment, and then remove several protecting groups. When both R2 and R3 represent hydrogen, the ring formation reaction can be conveniently In the presence of metal hydroxides, treatment with dihalogenated tigers (such as dibromomethane) in the presence of phase transfer conditions, preferably using, for example, tetraalkylammonium salts (such as tetrabutylammonium bromide) At ambient temperature. When at least one of R2 and R3 is Ci_.6 alkyl or oxyCu alkyl, or CR2R3 is c: 3_8 cycloalkyl, the ring formation reaction can be conveniently condensed with the compound of formula (in) Ketone (RO) 2CR2R3 (where R! Cl_6 alkyl, such as methyl) treatment is carried out, preferably in the presence of a suitable acid, such as p-toluic acid or p-methyl pyridine radium, in the appropriate The solvents such as ketones (such as acetone), nitriles (such as acetonitrile) or _-hydrocarbons (such as two gas methane) are carried out at about room temperature. The compound of formula (I a) 22- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297mm)-Order  A7 32U44-B7 V. Description of the invention (20) Object 'where X and / or  represent sulfur, can be used in a similar way Corresponding to the intermediate of formula (JJong), where one or two diol hydroxyl groups are replaced by thiols, prepared. When CR2R3 represents c = 0 or c = s, the ring formation reaction can be conveniently represented by formula (III) The compound is reacted with carbonyldiimidazole or thiocarbonyldiimidazole in a suitable solvent such as Nicotiana (such as toluene) or ether (such as tetrahydrofuran) under reflux. Or CR2R3 represents c = S, the ring formation reaction can be formula (III) The compound is treated with tin oxide (e.g. dibutyltin oxide) in a hydrocarbon solvent (e.g. toluene in reflux), and then added with a nannan thiocarbamate (e.g. gas sulfur) in a hydrocarbon solvent (e.g. toluene) at room temperature Phenyl carboxylate). According to another specific embodiment of the preparation method (A) 'compound of formula (I), wherein R1 and R4 are as defined in the above formula (I), one of R2 and R3 represents an alkyl group, another Represents hydrogen 'Cu alkyl or Cu alkoxy Cu alkyl, (CR5R6 ) n stands for CR5R6, here ruler 5 and jealousy are as defined by formula (1), and  &amp;amp;  both represent n oxygen. The diol of formula (111) and tin oxide (such as dibutyltin oxide) can be used in hydrocarbon solvents ( For example, prepared by reaction in refluxing toluene, and then added allyl southern compound HalCR5R6CR2 = CHRl4 (where Rl4 is hydrogen or Ci 6 alkyl, and Hal is Nansu, such as bromine) and fluoride salt (such as fluoride Tetrabutylammonium) in a suitable solvent such as ether (eg tetrahydrofuran), and the mixture is heated to 40. At a temperature of 80  C, prepare the compound of formula (IV), -23- (please read the precautions on the back before filling in this page). . Printed by the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. The paper size is applicable to China shed is unfamiliar f CNS) A4 draws a rose, 710X297 public sturgeon) \ Printed by the Consumers Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 321644</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> la)    A)Ia)Rl R4I)X cr9ri(r9rioCi 6 Ci_6Ci_434cR9R_l C = CHR&amp;quot;)III)    HalCR2R3CR9 = 0HR14 HalCR2R3c=CRl y R11R14Hal &amp;quot;24 - 1CNS ) A4210Xm) ----- (  -</span>This compound can be used to induce intramolecular electrophilic addition of mercury salts (such as mercury trifluoroacetate), and form a ring to convert to the desired compound of formula (la), and then perform a hydrogenation reaction, such as trialkyltin argon (such as Tributyltin hydride), and then remove the carboxyl protecting group. This reaction can be conveniently carried out in the presence of a suitable solvent (e.g. tetrahydrofuran) at about room temperature. In another specific embodiment of the manufacturing method (A), the compound of formula (Ia), wherein R1 to R4 are as defined in the above formula (I),  is zero, one of X and  represents oxygen and the other represents cr9ri. Here, one of r9 and rio represents Ci 6 alkyl and the other represents hydrogen, Ci_6 burned group or Ci_4 pitoxy group (3 Bu 4 pit group or c: R9R_l represents C = CHR &amp;quot;), and the compound of formula (III) can be used. It is prepared by reacting with tin oxide (such as dibutyltin oxide) in a hydrocarbon solvent (such as benzene in reflux), and optionally in the presence of a fluoride salt (such as tetrabutylammonium fluoride), and then in the second After the alcohol is protected by one of the groups, the two-enyl sulfide HalCR2R3CR9 = 0HR14 or the alkynyl halide HalCR2R3c = CRl y where R11, R14 and Hal are as defined above) or the addition of allyl sulfide or block "24- Winter Paper Magic 1 uses China National Crushing Rate (CNS) A4 threat (210X; mmm) ----- (please read the precautions on the back before filling out this page) -</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T A7 B7 22) (-V) X1</span>1T A7 B7 5. Description of the invention (22) based halide, prepared into compound of formula (-V) X1</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R4 (V) () ( X1  0H Y1  cr2r3cr9 = chr144 OCI^I^CsCR11   0CR2R3CR9 = CHR14   CR2 R 3 C sC R 1 1Y 1 . S-8_ .   . S-  V ) X  Y1 H cr2r3cr9 = chr14  CR2R3CsCRll   -25  32^44 7 --------.-- 23 ) ~~~~~~-- * .  A):1) r2r3x*CR9r10 (V) 4  </span>R4 (V) (Please read the precautions on the back before filling in this page) (Here X1 stands for 0H and Y1 stands for cr2r3cr9 = chr144 OCI ^ I ^ CsCR11, or l stands for 0CR2R3CR9 = CHR14 or  CR2 R 3 C sC R 1 1 and Y 1 represents a protected hydroxyl group). The completion of cyclization is: in the presence of a hydroxyl protecting group, first remove the cold protecting group, and then borrow, for example, to form S-alkyl dithiocarbonate (such as 8_ methyl dithiocarbonate) Activate the free hydroxyl group, and then close the ring under root conditions, for example, in a hydrocarbon solvent (such as toluene) under reflux with a hydrogen donor, such as a hydride reducing agent (such as trialkyltin hydride, such as tributyltin hydride ) Treat the activated intermediate solution in an activator (such as azobis (isobutyronitrile)), and then remove the carboxyl protecting group. S-alkyl dithiocarbonate can be conveniently prepared as a strong alkali metal emu (eg sodium hydride) in the presence of imidazole in a suitable solvent such as ether (eg tetrahydrofuran) at low temperature (eg about 0).) Treatment of the compound of formula (V), where one of X and Y1 is H, and the other is cr2r3cr9 = chr14 or CR2R3CsCRll, and then add carbon disulfide and alkyl at the room temperature to the Ministry of Economic Affairs Central Standards Bureau staff consumption Cooperative printing and cracking -25 Printed by the Central Consumers Bureau of the Ministry of Economic Affairs 32 ^ 44 7 --------  .-- V. Description of the invention (23) ~~~~~~ ---- *. Halides (such as methyl iodide). According to another method of preparation (A): a specific embodiment, the compound of formula (1), wherein  is oxygen,  is zero, r2 and r3 are hydrogen, and x * CR9r10 base, you can use the compound of formula (V), where  It is a hydroxyl group, which reacts with triphenylphosphine, iodine and imidazole in a suitable solvent (such as tetrahydrofuran) to produce the desired 4-iodine derivative. The desired ring closure is then carried out under root conditions, for example by heating the reaction with trialkyltin hydride in a hydrocarbon solvent.</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">)) XNRUCR2R3c = VI) Ri2NC0  A)1)Ri R4I)R2R36 Ci4C4CR2R338 X-N.R12-(R12 VI)n- 26 CNS )4_ ( 2x297 ---------7------------f V () 7 7 24  X11</span>In another specific embodiment of the manufacturing method (), the compound of formula (), wherein  is oxygen, X is NRU, and the CR2R3 group is c = , can use the compound of formula (VI) with sodium hydride and isocyanate Ri2NC0 in non- Proton solvent such as tetrahydrofuran reacts and then removes the carboxylic acid protecting group to prepare. In another specific embodiment of the manufacturing method (A), the compound of formula (1), wherein Ri and R4 are as defined in the above formula (I), R2 and R3 each independently represent hydrogen, 6 alkyl or Ci  4 alkoxy C 4 alkyl or CR2R3 represents 38 cycloalkyl,  is zero, one of X and  represents -N.R12- (where R12 is as defined by the above formula ()) The other represents oxygen, available formula (VI) Compounds or their protected derivatives borrow n-   26  This paper is used by China National Counties (CNS)   _ (2  x297  ) --------- 7-- ---- ls ------ f V (Please read the precautions on the back before filling in this page) 7 7 5. Description of the invention (24 chemical preparation X11</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(VI) Y11 () . (X11Y110HNH2) r2r3C =  r2r3c(o2p_ p -p ( A)Ia)Ri R4I)-X-CR2R3-Y-CR2R3-N = CR3-(R3Cl_64 Ci-4YXR3c( = NH)OR( RCl _6VI)</span>(VI) Y11 (please read the precautions on the back before filling in this page) . (Where one of X11 and Y11 is 0H and the other is NH2), for example, with an acyl halide (such as brewing base gas) under traditional conditions Reaction, and then use the net or r2r3C =  or dialkyl acetal r2r3c (o alkyl) 2 in the presence of a suitable acid (such as p-toluenesulfonic acid or p-toluene acid p than recorded) The reaction is carried out in a suitable solvent such as halogenated nicogen (such as dimethane) at about room temperature, and then any protective group is removed. In another specific embodiment of the manufacturing method (A), the compound of formula (Ia) wherein Ri and R4 are as defined in the above formula (I),  is zero, -X-CR2R3 or -Y-CR2R3 represents -N = CR3 -(Where R3 is Cl_6 alkyl or (: Bu 4 alkoxy Ci-4 alkyl) 'and Y or X is oxygen' available imine ester R3c (= NH) OR (where R is Cl_6 alkyl, For example, methyl) is prepared by treating the compound of formula (VI).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">I B I)za)Y R2R3XCHVII) -27- CNS ) 4210X297 '1  r 32l^44 A7 --B7 25) 0</span>I Another general method B 'compound of formula (I), wherein z is (a) group, Y is oxygen,  is zero, R2 and R3 are hydrogen' and X is CH, compound of formula (VII) can be used The paper standard is applicable to China National Standard (CNS) 4 specification (210X297mm). '1 Printed by the Consumer Cooperative of the Central Bureau of Economics of the Ministry of Economic Affairs r 32l ^ 44 A7 --B7 V. Description of invention (25) 0</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(VII) R21CHO RP :_)  Rp 4 _S w ern 4 - I)Zb)W VII) ()</span>(VII) where R21 is a CHO group or a protected derivative thereof. RP is a protected carboxyl group and a carboxyl group: a diazomethylphosphonate is tested (such as tertiary butane oxidation) in an aprotic solvent (such Ether, such as tetrahydrofuran), and then remove the carboxyl protecting group Rp, and then remove the aldehyde protecting group if necessary. 4_ Ketotetrahydropyran derivatives can be prepared by oxidizing the corresponding 4-keto derivatives with traditional methods (such as Swern oxidation). General methods for preparing compounds of formula (I) (where Z is (b) base map, W is oxygen) including cyclization of compounds of formula (VII)  (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T </span>, Printed by 1T Beigong Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R 15a R 17a 1 (VIII) -28- CNS ) A4210X297 26) A7 B7 (R15aRbaKRUar15r16r17 RPL -R22R22 L -* . .(  V111) OR22L  VIII) Q   W0B IX) </span>R 15a R 17a 1 (VIII) -28- Full paper size is not universal Ningguo National Standard (CNS) A4 specification (210X297 mm) 5. Description of invention (26) A7 B7 (where R15a, RbaKRUa are as above ( Defined by r15, r16 and r17 or protected derivatives thereof, RP is a hydrogen or carboxy protecting group, L is a suitable leaving group, such as alkyl- or aryl acyloxy, R22 is hydrogen, or R22 Is the same base as defined by L), if necessary, remove any existing protective groups.-*. Cyclization can be easily used as a strong base such as hydrogenated eyelid metal (such as sodium hydride) in such as dimethylformamide Treatment of the compound of formula (V111) in an amine or ether (such as tetrahydrofuran) solvent at about room temperature is completed. Alternatively, alcohol solvents (such as sodium in formic acid) can also be used, especially when OR22 is the same base defined by L This is true. In this example, the test system is added to a solution of the compound of formula (VIII) in a suitable solvent such as a southern sulfonated hydrocarbon (for example, Erqijiajing). . Another preparation formula W is sulfur (0 compound general method B includes the use of sulfur to formula (IX) compound of the Ministry of Economic Affairs Printed by Peking Consumer Cooperative of Central Bureau of Standards</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">15 R R 17 16 (IX) (R15R6R7I)  ---------t^----------- v (k -29- CNS ) A4210X297  ^^1644 27 ) 5,5-_2_2_]3 2 ;^ )( : (IX) L) ()l  w- C) E) I) E) 2&amp;amp;)*Rl I)Rl S-ii) 8 12)   E)I)za) R1C_4/r4c_4 I)Ri /R4    030( -30 CNS ) A4210X297</span>15 RR 17 16 (IX) (where R15, R] 6 and R] 7 are defined as above (I). Therefore, this reaction --------- t ^ ---------- Order ----- v (please read the precautions on the back before filling in this page k -29- This paper size is easy to use China National Standard (CNS) A4 specification (210X297mm) Employee Consumer Cooperative of Central Bureau of Standards of the Ministry of Economic Affairs Printed ^^ 1644 5. Description of the invention (27) 5,5-dimethyl_2  thiol_2_thio]] 2 can be conveniently used in a solvent such as dimethylmethylamine, and Preferably, it is done in the presence of a trivalent amine such as triethylamine at a high temperature (e.g., a compound of formula (IX). L) The treatment of the formula group can be conveniently made of a compound of formula (), where l It is a suitable leaving group, such as an alkyl- or arylsulfonyloxy group, prepared using the conditions described in method (C), and then removing any protecting groups if necessary. Another general method (E) includes interconversion Reaction, wherein the compound of formula (I) is prepared from a different compound of formula (I) or a protected derivative thereof. According to the first specific embodiment of general method (E), the protected carboxyl group of the compound of formula (), Where 2 is (&amp;amp;) base Group, and * Rl is a hydroxyl group, which can be converted into the corresponding compound of formula (I), wherein Rl is hydrogen, the method is: according to the aforementioned method to generate S-alkyl dithiocarbonate, (ii) in a hydrocarbon solvent ( For example, toluene) treats this intermediate compound solution with a hydride reducing agent (such as trialkyltin hydride, such as tributyltin hydride) at a high temperature (for example, about 80 to 120) and then removes several protecting groups. In a general method (E), the compound of formula (I), wherein z is (a) aryl ring, and wherein R1 is C _4 alkoxy and / or r4 is c] _4 alkoxymethyl, can be alkyl Preparation of a protected derivative of the compound of formula (I), where Ri is hydroxy and / or R4 is hydroxymethyl and any protected unstable group (such as carboxy and hydroxy), and then remove the existing protected Alkylation can conveniently use a strong alkali metal base (such as sodium hydride) for the initial reaction, and then use an alkyl halide (such as methyl iodide) reaction. This reaction can be in a suitable solvent such as ether (such as Tetrahydrofuran) within 0  to 30. (: proceed. -30 This paper size is suitable for Chinese nursery Associate (CNS) A4 size (210X297 mm)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">() A728)  E)1)R1/ R4CH2CR8 R/4CH2H    4-  E)I)R1 1)Rl CH  i)[ _ ]2-Hii) H  1 0 C E)I)R1 R1I)  OH   _ -31 - CNS ) A4210X297f ------ () </span>(Please read the precautions on the back before filling in this page) A7 V. Description of Invention (28) Printed by the Ministry of Economic Affairs Central Bureau of Customs and Industry Beigong Consumer Cooperative, another general method (E), the compound of formula (1), where R1 Is an oxy group and / or R4 is CH2CR8, can be prepared by acidifying a protected derivative of formula (1) where R is a group and / or 4 is CH2H and any unstable group is protected Obey 'and then remove the existing protected foundation. The brewing reaction can be carried out by traditional methods, for example, using carboxylic acid in the presence of an activator, such as dicyclohexylcarbodiimide, and a suitable base, such as dimethylaminopyridine, and if necessary, a suitable Treated in the presence of a base such as pyridine or 4-dimethylaminopyridine. According to another general method (E), a compound of formula (I), wherein R1 is a hydroxyl group in a flat configuration, can be prepared from a protected derivative of formula (1), wherein Rl is a hydroxyl group in an axial configuration and any unstable base map (Such as carboxyl, hydroxyl and CH groups) are subject to compliance, and then remove the existing protected groups. This isomerization reaction can be conveniently carried out in two steps: (i) using a suitable oxidation system [such as chromium oxide, in the presence of pyridine, in a solvent containing acetic anhydride, such as dioxo methane, (such as methane) ] Oxidation of 2, -axial OH to oxy groups, (ii) Reduction of oxy groups to OH groups using a suitable reducing agent such as borohydride (eg sodium borohydride). This reduction can be conveniently carried out in a solvent such as alcohol (e.g. aqueous methanol solution). To 1 0 C. In another general method (E), the compound of formula (I), wherein R1 is a halogen atom, can be prepared from a protected derivative of formula (I) in which R1 is a hydroxy group, and then any protective groups present are removed. This substitution reaction is completed in a transformed configuration. Therefore, for example, the axial OH group can be added to the solution of the starting material in a suitable solvent such as hydrocarbons (eg toluene) in the presence of triphenylphosphine and iodine and heated (eg under reflux) ) This mixture is converted into flat iodine atoms. _ -31-This paper scale is applicable to the Chinese Standard (CNS) A4 specification (210X297 public f ------ (please read the note  item on the back and fill in this page) </span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  - - I In 1^1</span>, 1T --I In 1 ^ 1</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> DAST)   E)1)n RR2XCH /  E)1) R2R3XC = CH2 (= I)n23 XC = CH2  (I)R2R3 =  E)r 1 5j)  R1S1) DAST)   E)1)Ri5 Cu/^# Rl5/ R1 7  _ _ 32 - CNS )4210X297) '  ()</span>Printed by the Consumer Cooperative of the Central Ministry of Economic Affairs of the Ministry of Economic Affairs with a suitable fluorinating agent (such as diethylaminosulfur trifluoride (DAST) in a suitable solvent such as a southern hydrocarbon (such as methane) or aromatic Fluorine can be introduced in a hydrocarbon group (such as toluene) at room temperature. In another general method (E), the compound of formula (1) where  is oxygen, n is zero, R and R2 are hydrogen, and X is CH , Or its protected derivatives, can be prepared using hydrogen and a suitable catalyst (such as palladium / carbon) reduction in a suitable solvent and then removing the carboxyl protecting group. In another general method (E), formula (1) Compounds, where  is oxygen,  is zero, R2 and R3 are hydrogen, and X is C = CH2, can be converted to the corresponding compound (: = ) by oxidation of sodium tetraoxide and sodium periodate. Similarly, Compound of formula (I), where  is oxygen, n is zero, ruler 2 and ruler 3 are hydrogen 'and X is C = CH2' oxidized in pyridine with chromium trioxide, can be converted to compound of formula (I), where R2 And the carbon atom to which R3 is associated represents  = . According to another specific embodiment of method (E), the compound of formula (j) where r 1 5 is a hydroxyl group The protected derivative can be converted into a compound of formula (1) with R1S as a southern element by standard substitution reaction, and then the carboxyl protecting group is removed. Therefore, by replacing the hydroxyl group with a fluorine atom, a trifluorodiethylamino group can be added Sulfur (DAST) is converted into a configuration in a solution of the starting material in a suitable solvent such as a chlorinated hydrocarbon (such as methane). This reaction can be conveniently carried out at room temperature. In another (E) In a specific embodiment of the method, the compound of formula (1), wherein Ri5 is Cu tigeroxy or optionally substituted alkoxy and / or ruler "is ## alkoxymethyl, a protected compound derivative of the formula can be used, Wherein Rl5 and / or R1 7 contain free hydroxyl groups, and any unstable radicals (such as carboxyl groups and hydroxyl groups) have been properly protected, prepared by alkylation, and then remove the existing _ _ 32 Use the Chinese National Standard (CNS) 8 4 threats (210X297mm) '1 (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T A7 A7  B7 30)    5 0 C (   _ 050C 1 0 %/ E)I)R15 CH2OCOR20R1OCOR181) R17CH2OHR15      E)crUr!6(=0 I)1) R15    4 8 0 C ) () X. &amp;lt;11 -33 B7 31) I)CR15R16ch = CH2 CR15Rc =  -  R15I)R15 I)    I)F ) (I) ,,prtective Groups in Organic Chemistry&amp;quot;, Ed. J. F. W. McOmie (Plenum Press, 1973 )&amp;quot;Protective Groups in Organic</span> 1T A7 A7 Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs B7 V. Description of invention (30) Protection base. The alkylation can be conveniently carried out with a strong alkali metal eyelid (such as sodium hydride) as the initial reaction, and then with an alkylnanate compound (such as methyl bromide). This reaction can be completed in a solvent such as ether (eg, tetrahydrofuran) at a temperature of about 0  to 50  C. Where appropriate, there may also be the presence of a basic compound such as tetrabutylammonium (eg, tetrabutylammonium). Alternatively, straight-chain or branched-chain alkyl groups can be conveniently introduced in two steps: the first step involves the use of a suitable alkenyl compound in the presence of a base such as a carbonate (eg cesium carbonate) at about 0  to 50 The alkylation is carried out at a temperature of  C; the second step involves hydrogenation of the catalyst (for example, 10% / cracked) at about room temperature. In another specific embodiment of the method (E), the compound of formula (I), wherein R15 is CH2OCOR20 or R1 is OCOR18, a derivative of the protected compound of formula (1) can be synthesized, wherein R17 is CH2OH or R15 is Hydroxyl group, and any unstable group (such as carboxyl group and hydroxyl group) has been protected, and then remove the existing protecting group to prepare. The acylation reaction can be carried out by conventional methods, for example, using carboxylic acid in the presence of an activator such as dicyclohexylcarbodiimide and a suitable base (such as dimethylaminopyridine), or using acetynannan (acidyl gas) ), If necessary, in the presence of a suitable base (such as dimethylaminopyridine). According to another specific embodiment of method (E), crUr! 6 represents (: = 0 the compound of formula (I) can be oxidized by the protected compound of formula (1) derivative, where R15 is a few groups' and any unstable The groups (such as carboxyl and hydroxy) have been preserved, and then the existing protecting groups are removed to prepare. The oxidation reaction can be conveniently carried out in the presence of trifluoroacetic anhydride by adding an oxidizing agent such as dimethyl sulfa. Oxidation can be carried out in a suitable solvent such as halogenated hydrocarbons (such as dimethane) at high temperature (for example, about 40. to 80  C). (Please read the notes on the back before filling this page ) X. &amp;lt; 11 -33 B7 V. Description of the invention (31) The compound of formula (I), wherein CR15R16 represents a ch = CH2 group, which can correspond to the compound of formula  of CR15R, c =  or its protected derivatives and Nansuated alkyl-triphenylscale and alkyllithium are prepared by reaction in an aprotic solvent (such as tetrahydrofuran). The compound of formula (I) where R15 is an azido ring can be used as the corresponding compound of formula (I) where R15 is a hydroxyl group Or its protected derivative reacts with tolsulfonamide and then uses alkali gold azide (Such as lithium azide) is prepared by treating the tosylate derivative in an aprotic solvent (such as two-gas methane). Many of the above methods require the removal of one or more protective groups in the final step to obtain A compound of formula (I) is required. Another general method (F) includes deprotection of the protected compound derivative of formula (I). Suitable carboxy protecting groups and protected groups used herein include any traditional protecting groups , For example ,, Protective Groups in Organic Chemistry &amp;quot;, Ed. JFW McOmie (Plenum Press, 1973) or &amp;quot; Protective Groups in Organic</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Synthesis&amp;quot; by Theodora W. Greene (John Wiley and Sons,  () 1991)  P-  P-   0%/)  10%/p -2,3 -- ____ -34- __ CNS ) A4210X297  321644 7 ___7 32) 5,6 --1,4 - t -_  II)VII)</span>Synthesis &amp;quot; by Theodora W. Greene (John Wiley and Sons, Printed by the Ministry of Economic Affairs, Central Bare Bureau, Beigong Consumer Cooperative (please read the precautions on the back before filling out this page) 1991). Examples of suitable carboxy-protecting groups include arylalkyl groups such as diphenylmethyl'P-methoxybenzyl and silyl groups (e.g. trimethylsilyl or secondary butylmethylsilyl groups). Examples of suitable hydroxy protecting groups include arylalkyl 'such as P-methoxybenzyl and ester groups such as benzyloxycarbonyl. The aldehyde group can be protected in the form of a cyclic ketal. The protecting group can be removed by conventional techniques. Therefore, diphenylmethyl can be removed with trifluoroacetic acid 'or hydrodecomposed in the presence of a palladium catalyst (e.g. 0% palladium / carbon). The fluorenyloxycarbonyl group can be removed by hydrodecomposition in the presence of a palladium catalyst (for example, 10% / carbon). p-Methoxybenzyl can be used in 2,3-digas- ____ -34- __ This paper scale is applicable to China National Standard Rate (CNS) A4 specification (210X297 ounces) Printed by the Employees Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 321644 7 ___ 7 5. Description of the invention (32) 5,6-Dicyano-1,4-benzoquinone is removed. Silyl groups, but trimethylsilyl groups or t-butyl dimethylmethyl pyroalkyl groups can be removed with fluoride ions. The cyclic condensed group can be converted to aldehyde by adding a suitable acid, such as hydrochloric acid. The compound of formula (II) can be used as the compound of formula (VII)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(RPX)</span>(Where RP is a carboxyl protecting group) and the compound of formula (X)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">XH \ X (XI) R4 (R1R4XY11)  )) 4080C_ X)XHYH X)   _____-35- CNS ) 21297 ()  33) A7 B7 R4II) R4JI)V-XII) </span>XH \ X (XI), R4 (where R1, R4, X and Y are as defined in the above formula (11)) or its protected derivatives are prepared by reaction, and the existing protecting groups are removed if necessary. This reaction can be achieved by heating () and () to about 40 in a suitable solvent such as hydrocarbons (such as toluene). To 80  C and in the presence of acid hydrobromic acid triphenylphosphine. When XH and YH in the formula (X) represent a hydroxy group, they can be protected by an oxy group (such as acetoxy), and the protective group is removed by the compound of the formula (X) after the reaction. The removal of the acetyloxy protecting group is performed by adding a suitable base, such as an alkoxide (e.g. sodium methoxide), in a suitable solvent such as an alcohol (e.g. methanol) at about room temperature. _____- 35- The size of this paper uses the Chinese National Standard (CNS)  specifications (21  297 public director (please read the notes on the back before filling in this page). Order V. Invention description (33) A7 B7 The above reaction is particularly suitable For the preparation of compounds of formula (II) where R4 is not methyl. When R4 is methyl, the compound of formula (JI) can be prepared with V-demethyl sodarin, compound of formula (XII).</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">()  R4III). XII)2_ Ri2_ 34a)   XII) XII) /   XY11) I)CR2R3c =  -36- aCNS )21297 1 A7 B7  34 )  CHsONa) X) X)RP 0-[2-(]_N,N_  RP   P -  _  4-  VII)LL_ /R220R22_ )_  4- 4_   C) 37- it(6NS )A4^( 210x1^^7 ()                321644 35 4_ R)4- R1^ ^4 5 i)   c)s - ii) 8 020 c ) [] C2_6i)8_ ii) S - i i i)i 0 %/  I)1) I)  L  I) 0 C8 0 C -38- CNS ) A4210X297</span>(Please read the precautions on the back and then fill out this page) The Ministry of Economic Affairs Central Standard and Semi-bureau Beigong Consumer Cooperative Printed is based on the formula (III) where R4 represents methyl. The compound can be protected by traditional methods (XII) Several groups, and then, if appropriate, the 2, _ axial hydroxyl groups are converted into different Ri groups by the aforementioned interconversion method. It may be necessary to protect the 3  and 4 'hydroxyl groups when using 2, _axial hydroxyl groups. Protection can be achieved by forming the isopropylidene in the first specific embodiment of method (a). It is then treated with an acid, such as an inorganic acid (e.g. hydrochloric acid) to form a diol to remove this group. When the carboxyl group of the compound of formula (XII) is protected by diphenylmethyl, the protection reaction can be a solution of the compound of formula (XII) in an alcoholic solvent (such as methanol) and / or a sulfonated hydrocarbon (such as methane gas) ) The solution inside is treated with diphenyl diazomethane, preferably as an addition. A solution in a genus of hydrocarbons (such as methane). Compounds of formula (11) where X and Y represent oxygen or sulfur can also use corresponding protected derivatives of compounds of formula (I), where CR2R3 represents c = , and  is zero-36- A home standard rate (CNS) is printed from the threat (21297 public law, 1T A7 B7, Ministry of Economic Affairs, Central Bureau of Economic Cooperation, Employee Consumer Cooperatives. Fifth, the invention description (34), prepared by decarbonylation. Decarbonylation can be added by adding alkyl Oxygen compounds (for example, CHsONa) are completed in a suitable solvent such as alcohol (for example, methanol). The compound of formula (X) can be prepared by sodarin using the traditional carboxyl protection method. It is represented by the RP in the compound of formula (X) In the case of trimethyl and silylethyl, this base can be introduced by 0- [2- (trimethylsilyl) ethyl] _N, N_diisopropylisourea treatment sodarin, preferably in Such as ether in a suitable solvent (such as tetrahydrofuran) at a high temperature (such as reflux). When RP represents diphenylmethyl, this group can be introduced by the aforementioned method. The carboxyl-protected derivative of sodarin or When the hydroxyl group of the compound of formula ( is protected by P-methoxybenzyl, this group can be oxidized (For example, dibutyltin oxide) is reacted with a hydrocarbon solvent (for example, toluene in reflux), and then added with methoxyphenyllinated compound in the presence of a fluoride salt (for example, tetrabutylammonium fluoride). When protected with a fluorenyloxycarbonyl group, this group can be used as a fluorenyl autoformate in the presence of a suitable amine base, such as 4-dimethylaminopyridine, in a halogenated hydrocarbon genus (such as methane) Introduced into the reaction within the solution. Formation of the L group in formula (VII), where L is an alkyl_ or arylsulfonyloxy group and / or R220 group, where R22 is an alkyl_ or arylsulfonate Acetyloxy, suitably protected sodarin or a compound of formula (XII) and alkyl- or arylsulfonyl halide in the presence of a suitable solvent such as pyridine and optionally containing amine eyelids (eg 4- Dimethylaminopyridine) or halogenated hydrocarbons (such as methane) in the presence of a suitable amine base (such as 4-dimethylaminopyridine). This reaction can be conveniently carried out at room temperature. Other groups can be introduced in a similar manner using traditional methods. It will be understood that according to method (C), The base is converted into the desired 37-sheet paper size before it is cyclized. It's a financial solution (6NS) A4 ^ (210x1 ^^ 7 (please read the precautions on the back before filling out this page) jingyang Standards Bureau  Printed by Industrial and Consumer Cooperatives 321644 V. Description of the invention (35 bases. Therefore, properly protected 4, _demethylsodarin derivatives or compounds of formula () where R is hydroxy can be reacted by traditional methods to make 4 , -Hydroxy group is converted to the desired R1 group. Therefore, for example, the conversion into ... ^ alkoxyalkyl or aryl ^ -4 alkoxy group can be accomplished by traditional alkylation methods, for example, according to the aforementioned methods .Remove the hydroxyl group to make the ruler! 5 is a hydrogen compound, which can be conveniently done in two steps: (i) with a strong base (such as sodium hydride) in the presence of imidazole, in a suitable solvent such as ether (such as tetrahydrofuran) Processed at low temperature (eg, scoop c) to produce s-alkyl dithiocarbonate, and then add carbon disulfide and alkyl radicals (such as methyl iodide) at about room temperature; (ii) the intermediate The solution of the compound in a solvent of the genus (such as toluene) is at a high temperature (for example about 80. To  20 c) Treated with a hydride reducing agent (such as trialkyltin hydride, such as tributyltin hydride), if necessary, remove this group in the presence of an activator [such as azobis (isobutyl quinidine)] group. Conversion to C2_6 alkyl can generate (i) the aforementioned 8-alkyl dithiocarbonate, (ii) react with a trialkylalkenyl tin compound under the aforementioned conditions to replace this group with a silyl group to remove S- The alkyl dithiocarbonate group, and (iii) reduce this alkenyl group to an alkyl group in the presence of a suitable palladium catalyst (eg, i 0% palladium / carbon). The base salt of the compound of formula (I) can be produced by treating the compound of formula (1) with a suitable salt or base. Therefore, for example, the compound of formula (I) may be selected from sodium hydroxide or sodium hydroxide, bicarbonate, carbonate or acetate (such as potassium hydroxide, hydrogen carbonate, sodium bicarbonate, or potassium acetate), acetic acid Salt or test preparation of ammonium, calcium acetate and Llysine. This salt can be added, for example, to a solution or suspension of a compound of formula (I) in a suitable solvent such as alcohol (eg methanol) or dioxane by adding a suitable salt or base (aqueous solution if necessary)  C to 8 0  C, preferably, about room-38- The paper size is free to use the Chinese National Standard (CNS) A4 specification (210X297mm)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">X  A7  36)  1)  I)   XII)  XII) XII) XII)   CAB International Mycological Institute, Genetic Resource Reference Collection Bakeham Lane, EghamSurrey TW20 9TY 1994610 IMI 362184 199461321 aInternatinai Depository) IMI 362 1847 4 IMI 362184 IMI 3 62184HI Adler  Radiation and Radioisotops for Industrial -39 CNS ) A4210X297 ()</span>X Order A7 Printed by the Employees' Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs V. Description of invention (36), prepared by Wen . Pharmaceutically acceptable salts can also be prepared from other salts, including other pharmaceutically acceptable salts of compounds of formula (1), using conventional methods. Metabolically unstable esters of compounds of formula (I) can be prepared by reaction with the existing bases by conventional methods. Similarly, metabolically unstable esters can also be formed with free radicals present on the molecule. The novel compound of formula (XII) can be prepared according to the fermentation method described later, or can be prepared by demethylation of sodarin by a biotransformation method. The fermentation method involves culturing a microorganism capable of producing the compound of formula (XII), and then separating the compound of formula (XII) from the culture. The microorganism capable of producing the compound of formula (XII) may be a variant of D. arachnoides. This strain can be confirmed by analyzing the survival rate of the mutant by screening test samples obtained by fermentation of microorganisms by standard methods. In particular, the microorganisms that are convenient to use are the strains of arachnid coccidioides stored in the constant culture collection of CAB International Mycological Institute, Genetic Resource Reference Collection Bakeham Lane, Egham, Surrey TW20 9TY, United Kingdom. This strain was received by this organization on June 10, 1994, and the acquisition number was given as IMI 362184, and the date of receipt and the date of confirmation of survival were indicated on June 13, 1994 and 21, respectively. This institution is accepted as an international depository (Internatinai Depository) authority under the Buda Pace Treaty. For the characteristics proven so far by IMI 362 184, see Example 74. In yet another aspect, the present invention provides the original IMI 362184 microorganism and variants thereof. The IMI 3 62184 variant can occur naturally or in a variety of ways, including HI Adler s Radiation and Radioisotops for Industrial -39. The paper size applies to the Chinese National Standard (CNS) A4 (210X297) (please read the notes on the back (Fill in this page again)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T A7 B7 8^1644 37)</span> 1T A7 B7 8 ^ 1644 V. Description of the invention (37)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Microorganisms'  Techniques for the Development of MicroorganismsProceedings of the</span>Microorganisms  Techniques for the Development of Microorganisms, and Proceedings of the</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Symposium, Vienna 1973, p241, International Atomic Energy authority N --N'--N -n T G)   XII)     D_  . 51  %     11%     -40- BCNS ) A4210X297 (} .    A7 ---------- 38)  *- 2040C2( 35C 25( /  seed stages ) pH 3.59.5 457.5pH    4-305-15 /  XII)   p 6 (4.5 ) XII) :-  IX)   CG161  Amberlite XAD-2XAD-4XAD-16  XAD-1180 -41 - iCNS ) A4210X297 ~ ---------f ------IT------f ()</span>Symposium, Vienna 1973, p241, International Atomic Energy authority. These methods include ionizing radiation, chemical methods such as N-methyl-N'-nitro-N-nitroisomai (n TG), thermal 'gene technology' such as gene recombination and gene conversion, treatment, and Selective natural variant technology. The preparation of the compound of formula (XII) by fermentation can be accomplished by traditional methods, that is, cultivating suitable microorganisms in the presence of assimilable sources of carbon, nitrogen, and mineral salts, and then isolating the desired product. The sources of assimilable carbon, nitrogen, and mineral salts can be supplied by simple or compound nutrients. Carbon sources generally include glucose, maltose, starch, glycerin, molasses dextrin, lactose, sucrose, fruit sugar, galactose, inositol, D_mannose 'soybean oil' carboxylic acid, amino acid 'glyceride, alcohol , Alkanes and vegetable oils. The carbon source generally constitutes 0.5 to 10% by weight of the fermentation base. Fruit sugar 'glucose and sucrose represent preferred carbon sources. Nitrogen sources generally include soybean meal, corn broth, lees, yeast extract, cottonseed meal, glands, ground hard fruit powder, malt extract, molasses, casein 'amino acid mixture, ammonia (gas or solution ), Ammonium or nitrate, urea and other amides can also be used. Nitrogen sources generally constitute 0.01 to 10% by weight of the fermentation base. The nutrient mineral salts that can be used in the culture medium include commonly used sodium, sodium, aluminum, iron, iron, zinc, aluminum, aluminum, phosphate, sulfate, Salts of vapors and carbonate ions. -40- This paper scale is applicable to China s B Family Standard (CNS) A4 specification (210X297 public daughter (please read the precautions on the back and then fill out this page) . Order the Ministry of Economic Affairs, Central Bureau of Industry and Commerce Printing Co., Ltd. Printed by the Central Sassafrass Bureau Beigong Consumer Cooperative A7 ---------- V. Description of the invention (38) One *-The cultivation of microorganisms is generally at 20. To 40  C, preferably 2 . (: To 35C 'especially about 25. (:, sometimes need to be carried out under ventilation and shaking (such as shaking or stirring). At the beginning of the medium can be inoculated with a small amount of mycelium and / or spores obtained The plant-based inoculum can be transferred to the fermentation substrate, or to one or more seed stages, where it is further grown, and then transferred to the main fermentation substrate. The fermentation is generally carried out at pH 3.5 to 9.5, preferably 4.5 to 7.5. It may be necessary to add alkali or acid to the fermentation substrate to maintain the pH in the desired range. Suitable alkalis that can be added include alkali metal hydroxides, such as aqueous sodium hydroxide or potassium hydroxide. Suitable acids include Mineral acids, such as hydrochloric acid, sulfuric acid or succinic acid .. Fermentation can be carried out 4-30 , Preferably about 5-15 days. To control excessive foaming, anti-foaming agent can be added, the time of addition depends on the need. Carbon and / or nitrogen source can also be added to the fermentation matrix as needed. Compound of formula (XII) Mainly attached to cells, it can be added with acid or water-soluble organic solvent, more preferably with alkali (such as sodium hydroxide) to make a solution. The cells in the solution can be separated by centrifugation, traditional filtration method or membrane filtration This liquid can be re-used with acid, such as sulfuric acid, if necessary, and treated to a pH of less than 6 (eg, about 4.5). The compound of formula (XII) can be separated and purified by various distribution techniques, such as washing away by adsorption, Shen Dian, classification: Crystallization, solvent extraction, and liquid-liquid distribution methods can also be used in combination. Separation and purification of the compound of formula (IX) is most suitable for adsorption on a solid support followed by washing away. Suitable solid supports include dioxide ; Non-functional large-mesh adsorption resins, such as cross-linked styrene divinylbenzene polymer resins, such as CG161 and Amberlite XAD-2, XAD-4, XAD-16 or XAD-1180 -41 -i China National Standard (CNS) A4 specification (210X297 PCT) ~ --------- f  ------ IT ------ f (Please read the Notes on the back to fill out this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Rohm &amp;amp; Haas Limited)Kastell SI 12 (Montedison); Diaion SP207 (Mitsubishi);[ ira-958  MacroPrep High Q (BioRad)] Sephadex LH20 (Pharmacia UK Limited) C18 XII)LA2  XII) X AD-16)   /)  (HPLC)UV  ()</span>Resin (Rohm &amp;amp; Haas Limited) or Kastell SI 12 (Montedison); substituted styrene diethylbenzylbenzene polymer, such as Diaion SP207 (Mitsubishi); anion exchanger [eg ira-958 or MacroPrep High Q (BioRad )], Cross-linked dextran compatible with organic solvents, such as Sephadex LH20 (Pharmacia UK Limited), or reversed-phase supports, such as silicon dioxide with hydrocarbons, such as C18  linked silica. The compound of formula (XII) can also be separated and purified using a liquid anion exchanger such as LA2. A suitable solvent for washing away the compound of formula (XII) will naturally depend on the nature of the adsorption. When using polymer resins (such as X AD-16), solvents that are compatible with water, such as methanol, acetone, isopropanol, or acetonitrile, can be used in different proportions with water. During the extraction / separation process, the presence of the compound of formula () can be detected by using the optical rotation property or other properties of the secondary compound by traditional techniques, such as high performance liquid chromatography (HPLC) or UV spectroscopy. Printed by the Central Sample Bureau of the Ministry of Economic Affairs-Workers and Consumers Cooperatives (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T XII) /     )/ / C 8 ____- 42 - i( 21&amp;gt;&amp;lt;297 - A7 B7  40 )   -1,2-_3_  XII) DEAE-   4-)   XII)</span>1T When the compound of formula (XII) obtained is in the form of a solution in an organic solvent, such as those obtained by adsorption / washing, the solvent can be prepared by conventional methods, such as evaporation. If necessary, this compound can be further purified by chromatography, such as using a rotary extractor (such as a multi-layer coil extractor) for countercurrent chromatography, or with or without a bonded phase adsorbent (such as carbon , Oxidation Ming 'Xun' polymer resin or silica) for high-performance liquid chromatography or supercritical fluid chromatography. The suitable solvent / eluting agent suitable for the purification / separation of the compound of formula () by chromatographic analysis naturally depends on the nature of the adsorbent. When using C 8 bonded silica, a mixture of acetonitrile and water is most suitable. Or ____- 42-This paper ruler uses Chinese national standards ((21 &amp;gt; &amp;lt; 297mm)-A7 B7 Printed by the Consumer Cooperative of the Central Diplomatic Bureau of the Ministry of Economic Affairs V. Invention Instructions (40), This compound can be further purified by solvent extraction, for example, using a suitable organic solvent, such as a net (such as acetone or methyl ethyl ketone), a sulfonated genus, alcohol (such as methanol), diol (such as propane-1 , 2-diol or butane _: , 3_ diol), or ester (such as methyl acetate or ethyl acetate). Another purification method, the compound of formula (XII) solution is treated with an adsorbent, such The amount of adsorbent (such as DEAE-cellulose) can be selectively removed when appropriate, or purified by recrystallization (for example, recrystallized with a mixture of acetonitrile and water), or combined to purify using the above methods. Darling is biologically converted into 4, -demethyl sodarin and a compound of formula (). Sodarin can be used in a culture containing suitable microorganisms, carbon sources and nitrogen sources, including the above sources' Medium culture 'and then the compound of formula (XII) is isolated from the culture.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">4- HPLC ATCC 31963 Strepomyces avermitillis ATCC 31272 NRRL 3176ATCC 31771 ^ATCC 23955,. 29778ATCC 23934 ATCC 14975 ATCC 43491 36112  204(TC2035 28C /  -43- ---------f I------w------ () CNS ) 210X297  321644 A7 B7 41 ) seed stages)1-3)  pH 3.5954 57 5 pH   2 - 53 / . XII) pH62.5)        1162,027NRRL 3196(t&amp;amp;ATCC 363 86ATCC) </span>Microorganisms capable of demethylating sodarin at the 4'-position can be determined by small-scale tests and analysis of test samples obtained by standard methods (such as HPLC analysis). Examples of microorganisms that have been shown to demethylate sodarin include A. tangutorium ATC: C: 31963 'Strepomyces avermitillis ATCC 31272, herd key mold NRRL 3176, Streptomyces praxis ATCC 31771 ^ Streptomyces spp. ATCC 23955 , Streptomyces platatus , . 29778, Streptomyces mascus ATCC 23934 Streptomyces pantherus ATCC 14975 Nocardia orientalis ATCC 43491, and Agaricus lanceolata A.  36112  microorganisms can be cultured at 20. To 4 (TC, preferably 20. To 35, most preferably about 28  C, sometimes need to be carried out under ventilation and shaking (such as shaking or stirring). The culture medium can be inoculated with a small amount of hypha Body and / or spores. The resulting plant inoculum can be transferred to the fermentation substrate, or to a -43- --------- f I ------, w ------ (Please read the precautions on the back before filling in this page) This paper scale is applicable to the Chinese National Standard (CNS) grid (210X297 Gonghuang) Printed 321644 A7 B7 by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of invention (41 ) Multiple seed stages, where they are further grown (for example, about 1-3 days), and then transferred to the main fermentation substrate. The main fermentation substrate can also contain sodarin, and the fermentation is generally at pH 3.5 to 9  5 is carried out, preferably 4 5 to 75. The fermentation medium may need to add eyelid or acid to maintain the pH in the desired range. Suitable tests may include alkali metal hydroxide, such as sodium hydroxide or hydroxide Potassium aqueous solution. Suitable acids include mineral acids such as hydrochloric acid, sulfuric acid or phosphoric acid. Fermentation can be carried out for 2 to 5 days, preferably about 3 days. If there is too much foaming, anti-foaming agent can be added. The time of addition depends on the need. The carbon and / or nitrogen source can also be added to the fermentation matrix as needed. Carry out. When it is necessary to reduce the pH of the liquid to below 6 (such as about 2.5), you can add acid, such as orthosquaric acid, to achieve. It should be understood that biotransformation can be completed according to various methods. For example, buffers, used fermentation substrates and solutions in water are inoculated and harvested before. In addition, it is also feasible to isolate and use appropriate enzymes (while using appropriate coenzymes) or to clone and overexpress the enzymes. As mentioned above, Both Sodarin and Sodarin are known compounds and can be prepared by the method described in the art. Therefore, for example, British Patent No. 1,162,027 describes the cultivation of D. arachnoidis NRRL 3196 (t &amp;amp; ATCC 363 86 Stored at ATCC) to prepare sodarin. Specific examples of preparing sodarin in a similar manner will be described later.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">NRRL 3196  CAB _ - 44 - CNS ) A4*L210X297 () &amp;lt;   A7 B7 42 )</span>Sodarin can be prepared using a similar fermentation method used to prepare Sodarin using D. arachnoides NRRL 3196 or a suitable variant thereof, using appropriate chromatographic analysis to isolate the desired compound. One such variant has been stored in the British CAB _-44-This paper scale is suitable for China's Jiejia Step Standard (CNS) A4 * L grid (210X297mm) (Please read the precautions on the back before filling this page)  A7 B7 printed by Beigong Consumer Cooperative of Central Bureau of Standards of the Ministry of Economy V. Description of invention (42)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">International Mycological Institute, Genetic Resource Reference Collection Bakeham Lane, Egham, Surrey TW20 9TY1994811 IMI 36294719948 19 (International Depository)IMI 362947 26 IMI 362947 IMI 362947IMI 362184      HPLC National Collections of Industrial and Marine Bacteria Limited (NCIMB), 23 St. Machar Drive, Aberdeen AB2 1RY,</span>International Mycological Institute, Genetic Resource Reference Collection Bakeham Lane, Egham, Surrey TW20 9TY. This strain was received by this institution on August 11, 1994, and the obtained accession number was IMI 362947, and the date of survival confirmation was August 19, 1994, respectively. This institution is recognized as an international depository authority under the Budapest Treaty. See Example 26 for the characteristics demonstrated so far by IMI 362947. The present invention further provides the microorganism IMI 362947 itself and its mutants. The method for obtaining the IMI 362947 variant and its genetic material is similar to the method for operating IMI 362184 described above. Sodarin can also be prepared from Sodarin using biotransformation. The biotransformation is accomplished by growing Sodarin in a culture containing suitable microorganisms and carbon and nitrogen sources (including the aforementioned various carbon and nitrogen sources), and then separating Sodarin from the culture. New microorganisms that can convert Sodarin into Sodarin can be determined by small-scale tests and analysis of test samples obtained by standard methods (such as HPLC analysis). The inventors have confirmed one such microorganism and have deposited it in National Collections of Industrial and Marine Bacteria Limited (NCIMB), 23 St. Machar Drive, Aberdeen AB2 1RY,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ScotlandNCIMB199484  Coryneform species)2 7 NCIMB 40675MCIMB International Depository  -45- CNS ) A4210X297 () %</span>Scotland. NCIMB received this strain on August 4, 1994 and accepted the strain as a patent on the same day and confirmed that the microorganism was alive. This microorganism is a Coryneform species, and its characteristics are as described in Example 27, and it has been designated as NCIMB No. 40675. MCIMB is the international depository authority recognized by the Budapest Treaty. -45- This paper uses the Chinese National Standard (CNS) A4 standard (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">tT  38^44 7 7 43) NCIMB 40675  NCIMB 40675  NCIMB 40675IMI 362184 NCIMB 40675204(2035 C28C /  seed stages )_ 3 pH 3.59.54575    4 - 86 /  '      () 11</span>Printed by the employee consumer cooperative of the Central Standardization Bureau of the Ministry of Economic Affairs 38 ^ 44 7 7 V. Description of the invention (43) The NCIMB 40675 microorganism and its variants are also provided on the other hand of the present invention. According to another aspect of the present invention, the inventors provided the genetic material of NCIMB 40675 and its variants, which can convert sodarin to sodaris. The method for obtaining the NCIMB 40675 variant and its genes is similar to the method for operating IMI 362184 described above. NCIMB 40675 can be cultivated on 20. To 40. (:, Preferably 20. to 35 C, most preferably about 28  C. Sometimes it needs to be carried out under ventilation and shaking (such as shaking or stirring). A small amount of mycelium and / Or spores. The resulting plant inoculum can be transferred to the fermentation substrate, or transferred to one or more seed stages (seed stages), where it is further grown (for example, about 3 days), and then transferred to the main fermentation Substrate. The main fermentation substrate may also contain sodarin, and the fermentation is generally carried out at a pH of 3.5 to 9.5, preferably 4.5 to 75. It may be necessary to add alkali or acid to the fermentation substrate to maintain the pH in the desired range. Suitable bases to be added include alkali metal hydroxides, such as aqueous sodium hydroxide or potassium hydroxide. Suitable acids include mineral acids such as hydrochloric acid, sulfuric acid or phosphoric acid. Fermentation can take 4-8 days, preferably about 6 days . To control excessive foaming, anti-foaming agents can be added, the time of addition depends on the need. Carbon and / or nitrogen sources can also be added to the fermentation substrate as needed. It should be understood that biotransformation can be accomplished according to various methods. Cells can be added to sodarin in eg buffers, used The solution in the fermentation substrate and water is inoculated and harvested. In addition, it is also feasible to isolate and use the appropriate enzyme (while using the appropriate coenzyme) or to clone and overexpress the enzyme. Sodarin is separated from the fermentation broth It can be done by the general method mentioned above. (Please read the precautions on the back before filling this page), 11</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 ______B7 44) pH6     1  NRRL3196(ATCC 36386) 6 Brain Heart Infusion broth) (Oxoid) + 1 0 %_ i 4 2 50FS250 Erlenmyer   FS /  OxoidL34) 10  Oxoid L39) 2 1  Glycerine CP) 40  Junlon 110 (Honeywell &amp;amp; Stein) 1  25C5 50250/2 250FS50 _-47-__ CNS ) A4210X297 () X.</span>A7 ______B7 printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (44) When the pH of the liquid needs to be lowered to below 6, acid can be added, such as orthophosphoric acid, to achieve . Fermentation and biotransformation methods represent yet another aspect of the present invention. The following examples illustrate various aspects of the invention, but do not limit the invention. Preparation 1 Production of sodarin The culture of arachnid arachnoides NRRL3196 (ATCC 36386) and agar medium were grown to maturity. Move the 6 mm agar plug containing the mature bacteria to sterile water or Brain Heart Infusion broth (Oxoid) + 10% glycerol, and store at ambient temperature or _i 4, respectively. A 250 ml Erlenmyer flask containing 50 ml FS medium was incubated with a suspension containing 2 of this agar plug. FS medium g / L gland (OxoidL34) 10 Malt extract (Oxoid L39) 2 1 Glycerine CP 40 Junlon 110 (Honeywell &amp; Stein) 1 Distilled water Incubate the culture on a rotary shaker at 25  C 5 Today, this rotary shaker is operated at 250 rpm on a 50 mm diameter track. Inoculate 250-ml FS-containing medium (50 ml) with the whole (2 ml) of the developed inoculum and inoculate _-47 -__ sheet paper scale to use the Chinese National Standard (CNS) A4 specification (210X297mm) (please (Read the notes on the back before filling this page) X.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 B7 45 ) 250ErlenmyerFS 807 5FS25 C 400/2/ 310500 SM55VAR780 SM55VAR /</span>1T Printed by the Employees Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economic Affairs A7 B7 5. Description of the invention (45) In a 250 ml Erlenmyer flask, this FS medium has been cultivated as described above. 80 ml of the inoculum developed in the shaking flask was inoculated into two 7-liter fermentors containing 5 liters of FS medium. The fermentation is controlled at a temperature of 25  C. The culture was shaken at 400 rpm and aerated at a rate of 2 liters / min. After 3 days of fermentation, a 780 liter fermentor containing 500 liters of SM55VAR medium was inoculated with 10 liters of culture. SM55VAR g / L</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Glucidex 32D (Roquette Frere) 74 (OxoidL37) 10</span>Glucidex 32D (Roquette Frere) 74 glands (OxoidL37) 10</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Proflo (Traders Protein) 30  15</span>Proflo (Traders Protein) 30 Beet molasses 15</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">MgS04 .7H2 O(BDH) 5</span>MgS04 .7H2 O (BDH) 5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CaC03 (BDH) 5</span>CaC03 (BDH) 5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">FeS04 .7H2 O(Sigma) 2</span>FeS04 .7H2 O (Sigma) 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ZnS04 ,7H2 O(BDH)  4 (Sigma) 2 PPG2000 (K&amp;amp;K Greef) 0.5</span>ZnS04, 7H2O (BDH)  4 L-tryptophan (Sigma) 2 PPG2000 (K &amp;amp; K Greef) 0.5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Silicone 1520 (Dow Coming) 0.04  2 5C300-350/ 200/70 % (/ Meritose (Tunnel Refineries) _ -48- CNS ) A4210X2.97 () *.   A7 _ _____B7__ 46) 500 PPG2000HPLC +1%n 0.6/ 0.1M Dicalite1 /0 Dicalite  6-7XAD16/1 /1 : 3 ) _3 : 1 ; 1 - 2/8 5) pH3  7 5 %3  9 1.00.2M4204 pH4.060%_im NH4H2P450 (5_07Kromasil C81 5X 251  450-550HPLC 50%-0.1\1&amp;gt;1114112?4114(50 100575NH4H2P440h3P4) 600/UV210 15.419.21  2 35 02 8 -49- CNS ) A4210X297 ---- --------- X II  () ,11 A7 38l644 ._____ B7 47) /Kromasil25 9 0 %1 3 105.6 MS)NMR)  2 _ NRRL 3196 (ATCC 36386)-140C + 1  %12 50FS250 Erlenmy er25(5 50250/ 2250F S 5 0250Erlenmyer 807 5FS25 C 400/2/ 3105 SD1780 -50- CNS ) M210X 297 ()   A7 B7</span>Silicone 1520 (Dow Coming) 0.04 Distilled water Fermentation is controlled at a temperature of 25  C. The broth is shaken at 300-350 rpm and aerated at a rate of 200 liters / min. Add 70% (weight / volume) Meritose (Tunnel Refineries) solution to the culture to maintain positive residual Portuguese _ -48- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X2.97mm) (please Please read the precautions on the back and then fill out this page) * . Order the A7 _ _____B7__ printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy. V. Invention Instructions (46) Sugar Concentration. Distilled water was added to maintain the culture volume at 500 liters. Add PPG2000 anti-foaming agent as needed to control foaming. Reverse phase HPLC was used to identify Sodarin in all broth extracts (+ 1% trifluoroacetic acid in acetonitrile in water). After n days', the culture was harvested when the broth extract sample showed a sodarin titer of 0.6 g / liter. Make the fermentation broth contain 0.1M sodium hydroxide, store it at ambient temperature overnight and filter with Dicalite on the rotary hollow filter (add 10/0 Dicalite as a filter aid in the broth). The filtrate was adjusted to 6-7 with concentrated sulfuric acid to 6-7, and this solution was added to XAD16 resin (10 times the volume of the filtrate / resin). Wash the adsorbent with water and acetone / water (1: 3) to get a clear effluent, and then _ wash away the sodarin with acetone: water (3: 1; charge two column volume). The flow rate for this process is 1-2 column volumes / hour. Concentrate the eluate to a small volume (85 liters). The pH of the concentrate was adjusted to 3 with squamous acid, and the sodarin precipitated out by standing at ambient temperature overnight. Pour out the floating solution, then centrifuge to discard the floating solution. Dissolve the centrifugal pills and the precipitate in 75% acetonitrile aqueous solution to obtain 3.9 liters of dark standard solution. To this solution was added 1.0 liter of 0.2M NH4204 'under stirring, and then the pH of the solution was adjusted to 4.0 with squamous acid, and the final volume was 5.0 liter with nearly 60% acetonitrile_im NH4H2P4. The above crude Sodarin solution (5_0 liter) was subjected to preparative HPLC treatment with 10 injections (450-550 ml each time) on a 7 mm Kromasil C8 column (15 cm X 25 cm) with a mobile phase of 50% Acetonitrile-0.1 \ 1&gt; 1114112? 4, ie 114 (add 50 liters of water to 100 liters of acetone 'containing 575 grams of NH4H2P4 and 40 milliliters of h3P4), with a flow rate of 600 milliliters / minute, with UV absorbance Nano) determination. Collect eluent in portions between 15.4 and 19.2 minutes. Concentrate 10 injections of eluent (2 3 liters), dilute with water to 50 liters, and then use this solution at 28-49-paper size to use the Chinese National Standard (CNS) A4 specifications (210X297 %) ---- --------- 'X II  (please read the precautions on the back before filling in this page), 11 A7 38l644 ._____ B7 V. Description of the invention (47) Liter / hour speed Haw back through the Kromasil column. The column was washed with water (25 liters) and then washed away with 90% acetonitrile (10 liters). The eluate was evaporated to 300 ml of residue, and then dried to prepare the title compound as a beige powder (105.6 g). The product was analyzed by mass spectrometry (MS) and nuclear magnetic resonance (NMR) and showed the same as the confirmed sodarin sample. Preparation 2 Production of Sodarin_Salt The D. arachnoidis NRRL 3196 (ATCC 36386) was stored in brain-heart infusion broth at + 140  C + 10% glycerol as described in Preparation 1. A suspension containing 2 fat plugs was used to inoculate a 250 ml Erlenmy er flask containing 50 ml FS medium. This culture is 25 on a rotary shaker. (: Incubate for 5 days. This rotary shaker is operated at 250 rpm on a 50 mm diameter track. The entire (2 ml) of the developed inoculum is then inoculated into 250 ml of 250 containing FS medium (50 ml) Inoculate Erlenmyer flasks, cultivated as described above. Inoculate two fermenters containing 5 liters of FS medium each of 7 liters with 80 mL of inoculum developed in the shaking flask. Fermentation is controlled at a temperature of 25  C. Shake at 400 rpm and ventilate at a rate of 2 liters / minute. After 3 days of fermentation, inoculate a 780 liter fermentor containing 500 liters of SD1 medium with 10 liters of culture. -50- This paper size Applicable to China National Standard (CNS) M specifications (210X 297mm) (Please read the precautions on the back before filling in this page)  Printed Bag A7 B7 of the Employees Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">I 48) SD1 /</span>Printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of Invention (48) SD1 g / L</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Meritose (Tunnel refineries) 22  20</span>Meritose (Tunnel refineries) 22 Lactose 20</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Glucidex 32D (Roquette Frere) 30</span>Glucidex 32D (Roquette Frere) 30</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Arkasoy (The British Arkady Co) 20 CSL 20</span>Arkasoy (The British Arkady Co) 20 CSL 20</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">FeCl3  6H2 O 0.05 NH4H2P04 5</span>FeCl3  6H2 O 0.05 NH4H2P04 5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ZnS04 ,7H2 O(BDH) .i PPG2000 0.5  2 5C350/ 200/ 500HPLC6 1.3/ 500.1M4C 2/Dicalite Dicalitep  6Amberchrom CG161320 /0.64HPLC 4514.4 22 5 %/ -51 - CNS )4^21297 () *.  ^^1644 A7  7 49 ) 275 %/15 75 %/4( 200200-1 _ -1 -2 X 500Whatman 1 4045 C2x 500 _ 2 3504 5 C -2 -39 %/_2 54500_ 2 -4 54 C34 -2 -2 0 - 3 0 P251610.5  3  15 00o.im C4Dicalite 1 % Dicalite pH9.67510pH 3?46XAD-16200 1-1.5/1 _ ' -52- 1^)/^4/210297 () Tr 44</span>ZnS04, 7H2 O (BDH) .i PPG2000 0.5 Distilled water Fermentation is controlled at a temperature of 25  C. The broth is shaken at 350 rpm and aerated at a rate of 200 liters / min. Add distilled water to maintain the culture volume at 500 liters. The presence of Sodarin was identified by reverse-phase HPLC. After 6 days of culture, the culture was harvested when the broth extract sample showed a soda titre of 1.3 g / liter. Make 50 ml of harvest broth sample containing 0.1 M sodium hydroxide and store at 4  C overnight. Add 2  /  of Dicalite to the broth as a filter aid and use a Dicalite bed as a filter to remove the cells. The filtrate was adjusted to pH 6 with concentrated sulfuric acid to nearly 6. The broth extract was pumped through the Amberchrom CG161 resin bed at 320 mL / min (0.64 bed volume per minute). The effluent was identified by HPLC. After 45 minutes (equivalent to 14.4 liters of pumping volume), Sodarin started to pass through and stopped pumping. The adsorbate is washed with water (2 liters), and then with 25% volume / volume water-51-This paper size is used by the Chinese National Standard (CNS) 4 ^ and (21297297mm) (please read the back page first (Notes and then fill out this page) * . Order ^^ 1644 A7 Printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 7. The invention description (49) is washed with acetone (2 liters). Wash off Sodarin with acetone (15 litres) in 75% volume / volume water. The 75% volume / volume acetone was washed away at 40. (: Rotary evaporate to about 200 ml. Add 200 ml of butan-1-ol, and then evaporate to a dry oil body (containing a little butan-1-ol). The oily residue is then heated with methanol (2 X 500 ml) extraction. Combine the extracts, filter (Whatman No. 1 paper), and evaporate at 40 to 45  C to obtain a dry oil body. Then extract with propylene (2x 500 ml). Combine the acetone extracts, Filter and evaporate to a viscous oil body. Add propane _ 2  alcohol (350 ml), this oil body dissolves at 4 5  C to a clear brown solution. The potassium 2-ethylhexanoate solution (39% Weight / weight solution in propane-2 alcohol, 54 g) was weighed into a 500 ml Erlenmeyer flask. The propane-2-alcohol solution containing Sodarin was poured into the Erlenmeyer flask, the contents were mixed and placed in the chamber Allow to stand for 4 hours. Sodium hydrochloride (approximately 5 mg) is planted in this solution. The flask is stoppered and stored at 4  C for 3 days. The off-white solid formed by air filtration (using a No. 4 porous funnel) is filtered The cake was washed with propane-2-ol (approximately 20-30 mL). The solid was transferred to a crystallization dish and dried on P205 for 16 hours to prepare the title compound ( 10.5 g). Preparation 3 Sodalin Potassium Cullin was prepared in Method 1 to prepare 500 liters of culture broth. The broth containing o.im hydrogen emulsifier was used after 4 days at 0  C. The Dicalite bed is filtered on a rotary air filter. 1% Dicalite is added as a filter aid in the broth. The pH of the filtrate is adjusted from 9.6 to 7.5 with concentrated sulfuric acid. The pH of the filtrate (10 liters) is then adjusted to 3? 4 Adjust to 6 and use it on XAD-16 resin bed (200 ml) wrapped in water with a flow rate of 1-1.5 bed volume / hour. Wash this tree with water (1 bed volume) _ '-52- This paper size Applicable to Chinese National Standards ((: 1 ^) / ^ 4 gauge / grid (210 to 297 mm) (please read the precautions on the back before filling out this page), Tr 44</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">5)  25%2 5 51 2-6 500   (4002 -81 4 3 4.85  t+ (01IMI3 62 1 84-14(TC + 1 0 %2 50FS250Erlenmyer 25C5 50250/ (2250FS (50250Erlenmyer 807 5FS25 C400/2 /31 53 1&amp;lt;4210297 () 4*.  A7 ^^1644 B7 51 ) 500SM55VAR780 125 C350 /500/  70 %  /  Meritose (Tunnel Refineries)  500HPLC 4'-10 4'-0.8/ 0.1M 1Dicalite 1 % Dicalite pH4.5XAD1620 /0.1 %10 1 : 4 (61 ; 2 1 _ 2/ -1 -1 2 60 C1 3 3 : 7) P 2  5 244.0NMR 4'- (ii)i)0.1METNA 10A10K Dalton cut-off) -54- CNS ) A4210X297) () fc.A_ ?  ^2164 4 A7 B7  52) pH5.2 XAD162/ 324-0.1% /20%// 102/ 6 5 %/2/ 0751.6 85%42/ /DE525 DE52 4 3 %6 2 %4 1 5 43 0 %// 3 0 C94  5 4' 28( 25C (501 SB1(FBI(250/ 20 5/ 80 %200/3 50050080%/2% Eppendorf3 -55- CNS ) A4210X297) I&amp;quot;------- . I ()</span>3. Description of the invention (50) The grease bed printed by the Employee Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs was washed with a 25% aqueous solution of isopropyl alcohol (25 bed volume) and then washed away with net isopropyl alcohol. After 50 ml was flowed out, 100 ml of isopropanol was collected in batches. Collect 2-6 parts rich in sodarin and evaporate to half volume. Isopropanol was added to bring the volume back to 500 ml, and the evaporation was repeated to half volume to co-evaporate the remaining water. After the third evaporation to half volume, the residue was passed through and the filter was washed with isopropyl alcohol. A solution of potassium 2-ethylhexanoate (8g) in isopropyl alcohol (100ml) was added to the combined filtrate and wash (400ml). Sodium hydrochloride is grown in this mixture.  Crystals formed slowly after standing for several days. Filter the crystals on the No. 3 porous filter, wash with a little ice-cold isopropanol, and dry it to obtain the title compound as a brown powder (4.85g). Demethylated product (0 to prepare 1 IMI3 62 1 84 at -14 (TC maintained in brain heart infusion broth + 10% glycerol. 250 ml Erlenmyer flask containing 50 ml FS medium was inoculated with a suspension containing 2 agar plugs This culture was incubated on a rotary shaker for 5 days at 25  C. The rotary shaker was operated at 250 rpm on a 50 mm diameter track. The whole (2 ml) of the developed inoculum was re-inoculated in The 250 ml Erlenmyer flask containing FS medium (50 ml) was cultivated as described above. 80 ml of inoculum developed in the shaking flask was inoculated into two 7 liter fermentors containing 5 liter FS medium. Fermentation Controlled at a temperature of 25  C. The culture was shaken at 400 rpm and aerated at a rate of 2 liters / minute. After 3 days of fermentation, the 10 liter culture was used to inoculate 53 1 paper scales. (&amp;Lt;: Yang) Eight 4 specifications (210 father 297 mm) (please Read the notes on the back and fill in this page) 4 * . Order A7 ^^ 1644 B7 5. Description of the invention (51) In a 780-liter fermenter of 500-liter SM55VAR medium (as described in Preparation 1). Control the fermentation At a temperature of 25  C. The broth is shaken at 350 rpm and aerated at a rate of 500 liters / minute. A 70% weight / volume Meritose (Tunnel Refineries) solution is added to the culture to maintain a positive residual glucose concentration Add distilled water to maintain the volume of the culture to 500 liters. Identify the presence of 4'-demethyl sodarin in all broth extracts by reversed-phase HPLC. Samples of the broth extract show 4'-dehydration after 10 days of culture When the titer of methyl sodarin is 0.8 g / L, the culture is harvested. Make the fermentation broth contain 0.1 M sodium hydroxide, and after 1 hour at the ambient temperature, use Dicalite to filter on the rotary empty filter (broth Add 1% Dicalite as a filter aid.) Adjust the pH of the filtrate to 4.5 with concentrated sulfuric acid, add this solution to XAD16 resin (20 g product / liter resin). The adsorbate is washed with 0.1% phosphoric acid (10 column volume) , In acetonitrile: water 1: 4 (6 column volume ) Wash, and then wash away the product with acetonitrile: water (: 1; 2 column volume). The flow rate of this process is 1 _ 2 column volume / hour. Add butane-1-ol to concentrate the eluate to dryness, use Methanol (12 liters) was extracted and solidified, and then extracted with acetone (10 liters) at 60  C. In each step, the insoluble material was removed with a No. 3 glass porous filter, and then the extract was concentrated to dry. The solid was crystallized from acetonitrile: water (3: 7), then recrystallized from the same solvent, and dried to a constant weight on P 2 5 to obtain the title compound (244.0 g), which was confirmed by proton NMR analysis. 4'-demethyl sodarin is the same. (ii) According to (i) fermentation method, after adding 0.1M sodium hydroxide to the broth, use ETNA 10A membrane (10K Dalton cut-off) for ultrafiltration. After water is used for infiltration and filtration -54- This paper scale is used in the Chinese National Standard (CNS) A4 specification (210X297 public shame) (please read the precautions on the back before filling this page) fc.A_ ?  Central Ministry of Economic Affairs StandardsPrinted by the Industrial and Consumer Cooperatives ^ 2164 4 A7 B7 Printed and printed by the Employees Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs V. Description of the invention (52) 'The exudate is a clear solution. After adjusting the pH to 5.2 with concentrated sulfuric acid, the exudate was loaded on a XAD16 resin column at a loading rate of 2 column volumes / hour, and finally 32 grams of 4, -demethyl sodarin was loaded per liter of resin. This column was washed with 0.1% volume / volume phosphoric acid, and then with 20% volume / volume acetonitrile / water (each with 10 column volumes) at a rate of 2 column volumes / hour. The column was washed off with 65% acetonitrile / water, and the washing off rate was 2 column volumes / hour. Discard the 0.75 column volume that flowed out first, and collect 85% of the loaded 4.  demethylsodarin from the eluate of 1.6 column volume later. This large amount of washed material was treated with 20% weight / volume DE52 cellulose with stirring for 5 minutes, and then taken out and filtered. An aliquot of the eluate treated with DE52 was concentrated using a rotary evaporator to 62% of the original volume (43% acetonitrile). The concentrated eluate was kept at 4 for 15 hours to crystallize, and the collected solid was filtered with a glass porous filter. The crystals were washed with 30% volume / volume acetonitrile / water of 4 cake volume and dried at 30  C. The title compound (94 g) collected from the concentrated eluate was a light gray solid. Preparation of 5 sieving microorganisms capable of demethylating sodarin at the 4 'position. Microorganisms capable of demethylating sodarin at the 4 position can be obtained at 28. (: (Bacteria) or 25  C (strains) grown in a 50-mL Erlenmeyer flask with a volume of 10 mL of SB1 (bacteria) or FBI (strains). This flask was shaken at 250 rpm. 2 Days later, add sodarin to a final concentration of 0.5 mg / ml (taken from a 200 mg / ml stock solution in 80% ethanol), and incubate the flask for another 3 days. A 500 l sample is taken from the entire culture Mix with 500 l of 80% acetonitrile / 2% trifluoroacetic acid in an Eppendorf tube, and allow it to be extracted at room temperature for 30 minutes -55 I &amp;quot; ------- . I (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">'1T 3^144 7 753) HPLC 4 '-3 5 % 4'-3.3 52/ Spherisorb C6515X4.6    ATCC 31963  Streptomyces avermitilis ATCC 31272   NRRL 3176   ATCC 31771   ATCC 23955   ATCC 29778   ATCC 23934   ATCC 14975   ATCC 43491   ATCC 36112  SB1 /  Arkasoy 25   5  kh2po4 5   20     pH 7 () -56- CNS ) A4210X297 / 30 10 5 5 20 ^^1644  __2_7 54) FBI </span>'1T 3 ^ 144 7 7 V. Description of the invention (53). The extracted float obtained from the sample centrifuged by the microcentrifuge was identified by isocratic HPLC using 4'-demethylsodarin. The mobile phase of 35% acetonitrile in water was used to wash away 4'-demethyl sodarin for 3.3 5 minutes at a flow rate of 2 ml / min using a Spherisorb C6 column (5 microns, 15 cm X 4.6 mm). In this way, the following microorganisms can be confirmed as Sodarin demethylators: Ministry of Economic Affairs, Central Bureau of Standards, Employee Consumer Cooperative, Bag-printed Streptomyces ATCC 31963 Streptomyces avermitilis ATCC 31272, Streptomyces herd NRRL 3176, Money-resistant molds ATCC 31771 Mildew ATCC 23955 Streptomyces platensis ATCC 29778 Streptomyces martiniformis ATCC 23934 Streptomyces thermophilus ATCC 14975 Nocardia orientalis ATCC 43491 Streptomyces chrysosporioides Aureobasidium chrysosporium ATCC 36112 SB1 medium g / L Arkasoy 25 Yeast extract 5 kh2po4 5 glucose 20 Distilled water pH 7 (Please read the precautions on the back before filling in this page) -56- This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 mm) g / L 30 10 5 5 20 ^^ 1644  __2_7 5. Description of the invention (54) FBI medium soybean</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Arkasoy  k2hpo4   pH 5.5 6 41- 03ATCC 3 19635 % /-20 C250 Erlenmeyer30SB1 28 C250/ 40.5250 35SB128C250/48 10Erlenmeyer 5200/ 31480% /1 4 30 pH2.5 Amberlite XAD-165 -57- CNS ) A4210X297 ~ ()   A7 32l644 B7 55 ) () 1010 %/2 30 %/209 % /1HPLC 50 %/4'- 4'- 35 %/15 HPLC4-  Spherisorb 5C 6 2 5X 2.5  25/  UV210  3500.05M 1000pH2.5 4  5  104'-HPLC 1 : 1 200 95%/200 /;4_ 1.5 ^ ('H, CDC13); 9.74 (s, 1H); 6.08 (brd, 3, 1H); 4.70 (d, 1.5, 1H); 4.16 (d, 9.5, 1H); 4.08 (dd, 4.5, 3.5, 1H); 3.88 (dd, 4.5, 1-5, 1H); 3.75 (dq, 8.5, 6, 1H); 3.62 (d, 9.5, 1H); 3.68 (dd, 8.5, 3.5, 1H); 2.65 (m, 1H); 2.34 (m, 1H); 1.32 (d, 6, 3H); __ -58- CNS ) A4210X297  A7 ----____B7_ 56)^ ' ' - (d12.5, 1H); 1.23 (m1); 4 (d7, 3H); 0.99 (d7 3H) 0.81 (d, 7, 3H)   1HpLC2i 4 ^1022 Krmasil2 8/ 29%4 5  (4_59% .66(TC 4 C3 40 : 6) 2 5 %17 NMR 8  0.2NCIMB 4067550 0.2%xid)250 Erlenmyer28t 2950250/ 150 Oxoid)250Erlenmyer -59- CNS ) A421GX297) ''~~~--- ()</span>Arkasoy Yeast Extract k2hpo4 Glucose Distilled Water pH 5.5 Preparation 6 Preparation of 41-Demethyl Soxaline by Sodarin Biotransformation 0.3 ml of Streptomyces tangulans ATCC 3 1963 Spore Suspension ( 5% volume / volume The solution in glycerol, stored at -20  C) was inoculated in 30 ml of SB1 medium in a 250 ml Erlenmeyer flask to form a seed culture. / Minute shaking. After 4 days, 0.5 ml of this culture was used to inoculate 35 ml of SB1 in a 250 ml flask and grown at 28  C, 250 rpm for 48 hours. At this stage, the culture was divided into 10 ml into Erlenmeyer flask, and 5 mg of sodarin (from the storage solution in 200 mg / ml of ethanol) was added to the flask. Continue to cultivate for another 3 days. Add 80% volume / volume of acetonitrile in water (14 ml) to the entire broth (14 ml). Store this mixture at room temperature with shaking from time to time. After 30 minutes, the cells were removed by centrifugation. The acetonitrile was removed by evaporation, and the pH of the aqueous solution was adjusted to 2.5 with n-scalic acid. This solution was passed through a column containing Amberlite XAD-16 resin (bed volume 5 ml). Adsorbate phase-57- This paper scale is free of Chinese National Standard (CNS) A4 specification (210X297mm) ~ (please read the precautions on the back before filling in this page). Printed by the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy A7 32l644 B7 5. Description of the invention (55) (please read the precautions on the back and then fill in this page) Follow up with water (10ml), 10% volume / volume solution of acetonitrile in water (20ml), 30% Wash the volume / volume acetonitrile solution in water (20 ml) and 90% volume / volume acetonitrile solution in water (10 ml). Each part was identified by HPLC: there was 4'-demethylsodarin in the eluate of 50% volume / volume acetonitrile in water. The portion containing 4'-demethyl sodarin was evaporated to dryness at room temperature, and the residue was redissolved in a 35% volume / volume solution of acetonitrile in water (15 mL). 4'-Demethyl sodarin was purified by preparative HPLC. Column Spherisorb 5 m C 6 2 5 cm X 2.5 cm Flow rate 25 mL / min UV, 210 nm Mobile phase Use 350 mL of acetonitrile to make up to 1000 mL with 0.05 M ammonium hydrogen phosphate aqueous solution. The pH was adjusted to 2.5 with orthophosphoric acid. The injection volume was 4.5 ml. Printed by the Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. After 10 minutes, the 4'-demethylsodarin was washed away under this condition. The four concentrated HPLC flows were diluted 1: 1 with water, and then pumped back onto the silica (after washing with water and with water after equilibration). The adsorbate was washed with water (200 ml), and the adsorbed product was washed away with a 95% volume / volume acetonitrile solution in water (200 ml). The acetonitrile / water washes were evaporated to remove the base solvent, and the aqueous solution was dried to prepare 4, _demethylsodarin (1.5 mg) as a white powder. ^ ('H, CDC13); 9.74 (s, 1H); 6.08 (brd, 3, 1H); 4.70 (d, 1.5, 1H); 4.16 (d, 9.5, 1H); 4.08 (dd, 4.5, 3.5, 1H); 3.88 (dd, 4.5, 1-5, 1H); 3.75 (dq, 8.5, 6, 1H); 3.62 (d, 9.5, 1H); 3.68 (dd, 8.5, 3.5, 1H); 2.65 (m , 1H); 2.34 (m, 1H); 1.32 (d, 6, 3H); __ -58- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297 mm) Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Printed A7 ----____ B7_ V. Description of the invention (56) ^ ''-(d, 12.5, 1H); 1.23 (m, 1); l  4 (d, 7, 3H); 0.99 (d, 7, 3H); 0.81 (d, 7, 3H)  The new production is carried out according to the preparation 1 method to include the preparative HpLC stage. Charge 2i 4 and the part of the wash off. The knife obtained from 10 injections (22 liters) was concentrated, diluted with an equal amount of water, and the solution was pumped back at a rate of 28 liters / hour through a Kromasil column. The column was washed with water (20 litres) and then washed away with 90% acetonitrile (45 litres). Combine this eluate with the eluate fermented in the same way (4-5 liters). The combined 90% acetonitrile washes were rotary evaporated until the product began to crystallize (volume is about 1.6 liters). The residue was heated on a 6  C water bath while adding a minimum volume of acetonitrile to prepare a clear solution. The solution was cooled and stored at 4 C. The crystals were filtered on a No. 3 porous filter and dried to produce a brown solid. This solid was recrystallized from acetonitrile water (40:60), and the product was filtered, washed with 25% acetonitrile, and dried in vacuo to obtain the title compound (107 g). This product was analyzed by mass spectrometry and NMR analysis. The Dalixin sample is the same. Preparation 8 Sodarin to Sodarin Biotransformation Inoculate 0.2 ml of NCIMB 40675 suspension in 50 ml of 250% nutrient broth (xid) supplemented with 0.2% yeast extract Ml Erlenmyer flask. The culture was incubated on a rotary shaker at 28t for 29 hours. The shaker was shaken on a 50 mm track at 250 rpm. The inoculum developed with aliquots (1 ml) was re-inoculated into 50 ml of Erlenmyer -59 double-strength nutrient broth (Oxoid) supplemented with% alcohol precursor extract- This paper is used in the Zhongguanjia Standard (CNS) A4 threat (21GX297 Gongjia) '' ~~~ ---, (Please read the notes on the back before filling this page )</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 A7  57 2462 2.653 pH7_5i7 30C200/5 175616  Dicalite31 5pH 8_2 ;H3P4pH6.0Amberchrom CG161 25X 5290/ Amberchrom _1/H3P4(2  25/ 4 60% CH3 C N(2 6   4 25% 14 0 : 6 0) 615  9  NCIMB 40675 500.2 %xid) 250Erlenmeyer 25C2650250 /1250 -60- CNS ) A4210X297 () X  - ^^1644 A7 B7 58) 1&amp;quot;1611!116&amp;gt;^1^80% 1_25/8 365 NCIMB40675350 Whatman Partisil P40 ODS-3(5 H3P04PH4.0 BuchnerPartisil 1 75%100_15 6 0 C  4 C3 P 2 0 5 (92 10  IMI 362947250Erlenrmyer 50FS25^ 26501  {) 50 SM55/A  250 Erlenmeyer -61 -</span>A7 A7 Printed by the Consumers Cooperative of the Central Bureau of Samples of the Ministry of Economic Affairs 5. Description of the invention (57 in the flask. Cultivated as above for 24 hours. Concentrate the contents of 62 of this flask into 2.65 liters of developed culture, add 30 liters In the Darling fermentation filtrate, the pH was adjusted to 7-5, as described in Preparation i. This reaction was carried out in a 70-liter fermentor at 30  C, vibrated at 200 rpm, and aerated at 0.5 . Add 1 The equivalent amount of hydrochloric acid controlled the pH to 7.5. After 6 days, nearly 16 grams of sodarin was converted to sodarin. The biological conversion broth was filtered through Dicalite on the empty filter, and the bed was washed with water. Liter filtrate, pH 8_2. Here, the pH was adjusted to 6.0 with H3P4, and it was pumped through Amberchrom CG161 resin bed (25 cm X 5 cm) at a rate of 290 ml / min. H3P4 (2 liters) and 25 /  acetonitrile (4 liters) was washed 'and then washed away with 60% CH3 CN (2 liters). Concentrate the washings by rotary evaporation to start crystallization, and then the residue in 6 Heating on a water bath while adding a minimum amount of acetonitrile to get a clear solution. Cool the solution , Put it on 4 overnight. Filter the crystals, wash with 25% acetonitrile, and dry it to give a brown powder. Then recrystallize this crude product with 1 liter of acetonitrile: water (40:60), filter, wash as above, and After drying, sodarin is obtained as light-colored needle-like crystals (615 g). Preparation 9 Biotransformation of sodarin to soyuanlixin. A ring of surface growth obtained from NCIMB 40675 agar culture was used to inoculate 50 Ml of a 250 ml Erlenmeyer flask supplemented with 0.2% yeast extract in nutrient broth (xid). The culture was incubated on a rotary shaker at 25  C for 26 hours with the shaker on a 50 mm orbit Shake at 250 rpm on the top. Re-inoculate 250 -60 of the above-mentioned inoculum with 1 ml aliquot of the inoculum as described above. This paper scale is applicable to the China Aided Standard (CNS) A4 specification (210X297 mm) Please fill out this page again) X  Order-^^ 1644 A7 B7 V. Description of the invention (58)  1 &amp;quot; 1611! 116 &amp;gt; ^ 1 ^ ml in a flask. This flask is added to pure Soda in 80% ethanol Lin, make the final concentration 1_25 mg / ml. Incubate the flask as above for 8 days, then Zhongcheng 365ml broth containing Sodarin's new culture. The biotransformation mixture was centrifuged to remove NCIMB40675 cells, and the floating solution (350ml) was decanted. Whatman Partisil P40 ODS-3 (5ml, already Wet with acetonitrile), the pH of the mixture was adjusted to 4.0 with H3P04. The Partisil was filtered off on a Buchner funnel and washed away with acetonitrile (100 ml) and then with 75% acetonitrile (100 ml). The combined washings were evaporated to 10-15 mL of aqueous residue. Then the residue was heated on a water bath at 60  C, while adding acetonitrile until it became a clear solution, then heating was continued, and water was added until the solution became cloudy. Cool this solution to 4 C for several days. After passing through the No. 3 porous filter, the crystal was 'washed with water' and dried on P 2 0 5 to obtain white needle crystals (92 mg). Preparation 10 New production of Sodari 50 ml of seed FS medium in 250 ml Erlenrmyer flasks were inoculated with an Anxu ice beam IMI 362947. This flask is 25 on a rotary shaker. ^ Poetry After 26 hours of incubation, this shaker was shaken on a 50 mm diameter orbit. Use the whole cent (1 cent of the Ministry of Economic Affairs, Central Bureau of Samples and Employee s Consumer Cooperative s policy {please read the precautions on the back and fill out this page) l) and then inoculate the four inoculated flask production media SM55 / A Inside a 250 ml Erlenmeyer flask. -61-</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 59) SM55/A / MD30E (Roquette Frere) 120  15 (OxoidL37) 10</span>Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 5. Description of the invention (59) SM55 / A g / L Maltodextrin MD30E (Roquette Frere) 120 Sugar beet syrup 15 Vein (OxoidL37) 10</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Proflo (Traders Protein) 30 L-(Sigma) 2</span>Proflo (Traders Protein) 30 L-Tryptophan (Sigma) 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ZnS04 ,7H2 O(BDH) 0 04</span>ZnS04, 7H2 O (BDH) 0 04</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">FeS04 .7H2 O(Sigma) 2</span>FeS04 .7H2 O (Sigma) 2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CaC03(BDH) 5</span>CaC03 (BDH) 5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">MgS04 ,7H2 O(BDH) 5 121 C120 740 1445 3000/201 pH3Bond Elut1 ;C18)2090%/ 1 5 50%/9 HPLC  Spherisorb 5  ODS-2(25 X2.1   2 5/ -62- CNS ) A4210X297 ()</span>MgS04, 7H2 O (BDH) 5 Complete the formula with distilled water and autoclave at 121  C for 120 minutes. These cultures were incubated for 7 days as described above. Concentrate the contents of the flask and take 40 ml with 1 equivalent of sodium hydroxide (4 ml) for 45 minutes, shaking occasionally. Then, the cells were centrifuged at 3000 rpm for 20 minutes to remove the cells, the floating solution was taken, and the pH was adjusted to 3 with 1 equivalent of hydrochloric acid. The solution was passed through a Bond Elut column (1 g size; C18), and the adsorbate was washed with water (20 ml), and then washed away with a 90% volume / volume acetonitrile solution in water (15 ml). The eluate was evaporated to dryness at room temperature, and the residue was dissolved in a 50% volume / volume solution of acetonitrile in water (9 ml). Purify Sodarin by preparative HPLC: Column Spherisorb 5 micron ODS-2 (25 cm X2.1 cm) Flow rate 25 mL / min-62- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297 Cli) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7</span>A7</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 5501000 1  210 4.5 6  8.9 1 [1R-(1 a3a/?44a/577aa8a/? )]8a-[(6- D-4__4,4a56,7,7a 8,8a --7-- 3- (1--14 -- s-p5 -3a(lH)- 4-12 0.35 90 6  (3 : 1)12.6   (^, CDC13) 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd1H, H-2, J=1.53.6 Hz), 4.65 (d1H, H-lJ=1.5</span>Printed mobile phase of 550 ml of acetonitrile to 1000 ml of water in the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. Add 1 ml of trifluoroacetic acid per ml of mobile phase to measure 210 nanometers. Injection volume 4.5 ml. Lixin. The new part containing Sodarin was concentrated, and the acetonitrile was removed by rotary evaporation at room temperature, and the aqueous solution was lyophilized to obtain the title compound (8.9 mg) as a white powder. Intermediate 1 [1R- (1 a, 3a / ?, 4 Lu, 4a / 5, 7 o'clock, 7aa, 8a /?)] 8a-[(6-deoxyD-azorpiperanyloxy) Methyl Bu 4_Methanoyl_4,4a, 56,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene- s-p5 Shunjian-3a (lH) -carboxylic acid, diphenyl methyl ester in a solution of 4  -demethylsodarin (10 g) in methanol (200 mL) A solution of 0.35 M diphenyl diazomethane (90 ml) in methane gas was added dropwise, and the mixture was stirred for 6 hours. The solvent was evaporated to dryness, and the residue was analyzed on a silica gel flash column using hexane: ethyl acetate (3: 1) as the eluent to obtain the title compound (12.6 g) as a light yellow foam end.  (^, CDC13): 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.65 (d, 1H, H -l ', J = 1.5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.09, 3.76 (2d, 2H, 8a-CH2, J=9 Hz), 4.01 (m, 1H, H-2'), 3.84 (m, 1H, H-3'), 3.75 (m, 1H, H-5'), 3.69 (m, 1H, H-4)2.73 (t, 1H, H-lJ=4.2 Hz) -63-  CNS ) A4210x297 ()</span>Hz), 4.09, 3.76 (2d, 2H, 8a-CH2, J = 9 Hz), 4.01 (m, 1H, H-2 '), 3.84 (m, 1H, H-3'), 3.75 (m, 1H , H-5 '), 3.69 (m, 1H, H-4,), 2.73 (t, 1H, Hl, J = 4.2 Hz). -63-  This paper scale is applicable to China National Standard Rate (CNS) A4 (210x297mm)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">32l64 4 A7 B7  61) HR-(1 a3a44a5 ,7/?7aa ,8ay5 )]8a-[(6--3,4-0---D-]-4--4,4a5,6,7,7a8,8a--7--3-(l--(1H)-14--s-H-3a(lH)- 1(650151 : 2)p -10 1.51,3 50 (252x50  1 : 3 ) 600 e GhCDC13): 9.73 (s1HCHO)7.45-7.24 (m10H 2Ph),6.98(s,lH,CHPh2)6.06(ddlH,H-2J=1.5&amp;amp;3.3</span>32l64 4 A7 B7 Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Invention description (61) 6-deoxy-3,4-0-isopropylidene--D-azhopyranosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a , 8,8a-octahydro-7-methyl-3- (l-methylethyl)-(1H) -1,4-methylene-sH-da-3s (lH) -carboxylic acid, di P-toluenesulfonic acid (10 mg) was added to a solution of phenylmethyl ester in intermediate 1 (650 mg) in 15 ml of dimethoxypropane: acetone (1: 2). This solution was stirred at room temperature for 1.5 hours, then potassium carbonate (1,0 g) was added, stirring was continued for 30 minutes, and the solvent was evaporated to dryness. The crude mixture was separated between ethyl acetate (50 mL) and water (25 mL). The aqueous phase was extracted with ethyl acetate (2x50 mL). The organic phase was washed with brine, dried over magnesium sulfate, and evaporated to dryness. The residue was analyzed by flash layer on silica gel and washed with ethyl acetate: hexane (1: 3) to obtain the title compound (600 mg) as a white foam. e Gh, CDC13): 9.73 (s, 1H, CHO), 7.45-7.24 (m, 10H, 2Ph), 6.98 (s, lH, CHPh2), 6.06 (dd, lH, H-2, J = 1.5 &amp;amp; 3.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.57 (d, 1H, H-l', J=3.0 Hz), 4.30 (dd, 1H, H-3', J=3.6 &amp;amp;5.7Hz)4.07(dlH8aCH2J=9.0Hz)3.95-3.93 (mlH, H-2'),3.85(dd,lHH-4J=5.7&amp;amp;9.3Hz)3.75(dlH 8aCH2, J=9.0 Hz), 3.44 (dq, 1H, H-5', Jd=9.3 Hz,Jq=6.3 Hz), 2.73 (t, 1H, H-l, J=3.6 Hz)  3 [111-(13&amp;amp;44&amp;amp;77&amp;amp;83]83-[(6--3,4--(2 --p-D -]-4 --4,4a5,6,7,7a8,8a--7-- 3- (1--1,4- -64 - CMS421&amp;gt;&amp;lt;2 () 11  A7 B7 S21644 62) -s--3a(lH)- 1(500P-55 2,2-2 21503  15 : 85) (474 e Oh, CDC13): 9.73 (s, 1H, CHO), 7.45-7.24 (m10H 2Ph)6.98(slHCiiPh2)6.06(ddlHH-2J=1.5&amp;amp;3.3</span>Hz), 4.57 (d, 1H, H-l ', J = 3.0 Hz), 4.30 (dd, 1H, H-3', J = 3.6 &amp;amp; 5.7Hz), 4.07 (d, lH, 8aCH2, J = 9.0Hz), 3.95-3.93 (m, lH, H-2 '), 3.85 (dd, lH, H-4 ,, J = 5.7 &amp;amp; 9.3Hz), 3.75 (d, lH, 8aCH2, J = 9.0 Hz ), 3.44 (dq, 1H, H-5 ', Jd = 9.3 Hz, Jq = 6.3 Hz), 2.73 (t, 1H, Hl, J = 3.6 Hz)  Intermediate 3 [111- (1 , 3 &amp;amp; , 4 Lu, 4 &amp;amp; Lu, 7 Lu, 7 &amp;amp; Heart 83)] 83-[(6-deoxy-3,4-- (2-pentylidene) -pD-azorpiperanosyl Oxy) methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1, 4- -64-This paper uses the Chinese National Standard Rate (CMS&gt; 4 specification (21 &amp;gt; &amp;lt; 2mm) (please read the precautions on the back before filling this page), 11  A7 B7 S21644 V. Description of the invention (62) Methylene-s-pyda-3a (lH) -carboxylic acid, diphenyl methyl ester in intermediate 1 (500 mg) and P-toluenesulfonic acid (5 mg) Add 2,2-dimethoxypentane (2 ml) to the suspension in Erqijiayuan (5 ml). Stir the mixture at room temperature for 2 hours. Add potassium carbonate (150 mg) and continue to teach Drop 3 The solvent was evaporated to dryness, and the residue was analyzed by flash chromatography on silica gel and washed away with ethyl acetate: hexane (15:85) to obtain the title compound (474 mg). E Oh, CDC13) : 9.73 (s, 1H, CHO), 7.45-7.24 (m, 10H, 2Ph), 6.98 (s, lH, CiiPh2), 6.06 (dd, lH, H-2, J = 1.5 &amp;amp; 3.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.57 (d, 1H, -, J=2.1 Hz), 4.30 (dd, 1H, H-3', J=3.9 6.0 Hz), 4.04 (d, 1H8aCH2, J=9.0 Hz), 3.94-3.91 (m1H H-2')3.86 (dd, 1HH.4'J=6.39.6 Hz)3.73 (d1H 8aCH2, J=9.0 Hz), 3.45 (dq, 1H, H-5, Jd=9.0 Hz,Jq-6.0 Hz), 2.72 (t, 1H, H-l, J~3.6 Hz)  4 [1R-(1 a3a04A4a07 7aa8a0 )]8a-[(6--3,4-0-(4--2-_-D-]_ 4 --4,4a,56,7,7a, 8,8a--7 --3-(1- -14--s-_3a(iH)- 1(3 50p-54 2,2,4-1 15 3 0 : 7)4 : 6) _ -65- CNS ) A4210X297 ()    A7 ___B7 ______ 63 ) 2903 : 1 4, CDC13)9_73 (s1HCH)7.45_7.20 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.06 (dd, 1H, H-2, J=1.53.6 Hz), 4.57 (d1H, -J=2.1 Hz), 4.31 (dd1H, H-3', J=3.9^.6.0 Hz), 4.05 (d, 1H, 8aCH2, J=9. Hz), 3.95- (d, 1H, 8aCH2, J=9.0 Hz), 3.51(t, 2H, CH2, J=7.2 Hz), 3.50-3.45 (m, 1H, H-5'), 3.33 (s, 3H, CH30), 2.72 (t, 1H, H-1J=3.6 Hz) 5 [1R-(1 or3a044ay3 ,7 7aa/8a/3 )]8a-[(6 -- 3,4-- A-D-]-4 - 4,4a,5,6,7,7a,8,8a--7 --3-(1--1,4-- s-?- 3a(lH) - 1(160_ (3: 1 ; 4p -5 21  &amp;gt;(1 : 4)m2  (ln, CDC13) 9.73 (s, 1H, CHO), 7.45-7.25 (m, 10H, 2Ph)6.98(slHCHPh2)6.06(ddlHH-2j=i_5&amp;amp;3.6</span>Hz), 4.57 (d, 1H, -, J = 2.1 Hz), 4.30 (dd, 1H, H-3 ', J = 3.9 and 6.0 Hz), 4.04 (d, 1H, 8aCH2, J = 9.0 Hz ), 3.94-3.91 (m, 1H, H-2 '), 3.86 (dd, 1H, H.4', J = 6.3 and 9.6 Hz), 3.73 (d, 1H, 8aCH2, J = 9.0 Hz), 3.45 (dq, 1H, H-5, Jd = 9.0 Hz, Jq-6.0 Hz), 2.72 (t, 1H, Hl, J ~ 3.6 Hz)  Intermediate 4 [1R- (1 a, 3a0, 4A, 4a0, 7 Lu, 7aa, 8a0)] 8a-[(6-deoxy-3,4-0- (4-methoxy-2-butylene) _-D-azorpiperanyloxy) methyl Radical] _ 4 -carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene -S-indap_3a (iH) -carboxylic acid, diphenylmethyl ester in intermediate 1 (3 50 mg) and p-toluenesulfonic acid (5 mg) in difluoromethane (4 mL) Add 2,2,4-trimethoxybutane (1 ml) to the suspension inside. The mixture was stirred at room temperature for 1 hour. Add carbonated shirt ( 50 mg) and continue stirring for 30 minutes. The solvent was evaporated to dryness, and the residue was analyzed on the silica gel for flash layer analysis, and washed away with ethyl acetate: hexane: 7) and (4: 6), and the obtained standard _ -65- This paper size is suitable for China National Standard (CNS) A4 specification (210X297mm) (Please read the note  on the back before filling in this page) Ding printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy Printed A7 ___B7 by the Employee Consumer Cooperative of the Central Bureau of Standards ______ 5. Description of the invention (63) The title compound (290 mg), epimer ratio 3: 1. The component signals of Xi (4, CDC13): 9_73 (s, 1H, CH), 7.45_7.20 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.06 (dd, 1H, H-2 , J = 1.5 and 3.6 Hz), 4.57 (d, 1H, -, J = 2.1 Hz), 4.31 (dd, 1H, H-3 ', J = 3.9 ^ .6.0 Hz), 4.05 (d, 1H , 8aCH2, J = 9.Hz), 3.95- (d, 1H, 8aCH2, J = 9.0 Hz), 3.51 (t, 2H, CH2, J = 7.2 Hz), 3.50-3.45 (m, 1H, H -5 '), 3.33 (s, 3H, CH30), 2.72 (t, 1H, H-1, J = 3.6 Hz). Intermediate 5 [1R- (1or, 3a0, 4 cold, 4ay3, 7 cold, 7aa /, 8a / 3)] 8a-[(6 -deoxy-3,4-. Cyclopentylene-AD- Azuroporanyloxy)]-4 -carboxamide 4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s- ? Shun Province-3a (lH)-carboxylic acid, diphenyl methyl vinegar in intermediate 1 (160 mg) in dimethane: , _ di To the suspension of methoxycyclopentane (3: 1; 4 ml) was added p-toluenesulfonic acid (5 mg), and the mixture was removed at room temperature for 2 hours. Add carbonated rape (1 g) and continue to mix for another minute. The solvent was evaporated to dryness, and the residue was analyzed by flash layer on silica gel, and washed away with ethyl acetate: ethyl acetate&gt; (1: 4) to obtain the title compound (m2 mg). (ln, CDC13): 9.73 (s, 1H, CHO), 7.45-7.25 (m, 10H, 2Ph), 6.98 (s, lH, CHPh2), 6.06 (dd, lH, H-2, j = i_5 &amp;amp; 3.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.55 (d, 1H, H-l', J=1.8 Hz), 4.17 (dd, 1H, H-3', J=3  5.1 Hz), 4.08 (d, 1H, 8aCH2, J=9.0 Hz)3.95 (dt1HH-21 -66 - CNS ) A4210&amp;gt;&amp;lt;297 -- ()</span>Hz), 4.55 (d, 1H, H-l ', J = 1.8 Hz), 4.17 (dd, 1H, H-3', J = 3  and 5.1 Hz), 4.08 (d, 1H, 8aCH2, J = 9.0 Hz), 3.95 (dt, 1H, H-21 -66-this paper standard uses the Chinese National Standard (CNS) A4 specification (210 &amp;gt; &amp;lt; 297mm) --- (please read the precautions on the back Fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7  321644 B7 </span>A7 Printed and printed by the Employees Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs 321644 B7 V. Description of invention (</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd = 1.8 Hz, Jt=3.0 Hz), 3.81 (dd1HH-4J=5.1 9.3 Hz) 3.76 (d, 1H, 8aCH2, J=9.0 Hz), 3.42 (dq, 1H, H-5', Jd=9.3</span>Jd = 1.8 Hz, Jt = 3.0 Hz), 3.81 (dd, 1H, H-4, J = 5.1 and 9.3 Hz), 3.76 (d, 1H, 8aCH2, J = 9.0 Hz), 3.42 (dq, 1H, H-5 ', Jd = 9.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">HzJq=6.3 Hz), 2.73 (t, 1H, H-l, J=3.9 Hz) 6 [1R-(1 a3a04/? ,4 a/? ,7/57aa8ay5 )]8a-[(6 -- 3,4- 0 -- 2- (-d_) ]-4--4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7_-3-(1- -1,4 -- s-M- 3a(lH) -  2(1001 45 0_52720 18212 3x25  9) 110 U, CDC13): 9.71 (s, 1H, CHO), 7.44-7.25 (m, lH, 2Ph), 6.96 (s1HCHPh2), 6.01 (dd1HH-2, &amp;gt;1.23 6 Hz)6.90 (dd, 1HH-2J=2.45.4 Hz)485 (aihH-i J=2.4 Hz)4.53 (dd1HH-31, J=5.46.3 Hz)4.00 (dd1H, H-4J=6.38.7 Hz)3.93 (d1H, 8aCH2, J=9.3 Hz), 3.65 (dq, 1H, H-5', Jd=8.7, Jq=6.3 Hz), 2.68 (t, 1H, H-l, j=3.9 Hz)2.59 (s, 3HCH3 S) ____-67-___ CNS ) A421 OX297) ~~ ()</span>Hz, Jq = 6.3 Hz), 2.73 (t, 1H, H-l, J = 3.9 Hz). Intermediate 6 [1R- (1 a, 3a0, 4 / ?, 4 a / ?, 7/5, 7aa, 8ay5)] 8a-[(6 -deoxy-3,4- 0 -isopropylidene- 2- (Methylthio) thiocarbonyl-d_azorranosyloxy) methyl] -4-carboxamide-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp;- Octahydro-7_methyl-3- (1-methylethyl) -1,4-methylene-sM  default- 3a (lH) -tetanoic acid, diphenylmethyl ester in intermediate 2 (100 mg) and imidazole (1 mg) were dissolved in anhydrous tetrahydrofuran (4 ml) under nitrogen. Sodium hydride (5 mg) was added, and the suspension was stirred at room temperature for 0-5 hours. Add carbon disulfide (27 l), continue stirring for 20 minutes, and add methyl iodide (18 l). After 2 hours, 1 equivalent of ammonium vapor (20 mL) was added to stop the reaction. The mixture was extracted with ethyl acetate (3x25 ml), the organic phase was washed with brine, dried over magnesium sulfate, and the solvent was evaporated to dryness. The residue was purified on silica gel as a flash chromatography column, and washed with ethyl acetate: hexane (: 9) to obtain the title compound (110 mg). U, CDC13): 9.71 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.96 (s, 1H, CHPh2), 6.01 (dd, 1H, H-2, &amp;gt; 1.2 And 3 6 Hz), 6.90 (dd, 1H, H-2, J = 2.4 and 5.4 Hz), 4.85 (a, ih, Hi , J = 2.4 Hz), 4.53 (dd, 1H, H- 31, J = 5.4 and 6.3 Hz), 4.00 (dd, 1H, H-4 ', J = 6.3 and 8.7 Hz), 3.93 (d, 1H, 8aCH2, J = 9.3 Hz), 3.65 (dq, 1H, H -5 ', Jd = 8.7, Jq = 6.3 Hz), 2.68 (t, 1H, Hl, j = 3.9 Hz), 2.59 (s, 3H, CH3 S). ____- 67 -___ The paper size is applicable to China National Standard (CNS) A4 specification (21 OX297mm) ~~ (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 65) 7 [1-(1^3&amp;amp;;5,45,4/5,773^8&amp;amp;/5)]83-[(2,6--3,4-0 ---D]_4__ 4,45,6,7,73,8,8&amp;amp;--7--.3-(1--14--s--3a(lH)- (i)6(955 110C1.5 (645 1.52  ^1  9)42 ^ CDC13): 9.73 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph)6.98 (1HsCHPh2), 6.05 (dd1HH-2, J=1.2 33 Hz)454 (dd1H, -, J=2.7  9.3 Hz)4.39 (dt 1H, H-3', Jd=2.7 Hz, Jt=3.6 Hz), 4.04 (d, 1H, 8aCH2, J=9.0 Hz), 3.67 (d, 1H, 8aCH2, J-9.0 Hz), 3.65 (dd, 1H, H-4J=3.68.7 Hz), 3.44 (d1HH-5', Jd=6.3 HzJq=8.7 Hz)2.75 (t1H, J=3.9 Hz) ()5.5150 12 6(65 1 _ 5  20 : 115 : 1) ------------68 - ______ CN$)4210 X 297 1&amp;quot; ()</span>A7 B7 printed by the Employee Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economy V. Description of the invention (65) Intermediate 7 [1 foot- (1 ^ 3 &amp;5;4; ^, 8 &amp;amp; / 5)] 83-[(2,6-dideoxy-3,4-0-isopropylidene-Lu-D  piperanyloxy) methyl] _4_formyl Radical _ 4,4 M, 5,6,7,73,8,8 &amp;amp; -octahydro-7-methyl-.3- (1-methylethyl) -1,4-methylene-s- Chita-3a (lH) -carboxylic acid, diphenylmethyl ester (i) Intermediate 6 (95 mg) was dissolved in anhydrous toluene (5 ml) under nitrogen and heated at 110  C. A solution of tributyltin hydride (64 l) in anhydrous toluene (5 ml) was added dropwise over 1.5 hours while stirring. Continue heating for another 1.5 hours, add methanol (2 ml) and evaporate the solvent to dryness. The residue was analyzed by flash layer on silica gel, and the title compound (42 mg) was prepared by washing away with ethyl acetate: hexane ^ 1.9). ^ CDC13): 9.73 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.98 (1H, s, CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.54 (dd, 1H, -, J = 2.7 and 9.3 Hz), 4.39 (dt, 1H, H-3 ', Jd = 2.7 Hz, Jt = 3.6 Hz), 4.04 (d, 1H , 8aCH2, J = 9.0 Hz), 3.67 (d, 1H, 8aCH2, J-9.0 Hz), 3.65 (dd, 1H, H-4 ', J = 3.6 and 8.7 Hz), 3.44 (d, 1H, H- 5 ', Jd = 6.3 Hz, Jq = 8.7 Hz), 2.75 (t, 1H, J = 3.9 Hz). () A solution of tributyltin hydride (5.5 ml) in anhydrous toluene (150 ml) was degassed with a stream of argon for 1 hour and heated at reflux. A solution of Intermediate 6 (6g) in anhydrous toluene (50ml) was added over 2 hours. Continue heating until the reaction is complete (1_5 hours). Remove the solvent under dust reduction to obtain the crude product, and then analyze the flash layer on the silica gel, and wash it off with hexane and ethyl acetate: ethyl acetate (20: 1 to 15: 1) to obtain the title compound- ---------- 68-______ This paper New Zealand's National Finance Standard (CN $) 8 4 threats (210 X 297 public and 1 &amp;quot; (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 321644 at __B7_ 66 ) (4  8 [lR-(la,3ay9,4/?4ay5,77aa8a]8a-[(2,6-:i*- 3,4-0-(4 --2---D-] -4 --4,4a56,7,7a8,8a --7-- 3- (1- -1,4--s--3 a(lH)- 4(6001 C305 1014720 1273012 3x25  5 : 8 5)  115 C2 46) 102  15 . 85)260 4 : 1 ^ CDC13) 963 CHO), 7.44-7.20 (m, 10H, 2Ph)6.99(slHCHPh2)6.06(ddlH,H-2J=1.2&amp;amp;3.3 Hz), 4.53 (dd1H, H-lJ-2.7  8.7 Hz)4.42 (dt1H H-31</span>Printed 321644 at __B7_ by the Pongong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs. V. Description of Invention (66) (4 grams). Intermediate 8 [lR- (la, 3ay9,4 / ?, 4ay5,7, 7aa, 8a)] 8a-[(2,6-: i *-3,4-0- (4-methoxy -2-butylidene) --D-pyranoyloxy) methyl] -4 -methylbromo-4,4a, 5, 6,7,7a, 8,8a -octahydro-7- Methyl-3- (1-methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl acetate in intermediate 4 (600 mg ) Sodium hydride (30 mg) and imidazole (5 mg) were added to a solution of anhydrous tetrahydrofuran (10 ml) at 0  C under nitrogen. This solution was stirred for 10 minutes, and then carbon disulfide (147 l) was added. After 20 minutes, add methyl bromide (127 microliters) and continue stirring for 30 minutes. Add 1 equivalent of vaporized ammonium (20 mL). This mixture was extracted with ethyl acetate (3x25 mL). The organic phase was washed with brine, dried over magnesium sulfate, and evaporated to dryness. The residue was analyzed by flash layer on silica gel and washed with ethyl acetate: hexane (5:85) to obtain a white foam. This foam was dissolved in anhydrous toluene under nitrogen), and a solution of tributyltin hydride (46 mL) in toluene (10 mL) was added dropwise at 115  C over 2 hours. Continue heating for 2 hours. The solvent was evaporated to dryness, and the residue was analyzed and purified by flash chromatography on silica gel, washed away with ethyl acetate and hexane (15.85) to obtain the title compound (260 mg), epimer ratio 4: 1. ^ CDC13): 9.63 CHO), 7.44-7.20 (m, 10H, 2Ph), 6.99 (s, lH, CHPh2), 6.06 (dd, lH, H-2, J = 1.2 &amp;amp; 3.3 Hz), 4.53 (dd, 1H, Hl, J-2.7 and 8.7 Hz), 4.42 (dt, 1H H-31</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd=3.0 Hz, Jf=4.2 Hz), 4.03 (d, 1H, 8aCH2, J=9.0 Hz), 3.68 (dd1H, H-4', J=5.1 9.3 Hz)3.66 (d1H, 8aC^J=9. -69- CNS ) A4210X2.97_)~~~' ()</span>Jd = 3.0 Hz, Jf = 4.2 Hz), 4.03 (d, 1H, 8aCH2, J = 9.0 Hz), 3.68 (dd, 1H, H-4 ', J = 5.1 and 9.3 Hz), 3.66 (d, 1H, 8aC ^  J = 9.-69- This paper scale is suitable for China National Standard (CNS) A4 specification (210X2.97mm_) ~~~ '(please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 67)</span>Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Invention Instructions (67)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.52 (t, 2H, CH2, J=7.2 Hz), 3.40 (dq, 1H, H-5',</span>Hz), 3.52 (t, 2H, CH2, J = 7.2 Hz), 3.40 (dq, 1H, H-5 ',</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd=9.3 Hz, Jq=6.3 Hz), 3.34 (s, 3H, CH30), 2.74 (t, 1H, H-l, J=4.2 Hz) 9 [1R-(1 or ,3a44a57y97aa8ay5 )]8a-[(6-3,4---/? -D-]_4-4,4a5,6,7,7a8,8a--7-- 3- (1--14_ -s--3a(lH)- 1 (0.5000.270 (106  :3 : 1)0.263 ^ (^, CDC13): 9.71 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2xPh)697 (s1H, C02C|iPh2), 6.06 (dd1HH-2, J=1.5 3.3 Hz)4.93 (dd1H3'J=3.9&amp;amp;7.2Hz),4.63(d,lHH-1'J=2.1 Hz)4.61 (dd1HH-4J=7.29.3 Hz)4.12 (m, 1H, H-2'), 4.08 (d, 1H, 8aCH2, JAB=9.3 Hz), 3.74 (d, 1H, 8aCH2, Jab=9.3 Hz), 3.64 (m, 1H, H-5'), 2.69 (m, 1H, H-l) o 1 0 [111-(1?3&amp;amp;044&amp;amp;773835)]8&amp;amp;-[(2,6---D-]-4__44a5,6,7,7a, 8,8a--7 --3-(1--14--s- -3a(lH)- -70- CNS ) A4210X297 () tx  321644 1 A7 B7 68) 7(1.5315 115 TLC 502 2x 100  5 : 1 )2 : 1 ) (1.1 R, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s1HCHPh2)6.05 (dd1HH-2, J=1.23.3 Hz) 4.64 (dd1H, -J=2.1 9.6 Hz)4.11 (m1H, H-3')4.06 (d1H8aCH2, JAB=9.3 Hz), 3.70 (m, 2HH-5,8aCH2), 3.34 (m, 1HH-4')2.75 (t, 1HH-l, J=3.6 Hz) 1 1 [1R-(1 a3ay?44a77aa8a5 )]8a-[(2,6--3,4-----]_4_-4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7_-3-(1--14-- s-- 3a(lH) - 10(160124 5 15Dean_stark 2 -695 6TLC  _ -71- CNS ) ( 21&amp;gt;&amp;lt;297 --------- .t------tr------f () A7 B7 ec H 321644 69) 20 : 1)15 : 1)15  ci n, CDC13): 9.72 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.97 (s1HCHPh2), 6.05 (dd, 1H, H-2, J=1.53_6 Hz), 5_10 (m, 1HH-34.61 (dd1H-J=2.48.4 Hz), 4.44 (dd, 1H, H-4', 1=6.6^9.0 Hz), 4.04^3.67 (2d, 2H, 8aCH2, JAB=9 Hz), 3.62 (m, 1H, H-5'), 2.70 (t, 1H, H-l, J=2.0 Hz) 0 1 2 [lR-(lX4/?4a/5,7/?7aa,8a5)]8a-[(4-0il 2,6--_0_]_4__ 4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7__3_(_14_ -s--3a(lH)- 10(40024 50DeanStark 1 71 1M0.955(rc 24 1 : 2)15) 3 00 (1^ CDC13): 9.72 (s, 1H, CHO), 7.52-7.2 (m5 10H, 2Ph), ^98 (s, H, CHPh2), 6.05 (dd, 1H, H-2, J-l.5^3.6 Hz) 5-89 (m, 1H, CH=CH2)5 5.30-5.20 (m, 2H, CH=CH2), 4.64 -72- ()</span>Jd = 9.3 Hz, Jq = 6.3 Hz), 3.34 (s, 3H, CH30), 2.74 (t, 1H, H-l, J = 4.2 Hz). Intermediate 9 [1R- (1 or, 3a Lu, 4 Lu, 4a; 5, 7y9, 7aa, 8ay5)] 8a-[(6-deoxy  3,4--thiocarbonyl-/?-D- Azuroprenyloxy) methyl] _4  carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl Group) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester, intermediate 1 (0.500 g) and thiocarbonylimidazole (0.270 g) in tetrahydrofuran (10 ML) of the mixture was refluxed for 6 hours. The solvent was evaporated to give a yellow residue. This residue was analyzed by flash layer on silica gel and washed away with hexane: ethyl acetate (3: 1) to obtain the title compound (0.263 g). ^ (^, CDC13): 9.71 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2xPh), 6.97 (s, 1H, C02C | iPh2), 6.06 (dd, 1H, H-2, J = 1.5 and 3.3 Hz), 4.93 (dd, 1H,   3 ', J = 3.9 &amp;amp; 7.2Hz), 4.63 (d, lH, H-1', J = 2.1 Hz), 4.61 (dd, 1H , H-4, J = 7.2 and 9.3 Hz), 4.12 (m, 1H, H-2 '), 4.08 (d, 1H, 8aCH2, JAB = 9.3 Hz), 3.74 (d, 1H, 8aCH2, Jab = 9.3 Hz), 3.64 (m, 1H, H-5 '), 2.69 (m, 1H, Hl) o Intermediate 1 0 [111- (10 , 3 &amp;amp; 0, 4 Lu, 4 &amp;amp; point, 7 Lu , 73 ", 83; 5)] 8 &amp;amp;-[(2,6-dideoxy--D-epiperanosyloxy) methyl] -4_methylaceto_44a, 5,6, 7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-theta province-3a (lH) -carboxylic acid, Diphenyl methyl ester-70- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page), tx printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 321644 1 A7 B7 5. Description of the invention (68) To the solution of the intermediate 7 (1.5g) in the mixture of tetrahydrofuran (30ml) and yeast (15ml), add 1 equivalent dropwise at room temperature Hydrochloric acid solution (15 ml) with vigorous stirring. Once the reaction is complete (controlled by TLC), saturated sodium bicarbonate (50 ml) and ethyl acetate (200 ml) are added and the mixture is separated. The organic phase is water (2x 100ml) Wash and dry over magnesium sulfate. Remove the solvent to obtain a residue. This residue was analyzed by flash layer on silica gel, using hexane  ethyl acetate (5: 1) and (2 : 1) Wash off to obtain the title compound (1.1 g) as a white foam. R, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H , CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.64 (dd, 1H, -, J = 2.1 and 9.6 Hz), 4.11 (m, 1H, H-3 ' ), 4.06 (d, 1H, 8aCH2, JAB = 9.3 Hz), 3.70 (m, 2H, H-5, and 8aCH2), 3.34 (m, 1H, H-4 '), 2.75 (t, 1H, Hl, J = 3.6 Hz). Intermediate 1 1 [1R- (1 a, 3ay ?, 4 Lu, 4a point, 7 Lu, 7aa, 8a; 5)] 8a-[(2,6-dideoxy-3,4--thiocarbonyl -Zhao--piperanosyloxy) methyl] _4_carboxyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp; -octahydro-7_methyl-3 -(1-methylethyl) -1,4-methylidene-s-theta province-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 10 (160 mg) and dibutyltin oxide A mixture of (124 5 mg) in anhydrous toluene (15 ml) was heated at reflux for 2 hours in a flask equipped with a Dean_stark condenser, and then allowed to stand at room temperature under nitrogen. To the resulting solution was added a solution of phenyl-gasthiocarbonyl formate (69 l) in anhydrous toluene (5 mL). After 6 hours, TLC showed that the reaction was complete. The solvent was removed under reduced pressure, and the crude mixture was subjected to a flash layer analysis on silica gel, using hexane: _ -71- This paper scale was used in China National Standards (CNS) (21 &amp;lt; 297 public --- ------  .t ------ tr ------ f (Please read the precautions on the back before filling this page) A7 B7 Printed by ec H Consumer Cooperative, Central Bureau of Economic Affairs, Ministry of Economic Affairs 321644 V. Description of the invention (69) Ethyl acetate (20: 1) and (15: 1) were washed away to obtain the title compound (15 mg) as a colorless oil. Ci n, CDC13): 9.72 (s , 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.97 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3_6 Hz), 5_10 (m, 1H, H-3 '), 4.61 (dd, 1H, -, J = 2.4 and 8.4 Hz), 4.44 (dd, 1H, H-4', 1 = 6.6 ^ 9.0 Hz), 4.04 ^ 3.67 (2d, 2H , 8aCH2, JAB = 9 Hz), 3.62 (m, 1H, H-5 '), 2.70 (t, 1H, Hl, J = 2.0 Hz) 0 Intermediate 1 2 [lR- (l X4 / ?, 4a / 5,7 / ?, 7aa, 8a; 5)] 8a-[(4-0, il 2,6-dideoxy-cold_0_epiperanyloxy) methyl] _4_formyl Base_4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl_3_ ( methylethyl) _1,4_methylene-s-    -3a lH) -carboxylic acid Diphenylmethyl ester A mixture of Intermediate 10 (400 mg) and tributyltin oxide (24 mg) in anhydrous toluene (50 mL) was heated to reflux in a flask equipped with a DeanStark condenser, and then allowed to stand Under nitrogen at room temperature (nearly 10 ml of azeotropic mixture can be removed). Allyl bromide (71 l) and tetrabutylammonium fluoride (1M solution in tetrahydrofuran, 0.95 mL) were added successively. A flash layer was analyzed on the silica gel, and washed away with acetone: hexane (1: 2) and (: 15) to obtain the title compound (300 mg) as a colorless oil. (1 ^ CDC13) : 9.72 (s, 1H, CHO), 7.52-7.2 (m5 10H, 2Ph), ^  98 (s, H, CHPh2), 6.05 (dd, 1H, H-2, Jl.5 ^ 3.6 Hz) 5- 89 (m, 1H, CH = CH2) 5 5.30-5.20 (m, 2H, CH = CH2), 4.64 -72- (please read the notes on the back before filling in this book)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">- - r c I *  321644 A7 B7 7) (dd1H-J=2.1 9.6 Hz)4.19 (m1HH-34.15-3.95 (m, 3H, CH2CH=CH2+8aCH2), 3.80-3.60 (m, 2H, H-5'+8aCH2)3.06(ddlHH-4J=3.3&amp;amp;9.3Hz)2.75(t,lH H-lJ=3.9 Hz)2.38 (bd1HOH) 1 3 [1R-(1 a3a044a 77a8a)]8a-[(2,6_--4-0-(2--2---D-]-4--4,4a,5,6,7,7a,8,8a--7 --3-(1- -14--s-5-3a(lH)- 10(500300 50Dean-Stark 10 3--2-202 1M0.9050 C24 1 : 20)1 : 15) 340  (^, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph)6.98 (s1H, CHPh2)605 (dd, 1H, H-2, J=1.53.6 Hz), 4.964.91 (2m2H=CH2)4.65 (dd1H, -, J=1.8 9.6 Hz)4.20 (m, 1H, H-3')4.053.68 (2d, 2H, 8aCH2 Jab=9.3 Hz), 4.00A3.87 (2d, 2H, OCH2, Hz), 3.75 (m1HH-53.06 (dd1H, H-4J=39.6 Hz)2.75 (t1H, H-l, J=3.6 Hz), 2.37 (bd, 1H, OH), 1.76 (bs, 3H, CH,C=CH7) -73- CNS ) A4210X297 ()</span>--rc I * Printed by 321644 A7 B7, Beigong Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs V. Description of invention (7) (dd, 1H, -, J = 2.1 and 9.6 Hz), 4.19 (m, 1H , H-3 '), 4.15-3.95 (m, 3H, CH2CH = CH2 + 8aCH2), 3.80-3.60 (m, 2H, H-5' + 8aCH2), 3.06 (dd, lH, H-4 ', J = 3.3 &amp;amp; 9.3Hz), 2.75 (t, lH, Hl, J = 3.9 Hz), 2.38 (bd, 1H, OH). Intermediate 1 3 [1R- (1 a, 3a0, 4, 4a Lu, 70,000, 7a, 8a)] 8a-[(2,6_dideoxy--4-0- (2-methyl- 2-propenyl) --D-alsylranosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7- Methyl-3- (1-methylethyl) -1,4-methylene-s-5 Shuda province-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 10 (500 Mg) and tributyltin oxide (300 mg) in anhydrous toluene (50 ml), heated to reflux in a flask equipped with a Dean-Stark condenser, and then left to stand at room temperature under nitrogen (can remove nearly 10 ml Azeotrope). 3-Bromo-2-methylpropene (202 l) and tetrabutylammonium fluoride (1M solution in tetrahydrofuran, 0.90 mL) were added successively, and the mixture was heated at 50  C for 24 hours. After removing the solvent, a residue was obtained. This residue was subjected to flash chromatography on silica gel and washed away with acetone: hexane (1: 20) and (1: 15) to obtain the title compound (340 mg) as colorless. Oil body.  (^, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.96 and 4.91 (2m, 2H, = CH2), 4.65 (dd, 1H, -, J = 1.8 and 9.6 Hz), 4.20 (m, 1H, H-3 '), 4.05 and 3.68 (2d, 2H, 8aCH2, Jab = 9.3 Hz), 4.00A3.87 (2d, 2H, OCH2, Hz), 3.75 (m, 1H, H-5 '), 3.06 (dd, 1H, H-4' , J = 3 and 9.6 Hz), 2.75 (t, 1H, Hl, J = 3.6 Hz), 2.37 (bd, 1H, OH), 1.76 (bs, 3H, CH, C = CH7) -73- paper size Use the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  ^^1644 A7 _ B7 71 ) 1 4 [lR-(la3a5,4/5,4a^7y?7aa8a^)]8a-[[lS,7R9R]- 2.5.8- -37---[4.4.0]--9- -]-4--4,43,5,6,7,7&amp;amp;8,83--7--3-(1--14--s--3a(lH)-  12(2001 213 30 1353050 3 X 100 1 : 15) 1201 : 1C-3  6(111(13)4.73((1(1111,11-9,,=3.06.3 112) 4.62 (dd, 1H, H-9'J=2.1 9.9 Hz) 1 5 [1R-(1 a,3a/3  ,4a/? ,7 ,7a or ,8ay5 ) ] 8 a-[ [ 1 S , 7 R, 9 R]- 2.5.8- -3,3,7---[4.4.0]--9---]-4 --4,4a5,6,7,7a,8,8a --7--3-(1--l4--s-p_3a(iH) -  ___ -74- CNS ) A4210X297 ()   A7 B7  321644 72) 13(3251 33 30 192305 3   2)i  15)210 ^ (!, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.03 (dd, 1H, H-2, J=1.2 Hz, J=3.3 Hz), 4.54 (dd1HH-9J=2.1 9.6 Hz)4.25 (m2H H-7,-)4.053_66 (2d2H8aCH2, JAB=9 Hz)3.41  3.18 (2d2HOCH2, JAB = 11.7 Hz)325 (dd, 1H, H-61 J=3.3 10_2 Hz), 2.75 (t1HH-lJ=3.3 Hz)1.25 1.16 (2s 2CH3) 1 6 [1R-(1 a3ayS4y5 ,4a7y57aa ,8a]8a-[2,6--4-O-p---D-]-4 - -4,4a5,67,7a,8,8a--7-- 3-(1--14--s--3a(lH)- 10(500374 50Dean-Stark 1 P-135 -75- CNS ) A4210X297 ()</span>, 1T Printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy ^^ 1644 A7 _ B7 V. Description of the invention (71) Intermediate 1 4 [lR- (la, 3a; 5,4 / 5,4a ^, 7y? , 7aa, 8a ^)] 8a-[[lS, 7R, 9R]-2.5.8- trihum-3,7-dimethyl) -cis-bicyclo [4.4.0] -dec-9  yl- Oxy-methyl] -4-carboxamide-4,43,5,6,7,7 &amp;amp;, 8,83-octahydro-7-methyl-3- (1-methylethyl) -1 , 4-Methylene-s-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester in a solution of intermediate 12 (200 mg) in anhydrous tetrahydrofuran (10 mL) at room temperature Add solid mercury trifluoroacetate (213 mg) in small batches under nitrogen. The reaction mixture was left at room temperature for 30 minutes, and tributyltin hydride (135 l) was added under vigorous stirring. After 30 minutes, ethyl acetate (50 ml) was added, and the resulting suspension was filtered through celite to obtain a colorless solution. This solution was washed with water (3 X 100 ml) and dried over magnesium sulfate. After removing the solvent, an oil body was obtained. This oil body was subjected to a flash layer analysis on silica gel and washed away with acetone: hexane (1:15) to obtain the title compound (120 mg) as 1: 1 C-3 ' Epimer mixture. 6 (111,   (: 13) includes: 4.73 ((1 (1,111,11-9 ,,) = 3.0 and 6.3 112), 4.62 (dd, 1H, H-9 ', J = 2.1 and 9.9 Hz). Intermediate 1 5 [1R- (1 a, 3a / 3 , 4a /?, 7, 7a or, 8ay5)] 8 a- [[1 S, 7 R, 9 R]-2.5.8- Three-threat-3,3,7-trimethyl) -cis-bicyclo [4.4.0] -dec-9-yl-oxy-methyl] -4-carboxamide-4,4a, 5,6 , 7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-sp Yinjian province_3a (iH) -tetanoic acid, di Phenyl Methyl Ester___ -74- The size of this paper uses the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)  Order A7 B7 Central Bureau of Standards, Ministry of Economic Affairs Printed by Beigong Consumer Cooperative 321644 V. Description of the invention (72) In a solution of intermediate 13 (325 mg) in anhydrous tetrahydrofuran (10 mL), add solid mercury trifluoroacetate in small batches at room temperature under nitrogen ( 33 mg). The reaction mixture was left at room temperature for 30 minutes, and then tributyltin hydride (192 l) was added under vigorous stirring. After 30 minutes, ethyl acetate (50 mL) was added, and the resulting suspension Filtered through diatomaceous earth to be colorless This solution was washed with water (3  100 mL) and dried over magnesium sulfate. The solvent was removed to obtain an oil body. This oil body was subjected to a flash layer analysis on silica gel. Acetone: hexane (: 2) and (i   15) wash away to obtain the title compound (210 mg) as a colorless oil. ^ (! , CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m , 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.03 (dd, 1H, H-2, J = 1.2 Hz, J = 3.3 Hz), 4.54 (dd, 1H, H-9 ', J = 2.1 And 9.6 Hz), 4.25 (m, 2H, H-7, and -), 4.05 and 3_66 (2d, 2H, 8aCH2, JAB = 9 Hz), 3.41 and 3.18 (2d, 2H, OCH2, JAB = 11.7 Hz), 3.25 (dd, 1H, H-61, J = 3.3 and 10_2 Hz), 2.75 (t, 1H, Hl, J = 3.3 Hz), 1.25 and 1.16 (2s, 2CH3). Intermediate 1 6 [1R- (1 a, 3ayS, 4y5, 4a Lu, 7y5, 7aa, 8a)] 8a- [2,6-dideoxy-4-Op-methoxybenzyl--D-piperan Glycosyloxy) methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl)- 1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 10 (500 mg) and tributyltin oxide (374 G) in a mixture of dry toluene (50 ml) was heated to reflux in a flask equipped with a Dean-Stark condenser and then left to stand (removable near azeotropic mixture 1 ml at room temperature under nitrogen). Add P-methoxybenzyl chloride (135 microliters) and tetrabutyl-fluoride-75 successively. This paper uses the Zhongpu Gujia rubbing rate (CNS) A4 specification (210X297mm) (please read the back (Notes and then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7  ^21644 _ _ B7 73 ) 1M1.56 C24 1 : 20)1 : 15) 300  GHCDC13): 9.72 (s1HCHO)7.5-7.2 (m12H2Ph 2H(6.97 (sHCHPh2)6.88 (m2H2H6.04 (dd, 1H, H-2, J=1.5 Hz, J=3.6 Hz), 4.64 (dd, 1H, H-l', J=2.4 &amp;amp;9.9Hz)4.55&amp;amp;4.50(2d,2H,CH2PhJAB = li.2Hz)4.18 (m1HH-34.04366 (2d2H8aCH2, JAB=9 Hz), 3.80 (s3HCH30)3.74 (m1HH-51)3.12 (dd1HH-4J=3.0 9.3 Hz)2.75 (t1HH-lJ=3.9 Hz) 1 7 [1R-(1 a,3a44a77&amp;amp;&amp;lt;^88/?)]8-[(3--_ 2,6 - - 4- O- p-- D- ]-4 --4,4a5,6,7,7a,8,8a--7-- 3- (1- -14--s--3a(lH)-  1 6(40010  C48 19 i 2 4110 2001 X   1 : 2)1 _  - 76 - CNS ) A4210X297)&amp;quot; ' ()</span>A7 Printed by the Beigong Consumer Cooperative of the Central Kneading Bureau of the Ministry of Economic Affairs ^ 21644 _ B7 5. Description of the invention (73) Ammonium ammonium (1M solution in tetrahydrofuran, 1.5 ml). This mixture was heated at 60  C for 24 hours. The solvent was removed to obtain a residue. This residue was subjected to flash layer analysis on the crushed silica and washed away with acetone: hexane (1:20) and (1:15) to obtain the title compound (300 mg) as Colorless oil body.  GH, CDC13): 9.72 (s, 1H, CHO), 7.5-7.2 (m, 12H, 2Ph and 2H (ortho), 6.97 (s, H, CHPh2), 6.88 (m, 2H, 2H meta) , 6.04 (dd, 1H, H-2, J = 1.5 Hz, J = 3.6 Hz), 4.64 (dd, 1H, H-l ', J = 2.4 &amp;amp; 9.9Hz), 4.55 &amp;amp; 4.50 (2d, 2H , CH2Ph, JAB = li.2Hz), 4.18 (m, 1H, H-3 '), 4.04 and 3.66 (2d, 2H, 8aCH2, JAB = 9 Hz), 3.80 (s, 3H, CH30), 3.74 (m, 1H, H-51), 3.12 (dd, 1H, H-4, J = 3.0 and 9.3 Hz), 2.75 (t, 1H, Hl, J = 3.9 Hz). Intermediate 1 7 [1R- (1 a, 3a Lu, 4 o'clock, 4a, 7 Lu, 7 &amp; &amp;lt; ^, 88 /?)] 8 Du-[(3--allyl_ 2,6-one to milk-4- O-p-methoxybenzyl-D-dopyranosyloxy) methyl] -4-methylbromo-4,4a, 5,6,7,7a, 8,8a-octahydro-7 -Methyl-3- (1-methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester in vigorously stirred intermediate 1 6 (400 mg) in anhydrous tetrahydrofuran (10 ml) was added sodium hydride (48 mg) in small batches under argon at 0  C. After the addition was complete, the mixture was allowed to stand at room temperature for 1 hour, then Add allyl bromide ( 9 i microliter ). After 4 hours, gasified ammonium (1 equivalent aqueous solution; 100 mL) was added, and the mixture was extracted with ethyl acetate (200 mL). The organic phase was washed with water (1  100 mL) on magnesium sulfate After drying and concentrating to dryness, an oil body is obtained. This oil body is subjected to a flash layer analysis on the crumb of silica, to Bing Si: hexane (1: 2) and (1 _ -76-the size of the paper. Use the Chinese Sleeping Home (CNS) A4 specification (210X297 public and public) &amp;quot; '(Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">^21644 A7 B7 74) :15)400  (iHCDC13): 9.74 (s, 1HCHO)7.5-7.2 (m12H2Ph 2H6.98 (sHCHPh2), 6.86 (m2H2H6.04 (ddlHH2J=1.2&amp;amp;3.3Hz)5_95(mlHC|i=CH2)5.28&amp;amp; 5.15 (2m, 2H, CH=CH2), 4.60 (m, 2H, H-1'^L CH2Ph), 4.42 (d1H, CH2Ph, JAB 114 Hz)4.13 (m, 2H, C^-CH=) 4.02&amp;amp;3.68(2d2H8aCH2JAB=9.6Hz)3.89(m2HH-5i &amp;amp;H-3')3.80(s3HCH30),3.09 (dd,lHH-4J=3.0&amp;amp;9.3</span>^ 21644 A7 B7 V. Description of the invention (74): 15) Wash off to obtain the title compound (400 mg) as a colorless oil.  (iH, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 12H, 2Ph and 2H ortho), 6.98 (s, H, CHPh2), 6.86 (m, 2H, 2H meta) , 6.04 (dd, lH, H2, J = 1.2 &amp;amp; 3.3Hz), 5_95 (m, lH, C | i = CH2), 5.28 &amp;amp; 5.15 (2m, 2H, CH = CH2), 4.60 (m, 2H , H-1 '^ L CH2Ph), 4.42 (d, 1H, CH2Ph, JAB II 11.4 Hz), 4.13 (m, 2H, C ^ -CH =), 4.02 &amp;amp; 3.68 (2d, 2H, 8aCH2, JAB = 9.6Hz), 3.89 (m, 2H, H-5i &amp;amp; H-3 '), 3.80 (s, 3H, CH30), 3.09 (dd, lH, H-4 ,, J = 3.0 &amp;amp; 9.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)2.73 (t1HH-lJ=3.9 Hz) 18  (^^} [1R-(1 a3a/?44a077aa ,8ay5 )]8a-[(3-0--2,6-/? -D -]_4-_ 44a5,6,77a8,8a --7--3-(1--1,4-- s-- 3a(lH) - 17(2.3200 (202,3--5,6-0.79    4 9 : 1 ) 1.95  (!, CDC13) 9.75 (s, 1H, CHO), 7.45-7.24 (m, 10H, Ph2)6.99 (s1HC|iPh2), 6.05 (dd, 1H, H-2, J=1.533 Hz), 5.95 (m, 1H, CH=CH2), 5.26(m, 2H, CH^Ci^), 4.53 -77- CNS ) A4210X297  A 7 B7 75) (ddlHH-rJ=1.8&amp;amp;9.6Hz)4.19&amp;amp;3.96(2m2H CH2CH=CH2), 4.03^3.69 (2d, 2H, 8a-CH2, J=9.3 Hz), 3.80 (q1H, H-3', J=3.3 Hz), 3.60 (dq, 1H, H-5', J=9.66.3 Hz), 3.23(dddlH,H-4J=10.8,9.6&amp;amp;3.3Hz)2.74(t,lHH-l J=3.6 Hz), 2.25 (d1H, OH, J=10.8 Hz) 1 9 [1R-(1 a3a/?4/54a/577aa8a/? )]8a-[(3-0-_ 26-- 4- 0- (-D - ]-4 -_4,4&amp;amp;5,6,7,7&amp;amp;,8,8&amp;amp;--7-_3_ (1--1,4 -- s-H- 3a(lH) -  18(1.950 240 1 1.51.25 TCL5 .1250 1 X 5001 X 500  3 : 5)185  ^ U, CDC13): 9.74 (s, 1H, CHO), 7.45-7.24 (m, 10H,</span>Hz), 2.73 (t, 1H, H-1, J = 3.9 Hz). Intermediate 18 Printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the note ^^ on the back and fill in this page) [1R- (1 a, 3a / ?, 4 o'clock, 4a0, 7, 7aa, 8ay5) ] 8a-[(3-0-allyl-2,6  dideoxy-/?-D-piperanyloxy) methyl] _4-methylaceto_4,4a, 5,6 , 7,7a, 8,8a -Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-  Province-3a (lH) -carboxylic acid , Diphenylmethyl ester, a solution of intermediate 17 (2.3 g) in methane (200 ml) was stirred with water (20 ml), and 2,3-digas-5,6-dicyanoquinone was added ( 0.79g). After stirring at room temperature overnight, the mixture was filtered with diatomite with the aid of more methane. Then the methane phase was washed with aqueous sodium bicarbonate solution, then with sodium chloride solution, and then washed Dry over sodium, filter and concentrate to dryness. The residue was analyzed by flash layer on silica gel and washed away with methane: methanol (4 9: 1) to give the title compound (1.95 g) as white Foam.  (! , CDC13): 9.75 (s, 1H, CHO), 7.45-7.24 (m, 10H, Ph2), 6.99 (s, 1H, C | iPh2), 6.05 (dd, 1H, H-2 , J = 1.5 3  3 Hz), 5.95 (m, 1H, CH = CH2), 5.26 (m, 2H, CH ^ Ci ^), 4.53 -77- This paper size is suitable for China National Standard (CNS) A4 specification (210X297mm ) A 7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economy V. Description of invention (75) (dd, lH, Hr, J = 1.8 &amp;amp; 9.6Hz), 4.19 &amp;amp; 3.96 (2m, 2H, CH2CH = CH2), 4.03 ^ 3.69 (2d, 2H, 8a-CH2, J = 9.3 Hz), 3.80 (q, 1H, H-3 ', J = 3.3 Hz), 3.60 (dq, 1H, H-5', J = 9.6 and 6.3 Hz), 3.23 (ddd, lH, H-4 ', J = 10.8,9.6 &amp;amp; 3.3Hz), 2.74 (t, lH, Hl, J = 3.6 Hz), 2.25 (d, 1H, OH , J = 10.8 Hz). Intermediate 1 9 [1R- (1 a, 3a / ?, 4/5, 4a / 5, 7 cold, 7aa, 8a /?)] 8a-[(3-0-propylene Group _ 2,6-dideoxy- 4- 0- (methylthio) thiocarbonyl point -D --piperanyloxy) methyl] -4 -methyl acetyl_4,4 &amp;amp;, 5 , 6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl_3_ (1-methylethyl) -1,4-methylidene-sH   -3a (lH) -trait Acid, diphenylmethyl ester in a solution of intermediate 18 (1.9 g) in anhydrous tetrahydrofuran (50 ml) was added sodium hydride (240 mg) and a catalytic amount of imidazole in small portions under nitrogen. The ice bath was then removed and the reaction mixture was stirred at room temperature for 1 hour. Carbon disulfide (1.5 ml) and methyl bromide (1.25 ml) were added successively. Once the reaction was complete (controlled by TCL), the crude mixture was poured into ethyl acetate (500 mL), and the reaction was stopped with 0.1 equivalent of an aqueous vaporized ammonium solution (250 mL). The organic phase was washed from brine (1 X 500 mL) and water (1 X 500 mL), dried over anhydrous sodium sulfate, and concentrated to dryness. The residue of the oil body was analyzed by flash layer on silica gel, and washed away with hexane: methane (3: 5) to obtain the title compound (185 g) as a white foam. ^ U, CDC13): 9.74 (s, 1H, CHO), 7.45-7.24 (m, 10H,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ph2)6.99(slHCiiPh2)6.06(ddlHH-2J=i.2&amp;amp;3.3 Hz)5_88 (m1H, C|i=CH2)541 (dd1HH-4J=2.79. 78 (}</span>Ph2), 6.99 (s, lH, CiiPh2), 6.06 (dd, lH, H-2, J = i.2 &amp;amp; 3.3 Hz), 5_88 (m, 1H, C | i = CH2), 5.41 (dd , 1H, H-4, J = 2.7 and 9. 78 (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T ft   M  ?t ( A/Ui   V 7Q7A \ s21644 at B7 76)</span> 1T Tai paper ft ruler is widely used  M  fixed? T (A / Ui so (  V 7Q7A building  \ s21644 at B7 V. Invention description (76)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.20-4.02 (m5H-5', CH2-CH=CH2, -3'8a-CH2 (1H)), 3.71 (d, 1H, 8a-CH2, J=9.3 Hz), 2.75 (t, 1H, H-l, J=3.9 Hz), 2.58 (s, 3H, SCH3) 20 (a) [lR-(la3a4a7/?7aa8a]8a-[[lS4s 611811]-2,7--4,6---[3.4.0]--8--]-4 --44a56,7,7a,8,8a--7--3(1--l4--s-_3a(lH)-  (b) [lR-(la3a044a7aa ,8a/5 )]8a-[[lS4R 6R8 ]-2,7-- 4,6---[3.4.0]-_ 8---]-4 --4,4a56,7,7a,8,8a--7-- 3(1--1,4 -- s- - 3a(lH) -   () 19(1.8250 12 50 0.95 1  *9 : 1)2(a)(680 Rf=0.314 : 1 20(b)(180Rf=.254: 1 -79- CNS ) M2&amp;gt;&amp;lt;297  A7 ___ _B7_ 77)  (a) e Oh, CDC13): 9.73 (s1H, CHO)7.45-7.28 (m, 10H Ph2)6.99(slHCHPh2)6.05(ddlHH-2J=1.2&amp;amp;3.6 Hz)4.46 (dd1H, H-8J=2.49.6 Hz)4.14-4.05 (m3H 8a-CH2 (1H)-CH2-31H))3.67 (d1H8a-CH2 J=9.3Hz)3.36-3.25 (m2HH-6,CH2-3,1H))2.77 (t1H, H-lJ=3.9 Hz), 1.05 (d3H4'-(3,6.9 Hz) (b)  pH, CDC13): 9.72 (s1H, CHO)7.45-7.24 (m10H Ph2)6.99(s,lH,CHPh2)6.05(ddlHH-2J=1.5(^3.6 Hz)4_42 (dd1H, H-8'J=2.1 9.6 Hz), 4.20 (m1H-) 4.07&amp;amp;3.67(2d,2H,8a-CH2,J=9.3Hz)3.97(tlHCH2-3 J=8.4 Hz), 3.54 (m, 1H, H-6'), 3.46 (dd, 1H, CH2-3', J=10.5</span>Hz), 4.20-4.02 (m, 5, H-5 ', CH2-CH = CH2, -3' and 8a-CH2 (1H)), 3.71 (d, 1H, 8a-CH2, J = 9.3 Hz) , 2.75 (t, 1H, Hl, J = 3.9 Hz), 2.58 (s, 3H, SCH3). Intermediate 20 (a) [lR- (la, 3a point, 4a, 7 / ?, 7aa, 8a Lu)] 8a-[[lS, 4s, 611, 811] -2,7-diox-4 , 6-dimethyl) -cis-bicyclo [3.4.0] -non-8-yl-oxy  methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8 , 8a-octahydro-7-methyl-3  (1-methylethyl) -1,4-methylene-s-pyridine_3a (lH) -chiric acid, diphenylmethyl ester And (b) [lR- (la, 3a0, 4, 4a Lu, 7aa, 8a / 5)] 8a-[[lS, 4R, 6R, 8 end] -2,7-diox-4,6 -Dimethyl) -cis-bicyclo [3.4.0] -non_8-yl-oxy-methyl] -4-methylacyl-4,4a, 5,6,7,7a, 8,8a -Octahydro-7-methyl-3 (1-methylethyl) -1,4-methylene-s--pyridine-3a (lH) -carboxylic acid, diphenylethyl ester Ministry of Economic Affairs Printed by the Central Consumer Council Cooperative Employees (please read the precautions on the back before filling in this page). Degas the solution of Intermediate 19 (1.8g) in anhydrous toluene (250ml) with argon flow for 1 hour, then Heat to reflux. A catalytic amount of azobis (isobutyronitrile) and tributyltin hydride (0.95 ml) dissolved in anhydrous toluene (50 ml) were added to the syringe in about 2 hours while heating and maintaining the argon flow. After the addition is complete, add the reaction mixture and continue to reflux for another 1 hour, then cool, then concentrate to dryness, and analyze the flash layer on the silica gel, using hexane, and then using hexane * ethyl acetate (9: 1 ) Wash away. Intermediate 2 (a) (680 mg; Rf = 0.31 in hexane: ethyl acetate 4: 1) was prepared as a white foam, and intermediate 20 (b) (180 mg; Rf = 0.25. Yuji burning: ethyl acetate 4: 1) -79- This paper standard is used by the Chinese family rate (CNS) M specification (2  &amp;gt; &amp;lt; 297mm) Beigong consumption of the Central Standards Bureau of the Ministry of Economic Affairs Cooperative cooperative printing A7 ___ _B7_ V. Description of invention (77), white solid. (a) e Oh, CDC13): 9.73 (s, 1H, CHO), 7.45-7.28 (m, 10H, Ph2), 6.99 (s, lH, CHPh2), 6.05 (dd, lH, H-2, J = 1.2 &amp;amp; 3.6 Hz), 4.46 (dd, 1H, H-8, J = 2.4 and 9.6 Hz), 4.14-4.05 (m, 3H, 8a-CH2 (1H), - and CH2-3 '( 1H)), 3.67 (d, 1H, 8a-CH2, J = 9.3Hz), 3.36-3.25 (m, 2H, H-6, and CH2-3, (1H)), 2.77 (t, 1H, Hl, J = 3.9 Hz), 1.05 (d, 3H, 4 -(: 3, Bu 6.9 Hz). (B)  pH, CDC13): 9.72 (s, 1H, CHO), 7.45-7.24 (m, 10H, Ph2), 6.99 (s, lH, CHPh2), 6.05 (dd, lH, H-2, J = 1.5 (^ 3.6 Hz), 4_42 (dd, 1H, H-8 ', J = 2.1 and 9.6 Hz), 4.20 (m, 1H, -), 4.07 &amp;amp; 3.67 (2d, 2H, 8a-CH2, J = 9.3Hz), 3.97 (t, lH, CH2-3, J = 8.4 Hz), 3.54 (m , 1H, H-6 '), 3.46 (dd, 1H, CH2-3', J = 10.5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 2.77 (t1H, H-lJ=3.9 Hz), 2.53 (m1HH-4)1.02 (d, 3H, 6-CH3)  2 1 [1R-(1 a,3a404aA7/5 ,7aa8a/9 )]8a-[(4-0--2,6-- 3- 0- (--D - ]-4 --44a, 56,7,7a8,8a--7 --3-(1--1,4--s--3a(lH)-  12(3801 0C240 1 3002504 -80- CNS ) A4210X297) () -  A7 _____B7 78) 100 5011 IX 100  1 : 25)1 : 20)35  S (^, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph), 6.98 (s, H, CHPh2), 6.24 (m, 1H, H-3'), 6.05 (dd, 1H, H-2, J=1.5^3.6 Hz), 5.85 (m, 1H, CH=CH2), 5.30-5.20 (m, 2HCH=C^)4.56 (dd, 1H, -J=1.89.3 Hz), 4.15-3.75 (m, 4H, CH2CH=CH2+8aCH2+H-5'), 3.69 (d, 1H, 8aCH2, J=9.3Hz)3.21(ddlHH-4,,J=3.3&amp;amp;9.3Hz),2.72(t,lH H-l, J=3.89 Hz), 2.59 (s, 3H, SCH3)  2 2 [1-(1(^334 0437738&amp;amp;/?)]83-[(2,6-- 3-0-(-4-0-(2 --2--e-D- ]-4 --4,4&amp;amp;5,6,7,7&amp;amp;,8,8&amp;amp;- -7 --3-(1_-14--s-_3a(lH)- 13(70030 8 5 1 0.540.45 TL C200 -81 - CNS ) 210X297 () t^</span>Hz), 2.77 (t, 1H, Hl, J = 3.9 Hz), 2.53 (m, 1H, H-4 ), 1.02 (d, 3H, 6-CH3) Intermediate 2 1 [1R- (1 a , 3a, 40,4aA, 7/5, 7aa, 8a / 9)] 8a-[(4-0-allyl-2,6-dideoxy- 3- 0- (methylthio) thio Carbonyl-dot-D-perpiperanosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 12 (380 mg) in anhydrous tetrahydrofuran (1 (0 ml) was added solid sodium hydride (240 mg) and a catalytic amount of imidazole in small batches at 0  C under nitrogen at 0  C. After the addition was complete, the cold bath was removed and the reaction was stirred at room temperature for 1 hour. Add carbon disulfide (300 microliters) and methyl iodide (250 microliters) successively. 4 hours later -80- This paper is used in China National Standards (CNS) A4 (210X297). (Please read the precautions on the back and then fill out this page)-Printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 _____B7 V. Description of the invention (78) Pour the mixture into ethyl acetate (100 ml) and stop the reaction with an equivalent of aqueous vaporized ammonium solution (50 ml). The organic phase was washed with brine (1  100 mL) and water (IX 100 mL), dried over magnesium sulfate, and concentrated to dryness to obtain a yellow oil body. This oil body was subjected to flash layer analysis on silica gel to Ethyl acetate: hexane (1: 25) and (1: 20) were washed away to give the title compound (35g) as a white foam. S (^, CDC13): 9.73 (s, 1H, CHO), 7.50-7.20 (m, 10H, 2Ph), 6.98 (s, H, CHPh2), 6.24 (m, 1H, H-3 '), 6.05 ( dd, 1H, H-2, J = 1.5 ^ 3.6 Hz), 5.85 (m, 1H, CH = CH2), 5.30-5.20 (m, 2H, CH = C ^), 4.56 (dd, 1H, - , J = 1.8 and 9.3 Hz), 4.15-3.75 (m, 4H, CH2CH = CH2 + 8aCH2 + H-5 '), 3.69 (d, 1H, 8aCH2, J = 9.3Hz), 3.21 (dd, lH, H -4,, J = 3.3 &amp;amp; 9.3Hz), 2.72 (t, lH, Hl, J = 3.89 Hz), 2.59 (s, 3H, SCH3) Intermediate 2 2 [1 ft- (1 (^, 33 , 4 0, 43 cold, 7 cold, 73 Shen, 8 &amp;amp; /?)] 83-[(2,6-dideoxy-3-0- (methylthio) thiocarbonyl-4-0- ( 2-methyl-2-propenyl) -eD-piperonyloxy) methyl] -4-carboxyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp;- Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-pyridine_3a (lH) -carboxylic acid, diphenylmethyl ester in the intermediate 13 (700 mg) in a cold solution in anhydrous tetrahydrofuran (30 mL) was added sodium hydride (85 mg) and a catalytic amount of imidazole in small batches under nitrogen. The cooling bath was removed and the reaction was placed at room temperature to Stir for 1 hour with a magnetic stir bar. Add carbon disulfide (0.54 ml) and A Iodine (0.45 ml). After the reaction is complete (controlled by TLC), pour the crude mixture into ethyl acetate (200 ml). -81-This paper scale uses the Chinese National Standards (CNS) M specifications (210X297 mm) (Please read the precautions on the back before filling in this education) t ^ </span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T A7 B7 79) 0.1120 1 X 2001 X 200  1 9 : 1) 600 (y On, CDC13): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H,</span>, 1T A7 B7 V. Description of the invention (79) Use 0.1 equivalent of a vaporized aqueous ammonium solution (120 ml) to stop the reaction. The organic layer was washed with brine (1 X 200 ml) and water (1 X 200 ml), dried over anhydrous sulfuric acid, and concentrated to dryness. The residue of the oil body was analyzed by flash layer on the hard rubber dioxide and washed away with hexane: ethyl acetate (19: 1) to obtain the title compound (600 mg). (y On, CDC13): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ph2), 6.98 (s, 1H, CHPh2), 6.24 (m, 1H, H-3'), 6.05 (dd, 1H, H-2, J=1.53.6 Hz), 4_924_88 (2m2H, 0=(4.55 (dd 1HH-l'J=2.1 9.6 Hz), 4.033.69 (2d2H8a-CH2, J=9.3 1HH-53.19 (dd, 1HH-4'J=39.3 Hz), 272 (t1HH-l J=3.9 Hz), 2.58 (s, 3H, SCH3), 1.70 (s, 3H, CH^C=CH2) 2 3 (a) [lR-(la ,3a/? ,  ,4a/? ,7/3 ,1 a a ,8a/? )]8a-[[lS,4R 7R9R]-2,8-- 4,9---[4.4.0]-_ 7 ---]-4 --4,4a,5,6,7,7a8,8a --7--3-(1--14-s-- 3a(lH)-   () (b) [lR-(l^ ,3a/?  ,4a/? ,1  ,l^a ,8a/? )]8a-[[lS,4S 711911]-2,8--4,9---[3.4.0]-_ 7---]-4 -- 4,4a,5,6,7,7a,8,8a--7--3-(l--l4--s-3a(lH)- </span>Ph2), 6.98 (s, 1H, CHPh2), 6.24 (m, 1H, H-3 '), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4_92 and 4_88 (2m, 2H, 0 = (: fast), 4.55 (dd, 1H, H-l ', J = 2.1 and 9.6 Hz), 4.03 and 3.69 (2d, 2H, 8a-CH2, J = 9.3 1H, H-5,), 3.19 (dd, 1H, H-4 ', J = 3 and 9.3 Hz), 2.72 (t, 1H, Hl, J = 3.9 Hz), 2.58 (s, 3H, SCH3), 1.70 (s, 3H, CH ^ C = CH2). Intermediate 2 3 (a) [lR- (la, 3a /?,  , 4a /?, 7/3, 1 aa, 8a /?)] 8a-[[lS, 4R, 7R, 9R] -2,8-dioxo-4,9-dimethyl) -cis-bicyclo [4.4.0] -non-7-yl-oxy-methyl] -4-methylacyl- 4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4  methylene-s-pyda province-3a (lH) -Chiral acid, diphenylmethyl ester and printed by the Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) (b) [lR- (l ^, 3a / ? , 4a /?, 1 , l ^ a, 8a /?)] 8a-[[lS, 4S, 711,911] -2,8-dioxo-4,9-dimethyl) -cis -Bicyclo [3.4.0] -nonan-7-yl-oxy-methyl] -4 -methylbromo-4,4a, 5,6,7,7a, 8,8a-octaamino-7-methyl -3- (l-methylethyl) -l, 4-methylene-s-indap 3a (lH) -chiric acid , Diphenyl methyl ester</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A -82- CNS ) A4210X297 A7 B7 80) 21(1.5150 90 84733 3 0 20 : )(150110.6 4 : 1b) (260Rf=.4 4 : 1 (a)  (!, CDC13) 9.75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph)6.99(slHCHPh2),6.06(ddlHH-2,J=1.5&amp;amp;3.6 Hz)446 (dd, 1H, H-7J=37.5 Hz), 4.06-3.95 (m, 2H, H-3,8aCH2)3.78-3.60 (m2H, H-l'8aCH2), 3.38-3.26 (m, 2HH-9,H-3')2.75 (t, 1HH-lJ=3.6 Hz), 0.98 (d, 3H CICH J=6.9 Hz) (b) d (lR, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph)6.99 (s, 1HCHPh2)6.04 (dd1HH-l 1.53.6 Hz),4.74(tlHH-7,J=3Hz)3.94&amp;amp;3.61(2d,2H8aCH2 JAB=9.3Hz),3.88&amp;amp;3.76(2d,2HH-3,),3.66(mlHH-9') 3.43 (t, 1H- J=7.8 Hz), 2.72 (t1HH-lJ=3_6 Hz) 2.46 (2m, 2HC|iCH20H-5097 (d, 3HC^CHJ=6.9</span>Method A -82- This paper scale is applicable to China National Bare Standard (CNS) A4 specification (210X297mm) A7 B7 5. Description of invention (80) A solution of intermediate 21 (1.5g) in anhydrous toluene (150ml) Degas with a stream of gas for 90 minutes, then heat to reflux. To this boiling solution, gasified tributyltin (847 l) and azobis (isobutyronitrile) (33 mg) were added. Continue heating for another 30 minutes. The solvent was removed to obtain a crude mixture. This mixture was subjected to a flash layer analysis on silica gel twice, and washed with hexane: ethyl acetate (20: ). The title compound ) (150 mg; 11 Bu 0.6, in hexane: ethyl acetate 4: 1) and the title compound (b) (260 mg; Rf = 0.4 in hexane: ethyl acetate 4: 1) Both are colorless oil bodies. (a)  (! , CDC13): 9.75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, lH, CHPh2), 6.06 (dd, lH, H-2, J = 1.5 &amp;amp; 3.6 Hz), 4.46 (dd, 1H, H-7, J = 3 and 7.5 Hz), 4.06-3.95 (m, 2H, H-3, and 8aCH2), 3.78-3.60 ( m, 2H, H-l 'and 8aCH2), 3.38-3.26 (m, 2H, H-9, and H-3'), 2.75 (t, 1H, Hl, J = 3.6 Hz), 0.98 (d, 3H , CICH J = 6.9 Hz). (b) d (lR, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.04 (dd, 1H, Hl, Bu 1.5 and 3.6 Hz), 4.74 (t, lH, H-7 ,, J = 3Hz), 3.94 &amp;amp; 3.61 (2d, 2H, 8aCH2, JAB = 9.3Hz), 3.88 &amp;amp; 3.76 (2d, 2H, H-3, ), 3.66 (m, lH, H-9 '), 3.43 (t, 1H, H-  J = 7.8 Hz), 2.72 (t, 1H, Hl, J = 3_6 Hz), 2.46 (2m, 2H, C | iCH20 and H-5,), 0  97 (d, 3H, C ^ CH, J = 6.9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)</span>Hz).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">B 98( 685o-I5 6 0 CNS ) 210X 297 () -4**^ ,1  A7 81) (3793 (1501   20 : 1)a)(13 b)(235</span>Method B The intermediate 98 (685 mg) in o-xylene (15 mL) was degassed with argon flow for 60 minutes and then heated to reflux. The paper standard of dibutyltin nitride is applicable to the Chinese National Standard (CNS)  specifications (210X 297 mm) (please read the notes on the back before filling in the cornel) -4 ** ^ , 1 Employee of Central Standards Bureau A7 printed by the consumer cooperative V. Description of invention (81) (379 microliters) Continue heating for another 30 minutes. After cooling, the mixture was separated between ether (150 ml) and water (100 ml). The organic layer was washed with saturated potassium fluoride solution until there was no more vaporized tributyltin precipitate, filtered and evaporated to dryness to obtain a residue. This residue was analyzed twice on a silica gel as a flash layer, using hexane: acetic acid The ethyl acetate (20: 1) was washed away. The title compound (a) (103 mg) and the title compound (b) (235 mg) were prepared.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">C 68425 12 98(6103 3.5  (10 : 1)8 : 1)a)(357 2 4  (} [1R-(1 a ,3 a  ,4/? ,4 a J3 ,  ,7a^,8ay5 )]8a-[[lS,7R,9R]-2,8 -- 4,4,8---[44]-7_- -]-4 --4,4a5,6,7,7a8,8a --7--3. (1--1,4 --s-- 3a(lH) -  22(5 80150 1 2027 20 3 84 CNS ) A4210X297 A7 B7  82) 4 : 1) 100 ^ (lH, CDC13): 9.74 (s, 1H, CHO), 7.45-7.26 (m, iH, Ph2)6.99(SlHC|iPh2)6.04(ddlHH-2j=i.5A3.6</span>Method C: A solution of dibutyltin hydride (684 l) in anhydrous toluene (25 ml) was degassed under reflux with argon gas flow for 1 hour, and then the intermediate 98 (610 mg) in anhydrous toluene was added to the syringe for more than 2 hours. (30mL). Continue heating for another 3.5 hours. The solvent was removed under reduced pressure to obtain the crude product, which was analyzed twice on a silica gel as a flash layer, washed away with hexane and hexane: ethyl acetate (10: 1) to (8: 1) to obtain the title Compound (a) (357 mg). Intermediate 2 4 Printed by the Employee Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) [1R- (1 a, 3 a , 4 /?, 4 a J3,  , 7a ^, 8ay5)] 8a-[[lS, 7R, 9R] -2,8 -dioxo-4,4,8-trimethyl) -cis-bicyclo [44]  non-7_yl- Oxy-methyl] -4 -methylbromo-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3. (1-methylethyl) -1, 4 -methylene-s-pyridone-3a (lH) -carboxylic acid, diphenylmethyl ester The solution of intermediate 22 (5 80 mg) in anhydrous toluene (150 ml) was degassed with argon flow 1 hour, then heated to reflux. While heating, use a syringe to add a solution of a catalytic amount of azobis (isobutyronitrile) (027 ml) dissolved in anhydrous toluene (20 ml) over 2 hours, while continuing to add argon. After the addition is complete, continue to heat for 3 hours, then cool, concentrate, and make a flash layer on the silica. 84 This paper scale uses the Chinese nursery rubbing rate (CNS) A4 specification (210X297 mm) A7 B7 Central Standard of the Ministry of Economic Affairs Printed by the Bureau Staff Consumer Cooperative V. Description of invention (82) Analysis, wash off with hexane and then with hexane: ethyl acetate (4: 1) to prepare the title compound (100 mg) as a white foam. ^ (lH, CDC13): 9.74 (s, 1H, CHO), 7.45-7.26 (m, iH, Ph2), 6.99 (S, lH, C | Ph2), 6.04 (dd, lH, H-2, j = i.5A3.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.71 (t1HH-7J=3.3 Hz), 3.93&amp;amp;3.6l(2d2H8a_ CH2, J=9.3 Hz)3.85 (t1H, H-l. J=8.7 Hz)3.56 (mlH H-93.553_43 (d, 2HCH2-3', J=8.4 Hz)2.73 (m, lH, H-l)1.080.99 (2s, 6H4--() 2 5 [1R-(1 a ,3ay3404ay57/?7aa8ay5 )]8a-[(6- _ D -]_4_(i,3 --2-_ 4,4&amp;amp;5,6,7,7&amp;amp;8,83--7--3-(1--14_ -3a(lH)- .1(2.51 302 p -3 3005%  3 : 1) 26  &amp;quot;, CDC13): 7.46-7.24 (m, 10, Ph2)6.94 (s, 1 CPh2)5.83 (dd1HH-2J=1.23.6 Hz)5.07 (sijj beta), 4.65 (d1H-J=1.8 Hz), 4.07-4.04 (m2H8a CH2 (1H)H-3.)3.88-3.69 (m8HOC^Ci^O, 8a-CH2 -85- CNS ) A4B( 210X297 ()</span>Hz), 4.71 (t, 1H, H-7 ', J = 3.3 Hz), 3.93 &amp;amp; 3.6l (2d, 2H, 8a_ CH2, J = 9.3 Hz), 3.85 (t, 1H, Hl,. J = 8.7 Hz), 3.56 (m, lH, H-9 '), 3.55 and 3_43 (d, 2H, CH2-3', J = 8.4 Hz), 2.73 (m, lH, Hl), 1.08 and 0.99 (2s, 6H, 4-(). Intermediate 2 5 [1R- (1 a, 3ay3,40,4ay5,7 / ?, 7aa, 8ay5)] 8a-[(6-deoxy, Lu_D -Azhuo Piperanosyloxy) methyl] _4_ (i, 3-dioxolane-2-yl) _ 4,4 &amp;, 5,6,7,7 &amp;amp;, 8,83-octahydro-7-methyl 3- (1-methylethyl) -1,4-methylidene-3a (lH) -carboxylic acid, diphenylmethyl ester. In intermediate 1 (2.5 g) in anhydrous acetonitrile ( 100 ml) of the stirred solution, ethylene glycol (30 ml), trimethyl orthoformate (2 ml) and a catalytic amount of p-toluenesulfonic acid were added at room temperature. The mixture was stirred for 3 Hour, and then diluted with ethyl acetate (300 ml), then washed successively with 5% aqueous sodium bicarbonate solution and brine. The organic layer was dried over sodium sulfate, concentrated, and purified by silica gel chromatography for chromatography. Hexane: ethyl acetate (3: 1) washes away to prepare the title compound ( 2.6 g).  &amp;quot; , CDC13): 7.46-7.24 (m, 10, Ph2), 6.94 (s, 1, C Ph2), 5.83 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 5.07 (s, ijj beta), 4.65 (d, 1H, -, J = 1.8 Hz), 4.07-4.04 (m, 2H, 8a CH2 (1H) and H-3.), 3.88- 3.69 (m, 8H, OC ^ Ci ^ O, 8a-CH2 -85- This paper size is easy to use China National Standards (CNS) A4B (210X297mm) (Read the precautions on the back first and fill in this book)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">=I A7 321644 ______B7__ 83 ) (1H)H-2H-4,H-52.51 (t1HH-l, J=4.5 Hz)2.37 (d 1H, OH, J=2.7 Hz), 2.28 (d, 1H, OH, J=3.6 Hz), 2.04 (d, 1H, OH, J=5.7 Hz) 2 6 [1R-(1  ,3a,4# ,7y57aa ,8a/? )]8a-[(6--3,4_ --D-]_4_(1,3- -2--4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1- -14-_s__3a(iH)- 25(2006 2,2-6p_ 4 202   4 : 1) 205 S CDC13): 7.47-7.2 (m, 10H, 2Ph), 6.93 (s, 1H, C|iPh2)5.83 (dd, 1H, H-2, J=1.23.6 Hz)5.08 (s1H 1,3-)4.56 (d, 1H-J=2.1 Hz)4.3(dd, 1HH-3', J-3.65.7 Hz)4.04 (d1H8aCH2  AJAB=9 Hz) 3.95-3.75 (m7HH-2H-4'OC^C^O8aCH2 B 3.44 (dq1HH-5J=69 Hz)2.65 (m1HCMe2)2.51 (bt1HH-lJ=3.6 Hz)2.35 (d1HOH2)1.47, 1.36 (2s 6H, 2CH3 -86- ACNS ) A4210X297 ()    A7 B7  2 7 [1R-(1 3a044a 7 7aa8a9 )]8a-[(6 --3,4_ - D-]_4_(3_ -2--4,4&amp;amp;5,6,7,78,8&amp;amp;-_7--3-(1- -1,4--s--3a(lH)- 0.670CCrOjHi2 2515.4 1026(750 252  1 0 : 1 ; 1 1 0 C4 0 c 2 1pH6-7  6: 1)2: 1) 585 H, CDC13) 7.24-7.46 (m, 10H, 2Ph), 6.92 (s, 1H, CPh2)5.87 (dd1HH-2, J=3.9 1.5 Hz), 5.09 (s, 1H, -4.52 (t1H, H-3'J=4.5 Hz), 4.45 (d1HH-l' J=7.8 Hz, 4.07 (d, 1H, 8aCH2, J=9 Hz), 3.74-3.86 (m, 6H, 2C^H-4'8aCH2)3.67 (m, 1HH-22.65 (m1H H-14)2.58 (t, 1H, H-ll) 2 8 [lR-(lor3a44a77aa ,8a^ )]4- _ -87- CNS ) A4210X297 () - A7 B7 85 ) 4,4&amp;amp;5,6,7,7&amp;amp;,8,8&amp;amp;--8&amp;amp;--7--3-(1- -14--s--3a(lH)-2-(  6.6-[2-(]-,-9.3150 3 7501 5 %  1  %) 6.8  (^, CDC13) 9.67 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)4.27(m,2HCH2C|i20)3.93&amp;amp;3.49(2m 2H, 8a-CH2), 2.75 (bs, 1H, OH), 2.54 (t, 1H, H-l), 1.05 (m, 2H, CH2C_H2Si), 0.07 (s, 9U, (CH3)3Si); c?(13C, CDC13): 204.9 (CHO), 173.6 (COOTMSE), 148.2 (C-3), 130.6 (C-2), 66.9 (8a-CH20), 64.0 (CH2CH2), 177.7 CH2C^H2Si), 1.6 (CH3)3Si)  () 1 L.J. Mathias, Synthesis, (1979)561 2 9 [1R-(1 a3a4/?4a0707aa ,8a]8a-[(3,4,6-- O--2--/? -D-]_4_-4,4a5,6,7,7a8,8a--7--3-(l--l4-- s-5- 3a(lH) - -88- CNS ) A4210X297 A7 A7  B7 86) ~~ 28(633,4,6___DaUall(2 1-9 60C2 100100   10 : 1)16  d (^, CDC13) 9.73 (s, 1H, CHO), 6.03 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)5.48(mlHH-3'),4.89(ddlHH-4 J=3.3&amp;amp;9.6Hz)4.65(ddlH,H-r,J=2.4&amp;amp;8.7Hz),4.23(m, 4H, H-6', C00CH? CH9 Si), 4.02 (ddd, 1H, H-5'J=3, 5.4 9.6Hz)3.92&amp;amp;3.69(2d2H,8aCH2,J=9.6Hz)2.75(tlH H-l), 2.28 (m, 1H, CH(CH3)2) 1 M. D. Wittman, R. L. Halcomb and S. J. Danishefsky, J.</span> = I A7 321644 ______B7__ V. Description of the invention (83) (1H), H-2 ', H-4, and H-5, 2.51 (t, 1H, Hl, J = 4.5 Hz), 2.37 (d , 1H, OH, J = 2.7 Hz), 2.28 (d, 1H, OH, J = 3.6 Hz), 2.04 (d, 1H, OH, J = 5.7 Hz). Intermediate 2 6 [1R- (1 , 3a cold, 4 #, 7y5,7aa, 8a /?)] 8a-[(6-deoxy-3,4_   isopropylidene--D- Azorpiperanyloxy) methyl] _4_ (1,3-dioxolan-2-yl) -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro- 7-methyl-3- (1-methylethyl) -1,4-methylidene_s_indap province_3a (iH) -carboxylic acid, diphenylmethyl ester, intermediate 25 (200 Mg) of the solution in anhydrous acetonitrile (6 ml) was treated with 2,2-dimethoxypropane (0.6 ml) and a catalytic amount of p_toluenesulfonate eianqiang under nitrogen. After 4 hours at room temperature, the mixture was treated with saturated aqueous sodium bicarbonate (20 ml) and extracted twice with ethyl acetate (20 ml). The combined organic phase was washed with water and brine, dried over magnesium sulfate, filtered and evaporated. The residue was chromatographed and purified on silica gel, washed away with hexane: ethyl acetate (4: 1), combined the appropriate fractions and evaporated to obtain the title compound (205 mg) as a white foam. S CDC13): 7.47-7.2 (m, 10H, 2Ph), 6.93 (s, 1H, C | iPh2), 5.83 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 5.08 (s, 1H, 1,3-dioxane), 4.56 (d, 1H, -, J = 2.1 Hz), 4.3 (dd, 1H, H-3 ', J-3.6 and 5.7 Hz), 4.04 (d, 1H, Part A of 8aCH2, JAB = 9 Hz) 3.95-3.75 (m, 7H, H-2 ', H-4', OC ^ C ^ O and Part B of 8aCH2) 3.44 (dq, 1H, H-5 ,, J = 6 and 9 Hz), 2.65 (m, 1H, Ctin Me2), 2.51 (bt, 1H, Hl, J = 3.6 Hz), 2.35 (d, 1H, OH2 ), 1.47, 1.36 (2s 6H, 2CH3 isopropylidene ketal). -86- This paper A degree is made in China National Standard (CNS) A4 (210X297mm) (please read the notes on the back before filling in this page). Order the Ministry of Economic Affairs Central Bureau of Samples and Printing Co., Ltd. A7 B7 printed by the Ministry of Standards and Staff Consumer Cooperative V. Invention description (Intermediate 2 7 [1R- (1, 3a0, 4 cold, 4a point, 7 point, 7aa, 8a; 9)] 8a-[(6- Deoxy-3,4_ .isopropylidene-D-bipyranosyloxy) methyl] _4_ (, 3-dioxolane-2-yl) -4,4 &amp;amp;, 5,6 , 7,7 ugly, 8,8 &amp;amp; -octahydro_7-methyl-3- (1-methylethyl) -1,4-methylene-s-called Shuda-3a (lH)- Carboxylic acid, diphenyl methyl ester Pyridine (0.67 ml) was added to a mixture of chromium oxide (CrOjHi 2 mg) and methane (25 ml) at 0  C. After 15 minutes, acetic anhydride (0.4. ML), after another 10 minutes, add a solution of intermediate 26 (750 mg) in methane (25 mL) at the same temperature. The mixture was stirred for 2 hours and filtered through a silica gel column with a magnesium sulfate top layer, The filtrate was evaporated to dryness under reduced pressure to obtain a slurry. This slurry was dissolved in methanol: water 1 0: 1; 11 ml), then add sodium borohydride (40 mg) at 0  C. Keep this mixture at 0  C for 2 hours' acidify the pH to 6-7 with 1 equivalent hydrochloric acid solution, then Evaporate to dryness under reduced pressure to obtain a white solid, which is analyzed and purified twice on a silica gel by chromatography, successively washed away with hexane: ethyl acetate (6: 1) and then (2: 1). The product was partially evaporated in vacuo to give the title compound (585 mg). H, CDC13): 7.24-7.46 (m, 10H, 2Ph), 6.92 (s, 1H, C Ting Ph2), 5.87 (dd, 1H, H- 2, J = 3.9 and 1.5 Hz), 5.09 (s, 1H, etiodioxane), 4.52 (t, 1H, H-3 ', J = 4.5 Hz), 4.45 (d, 1H, H-l ', J = 7.8 Hz, 4.07 (d, 1H, 8aCH2, J = 9 Hz), 3.74-3.86 (m, 6H, 2C ^  dioxane, H-4', 8aCH2), 3.67 (m, 1H, H-2,), 2.65 (m, 1H, H-14), 2.58 (t, 1H, H-ll). Intermediate 2 8 [lR- (lor, 3a, 4, 4a, 7, 7aa, 8a ^)] 4-   _ -87- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297mm) (keep reading the precautions on the back and then fill out this page) -Subscribe to A7 B7 5. Description of the invention 85) 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-8 &amp;amp; -hydroxymethyl-7-methyl-3- (1-methylethyl) -1,4 -Methylene-s-pyridine-3a (lH) -carboxylic acid, 2- (trimethylsilyl) ethyl ester, sodarin (6.6 g) and - [2- (trimethyl A silyl) ethyl] -,   -diisopropylisourea (9.3 g) in anhydrous tetrahydrofuran (150 ml) was heated at reflux for 3 hours. The mixture was then cooled to room temperature, filtered and evaporated to dryness. The residue was dissolved in ethyl acetate (750 ml) and washed successively with 1 equivalent hydrochloric acid, 5% aqueous sodium bicarbonate solution and brine. The organic layer was dried over anhydrous sodium sulfate, concentrated in vacuo, and purified by silica gel column chromatography, using (10%) ethyl acetate in hexane as the eluent to obtain the title compound (6.8 g ), A white bubble.  (^, CDC13): 9.67 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.27 (m, 2H, CH2C | i20), 3.93 &amp;amp; 3.49 (2m, 2H, 8a-CH2), 2.75 (bs, 1H, OH), 2.54 (t, 1H, Hl), 1.05 (m, 2H, CH2C_H2Si), 0.07 (s, 9U, (CH3) 3Si); c ? (13C, CDC13): 204.9 (CHO), 173.6 (COOTMSE), 148.2 (C-3), 130.6 (C-2), 66.9 (8a-CH20), 64.0 (CH2CH2), 177.7 CH2C ^ H2Si), 1.6 (CH3) 3Si). Printed by the Employee Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs (please read the precautions on the back before completing this page) 1 L.J. Mathias, Synthesis, (1979), 561. Intermediate 2 9 [1R- (1 a, 3a point, 4 / ?, 4a0, 70, 7aa, 8a)] 8a-[(3,4,6-tri-O-acetoxy-2-deoxy -/? -D-perpiperanosyloxy) methyl] _4_carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- ( l-methylethyl) -l, 4-methylidene-s-, 5 ~ da province- 3a (lH) -carboxylic acid, trimethylmethylsilyl ethyl ester-88- This paper size is suitable for China Standard (CNS) A4 specification (210X297mm) A7 A7 Printed B7 by Employee Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economic Affairs V. Description of invention (86) ~~ Intermediate 28 (63 mg) and 3,4,6_ A solution of tri__acetoyl DaUall (20 mg) in anhydrous Mizuki (1 ml) was hydrohydro-acid triphenylphosphine (9 mg). The reaction mixture was heated at 60  C for 2 hours and poured into 1M sodium bicarbonate solution (100 ml). Ethyl acetate (100 ml) was added, and the organic layer was washed with water ', dried over anhydrous sodium sulfate and filtered. The solvent was evaporated to dryness, and the residue was purified by chromatography on a silica gel flash column and washed away with hexane: ethyl acetate (10: 1) to obtain the title compound (16 mg) as a white foam. (^, CDC13): 9.73 (s, 1H, CHO), 6.03 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 5.48 (m, lH, H-3 '), 4.89 (dd, lH, H-4 ,, J = 3.3 &amp;amp; 9.6Hz), 4.65 (dd, lH, Hr, J = 2.4 &amp;amp; 8.7Hz), 4.23 (m, 4H, H-6 ', C00CH? CH9 Si), 4.02 (ddd, 1H, H-5 ', J = 3, 5.4 and 9.6Hz), 3.92 &amp;amp; 3.69 (2d, 2H, 8aCH2, J = 9.6Hz), 2.75 (t, lH, Hl), 2.28 (m , 1H, CH (CH3) 2). 1 M. D. Wittman, R. L. Halcomb and S. J. Danishefsky, J.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Org. Chem. (1990), 55^, 1979-1981  3 0 [1R-(1 a3a/?44a77aa ,8ay5 )]8a- [(2--3,4---6-0 ---D-]-4 - -4,4&amp;amp;5,6,7,7&amp;amp;,8,8&amp;amp;--7--3-(1-_ 14_-s--3a(lH)-2-()  29(27510 231M1.5 -89- CNS ) A4210X297 () </span>Org. Chem. (1990), 55 ^, 1979-1981  Intermediate 3 0 [1R- (1 a, 3a / ?, 4 cold, 4a, 7 Lu, 7aa, 8ay5)] 8a- [(2- Deoxy-3,4--isopropylidene-6-0-methyl--D-epiperanyloxy) methyl] -4-carboxamide-4,4 &amp;amp;, 5, 6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) _ 1,4-methylene-s--pyridine-3a (lH)- Carboxylic acid, 2- (trimethylsilyl) ethyl ester To a stirred solution of intermediate 29 (275 mg) in pure methanol (10 ml), add 2 or 3 drops of 1M sodium methoxide in methanol The solution inside. Stirring 1.5 small -89- This paper scale is easy to use Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 10 52,2_ 60p_75 1 2 5 (TC103 13 1 i  : i )   1 )4 : 1 ) 5 0 ^ (lU, CDC13): 9.73 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.236 Hz)4.61 (dd1HH-lJ=2.48.4 Hz)4.43 (m 111-34.34-4_10(111211,(112-81^)3.663.89 (2d, 2H, 8aCH2, J=9.3 Hz), 3.87 (m, 1H, H-4'), 3.48-3.64 (m, 3H2H-6'H-53.24 (s3H, 6OMe), 2.73 (t, 1HH-l, J=3.6 Hz)1.34 1.35 (2s6H, 3 1 [1R-(1 df,3ay5   ,  ,7a ^ ,8a/9 ) ] 8 a-[(4 - -((E)-2 --2,6-]-4- - 4,4a,5,6,7,7a8,8a--7-- 3-(1--14--s-_3a(lH)_ 10(1.50.9 -90- CNS ) A4210X297 f 1T_ ^ 7. 7 321644 88) (15Dean-Stark 220 0.37 361M4A 6c24  95 : 5)1   CDC13): 9.73 (s, 1H, CHO), 7.44-7.23 (m, 10H, 2Ph)6.98 (s1HC||JPh2)6.05 (dd, 1H, H-2, J=1.53.6 Hz)5.75-5.52 (m2HC=C)4.64 (dd, 1H-J=2.1  9.6 Hz), 4.16 (m1HH-3)498 (m3H8a-CH2,1H) CH2CH=CH(2H)), 3.74 (m, 1H, H-5'), 3.67 (d, 1H, 8a-CH2 (1H), J=9.3 Hz), 3.05 (dd, 1H, H-4', J=3.0A9.6 Hz), 2.75 (t, 1H, H-l, J=3.6 Hz), 2.40 (d, 1H, OH, J=2.1 Hz), 1.72 (m, 3H,</span>Description of the invention After A7 to B7, the reaction mixture was concentrated, diluted with toluene (10 mL), and concentrated to a yellow slurry. Re-dissolve in acetone (5 ml), add 2,2-dimethoxypropane (60 l) and p-toluenesulfonic acid monohydrate (75 mg). The reaction mixture was stirred at room temperature for 1 hour, neutralized with sodium carbonate, filtered, and the filtrate was concentrated to dryness. The resulting oil body residue was dissolved in ethyl acetate (20 ml), washed with water and brine, dried and concentrated to obtain an oil body. A solution of this oil body in anhydrous tetrahydrofuran (5 ml) was treated with (TC with sodium hydride (10 mg), and after stirring for 30 minutes, methyl iodide (100 l) was added. For 3 hours The mixture was gradually raised to room temperature. Methanol (1 mL) was added to stop the reaction, and the mixture was concentrated. The residue was purified by flash column chromatography three times, successively with hexane: ethyl acetate (i : i). (  1) and (4: 1) wash away, combine the appropriate fractions, and evaporate the solvent to obtain the title compound (50 mg) as a colorless oil. ^ (LU, CDC13): 9.73 (s, 1H , CHO), 6.04 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 4.61 (dd, 1H, H-l ', J = 2.4 and 8.4 Hz), 4.43 (m, 1's 11 -3 '), 4.34-4_10 (111, 211, (: 112-8  1 ^ protecting group), 3.66 and 3.89 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.87 (m, 1H, H-4 '), 3.48-3.64 (m, 3H, 2H-6' and H-5,), 3.24 (s, 3H, 6OMe), 2.73 (t, 1H, Hl, J = 3.6 Hz), 1.34 and 1.35 (2s , 6H, isopropylidene methyl). Intermediate 3 1 [1R- (1 df, 3ay5  ,  , 7a ^, 8a / 9)] 8 a-[(4--((E ) -2 -butenyl-2,6-dideoxypiperan Yloxy) methyl] -4-carboxamido-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1 , 4-methylene-s-indap _3a (lH) _carboxylic acid, diphenyl methyl ester, intermediate 10 (1.5 g) and dibutyltin oxide (0.9 g) in anhydrous toluene-90-this For paper size, please use the Chinese National Standard (CNS) A4 (210X297mm) f Please read the notes on the back before filling out this page], 1T_ Printed by the Employee Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs ^ 7. 7 321644 V. Inventions The mixture in (88) (15 mL) was heated at reflux in a flask equipped with a Dean-Stark condenser at reflux for 2 hours and then placed under nitrogen at room temperature (removed nearly 20 mL of azeotropic mixture). Crotonyl bromide (mainly trans, 0.37 ml), tetrabutylammonium fluoride (3.6 ml of 1M solution in tetrahydrofuran), and 4A molecular sieve (activated powder), this mixture was heated at 600  C for 24 The molecular sieve was filtered off. The solvent was removed, and the residue was analyzed by flash chromatography on silica gel and washed away with hexane: acetone (95: 5) to obtain the title compound (1 g) as white. Foam.  CDC13): 9.73 (s, 1H, CHO), 7.44-7.23 (m, 10H, 2Ph), 6.98 (s, 1H, C || JPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 5.75-5.52 (m, 2H, C = C); 4.64 (dd, 1H, H-, J = 2.1 and 9.6 Hz), 4.16 (m, 1H, H-3 ), 4  98 (m, 3H, 8a-CH2, (1H) and CH2CH = CH (2H)), 3.74 (m, 1H, H-5 '), 3.67 (d, 1H, 8a-CH2 (1H), J = 9.3 Hz), 3.05 (dd, 1H, H-4 ', J = 3.0A9.6 Hz), 2.75 (t, 1H, Hl, J = 3.6 Hz), 2.40 (d, 1H, OH, J = 2.1 Hz ), 1.72 (m, 3H,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Cl^CIKH) - 3 2 [1R-(1 3a/5404a/577aa8a/? )]8a-[(2,6-- 4-0---D -]_4__ 4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7__3_(1__14_ - s-M- 3a(lH) - 10(212 (150Dean-Stark 22 -91 - BCNSA4210297) () -.</span>Cl ^ CIKH). -Intermediate 3 2 [1R- (1 , 3a / 5, 40, 4a / 5, 7 Lu, 7aa, 8a /?)] 8a-[(2,6-dideoxy-4-4-propargyl -Lu-D-piperanosyloxy) methyl] _4_methyl _4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl_ 3_ (1_Methylethyl) _1,4_methylene-sM ~ Da province- 3a (lH) -chiric acid, diphenylmethyl acetate intermediate 10 (2g) and dibutyltin oxide (12g) ) The suspension in anhydrous toluene (150 ml) is heated at reflux in a flask equipped with a Dean-Stark condenser at reflux for 2 hours, and then placed under nitrogen at room temperature (remove nearly 20 ml -91-this paper size Happy to use the Chinese B Family Standard (CNS&gt; A4 specification (210  297mm) (know the precautions on the back before filling out this page) -.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 B7  89 ) '_5580% '4.81M '46(TC24  96 : 4) (1.25 ^ (lHj CDC13) 9.73 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2Ph)6.98(S1HciLPh2),6.05(ddlHH-2J=1.2&amp;amp;3.3 Hz)4.65 (dd1HH-l'J2.1 9.6 Hz)4.29 (m1HH-3 4.24^4.22 (2d, 2H, Ci^C.CH, J=2.4 Hz), 4.05^3.68 (2d, 2H, 8a-CH2, J=9.3 Hz), 3.75 (m, 1H, H-5')s 3.25 (dd, 1H, H- 4', 1=3.0^9.3 Hz), 2.75 (t, 1H, H-l, J=3.9 Hz), 2.46 (t, 1H, C^CH^ J=2.4 Hz)  3 3 [1R-(1 a3a44a77aa8a]8a-[(4-0-(3 - -2--26---D-]_4_ -4,4a56,7,7a8,8a--7 --3-(1- -1,4 -- s-n_3a(iH) - 10(1600150 Dean-stark 225 2 --4--2-2761M 2.450C24 1 : -92- CNS ) A4210X297 () 4.</span>1T printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 Printed by the Employee Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (89) Azeotrope 'Kun. Thing). Successively added propargyl bromide (_55 ml of 80% by weight in Yu, benzene, 'valley), tetrabutylammonium fluoride (4.8 ml of 1M in tetrahydrochlorinated' valley) and 4 people Molecular sieve (activated powder), the mixture was heated at 6  C for 24 hours to remove the molecular sieve. Remove the solvent, and the residue was analyzed on the hard rubber dioxide for a flash layer for two times, washed with your own hospital: Bingsi (96: 4) The title compound (1.25 g) was prepared as a white foam. ^ (LHj CDC13): 9.73 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2Ph), 6.98 (S, 1H, ciLPh2), 6.05 (dd, lH, H-2, J = 1.2 &amp;amp; 3.3 Hz), 4.65 (dd, 1H, H-l ', J-2 2.1 and 9.6 Hz), 4.29 (m, 1H, H-3,), 4.24 ^ 4.22 (2d, 2H, Ci ^ C.CH, J = 2.4 Hz), 4.05 ^ 3.68 (2d, 2H, 8a-CH2, J = 9.3 Hz), 3.75 (m, 1H, H-5 ') s 3.25 (dd, 1H, H- 4 ', 1 = 3.0 ^ 9.3 Hz), 2.75 (t, 1H, Hl, J = 3.9 Hz), 2.46 (t, 1H, C ^ CH ^ J = 2.4 Hz)  Body 3 3 [1R- (1 a, 3a , 4 Lu, 4a , 7 , 7aa, 8a )] 8a-[(4-0- (3-methyl-2-butenyl) -2 , 6-dideoxy--D-piperanosyloxy) methyl] _4_methylbrenyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl -3- (1-methylethyl) -1,4-methylidene-sn-inducing_3a (iH) -carboxylic acid, diphenylmethyl ester, intermediate 10 (1 g) and trioxide A suspension of butyl tin (600 mg) in 150 ml of anhydrous toluene was heated at reflux for 2 hours in a flask equipped with a Dean-stark condenser (25 ml of azeotropic mixture was removed), and then cooled to room temperature. Add 2-methyl -4-bromo-2-butane (276 l) and tetrabutylammonium fluoride (1M solution in tetrahydrofuran, 2.4 ml), the mixture was heated at 50  C for 24 hours. The solvent was removed and the crude product was used Flash layer analysis (ethyl acetate  hexane 1: -92- This paper standard uses the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back and fill in this page) 4.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 B7 90) 21 : 151 : 10)770 69%) ^ OH, CDC13) 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.98 (s1HCHPh2), 6.05 (dd1H, H2, J=1.53.3 Hz) 5.33(m, 1H, OCH2CH=), 4.64 (dd, 1H, HI', J=2.1^L9.6 Hz), 4.20 (m, 1H, H3'), 4.25-3.95 (m, 3H, OCH^C=+8aCH2), 3.75-3.65 (m, 2H, H5'+8aCH2)3.03 (dd, 1HH41J=3.3 9.6 Hz), 2.75 (t, 1H, HI, J=3.9 Hz), 2.44 (d, 1H, OH, J=2.1 Hz) 34 [1 R-( 1 or ,3a/? ,4^ ,4a^ ,7^ ,7a ,8a/5 )] 8a - [(4-0-((E)-2--2,6 -- 3- 0- (_b_D- ]-4 --4,4a5,6,7,7a8,8a--7--3-(l--l,4--S-_3a(lH)-  31(120 0 _ 15 6 1 (0.580.8tlc 4001 (50012 5%2002  6 : 4) -93- CNS ) A4210X297) &amp;quot; ' ' -------X---------1^ ()  A7 B7 91 ) 1.04 ^ (lH, CDCI3) 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.98 (s1HCl|Ph2)6.23 (dd, 1HH-31J=3.06.3 Hz)6.05 (dd1H, H-2, J=l_53.3 Hz)5.75-5.40 (m2H, CH=CH), 4.55 (dd, 1H, -, J-l.8^9.3 Hz), 4.05-3.80 (m, 4H8a-CH2(lH), (^(=((2)&amp;amp;H-5')3.75(dlH8a-CH2(1H)J=9.3 Hz)3.20 (dd1H, H-4'J=3.09.3 Hz) 2.72 (t, 1H, H-l, J=3.9 Hz), 2.58 (s, 3H, CH3S), 1.68 (m, 3H, C|^CH=CH) 3 5 [1R-(1 a ,3a4/54ayS708ay5 )]8a-[(2,6--3-0-(-4-0--b-D-) ]-4 --4,4a56,7,7a,8,8a--7 --3-(1--l4 --s-- 3a(lH)-  32(1.2525 0.2 1 0.60.75tic 41 500 (200 5%22)   ________ 94.  CNS ) A4^ (21Gx297) ()</span>, 1T Ministry of Economic Affairs Central Standards Bureau employee consumer cooperative printed and printed A7 B7 V. Description of the invention (90) 2, 1: 15 and 1: 10), 770 mg of the title compound was obtained as a foam (output rate 69%). ^ OH, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H2, J = 1.5 and 3.3 Hz) , 5.33 (m, 1H, OCH2CH =), 4.64 (dd, 1H, HI ', J = 2.1 ^ L9.6 Hz), 4.20 (m, 1H, H3'), 4.25-3.95 (m, 3H, OCH ^ C = + 8aCH2), 3.75-3.65 (m, 2H, H5 '+ 8aCH2), 3.03 (dd, 1H, H41, J = 3.3 and 9.6 Hz), 2.75 (t, 1H, HI, J = 3.9 Hz), 2.44 (d, 1H, OH, J = 2.1 Hz). Intermediate 34 [1 R- (1 or, 3a /?, 4 ^, 4a ^, 7 ^, 7a , 8a / 5)] 8a-[(4-0-((E) -2-butenyl ) -2,6 -dideoxy- 3- 0- (methylthio) thiocarbonyl_b_D-piperanyloxy) methyl] -4 -methylacetyl-4,4a, 5,6 , 7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-S-indjian_3a (lH) -tetioic acid, Diphenyl methyl ester in a cold solution of intermediate 31 (1 g) in tetrahydrofuran (20 ml) was added sodium hydride (0 _ 15 6 g) and a catalytic amount of imi in small batches under nitrogen. The ice bath was then removed, and the reaction mixture was stirred at room temperature for 1 hour. Carbon disulfide (0.58 ml) and methyl iodide (0.8 ml) were added successively. After the reaction was complete (tlc control), the crude mixture was poured into ethyl acetate (400 ml) and the reaction was stopped with 1 equivalent of ammonium gasification (500 ml). The organic layer was washed successively with 1 equivalent of hydrochloric acid (200 mL), 5% aqueous sodium bicarbonate solution (200 mL) and brine (200 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The resulting residue was analyzed by flash layer on silica gel, using methane: hexane (6: 4) -93- This paper scale is applicable to China National Standard (CNS) A4 (210X297 mm) &amp;quot; ' '------- X -----  ---- 1 ^ (please read the notes on the back before filling in this page) Employee Consumer Cooperative of the Central Bureau of Standards, Ministry of Economic Affairs A7 B7 Five Description of the invention (91) Wash off to obtain the title compound (1.04g) as a white foam. ^ (lH, CDCI3): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.98 (s, 1H, Cl | Ph2), 6.23 (dd, 1H, H-31, J = 3.0 and 6.3 Hz), 6.05 (dd, 1H, H-2, J = l_5 and 3.3 Hz), 5.75-5.40 (m, 2H, CH = CH), 4.55 (dd, 1H, -, Jl.8 ^ 9.3 Hz), 4.05-3.80 (m, 4H, 8a-CH2 (lH), (: ^ (:  = (:  (2) &amp;amp; H-5 '), 3.75 (d, lH, 8a-CH2 (1H), J = 9.3 Hz), 3.20 (dd, 1H, H-4 ', J = 3.0 and 9.3 Hz), 2.72 (t, 1H, Hl, J = 3.9 Hz), 2.58 (s, 3H, CH3S ), 1.68 (m, 3H, C | ^ CH = CH). Intermediate 3 5 [1R- (1 a, 3a, 4/5, 4ayS, 70, 8ay5)] 8a-[(2,6-di Deoxy-3-0- (methylthio) thiocarbonyl-4-0-propynyl-bD-epiperanosyloxy) methyl] -4-methylacetyl-4,4a, 5, 6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-s-pyridine- 3a (lH) -carboxylic acid , Diphenylmethyl unitary is intended for a cold solution of intermediate 32 (1.25g) in anhydrous tetrahydrofuran (25ml) under nitrogen under small batches of sodium hydride (0.2g) and a catalytic amount of imidazole. Then remove the ice The reaction mixture was stirred at room temperature for 1 hour. Carbon disulfide (0.6 ml) was added successively Methyl iodide (0.75 mL). After the reaction is complete (tic control), pour the crude mixture into ethyl acetate (400 mL) and stop the reaction with 1 equivalent of vaporization (500 mL). The organic layer is used successively ! Equivalent hydrochloric acid (200 mL) '5% aqueous sodium bicarbonate solution (200 mL) and brine (200 mL). The organic layer was dried over anhydrous sodium sulfate, filtered and concentrated in vacuo. The resulting residue was collected in two For the analysis of the flash layer on the silica gel, use hexane: ethyl acetate ________ 94. This paper is from the applicable China Solid Standard (CNS) A4 ^ (21Gx297). (Please read the precautions on the back before filling this page )</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T A 7 B7 92) 97 : 395 : 51.2  U, CDC13) 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.28 (q, 1H, H-3', J=3.3 Hz), 6.06 (dd1HH-2, J=1.53.6 Hz)4.57 (dd, 1HH-l'J=1.8 &amp;amp;9.3Hz)4.19&amp;amp;4.17(2d2HC|i2C^CHJ=2.4Hz)4.03&amp;amp; 3.70 (2d2H8a-CH2J=9.3 Hz)3.86 (dq 1H, H-5J=6.3 9.3 Hz)3.50 (dd1H, H-4J=3.09.3 Hz)2.73 (t1HH-l J=3.9 Hz)2.58 (s3HCH3S)2.42 (t1HCeCII) _3 6 [1R-(1 a3a04/?4a77aa8a]8a-[(4-0-(3 - -2 --26- 3- 0- (- b- D- ]-4 --4,4a5,6,7,7a8,8a- -7--3-(1--14--8-&amp;gt;^-3&amp;amp;(111)- 33(77015 0C10530 1300) 3111 (502   1 : 251 : 20) 78090 % ) ^ (lH, CDCI3): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), -95- CNS ) A4210X297 ()</span>, 1T A 7 B7 5. Description of the invention (92) 97: 3 and 95: 5 were washed away to obtain the title compound (1.2 g) as white foam. U, CDC13): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.28 (q, 1H, H-3 ', J = 3.3 Hz ), 6.06 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.57 (dd, 1H, H-l ', J = 1.8 &amp;amp; 9.3Hz), 4.19 &amp;amp; 4.17 (2d, 2H, C | i2C ^ CH, J = 2.4Hz), 4.03 &amp;amp; 3.70 (2d, 2H, 8a-CH2, J = 9.3 Hz), 3.86 (dq 1H, H-5 ', J = 6.3 and 9.3 Hz), 3.50 ( dd, 1H, H-4, J = 3.0 and 9.3 Hz), 2.73 (t, 1H, Hl, J = 3.9 Hz), 2.58 (s, 3H, CH3S), 2.42 (t, 1H, CeCII). _Intermediate 3 6 [1R- (1 a, 3a0, 4 / ?, 4a, 7 lu, 7aa, 8a lu)] 8a-[(4-0- (3-methyl-2-butenyl) -2,6  dideoxy-3-0- (methylthio) thiocarbonyl-b-D-piperanosyloxy) methyl] -4-carboxamide-4,4a, 5, 6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-8-&gt; ^    -3 &amp; (111 ) -Carboxylic acid, diphenylmethyl ester in a solution of Intermediate 33 (770 mg) in anhydrous tetrahydrofuran (15 ml) under nitrogen at 0  C with sodium hydride (105 mg) and imidazole (30 Mg). The mixture was stirred at room temperature for 1 hour, and then carbon disulfide (300 l) and methyl bromide (311 l) were added successively. After taking off for 1 hour, the reaction was stopped by adding equivalence of vaporization (50 mL), extracted twice with ethyl acetate (2  100 mL), dried over magnesium sulfate and concentrated to obtain an oil body, This oil body was subjected to flash layer analysis (silica dioxide, ethyl acetate: hexane 1: 25 and 1: 20) to obtain 780 mg of the title compound (90%;) as a white foam. ^ (lH, CDCI3): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), -95- This paper size is suitable for China In-House Rubbing Standard (CNS) A4 (210X297mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-MV    A7 _B7 __ 93) 6.98 (s, 1H, CHPh2), 6.26 (m, 1H, H3'), 6.06 (dd, 1H, H2, J=1.23.3 Hz)5.26 (m1H, OCH2Cm, 4.54 (dd, 1HHl J=l.89.6 Hz)4.10-3.75 (m4HSaCt^+OC^O+HS1), 3.69(dlH,8aCH2J=9.6Hz)3.18(ddlHH4',J=3&amp;amp;9.3 Hz), 272 (t1H, HI, J=3.9 Hz), 2.58 (s3HSCH3) 3 73 8 a) [lR-(la3a44a57/?7aa8ay5 )]8a-[[lS4R 711911]-2,8--4--9---[3.4.0]- -7---]]-4 --4,4a5,6,7,7a8,8a--7--3-(l--l4--S-&amp;gt;^5-3a(lH)- b) [lR-(l ,3ay9 ,4/3 ,4a^ ,  ,laa ,8ay9 )]8a-[[lS,4S 7911]-2,8--4--9---[3.4.0]- -7---]]-4 --4,4a,56,7,7a,8,8 a --7 --3-(1--i,4_-s__3a(iH )- 34(1.0450 155 2  94 : 6)3 7(220 Rf= 0.274 : 1 38(444Rf= 0.27i :4 : 1  ____-96-___ CNS ) 4 ( 210X297 () 1  A7 B7 _ 94) 3 7  (^, CDC13) 9.75 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph)6.99(slH,CliPh2)6.06(dd,lHH-2J=1.5&amp;amp;3.6</span>-MV Ding, Ministry of Economic Affairs, Central Bureau of Accreditation, Employee Consumer Cooperative Printed by the Ministry of Economic Affairs, Central Standards Bureau, Beigong Consumer Cooperative Printed A7 _B7 __ V. Description of Invention (93) 6.98 (s, 1H, CHPh2), 6.26 (m, 1H, H3 '), 6.06 (dd, 1H, H2, J = 1.2 and 3.3 Hz), 5.26 (m, 1H, OCH2Cm, 4.54 (dd, 1H, Hl, J = 1.8 and 9.6 Hz), 4.10-3.75 (m, 4H, SaCt ^ + OC ^ O + HS1), 3.69 (d, lH, 8aCH2, J = 9.6Hz), 3.18 (dd, lH, H4 ', J = 3 &amp;amp; 9.3 Hz), 2.72 ( t, 1H, HI, J = 3.9 Hz), 2.58 (s, 3H, SCH3). Intermediate 3 7 and 3 8 a) [lR- (la, 3a Lu, 4 points, 4a; 5, 7 / ?, 7aa, 8ay5)] 8a-[[lS, 4R, 711, 911] -2,8-dioxo-4-ethyl-9-methyl-cis-bicyclo [3.4.0] -non-7-yl -Oxy-methyl]]-4-methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl)- l, 4-methylene-S-&gt; ^ 5  pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester b) [lR- (l , 3ay9, 4/3, 4a ^,  , laa, 8ay9)] 8a-[[lS, 4S, 7 feet, 911] -2,8-dioxo-4-ethyl-9-methyl-cis-bicyclo [3.4.0] -non -7-yl-oxy-methyl]]-4 -formyl-4,4a, 5,6,7,7a, 8,8 a -octazo-7 -methyl-3- (1-methyl Ethyl) -i, 4_ Yl -s_ wail pyridazin Province _3a (iH) - betray acid, diphenyl ethyl ester of Intermediate 34 (1.04 g) in anhydrous toluene solution (50 mg) in a stream of argon within the gas back down for 1 hour. Add tributyltin hydride (0.55 ml) and a catalytic amount of azobis (isobutyronitrile). The reaction mixture was further refluxed for 20 minutes, then cooled, concentrated, and analyzed as a flash layer on silica gel twice, and washed away with hexane and hexane: ethyl acetate (94: 6). Intermediate 37 (220 mg; Rf = 0.27 in hexane: ethyl acetate 4: 1) was obtained as a white foam 'and intermediate 38 (444 mg; Rf = 0.27 in ethyl acetate: ethyl acetate 4: 1)) is white foam. ____- 96 -___ This paper scale is applicable to China Hoarding Standard (CNS) 4 (210X297mm) (please read the precautions on the back before filling in this page), 1T 7T7 printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (94) Intermediate 3 7  (^, CDC13): 9.75 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.99 (s, lH, CliPh2), 6.06 (dd , lH, H-2, J = 1.5 &amp;amp; 3.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz),4.50(ddlHH-7J=2.7&amp;amp;6.9Hz)4.06&amp;amp;3.38(2dd 2HCH2-3J=8.47_5 Hz), 4.01 3.65 (2d2H8a-CH2 J=9.0 Hz), 3.71 (dd1H-, J=7.59.0 Hz), 3.34 (m1H H-91)2.75 (t1HH-l)093 (t3HC^3CH2, J=7.5 Hz) 3 8 (i (lU, CDC13): 9.74 (s, 1H, CHO), 7.45-7.26 (m, 10H, Ph2),6.99(slHCiiPh2)6.04(ddlHH-2J=1.2&amp;amp;3.6 Hz), 4.73 (t, 1H, H-7', J-3.0 Hz), 3.92 (m, 2H, 8a-CH2(lH) CHj-SXlH))3.75 (m2HH-9'&amp;amp;H-r),3.62(d,lH8a-CH2, J=9.3 Hz), 3.48 (m, 1H, CH2-3'(1H)), 2.71 (t, 1H, H-l, J=3.6Hz)2.55&amp;amp;2.23(2m3HH-4',H-5&amp;amp;3-CH)0.96(m 3HCl3CH2) 3940 [lR-(la3ab4b4ab7b,7aa8ab)]8a-[[ 1 S4R ,7R,9R]-2,8--4-(1--9---[3.4.0]--7--]-4--4,4a,5,6,77a8,8 a --7--3-(1--14-S-- 3a(lH)-[lR-(la,3ab4b,4ab7b,7aa8ab)]8a -[[1S4S ,711911]-2,8--4-(1--9-- -[3.4.0]--7--]-4--4,4&amp;amp;5,6,7,78,8&amp;amp;--7--3-(1--14- _ -97- CNS ) A4210X297  i - I - - - ^ XI I I I - - - II----^ ()  A7 B7 95 ) - S- - 3a(lH) - 3 6 (78050 1367 aa  -2  25: 120: 118: 115: 1)28039(41%)300 40(44%)ijRf : 0,50.3 /3 : 1 3 9  (^, CDC13) 9.75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1HCHPh2), 6.05 (dd, 1HH2, J=1.23.6 Hz), 4.57 (dd1H, H7'J=2.75.7 Hz)4.05-3.90 (m2H H3+8aCH2)3.73 (dd1H, J=8.1 9.3 Hz)3.62 (d1H 8aCH2, J=9 Hz), 3.50-3.45 (m, 2H, H3'+H9'), 2.74 (t, 1H, H1J=3.9Hz) 4 0 ^ R, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s1HCHPh2)6.03 (dd, 1HH2, J=1.53.3 Hz) 4.74 (t, 1H, H7', J=3 Hz), 4.0-3.8 (m, 8aCH2+H9'+H3,), 3.73 (ddlHHrJ=3.3&amp;amp;4.5Hz)3.63(d,lH8aCH2J=9.6Hz), 3.52 (dd1HH3'J=8.1  10.5 Hz)2.70 (t1HHlJ=3.9 Hz) 4 1 -98 - CNS ) A421297 ()</span>Hz), 4.50 (dd, lH, H-7 ', J = 2.7 &amp;amp; 6.9Hz), 4.06 &amp;amp; 3.38 (2dd, 2H, CH2-3', J = 8.4 and 7_5 Hz), 4.01 and 3.65 (2d , 2H, 8a-CH2, J = 9.0 Hz), 3.71 (dd, 1H, -, J = 7.5 and 9.0 Hz), 3.34 (m, 1H, H-91), 2.75 (t, 1H, Hl) , 0  93 (t, 3H, C ^ 3CH2, J = 7.5 Hz). Intermediate 3 8 (i (lU, CDC13): 9.74 (s, 1H, CHO), 7.45-7.26 (m, 10H, Ph2), 6.99 (s, lH, CiiPh2), 6.04 (dd, lH, H-2 , J = 1.2 &amp;amp; 3.6 Hz), 4.73 (t, 1H, H-7 ', J-3.0 Hz), 3.92 (m, 2H, 8a-CH2 (lH) and CHj-SXlH)), 3.75 (m, 2H, H-9 '&amp;amp; Hr), 3.62 (d, lH, 8a-CH2, J = 9.3 Hz), 3.48 (m, 1H, CH2-3' (1H)), 2.71 (t, 1H, Hl, J = 3.6Hz), 2.55 &amp;amp; 2.23 (2m, 3H, H-4 ', H-5, &amp;amp; 3-CH), 0.96 (m, 3H, Cl3CH2). Intermediates 39 and 40 [lR- (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[[1 S, 4R, 7R, 9R] -2,8-diox-4- (1- Methyl ethyl) -9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl)]-4-carboxamide-4,4a, 5,6,7, 7a, 8,8 a -octahydro-7-methyl-3- (1-methylethyl) -1,4  methylidene-S-indazole province-3a (lH) -tetioic acid'diphenyl Methyl vinegar and [lR- (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[[1S, 4S, 711, 911] -2,8-diox-4- (1-methyl Ethyl) -9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl)]-4-methyl-4,4 &amp;amp;, 5,6,7, 7 lines, 8,8 &amp;amp; -octazo-7-methyl-3- (1-methylethyl) -1,4- _ -97- This paper scale is applicable to China National Standards (CNS) A4 specification (210X297 Mm)  i-I---^ XI III---II ---- ^ (please read the precautions on the back before filling this page) A7 B7 printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs Description (95) Methylene-S-M | Da Province-3a (lH) -carboxylic acid, diphenylmethyl ester. A solution of intermediate 3 6 (780 mg) in anhydrous toluene (50 ml) was treated with argon Degassed for 1 hour, then heated to reflux. Tributyltin hydride (367 microliters) and a catalytic amount of a, a -azoisobutyl are added, and the reaction mixture is refluxed for 2 hours, and then cooled to room temperature. The solvent was removed and the residue was analyzed by flash chromatography (silica dioxide, hexane: ethyl acetate 25: 1, 20: 1, 18: 1, and 15: 1) to obtain 280 mg of intermediate 39 (yield rate) 41%) and 300 mg of intermediate 40 (yield rate 44%), which is an oil body (divided ij is Rf: 0,5 and 0.3, in hexane: volume of ethyl acetate volume / volume 3: 1). Intermediate 3 9  (^, CDC13): 9.75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 4.57 (dd, 1H, H7 ', J = 2.7 and 5.7 Hz), 4.05-3.90 (m, 2H, H3, + 8aCH2), 3.73 (dd, 1H, H, J = 8.1 and 9.3 Hz), 3.62 (d, 1H, 8aCH2, J = 9 Hz), 3.50-3.45 (m, 2H, H3 '+ H9'), 2.74 (t, 1H, H1, J = 3.9Hz). Intermediate 4 0 ^ R, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.03 (dd, 1H, H2, J = 1.5 and 3.3 Hz), 4.74 (t, 1H, H7 ', J = 3 Hz), 4.0-3.8 (m, 8aCH2 + H9' + H3,), 3.73 (dd, lH, Hr, J = 3.3 &amp;amp; 4.5 Hz), 3.63 (d, lH, 8aCH2, J = 9.6Hz), 3.52 (dd, 1H, H3 ', J = 8.1 and 10.5 Hz), 2.70 (t, 1H, Hl, J = 3.9 Hz). Intermediate 4 1 -98-This paper scale is suitable for China Pujia Rubbing Standard (CNS) A4 (21297mm) (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  3^1644 A7 ____B7 96) [1R-(1 a3a4/S4a77aa8ay5 )]8a-[[lS7R,9R]-2,8 --4--9--[340]-7__ -]]-4 --4,4a5,6,7, 7a,8,8a --7- -3-(1--i4--S__3a(lH)_  3 5 ( 1.0250 155   94 : 6) (380  CDC13): 9.75 (s, 1H, CHO), 7.44-7.28(m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J=1.5A3.6 Hz), 5.075.5.02 (2dd, 2H, Ci^^C, J=2.4^L4.8 Hz), 4.49-4.31 (m, 3HH-71CH2-3')3.95&amp;amp;3.66(2d2H8a-CH2J=9.3Hz) 3.80 (dd1H-J=7.59.3 Hz), 3.26 (m, 1H, H-9')3.02 (m, 1H, H-5'), 2.76 (t, 1H, H-l, J=3.9 Hz)  i (13C, CDC13): 204.4 (QHO)171.0 (gpDPM)148.8 148.3 (C-3C-41) 139.5 139.4 (2 CIV Ph), 130.7 (C-2), 128.6, 128.5, 128.2 128.0127.7&amp;amp;127.0(2x5H(Ph))103.9(gH2=C)98.3 (C-7')80.469_5 (C-lC_9'), 78.5 (CHPh2), 73.9 70.6(C8a-fC-31) 42</span> 1T Printed and printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 3 ^ 1644 A7 ____B7 V. Description of invention (96) [1R- (1 a, 3a ten thousand, 4 / S, 4a cold, 7 cold, 7aa, 8ay5)] 8a -[[lS, 7R, 9R] -2,8-dioxo-4-methylene-9-methyl  cis-bicyclo [340]  non-7_yl_oxy-methyl]]- 4 -Methyl-4,4a, 5,6,7, 7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -i, 4-methylidene-S _    _3a (lH) _carboxylic acid, diphenylmethyl ester A solution of intermediate 3 5 (1.02 g) in anhydrous toluene (50 mg) was degassed with argon for 1 hour at reflux. Add tributyltin hydride (0.55 ml) and a catalytic amount of azobis (isobutyronitrile). The reaction mixture was refluxed for another 1 hour, then cooled and concentrated, and then subjected to a flash layer analysis on silica gel twice, using hexane and hexane: ethyl acetate (94: 6) as the eluent. The pure title compound (380 mg) was prepared, and the white foam was isolated.  CDC13): 9.75 (s, 1H, CHO), 7.44-7.28 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5A3.6 Hz ), 5.075.5.02 (2dd, 2H, Ci ^^ C, J = 2.4 ^ L4.8 Hz), 4.49-4.31 (m, 3H, H-71CH2-3 '), 3.95 &amp;amp; 3.66 (2d, 2H, 8a-CH2, J = 9.3Hz), 3.80 (dd, 1H, -, J = 7.5 and 9.3 Hz), 3.26 (m, 1H, H-9 '), 3.02 (m, 1H, H-5' ), 2.76 (t, 1H, Hl, J = 3.9 Hz); i (13C, CDC13): 204.4 (QHO), 171.0 (gpDPM), 148.8 and 148.3 (C-3 and C-41), 139.5 and 139.4 (2 CIV Ph), 130.7 (C-2), 128.6, 128.5, 128.2, 128.0, 127.7 &amp;amp; 127.0 (2x5  H (Ph)), 103.9 (gH2 = C), 98.3 (C-7 '), 80.4 and 69_5 (Cl, and C_9 '), 78.5 (CHPh2), 73.9 and 70.6 (C8a-f and C-31). Intermediate 42</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1 a ,3a44a/?7y?7aor8ayS ()</span>[1R- (1 a, 3a Lu, 4 o'clock, 4a / ?, 7y ?, 7aor, 8ayS (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 97) 2,8--9 --4--3 ---[3.4.0] - -7---]]-4--4,43,5,6,77&amp;amp;8,8&amp;amp;- -7 -- 3- (1--1,4--S-- 3a(lH)- VI)(0_2337 33 4 1 ( . 156  65  ^ (, CDC13) 9.74 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph)6.98(slH,C^y&amp;gt;h2),6.37&amp;amp;5.64(2d,2HC||2=C) 6.04 (dd1HH-2, J=1.23.3 Hz)4.47 (dd1HH-7', J=3.6 6.0 Hz)4.29 (m,lHH-l4.003.64 (2d, 2H, 8a-CH2, J=9.3 Hz), 3.40 (m, 1H, H-5'), 3.30 (m, 1H, H-9'), 2.73 (t, 1H, H-l, J=3.9 Hz) 43</span>A7 B7 printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs 5. Description of the invention (97) 2,8-dioxo-9-methyl-4-methylene-3-oxy-cis-bicyclo [3.4.0 ] -Non-7-yl-oxy-methyl]]-4-carboxamide-4,43,5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-Methylethyl) -1,4-methylene-S-indjian-3a (lH) -carboxylic acid, diphenylmethyl ester in chromium oxide (VI) (0_23g) and anhydrous pyridine (.37 ml) in a stirred solution in anhydrous digas methane (3 ml) at 0. Intermediate 4 1 (0.15 g) in anhydrous digas methane (3 mL) was added. Continue to stir at room temperature for 6 hours, and then directly analyze the reaction mixture on silica gel for flash layer analysis, and use difluoromethane as the eluent to prepare the title compound (65 mg) as a white foam. , CDC13): 9.74 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.98 (s, lH, C ^ y &amp;gt; h2), 6.37 &amp;amp; 5.64 (2d, 2H, C || 2 = C), 6.04 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.47 (dd, 1H, H-7 ', J = 3.6 and 6.0 Hz), 4.29 (m, lH, Hl,) , 4.00 and 3.64 (2d, 2H, 8a-CH2, J = 9.3 Hz), 3.40 (m, 1H, H-5 '), 3.30 (m, 1H, H-9'), 2.73 (t, 1H, Hl , J = 3.9 Hz). Intermediate 43</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1 a3a44a7y9 ,7aa8a]8a-[[lS,7R9R]-28--9--4---[3.4.0] --7-- -]]-4 --4,4a5,6,7, 7a,8,8a --7 --3-(1--1,4 --S-- 3a(lH) -  A 41(105N -N_43) -100- CNS ) A4210X297 (} 11  A7 B7 98) ~ 8 : 1  9 (2/5 %2--2-0.075 2 4 1 (100(3013 3030 2 : 16 0 C03 t 66 60 85 : 15)0.045</span>[1R- (1 a, 3a Lu, 4 Lu, 4a Lu, 7y9, 7aa, 8a Lu)] 8a-[[lS, 7R, 9R] -2, 8-diox-9-methyl-4-oxo -Cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl]]-4 -carboxyl-4,4a, 5,6,7, 7a, 8,8a -octahydro -7-Methyl-3- (1-methylethyl) -1,4-methylene-S-M ~ Da province-3a (lH) -carboxylic acid, diphenylmethyl ester Method A in the middle Body 41 (105 mg) and N-oxidized N_methylmorpholine (43 mg) -100- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297 mm) (please read the notes on the back first Refill this page}, 11 Printed A7 B7 by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs V. Description of the invention (98) ~ Yu Bingwang: add tetroxide to the ice-cold mixture in water (8: 1  9 ml) (2/5% by weight solution in 2-methyl-2-propanol, 0.075 ml). The ice bath was removed, and the mixture was stirred at room temperature for 24 hours. The reaction was stopped with sodium bisulfate and stirred again. After 1 hour, the solvent was evaporated. The crude residue was diluted with ethyl acetate (100 mL) 'successively with water (30 mL), 1 equivalent of hydrochloric acid (30 mL), saturated bicarbonate Wash with aqueous solution (30 ml) and water (30 ml), then dry and evaporate. Dissolve the crude product in dioxane: water (2: 1, 6 ml), then cool to 0  C. Raise in small batches Sodium iodate (0.3g), the mixture was stirred at 0 to room temperature for 6 hours, and then concentrated, the crude product was separated between (60ml) and ethyl acetate (60ml). The organic phase was dried and The residue obtained by concentration was analyzed and purified by flash chromatography on silica gel (hexane: ethyl acetate 85:15) to obtain the title compound (0.045 g).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">B 0.432_5 -60C 22 107 7(47 2.5_6c2 1014-2 C20i 10 11001 100   __ -101 - CNS ) A4210x297~~&amp;quot; ---~ ()  ,I m  A7 _________B7 99) ~~' ~ 11  25  1 : 201 : 15)400 (8 6 % ) ^ (lHCDC13&amp;gt;: 9.71 (s, 1H, CHO), 7.44-7.26 (m, 10H, h), 6.97 (s, 1H, CHPh2), 6.06 (dd, 1H, H-2, J=1.5^L3.6 z) 4_18-4.11 (m3HH_7,H1H 3ih)3 62 (2d !H, 8a-CH2, J=9.3 Hz), 3.91 (d, 1H, H-3', J=18 Hz), 3.30 (m, 1H, H-9'), 2.85 (bt, 1H, H-5', J=7.8 Hz), 2.75 (t, 1H, H-l, J==3.9 Hz) _  44 [1R-(1 a ,3a^ ,4^ ,4a^ ,7/9,7aa,8a/5)]8a-{[4-0-(&amp;gt;l^- 2 -6 -_b_D_4- -4,4a5,6,7,7a8,8a-7 - _3(1- --S--3a(1H)_ 1(5233 Dean_Stark 36(4A 2.4 1M2.4^ 1 2 9 : 1) 3.2 (^, CDC13): 9.73 (s, 1H, CHO), 7.45-7.2 (m, 10H, 2Ph), 6.98 (s1HCPh2)6.05 (dd1H, H-2, J=1.53.6 Hz) 5.8-5.65 (m, 1H, CH=CH), 5.65-5.5 (m, 1H, CH=CH), 4.63 -102- CNS ) A421 OX 2.97 ()</span>Method B To a solution of trifluoroacetic anhydride (0.43 ml) in anhydrous dioxane (2-5 ml) was added dimethyl sulfoxide (0.2 ml) at -60  C under nitrogen with vigorous stirring. After 10 minutes, a solution of intermediate 7 7 (47 mg) in anhydrous dioxane (2.5 ml) was added, and the mixture was stirred at -600  C for 2 hours. Triethylamine (1.4 ml) was added dropwise over 10 minutes, and the temperature was allowed to rise to -20  C. Then water (20 ml) was added and the mixture was stirred at room temperature for 1 hour. The mixture was separated, and the aqueous layer was extracted with methane (100 ml). The combined organic layer was washed with 1 equivalent of hydrochloric acid (100 ml), saturated aqueous sodium bicarbonate solution (100 ml) and brine (100 ml), dried over magnesium sulfate and concentrated to dryness to obtain an oil body. Re-dissolve in methane and treat with triethylamine overnight. After removing the solvent, the resulting oil body was subjected to a flash layer analysis (silica dioxide, ethyl acetate: ___101)-The paper size is in accordance with the Chinese National Standard (CNS) A4 specification (210x297mm) ~~ &amp;quot;- -~ (Please read the precautions on the back before filling in this page). Ordered, I-m A7 _________B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs 5. Description of the invention (99) ~  ~ '~ Burn 11 25 '1: 20, and 1: 15), that is, 400 mg of the title compound (yield 86%). ^ (lH, CDC13&gt;: 9.71 (s, 1H, CHO), 7.44-7.26 (m, 10H, h), 6.97 (s, 1H, CHPh2), 6.06 (dd, 1H, H-2, J = 1.5 ^ L3.6 z) '4_18-4.11 (m, 3H, H_7, H1, and H 3, (ih), paste and 3 62 (2d,! H, 8a-CH2, J = 9.3 Hz), 3.91 (d , 1H, H-3 ', J = 18 Hz), 3.30 (m, 1H, H-9'), 2.85 (bt, 1H, H-5 ', J = 7.8 Hz), 2.75 (t, 1H, Hl , J == 3.9 Hz). Soil_ Body 44 [1R- (1 a, 3a ^, 4 ^, 4a ^, 7 / 9,7aa, 8a / 5)] 8a-{[4-0-(&amp;gt; l ^ -2 butenyl) -6-deoxy_b_D_azorpiperanosyloxy) methyl 4-methyl-4,4a, 5,6,7,7a, 8,8a -Octahydro  7-methyl_3  (1methylethyl) -M-methylene-S-, Jianshen-3a (1H) _carboxylic acid, diphenylmethyl ester will be intermediate 1 ( 5 g) and a suspension of dibutyltin oxide (23 g) in anhydrous toluene (300 mL) was refluxed under nitrogen for 3 hours in a flask equipped with a Dean_Stark condenser, and then allowed to cool to 60  :. Then, molecular sieve (4A 'powder') crotonyl bromide (2.4 ml) and tetrabutylammonium fluoride in tetrahydrofuran in 1M solution (2.4 ml) were added successively. 12 hours. After the solvent was washed, the residue was analyzed by flash chromatography on silica gel, and washed away with hexane to hexane: acetone (9: 1) to obtain the title compound (3.2 g) as a white foam. (^, CDC13): 9.73 (s, 1H, CHO), 7.45-7.2 (m, 10H, 2Ph), 6.98 (s, 1H, C up to Ph2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz ), 5.8-5.65 (m, 1H, CH = CH), 5.65-5.5 (m, 1H, CH = CH), 4.63 -102- This paper scale is easy to use China National Standard (CNS) A4 specification (21 OX 2.97 Mm) (Please read the notes on the back before filling in this education)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IT  A7 B7 _ 1 (d1-J=.9 Hz), 4.2-3.8 (m5HH-2'H-3', 8aCH2  0-CH2-C=C), 3.8-3.65 (m, 2H, H-5', 8aCHb), 3.6 (dd, 1H, 4'J=39.3 Hz), 2.74 (t1H, H-l, J=3.9 Hz)1.71 (dd 3HCH3-C=CJ=1.26.3 Hz) 454647 a) [lR-(l a3a44a/37S ,7aa8a0 )]8a-{[2,3--4-0-(-2--6--b-D-] }-4--4,4&amp;amp;5,6,7,7&amp;amp;,8,8&amp;amp;--7--3-(1- -1,4--S--3a(lH)-  b) [lR-(l^ ,3a^ , ^ ,  ,&amp;amp; ,8a^ ) ] 8 a-[ (1 S, 4 S , 6S7R9R]-2,8-4--6--9--- [3.4.0] --7---]-4 --4,4a,5,6,7,7a 8,8a --7-- 3- (1--1,4 --s- -3a(lH)- c) [ 1 R - (la3ab4b4ab7b7aa8ab) ]8a-[[lS4R6S7R9R] -2,8--4 --6 --9 ---[3.4.]-_ 7 ---]-4 --4,4a5,6,7,7a8,8a-_ 7-- 3- (1--l4-- S- 4- 3a(lH).  44( 1.2251.3836 35 89 152 (0.21 -103- CNS ) 4210X2.97 ()</span>A7 B7 _ printed by the Staff Consumer Cooperative of the Central Bureau of Standards and Technology of the Ministry of Economy and Economics V. Description of the invention (1 is called (d, 1, -, J = 0.9 Hz), 4.2-3.8 (m, 5H, H-2 ' , H-3 ', 8aCH2 and 0-CH2-C = C), 3.8-3.65 (m, 2H, H-5', 8aCHb), 3.6 (dd, 1H,   4 ', J = 3 and 9.3 Hz ), 2.74 (t, 1H, Hl, J = 3.9 Hz), 1.71 (dd, 3H, CH3-C = C, J = 1.2 and 6.3 Hz). Middle ceremony 45, 46 and 47 a) [lR- (la , 3a Lu, 4 Lu, 4a / 3, 7; S, 7aa, 8a0)] 8a-{[2,3-anhydro-4-0- (trans-2-butanyl) -6-deoxy-bD- Piperanmannosyloxy] methyl} -4-carboxamide-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1- Methylethyl) -1,4-methylene-S-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester b) [lR- (l ^, 3a ^,   ^  ,  ,  &amp;amp; , 8a ^)] 8 a- [(1 S, 4 S, 6S, 7R, 9R] -2,8-dioxo  4-ethyl-6-hydroxy-9-methyl -Cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4 -methyl-4,4a, 5,6,7,7a, 8,8a -octahydro-7 -Methyl-3- (1-methylethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester c) [1 R-( la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[[lS , 4R, 6S, 7R, 9R] -2,8-dioxo-4 -ethyl-6 -keto-9 -methyl-cis-bicyclo [3.4.] -non-7-yl-oxy -Methyl] -4 -Methylene-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4- Methylene-S-4 4 Da Da-3a (lH). Carboxylic acid, diphenylmethyl ester intermediate 44 (1.225g), triphenylphosphine (1.38g) and imidazole (36g) in Toluene (35 ml) was refluxed while stirring, and then treated with a solution of iodine (0.89 g) in toluene (15 ml) dropwise for 2 hours. Add tetrabutyl iodide (0.2 g) and continue to reflux for 1 hour. Cool the mixture to ethyl acetate -103- This paper is suitable for China National Standard (CNS) 4 specifications (210X2.97mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 1(J1) (100150 1 Na2S4)  7 : 1} 1.082 : 1 4 : 1 Rf=0_4)25 1 (0.36202 1    95 : 5)9 : a)4 7 (230Rf=.8 9 : 1)b)45(275  Rf-0.59 : 1)c) 46(200Rf=.49 :  4 5 ^ (^, CDC13): 9.72 (s, 1H, CHO), 7.46-7.23 (m, 10H, 2Ph), 698 (s1H, CHPh2)6.05 (dd1H, H-2, J=1.233</span>A7 B7 is printed by the employee consumer cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs. 5. Description of the invention (1 (J1) (100 ml) and 1 equivalent of hydrochloric acid aqueous solution (50 ml). The organic layer is successively used with 1 equivalent of hydrochloric acid aqueous solution, water, Sodium metabisulfite aqueous solution, washed with water and brine, then dried (Na2S4), concentrated over the air and emptied. The residue was analyzed by flash layer on silica gel. Wash off with hexane: ethyl acetate (7: 1) 'Made 1.08 g of a 2: 1 mixture of a compound, the two compounds are very similar in the ratio of the ratio of Jihu: ethyl acetate (Rf = 0_4 in Yuji: ethyl acetate 4: 1). This mixture Dissolved in anhydrous toluene (25 ml), the solution was degassed with argon flow for 1 hour, and then heated to reflux. Tributyltin hydride (0.36 ml) was added, and reflux was continued for another 20 minutes. After cooling, carbon tetrachloride (2 Ml) 'This solution was stirred at room temperature for 1 hour. Then add the solution of Qiqi in the mystery until it became colored. Then remove the solvent by emptying, dissolve the residue in diethyl ether, and wash it with saturated potassium fluoride solution several times until No more precipitation of tributyltin fluoride The base layer was dried and evaporated, and the residue was used as a flash layer for analysis on the crushed dioxide. The second compound was washed away with methane: ethyl acetate (95: 5) and (9: ) to prepare the title compound. (A) Intermediate 4 7 (230 mg, Rf = 0.8, dimethane: ethyl acetate 9: 1), the title compound (b) Intermediate 45 (275 mg 'Rf-0.5, methane: Ethyl acetate 9: 1) and the title compound (c) Intermediate 46 (200 mg, Rf = 0.4, Difluoromethane: ethyl acetate 9: Intermediate 4 5 ^ (^, CDC13): 9.72 (s , 1H, CHO), 7.46-7.23 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.61 (d, 1H, H-7', J=3.3 Hz), 4.03 (d, 1H, 8a-CHa, 9.3 Hz), 3.90 (dd1H, Ha-3J=6.98.7 Hz)382_3.69 (m _ -104- CNS ) A4210X297 ()   A7 B7 19 3HH-6'H-1'H-9')3.66 (d1H8a-CHbJ=9.6 Hz)3.61 (dd1HHb-3'J=6.68.4 Hz)2.69 (t1HH-l, J=3.9 Hz) o 46  (^, CDC13): 9.74 (s, 1H, CHO), 7.45-7.22 (m, 10H, 2Ph)6.99(slHCiiPh2)6.06(ddlHH-2J=1.5&amp;amp;3.6 Hz), 4.50 (d, 1HH-7'J=2.1 Hz)4.1-4.02 (m2H8aCHa&amp;amp; Ha-31)3.84 (dd1HH-lJ=7.58.7 Hz)3.76-3.66 (m2H 8aCHbH-6')3.5-3.38 (m2HH-9,Hb-32.72 (t1H H-lJ=3.9 Hz), _94 (t3HCH2-C^3, J=7.5 Hz) 4 7  (!, CDC13) 9.75 (s, 1H, CHO), 7.45-7.2 (m, 10H, 2Ph), 6.99(s,lH,CiiPh2)6.08(ddlHH-2,J=1.5&amp;amp;3.6Hz), 5.85-5.7 (m, 1H, CH=CH), 5.65-5.5 (m, 1H, CH=CH), 4.67 (s, 1HH-l4.2-4.05 (m2HOCHa-C=C&amp;amp;8aCHa),4.05_ 3.9 (m, 1H, CHb-C=C), 3.78 (d, 1H, 8aCHb, J=9 Hz), 3.3-315 (m3H, H-3'H-4'H-53.12 (d1H, H-2'J=3.9 Hz) 2.86 (t1HH-lJ=3.9 Hz) 4 8 HR-(1 a3a/544a7/?,7a,8ay5)]8a-[(6--4-0 --D-]-4--4,4a5,6,7,7a8,8a--7--3-(-l4--s_5|_3a(lH)_ 10.0150 ______-105-__ cNS) A4 21297  ()</span>Hz), 4.61 (d, 1H, H-7 ', J = 3.3 Hz), 4.03 (d, 1H, 8a-CHa, Bu 9.3 Hz), 3.90 (dd, 1H, Ha-3', J = 6.9 and 8.7 Hz), 3'82_3.69 (m, _ -104- This paper scale is used in China National Standard (CNS) A4 specification (210X297mm) (Read the precautions on the back before filling out this page) Ding Economics A7 B7 printed by the Beigong Consumer Cooperative of the Central Prototype Bureau of the Ministry V. Description of the invention (19 3H, H-6 ', H-1' and H-9 '), 3.66 (d, 1H, 8a-CHb, J = 9.6 Hz), 3.61 (dd, 1H, Hb-3 ', J = 6.6 and 8.4 Hz), 2.69 (t, 1H, Hl, J = 3.9 Hz) o Intermediate 46  (^, CDC13): 9.74 ( s, 1H, CHO), 7.45-7.22 (m, 10H, 2Ph), 6.99 (s, lH, CiiPh2), 6.06 (dd, lH, H-2, J = 1.5 &amp;amp; 3.6 Hz), 4.50 (d, 1H, H-7 ', J = 2.1 Hz), 4.1-4.02 (m, 2H, 8aCHa &amp;amp; Ha-31), 3.84 (dd, 1H, H-l', J = 7.5 and 8.7 Hz), 3.76-3.66 (m, 2H, 8aCHb and H-6 '), 3.5-3.38 (m, 2H, H-9, and Hb-3,), 2.72 (t, 1H, Hl, J = 3.9 Hz), _94 ( t, 3H, CH2-C ^ 3, J = 7.5 Hz). Intermediate 4 7  (! , CDC13): 9.75 (s, 1H, CHO), 7.45-7.2 (m, 10H, 2Ph), 6.99 ( s, lH, CiiPh2), 6.08 (dd, lH, H -2, J = 1.5 &amp;amp; 3.6Hz), 5.85-5.7 (m, 1H, CH = CH), 5.65-5.5 (m, 1H, CH = CH), 4.67 (s, 1H, H-l '), 4.2-4.05 (m, 2H, OCHa-C = C &amp; 8aCHa), 4.05_ 3.9 (m, 1H, CHb-C = C), 3.78 (d, 1H, 8aCHb, J = 9 Hz), 3.3-315 (m, 3H, H-3 ', H-4' and H-5 '), 3.12 (d, 1H, H-2', J = 3.9 Hz), 2.86 (t, 1H, Hl, J = 3.9 Hz ). Intermediate 4 8 HR- (1 a, 3a / 5, 4, 4a point, 7 / ?, 7a, 8ay5)] 8a-[(6-deoxy-4-0 methyl--D-Azhuo Piperanosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (bmethylethyl) -1 , 4-methylene-s_ 5 | pyridine_3a (lH) _carboxylic acid, diphenyl methyl ester ______- 105 -__ The paper size is applicable to the Chinese National Standard (cNS) A4 (21297297 mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7 321644 103) 35M85 24  4 vl)2 : 1) 11.8 ci CDC13): 10.00 (S, 1H, CHO), 7.63 (m, lH, 2Ph), 7.26 (s1H, C||_Ph2)6_30 (dd, 1H, H-2, J=1.23.3 Hz), 4.92 (d, 1H, H-l', J=.9 Hz), 4.84 (t, 1H, H-3', J=3.3 Hz), 4.035.4.35 (2d, 2H, 8aCH2, J=9 Hz), 3.88 (m, 1H, H-2'), 3.70 (dq, 1H, H-5', 1=6.3^9.3 Hz), 3.41 (s, 3H, 4'-Me), 3.20 (dd1H, H-4'J=3.39 Hz), 2.75 (t, 1HH-l) 4 9 a) [lR-(l a3a0404ay57/?7aa8ay5 )]8a-[(6--4_ O -- 2,3 ----D -u ]-4--4,45,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1_ -1,4--s-&amp;lt;-3a(lH)-  b) [lR-(l a3aS44a7/?7aa8ayS )]8a-[(6--4-  -- 2- 0--D -t]_ 4 --4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1- -14--s--3a(lH)- 48(24 -500 30960 (204 -106 &amp;lt; CNS ) 4210297 ($)</span>A7 B7 321644 V. Description of the invention (103) The solution (35M, 85 ml) of the base diazomethane in methane gas is treated drop by drop. The resulting solution was stirred at room temperature for 24 hours. The solvent was removed under reduced pressure, and the residue was subjected to flash chromatography on silica gel and washed away with hexane: ethyl acetate (4 vl) and (2: 1). The parts were combined and evaporated to give the title compound (11.8g) as a white foam. ci CDC13): 10.00 (S, 1H, CHO), 7.63 (m, lH, 2Ph), 7.26 (s, 1H, C | _Ph2), 6_30 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.92 (d, 1H, H-l ', J = .9 Hz), 4.84 (t, 1H, H-3', J = 3.3 Hz), 4.035.4.35 (2d, 2H, 8aCH2, J = 9 Hz), 3.88 (m, 1H, H-2 '), 3.70 (dq, 1H, H-5', 1 = 6.3 ^ 9.3 Hz), 3.41 (s, 3H, 4'-Me), 3.20 (dd, 1H, H-4 ', J = 3.3 and 9 Hz), 2.75 (t, 1H, Hl). Intermediate 4 9 a) [lR- (la, 3a0, 40, 4ay5, 7 / ?, 7aa, 8ay5)] 8a-[(6-deoxy-4_O-methyl-2,3-di-- Toluoyl-D-Azzurol (anranoyloxy)) methyl] -4-carboxyl-4,4,5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro- 7-methyl-3- (1-methylethyl) -1,4-methylidene-s- &amp;lt; pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester and b) [lR- (la, 3a; S, 4 Lu, 4a , 7 / ?, 7aa, 8ayS)] 8a-[(6-deoxy-4--methyl- 2- 0-methylbenzene-based -D- Azur t Guaranosyloxy) methyl] _ 4 -carboxamide-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 48 (2 g) and 4-dimethyl Aminopyridine (500 mg) was dissolved in anhydrous leaf dagger lake (30 ml). Add dropwise a solution of toluene gas (960 mg) in anhydrous bismuth (20 ml). The reaction mixture was stirred at room temperature for 4 days.  -106 The size of this paper is based on China's Pujiajiao rate &amp;lt; CNS) 4 specification (210297mm) (please read the note $ item on the back and fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  A7 _ B7 _ 1  4 : 1)1 : 1) a)Rf1.65 b)Rf1.17 (a) ( (!, CDC13) 9.71 (s, 1H, CHO), 7.85-7.91 (m, 4H, -Ts)7.26-7.41 (m14H, Ts  2Ph), 6.95 (s, 1H, C02CHPh2_)5.87(ddlHH-2J=1.2&amp;amp;3.3Hz)4.92(dd 1HH-3J=3.34_2 Hz)4.65 (dd1HH-21J=1.24.5 Hz) 4.61 (d, 1H-J=1.2 Hz)3.50394 (2d, 2H8aCH2 J=9 Hz)3.68 (dq1H, H_5'J=6.69Hz)3.16 (dd1HH-4, J=39 Hz), 2.78 (s3H4'-OMe)2.452_47 (2s6H2Ts) o (b) ci ([HCDC13): 9.71 (s, 1HCHO)7.85 (m2H-</span>Printed by the Ministry of Economic Affairs, Central Bureau of Standards, Employee Consumer Cooperative Printed by the Ministry of Economic Affairs, Central Bureau of Standardization, Employee Cooperative, printed A7 _ B7 _ V. Description of the invention (1 called evaporation of the solvent to obtain a yellow residue, which is on silica gel. For flash layer analysis, wash away with hexane: ethyl acetate (4: 1) and (1: 1) to obtain the title compound (a), with higher Rf, as a white foam (1.65 g) and the title compound ( b), with lower Rf and white foam (1.17g). (a) ( (! , CDC13): 9.71 (s, 1H, CHO), 7.85-7.91 (m, 4H, ortho-Ts ), 7.26-7.41 (m, 14H, meta Ts and 2Ph), 6.95 (s, 1H, C02CHPh2_), 5.87 (dd, lH, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.92 (dd, 1H , H-3, J = 3.3 and 4_2 Hz), 4.65 (dd, 1H, H-21, J = 1.2 and 4.5 Hz), 4.61 (d, 1H, -, J = 1.2 Hz), 3.50 and 3.94 (2d, 2H, 8aCH2, J = 9 Hz), 3.68 (dq, 1H, H_5 ', J = 6.6 and 9Hz), 3.16 (dd, 1H, H-4', J = 3 and 9 Hz) , 2.78 (s, 3H, 4'-OMe), 2.45 and 2_47 (2s, 6H, 2Ts) o (b) ci ([H, CDC13): 9.71 (s, 1H, CHO), 7.85 (m, 2H, Position-</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ts)7.26-7.41 (m12H, Ts  2Ph)6_95 (s1H C|iPh2)5.87 (dd1HH-2, J=1.5&amp;amp;3.3Hz)4.61(dlHH-J=1.5 Hz), 4.55 (dd1HH-21J=1.24.2 Hz)4.37 (m, 1HH-3')3.503.95 (2d2H, 8aCH2, J=9 Hz)3.70 (dq, 1H H-5J=8.46.3Hz)3.23 (dd, 1HH-4'J=3.38.7 Hz) 2.42 (s, 3H,Ts)  5 0 [1R-(1 a3ay544a7y57aa8a/? )]8a-[(2,3--6--4-0 -]-4 - -44a5,6,7,7a8,8a --7-- 3- (1--14--s--3a(lH)- __-107-_ CNS ) A4210X297 ()</span>Ts), 7.26-7.41 (m, 12H, meta Ts and 2Ph), 6_95 (s, 1H, C | iPh2), 5.87 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.3Hz), 4.61 ( d, lH, H-, J = 1.5 Hz), 4.55 (dd, 1H, H-21, J = 1.2 and 4.2 Hz), 4.37 (m, 1H, H-3 '), 3.50 and 3.95 (2d, 2H, 8aCH2, J = 9 Hz), 3.70 (dq, 1H, H-5 ', J = 8.4 and 6.3Hz), 3.23 (dd, 1H, H-4', J = 3.3 and 8.7 Hz), 2.42 ( s, 3H, Ts)  Intermediate 5 0 [1R- (1 a, 3ay5, 4 points, 4 million, 7y5, 7aa, 8a /?)] 8a-[(2,3-anhydro-6-deoxy- 4-0 -methylazorpiperanyloxy) methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3 -(1-methylethyl) -1,4-methylene-s-tida-3a (lH) -carboxylic acid, diphenylmethyl ester __- 107-_ This paper size is used in China National Standard (CNS) A4 specification (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 10) A7 B7  0.5C5 2049( 670 54 3 : i) 330 (^, CDC13): 9.75 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph)6.99 (s, 1HC02CiiPh2)6.08 (dd1HH-2, J=1.53 Hz), 4.68 (s, 1H, H-l'), 3.78-4.11 (2d, 2H, 8aCH2, J=9 Hz), 3.49 (s, 3H, 4'-OMe), 3.26 (d, 1H, H-2', J=3.9 Hz), 3.18 (m, 1H, H-5'), 3.12 (d, 1H, H-3', J=3.6 Hz), 3.08 (m, 1H, H-4'), 2.86 (m, 1H, -) 5 1 [1R-(1 a3a044a/577aa8ay9 )]8-[(2,3-_6_ -4-0 ---D -]_4_ 4,4a5,6,7,7a8,8a--7--3-(1-4_ -s-_3a(lH)_ 25.95 49(b)(47 40 203 X 20  (5 : 1)332 ^ On, CDC13): 9.73 (s, 1H, CHO), 7.26-7.44 (m, iHj ()    I -II - - -108  A7 __B7 16) 2Ph)6.98 (s1HC02CHPh2)6.08 (dd1HH-2, J=1.53 Hz)4.60 (s1H-)3.764.03 (2d2H8aCH2, J=9.3 Hz)3.51 (m4H, H-4'4'-OMe)3.33 (m, 3HH-2H-3' H-52.80 (m1H, H-l) 5 2 [1-(1,3&amp;amp;447/?73?8]8&amp;amp;-[(2,3_-6--4-0---D-]_4_ -4,43,5,6,7,78,8&amp;amp;--7--3-(1--14--s--3a(lH)- 51(10015 10%/100 1 5/21  :3 : 1)15 : 1) 7 </span>V. Description of the invention (10) A7 B7 The Ministry of Economic Affairs Central Consortium Bureau Consumer Cooperative Printed Sodium (0.5 g) in anhydrous methanol (50 ml) at 0  C, and then added it as water digas methane ( 20 ml) of Intermediate 49 (670 mg). The mixture was stirred at room temperature for 5 days and at reflux for 4 days. The mixture was filtered to remove the solvent. The residue was purified by flash chromatography and washed with hexane: ethyl acetate (3: i) to obtain the title compound (330 mg). (^, CDC13): 9.75 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph), 6.99 (s, 1H, C02CiiPh2), 6.08 (dd, 1H, H-2, J = 1.5 and 3 Hz), 4.68 (s, 1H, H-l '), 3.78-4.11 (2d, 2H, 8aCH2, J = 9 Hz), 3.49 (s, 3H, 4'-OMe), 3.26 (d, 1H, H -2 ', J = 3.9 Hz), 3.18 (m, 1H, H-5'), 3.12 (d, 1H, H-3 ', J = 3.6 Hz), 3.08 (m, 1H, H-4') , 2.86 (m, 1H, -). Intermediate 5 1 [1R- (1 a, 3a0, 4 Lu, 4a / 5, 7, 7aa, 8ay9)] 8 has-[(2,3-anhydro_6_deoxy-4-0 -methyl- -D-piperidinosyloxy) methyl] _4_carboxamide  4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1- Methylethyl 4_methylidene-s-indazole _3a (lH) _carboxylic acid, diphenylmethyl ester Suspended sodium nitrate (25.9 mg) in anhydrous dimethylmethylamine (5 Ml). Intermediate 49 (b) (47 mg) in anhydrous dimethylformamide was added dropwise, and the mixture was stirred at room temperature for 40 minutes. The reaction mixture was poured into ice-cold water with stirring ( 20 ml), the resulting solution was treated with ethyl acetate (3 X 20 ml). The organic layers were combined and dried over anhydrous magnesium sulfate. After evaporation, a gel-like residue was obtained and purified by flash chromatography, using hexane : Ethanol acetate (5: 1) washes away to obtain the title compound (332 mg) as white foam. ^ On, CDC13): 9.73 (s, 1H, CHO), 7.26-7.44 (m, iHj (Please read the precautions on the back before filling in this page)  Order  I -II---108 Printed by the Ministry of Economic Affairs Central Cooperative Bureau Consumer Cooperative A7 __B7 5. Description of the invention (16) 2Ph), 6.98 (s, 1H, C02CHPh2), 6.08 (dd, 1H, H-2, J = 1.5 and 3 Hz), 4.60 (s, 1H, -), 3.76 and 4.03 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.51 (m, 4H, H-4 'and 4'-OMe), 3.33 (m, 3H, H-2 , H-3' and H -5,), 2.80 (m, 1H, Hl). Intermediate 5 2 [1 foot- (1 , 3 &amp;amp; cold, 4 oclock, 4 million, 7 / ?, 73 ?, 8 million)) 8 &amp;amp;-[(2,3_dehydration-6-go Oxo-4-0-methyl-lu-D-azoroperanyloxy) methyl] _4_methanyl-4,43,5,6,7,7, 8,8 &amp;amp; -octa Hydrogen-7-methyl-3- (1-methylethyl) -1,4-methylene-s--pyridin-3a (lH) -carboxylic acid in intermediate 51 (100 mg) in ethyl acetate To a solution in the ester (15 ml) was added 10% palladium / carbon (100 mg) under nitrogen. This mixture was shaken in a Parr device under 15 psi hydrogen at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash layer on silica gel, washed away with hexane: ethyl acetate (3: 1) and two-gas methane: methanol (15: 1). The appropriate fractions were combined and the solvent was removed to prepare the title compound (70 mg) as a white foam.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">On, CDC13): 9.77 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J=1.2&amp;amp;3.6Hz)4.67(dlHH-lJ=.9Hz),3.58&amp;amp;4.17(2d, 2H, 8aCH2, J=9.6 Hz), 3.51 (m, 4H, H-3'^L4'-OMe), 3.38 (m, 1H, H-S*), 3.34 (d, 1H, H-2', J=4.2 Hz), 3.30 (dd, 1H, H-4', J=9 1.5 Hz), 2.65 (t, 1HH-l, J=3.9 Hz) 5 3 [1R-(1 a3a04y54a/? ,7/?7aa ,8ay5 )]8a-[(4-0-_ 6---D-]_4_- _______ -109- CNS ) A# ( 210X297) ' ()</span>On, CDC13): 9.77 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 4.67 (d, lH, Hl, J = .9Hz), 3.58 &amp;amp; 4.17 (2d, 2H, 8aCH2, J = 9.6 Hz), 3.51 (m, 4H, H-3 '^ L4'-OMe), 3.38 (m, 1H, HS *), 3.34 (d, 1H, H -2 ', J = 4.2 Hz), 3.30 (dd, 1H, H-4', J = 9 and 1.5 Hz), 2.65 (t, 1H, Hl, J = 3.9 Hz). Intermediate 5 3 [1R- (1 a, 3a0, 4y5, 4a / ?, 7 / ?, 7aa, 8ay5)) 8a-[(4-0-allyl-6-deoxy--D-A Drupranosyloxy) methyl] _4_formyl- _______ -109- This paper scale is easy to use Zhongguanjia rubbing standard (CNS) Ashi #  (210X297mm) '(Please read the back of the first (Notes and then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 __B7 17) 4,4&amp;amp;5,6,7,78,8&amp;amp;--7-_3-(1__14_ - s-- 3a(lH) - 1(2870 (25Dean-Stark 2 3 1M3.5 40 C24 _(! :1)9 :1)1.7 d CDC13): 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 605 (dd, 1H, H-2, J=1.53.6 Hz)5.89 (m, 1H CH=CH2),5.25 (m, 2H, CH=CH2), 4.64 (d, 1H, H-l', J=1.5 Hz), 4.15 (t, 1H, H-3', J=3.3 Hz), 4.09 (m, 3H, Ci^-CH=CH2  ea-C^)3.87 (m1HH-21)3.74 (m2H, H-5, Sa-Cl^)3.38 (dd1HH-4' J=3.39 Hz)2.74 (t1HH-l J=3.9 Hz) 5 4  () [1R-(1 a3a44a7y5,7a8a3)]8a-[(4-0--6--/3-D-]-4--4,4a5,6,7,7a8,8a--7--3-(l--l4--s--3a(lH)- 1(6.03.55 (2 5Dean-Stark 3 C -110- CNS ) A4210X297  A7 B7 18) 1.21m 140(18  6 : 1)4 : 1) 373 CDC13): 9.73 (s1, CHO)7.24-7.44 (m15 3Ph)6.98 (s1HC02CHPh2), 6.05 (dd1HH-2, J=1.5 3.6 Hz), 4.65 (d1H-J=1.2 Hz), 457 (AB  4OCH2PhJ=U.i Hz), 421 (m1HH-33.764.07 (2d, 2H, 8aCH2, J=9 Hz), 3.87 (m, 1H, H-2'), 3.76 (m, 1H, H-5'), 3.49 (dd1HH-4' J=3.39 Hz)2.74 (t1H, H-lJ=3.6 Hz) 0 5 5 or 3a/5 4/?4a707aor8a]8a-[(2-0- -6--4-0_a_d_4_ -4,4a5,6,7,7a8,8a--7__3(1_ -I4--S4_3a(1H)_ 48(315 0C4-6 3b _2(rc(3 6 1 5^ 3 12 (JH, CDC13): 9.70 (s, 1H, CHO), 7.35 (m, 15H, 3xPh), ______-111 - sCNS ) A421GX297) - (&amp;gt;</span>A7 __B7 5. Description of the invention (17) 4,4 &amp;amp; 5,6,7,7, 8,8 &amp;amp; -octahydro-7-methyl_3- (1_methylethyl) _1, 4_ methylene-s-  shou province-3a (lH) -tetanoic acid, diphenylmethyl vinegar Intermediate 1 (2g) and dibutyltin oxide (870mg) in anhydrous toluene (25ml) The suspension was refluxed in a flask equipped with a Dean-Stark condenser under nitrogen for 2 hours, and then placed at room temperature. Allyl bromide (03 mL) was added successively, followed by 1M tetrabutylammonium fluoride solution (3.5 mL), and the mixture was heated at 40  C under nitrogen for 24 hours. The solvent was evaporated to dryness, and the residue was chromatographed on a silica gel flash column, which was washed away with hexane: propyl (! : 1) and (9: 1) to obtain the title compound (1.7 g) , Is a white foam. d CDC13): 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 5.89 (m, 1H, CH = CH2), 5.25 (m, 2H, CH = CH2), 4.64 (d, 1H, H-l ', J = 1.5 Hz), 4.15 (t, 1H, H-3', J = 3.3 Hz), 4.09 ( m, 3H, Ci ^ -CH = CH2 and ea-C ^), 3.87 (m, 1H, H-21), 3.74 (m, 2H, H-5, and Sa-Cl ^), 3.38 (dd, 1H , H-4 'J = 3.3 and 9 Hz), 2.74 (t, 1H, Hl, J = 3.9 Hz). Intermediate 5 4 Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs (please read the precautions on the back before filling out this page) [1R- (1 a, 3a Lu, 4 Lu, 4a points, 7y5, 7a, 8a ; 3)] 8a-[(4-0-benzyl-6-deoxy- / 3-D-azorpiperanyloxy) methyl] -4-carboxamide-4,4a, 5, 6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-s-pyridine-3a (lH) -carboxylic acid , Diphenylmethyl ester The mixture of Intermediate 1 (6.0 g) and dibutyltin oxide (3.55 g) in anhydrous toluene (25 mL) was stirred vigorously in a flask equipped with a Dean-Stark condenser under nitrogen Reflux for 3 hours. The reaction mixture was cooled to 0  C, and then -110- the paper size was used in accordance with the Chinese National Standard (CNS) A4 specification (210X297 mm). The A7 B7 was printed by the Consumer Labor Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs. 18) and then treated with octyl bromide (1.2 ml) and tetrabutylammonium fluoride solution (1 m in tetrahydrofuran, 10 ml). 40. (: After heating under nitrogen for 18 hours, the mixture was concentrated under reduced pressure, and the residue was analyzed and purified by flash chromatography. It was washed away with ethyl acetate: ethyl acetate (6: 1) and (4: 1), and the appropriate parts were combined. , Evaporate the solvent to obtain the title compound (3.73g) as a white foam. CDC13): 9.73 (s, 1, CHO), 7.24-7.44 (m, 15, 3Ph), 6.98 (s, 1H, C02CHPh2 ), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.65 (d, 1H, -, J = 1.2 Hz), 4.57 (AB system, 4OCH2Ph, J = Ui Hz) , 4.21 (m, 1H, H-3,), 3.76 and 4.07 (2d, 2H, 8aCH2, J = 9 Hz), 3.87 (m, 1H, H-2 '), 3.76 (m, 1H, H -5 '), 3.49 (dd, 1H, H-4' J = 3.3 and 9 Hz), 2.74 (t, 1H, Hl, J = 3.6 Hz) 0 Intermediate 5 5 or '3a / 5' 4 /? , 4a Lu, 70, 7aor, 8a)] 8a-[(2-0-benzyloxycarbonyl-6-deoxy-4-0  methyl_a_d_azorpiperanosyloxy) methyl 4_ Methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7_methyl_3  (1_methylethyl) -I, 4-methylidene-S4 Dasheng_3a (1H) _carboxylic acid, diphenylmethyl ester in a solution of intermediate 48 (3 millimoles) in anhydrous digas methane (15 ml) at 0C Add 4-dimethylaminopyridine (63 mmol) under nitrogen. After stirring for b minutes, the mixture was cooled to _2 (rc, and a solution of benzyl gas formate (36 mmol) in anhydrous two-gas methane (15 ml) was added dropwise. After ^ hours, the solvent was evaporated The residue was analyzed and purified by flash chromatography, using hexane: ethyl acetate (3 washed away) to prepare the title compound (1.2 g). (JH, CDC13): 9.70 (s, 1H, CHO), 7.35 ( m, 15H, 3xPh), ______- 111-This paper size is suitable for s home materials (CNS) A4 threat (21GX297mm) - (please read the precautions on the back before filling this page &amp;gt;</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 -------^ 1Q9) 6.96 (s1HC|i_Ph2)5.99 (dd1HH-2, J=l_53.6 Hz) 5.18 (AB2HOC^PhJ=12 Hz), 5.00 (dd1H2' J=1.5&amp;amp;4.2Hz),4.70(dlHH-lJ=1.8Hz)4.13(mlH H-3')4.01 3.66 (dd1H1H, 8a-CH2, J=9 Hz)3.75 (m 1HH-5)340 (s3H, OMe)3_17 (dd1H, H-4, J=3.38.4 Hz), 2.62 (t, 1H, H-l, J=3.6 Hz), 2.43 (d, 1H, OH, J=2.4 Hz), 2.21 (m, 1H, CH(CH3)2)  5 6 [1R-(1 a3a/5 ,4^4ay57y97aa ,8a/? )]8a-[(4 --2-0--6-_-D-f]-4 - -4,4&amp;amp;,5,6,7,7&amp;amp;8,8&amp;amp;-_7--3-(1-_ 1,4--s--3a(lH)- 53(1.430 C5131 5 150.35 (1 54 (1201  7 : 1) 5 : 1)1.1  (JH, CDC13) 9.70 (s, 1H, CHO), 6.96 (s, 1H, CH^Ph2), 5.99(ddlHH-2J=1.5&amp;amp;3.6Hz)5.88(mlH,C|i=CH2) 5.20 (m, 4H, Ph-CI^-O, CH2-CH=CH2), 4.99 (dd, 1H, H-2', J=1.54.2 Hz)4.70 (d1H, -, J=1.5 Hz)4.12 (m, 1H, -112- CNS ) A4210X297) fj   A7 B7 __ 110) H-3)4.03 (m3H2-(=(2 H-Sa-C^)3.76 (m1H H-3'), 3.64 (d, 1, ea-CI^, 8.7 Hz), 3.34 (dd, 1H, H-4', J=3.38.7 Hz)2.61 (t, 1H, H-lJ=3.9 Hz) 5 7 [1R-(1 a3a/3 ,404ay5707aa8a3 )]8a-[(4-0 -- 2---6---D-]-4- -4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1- 1,4--s-5-3a(lH)- 54(3.725 C4-1.8515 -20C0.68 1 tu 4 : 1) 6 : 1) (1  2 d Cn, CDC13): 9.70 (s, 1H, CHO), 7.26-7.42 (m, 20H, 4Ph)6.96 (s, 1H, C02C|iPh2), 5.99 (dd1H, H-2, J=1.2 3.3 Hz), 5 1 8 (AB I'-OCC^C^^PhJ=12.3 Hz), 5.00 (dd1HH-2'J=1.54.2 Hz)4.71 (d, 1HH-l'J=1.5 Hz) 4.56 (AB 4-OCLPhJ=ll.l Hz), 4.15 (m1HH-3 3.66&amp;amp;4.00(2d2H,8aCH2J=9Hz),3.81(dq,lHH-5', J=6.69 Hz), 3.43 (dd, 1H, H-4, J=3.39 Hz), 2.60 (t, 1H, H-lJ=3.6 Hz) 5 8 -113- CNS ) A4210X297~ ~ ()  ?  A7 ------B7__ 111) &amp;quot; -- HR-U  3ayS44a77aor8ay5 )]8a-[(2-0- -6--4-__3___D_ ]4_-4,43,5,6,7,7&amp;amp;8,8&amp;amp;--7- -3-(1-14s-m_3a(1H)_  55 (34-5.1 6045 2 2 4  5 : 1)1 8  (lH&amp;gt; CDC13) 9.70 (Sj 1H, CHO), 7.84A7.32 (d, m, 2H, 17H, Ar), 6.96 (s1H, C^JPh2)5.94 (dd1H, H-2, J=1.5 3.6 Hz)5.17 (AB 2HOCLPhJ=12 Hz), 5.10 (m1H, H-34.88 (dd1HH-2J=35.4 Hz)4.68 (d, 1H, H-l J=2.1 Hz)3.973.63 (2d2H8a-CH2, J=9 Hz), 376 (dd, 1HH-5'J=6.38.1 Hz)3.18 (dd1HH-4' J=38.1 Hz), 3.05 (s, 3H, OMe), 2.51 (t5 1H, H-l, J=3.6 Hz), 2.43 (s, 3H, CI^Ar), 2.01 (m, 1H, CH(CH3)2)  5 9 [1R-(1 a3a044a5 ,7/?7aa8a/5 )]8a-[(4--2--6--3-0-j-D- ]4 -_4,4a,5,6,7,7a8,8a-_fti-7-3-(l-_l,4--s_3a(lH)-  ______-114- _ _ CNS ) 4210X297 &amp;quot; (}</span>A7 B7 printed by the Employees Consumer Cooperative of the Central Escalation Bureau of the Ministry of Economic Affairs ------- ^ V. Description of Invention (1Q9) 6.96 (s, 1H, C | i_Ph2), 5.99 (dd, 1H, H-2, J = l_5 and 3.6 Hz), 5.18 (AB system, 2H, OC ^ Ph, J = 12 Hz), 5.00 (dd, 1H, H  2 ', J = 1.5 &amp;amp; 4.2Hz), 4.70 (d, lH, Hl ,, J = 1.8Hz), 4.13 (m, lH, H-3 '), 4.01 and 3.66 (d, d, 1H, 1H, 8a-CH2, J = 9 Hz), 3.75 (m, 1H, H -5 ), 3  40 (s, 3H, OMe), 3_17 (dd, 1H, H-4, J = 3.3 and 8.4 Hz), 2.62 (t, 1H, Hl, J = 3.6 Hz), 2.43 ( d, 1H, OH, J = 2.4 Hz), 2.21 (m, 1H, CH (CH3) 2)  Intermediate 5 6 [1R- (1 a, 3a / 5, 4 ^, 4ay5, 7y9, 7aa, 8a /?)] 8a-[(4-dipropyl-2-0-benzyloxycarbonyl-6-deoxy_-D-azorpiperanosyloxy) f]]-4-carboxyl- 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro_7-methyl-3- (1-methylethyl) _ 1,4-methylene-s-indap Provincial-3a (lH) -carboxylic acid, diphenylmethyl ester in a solution of intermediate 53 (1.4 g) in anhydrous digas methane (30 ml) was added dimethylaminopyridine (513 mg ), The mixture was stirred for 15 minutes. A solution of benzyl carbamate (0.35 ml) in anhydrous digas methane (15 ml) was added dropwise over 15 minutes and stirred for 4 hours. This mixture was then diluted with methanol (1 ml) and dichloromethane (20 ml) and washed with water, 1 equivalent hydrochloric acid and brine. The organic layer was dried over magnesium sulfate, filtered and the solvent was evaporated to dryness. The residue was purified by flash column chromatography, and washed away with hexane: ethyl acetate (7: 1) and (5: 1) to obtain the title compound (1.1 g).  (JH, CDC13): 9.70 (s, 1H, CHO), 6.96 (s, 1H, CH ^ Ph2), 5.99 (dd, lH, H-2, J = 1.5 &amp;amp; 3.6Hz), 5.88 (m, lH, C | i = CH2), 5.20 (m, 4H, Ph-CI ^ -O, CH2-CH = CH2), 4.99 (dd, 1H, H-2 ', J = 1.5 and 4.2 Hz), 4.70 ( d, 1H, -, J = 1.5 Hz), 4.12 (m, 1H, -112- This paper scale is applicable to China National Standard (CNS) A4 specification (210X297mm) f Please read the back of this item first Fill in this page j Order A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy __ V. Description of Invention (110) H-3,), 4.03 (m, 3H, (: 2- (:  = (: 2 and H-Sa-C ^), 3.76 (m, 1H, H-3 '), 3.64 (d, 1, ea-CI ^, 8.7 Hz), 3.34 (dd, 1H, H-4', J = 3.3 and 8.7 Hz), 2.61 (t, 1H, Hl, J = 3.9 Hz). Intermediate 5 7 [1R- (1 a, 3a / 3, 40, 4ay5, 70, 7aa, 8a; 3)] 8a-[( 4-0-character-2--fluorenyloxycarbonyl-6-deoxy-dot-D-azorpiperanosyloxy) methyl] -4-methylbranyl-4,4 &amp;amp;, 5, 6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl), 1,4-methylene-s-, 5 da da province-3a (lH ) -Carboxylic acid, diphenyl methyl ester in intermediate 54 (3.7 g) in anhydrous dimethane 25 mL) was added 4-dimethylaminopyridine (1.85 g) under nitrogen at 0  C. After stirring for 15 minutes, the mixture was cooled to -20  C and benzyl gas formate was added dropwise ( 0.68 mL) in anhydrous dioxane (10 mL) until the product was detected by TU (hexane  ethyl acetate 4: 1). Then the solvent was evaporated to dryness and the residue was analyzed by flash chromatography Purify and wash off with hexane: ethyl acetate (6: 1) to obtain the title compound (1.2 g) as a white foam. D Cn, CDC13): 9.70 (s, 1H, CHO), 7.26-7.42 (m, 20H, 4Ph), 6.96 (s, 1H, C02C | iPh2), 5.99 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5. 1 8 (AB system, I'-OCC ^ C ^^ Ph, J = 12.3 Hz), 5.00 (dd, 1H, H-2 ', J = 1.5 and 4.2 Hz), 4.71 (d, 1H, H-l', J = 1.5 Hz), 4.56 (AB System, 4-OCLPh, J = ll.l Hz), 4.15 (m, 1H, H-3,), 3.66 &amp;amp; 4.00 (2d, 2H, 8aCH2, J = 9Hz), 3.81 (dq, lH, H- 5 ', J = 6.6 and 9 Hz), 3.43 (dd, 1H, H-4, J = 3.3 and 9 Hz), 2.60 (t, 1H, Hl, J = 3.6 Hz). Intermediate 5 8 -113- This paper scale is applicable to China National Standard (CNS) A4 (210X297mm) ~ ~ (Please read the precautions on the back before filling out this page) Order? Employees Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs Printed A7 ------ B7__ 5. Description of the invention (111) &amp;quot;-HR-U '3ayS, 4 cold, 4a point, 7 cold, 7aor, 8ay5)] 8a-[(2-0- Benzyloxycarbonyl-6-deoxy-4-_methyl_3__toluenesulfonyl  cold_D_azorpiperanosyloxy) methyl]  4_methylacyl-4 , 43,5,6,7,7 &amp;amp;, 8,8 &amp; -octahydro-7-methyl-3- (1-methylethyl)  14  methylene sm  da province_3a (1H) _Carboxylic acid, diphenylmethyl ester. A solution of intermediate 55 (3 mmol) and 4-dimethylaminopyridine (5.1 mmol) in water and one gas methane (60 ml) was treated with toluenesulfonate A solution of distillate gas (45 millimoles) in anhydrous digas methane (20 ml) was treated dropwise. After 4 hours, the solvent was evaporated, and the residue was purified by flash chromatography and washed with hexane: ethyl acetate (5: 1) to obtain the title compound (18 g).  (lH &amp;gt; CDC13): 9.70 (Sj 1H, CHO), 7.84A7.32 (d, m, 2H, 17H, Ar), 6.96 (s, 1H, C ^ JPh2), 5.94 (dd, 1H, H- 2, J = 1.5 and 3.6 Hz), 5.17 (AB system, 2H, OCLPh, J = 12 Hz), 5.10 (m, 1H, H-3 '), 4.88 (dd, 1H, H-2 ,, J = 3 and 5.4 Hz), 4.68 (d, 1H, Hl ,, J = 2.1 Hz), 3.97 and 3.63 (2d, 2H, 8a-CH2, J = 9 Hz), 3.76 (dd, 1H, H-5 ', J = 6.3 and 8.1 Hz), 3.18 (dd, 1H, H-4' J = 3 and 8.1 Hz), 3.05 (s, 3H, OMe), 2.51 (t5 1H, Hl, J = 3.6 Hz), 2.43 (s, 3H, CI ^ Ar), 2.01 (m, 1H, CH (CH3) 2) Intermediate 5 9 [1R- (1 a, 3a0, 4 cold, 4a; 5, 7 / ?, 7aa, 8a / 5)] 8a-[(4-allyl-2--yetoxycarbonyl  6-deoxy-3-0-tosylsulfonyl jD- atrazolanoyloxy) methyl]  4 -Methylamino_4,4a, 5,6,7,7a, 8,8a-octa_fti-7  Methyl-3- (l-methylethyl) _l, 4-methylene- s indida province _3a (lH) -carboxylic acid, diphenylmethyl ester ______- 114- _ _ This paper scale uses Chinese National Standard (CNS) 4 specifications (210X297 mm) &amp;quot; (please read first Note on the back then fill out this page}</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">321G44 A7 B7 112)  56(1.1300 40400 203  9 : 1)6 : 1) 820 ^ CDC13): 9.70 (s, 1H, CHO), 6.95 (s, 1H, CHPh2), 5.94 (dd, 1H, H-2, J=1.5^3.9 Hz), 5.61 (m, 1H, CH=CH2), 5.12 (m, 4H, Ph-C^-O, CH2-CH=CH2), 4.84 (dd, 1H, H-2', J=3&amp;amp;5_lHz),4.69(dlH,H-rJ=1.8Hz)3.96&amp;amp;3.63(2d 2H, Sa-CH^, J=9. Hz), 3.76 (m, 4H, H-3', CH=CH2), 3.38 (dd, 1H, H-4' J=38.1 Hz), 2.50 (t, 1HH-l J=3.9 Hz), 2.42 (s, 3H, Ci^Ph)  6 0 [lR-(lor,3ay3 ,4^4a97y57aa8a/? )]8a-[(4-0 - -6--3-0-_-_ ]-4 - _4,4&amp;amp;5,6,7,7&amp;amp;8,8-_7--3-(1- -1,4-_3a(1H)_  57(3.51 3 802 503  .9 : 3.14 </span>321G44 A7 B7 V. Description of the invention (112) Printed by Intermediate Bureau of Economic Affairs of the Ministry of Economic Affairs, Shell Co., Ltd. is printed on intermediate 56 (1.1 g) and dimethylpyridine (300 mg) in anhydrous gas methane (40 ml) To the solution was added dropwise a solution of tosylate gas (400 mg) in anhydrous methane (20 ml), and the mixture was stirred at room temperature for 3 days. The solvent was evaporated to dryness, and the residue was analyzed by chromatography on a silica gel flash column, and washed away with hexane: ethyl acetate (9: 1) and (6: 1) to obtain the title compound (820 mg). ^ CDC13): 9.70 (s, 1H, CHO), 6.95 (s, 1H, CHPh2), 5.94 (dd, 1H, H-2, J = 1.5 ^ 3.9 Hz), 5.61 (m, 1H, CH = CH2) , 5.12 (m, 4H, Ph-C ^ -O, CH2-CH = CH2), 4.84 (dd, 1H, H-2 ', J = 3 &amp;amp; 5_lHz), 4.69 (d, lH, Hr, J = 1.8 Hz), 3.96 &amp;amp; 3.63 (2d, 2H, Sa-CH ^, J = 9.0 Hz), 3.76 (m, 4H, H-3 ', CH = CH2), 3.38 (dd, 1H, H-4 'J = 3 and 8.1 Hz), 2.50 (t, 1H, Hl, J = 3.9 Hz), 2.42 (s, 3H, Ci ^ Ph) Intermediate 6 0 [lR- (lor, 3ay3, 4 ^, 4a ; 9,7y5,7aa, 8a /?)] 8a-[(4-0 -Esteroxycarbonyl-6-deoxy-3-0-tosylsulfonyl _-;  _Azetopranosyl Oxy) methyl] -4 -methyl _4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 pressure-octahydro_7-methyl-3- (1-methylethyl) -1,4-methylene lead pyridine_3a (1H) _carboxylic acid, diphenyl methyl ester in intermediate 57 (3.5 g) and dimethylaminopyridine (13 g) in anhydrous digas methane To the solution (80 ml) was added dropwise a solution of tosylate gas (2 g) in anhydrous digas methane (50 ml), and the mixture was stirred at room temperature for 3 days. The solvent was evaporated to dryness, and the residue was analyzed by chromatography on a silica gel flash column, and the title compound (3.14 g) was prepared by washing with hexane. Ethyl acetate (9: ).</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">()</span>(Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  !  A7 ____B7_ 113) ^ (^, CDC13): 9.70 (s, 1H, CHO), 6.95 (s, 1H, CHPh2), 5.95 (dd, 1HH-2, J=1.23.3 Hz), 5.16 (m, 3H-Ph-C^-0 H-2')4.93 (dd1H, H-31J=34_8 Hz)4.71 (d, 1H-, J=1.8 Hz), 4.25 (AB 2H, 0-CH2PhJ=11.5 Hz), 3.96 3.63 (2d2H8a-C^J=9.0 Hz), 3.83 (m1HH-5)3-45 (dd1HH-4, J=38.4 Hz)2-51 (t1HH-lJ=3.9 Hz), 2_35 (s, 3HCH3-Ph) 6 1 [1R-(1 a3a044a77aa8a]8a-[(6--4-0-- 3- 0--_d_]_4_ -4,4a5,6,7,7a,8,8a--7 --3-(1- -14--s_3a(1H)- 5 8(1.960 10 %/1 1 5/21 0.35M2  3 : 1)1.3 (M1!!CDC13): 9.72 (s1HCHO)7.857.32 (dm2H, 12HAr), 6.98 (s1HC|iPh2), 6.06 (dd1H, H-2, J=1.2 3.3 Hz)4.84 (dd, 1HH-3'J=34.2 Hz)4.64 (d, 1H-, J=1.5Hz),4.06&amp;amp;3.75(2d2H8a-CH2J=9.3Hz),4.02(m 1HH_2')3.70 (m 1HH-53.16 (dd, 1HH-4J=39Hz) 2.93 (s, 3H, OMe), 2.69 (t, 1H, H-l, J=3.9 Hz), 2.45 (s, 3H, _ -116- 442&amp;gt;&amp;lt;297)  ()</span> 1T ! A7 ____B7_ printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (113) ^ (^, CDC13): 9.70 (s, 1H, CHO), 6.95 (s, 1H, CHPh2), 5.95 ( dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5.16 (m, 3H-Ph-C ^ -0, H-2 '), 4.93 (dd, 1H, H-31, J = 3 and 4_8 Hz), 4.71 (d, 1H, -, J = 1.8 Hz), 4.25 (AB system, 2H, 0-CH2Ph, J = 11.5 Hz), 3.96, 3.63 (2d, 2H, 8a-C ^, J = 9.0 Hz), 3.83 (m, 1H, H-5 '), 3-45 (dd, 1H, H-4, J = 3 and 8.4 Hz), 2-51 (t, 1H, Hl, J = 3.9 Hz), 2_35 (s, 3H, CH3-Ph). Intermediate 6 1 [1R- (1a, 3a0, 4lu, 4a, 7lu, 7aa, 8a lu)] 8a-[(6-deoxy-4-0-methyl-3-0-toluenesulfon Acetyl-_d_azorpiperanosyloxy) methyl] _4_ methacryl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s  gongda province_3a (1H) -carboxylic acid, diphenylmethyl ester at intermediate 58 (1.9 mmol) To a solution in ethyl acetate (60 ml) was added 10% palladium / carbon (100 mg) under nitrogen. This mixture was shaken in a Parr apparatus under 15 psi hydrogen at room temperature for 1 hour. The catalyst was filtered off, and the solution was treated with 0.35M diphenyldiazomethane (20 ml). After two hours, the solvent was evaporated, and the residue was purified by flash chromatography and washed with hexane: ethyl acetate (3: 1) to obtain the title compound (1.3 mg). (M1 !!, CDC13): 9.72 (s, 1H, CHO), 7.85 and 7.32 (d, m, 2H, 12H, Ar), 6.98 (s, 1H, C | iPh2), 6.06 (dd, 1H, H -2, J = 1.2 and 3.3 Hz), 4.84 (dd, 1H, H-3 ', J = 3 and 4.2 Hz), 4.64 (d, 1H, -, J = 1.5Hz), 4.06 &amp;amp; 3.75 (2d, 2H, 8a-CH2, J = 9.3Hz), 4.02 (m, 1H, H_2 '), 3.70 (m 1H, H-5,), 3.16 (dd, 1H, H-4, J = 3 And 9Hz), 2.93 (s, 3H, OMe), 2.69 (t, 1H, Hl, J = 3.9 Hz), 2.45 (s, 3H, _ -116- 2   &amp;gt; &amp;lt; 297mm)  (Please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">ltT  A7 B7  CILAr), 2.30 (d, 1H, OH, J=3 Hz), 2.23 (m, 1H, CH(CH3)2) o 6 2 [1R-(1 or3ay94y94ay5 ,7/9 ,7aa8ay5 )]8a-[(6 -- 4-0--3-- -]-4 - -44a5,6,77a8,8 a--7 --3-(1--1,4-_s-_3a(lH)- 59(800200 10%/300 20/21 5 0.35M^6 3 8 : 1)3 : 1) 630</span>ltT A7 B7 printed by the Employee Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economy V. Description of invention (CILAr), 2.30 (d, 1H, OH, J = 3 Hz), 2.23 (m, 1H, CH (CH3) 2) o Intermediate Body 6 2 [1R- (1 or, 3ay9,4y9,4ay5, 7/9, 7aa, 8ay5)] 8a-[(6 -deoxy-4- 4-0-propyl-3-tosylsulfonyl- -A Zhuolanosyloxy) methyl] -4 -toluo-4,4a, 5,6,7,7a, 8,8 a-octahydro-7 -methyl-3- (1-methyl Ethyl) -1,4-methylidene_s-indap_3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 59 (800 mg) in ethyl acetate (200 ml) To the solution was added 10% palladium / carbon (300 mg) under nitrogen. This mixture was shaken in a Parr apparatus under 20 psi hydrogen at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was dissolved in dichloromethane (50 mL), and 0.35 M diphenyl diazomethine (6 mL) was added dropwise. This mixture was stirred at room temperature for 3 hours. The solvent was evaporated, and the residue was subjected to flash chromatography on a silica gel flash column and washed away with hexane: ethyl acetate (8: 1) and (3: 1) to obtain the title compound (630 mg).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">On, CDC13): 9 72 (s&amp;gt; 1 CHO), 6.98 (s, 1H, CHPh2), 6.06(ddlHH-2J=1.2^.3Hz)4.84(dd,lHH-2J=3&amp;amp; 4.2 Hz), 4.64 (d, 1H, -, J=1.5 Hz)4.05 (m2HH-3, H-8a-CH2), 3.73 (m, 2H, H-5H-8a-C|^)3.29 (dd, 1H, H- 4'J=2.79 Hz)3.01 (t2HOC^CH/l^J=7 Hz)2.68 (t1HH-lJ=3.9 Hz), 2.44 (s, 3Hp-Ts) 6 3 [1-(1,3&amp;amp;4&amp;gt;9,4&amp;amp;5,7;5,7&amp;amp;(^835)]8&amp;amp;-[(4-0--6-- 3- 0---D-]_4_ -117 - CNS ) A4210X297 ()  f !  A7 B7 __ 13 -4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1- -1,4 -- s-- 3a(lH) - 60( 1.070 10 %/ (30015 /24  3 : 1)1 : 1) 530</span>On, CDC13): 9 72 (s&gt; 1 CHO), 6.98 (s, 1H, CHPh2), 6.06 (dd, lH, H-2, J = 1.2 ^ .3Hz), 4.84 (dd, lH, H- 2, J = 3 &amp;amp; 4.2 Hz), 4.64 (d, 1H, -, J = 1.5 Hz), 4.05 (m, 2H, H-3, and H-8a-CH2), 3.73 (m, 2H , H-5 'and H-8a-C | ^), 3.29 (dd, 1H, H-4', J = 2.7 and 9 Hz), 3.01 (t, 2H, OC ^ CH / l  ^, J = 7 Hz), 2.68 (t, 1H, Hl, J = 3.9 Hz), 2.44 (s, 3H, p-Ts). Intermediate 6 3 [1 ruler- (1 , 3 &amp; , 4 &amp;gt; 9,4 &amp;amp;;5,7; 5,7 &amp;amp; (^, 83; 5)] 8 &amp;amp;-[(4-0-fluorenyl -6-deoxy- 3- 0-tosylsulfonyl-lu-D-azorpiperanosyloxy) methyl] _4_ -117-This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297 Mm) (Please read the precautions on the back before filling out this page) Order f! Printed by the Ministry of Economic Affairs, Central Bureau of Accreditation and Employee Consumer Cooperatives A7 B7 __ 5. Description of the invention (13   -4,4 &amp;amp;, 5, 6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4 -methylene-s-   -3a (lH) -Add a 10% palladium / (300 mg) antacid to a solution of Intermediate 60 (1.0 g) in ethyl acetate (70 mL) under nitrogen. This mixture is in a Parr unit under 15 psi hydrogen Shake at room temperature for 4 hours. Filter off the catalyst and evaporate the solvent to dryness. Purify the residue on silica gel by flash layer analysis and wash with hexane: ethyl acetate (3: 1) and (1: 1) Combine the appropriate fractions and evaporate the solvent to obtain the title compound (530 mg).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">OhCDC13): 9.70 (s, 1HCHO)7.81 7.10-7.30 (2m 9HTsPh)6.08 (dd, 1HH-2, J=1.53.3 Hz)4.91 (dd, 1HH-3'J=3.34.5 Hz)4.68 (d1H-J=1.5 Hz)4.12 (m3HCi|2Pt^H-2')4.06&amp;amp;3.64(2(i2H8aCli2J=9.3 Hz), 3.46 (m, 1H, H-4'), 2.65 (m, 1H, H-l), 2.36(s, 3H, Ts) o 6 4 [1R-(1 3a4 04a077aa8ay5 )]8a-[(2,3--6-- 4- 0---D-]_4_-4,4a5,6,7,7a8,8a--7-_3_(l_-l4--s--3a(lH)- 3.26 61(1.66 401 : 160  4 : 1)96 _ _____-118- _ CNS ) A4*^M 21GX297) () - !  A7 B7 116) NMR50 6 5 [1R-(1 a3ay? ,44a/577aa8aS )]8a-[(2,3--6--4-0--/5 -D-*1 ]_4 --4,4a5,6,7,7a8,8a--7--3-(l--l,4--s--3a(lH)- 351 62(60015 1 15070  8 :6 : i) 450 (lU, CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPH2), 6.08(dd,lH,H-2J=1.5&amp;amp;4.8Hz)4.68(s,lHH-l')4.ll&amp;amp; 3.79 (2d, 2H, 8a-CH2, J=9.0 Hz), 3.68 (m, 1H, H-5(), 3.45 (mlHH-43.24&amp;amp;3.12(2d2HH-2'H-3J=3.9Hz) 3.19 (t, 2H, OCH2CH2CH3, J=7 Hz), 2.86 (t, 1H, H-l, J=3.9 Hz) 66 [111-(13&amp;amp;/5,44&amp;amp;9,707&amp;amp;?8&amp;amp;/3)]8&amp;amp;-[(6-_3_- --D-]_4_ 4,4a,5,6,7,7a8,8a--7-- 3- (1- 4_ -s-- 3a(lH)- -119- CNS ) A4210X297 -- ----------^------------_ () A7 B7 117) 10%/80060 60(1.030 1N3 : 1 ; 4 30/218  2 : 1) 380  cM1HCDCl3):9.70(slHCHO)7.84&amp;amp;7.38(2d4HTs) 6.06 (dd1HH-2, J=1.53.6 Hz)4.75 (dd1HH-3'J=3.3 &amp;amp;4.5Hz),4.61(dlH,H-l'J=1.2Hz)4.05(dlH,H-8aCH2aJ=9.3Hz)3.92(ddlHH-2'J=1.2&amp;amp;4.5Hz)3.65 (m3HH-5'H-4,H-8aCH2b)2.63 (m1HH-l)2.46(s 3HTs)  67 [lR-(l&amp;lt;ar3a04/?4a077aa8a/? )]8a-[(2,3--6_ --D-]_4__ 4,45,6,7,7&amp;amp;8,8&amp;amp;--7_-3-(1__14_  () A I. -S--3a(lH)- 55(5852 35 M; 8 14  6 : 1)4  1) -120- CNS ) A4210X297 321644 A7 B7 118) 764 e GHCDC13): 9.75 (s1HCHO)7.26-7.44 (m10H 2Ph)7.00 (s1HC02CPh2)6.09 (dd, 1HH-2, J=1.2 3.6 Hz), 4.71 (s1HH-l3.794.12 (2d2H8aCH2 J=9.3 Hz), 3.63 (dd, 1H, H-4', J=5.7^8.7 Hz), 3.21 (m, 1H, H-5)3.15A3.24(2d2HH-2^H-3J=3.6Hz)2.86(t 1HH_lJ=3.9 Hz) 6 8 [lR-(la3ay54/54a/577aa8a/9 )]8a-[(2,3-- 4,6--4__/?-0-]_4_ -4,45,6,7,7&amp;amp;8,8--7-_3_(1__ 14--s--3a(lH)- 67(30025 0.16 0C15  6 : 1)4 : 1) 160 CDC13) 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.98 (s1H, CliPh2)6.09 (dd1HH-2, J=1.53.9 Hz)5_09 (d1HH-lJ=l_5 Hz)4.75458 (2dq1HH-5' J5F=48.6 Hz, J=6.6 HzJ=3.9 Hz), 4.184.11(2d1H, H-41, J4F=23.1HzJ=3.9Hz)3.97&amp;amp;3.81(2d2H8aCH2,J=9.3 Hz),3.75&amp;amp;3.70(2m2HH-2m-3')2.84(tlH,H-l) ___ -121 -__ CNS ) A4210X297 (}</span>Oh, CDC13): 9.70 (s, 1H, CHO), 7.81 and 7.10-7.30 (2m, 9H, Ts and Ph), 6.08 (dd, 1H, H-2, J = 1.5 and 3.3 Hz), 4.91 (dd , 1H, H-3 ', J = 3.3 and 4.5 Hz), 4.68 (d, 1H, -, J = 1.5 Hz), 4.12 (m, 3H, Ci | 2Pt ^ H-2'), 4.06 &amp;amp;; 3.64 (2 (i, 2H, 8aCli2, J = 9.3 Hz), 3.46 (m, 1H, H-4 '), 2.65 (m, 1H, Hl), 2.36 (s, 3H, Ts) o Intermediate 6 4 [1R- (1 , 3a, 4 0, 4a0, 7, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy- 4- 0-methyl--D-  Chenranosyloxy) methyl] _4_carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl_3_ (l_methylethyl ) -L, 4-methylene-s-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester. Sodium hydride (3.2 mmol) in anhydrous dimethylformamide (6 ml) ) The suspension in was treated with a solution of intermediate 61 (1.6 mmol) in anhydrous dimethylformamide (6 mL). After 40 minutes, water: ethyl acetate (1: 1, 60 mL) was added. The organic phase was evaporated, and the residue was purified by flash chromatography, and washed away with hexane: ethyl acetate (4: 1) to obtain the title compound (96 mg), with protons _____- 118-_ This paper size is suitable for home fresh (CNS) A4 * ^ M 21GX297mm) (please read the notes on the back before filling in this page)-Order A! Printed A7 B7 by Beigong Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs Description of the invention (116) NMR spectrum confirmed intermediate 50 compound. Intermediate 6 5 [1R- (1 a, 3ay ?, 4 Si, 4a / 5, 7, 7aa, 8a; S)] 8a-[(2,3-anhydro-6-delactated-4-0- Propyl- / 5 -D- * 1 glucopyranosyloxy) methyl] _4 -methoxy-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl- 3- (l-methylethyl) -l, 4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester in sodium hydride (35 mg) in anhydrous dimethyl A solution of intermediate 62 (600 mg) in anhydrous dimethylmethylamine (15 ml) was added dropwise to the suspension in methylformamide (10 ml). The mixture was stirred at room temperature under nitrogen for 1 hour, and then treated with 1 equivalent of vaporized ammonium (50 ml) and ethyl acetate (70 ml). The organic layer was washed with water and brine, and dried over anhydrous magnesium sulfate. The residue was chromatographed on a silica flash column and washed away with hexane: ethyl acetate (8: ) and (6: i) to obtain the title compound (450 mg) as a white foam. (lU, CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPH2), 6.08 (dd, lH, H-2, J = 1.5 &amp;amp; 4.8Hz), 4.68 (s, lH, H -l '), 4.ll &amp; 3.79 (2d, 2H, 8a-CH2, J = 9.0 Hz), 3.68 (m, 1H, H-5 (), 3.45 (m, lH, H-4,), 3.24 &amp;amp; 3.12 (2d, 2H, H-2 ', H-3 ,, J = 3.9Hz), 3.19 (t, 2H, OCH2CH2CH3, J = 7 Hz), 2.86 (t, 1H, Hl, J = 3.9 Hz ). Intermediate 66 [111- (1 , 3 &amp;amp; / 5, 4, 4 &amp;amp;; 9,70, 7 &amp;amp;  ?, 8 &amp;amp; / 3)] 8 &amp;amp;-[(6-deoxy_3_ -tosyl--D- azepinelpyranosyloxy) methyl] _4  methylbrenyl_4,4a, 5,6,7,7a, 8,8a-octammine-7- Methyl- 3- (1-methylethyl)   4_ methylene-s-indida-3a (lH) -carboxylic acid-119- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 Mm) 1 ----------- ^ ------ order ------ &lt;_ (please read the notes on the back before filling this page) A7 B7 5. Invention Instructions (117) In a suspension of 10% palladium / carbon (800 mg) in ethyl acetate (60 ml) in a hydrogenation flask, add intermediate 60 (1.0 g) in ethyl acetate (30 ml) under nitrogen Solution and methanol: 1N hydrochloric acid (3: 1; 4 mmol ). The bottle was shaken in a Parr hydrogenation unit at 30 psig for 18 hours. The reaction mixture was filtered and the filtrate was evaporated to dryness. The residue was purified by flash chromatography on silica gel , Washed off with difluoromethane: methanol (20: 1). Combine the appropriate fractions and evaporate the solvent to obtain the title compound (380 mg) cM1H, CDCl3): 9.70 (s, lH, CHO), 7.84 7.38 (2d, 4H, Ts), 6.06 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.75 (dd, 1H, H-3 ', J = 3.3 &amp;amp; 4.5Hz), 4.61 (d , LH, H-l ', J = 1.2Hz), 4.05 (d, lH, H-8aCH2a, J = 9.3Hz), 3.92 (dd, lH, H-2', J = 1.2 &amp;amp; 4.5Hz), 3.65 (m, 3H, H-5 ', H-4, and H-8aCH2b), 2.63 (m, 1H, Hl), 2.46 (s, 3H, Ts) Intermediate 67 [lR- (l &amp;lt; ar, 3a0, 4 / ?, 4a0, 7 cold, 7aa, 8a /?)] 8a-[(2,3-anhydro-6_deoxy-cold-D-slightly mannosyloxy) methyl] _4_A Acetyl_4,4, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl-3- (1_methylethyl) _1,4_ Central Ministry of Economic Affairs Printed by industrial and consumer cooperatives (please read the notes on the back before filling out this page) A I. Methyl-S-indap-3a (lH) -carboxylic acid, diphenylmethyl ester A solution of intermediate 55 (585 mg) in anhydrous digas methane (20 mL) was used with monophenyl diacyl Treat the purple solution of nitrogen methane in two gas methane (35 M; 8 ml). The resulting solution was stirred at room temperature for 14 hours. The solvent was removed under reduced pressure, and the residue was analyzed and purified by flash chromatography on silica gel, and washed away with hexane: ethyl acetate (6: 1) and (4.1). Combine the appropriate parts and evaporate to make -120- This paper scale is applicable to China National Standards (CNS) A4 specifications (210X297mm&gt; 321644 A7 B7. V. Description of the invention (118) The title compound (764 mg) is obtained in white Bubbles. E GH, CDC13): 9.75 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph), 7.00 (s, 1H, C02C Ting Ph2), 6.09 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 4.71 (s, 1H, H-l '), 3.79 and 4.12 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.63 (dd, 1H, H-4', J = 5.7 ^ 8.7 Hz), 3.21 (m, 1H, H-5), 3.15A3.24 (2d, 2H, H-2 ^ H-3 ,, J = 3.6Hz), 2.86 (t, 1H, H_l, J = 3.9 Hz). Intermediate 6 8 [lR- (la, 3ay5, 4/5, 4a / 5, 7, 7aa, 8a / 9)] 8a-[(2,3-anhydro-4,6-dideoxy-4_ Fluorine _ /?-0-Loranotarosyloxy) methyl] _4_Methyl-4,4, 5,6,7,7 &amp; 8,8-octahydro-7-methyl Yl_3_ (1_methylethyl) _ 1,4-methylidene-s-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 67 (300 mg) in anhydrous The solution in methane (25 ml) was treated with diethylaminosulfur trifluoride (0.16 ml), and the resulting mixture was stirred at room temperature overnight. The mixture was cooled to 0  C, methanol (15 ml) was added to stop the reaction, and then potassium pressure was concentrated. The residue was analyzed and purified on silica gel as a flash layer, and washed away with hexane: ethyl acetate (6: 1) and (4: 1) to obtain the title compound (160 mg). CDC13): 9.73 (s, 1H, CHO), 7.45-7.26 (m, 10H, 2Ph), 6.98 (s, 1H, CliPh2), 6.09 (dd, 1H, H-2, J = 1.5 and 3.9 Hz), 5_09 (d, 1H, H-l ', J = l_5 Hz), 4.75 and 4'58 (2dq, 1H, H-5', J5, F = 48.6 Hz, J = 6.6 Hz, J = 3.9 Hz), 4.18 and 4.11 (2d, 1H, H-41, J4, F = 23.1Hz, J = 3.9Hz), 3.97 &amp;amp; 3.81 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.75 &amp;amp; 3.70 (2m, 2H , H-2m-3 '), 2.84 (t, lH, Hl). __; _ -121 -__ This paper scale is applicable to China National Crushing Rate (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">  A7 B7___ 119) 6 9 [1R-(1 a3a454ayS7y37aa8a/? )]8a-[(2,3--6-- 4- 0- (2 ---D -] -4 --4,4a, 5,67,7a8,8a--7 --3-(1- -14--s-,5-3a(lH)- 2420 0C67(300 302-3001 240 21 1030   5 : 1)  CU, CDC13): 975 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J=1.23.3 Hz)4.67 (s, 1H, -)4.10 3.78 (2d, 2H, J=9.0 Hz), 4.09-4.00 (m, 2H, H-4', H- 5'), 3.90-3.53 (m, 4H, OCi^ Ci^ OCH3), 3.40 (s, 3H, CH3CH2CH2)5 3.29^.3.11 (2d, 2H, H-3'^H-2'5 J=3.9^ 3.9Hz), 2.86 (t, 1HH-l, J=3.7 Hz) 7 0 [1R-(1 a ,3a/? ,4 4a/? ,7y57aa ,8ay5 )]8a-[(2,3--6-- 4-0-(2 --2--D- ]-4 -- 4,4a5.6,7,7a,8,8a --7-- 3- (1--l4 --s -- 3a(lH) - _-122-__________ CNS ) A4210X297 ()</span>Printed by the Central Sample Bureau of the Ministry of Economic Affairs Beigong Consumer Cooperative Printed by the Consumer Cooperative of the Central Standard Bureau of the Ministry of Economic Affairs A7 B7___ V. Description of the invention (119) Intermediate 6 9 , 7y3, 7aa, 8a /?)] 8a-[(2,3-anhydro-6-deoxy- 4- 0- (2-methoxyethyl) --D-piperanmannosyloxy ) Methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4- Methylene-s-, 5-da-3-3 (lH) -carboxylic acid, diphenylmethyl ester in a suspension of sodium hydride (24 mg) in anhydrous tetrahydrofuran (20 ml) at 0  C Intermediate 67 (300 mg) was added under nitrogen, and the mixture was stirred for 30 minutes. 2-Bromoethyl methyl ether (300 mg) and 1 equivalent of tetrabutylammonium iodide (2 ml) were added, and the mixture was heated at 40  for 2 days. The reaction was stopped with 1 equivalent of vaporized ammonium (10 ml), and the mixture was diluted with ethyl acetate (30 ml). The organic layer was washed with water and brine, dried over magnesium sulfate, and the solvent was evaporated to dryness. The residue was analyzed by chromatography on a silica flash column and washed away with hexane: ethyl acetate (5: 1) to obtain the title compound as a colorless oil.  CU, CDC13): 9.75 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.67 (s, 1H, -), 4.10 and 3.78 (2d, 2H, J = 9.0 Hz), 4.09-4.00 (m, 2H, H-4 ', H- 5'), 3.90-3.53 (m, 4H, OCi ^ Ci ^ OCH3), 3.40 (s, 3H, CH3CH2CH2) 5 3.29 ^ .3.11 (2d, 2H, H-3 '^ H-2'5 J = 3.9 ^ 3.9Hz), 2.86 (t, 1H, Hl, J = 3.7 Hz). Intermediate Zhao 7 0 [1R- (1 a, 3a /?, 4 Lu, 4a /?, 7y5,7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2 -Methylprop-2-enyl)  dot-D-Nimranylmannosyloxy) methyl] -4 -methylbranyl-4,4a, 5., 6,7,7a, 8,8a- Octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-s-indida-3a (lH) -carboxylic acid'dibenzylmethacrylate_-122 -__________ The size of this paper is suitable for Zhongpu National Abrasive (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 12)  67(0.333__2_ -0.515 3  4 : 1)62  cJ B, CDC13) 9.75 (s, 1H, CHO), 7.35 (m, 10H, 2xPh), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J=1.5^L3.6 Hz), 5.004.93 (m, m1H1HCH2=C)4_70(s1HH-l4.12 &amp;amp;3.79(2d,2H8a-CH2J=9.3Hz)4.12&amp;amp;3.96(ddlHlH, CH2, J=12 Hz), 3.26 (m, 3H, H-3', H-4'^LH-5'), 3.13 (d, 1H, H-2', J=3.9 Hz), 2.86 (t, 1H, H-l, J=3.9 Hz), 2.23 (m, 1H, CH(CH3)2)  t7 1 [1 R-( 1 a3a/? ,4/?4a/5 ,77aor8a/? )] 8a-[(2,3 --6--4-0-(1---D- ]-4 --4,4a, 56,7,7a, 8,8a --7--3-(1- -14 -- s-3- 3a(lH) -  67(1605 4 -7060  5 : 1) _ -123- CNS ) A4210X297 ()</span>A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (12) Based on the purpose of the intermediate unit 67 (0.3 millimoles), carbonate (3 millimoles) and 3_ bromine_2_ A mixture of methyl-propionate (0.5 mmol) in anhydrous dimethylformamide (15 ml) was stirred at room temperature for three days. After dilution with ether (30 mL), the mixture was washed with water. The solvent was evaporated, and the residue was purified by flash chromatography. Using hexane: ethyl acetate (4: 1) as the eluent, the title compound (62 mg) was obtained (cJ B, CDC13): 9.75 (s, 1H, CHO), 7.35 (m, 10H, 2xPh), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J = 1.5 ^ L3.6 Hz), 5.00 and 4.93 (m, m , 1H, 1H, CH2 = C), 4_70 (s, 1H, Hl,), 4.12 &amp;amp; 3.79 (2d, 2H, 8a-CH2, J = 9.3Hz), 4.12 &amp;amp; 3.96 (d, d, lH, lH, CH2, J = 12 Hz), 3.26 (m, 3H, H-3 ', H-4' ^ LH-5 '), 3.13 (d, 1H, H-2', J = 3.9 Hz), 2.86 (t, 1H, Hl, J = 3.9 Hz), 2.23 (m, 1H, CH (CH3) 2)  t Interbody 7 1 [1 R- (1 a, 3a /?, 4 / ?, 4a / 5, 7 o'clock, 7aor, 8a /?)] 8a-[(2,3-anhydro-6-deoxy-4-0- (1-methylethyl) carbonyl-Lu-D-piperanmannosyl Oxy) methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1, 4-Methylidene-s-, 3-dipyridine-3a (lH) -carboxylic acid, diphenylmethyl ester was added to a solution of intermediate 67 (160 mg) in anhydrous digas methane (5 ml) 4-Dimethylpyridine (70 mg) and isobutyl chloride (60 l). The mixture was stirred at room temperature overnight, and then concentrated to obtain a yellow oil body. This oil body was subjected to chromatography on a silica flash column, using hexane: ethyl acetate (5: 1) as _ -123- this paper For standard use, Chinese National Standard (CNS) A4 specification (210X297mm) (Read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 _____ B7 121) 162</span>1. Printed by the 1T Ministry of Economic Affairs, Central Bureau of Industry and Commerce, Beigong Consumer Cooperative A7 _____ B7 5. Description of Invention (121) Eluent The title compound (162 mg) was obtained as a white foam.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">On, CDCI3): 9.75 (s, 1H, CHO), 7.26-7.44 (m, lHs 2Ph), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2), 5.75 (s, 1H, -), 4.68 (d1HH-4J=9 Hz), 4.12 3.80 (2d, 2H 8aC^J=9 Hz), 3.43 (dq1H, H-5'J=6.69 Hz)3.15 (s 2HH-2H-32.86 (m1HH-ll)2.59 (m1H4- OCOC|iMe2) 7 2 [1R-(1 a3a/544a7y57aa8a]8a-[(2,3--6-- 4- 0- (2,2 ---D-p ]-4--4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1--14--s--3a(lH)-  67(0.34-06 150.45 25 5 : 1) 190 ^ (^, CDC13): 9.76 (s, 1H, CHO), 7.83 (m, 10H, 2xPh), 7_ (s1H, C|Ph2)6.08 (dd, 1HH-2, J=1.53.3 Hz), 4.77 (s1H-)4_67 (d1HH-41J=9 Hz), 4.133-81 (dd1H1H8a-CH2, J=9 Hz), 3.43 (m, 1HH-5)3.13 (m 2HH-2H-3'), 2.86 (t, 1H, H-lJ=3.9 Hz)2.24 (m1H CH(CH3)2) _____-124-________ CNS ) A4210X 297 ()</span>On, CDCI3): 9.75 (s, 1H, CHO), 7.26-7.44 (m, lHs 2Ph), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2), 5.75 (s, 1H, -), 4.68 (d, 1H, H-4 ,, J = 9 Hz), 4.12 and 3.80 (2d, 2H, 8aC ^, J = 9 Hz), 3.43 (dq, 1H, H-5 ', J = 6.6 and 9 Hz), 3.15 (s, 2H, H-2' and H-3 '), 2.86 (m, 1H, H-ll), 2.59 (m, 1H, 4,-OCOC | iMe2 ). Intermediate 7 2 [1R- (1 a, 3a / 5, 4 Lu, 4a million, 7y5, 7aa, 8a point)] 8a-[(2,3-anhydro-6-deoxy- 4- 0- (2 , 2-Dimethylpropanoyl) -Lu-Dp mannanosyloxy) methyl] -4-methylacyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester will be in the middle A mixture of body 67 (0.3 millimoles) and 4-dimethylaminopyridine (0.6 millimoles) in anhydrous digas methane (15 ml) was treated with neopentyl gas (0.45 millimoles). After 2.5 hours, the mixture was washed with water. The organic phase was evaporated, and the residue was purified by flash column chromatography, using hexane: ethyl acetate (5: 1) as the eluent to obtain the title compound (190 mg). ^ (^, CDC13): 9.76 (s, 1H, CHO), 7.83 (m, 10H, 2xPh), 7_ (s, 1H, C |  Ph2), 6.08 (dd, 1H, H-2, J = 1.5 and 3.3 Hz), 4.77 (s, 1H, -), 4_67 (d, 1H, H-41, J = 9 Hz), 4.13 and 3-81 (d, d, 1H, 1H, 8a -CH2, J = 9 Hz), 3.43 (m, 1H, H-5 '), 3.13 (m, 2H, H-2' and H-3 '), 2.86 (t, 1H, Hl, J = 3.9 Hz ), 2.24 (m, 1H, CH (CH3) 2)  _____- 124 -________ This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X 297 public daughter) (please read the notes on the back before filling in page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">7 7  3^644 122) 7 3 [1R_(1 a3a544a77aa8ay5 )]8a-[(2,3--4- --5---D_]_4_ -4,4a5,6,7,7a8,8a--7 --3-(1-- 14--s-M 67(0.34-.8 150.7 3 5 :1)185 d (lHCDC13): 9.75 (s1HCHO)7_32 (m15H3xPh) 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J=1.2J2L3.3 Hz), 5.20 (m, 2H, OCI^Ph), 4.72 (s, 1H, -), 4.57 (d, 1H, H-4', J=8.4 Hz)4.11 3.79 (2d, 2H8a-CH2, J=9 Hz), 3.43 (m 1H, H-5'), 3.27^3.15 (2d, 2H, H-2'^H-3'5 J=3.6 Hz), 2.85 (t, 1H, H-lJ=3.9 Hz)2.24 (m1HC|i(CH3)2) 7 4 [1R-(1 a3a044a/?7/? ,7aa8ay3 )]8a-[(2,3--6--4-- -D -4_-44a5,6,77a8,8a--7_-3-(l--l4--s-- 3a(lH)- 0.15 -60C0667(.39 56 -125- CNS ) A4210X297 ()</span>7 7 Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economy 3 ^ 644 V. Description of Invention (122) Intermediate 7 3 [1R_ (1 a, 3a; 5, 4 cold, 4a, 7 oclock, 7aa, 8ay5 )] 8a-[(2,3-anhydro-4-o-oxocarboxy-5-deoxy--D-piperanmannosyloxy) methyl] _4_carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-sM carboxylic acid 'diphenylmethyl The mixture of intermediate 67 (0.3 millimoles) and 4-dimethylaminopyridine (0.8 millimoles) in anhydrous two gas systems (15 ml) was treated with benzyloxycarbonyl gas (0.7 millimoles) Ear) Drop by drop and stir for 3 hours. After washing with water and brine, the solvent 'residue was evaporated and purified by flash chromatography, using hexane: ethyl acetate (5: 1) as the eluent to obtain the title compound (185 mg). d (lH, CDC13): 9.75 (s, 1H, CHO), 7_32 (m, 15H, 3xPh), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-2, J = 1.2J2L3.3 Hz), 5.20 (m, 2H, OCI ^ Ph), 4.72 (s, 1H, -), 4.57 (d, 1H, H-4 ', J = 8.4 Hz), 4.11 and 3.79 (2d, 2H, 8a-CH2, J = 9 Hz), 3.43 (m, 1H, H-5 '), 3.27 ^ 3.15 (2d, 2H, H-2' ^ H-3'5 J = 3.6 Hz), 2.85 (t, 1H, Hl, J = 3.9 Hz), 2.24 (m, 1H, C | i (CH3) 2). Intermediate 7 4 [1R- (1 a, 3a0, 4 Lu, 4a / ?, 7 / ?, 7aa, 8ay3)] 8a-[(2,3-anhydro-6-deoxy-4-oxy-methane -D-piperanmannosyloxy) methyl bu 4_caramyl-4'4a, 5,6,7,7a, 8,8a-octahydro-7_methyl-3- (l-methyl Ethyl) -l, 4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester in trifluoroacetic anhydride (0.1 ml) in anhydrous difluoromethane (5 ml ) The solution in) was treated dropwise with a solution of dimethyl sulfa (00.6 ml) and intermediate 67 (0.39 mmol) in anhydrous dioxane (5 ml) at -60  C. After 60 minutes, -125- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 public shame) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">123)  0.2422 20 4 : 1) 171 ^ C1!!, CDC13): 9-76 (s, 1H, CHO), 7.36 (m, 10H, 2xPh), 6-59 (s, 1H, CHPh2), 6.09 (dd, 1H, H-2, J=1.5^3.6 Hz), 4-84(slHH-l4.11&amp;amp;3.84(2d2H8a-CH2J=9Hz) 3-92(qlHH-5',J=6_9Hz)3.59&amp;amp;3.37(2dH-2m-3 J=4.2 Hz), 2.86 (t, 1H, H-l, J^3.9 Hz), 2.26 (m, 1H, CH(CH3)2) 7 5 [1R-(1 a3a/?44a77aa ,8ay5 )]8a-[(2-0- -6-- 4- 0---D -]_4_ -4,4a56,7,7a,8,8a--7 --3-(1- -1,4--s-a_3a(iH)_ 48(15.888.83 200_25 (21()45 11  6001500 1 0 %500  /1 : 201 : 7)8.75 4 8 % ) -126- CNS ) A4210X297 ()</span>Description of the invention (123) Printed by Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy. Add diethylamine (0.24 ml), and stir the mixture at 2  C for 2 hours. This mixture was diluted with methane (20 mL), washed with water, the solvent was removed, the residue was purified by flash chromatography, and hexane: ethyl acetate (4: 1) was used as the eluent to prepare the title compound (171 Mg). ^ C1 !!, CDC13): 9-76 (s, 1H, CHO), 7.36 (m, 10H, 2xPh), 6-59 (s, 1H, CHPh2), 6.09 (dd, 1H, H-2, J = 1.5 ^ 3.6 Hz), 4-84 (s, lH, Hl,), 4.11 &amp;amp; 3.84 (2d, 2H, 8a-CH2, J = 9Hz), 3-92 (q, lH, H-5 ', J = 6_9Hz), 3.59 &amp;amp; 3.37 (2d, H-2m-3 ,, J = 4.2 Hz), 2.86 (t, 1H, Hl, J ^ 3.9 Hz), 2.26 (m, 1H, CH (CH3) 2 )  Intermediate 7 5 [1R- (1 a, 3a / ?, 4, 4a cold, 70,000, 7aa, 8ay5)] 8a-[(2-0-benzoyl-6-deoxy-4 -0-Methyl-Van-D-Azepinelpyranosyloxy) methyl] _4_methylbromo-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl -3- (1-Methylethyl) -1,4-methylene-sapyridine_3a (iH) _carboxylic acid, diphenylmethyl ester intermediate 48 (15.88 g) and dimethylamine A solution of pyridinium (8.83 g) in anhydrous dioxane (200 ml) was added at -25  C under nitrogen with benzoxane (2 ml) in anhydrous digas methane (1 () ml). After stirring for 45 minutes, remove the cold bath and carefully add 1 equivalent of hydrochloric acid (10 mL). The two phases were separated, and the organic phase was diluted with methane (600 ml), washed with 1 equivalent hydrochloric acid (500 ml), 10% sodium bicarbonate (500 ml) and brine. After removing the solvent to dryness, an oil body was obtained. This oil body was subjected to flash chromatography analysis (silica, ethyl acetate: hexane volume / volume 1: 20 and 1: 7) to obtain 8.75 g of the title compound (yield 4 8%), which is a foam. -126- This paper uses the Chinese National Standard (CNS) A4 specifications (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 124) e OH, CDC13): 9.66 (s1HCHO)8.15-8.05, 7.60-7 2 (2m 15H, 3Ph), 6.95 (s, 1H, CHPh2), 5.93 (bd5 1H, H2, J=2.1 Hz), 5.35 (dd, 1H, H2J=1.54.8 Hz)4.82 (d, 1H,  J=l 8</span>A7 B7 printed by the Employee Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economy V. Description of the invention (124) e OH, CDC13): 9.66 (s, 1H, CHO), 8.15-8.05, 7.60-7 2 (2m 15H, 3Ph), 6.95 (s, 1H, CHPh2), 5.93 (bd5 1H, H2, J = 2.1 Hz), 5.35 (dd, 1H, H2 ', J = 1.5 and 4.8 Hz), 4.82 (d, 1H,  J = l 8</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.25 (m1H, H3')3.99 (d, 1H8aCH2, J=9 Hz)3 86 (dq1H, H5', J=6.38.1 Hz)3.68 (d1H8aCH2, J=9 Hz), 3.43 (s3HOCH3), 3.22 (dd, 1HH4'=8.1 Hz) 2 02 (t, 1H, HI, J=3.9 Hz), 2.45 (d, 1H, OH, J=2.4 Hz), 2.19 (m 1HCH(CH3)2)   7 6 a 3a04A 4a0707aa8a^ )]8a-[(2-_ -36--4-0--3-_D- ]-4 --4,4&amp;amp;5,6,7,73,8,8&amp;amp;-_7-_3-(1 -14--s--3a(lH)-  1.2915 -60C10 (DMSO0_66 7 5(3.4530 -60 C15.76 -20C6 122  1 2 _________-127-__ CNS ) A4210X297 ()</span>Hz), 4.25 (m, 1H, H3 '), 3.99 (d, 1H, 8aCH2, J = 9 Hz), 3 86 (dq, 1H, H5', J = 6.3 and 8.1 Hz), 3.68 (d, 1H , 8aCH2, J = 9 Hz), 3.43 (s, 3H, OCH3), 3.22 (dd, 1H, H4 ', and = 8.1 Hz) 2 02 (t, 1H, HI, J = 3.9 Hz), 2.45 (d , 1H, OH, J = 2.4 Hz), 2.19 (m 1H, CH (CH3) 2). ,, Intermediate 7 6 a '3a0, 4A' 4a0, 70, 7aa, 8a ^)] 8a-[(2-_Benzyl 3,6-dideoxy-4-0-methyl- 3-Oxy_D-perpiperanosyloxy) methyl] -4 -methylbromo-4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octahydro-7-methyl _3- (1 methylethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester, trifluoroacetic anhydride (1.29 ml) in anhydrous To the solution in methane (15 ml), add dimethyl sulfite wind (DMSO, 0_66 ml) at -60  C under nitrogen for more than 10 minutes. To the suspension formed here was added a solution of Intermediate 75 (3.45 g) in anhydrous digas methane (30 ml), and the mixture was stirred at -60 C for 1 hour. Triethylamine (5.76 ml) was added dropwise, the temperature was raised to -20C, then water (6 ml) was added to the yellow solution formed, and the mixture was stirred at room temperature for 1 hour. Add two gas methane (200 ml) and water (200 ml) to separate the two phases. The organic layer was dried over magnesium sulfate and concentrated to dryness to give a crude product. This crude product was dissolved in dimethane (10 mL) and treated with triethylamine (2 mL) overnight. Remove the solvent to get the oil body, and make this oil body flash color _________- 127 -__ This paper uses the Chinese National Standard (CNS) A4 specification (210X297mm) page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 125) /1  15 1 : 10)2.676%) A (4, CDC13): 9.68 (s1HCHO), 8.2-8.0, 7.6-7.2 (2m 15H3Ph)6.96 (s, 1HCHPh2)5_76 (dd1HH2, J=i.2  3.3Hz)5.77(ddlH,H2J=1.2&amp;amp;3.3Hz)5.39(ddlH,H2' J=1.281 Hz)4.53 (d1H, J=8.1 Hz)4.09 ( d, 1H 8aCH2, J=9 Hz), 3.75 (d, 1H, 8aCH2, J=9 Hz), 3.7-3.4 (m, 5H, Ht+OCHs+HS')2.63 (t1H, HI, J=4.2 Hz) 7 7 [1R_( 1 a3a/?44ay57y97aa8a]8&amp;amp;-[(2,3,6- -4-O-_3---D ]_4_ -4,4&amp;amp;5,6,7,7&amp;amp;,8,8&amp;amp;--7--3-(1-_ 14-_s-_3a(1H)- 5.96120 Ar151 90 C76(5.7aa'-420 5 4015 1  1 : 151 : 1) 2.61%) ^ Cn, CDC13) 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.98 (s1HCHPh2)6.04 (dd1HH2, J=1.53.6 Hz)4.45 ) A4^ ( 210297-^) (^^)</span>A7 B7 of the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs. V. Description of the invention (125) layer analysis (silica dioxide, ethyl acetate: hexane volume / volume 1  15 and 1:10), obtained 2.6 g The title compound (yield rate 76%) is a foam. A (4, CDC13): 9.68 (s, 1H, CHO), 8.2-8.0, 7.6-7.2 (2m, 15H, 3Ph), 6.96 (s, 1H, CHPh2), 5_76 (dd, 1H, H2, J = i.2 and 3.3Hz), 5.77 (dd, lH, H2, J = 1.2 &amp;amp; 3.3Hz), 5.39 (dd, lH, H2 ', J = 1.2 and 8.1 Hz), 4.53 (d, 1H, , J = 8.1 Hz), 4.09 (d, 1H, 8aCH2, J = 9 Hz), 3.75 (d, 1H, 8aCH2, J = 9 Hz), 3.7-3.4 (m, 5H, Ht + OCHs + HS ' ), 2.63 (t, 1H, HI, J = 4.2 Hz). Intermediate 7 7 [1R_ (1 a, 3a / ?, 4 cold, 4ay5, 7y9, 7aa, 8a point)] 8 &amp;amp;-[(2,3,6-trideoxy-4-O-methyl_3 -Oxyl-Lu-D-Allopyranosyloxy) methyl] _4_methoxy-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl Yl-3- (1-methylethyl) _ 1,4-methylene_s-indap_3a (1H) -carboxylic acid, diphenylmethyl ester in tributyltin hydride (5.96 ml) In a fully degassed solution (Ar, 15 minutes) in anhydrous toluene (120 ml), add an intermediate 76 (5.7 g) and a, a'-azo at 90 C with a syringe for more than 1 hour. A solution of isobutyronitrile (420 mg) in anhydrous toluene (50 mL). Continue heating until the reaction is complete, then cool to room temperature. Water (40 ml) and potassium fluoride (15 g) were added and the mixture was disturbed overnight. After removing the solvent, the obtained crude product was stirred with ether for 1 hour, and the solid was removed by filtration. The ether solution was concentrated to dryness, and the resulting oil body was subjected to flash chromatography (silica gel, ethyl acetate: hexane 1: 15 and 1: 10) to obtain 2. g of the title compound (yield rate 61%) , After drying, it becomes foam. ^ Cn, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.04 (dd, 1H, H2, J = 1.5 and 3.6 Hz) , 4.45) A4 ^ (210297- ^ ) (Please read the note ^^ on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 126) (dd1HJ=2.78.7 Hz)4.06 (d, 1H, 8aCH2, J=9 Hz), 3.70 (d, 1H, 8aCH2, J=9 Hz), 3.52 (s, 3H, CH3), 3.5-3.3 (m, 2H, H4'+, H5'), 2.7-2.5 (m, 3H, H1+H2'), 2.24 (m, 1H, CH(CH3)2) 7 8 [1R-(1 ^ ,3a^ ,4^ ,4a^ ,7y3 ,7aa ,8ay5 )]8a-[(lS,7R,9R)-2,8-9---[3.4.0]__4_-7_- ]-4 --44a ,5,6,7,7a8,8a --7 --3-(1- -1,4 --S-- 3a(lH) -  77(26011 0-C 112 101 12X 1002 1 2 X 100  /1 : 151 : 12)2 77%) ( H, CDCI3): 9-75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 699 (s, 1HCHPh2)6.05 (dd1H, H2, J=i.23.3 Hz), 545 (m, 1H, H4), 4.65 (m, 2H, H3'), 4.25-4.15 (m, 2H, H7'+H1'), 4.07 (d, 1H, 8aCH2, J=9 Hz), 3.71 (d, lH, 8aCH2, J=9 Hz), 3.19 (dq1HH91J=68.4 Hz)2.77 (t, ih, HI, J = 3_9 Hz) 129- CNS ) A4210X297 )</span>A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (126) (dd, 1H, H, J = 2.7 and 8.7 Hz), 4.06 (d, 1H, 8aCH2, J = 9 Hz), 3.70 (d, 1H, 8aCH2, J = 9 Hz), 3.52 (s, 3H, CH3), 3.5-3.3 (m, 2H, H4 '+, H5'), 2.7-2.5 (m, 3H, H1 + H2 '), 2.24 (m, 1H, CH (CH3) 2). Intermediate 7 8 [1R- (1 ^, 3a ^, 4 ^, 4a ^, 7y3, 7aa, 8ay5)] 8a-[(lS, 7R, 9R) -2,8diox-9-methyl-cis Formula-Bicyclo [3.4.0] _non_4_en-7-yl-oxymethyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro- 7-methyl-3- (1-methylethyl) -1,4-methylene-S-pyridine-3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 77 (260 Mg) and diazodimethylphosphonate diphosphonate (110 mg) in anhydrous tetrahydrofuran slowly add tertiary potassium butoxide (112 mg) to anhydrous tetrahydrofuran ( mL) at 0-C under nitrogen. Solution (see gas discharge immediately). After 10 minutes, the mixture was diluted with methane (100 mL), washed with 1 equivalent of hydrochloric acid (2  100 mL), saturated sodium bicarbonate (2  100 mL), brine (2  100 mL), Dry over magnesium sulfate. After removing the solvent, an oil body was obtained, and this oil body was subjected to flash layer analysis (silica dioxide, ethyl acetate: hexane valley product / valley product 1: 15 and 1: 12) to obtain 200 g of the title compound (product The rate of 77%) is a bubble. (H, CDCI3): 9-75 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H2, J = i .2 and 3.3 Hz), 5.45 (m, 1H, H4 ), 4.65 (m, 2H, H3 '), 4.25-4.15 (m, 2H, H7' + H1 '), 4.07 (d, 1H, 8aCH2, J = 9 Hz), 3.71 (d, lH, 8aCH2, J = 9 Hz), 3.19 (dq, 1H, H91, J = 6 and 8.4 Hz), 2.77 (t, ih, HI, J = 3_9 Hz )  129- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm). Please read the precautions on the back before filling in this education)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T A7 B7  321644 127) 7 9 [lR-(la ,3a^ , , , ^  )]8a-[(lS,4R,7R, 9R)-2,8_4-_9___[3 4 ]__7_- ]-4--4,43,5,6,7,73,8,8&amp;amp;-_7- -3-(1--_s^_3a(1H)_  78(6205 9_[3.3.1].5]^ 65 1$  C3[3.3.1] 2 1 3535%/ 5c70X 11 2X1001 2X 1002X 11  /1 : 101 : 5)475 (74%)  CDC13) 7.5-7.2 (m, 10H, 2Ph), 7.04 (s, 1H, CHPh2), 5.90(dd,lHH2,J=1.5&amp;amp;3.6Hz),4.75(dlHHOCHo J=10.5 Hz)4.62 (dd1HH7'J=2.7 5.1 Hz)4.27 (m1H, __-130-___ CNS ) A4210x297 ()</span> 1T A7 B7 Printed by the Ministry of Economic Affairs Central Bureau of Accreditation and Consumer Cooperatives 321644 V. Description of the invention (127) Intermediate 7 9 [lR- (la, 3a ^, , ,  ^  )] 8a- [ (lS, 4R, 7R, 9R) -2,8diox_4-hydroxy_9_methyl_cis_bicyclo [3 4 ] _non_7_yl-'oxymethyl] -4- Hydroxymethyl-4,43,5,6,7,73,8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyloctadecyl-methylene_s ^  ida To save _3a (1H) _carboxylic acid, diphenylmethyl ester in a solution of intermediate 78 (620 mg) in anhydrous tetrahydrofuran (5 mL), add 9_boron bicyclo [3.3.1] nonane under nitrogen (.5] ^ in tetrahydrofuran solution; 6 ml). This mixture was heated to 5.0 1 hour. Then at $ C with more than 3 hours to add another with the same Dragon's bad double ring [ 3.3.1] The nonane drops to complete the reaction, and is stirred at room temperature for 1 hour. Carefully add ethanol (2 ml) (gassing occurs) 'and stir the solution for another 1 hour. Then successively at 0.  Add 3 equivalents Sodium hydroxide (5 ml) and hydrogen peroxide (35% volume / volume, 5 ml), the mixture was stirred at room temperature, 0  C and 70X: The resulting solution was cooled to room temperature and concentrated to half volume, then diluted with 1 equivalent of hydrochloric acid (100 mL) 'and extracted twice with ethyl acetate (2X100 mL). The basic layer was extracted with 1 equivalent of hydrochloric acid (2X 100 mL) ), Sodium bicarbonate (2X 100 mL), brine (100 mL), washed over magnesium sulfate, concentrated to dryness, to obtain a slurry, this slurry for flash layer analysis (acetone / hexane 1: 10 And 1: 5), 475 g of the title compound (yield 74%) was obtained as a foam.  CDC13): 7.5-7.2 (m, 10H, 2Ph), 7.04 (s, 1H, CHPh2), 5.90 (dd , lH, H2, J = 1.5 &amp;amp; 3.6Hz), 4.75 (d, lH, HOCHo, J = 10.5 Hz), 4.62 (dd, 1H, H7 ', J = 2.7 and 5.1 Hz), 4.27 (m, 1H , __- 130 -___ This paper scale uses the Chinese National Standard (CNS) A4 specification (210x297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 128)</span>Printed by the Beigong Consumer Cooperative of the Central Bureau of the Ministry of Economic Affairs A7 B7 V. Description of the invention (128)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">H4'), 4.16 (d, 1H, 8aCH2, J=9 Hz), 4.09 (dd, 1H, H3', J=6A 9.6 Hz), 3.91 (t1H, H3J=6.9 Hz)3.7-3.5 (m3H 8aCH2+Hl'+H9'), 3.35 (d, 1H, HOCH2, J=11.5 Hz), 3.22 (dd, 1H, HOCH2, J=ll.l 12 Hz), 2.57 (t1H, HlJ=4.5 Hz), 2.48 (m1HH52.30 (m1HCH(CH3)2) 8 0 [1R-(1 a3a/?4yS4a7/S7aa8a]8a-[(lS7R9R) 2,8--9--[3.4.0]--4--7--]_ 4-[-]4,4a5,6,7,7a 8,8a--7 --3-(-14--S- -3a(lH) - 78(2005 18.91( 30ye 100100  5204 --316 1/1 : 1} 111 (100 / 1 _ 20)21592 %) ^ (!11, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), _____ -131 -_ CNS )421GX297) ' --- C)</span>H4 '), 4.16 (d, 1H, 8aCH2, J = 9 Hz), 4.09 (dd, 1H, H3', J = 6A 9.6 Hz), 3.91 (t, 1H, H3, J = 6.9 Hz), 3.7 -3.5 (m, 3H, 8aCH2 + Hl '+ H9'), 3.35 (d, 1H, HOCH2, J = 11.5 Hz), 3.22 (dd, 1H, HOCH2, J = ll.l and 12 Hz), 2.57 ( t, 1H, Hl, J = 4.5 Hz), 2.48 (m, 1H, H5,), 2.30 (m, 1H, CH (CH3) 2). Intermediate 8 0 [1R- (1 a, 3a / ?, 4yS, 4a point, 7 / S, 7aa, 8a)] 8a-[(lS, 7R, 9R)  2,8-diox-9- Cis-Bicyclo [3.4.0] -non-4-en-7-yl-oxymethyl] _4- [tertiary butyl-dimethylsilyloxymethyl] 4,4a, 5 , 6,7,7a, 8,8a-octahydro-7-methyl-3- (bumethylethyl) -1,4-methylene-S-zhaoda-3a (lH) -carboxylic acid, di To a solution of phenylmethyl ester in intermediate 78 (200 mg) in tetrahydrofuran (5 mL) was added solid sodium hydride (18.9 mg) and water (1 mL). This mixture was added at 0. (: Stir for 30 minutes, then at room temperature! Hours. Be careful to add water to stop the reaction and separate between ethyl acetate (100 ml) and water (100 ml). The organic layer is dried over magnesium sulfate and concentrated to After drying, a slurry was obtained. This slurry was redissolved in anhydrous dimethylformamide (5 ml), and imidazole (204 mg) and tertiary butyl-methyl-silyl gas (316) were used under nitrogen at room temperature. Milligram) overnight. Pour the solution into a mixture of 1 equivalent of vaporized ammonium and ethyl acetate (volume / volume 1: 1) and stir for 1 hour. The organic layer is treated with 1 equivalent of vaporized ammonium (100 ml) Wash with brine (100 ml), dry over magnesium sulfate, and concentrate to dryness to obtain a foam. This foam is subjected to flash chromatography (silica, ethyl acetate: hexane volume / volume 1 _ 20) to obtain 215 g The title compound (total output rate 92%). ^ (! 11, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), _____ -131 -_ This paper recognizes the use of China National Standards (CNS) 8 4 threats (21GX297mm) '--- C Please read the notes on the back and fill in this book)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 129) 5.96 (dd1HH2, J=1.236 Hz), 5.54 (m1HH41)4.65 (m, 2HH34.25-4.15 (m3HSiOCH2+H7, )41 (d 1H, 8aCH2, J=9.3 Hz), 3.69 (d, 1H, SiOCH2, J=9 Hz), 3.30 (d1H, 8aCH2, J=9.3 Hz), 3_19 (dq1HH9J=69 Hz) 2.68 (dd, 1HH6J=2 13.2 Hz)2.57 (t1HHlJ=4.2), 2.3 (m, 2HCH(CH3)2+H6)-0.017-0.031 (2s6H, (CH3)2Si) 8 1 [1R-(1 ,3ay9 ,4y5 ,4a^ ,  ,7aa ,8a^ ) ] 8 a-[ (1 S , 4R, 7 R, 9R)-2,8--4--9 ---[3.4.0]--7- -]-4-[-- ]4,4a5, 6,7,7a,8,8a --7--3-(1-_ 14--S--3a(lH)- 80(7005 9 -[3.3.1]0.5M 65(TC 15(rc 39 -[3.3.1] 21 C35 (3 5 %/ 5 70C 11002 1 i21 100100 -132- CNS ) 4210X297) ------- ()</span>A7 B7 printed by Beigong Consumer Cooperative of Central Bureau of Standards of the Ministry of Economy V. Description of Invention (129) 5.96 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 5.54 (m, 1H, H41), 4.65 (m , 2H, H3 '), 4.25-4.15 (m, 3H, SiOCH2 + H7, ), 4.1 (d, 1H, 8aCH2, J = 9.3 Hz), 3.69 (d, 1H, SiOCH2, J = 9 Hz ), 3.30 (d, 1H, 8aCH2, J = 9.3 Hz), 3_19 (dq, 1H, H9, J = 6 and 9 Hz), 2.68 (dd, 1H, H6, J = 2 and 13.2 Hz), 2.57 (t, 1H, Hl, J = 4.2), 2.3 (m, 2H, CH (CH3) 2 + H6 ), -0.017 and -0.031 (2s, 6H, (CH3) 2Si). Intermediate 8 1 [1R- (1 , 3ay9, 4y5, 4a ^,  , 7aa, 8a ^)] 8 a- [(1 S, 4R, 7 R, 9R) -2,8-diox- 4-hydroxy-9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl] -4- [tertiary butyl-dimethylsilyl-oxymethyl ] 4,4a, 5, 6,7,7a, 8,8a -octaplex-7-methyl-3- (1-methylethyl) _ 1,4-methylene-S-pyda province- 3a (lH) -Carboxylic acid, diphenylmethyl ester in intermediate 80 (700 mg) in tetrahydrofuran (5 ml) was added 9-boron bicyclo [3.3.1] nonane (0.5M Solution in tetrahydrofuran; 6 ml). Heat the mixture to 5  C for 1 hour. Then add another 9-boron bicyclo [3.3.1] nonane solution of the same volume to the 5  C for more than 3 hours to complete the reaction, and then cool to room temperature. Add ethanol (2 mL) carefully. After 1 hour, add 3 equivalents of sodium hydroxide (5 mL) and hydrogen peroxide (35% valley product / valley product 5 mL) successively at 0  C. The mixture is at room temperature Stir for 1 hour, stir overnight at 70  C. The resulting solution was cooled to room temperature and concentrated to half volume, then diluted with 1 equivalent of hydrochloric acid (100 mL), and extracted twice with ethyl acetate (2  100 mL). The basic layer is washed with i equivalent hydrochloric acid (2  100 mL), saturated sodium bicarbonate (100 mL), brine (100 mL), and dried on magnesium sulfate-132- This paper size is applicable to China National Standards (CNS) 4 Specifications (210X297 public shame) ------- (please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 _____B7 _ 130) /1  20 1 : 15)55077%)  ^ Cn, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), 5.95 (m, 1H, H2)4_57 (dd1HH7'J=35.14.30-4.15 (m, 2H, H4'+CH2OSi), 4.10-3.95 (m, 2H, H3'+8aCH2), 3.87 (t, 1H, H3', J=6.9 Hz), 3.7-3.5 (m, 3H, Hl'+8aCH2 + H9'), 3.30 (d, 1H, CH2OSi, J=9.3 Hz), 2.53 (t, 1H, HI, J=3.9</span>A7 _____B7 _ Printed by the Central Consumer s Consumer Cooperative of the Ministry of Economic Affairs A. _____B7 _ 5. Description of the invention (130), concentrated to dryness to obtain a slurry, which is used for flash layer analysis (acetone / hexane 1.20 and 1:15), 550 g of the title compound (yield 77%) was obtained as a white foam. ^ Cn, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), 5.95 (m, 1H, H2), 4_57 (dd, 1H, H7 ', J = 3 and 5.1 edges ), 4.30-4.15 (m, 2H, H4 '+ CH2OSi), 4.10-3.95 (m, 2H, H3' + 8aCH2), 3.87 (t, 1H, H3 ', J = 6.9 Hz), 3.7-3.5 (m , 3H, Hl '+ 8aCH2 + H9'), 3.30 (d, 1H, CH2OSi, J = 9.3 Hz), 2.53 (t, 1H, HI, J = 3.9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 2.46 (m, 1H, H5)2.32 (m, 1HCH(CH3)2), -0.016-0.029 (2s, 6H, (CH3)2Si) 8 2 [lR-(la ,3a/3 ,4  ,  ,7aa ,8ay5 ) ] 8 a-[ (1 S, 4R, 7 R, 9R)-2,8--4 --9---[3.4.0]--7- -]-4-[-- ]4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1--14--S--3a(lH)- 81(5375 0C7510 374 10000 100 THF(511 240C24 AcOEI2 X 1 _ -133- CNS ) A4^210X297 ()</span>Hz), 2.46 (m, 1H, H5,), 2.32 (m, 1H, CH (CH3) 2), -0.016 and -0.029 (2s, 6H, (CH3) 2Si). Intermediate 8 2 [lR- (la, 3a / 3, 4 ,  , 7aa, 8ay5)] 8 a- [(1 S, 4R, 7 R, 9R) -2,8-diox-4- Methoxy-9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl] -4- [tertiary butyl-dimethylsilyl-oxymethyl ] 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-S-indene Dasheng-3a (lH) -carboxylic acid, diphenylmethyl ester in a solution of intermediate 81 (537 mg) in anhydrous tetrahydrofuran (5 mL) was added sodium hydride in small batches under nitrogen at 0  C 75 mg). After stirring for 10 minutes, methyl iodide (374 l) was added, and the mixture was left at room temperature until the reaction was complete. Water (100 ml) was added to stop the reaction, and then extracted with ethyl acetate ( 00 ml). The organic layer was washed with brine (100 mL) and concentrated to dryness to obtain a foam. This foam was dissolved in THF (5 mL), and tetrabutylammonium fluoride (1.1 M in tetrahydrofuran, 2 mL) Treat at 40  C for 24 hours. The resulting solution was concentrated to dryness, the residue was dissolved in AcOEI, washed with water (2 X 100 mL), and used on the paper standard _ -133- Chinese National Standard (CNS) A4 ^ (210X297 mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  S21644 A7 ________B7 131)  85215  (10%i2 1200  1 : 151 : 11 : 8)255 5 7 %)  ^ (^, CDC13) 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1HCHPh2)6.04 (dd1H, H2, J=1.23.6 Hz), 4.60 (m, 1H, H7'), 4.10-3.95 (m, 2H, H4'+8aCH2), 3.90-3.65 (m, 3H, H3'+H1'), 3.65-3.55 (m, 2H, 8aCH2+H9'), 3.35 (s, 3H, CH3), 2.73 (t, 1H, HI, J=3.6 Hz), 2.54 (m, 1H, H5'), 22.4 (m, 1H, CH(CH3)2)  8 3 [1R-(1 a3a44a7y57aa ,8ay5 )]8a-[(6--4-0--y3-D -]_4_(13__2--4,4a5,6,7,7a8,8a--7--3-(l--14_-s-_3a(iH)- 48(9.740 110 25 P-40 C3 1 : 1500  ____ -134-__ CNS ) A4210X297] ()</span> 1T Beigong Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs, Printed and Collected S21644 A7 ________B7 V. Description of the invention (131) Sulfuric acid is slowly dried and concentrated to dryness, and the slurry is redissolved in water digas methane (85 ml) . Aerated pyridium chromate (215 mg) was added, and the mixture was stirred at room temperature until the reaction was complete. Pour the suspension onto a mixture of methane and sodium metabisulfite (10% aqueous solution). The base layer was washed with i equivalent of hydrochloric acid (200 mL) and 1 equivalent of sodium hydroxide (200 mL), dried over magnesium sulfate, and concentrated to dryness to obtain an oil body, which was flashed on silica gel Layer analysis (ethyl acetate: hexane 1:15, 1:10 and 1: 8) to obtain 255 g of the title compound (total yield 57%). ^^^^, CDC13): 9.74 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), 6.99 (s, 1H, CHPh2), 6.04 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 4.60 (m, 1H, H7 ') , 4.10-3.95 (m, 2H, H4 '+ 8aCH2), 3.90-3.65 (m, 3H, H3' + H1 '), 3.65-3.55 (m, 2H, 8aCH2 + H9'), 3.35 (s, 3H, CH3), 2.73 (t, 1H, HI, J = 3.6 Hz), 2.54 (m, 1H, H5 '), 22.4 (m, 1H, CH (CH3) 2) Intermediate 8 3 (1R- (1 a, 3a, 40,000, 4a, 7y5, 7aa, 8ay5)] 8a-[(6-deoxy-4-0-methyl-y3-D-azorpiperanyloxy) methyl] _4_ (1,3_dioxolane-2-yl) -4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -1,4_methylene-s-pyridine_3a (iH) -carboxylic acid, diphenylmethyl ester, a solution of intermediate 48 (9.7 mmol) in anhydrous methanol (40 mL) was Ethylene glycol (110 ml ), Trimethyl orthoformate (25 ml) and catalytic amount of P-toluenesulfonic acid. This mixture was heated at 40  C for 3 hours. After cooling, the mixture was poured into a mixture of ethyl acetate: sodium bicarbonate aqueous solution (1: 1, 500 ml), and the aqueous layer was thoroughly extracted with ethyl acetate. Water for combined organic layer ____ -134 -__ The paper size is in accordance with Chinese National Standard (CNS) A4 (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 A7  ______B7   (6  )(619)  ^ (ln, CDC13): 7.435.7.30 (m, m, 4H, 6H, 2xPh), 6.94 (s, 1H, CHPh2), 5.83 (dd, 1H, H-2, J=1.2^3.6 Hz), 5.07 (s, 1H, 4-CH), 4.63 (d, 1H, H-l', J-1.5 hz), 4.20 (t, 1H, H-3', J=3.3 Hz), 4.07 (d, 1H, 8a-CHa, J=9.3 Hz), 3.84 (m, 6H, H-2', 8a- CHb0CH2CH20)3.71 (m1HH-51), 3.42 (s, 3HOCH3) 3.21 (dd1HH-4J=39 Hz), 2.63 (m1H, C(CH3)2) 2.54 (t1HH-lJ=3.9 Hz) 8 4 [lR-(la3ab4b4ab7b7aa8ab)] 8a-[(2-0-6 - 4- 0-_b-D -] -2--4,4&amp;amp;5,6,7,73,8,8&amp;amp;--7--3-(1- -1,4--s__3a(iH)_ 83 (12.126.3 155_2(rc (1.40502 5 500500  /1 : 4)5.8942%)   (^, CDC13): 8.14-8.05, 7.6-7.2 (2m, 15H, 3Ph), 6.91 (s, _-135- A4210X297 (f)</span>A7 A7 Printed by Beigong Consumer Cooperative of Central Bureau of Economic Development, Ministry of Economics ______B7 V. Description of invention (and brine washing 'drying. After removing the solvent, the residue is analyzed for flash layer, using hexane: ethyl acetate (6 ) As an eluent, the title compound (619 g) was obtained. (^, CDC13): 7.435.7.30 (m, m, 4H, 6H, 2xPh), 6.94 (s, 1H, CHPh2), 5.83 (dd, 1H , H-2, J = 1.2 ^ 3.6 Hz), 5.07 (s, 1H, 4-CH), 4.63 (d, 1H, H-l ', J-1.5 hz), 4.20 (t, 1H, H-3 ', J = 3.3 Hz), 4.07 (d, 1H, 8a-CHa, J = 9.3 Hz), 3.84 (m, 6H, H-2', 8a- CHb and 0CH2CH20), 3.71 (m, 1H, H- 51), 3.42 (s, 3H, OCH3), 3.21 (dd, 1H, H-4 ', J = 3 and 9 Hz), 2.63 (m, 1H, Cting (CH3) 2), 2.54 (t, 1H , Hl, J = 3.9 Hz). Intermediate 8 4 [lR- (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[(2-0-benzylamide  6  deoxy- 4- 0-methyl_bD -azorpiperanyloxy) methyl] dioxolane-2-yl) -4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octa Hydrogen-7-methyl-3- (1-methylethyl) -1,4-methylene-s_indap_3a (iH) _carboxylic acid, diphenylmethyl ester in intermediate 83 (12.12g) and dimethylaminopyridine (6.3g) A solution of benzoin gas (1.40 ml) in 50 ml of anhydrous digas methane was added dropwise to the solution in anhydrous digas formazan (155 ml) at _2 (rc under nitrogen. After stirring for 2 hours, let the mixture rise At room temperature, the solution was washed with equivalent hydrochloric acid (500 ml) 'saturated sodium bicarbonate (500 ml) and brine (500 ml). Remove the solvent' residue for flash chromatography (silica gel, ethyl acetate) Ester: hexane volume / volume 1: 4) to obtain 5.89 g of the title compound (42%) as a white foam.  (^, CDC13): 8.14-8.05, 7.6-7.2 (2m, 15H, 3Ph), 6.91 (s, _-135- A4 specification (210X297 public daughter) (Please read note f on the back and then fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 133) 1H, CHPh2), 5.70 (bd, 1H, H2, 1=2.1 Hz), 5.34 (dd, 1H H2' J=2.1 5.1 Hz), 5.01 (s, 1HOCHO), 4.82 (d1H, J=1 8</span>A7 B7 printed by the Employees Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs 5. Description of the invention (133) 1H, CHPh2), 5.70 (bd, 1H, H2, 1 = 2.1 Hz), 5.34 (dd, 1H H2 'J = 2.1 and 5.1 Hz), 5.01 (s, 1H, OCHO), 4.82 (d, 1H, , J = 1 8</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.26 (m, 1H, H3'), 3.98 (d, 1H, 8aCH2, J=9.3 Hz), 3.92-3.74 (m, 5H, H5'+OCH2CH2O), 3.72 (d, 1H, 8aCH2, J=9.3 Hz), 3.42 (s3H, OCH3), 3.23 (dd, 1HH4, J=3.3 8.1 Hz), 2.57 (m, 1H, CH(CH3)2), 2.44-2.38 (m, 2H, OH+H1) o 8 5 [1R-(1 a ,3ay5 ,4yS ,4a;9 ,7y3 ,7aa ,8a]8a-[(2-0_ -3,6 -- 4- 0--3-- b- D-) ]-4-(13--2--4,4a5,6,7,7a8,8a- -7 -- 3- (1-.-l4 --s-_3a(iH)_  0.455 -60 C1dms( 0.23 84(12 5_6c1 1.24_ 2  C  (200250  2  /1 : 151 : 10) 136- CNS ) A4^210X297 ()</span>Hz), 4.26 (m, 1H, H3 '), 3.98 (d, 1H, 8aCH2, J = 9.3 Hz), 3.92-3.74 (m, 5H, H5' + OCH2CH2O), 3.72 (d, 1H, 8aCH2, J = 9.3 Hz), 3.42 (s, 3H, OCH3), 3.23 (dd, 1H, H4 , J = 3.3 and 8.1 Hz), 2.57 (m, 1H, CH (CH3) 2), 2.44-2.38 (m, 2H, OH + H1) o Intermediate 8 5 [1R- (1 a, 3ay5, 4yS, 4a; 9, 7y3, 7aa, 8a)] 8a-[(2-0_Benzenyl-3,6 -Dideoxy- 4- 0-methyl-3-oxy-b-D-dezopiperanosyloxy) methyl] -4- (1,3-dioxolan-2-yl) -4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methyl.ethyl) -l, 4-methylene-s-  jian _3a (iH) _ carboxylic acid, diphenylmethyl ester in a solution of trifluoroacetic anhydride (0.45 ml) in anhydrous digas methane (5 ml) at -60  C under nitrogen for 10 minutes Add dms (0.23ml) for the above time. To the resulting suspension was added a solution of Intermediate 84 (12 g) in anhydrous methane (5 ml), and the mixture was stirred at -600  C for 1 hour. Triethylamine (1.24 ml) was added dropwise, and the temperature was raised to -20  C, then water was added to the yellow solution, and the mixture was stirred at room temperature for 1 hour. Add two gas methane (200 ml) and water (250 ml) to separate into two phases. The organic layer was dried over magnesium sulfate and concentrated to dryness to obtain the crude product. This crude product was redissolved in dichloromethane (mL) and treated with triethylamine (2 mL) overnight. After removing the solvent, the oil was obtained. The oil body was analyzed by flash layer (silica dioxide, ethyl acetate: hexane volume / volume 1: 15 and 1: 10) to obtain g of the title compound (yield 136- The size of this paper is applicable to the Chinese National Standard (CNS) A4 ^ (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 B7 _______ 134) 92%) ^ H, CDCI3): 8.2-8.0, 7.6-7.2 (2m, 15H, 3Ph), 6.90 (s, 1HCHPh2)5.57 (dd1H, H2, J=1.23.6 Hz), 5.37 (dd1H, H2J=1.58.1 Hz)5.05 (s1HOCHO)4.52 (d1H, Hl' J=8.1 Hz), 4.08 (d, 1H, 8aCH2, J=8.7 Hz), 3.9-3.7 (m, 5H, OCH2CH20+8aCH2), 3.6-3.4 (, 5H, H4'+OCH3+H5'), 2.62 (m, 1H, CH(CH3)2)2.43 (t1HHI, J=3.9 Hz) 8 6 [1R-(1 a3a4/?4a/J77&amp;amp;?8&amp;amp;]8&amp;amp;-[(2,3,6- 4-0 --3-- b- D-]-4-(1,3--2--4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1_ -14 --s -_3a(iH)-  2631 Ar151 90C85(250a,a-16) 50 51  1  1 : 151 : 1) 1688  %)  (^, CDC13): 7.6-7.1 (m, 10H, 2Ph), 6.92 (s, 1H, CHPh2), 5.80(ddlHH2J=0.9&amp;amp;3.6Hz)5.08(slHOCHO)4.44 ____-137_ CNS ) A4210X297 ()</span>, 1T Printed by Beigong Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs A7 B7 _______ V. Description of the invention (134) 92%), it is foam after drying. ^ H, CDCI3): 8.2-8.0, 7.6-7.2 (2m, 15H, 3Ph), 6.90 (s, 1H, CHPh2), 5.57 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 5.37 (dd , 1H, H2 ', J = 1.5 and 8.1 Hz), 5.05 (s, 1H, OCHO), 4.52 (d, 1H, Hl', J = 8.1 Hz), 4.08 (d, 1H, 8aCH2, J = 8.7 Hz) ), 3.9-3.7 (m, 5H, OCH2CH20 + 8aCH2), 3.6-3.4 (, 5H, H4 '+ OCH3 + H5'), 2.62 (m, 1H, CH (CH3) 2), 2.43 (t, 1H , HI, J = 3.9 Hz). Intermediate 8 6 [1R- (1 a, 3a Lu, 4 / ?, 4a / J, 7, 7 &amp;amp;  ?, 8 &amp;amp; )] 8 &amp;amp;-[(2,3,6-trideoxy  4-0-methyl-3-oxy-b-D-piperanyloxy) methyl] -4- (1,3-dioxolan-2-yl) -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1_ methylethyl) -1,4-methylene-s-indap_3a (iH) -Carboxylic acid, diphenyl methyl ester in a fully degassed solution (Ar, 15 minutes) in tributyltin hydride (263 microliters) in anhydrous toluene (10 ml), using a syringe for more than 1 hour At 90  C, add a solution of Intermediate 85 (250 mg) and a, a'-azoisobutyronitrile (16 mg) in anhydrous toluene (50 mL). Continue heating until the reaction is complete, then cool to room temperature. Water (5 ml) and potassium fluoride (100 mg) were added, and the mixture was stirred overnight. After removing the solvent, the resulting crude product was stirred with diethyl ether for 1 hour, and the solid was removed. The ether solution was concentrated to dryness, and the resulting oil body was subjected to flash chromatography (silica gel, ethyl acetate: hexane 1: 15 and 1: 10) to obtain 168 mg of the title compound (yield 80%) , After drying, it becomes foam.  (^, CDC13): 7.6-7.1 (m, 10H, 2Ph), 6.92 (s, 1H, CHPh2), 5.80 (dd, lH, H2, J = 0.9 &amp;amp; 3.6Hz), 5.08 (s, lH, OCHO), 4.44 ____- 137_ The size of this paper uses the Chinese National Standard (CNS) A4 specification (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 ^21644 B7________ 135) (dd1HHI', J=2.78.7 Hz)4.05 (d, 1H8aCH2, J=9.3 Hz) 3.9-3.7 (m, 5H, 0CH2CH20+8aCH2), 3.50-3.30 (m, 2H, H5'+H4'), 2.5-2.l(m, 3H, H2'+CH(CH3)2), 2.50 (t, 1H, HI, J = 4.5 Hz)  8 7 [lR-(la3ab4b4ab7b7aa8ab)]8a-[(l S7R9R)-2,8- -9 ---[3.4.0]--4--7--]-4-[1,3--2-]4,43,5,6,7,7&amp;amp;8,8&amp;amp;--7- -3-(1--1,4--S-- 3a(lH)-  86( 16063) 0 C 1002.3 101 12x 1002x1  2X100  /1 : 151 : 12)11 7 0 % ) cy On, CDC13) 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), 5.83 (dd1HH2, J=1.23.3 Hz)5.53 (m1HH4')5.06 (s, 1H, OCHO), 4.65 (m, 2H, H3'), 4.25-4.10 (m, 2H, H7'+H1')S 4.05 (d, 1H, 8aCH2, J=9.3 Hz), 3.90-3.70 (m, 5H, CH2CH20+8aCH2)3.18(dq1HH9J=68.7 Hz)2_75- _ -138- CNS ) A4210X297 ()    A7 B7 136) ' 2.50 (m3H6'+(((3)2+1) 8 8 [1R-(1 a3a44a 7/57aa,8ay5)]8a-[(4-0-_ 3,6--3--b-D-]_ 4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7_-3-(1-_1,4_ -s--3a(lH)- 53(gm 2008) (103197 515 (95 tic4 : 1) 513 1 Na2S04)  9 : 1)7 ^ (lU, CDC13) 9.73 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph)6.98(s,lHC|iPh2)6.03(dd,lHH-2J=1.5&amp;amp;3.6</span>A7 ^ 21644 B7________ 5. Description of the invention (135) (dd, 1H, HI ', J = 2.7 and 8.7 Hz), 4.05 (d, 1H, 8aCH2, J = 9.3 Hz), 3.9-3.7 (m, 5H, 0CH2CH20 + 8aCH2), 3.50-3.30 (m, 2H, H5 '+ H4'), 2.5-2.l (m, 3H, H2 '+ CH (CH3) 2), 2.50 (t, 1H, HI, J = 4.5 Hz) Intermediate 8 7 [lR- (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[(l S, 7R, 9R) -2,8-dioxo-9-methyl- Cis-bicyclo [3.4.0] -non-4-en-7-yl-oxymethyl] -4- [1,3-dioxolan-2-yl] 4,43,5,6, 7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-S-pyridine- 3a (lH) -carboxylic acid , A solution of diphenyl methyl ester in intermediate 86 (160 mg) and diazoxymethyl diphosphonate (63 mg) in anhydrous tetrahydrofuran was slowly added tertiary potassium butoxide under nitrogen at 0  C (100 mg) muddy substance in anhydrous tetrahydrofuran (2.3 ml) (an air discharge is immediately seen). After 10 minutes, the mixture was diluted with methane (100 mL), washed with 1 equivalent of hydrochloric acid (2  100 mL), saturated sodium bicarbonate (2  100 mL), brine (2  100 mL), and washed with sulfuric acid Dry on magnesium. After removing the solvent, an oil body was obtained. This oil body was subjected to flash chromatography analysis (silica dioxide, ethyl acetate: hexane volume / volume 1: 15 and 1: 12) to obtain 110 g of the title compound (yield 7 0%) is a bubble. cy On, CDC13): 7.5-7.2 (m, 10H, 2Ph), 6.94 (s, 1H, CHPh2), 5.83 (dd, 1H, H2, J = 1.2 and 3.3 Hz), 5.53 (m, 1H, H4 ' ), 5.06 (s, 1H, OCHO), 4.65 (m, 2H, H3 '), 4.25-4.10 (m, 2H, H7' + H1 ') S 4.05 (d, 1H, 8aCH2, J = 9.3 Hz), 3.90-3.70 (m, 5H, CH2CH20 + 8aCH2), 3.18 (dq, 1H, H9, J = 6 and 8.7 Hz), 2_75- _ -138- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification ( 210X297mm) (Please read the precautions on the back before filling out this page) Ordered by the Ministry of Economic Affairs Central Bureau of Standardization Bei Gong Consumer Cooperative Printed by the Ministry of Economic Affairs Central Bureau of Standards Bei Gong Consumer Cooperative printed A7 B7 V. Description of the invention (136) '2.50 (m, 3H, 6' + (:  ((: 3) + 1). Intermediate 8 8 [1R- (1 a, 3a , 4 Lu, 4a Lu, 7/5, 7aa, 8ay5 )] 8a-[(4-0-Phenylpropyl-3,6-dideoxy-3-iodo-bD-piperanmannosyloxy) methyl] _4,4 &amp;amp;, 5,6,7 , 7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl-3- (1-methylethyl) _1,4_methylene-s-indap-3a (lH) -carboxylic acid, diphenyl Methyl esters intermediates 53 (gm 2008) (103 mg), triphenylmethylphosphine (197 mg) and imidazole (51 mg) The solution in anhydrous tetrahydrofuran (5 mL) was treated in batches with Qi (95 mg). After stirring at room temperature for 1 hour, the solution was refluxed until all the starting material was consumed (tic analysis hexane: ethyl acetate 4: 1 ). The reaction mixture was cooled and separated between ethyl acetate (50 mL) and 1 equivalent aqueous hydrochloric acid (30 mL). The organic layer was washed successively with 1 equivalent aqueous hydrochloric acid, water, aqueous sodium metabisulfite, water and brine, then Dry (Na2S04), filter and concentrate. The residue was subjected to flash chromatography on silica gel and washed away with hexane: ethyl acetate (9: 1) to obtain the title compound (70 mg). , CDC13): 9.73 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph), 6.98 (s, lH, C | iPh2), 6.03 (dd, lH, H-2, J = 1.5 &amp;amp; 3.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 6.02-5.9 (m, 1H, -C-CH=C), 5.35-5.15 (m, 2H, 042-c=cH2)s 4.4-4.32 (m, 1H, 0-CHa-C=C), 4.35 (d, 1H, H-l', J=0.6 Hz), 4.18-3.96 (m, 4H, 0-CHb-C=C, H-2', H-3', 8aCHa), 3.75 (d, 1H, 8a-CHb, J=9 Hz), 3.45 (dd, 1H, H-4',  10.2 Hz), 3.34 (dq, 1HH-5', J=5_78.7 Hz)2.72 (t, 1HH-lJ=3.9 Hz) 89a _____-139- XACNS ) 4 ( 210X297) ()    A7 B7 13 a)[lR-(l a ,3ay3 ,4  ,4ay5 ,1  ,7aa ,8ay9 ) ] 8 a - [ (1 S , 4 S , 6 S , 7R9R)-2,8--4,9---[3.4.0]_ -7_ -]-4-_4a5,6,7,7a8,8a--7--3-(l--l4--S-o5-3a(lH)-  (b)[lR_( la3ab4b4ab7b7aa8ab)] 8a-[( 1 S4R6S7R 9R)-2,8--4,9---[3 4 ]__7__ ]-4-_4-45,6,7,7&amp;amp;8,8--7--3-(1--14 -_s__3a(lH) -  88(80 6041 1 55  TLC 95 : 5) a)89a(35Rf=.4 9 : 1)b)89b(24Rf=.3 9 : 1) 8 9 a S (]H, CDC13): 9.73 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph)6.99(slHC|^Ph2)6_05(ddlHH-2J=1.2&amp;amp;3.3</span>Hz), 6.02-5.9 (m, 1H, -C-CH = C), 5.35-5.15 (m, 2H, 042-c = cH2) s 4.4-4.32 (m, 1H, 0-CHa-C = C ), 4.35 (d, 1H, H-l ', J = 0.6 Hz), 4.18-3.96 (m, 4H, 0-CHb-C = C, H-2', H-3 ', 8aCHa), 3.75 ( d, 1H, 8a-CHb, J = 9 Hz), 3.45 (dd, 1H, H-4 ', and 10.2 Hz), 3.34 (dq, 1H, H-5', J = 5_7 and 8.7 Hz), 2.72 (t, 1H, Hl, J = 3.9 Hz). Intermediate 89a and _____- 139- This paper XA Xiao uses the Chinese National Standard (CNS) 4  (210X297 public daughter) (please read the precautions on the back before filling in this page) Order Printed by the consumer cooperative A7 B7 V. Description of the invention (13 is a) [lR- (la, 3ay3, 4 , 4ay5, 1 , 7aa, 8ay9)] 8 a-[(1 S, 4 S, 6 S, 7R, 9R) -2,8-dioxo-4,9-dimethyl-cis-bicyclo [3.4.0] _non-7_yl-oxymethyl] -4-methyl-4a, 5 , 6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -1,4-methylene-S-o5 Tetioic acid, diphenylmethyl ester (b) [lR_ (la, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[(1 S, 4R, 6S, 7R, 9R) -2,8- Dioxo-4,9-dimethyl-cis-bicyclo [3 4 ] _non_7_yl_oxymethyl] -4-carboxyl_4-4, 5,6,7, 7 &amp;amp;, 8,8-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene_s_indap province_3a (lH) -carboxylic acid, di Phenylmethyl ester A solution of intermediate 88 (80 mg) in anhydrous toluene was degassed with a stream of argon for 60 minutes, and then heated to reflux. Add tributyltin hydride (41 l) and continue to reflux for 15 minutes. The solvent was removed in vacuo, and the residue was dissolved in ether (50 mL) 'and washed several times with saturated aqueous fluorinated bell solution until no more precipitation of tributyltin fluoride was seen. The organic layer was dried and evaporated to obtain a residue, which was purified by TLC (silica dioxide 'difluoromethane: ethyl acetate 95: 5) to obtain the title compound (a) intermediate 89a (35 mg, Rf = 0). .4, Difluoromethane: ethyl acetate 9: 1) and the title compound (b) intermediate 89b (24 mg, Rf = 0.3, Difluoromethane: ethyl acetate 9: 1). Intermediate 8 9 a S () H, CDC13): 9.73 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph), 6.99 (s, lH, C | ^ Ph2), 6_05 (dd, lH , H-2, J = 1.2 &amp;amp; 3.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.63 (d, 1H, H-7', J-3.3 Hz), 4.02 (d, 1H, 8aCHa, J-9</span>Hz), 4.63 (d, 1H, H-7 ', J-3.3 Hz), 4.02 (d, 1H, 8aCHa, J-9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)3.86(ddlHHa-3'J=6.6&amp;amp;8.7Hz),3.83-3.6(m,4H -140- CNS ) A4^210X297 ()</span>Hz), 3.86 (dd, lH, Ha-3 ', J = 6.6 &amp;amp; 8.7Hz), 3.83-3.6 (m, 4H, -140- This paper scale is applicable to the Chinese National Standard (CNS) A4 ^ grid (210X297 Ali) (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T A7 B7   -6'-H-9'8a-CHb)3.52 (dd1HHb-3,   5.7 8.7</span> 1T A7 B7 Printed by Beigong Consumer Cooperative of Central Bureau of Standards of the Ministry of Economy V. Description of Invention (H-6 ', -, H-9' and 8a-CHb), 3.52 (dd, 1H, Hb-3,, , Bu 5.7 and 8.7</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)2.69 (t1H, H-lJ=3.9 Hz) 89b (1^ CDC13): 9.74 (s1HCHO)7.45-7.22 (m1H 2Ph)6.99 (s1HC|^Ph2)606 (dd1HH-2, 23 6</span>Hz), 2.69 (t, 1H, H-1, J = 3.9 Hz). Intermediate 89b (1 ^ CDC13): 9.74 (s, 1H, CHO), 7.45-7.22 (m, 10H 2Ph), 6.99 (s, 1H, C ^^ 2), 6.06 (dd, 1H, H-2, 2 and 3 6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)4.48 (d1HH-7J=2.1 Hz)4.1-4.0 (m2H{</span>Hz), 4.48 (d, 1H, H-7 , J = 2.1 Hz), 4.1-4.0 (m, 2H," {take and</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ha-3')3.85 (dd1H-, J=7.89 Hz), 376 i  (m2h 8a-CHbH-6')3.46-3.3 (m2HH-9'Hb-30  ,  ;z.73 (t1H H-lJ=3.9 Hz) 9 0 [1R-(1  ,3a^ ,4^ ,4a^ ,7^ ,7a^ ,8a^ )]8a-rr^ + ^ d -^ _ D-]-4 -_4 a c a5,6,7,7a 8,8a --7-- 3- (1--14-reI  &amp;amp; T S  p -3a(lH)- ^ 4-1 w  90 J, 6 3 : 12.6 ^ (^, CDC13) 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd1H, H-2J=1.53.6 Hz)4.65 (d, 1H H-l'1.5</span>Ha-3 '), 3.85 (dd, 1H, -, J = 7.8 and 9 Hz), 3.76 i, (m, 2h, 8a-CHb and H-6'), 3.46-3.3 (m, 2H, H-9 'and Hb-3, 0 ,';, z.73 (t, 1H, Hl, J = 3.9 Hz). Intermediate 9 0 [1R- (1 , 3a ^, 4 ^ , 4a ^, 7 ^, 7a ^, 8a ^)] 8a-rr ^ + ^ d deoxy- ^ _ D- azepinepyranosyloxy) methyl] -4 -methylacetyl_4 ac, Bucket a, 5,6,7,7a 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4-re A I '&amp;amp; T storm  S  p cited Semen-3a (lH) -carboxylic acid, diphenylmethyl ester ^ in 4'-demethylsodarin (10g) solution in methanol, w, dingyin to warm dropwise addition of diphenyl The diazomethane (90 ml) was dissolved in dichloromethane, and the mixture was stirred for 6 hours. The solvent was evaporated to dryness, and the residue was subjected to flash chromatography on a silica gel column. Using n-hexane: ethyl acetate (3: ) as the eluent, the title compound (12.6 g) was obtained as a pale yellow foam . ^ (^, CDC13): 9.73 (s, 1H, CHO), 6.98 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.65 (d, 1H H- l ', Bu 1.5</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.09, 3.76 (2d, 2H, Sa-Cl^, J=9 Hz), 4.i (m, 1H, H- 2'), 3.84 (m, 1H, H-3'), 3.75(m, 1H, H-5'), 3.69 (m, 1H, H-4')2.73 (t, 1H, H-lJ=4.2 Hz) -141 - CNS ) A421 OX 297 (</span>Hz), 4.09, 3.76 (2d, 2H, Sa-Cl ^, J = 9 Hz), 4.i (m, 1H, H- 2 '), 3.84 (m, 1H, H-3'), 3.75 (m, 1H, H-5 '), 3.69 (m, 1H, H-4'), 2.73 (t, 1H, Hl, J = 4.2 Hz). -141-This paper scale is applicable to China National Standard (CNS) A4 (21 OX 297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7  9 ] [1R-(1 a3a/?4/?4a077aa8a]8-[(6-_3,4---D-]-4--4,4a5,6, 7,7a, 8,8a--7-_3-(l--1,4-_s_ -3a(lH)- 90(650152,2- _(1 : 2)p -1 1.51.03 5 (252x50  g1 : 3) 600 ^ (!, CDC13) 9.73 (s, 1H, CHO), 7.45-7.24 (m, iH, 2Ph)6.98(slH,C|iPh2),6.06(ddlHH-2J=i.5&amp;amp;3.3 Hz), 4.57 (d, 1H, -, J=3.0 Hz), 4.30 (dd, 1H, H-3', J=3.6 5.7 Hz)4.07 (d1H8aCH2, J=9.0 Hz)3.95-3.93 (m1H, H-23.85(dd,lH,H-4J=5.7&amp;amp;9.3HZ)3.75(d1H, 8aCH2, J=9.0 Hz), 3.44 (dq, 1H, H-5', Jd=9.3 Hz, Jq=6.3 Hz), 2.73 (t1HH-lJ=3.6 Hz) 9 2 [1R-(1 a3a044a/?77aor ,8a]8a-[(6--3,4---2-0-(-D- ]-4 --4,4a5,6,7,7a8,8a--7-- -142- J^HZiFFiT^T^i^~i7^i^ ~~' ' ()</span>A7 B7 printed by the Staff Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (Intermediate 9] [1R- (1 a, 3a / ?, 4 / ?, 4a0, 7 points, 7aa, 8a points)] 8 Resistance- [(6-Deoxy_3,4---D-azorpiperanosyloxy) methyl] -4-carboxamide-4,4a, 5,6, 7,7a, 8, 8a-octahydro-7-methyl_3- (l-methylethyl) -1,4-methylene_s_indap-3a (lH) -carboxylic acid, diphenylmethyl ester in the middle Body 90 (650 mg) was added p-toluic acid (10 mg) in a solution of 15 ml of 2,2-dimethoxypropane: propane_ (1: 2). The solution was stirred at room temperature for 1.5 hours Then, potassium carbonate (1.0 g) was added, stirring was continued for 30 minutes, and the solvent was evaporated to dryness. The crude mixture was separated between ethyl acetate (50 mL) and water (25 mL), and the aqueous phase was treated with ethyl acetate ( 2x50 ml) extraction, the organic phase was washed with brine, dried over wok sulfate, and evaporated to dryness. The residue was analyzed by flash chromatography on rare earth dioxide, washed with ethyl acetate g Purpose: Hexane (1: 3) , To prepare the title compound (600 mg) as a white foam. ^ (! , CDC13): 9.73 (s, 1H, CHO), 7.45-7.24 (m, iH, 2Ph), 6.9 8 (s, lH, C | iPh2), 6.06 (dd, lH, H-2, J = i.5 &amp;amp; 3.3 Hz), 4.57 (d, 1H, -, J = 3.0 Hz), 4.30 (dd , 1H, H-3 ', J = 3.6 and 5.7 Hz), 4.07 (d, 1H, 8aCH2, J = 9.0 Hz), 3.95-3.93 (m, 1H, H-2'), 3.85 (dd, lH, H-4 ', J = 5.7 &amp;amp; 9.3HZ), 3.75 (d, 1H, 8aCH2, J = 9.0 Hz), 3.44 (dq, 1H, H-5', Jd = 9.3 Hz, Jq = 6.3 Hz), 2.73 (t, 1H, Hl, J = 3.6 Hz). Intermediate 9 2 [1R- (1 a, 3a0, 4 Lu, 4a / ?, 7, 7aor, 8a point)] 8a-[(6-Go Oxygen-3,4--isopropenyl-2-0- (methylthio) thiocarbo-D-Azzuranoglucosyloxy) methyl] -4 -methylsulfonyl-4, 4a, 5,6,7,7a, 8,8a-octahydro-7-methyl- -142- J  ^ HZiFFilT ^ T ^ i ^ ~ i7 ^ i ^  ~~ '(Please read the back of the first (Notes and then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">32n44 14) 3-(l --1,4 -_s_B_3a(iH) -  9 1(1001 4 0.52.72 18i2 3x25  i :9)11 ^ (], CDC13): 9.71 (s, 1H, CHO), 7.44-7.25 (m, lH, 2Ph)6.96 (s, 1HCHPh2)6.01 (dd1HH-2, J=1.23.6 Hz), 6.90 (dd, 1H, H-21, J=2.454 Hz), 4.85 (d, 1H, - J=2.4Hz)4.53(ddlHH-3J=5.4&amp;amp;6.3Hz)4.00(ddlH H-4J=6.3&amp;amp;8.7Hz),3.93(dlH8aCH2,J=9.3Hz)3.65 (dq1HH-5'Jd = 8.7, Jq=6.3 Hz), 2.68 (t1HH-lJ=3.9 Hz)2.59 (s3HCH3S) 9 3 [1R-(1 a3a/? ,4/?4a/37/?7aa8ay3 )]8a-[(6- _3,4_ ---D-]_4_-4,4a5,6,7,7a8,8a--7_-3-(l-_14_ -s--3a(lH)- 92(955 110C1.55 ___-143-_ CNS )4210X297) ' -- ()</span>32n44 V. Description of the invention (14) 3- (l-methylethyl) -1,4-methylene_s_B Yinda province_3a (iH) -carboxylic acid, diphenylmethyl ester intermediate 9 1 (100 mg) and imidazole (1 mg) were dissolved in anhydrous tetrahydrofuran (4 ml) under nitrogen. Sodium hydride (mg) was added, and the suspension was stirred at room temperature for 0.5 hour. Add carbon disulfide (2.7 ml) and continue stirring for 20 minutes, then add methyl iodide (18 ml). Two hours later, an equivalent of ammonium vapor (20 mL) was added to stop the reaction. The mixture was extracted with ethyl acetate (3x25 ml), the organic phase was washed with brine, dried over magnesium sulfate, and the solvent was evaporated to dryness. The residue was analyzed and purified by flash chromatography on silica gel, and washed away with ethyl acetate: hexane (i: 9) to obtain the title compound (110 mg). ^ () , CDC13): 9.71 (s, 1H, CHO), 7.44-7.25 (m, 10H, 2Ph), 6.96 (s, 1H, CHPh2), 6.01 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 6.90 (dd, 1H, H-21, J = 2.4 and 5.4 Hz), 4.85 (d, 1H, - J = 2.4Hz), 4.53 (dd, lH, H- 3 ', J = 5.4 &amp;amp; 6.3Hz), 4.00 (dd, lH, H-4', J = 6.3 &amp;amp; 8.7Hz), 3.93 (d, lH, 8aCH2, J = 9.3Hz), 3.65 (dq, 1H, H-5 ', Jd = 8.7, Jq = 6.3 Hz), 2.68 (t, 1H, Hl, J = 3.9 Hz), 2.59 (s, 3H, CH3S). Intermediate 9 3 [1R- (1 a, 3a / ?, 4 / ?, 4a / 3, 7 / ?, 7aa, 8ay3)] 8a-[(6-deoxy_3,4_ -isopropenyl- Cold-D-piperanosyloxy) methyl] _4_methylbromo-4,4a, 5,6,7,7a, 8,8a-octahydro-7_methyl-3- (l- Methylethyl) _1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester Intermediate 92 (95 mg) was dissolved in anhydrous toluene (5 ml) under nitrogen ), Heat at 110  C. Hydrogen in anhydrous toluene (5 ml) is added dropwise for more than 1.5 hours ___- 143-_ This paper scale is easy to use Zhongguanjia rubbing standard (CNS) 8 4 threat (210X297mm) '-(Please read the back first (Notes to fill out this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T </span>, 1T Printed by the Central Standards Bureau of the Ministry of Economy-Industrial and Consumer Cooperative</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 64i5 2 1 : 9) 42 '  (lH, CDC13): 9.73 (s, 1H, CHO), 7.44-7.25 (m, iHj 2Ph)6.98 (1HsCHPh2)6.05 (dd, 1HH-2, J=1.233 Hz)4.54 (dd1HH-lJ=2.79.3 Hz)4.39 (dt1HH-3</span>The Ministry of Economic Affairs, Central Standard Falcon Bureau Beigong Consumer Cooperative Printed Tributyltin (64ml) with stirring. Continue heating for 5 hours, add alcohol (2 ml) 'and evaporate the solvent to dryness. The residue was analyzed and purified by flash chromatography on dioxin gum, and washed away with ethyl acetate: hexane (1: 9) to obtain the compound (42 mg). ' (lH, CDC13): 9.73 (s, 1H, CHO), 7.44-7.25 (m, iHj 2Ph), 6.98 (1H, s, CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3'3 Hz), 4.54 (dd, 1H, H-l ', J = 2.7 and 9.3 Hz), 4.39 (dt, 1H, H-3,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd=2.7 HzJt=3.6 Hz)4.04 (d1H8aCH2, J=9.0 Hz;3 (d1H8aCH2, J=9.0 Hz)3.65 (dd1HH-4=3.68 7</span>Jd = 2.7 Hz, Jt = 3.6 Hz), 4.04 (d, 1H, 8aCH2, J = 9.0 Hz ;, 3 (d, 1H, 8aCH2, J = 9.0 Hz), 3.65 (dd, 1H, H-4 ,,  = 3.6 and 8 7</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)3.44 (dq1HH-51Jd=6.3 HzJq=8.7 Hz)2.75 (t1H, J=3.9 Hz) 9 4 [1R-(1 a ,3a44a/S ,7y3 ,7a&amp;lt;^8ay5 )]8a-[(2,6 - _ -D-]-4 --4,4a,5,6,7,7a 8,8a --7-- 3- (1--1,4 -_8_ -3a(lH)- 93(1 _53015 1 (15TLC5 2002 X 100 5 : 1 2 : 1)1.1 GHCDC13): 9.73 (s1HCHO), 7.5-7.2 (m10H, 2Ph) -144- CNS ) A4^210 X 297 () *?  7 7  6.99 (s1HCHPh2)6.05 (dd1HH-2, J=1.23.3 Hz) 4.64 (dd1H-J=2.1 9.6 Hz)4.11 (m1HH-3')4.06 (d1H8aCH2, JAB=9.3 Hz), 3.70 (m2HH-58aCH2) 3.34 (m1HH-4'), 2.75 (t1HH-lJ=3.6 Hz) 9 5 [1R-(1 a3a44ay577aa8a]8a-[(2,3,6- -3--D-]-4 --4,4 a, 5, 6,7,7a8,8a--7 --3-(1--1,4--s--3a(lH)- 94 (2_03.4186 610 4   15 : 1)5 : 1) 1.65 ^ CDC13) 9.73 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph)6.98 (s1HC||Ph2)6.04 (dd1H, H-2, J=1.23.3 Hz)425 (dd, 1H, H-lJ=1.89.3 Hz)4.08 (m1HH-41) 3.674.01 (2d2H8aCH2, J=9 Hz)3.40 (m1H, H-3 3.32(m,lHH-5')2.74(tlH,H-lJ=4.2Hz),2.32&amp;amp;2.53 (2m, 2H, 22 9 6 [1-(13,331)41)41)71)7&amp;amp;3,81))]8&amp;amp;-[(2,3,6--3- -145- CNS ) 4210X297 ()</span>Hz), 3.44 (dq, 1H, H-51, Jd = 6.3 Hz, Jq = 8.7 Hz), 2.75 (t, 1H, J = 3.9 Hz). Intermediate 9 4 [1R- (1 a, 3a, 4, 4a / S, 7y3, 7a &amp;lt; ^, 8ay5)] 8a-[(2,6 -dideoxy_ -D-piperanose Yloxy) methyl] -4 -methanyl-4,4a, 5,6,7,7a 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1, 4-Methylene _8_ called Shun Jian-3a (lH) -carboxylic acid, diphenyl methyl ester in the intermediate 93 (1 _ 5 grams) in tetrahydrofuran (30 ml) and methanol (15 ml of the mixture To the solution was added dropwise 1 N hydrochloric acid solution (15 ml) at room temperature under vigorous stirring. After the reaction was completed (TLC control), saturated sodium bicarbonate (50 ml) and ethyl acetate (200 ml) were added to separate the mixture The organic layer was washed with water (2 X 100 ml) and dried over magnesium sulfate. The solvent was evaporated to dryness. The residue was analyzed by flash layer on silica gel using ethyl acetate: hexane (5: 1 and ( 2: 1) Wash off to obtain the title compound (1.1 g) as a white foam. GH, CDC13): 9.73 (s, 1H, CHO), 7.5-7.2 (m, 10H, 2Ph), -144- this paper For standard use, Chinese National Standard (CNS) A4 ^ (210 X 297mm) (Please read the notes on the back before filling this page) *?  A7 7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of invention (6.99 (s, 1H, CHPh2), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.64 (dd, 1H , -, J = 2.1 and 9.6 Hz), 4.11 (m, 1H, H-3 '), 4.06 (d, 1H, 8aCH2, JAB = 9.3 Hz), 3.70 (m, 2H, H-5' and 8aCH2), 3.34 (m, 1H, H-4 '), 2.75 (t, 1H, Hl, J = 3.6 Hz). Intermediate 9 5 [1R- (1 a, 3a Lu, 40,000, 4ay5, 7 Lu , 7aa, 8a point)] 8a-[(2,3,6-trideoxy-3-iodo-D-piperanosyloxy) methyl] -4-carboxamide-4,4 a, 5, 6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-theta province-3a (lH) -Carboxylic acid, diphenylmethyl ester Intermediate 94 (2-0 g), triphenylphosphine (3.4 g) and imidazole (186 mg) were refluxed under stirring, and then treated with iodine (610 ml) in small batches. Continue to reflux for 4 hours. The reaction mixture was cooled, poured into excess aqueous sodium bicarbonate solution, and sodium thiosulfate was added to another funnel. The mixture was shaken until the iodine was exhausted. The toluene phase was washed with water and dried over magnesium sulfate And concentrated. The residue was purified by flash column chromatography and washed with hexane: ethyl acetate (15: 1) and (5: 1) to obtain the title compound (1.65 g). ^ CDC13): 9.73 (s, 1H, CHO), 7.26-7.44 (m, 10H, 2Ph), 6.98 (s, 1H, C || Ph2), 6.04 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.25 (dd, 1H, Hl ,, J = 1.8 and 9.3 Hz), 4.08 (m, 1H, H-41), 3.67 and 4.01 (2d, 2H, 8aCH2, J = 9 Hz), 3.40 (m, 1H, H-3,), 3.32 (m, lH, H-5 '), 2.74 (t, lH, Hl, J = 4.2Hz), 2.32 &amp;amp; 2.53 (2m, 2H, 2  2 '). Intermediate 9 6 [1 foot- (13,331), 41), 4 has 1), 71), 7 &amp;amp; 3,8 pressure 1))] 8 &amp;amp;-[(2,3,6-trideoxy-3- B-145- This paper scale is applicable to China National Standard (CNS) 4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 ____B7 143) - 3- N- 4- 0-b-D -]_4_ -4,4&amp;amp;56,7,7&amp;amp;8,8&amp;amp;--7-_3-(1-_ 14 --S -- 3a(lH) - 95(20015 241_015 0.0463 3x5 lx 5  3 : 17 5  ^ CDC13): 9.74 (s, 1H, CHO), 7.44-7.26(m, 10H, 2Ph), 6.98 (s1HCHPh2)6.03 (dd, 1HH-2, J=3.3 1.2 Hz) 4.60 (dd1H-J=5.1 3.9 Hz)4.12 (m2H, H-3', H-4') 4.01 (d, 1H, H-8a, J=9.3 Hz), 3.64 (d, 1H, H-8a, J=9.3 Hz), 3.61(dqlHH_5lJ=8.7&amp;amp;6.3Hz),3.49(mlHC^2-CH3) 3.13 (m, 1H, CH2-CH3), 2.70 (t, 1H, H-l, J=3.9 Hz), 2.24 (m, 1HC(CH3)2), 1.14 (t3HC^J=7.2 Hz) 9 7 [lR-(l&amp;lt;ar ,3a/? ,  ,1  ,la.a ,8a/? ) ] 8 a-[ (1 S , 4 R, 6 S , 711911)-2,8--4,9--6-(--[3.4.0]--7--]-4--4,4a,5,6,7,7a,8,8a--7--3_(l--l,4--S--3a(lH)- -146- &amp;gt;^~5)4210297 ()</span>A7 ____B7 Printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs V. Description of the invention (143) Amino- 3- N- 4- 0-carbonyl bD -piperanyloxy) methyl] _4_   - 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octaqi-7-methyl_3- (1-methylethyl) _ 1,4 -methylene-S-indap Provincial-3a (lH) -chiric acid, diphenylmethyl ester A solution of intermediate 95 (200 mg) in anhydrous tetrahydrofuran (15 ml) was treated with sodium hydride (24 mg; 1_0 mmol). After 15 minutes, ethyl isocyanate (0.04 ml) was added and the reaction mixture was stirred at reflux for 6 hours. After stopping the reaction with water (3 ml), the mixture was extracted with ethyl acetate (3x5 ml), the combined organic solution was treated with brine (lx 5 ml), dried over magnesium sulfate, filtered and concentrated to a slurry. Analyze and purify by flash layer on silica gel and wash off with hexane: ethyl acetate 3: 1 to prepare the title compound (75 mg). ^ CDC13): 9.74 (s, 1H, CHO), 7.44-7.26 (m, 10H, 2Ph), 6.98 (s, 1H, CHPh2), 6.03 (dd, 1H, H-2, J = 3.3 and 1.2 Hz) , 4.60 (dd, 1H, -, J = 5.1 and 3.9 Hz), 4.12 (m, 2H, H-3 ', H-4'), 4.01 (d, 1H, H-8a, J = 9.3 Hz ), 3.64 (d, 1H, H-8a, J = 9.3 Hz), 3.61 (dq, lH, H_5l, J = 8.7 &amp;amp; 6.3Hz), 3.49 (m, lH, C ^ 2-CH3), 3.13 ( m, 1H, CH2-CH3), 2.70 (t, 1H, Hl, J = 3.9 Hz), 2.24 (m, 1H, Cting (CH3) 2), 1.14 (t, 3H, C ^, J = 7.2 Hz ). Intermediate 9 7 [lR- (l &amp;lt; ar, 3a /?,  , 1 , la.a, 8a /?)] 8 a- [(1 S, 4 R, 6 S, 711,911)- 2,8-dioxo-4,9-dimethyl-6- (methylthio) thiocarbonyloxy-cis-bicyclo [3.4.0] -non-7-yl-oxymethyl]- 4-Methanoyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3_ (l-methylethyl) -l, 4-methylene-S- Chita province-3a (lH) -carboxylic acid, diphenylmethyl ester-146-this paper &amp;gt; ^ degree of using the Chinese national standard ( ~ 5) 8 4 specifications (210 to 297 mm) (please (Read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 144) 89b(250 45 201420 15021 0 550 (50  10 : 1)8 : 1)211  ^ (], CDC13): 9.72 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph)6.97 (s1HCHPh2)6.02 (dd1H, H-2, J=1.23.3 Hz)5.80 (dd, 1HH-6, J=2.1 6.3 Hz)4.72 (d1HH-7 J=2.1Hz)4.05(ddlHHa-3J=7.2&amp;amp;8.4Hz)3.98-3.86 (m 2H8aCHa)3.66-3.55 (m2H8aCHbH-9.)3.34 (t, 1H, Hb-3', J=8.4 Hz), 2.73 (t, 1H, HI, J=3.9 Hz), 2.59 (s, 3HSCH3) 9 8 [111-(13&amp;amp;44&amp;amp;7/?,7&amp;amp;8&amp;amp;]83_[(4-0--3 --2,3,6 -- b- D-]-4 - -4,4a56,7,7a8,8a--7--3-(1--1,4--S--3a(lH)- 12(67152 8 55 1 1.530 -147- CNS ) A4210X297 ()</span>Printed by Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 B7 V. Description of the invention (144) The intermediate 89b (250 mg) and imidazole (catalytic amount) were dissolved in anhydrous tetrahydrofuran under argon. Sodium hydride (45 mg) was added, and the suspension was stirred at room temperature for 20 minutes. Add carbon disulfide (14l), continue stirring for 20 minutes, and add methyl iodide (150l). After 2 hours, ethyl acetate (10 mL) was added to stop the reaction. Then water (5 mL) was added dropwise. This mixture was separated between ethyl acetate (50 mL) and water (50 mL), and the organic layer was washed with water and brine, then dried and evaporated. The residue was analyzed and purified by flash chromatography on silica gel, and washed away with hexane: ethyl acetate (10: 1) to (8: 1) to obtain the title compound (211 mg). (^ , CDC13 ): 9.72 (s, 1H, CHO), 7.46-7.22 (m, 10H, 2Ph), 6.97 (s, 1H, CHPh2), 6.02 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5.80 (dd, 1H, H-6 , J = 2.1 and 6.3 Hz), 4.72 (d, 1H, H-7 ,, J = 2.1Hz), 4.05 (dd, lH, Ha-3 ', J = 7.2 &amp;amp;; 8.4Hz), 3.98-3.86 (m, 2H, 8aCHa and H), 3.66-3.55 (m, 2H, 8aCHb and H-9.), 3.34 (t, 1H, Hb-3 ', J = 8.4 Hz) , 2.73 (t, 1H, HI, J = 3.9 Hz), 2.59 (s, 3H, SCH3). Intermediate 9 8 [111- (1 , 3 &amp;amp; point, 4 points, 4 &amp;amp; , 7 / ?, 7 &amp;amp; heart 8 &amp;amp; )] 83 _ [(4-0-allyl-3 -iodine-2 , 3,6-Trideoxy-b-D-glucopyranosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro- 7-methyl-3- (1-methylethyl) -1,4-methylidene-S-pyrida-3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 12 (67 Mg), a solution of triphenylphosphine (105 mg) and imidazole (28 mg) in anhydrous tetrahydrofuran (5 ml) was treated dropwise with iodine (51 mg). This mixture is stirred at room temperature for 1.5 hours, and is in ethyl acetate (30 ml) -147- This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297 public daughter) (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T &amp;lt; A7 B7   32l644 145) 1301   9 : 1)68  ^ CH, CDC13) 9.73 (s, 1H, CHO), 7.45-7.22 (m, 10H, 2Ph), 6.97 (s1H, C|Ph2)6.07-5.9 (m, 2H, 11-20(- CH=C), 5.37-5.14 (m, 2H, O-C-C^CI^), 4.45-4.35 (m, 1H, -Ca-C=C), 4.25-4.1 (m2H, --C|b-C=C), 4.1-3.95 (m, 2HH-3'8a-CHa), 3.66 (d, 1H8a-CHbJ=9 Hz), 3.29 (dq, 1H, H-5', J=6^.8.7 Hz), 3.15 (dd, 1H, H-4', J-8.7iL9.9 Hz)2.73 (t1H, H-lJ=3.9 Hz) 9 9 [1R-(1  ,3aA44a7 0 ,7aa8aA )]8a_[(2,3-6--b-D--4_(i3_2_ -44a56,7,7a8,8a --7--3-(1--14--s--3a(lH)- 67(3.240 391.1p_30 5 3 : 12.08 &amp;lt;y(1H,CDCl3):7.43&amp;amp;7.29(mm,4H6H2xPh)6.95(s 1H, CHPh2), 5.86 (d, 1H, H-2, J-3.3 Hz), 5.08 (s, 1H, 4-CH), 148- CNS ) A4210X297 (H)</span>, 1T &amp;lt; A7 B7 V. Du Printed by the Beigong Consumer Cooperation of the Central Standards Bureau of the Ministry of Economic Affairs 32l644 Description of the invention (145) and 1 equivalent of hydrochloric acid aqueous solution (30 ml). The organic layer was washed successively with 1N aqueous hydrochloric acid solution, water, aqueous sodium metabisulfite solution, water and brine, then dried, filtered and concentrated. The residue was chromatographically purified on silica gel and washed away with hexane: ethyl acetate (9: 1) to obtain the title compound (68 mg). ^ CH, CDC13): 9.73 (s, 1H, CHO), 7.45-7.22 (m, 10H, 2Ph), 6.97 (s, 1H, C |  Ph2), 6.07-5.9 (m, 2H, 11-2 and 0 (-CH = C), 5.37-5.14 (m, 2H, OCC ^ CI ^), 4.45-4.35 (m, 1H, -C ting aC = C), 4.25-4.1 (m, 2H, -  and -C | bC = C), 4.1-3.95 (m, 2H, H-3 'and 8a-CHa), 3.66 (d, 1H, 8a-CHb, J = 9 Hz), 3.29 (dq, 1H, H-5 ', J = 6 ^ .8.7 Hz), 3.15 (dd, 1H, H-4', J-8.7iL9.9 Hz), 2.73 (t, 1H, Hl, J = 3.9 Hz). Intermediate 9 9 [1R- (1 , 3aA, 4, 4a, 7 0, 7aa, 8aA)] 8a _ [(2,3  anhydro-6-deoxy-bD-piperanmannosyloxy ) Methyl-4_ (i, 3  dioxolane_2_yl) -4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methyl Ethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 67 (3.2 mmol) in acetonitrile (40 mL) The solution was treated with ethylene glycol (39 mL) 'trimethyl orthoformate (1.1 mL) and p-toluenesulfonic acid (30 mL). After 5 hours, the mixture was thoroughly extracted with ethyl acetate. After removing the solvent , The residue was purified by chromatography, washed away with hexane: ethyl acetate 3: 1 To prepare the title compound (2.08 g). &amp;Lt; y (1H, CDCl3): 7.43 &amp;amp; 7.29 (m, m, 4H, 6H, 2xPh), 6.95 (s, 1H, CHPh2), 5.86 (d, 1H, H-2, J-3.3 Hz), 5.08 (s, 1H, 4-CH), 148- The size of this paper is easy to use China National Standard (CNS) A4 specification (210X297mm) (please read the note on the back first (Fill in this page again)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 ^^_B7___ 146) 4-69 (s, 1H, H-1'), 4.11 (d, 1H, 8a-CHa, J=9.3 Hz), 3.81 (m, 5118&amp;amp;-0-(&amp;lt;|^-)3.63(111111,^1-53_233.15 (dd1H1HH-21 H-3, J=3.6 Hz)3.20 (m, 1HH-41) 2.63 (m, 2HH-lCCH3)2) 100 [1R-(1 a ,3a44a77aa8a]8&amp;amp;-[(2,3-.4_ -6--b-D--4-(1, 3- -2--4,4a,56,7,7a8,8a --7-- 3- (1 -14--s--3a(lH)- 2301 0C13899(0.9 10.60 554-20X2  4 : 1214  d(1HCDCl3):7.44&amp;amp;7.30(mm,4H6H2xPh),6.94(s 1HCl|Ph2)5.87 (dd1HH-2, J=1.53.6 Hz)5.10 (s1H 4-CH), 4.81 (s, 1H, H-l'), 4.09 (d, 1H, 8a-CHa, J-8.7 Hz), 3.88(m,5H8a-CHb&amp;amp;0-C|i2C|i2-0)3.58&amp;amp;3.36(ddlH, 1HH-2'H-3'J=3.9 Hz), 2.65 (m2H, H-lC(CH3)2) t101 [1-(1^313,415,4313,71?7&amp;amp;8&amp;amp;1))]8&amp;amp;-[(2,3--4,6- -4-- b- D-- 4- (1,3 - ___-149-___ CNS ) 210X297 () -   A7 B7  -2 --4,4&amp;amp;,5,6,7,7&amp;amp;8,8&amp;amp;--7-_3-(1- -1,4--s--3 a(lH)- 0.310 -78C2.44M (015 151 (0.21 5 1 4 : 1 9 1 6(4, CDC13): 7.45  7.29 (m,m, 462xPh)6.95 (S 112)5.87(1111,11-2)5.355.22((1,(1111111 CH2=CJ=2.4 Hz)5.08 (s1H, 4-CH)4.68 (s1HH-l 41 (m2H8a-CHaH-5')3.82 (m5H8a-CHbO-C^2Cll2-)3.57&amp;amp;3.35(dd,lHlHH-2m-3,,J=3.9 Hz)2.63 (m, 2HH-lC|i(CH3)2) 102 [1-(^3&amp;amp;/?447078&amp;amp;]83-[(2,3-_6_ -b-D -_4_(i,3_2_ -44a5,6,7,7a8,8a--7--3_(1__14_ -s-_3a(1H)_  10(11345 _78-2  1 (X )</span>A7 ^^ _ B7___ printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs 5. Description of the invention (146) 4-69 (s, 1H, H-1 '), 4.11 (d, 1H, 8a-CHa, J = 9.3 Hz), 3.81 (m, 511, 8 &amp;amp;-. Book, 0- (: out &amp;lt;: | ^ -), 3.63 (111, 111, ^ 1-5 '), 3_23 and 3.15 (d, d, 1H, 1H, H-21 and H-3, J = 3.6 Hz), 3.20 (m, 1H, H-41), 2.63 (m, 2H, H1 and C out CH3) 2). Interbody 100 [1R- (1 a, 3a, 4, 4a Lu, 7 o'clock, 7aa, 8a)] 8 &amp;amp;-[(2,3-dehydration.4_ gas-based-6-deoxy-bD -Piperanmannosyloxy) methyl-4- (1,3-dioxolan-2-yl) -4,4a, 5,6,7,7a, 8,8a -octahydro-7- Methyl-3- (1methylethyl) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid, diphenylmethyl acetate will trifluoroacetic anhydride (230 l ) In a solution of dichloromethane (10 ml) in water at 0  C with dimethyl salazo (138 l) and intermediate 99 (0.9 mmol) in anhydrous digas methane (10. ml) ) The solution inside is treated drop by drop. After 60 minutes, triethylamine (554 l) was added, and the mixture was stirred at -20X: 2 hours. Then dilute with methane and wash with water. After removing the solvent, the residue was purified by chromatography and washed with hexane: ethyl acetate 4: 1 to obtain the title compound (214 mg). d (1H, CDCl3): 7.44 &amp; 7.30 (m, m, 4H, 6H, 2xPh), 6.94 (s, 1H, Cl | Ph2), 5.87 (dd, 1H, H-2, J = 1.5 and 3.6 Hz ), 5.10 (s, 1H, 4-CH), 4.81 (s, 1H, H-l '), 4.09 (d, 1H, 8a-CHa, J-8.7 Hz), 3.88 (m, 5H, 8a-CHb &amp;amp;; 0-C | i2C | i2-0), 3.58 &amp; 3.36 (d, d, lH, 1H, H-2 'and H-3', J = 3.9 Hz), 2.65 (m, 2H, Hl and C Ting (CH3) 2). t Interbody 101 [1 Han- (1  ^, 3 Wang 13,415,4313,71 ?, 7 &amp;amp; Wang, 8 &amp;amp; 1))] 8 &amp;amp;-[(2,3-anhydro-4,6-dideoxy -4-Methylene-b-D-piperanmannosyloxy) methyl-4- (1,3-dioxo ___- 149 -___ This paper scale is applicable to China National Standards (CNS) M specifications ( 210X297mm) (please read the note  on the back and fill in this page)-Order V. Printed A7 B7 Invention Instructions (Pentacyclic-2-yl) -4,4 &amp;amp; , 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl_3- (1-methylethyl) -1,4-methylidene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester. A solution of methyltriphenylphosphonium bromide (0.3 millimoles) in anhydrous tetrahydrofuran (10 ml) was taken as n-butyl at -78  C under nitrogen. Lithium 2.44M (0.15ml) treatment. After 15 minutes, a solution of intermediate 100 (0.21 millimoles) in tetrahydrofuran (5ml) was slowly added, and the mixture was slowly warmed at room temperature. Diluted with ethyl acetate and washed with vaporized ammonium (1 equivalent) and brine. After removing the solvent, the residue was purified by chromatography, using hexane: ethyl acetate 4: 1 Wash away to obtain the title compound (91 mg). 6 (4, CDC13): 7.45 and 7.29 (m, m, 4, 6, 2xPh), 6.95 (S, out, (: Ying 112), 5.87 ( 1, 111, 11-2), 5.35 and 5.22 ((1, (1, 111, 111, CH2 = C, J = 2.4 Hz), 5.08 (s, 1H, 4-CH), 4.68 (s, 1H , H1,), 4.10 (m, 2H, 8a-CHa and H-5 '), 3.82 (m, 5H, 8a-CHb and OC ^ 2Cll2-), 3.57 &amp; 3.35 (d, d, lH, lH, H-2m-3 ,, J = 3.9 Hz), 2.63 (m, 2H, Hl and C | i (CH3) 2). Intermediate 102 [1 ft-(^, 3 &amp;amp; / ?, 4 , 4 to, 70, 7 ", 8 &amp;amp; )] 83-[(2,3-dehydrated_6_ de-lactated-bD-leantalosyloxy) methyl_4_ (i, 3diox Pentane_2_yl) -4'4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3_ (1_methylethyl) _14_methylene-s-chida To save _3a (1H) _carboxylic acid, diphenylmethyl ester, in a solution of intermediate 10 (1.13 millimoles) in anhydrous tetrahydrofuran (45 ml) under nitrogen at _78. Slowly add left-handed equivalent (2 milliliters). After one hour, the mixture was diluted with ethyl acetate, heated at room temperature, and washed with water (1 equivalent) and brine with gasification. After removing the solvent, the residue flashes (please read the precautions on the back before filling in this X)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-150- A7 ___ B7 14) 3 : 1 431 d(1H,CDCl3):7.44&amp;amp;7.31(m,m4H6H2xPh),6.95(s lHCiiPh2)5.85(ddlH,H-2,J=1.2&amp;amp;3.6Hz)5.08(slH 4-CH), 4.92 (s, 1H, -), 4.11 (d, 1H, 8a-CHa, J=9.3 Hz), 3.83 (m5H, 8a-CHbOC^Cii^O)3.62 (m1HH-4') 3.54 (dd, 1HH-31J=3.65.1 Hz)3.40 (m1H, H-5')3.24 (d1HH-2'J=3.9 Hz) 103 [1-(13&amp;amp;1)41)431)715,733,8&amp;amp;1))]8&amp;amp;-[(2,3--4-0- -6--b-D--4-(l3--2--4,4&amp;amp;,5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1--14--s--3a(lH)-  102 (0.24-0.4 150.3 30. 5 : 195  () d(1HCDCl3):7.44&amp;amp;7.30(mm4H6H2xPh)6.95(s 1HC|iPh2)5.85(dd1HH-2, J=1.23.6 Hz)5.08 (sin, 4-CH), 4.82 (t, 1H, H-4'J=3.9 Hz), 4.60 (s, 1H, H-l')412 (d1H8a-CHa, J=9.6 Hz), 383 (m5H8a-CHb-CO^CH^-O), 3.65 (m, 1H, H-5'), 3.53 (t, 1H, H-3', J=4.2 Hz), 3.17 (d, 1HH-21, J=4.2 Hz), 2.63 (m2HH_1  -151 - CNS ) A4210X297 &amp;quot;  321644 at B7 149) CH(CH3)2) 0 104 [1R-(1 a3ay5 ,44a77aa ,8ayS )]8a-[(4-0-- 23 --6-- b- D-4(13- -2--4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1_ -14 -- s-- 3a(lH) -  102 (0.31 0.6 3 00.9 101  4 : 1163  OH, CDC13): 7447_29 (mm4H6H2xPh)6.95 (S, 1HCPh2)5.96 (m1HH-2M), 5.85 (dd, 1H, H-2, J=1.2 3.6 Hz)5.30&amp;amp;5.12(mmlH,lHCH2_3)5.06(slH4- CH), 4.58 (s, 1H, -), 4.31 (m, 1H, H-4'), 4.10 (m, 2H, H-58a-CHa), 3.83 (m5H, 8a-CHb^O-CH7 CH -O), 3.53 (m 2HCH20), 4.23 (t1HH-3J=4.2 Hz)3.19 (d1HH-2 J=4.2 Hz), 2.65 (t, 1H, H-l, J=4.2 Hz), 2.61 (m, 1H, CH(CH3)2)  105 [1R-(1 a3a44a077aor8a]8a-[(2,3--6- - 4- 0- b- D-_4_ -152- CNS ) A4210X297 ()  -S!  A7 B7 15) (13--2--4,4&amp;amp;,5,6,7,73,8,8&amp;amp;--7__ 3-(1--1,4 -_s_p?_3a(1H)_  102 (0.45 4-1.350.9  3 : 1 277 ^ (!, CDC13): 7.86, 7.42^7.29 (m,m, 10H, Ar), 6.93 (s, 1H, CHPh2), 5.82 (m, 1H, H-2), 5.06 (s, 1H, 4-CH), 4.68 (t, 1H, H-3', J=4.2 Hz), 4.55 (s, 1H, H-l'), 4.07 (d, 1H, 8a-CHa, J=8.7 Hz)3.81 (m5H, 8a-CHbO-C^CI^-O)3.62 (m, 1H, H-5'), 3.30 (t, 1H, H-2', J=4.2 Hz), 3.15 (d, 1H, H-4', J=3.9 Hz), 261 (m, 2H, H-lC|i(CH3)2) 106 [1R-(1  ,3ay94y54a7aa8a]8&amp;amp;-[(2,3--4-4-4,6--1)-1)-_4_(13_ -2--4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1_ -1,4-u-3a(lH)-  105 (0_ 150.45 3lc  4 : 1 -153- CNS ) A4210X297 ()</span>-150- A7 ___ B7 V. Description of the invention (14) Layer analysis and purification, washing away with hexane: ethyl acetate 3: 1 to prepare the title compound (431 mg). d (1H, CDCl3): 7.44 &amp;amp; 7.31 (m, m, 4H, 6H, 2xPh), 6.95 (s, lH, CiiPh2), 5.85 (dd, lH, H-2, J = 1.2 &amp;amp; 3.6Hz) , 5.08 (s, lH, 4-CH), 4.92 (s, 1H, -), 4.11 (d, 1H, 8a-CHa, J = 9.3 Hz), 3.83 (m, 5H, 8a-CHb and OC ^ Cii ^ O), 3.62 (m, 1H, H-4 '), 3.54 (dd, 1H, H-31, J = 3.6 and 5.1 Hz), 3.40 (m, 1H, H-5'), 3.24 ( d, 1H, H-2 ', J = 3.9 Hz). Intermediate 103 [1-foot- (1 , 3 &amp;amp; 1), 41), 431), 715,733,8 &amp;amp; 1))] 8 &amp;amp;-[(2,3-anhydro-4-0-tertiary butylcarbonyl -6-deoxy-bD-piperantalosyloxy) methyl-4- (l, 3-dioxolan-2-yl) -4,4 &amp;amp;, 5,6,7,7 &amp;amp; , 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-pyridine-3a (lH) -carboxylic acid, diphenyl Methyl ester solution of intermediate 102 (0.2 millimoles) and 4-dimethylaminopyridine (0.4 millimoles) in anhydrous digas methane (15 ml) was neopentyl gas (0.3 millimoles) deal with. After 30 minutes, it was washed with water and purified by flash chromatography. It was washed away with hexane: ethyl acetate 5: 1 to obtain the title compound (95 mg). Printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please read the notes on the back before filling out this page) d (1H, CDCl3): 7.44 &amp;amp; 7.30 (m, m, 4H, 6H, 2xPh), 6.95 s, 1H, C | iPh2), 5.85 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 5.08 (s, in, 4-CH), 4.82 (t, 1H, H-4 ', J = 3.9 Hz), 4.60 (s, 1H, H-l '), 4.12 (d, 1H, 8a-CHa, J = 9.6 Hz), 3.83 (m, 5H, 8a-CHb and -CO ^ CH ^ -O), 3.65 (m, 1H, H-5 '), 3.53 (t, 1H, H-3', J = 4.2 Hz), 3.17 (d, 1H, H-21, J = 4.2 Hz ), 2.63 (m, 2H, H_1 and -151-This paper scale is applicable to China National Standard (CNS) A4 specification (210X297mm) &amp;quot; Printed by the Central Sample Bureau of the Ministry of Economic Affairs, 321644 at B7. DESCRIPTION OF THE INVENTION (149) CH (CH3) 2) 0 Intermediate 104 [1R- (1 a, 3ay5, 4 Lu, 4a million, 70,000, 7aa, 8ayS)] 8a-[(4-0-allyl- 2,3-Dehydrated-6-deoxy-b-D-piperantarosyloxy) methyl 4 (13-monooxolane-2-yl) -4,4 &amp;amp;, 5,6,7 , 7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-da da province-3a (lH) -tetioic acid, Diphenyl methyl ester in intermediate 102 (0 .3 millimoles) in anhydrous tetrahydrofuran (10 ml) was added sodium hydride (0.6 millimoles) and a catalytic amount of decomposed tetrabutylammonium under nitrogen. After 30 minutes, propyl bromide (0.9 mmol) was added, and the mixture was stirred at room temperature overnight. It was then diluted with ethyl acetate (10 mL) and washed with vaporized ammonium (1 equivalent) and brine. After removing the solvent, the residue was purified by flash chromatography and washed with hexane: ethyl acetate 4: 1 to obtain the title compound (163 mg).  OH, CDC13): 7.44 and 7_29 (m, m, 4H, 6H, 2xPh), 6.95 (S, 1H, Cin Ph2), 5.96 (m, 1H, H-2M), 5.85 (dd, 1H , H-2, J = 1.2 and 3.6 Hz), 5.30 &amp;amp; 5.12 (m, m, lH, lH, CH2_3 ), 5.06 (s, lH, 4-CH), 4.58 (s, 1H, - ), 4.31 (m, 1H, H-4 '), 4.10 (m, 2H, H-5' and 8a-CHa), 3.83 (m, 5H, 8a-CHb ^ O-CH7 CH-O), 3.53 (m, 2H, CH20), 4.23 (t, 1H, H-3 ', J = 4.2 Hz), 3.19 (d, 1H, H-2 ,, J = 4.2 Hz), 2.65 (t, 1H, Hl, J = 4.2 Hz), 2.61 (m, 1H, CH (CH3) 2) Intermediate 105 [1R- (1a, 3a Lu, 4 Lu, 4a0, 7 Lu, 7aor, 8a)] 8a-[( 2,3-anhydro-6-deoxy- 4-0 tosylate-b-D-piperantarosyloxy) methyl_4_-152- This paper scale uses the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the notes on the back before filling in this page) Order-S! Printed and printed A7 B7 by the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. Description of the invention (15 ) (1, 3- Dioxolane-2-yl) -4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octahydro-7_methyl_3- (1-methylethyl) -1,4 -Methylene_s_p?  da province_3a (1H) _carboxylic acid, diphenyl The ester was treated with 4-dimethylaminopyridine (1.35 mmol) and tosylate (0.9 mmol) in a solution of intermediate 102 (0.45 mmol) in anhydrous methane (mL). The mixture was stirred overnight at room temperature. After that, it was washed with water and brine. After removing the solvent, the residue was purified by chromatography and washed with hexane: ethyl acetate 3: 1. Evaporation of the appropriate fractions gave the title compound (277 mg ). ^ (! , CDC13): 7.86, 7.42 ^ 7.29 (m, m, 10H, Ar), 6.93 (s, 1H, CHPh2), 5.82 (m, 1H, H-2), 5.06 (s, 1H , 4-CH), 4.68 (t, 1H, H-3 ', J = 4.2 Hz), 4.55 (s, 1H, H-l'), 4.07 (d, 1H, 8a-CHa, J = 8.7 Hz) , 3.81 (m, 5H, 8a-CHb and OC ^ CI ^ -O), 3.62 (m, 1H, H-5 '), 3.30 (t, 1H, H-2', J = 4.2 Hz), 3.15 ( d, 1H, H-4 ', J = 3.9 Hz), 2  61 (m, 2H, Hl and C | i (CH3) 2). Intermediate 106 [1R- (1 , 3ay9, 4y5, 4a Lu, 7aa, 8a Lu)] 8 &amp;amp;-[(2,3-anhydro-4-4aza-4,6-dideoxy-1 ) -1) -piperanmannosyloxy) methyl_4_ (1,3-dioxol-2-yl) -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp;- Octahydro-7-methyl-3- (1_methylethyl) -1,4-methylidene u-da-3a (lH) -carboxylic acid, diphenylmethyl ester intermediate 105 (0_ 15 mmol) and lithium azide (0.45 mmol) in anhydrous dimethylformamide (3 mL) were heated at 100  C overnight. The mixture was diluted with ethyl acetate, washed with water and brine, and the residue was purified by flash chromatography. It was washed away with hexane: ethyl acetate 4: 1. Appropriate for evaporation, -153- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (Please read the precautions on the back before filling in this cornel)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">,1T r A7 B7_______ 151) 53  (^, CDC13) 7.46-7.23 (m, 10H, Ph2), 6.94 (s, 1H, CPh2)5.86(dd1H, H-2, J=1.2&amp;amp;3.6Hz)5.08(slH4- CH), 4.67 (s, 1H, H-l'), 4.10 (d, 1H, 8a-CHa, J=8.7 Hz), 3.83 (m, 4H, 8a-CHbO-Ci^CL-O), 3.40 (d, 1HH-4 J=9.3 Hz)3.31 3.15 (dd, H-2'H-3'J=3.6 Hz)3.23 (m 1H, H-52.65 (m2HH-lC|i(CH3)2) 107</span>, 1T r A7 B7_______ V. Description of the invention (151) The title compound (53 mg) was prepared.  (^, CDC13): 7.46-7.23 (m, 10H, Ph2), 6.94 (s, 1H, Ctin Ph2), 5.86 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 5.08 ( s, lH, 4-CH), 4.67 (s, 1H, H-l '), 4.10 (d, 1H, 8a-CHa, J = 8.7 Hz), 3.83 (m, 4H, 8a-CHb and O-Ci ^ CL-O), 3.40 (d, 1H, H-4 ', J = 9.3 Hz), 3.31 and 3.15 (d, d, H-2' and H-3 ', J = 3.6 Hz), 3.23 (m , 1H, H-5 '), 2.65 (m, 2H, Hl and C | i (CH3) 2). Intermediate 107</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1 a3a94y94a&amp;gt;577a^8ay9)]8a-[(4-0-_ 2,3-6--b-D-]-4- -44a5,6,7,7a8,8a--7--3-(1-_ 14--s--3a(lH)- A 2 1 (65050THFC 90C30 8755 51 ]^1804  ()  7 : 1500 </span>[1R- (1 a, 3a; 9, 4y9, 4a &amp;gt; 5, 7 cold, 7a ^, 8ay9)] 8a-[(4-0-associated propyl 2,3-anhydro-6-deoxy-bD -Piperanmannosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (1-methyl Ethyl) _ 1,4-methylidene-s--pyridin-3a (lH) -carboxylic acid, diphenylmethyl ester Step A solution of intermediate 2 1 (650 mg) in 50 ml of THF Add 90 mg of sodium hydride at 0  C. This mixture was stirred at 0  C for 30 minutes under nitrogen. Then 875 mg of allyl bromide and a catalytic amount of tetrabutylammonium iodide (50 mg) were added. After stirring at room temperature for 5 hours, the reaction was completed. This crude product is treated with 1 equivalent of gasified ammonium and ethyl acetate. The organic layer is washed with water and brine, dried on] ^ 1804, and printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page) and evaporate to dryness. The residue was subjected to chromatography on a silica gel column and washed away with n-hexane  ethyl acetate 7: 1 to obtain 500 mg of the title compound as a white foam.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">B 53(32 2.353.66 __ -154-___ 421(^297) ~ &amp;quot;  A7 B7 , '''~~~' ~ 100  2 25) 11  8 : 1 4 5 %) ci (}, CDC13) 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-12, J=1.2^3.3 Hz), 5.90 (m, 1H, CH=CH2), 5.28 (m, 2H, CH=CH2), 4.69 (d, 1HH-lJ=l.2 Hz), 4.23 (m 1H, H-5'), 4.11 (d, 1H, H-19a, J=9 Hz), 4.06 (m, 1H, H-4'), 3.79 (d, 1H, H-19b, J=9 Hz), 3.26 (d, 1H, H-2', J=3.9 Hz), 3.21 (m, 2H, Cii2-CH=CH2)3.13 (d1HH-3.J=3.9 Hz) 2.86 (t, 1HH-llJ=3.6 Hz) 108 [1R-(1 a3a44a/?77aa ,8a]8a-[(2,3--6--4-0-(2,3-b-D-] -4 --4,4a5,6,7,7a8,8a --7-- 3- (1- -14--s--3a(lH)- 107 (2505 C1N-.2 2.5 %3 GM 218045X -155- ^CNS ) A4210X297 ()</span>Step B To a solution of intermediate 53 (3 g) in anhydrous digas methane (200 ml) was added 2.35 g of dimethylaminopyridine at room temperature. Then slowly add 3.66 grams under stirring __ -154 -___ This paper is suitable for Zhongguanjia rubbing ((: called eight 4 threats (21 (^ 297mm) ~ &amp;quot; Beigong Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs Printed A7 B7 V. Description of the invention (, '' '~~~' ~ A solution of toluene continuous brewing gas in 100 ml of two-gas methane. This mixture was stirred at room temperature for three days until the reaction was complete. The crude product was equivalent Hydrochloric acid, saturated sodium bicarbonate solution and brine. The organic layer was dried over magnesium sulfate, filtered, and treated with 20 ml of sodium methoxide in methanol (25% by weight). The mixture was stirred at room temperature for 1 day. Crude The product was treated with 1 equivalent of hydrochloric acid, washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and evaporated. The residue was purified by flash chromatography analysis and washed away with n-hexane: ethyl acetate 8: 1 to obtain the title compound, It is a white foam (total output rate 45%). Ci (} , CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-12, J = 1.2 ^ 3.3 Hz), 5.90 (m, 1H, CH = CH2), 5.28 (m, 2H, CH = CH2), 4.69 (d, 1H, Hl, J = l.2 Hz), 4.23 (m, 1H , H-5 '), 4.11 (d, 1H, H-19a , J = 9 Hz), 4.06 (m, 1H, H-4 '), 3.79 (d, 1H, H-19b, J = 9 Hz), 3.26 (d, 1H, H-2', J = 3.9 Hz ), 3.21 (m, 2H, Cii2-CH = CH2), 3.13 (d, 1H, H-3., J = 3.9 Hz), 2.86 (t, 1H, H-ll, J = 3.6 Hz). Intermediate 108 [1R- (1 a, 3a point, 4 Lu, 4a / ?, 7, 7aa, 8a)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2,3 -Dihydroxypropyl) bD-piperanmannosyloxy) methyl] -4 -methyl-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl- 3- (1-Methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid, diphenylmethyl ester in intermediate 107 (2g) in 50ml To a solution of acetone and 5 ml of water, add 1 g of N-methylmorpholine at 0  C. To this mixture, slowly add 0.2 ml of a solution of tetrahydrochloride (2.5% by weight solution in isobutanol) The GM 218045X hydroxylation reaction is complete after 3 days at room temperature. The crude product is hydrosulfide-155- ^ paper size and used in China National Standards (CNS) A4 specification (210X297 (please read the precautions on the back (Fill in this page again)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 153)   1 : 1 50 : 150 : 50 1.75 0 (^, CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd1H, H-12, J=1.53.6 Hz), 4.69 (s1H-)4.10 (d, 1H, H-19a, J=9.3 Hz), 3.90-3.58 (m, 5H, CI^OH, CHOH, OC^-CHOH in 4'), 3.79 (d, 1H, H-19b, J=9.3 Hz), 3.27, 3.13 (d, d1H1HH-21 H-31J=3.9 Hz), 3.28-3.22 (m, 2H, H-4,H-5'), 2.85 (t1HH-ll, J=3.6 Hz) 109 [1 R-( 1 a3ab4b4ab7b7aa8ab) ]8a-[(2,3 --6--4--(2,3-0 --2,3 -]-b-D - ]-4 --44a,5,6,7,7a, 8,8a -- 7-f-3-(1--1,4--3_4-3&amp;amp;(1-  108 (350_(2 2502,2 -p_30) 2 7 6 : 1 5 0 : 5 0290 8 0 %) __ -156- CNS )4210X297) ' ()</span>Printed and printed by the Negative Consumers Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs A7 B7 V. Description of the invention (153) Sodium treatment, filtered on diatomaceous earth and evaporated to dryness. The residue was dissolved in ethyl acetate and washed with water and brine. The organic layer was dried over anhydrous magnesium sulfate and evaporated. Chromatographic analysis of the residue was carried out with n-hexane: ethyl acetate 1: 1 and dichloromethane: methanol 50: 1. The title compound (50:50 enantiomer mixture) was obtained as a white foam (1.75 g). 0 (^, CDC13): 9.75 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-12, J = 1.5 and 3.6 Hz), 4.69 (s, 1H,  -), 4.10 (d, 1H, H-19a, J = 9.3 Hz), 3.90-3.58 (m, 5H, CI ^ OH, CHOH, OC ^ -CHOH in 4 '), 3.79 (d, 1H, H -19b, J = 9.3 Hz), 3.27, 3.13 (d, d, 1H, 1H, H-21 and H-31, J = 3.9 Hz), 3.28-3.22 (m, 2H, H-4, and H- 5 '), 2.85 (t, 1H, H-ll, J = 3.6 Hz). Intermediate 109 [1 R- (1 a, 3ab, 4b, 4ab, 7b, 7aa, 8ab)] 8a-[(2,3 -anhydro-6-deoxy-4-- (2,3-0- Isopropylidene) -2,3-dihydroxypropyl] -bD-piperannomannosyl lactyl) methyl] -4-methylbromo-4,4a, 5,6,7,7a, 8, 8a -octagas- 7-fyl-3- (1-methylethyl) -1,4-methylene-3_4pyridine-3 &amp; (1 "-carboxylic acid, diphenylmethyl ester in the middle To a solution of body 108 (350 g) in anhydrous propylene (20 mL), add 250 mL of 2,2-dimethoxypropane and a catalytic amount of p-toluic acid (30 mg). This mixture is at room temperature Stir for 2 hours under nitrogen. The crude material was evaporated to dryness, and the residue was redissolved in ethyl acetate (70 mL), washed with water and brine. The organic layer was concentrated and used silica gel column with n-hexane: ethyl acetate 6: 1 Purification 'to prepare the title compound (50:50 isomer) as a white foam (290 mg, 80% yield). __ -156- This paper is used from the Chinese National Kneading Ratio (CNS) ) Eight 4 threats (210X297mm) '(Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 ____B7___ 154)  (, CDC13) 9.74 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1HH-12, J=.93.3 Hz), 4.67 (d, 1H, -, J=2.1</span>A7 ____B7___ Printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs 5. Description of Invention (154)  (, CDC13): 9.74 (s, 1H, CHO), 6.99 (s, 1H, CHPh2), 6.08 (dd, 1H, H-12, J = 0.9 and 3.3 Hz), 4.67 (d, 1H, -, J = 2.1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 4.32-4.22 (m, 1H, CHOH in 4'), 4.12-4.03 (m, 2H, H-19aOC^ in 43.82-3.51 (m4H, H-19bOC^-CHOH-Cii20)3.29&amp;amp;3.12(ddlHlH,H-2m-3J=3.9Hz) 3.26-3.20 (m2HH-4'H-5')2.85 (t, 1HH-llJ=3_9 Hz) 1_424.36 (dd3H3HCH3)2-C) 1 [1R-(1 a3a/54/54a/5 ,7/97aa8a]8a-[(6--3,4---/? -D-]_4__ 4,4a5,6,7,7a8,8a--7--3-(l--l,4--s --3 a (1 )- 10%/801() 2(1801 3 0/21  20 : (128</span>Hz), 4.32-4.22 (m, 1H, CHOH in 4 '), 4.12-4.03 (m, 2H, H-19a and OC ^ in 4'), 3.82-3.51 (m, 4H, H-19b, OC ^ -CHOH-Cii20), 3.29 &amp; 3.12 (d, d, lH, lH, H-2m-3, J = 3.9Hz), 3.26-3.20 (m, 2H, H-4 'and H-5') , 2.85 (t, 1H, H-ll, J = 3_9 Hz), 1_42 and 4.36 (d, d, 3H, 3H, isopropyl (CH3) 2-C). Example 1 [1R- (1 a, 3a / 5, 4/5, 4a / 5, 7/9, 7aa, 8a Lu)] 8a-[(6-deoxy-3,4--isopropylidene -/? -D-Azepinelpyranosyloxy) methyl] _4_formyl_4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-s-dipyridine-3 a (1 ) -carboxylic acid in 10% palladium / carbon (80 mg) in ethyl acetate (1 () Ml) of the suspension in Intermediate 2 (180 mg) in ethyl acetate (10 ml) under nitrogen, the mixture was hydrogenated at room temperature under 30 min / p 2 hydrogen pressure for 1 hour . The catalyst is eliminated and the solvent is evaporated to dryness. A flash layer analysis was carried out on the crushed silica, and washed away with methane: methanol (20: ) to obtain the title compound (128 mg).</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Ci CDC13) 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J-1.53.3 Hz)4.61 (d, 1H-, J=2.1 Hz), 4.30 (dd, 1H, H-3J=3.6&amp;amp;5.4Hz)4.04(d,lH8aCH2J=9.3Hz)3.95 (dd1HH-2'J=2.1 3_6 Hz)3.85 (dd1HH-4J=5.4 9.0 Hz), 3.66 (d, 1H, J=9.3 Hz), 3.49 (dq, 1H, H-5' Jd=9. Hz, Jq=6.3 Hz), 2.69 (t, 1HH-l, J=3.6 Hz); j (13(,  -157- lCNS ) A4210X297 ~ ()   A7 B7___. 15 CDC13) 204.8 (CHO), 175.4 (C02H), 148.3 (C-3), 137 (C-2), 109.3 (Cq.isop), (98.9 (C-l')5 76.9 (C-4'), 75.8 (C-2'), 74.2 (8aCH2), 71.7 (C-3'), 68.6 (C-5'), 65.6 (C-8a), 58.9 (C- 4) o 2 [1-(1&amp;lt;^3;5,4/?,4&amp;amp;77&amp;amp;8&amp;amp;/5)]8&amp;amp;-[(6-_3,4 0--y5-D-]-4 --4,4a5,6,7,7a8,8a--7--3-(_14_ -s--3a(lH)- 12462.51^ 0.9915 256  (^, CDC13) 9.88 (s, 1H, CHO), 5.95 (dd, 1H, H-2, J=1.53.3 Hz)4.51 (d1H, -J=1.8 Hz)4.26 (dd1H, H-3', J=4.8^16.0 Hz), 4.01 (d, 1H, 8aCH2, J=9.6 Hz), 3.87- 3.80 (m, 2HH-2'H-4')3.74 (d, 1H8aCH2, J=9_6 Hz), 3.50-3.42 (m, 1H, H-5'), 2.66 (t, 1H, H-l, J=3.9 Hz) 0 3 [1R-(1 a ,3a/? ,44a/?7y57aa8ay9 )]8a-[(6--3,4- 0-(2- --D-  ]-4- 44a5,6,7,7a8,8a--7--3-(1-_14_ -s --3 a (1 )- 10%/3010 3(140 _-158-____ CNS ) 4210 X 297 () - ,1  321644 A7 B7 _ 156) 3 0/24 5  30 : 1)75 26 : 74  E, CDC13): 9.82 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.53.3 Hz)4.60 (d1H, -J=1.8 Hz)4.30 (dd, 1H, H-3J=4.26.0 Hz), 3.98 (d1H, 8aCH2, J=9.3 Hz), 394 (ddlHH-2J=1.8&amp;amp;4.2Hz)3.87(ddlHH-4J=6.(m 9.3 Hz), 3.65 (d, 1H, 8aCH2, J=9.3 Hz), 3.47 (dq, 1H, H-5', Jd=9.3 Hz, Jq = 6.3 Hz), 2.70 (t, 1H, H-l, J-3.9 Hz); S(l3C, CDC13 ): 204.5 (CHO), 176.5 (C2H), 148.2 (C-3), 130.6 (C-2), 110.8 (Cq acetal), 98.8 (C-l'), 76.6 (C-4'), 75.6 (C-2'), 73.9 (8aCH2), 71.3 (C-3')5 68.9 (C-5'), 65.5 (C8a), 58.8 (C-4) 0 4 [111-(1&amp;lt;^3&amp;amp;/3,4/9,4&amp;amp;/?7/?7&amp;amp;&amp;lt;^8&amp;amp;]8&amp;amp;-[(6--3,4--(4--2---D-]_ 4 --44a5,6,7,7a8,8a --7-- 3- (1- -14--S-4_3a(lH)- 10 %/10015 4(26010 30/245  3 0 : 1)172 ___-159- CNS ) 4 ( 210X297) ~~ ()   A7 B7 157) ci On, CDC13) 9.71 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.536 Hz)4.60 (d1H-, J=2.4 Hz)4.31 (dd1H H-3J=4.26.0 Hz)3.98 (d1H8aCH2, J=9.3 Hz)3.94 (dd1HH-2J=2.44_2 Hz), 3.88 (dd1HH-41J=6_0 9.3 Hz)3.65 (d1H8aCH2, J=9.3 Hz)3.50 (t1HCH20, J=7.2 Hz), 3.50-3.40 (m, 1H, H-5'), 2.69 (t, 1H, H-l, J=3.9 Hz); d(13C, CDCI3): 204.5 (CHO), 176.2 (C02H), 148.2 (C-3), 130.6 (C-2), 109.8 (C-2&amp;quot;), 98.8 (C-l'), 76.7 (C-4'), 75.7 (C-2'), 73.8 (8aCH2), 71.2 (C-2'), 68.8 (C-5'), 68.4 (CH20), 65.6 (C8a), 58.9 (C-4), 58.5 (CH3)  5 [1R-(1 a3a/?44a/9 ,77aa8ay5 )]8a-[(6--3,4-  -- 0-D -]_4__ 4,4a5,6,7,7a8,8a--7_ 3-(1--1,4- -s--3a(lH)- 10 0//501() 5(232 3 5/25  30 : 1)67 ^ CDC13): 9.71 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.5&amp;amp;3.3Hz)4.59(dlHH-l'J=2.1Hz)4.17(ddlH H-3J=3.65.4 Hz)4.54 (d1H8aCH2, J=9.3 Hz)397 ________-160-_ gjCNS ) A4^ ( 21GX297 ()</span>Ci CDC13): 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J-1.5 and 3.3 Hz), 4.61 (d, 1H, -, J = 2.1 Hz), 4.30 (dd , 1H, H-3 ', J = 3.6 &amp;amp; 5.4Hz), 4.04 (d, lH, 8aCH2, J = 9.3Hz) 3.95 (dd, 1H, H-2', J = 2.1 and 3_6 Hz), 3.85 (dd, 1H, H-4, J = 5.4 and 9.0 Hz), 3.66 (d, 1H, J = 9.3 Hz), 3.49 (dq, 1H, H-5 'Jd = 9.Hz, Jq = 6.3 Hz), 2.69 (t, 1H, Hl, J = 3.6 Hz); j (13 (:, a-157-l paper size, Chinese National Standard (CNS) A4 specification (210X297mm) ~ (please first Read the notes on the back and fill out this page) Order A7 B7___ of the Employees Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy. , 13.7 (C-2), 109.3 (Cq. Isop), (98.9 (C-l ') 5 76.9 (C-4'), 75.8 (C-2 '), 74.2 (8aCH2), 71.7 ( C-3 '), 68.6 (C-5'), 65.6 (C-8a), 58.9 (C- 4) o Example 2 [1 ft- (1 &amp;lt; ^, 3 ; 5,4 / ?, 4 &amp;amp; Cold, 7 cold, 7 &amp;amp; , 8 &amp;amp; / 5)] 8 &amp;amp;-[(6-degassed_3,4 0-isopropylidene-y5-D-azhopranosyloxy) methyl ] -4 -Meluyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (p-methylethyl ) _1,4_ methylene-s-pyda-3a (lH) -carboxylic acid, sodium salt The compound of Example 1 (246 g) was dissolved in dioxane (2 ml), and carbonic acid 0.51 ^ was added Sodium hydrogen (0.99 ml). Stir the solution for 15 minutes and freeze-dry to prepare the title compound (256 mg).  (^, CDC13): 9.88 (s, 1H, CHO), 5.95 (dd, 1H, H- 2, J = 1.5 and 3.3 Hz), 4.51 (d, 1H, -, J = 1.8 Hz), 4.26 (dd, 1H, H-3 ', J = 4.8 ^ 16.0 Hz), 4.01 (d, 1H , 8aCH2, J = 9.6 Hz), 3.87- 3.80 (m, 2H, H-2 'and H-4'), 3.74 (d, 1H, 8aCH2, J = 9_6 Hz), 3.50-3.42 (m, 1H, H-5 '), 2.66 (t, 1H, Hl, J = 3.9 Hz) 0 Example 3 [1R- (1 a, 3a /?, 4 points, 4a / ?, 7y5,7aa, 8ay9)] 8a- [ (6-deoxy-3,4- 0- (2-pentylidene) --D-azorpiperanyloxy) methyl] -4-carboxamide  4,4a, 5,6 , 7,7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) _1,4-methylene-s-indap-3a (1 ) -carboxylic acid in A solution of 10% palladium / carbon (30 mg) in ethyl acetate (10 ml) and a solution of intermediate 3 (140 mg) in ethyl acetate under nitrogen is added to this paper's _-158 -____ Quickly use the Chinese national standard (CNS) 4 specification (210 X 297 mm) (please read the precautions on the back and fill in this booklet)-, 1 Printed by the Central Consumer s Consumer Cooperative of the Ministry of Economic Affairs 321644 A7 B7 _ V. Invention description (156 ) The mixture was hydrogenated at 30 psi hydrogen for 45 minutes. The catalyst was filtered off and the solvent was evaporated to dryness. A flash layer analysis was carried out on silica gel, using dichloromethane: methanol (30: 1) as the eluent to obtain the title compound (75 mg), with an epimer ratio of 26:74.  E, CDC13): 9.82 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 and 3.3 Hz), 4.60 (d, 1H, -, J = 1.8 Hz), 4.30 (dd, 1H, H-3 ', J = 4.2 and 6.0 Hz), 3.98 (d, 1H, 8aCH2, J = 9.3 Hz), 3.94 (dd, lH, H-2', J = 1.8 &amp;amp;; 4.2Hz), 3.87 (dd, lH, H-4, J = 6. (M 9.3 Hz), 3.65 (d, 1H, 8aCH2, J = 9.3 Hz), 3.47 (dq, 1H, H-5 ' , Jd = 9.3 Hz, Jq = 6.3 Hz), 2.70 (t, 1H, Hl, J-3.9 Hz); S (l3C, CDC13): 204.5 (CHO), 176.5 (C2H), 148.2 (C-3 ), 130.6 (C-2), 110.8 (Cq acetal), 98.8 (C-l '), 76.6 (C-4'), 75.6 (C-2 '), 73.9 (8aCH2), 71.3 (C-3' ) 5 68.9 (C-5 '), 65.5 (C8a), 58.8 (C-4) 0 Example 4 [111- (1 &amp;lt; ^, 3 &amp;amp; / 3,4 / 9,4 &amp;amp; / ?, 7 / ?, 7 &amp;amp; &amp;lt; ^, 8 &amp;amp; Lu)] 8 &amp;amp;-[(6-deoxy-3,4-- (4-methoxy-2-butylene-Lu-D-azoroperanyloxy Group) methyl] _ 4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4 -Methylene-S-4, Dasheng_3a (lH) -carboxylic acid was added Intermediate 4 (260 mg) in a suspension of 10% palladium on carbon (100 mg) in ethyl acetate (15 ml) Dissolved in ethyl acetate (10 ml) The mixture was hydrogenated under 30 psi hydrogen pressure for 45 minutes. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash chromatography on silica gel using methane: methanol (30: 1) ) Wash off to prepare the title compound (172 mg) ___- 159- This paper Caiguanjia County (CNS) 4  (210X297mm) ~~ (Please read the precautions on the back before filling this page) Order the Ministry of Economy Printed and printed by the Central Bureau of Standards and Technology Beigong Consumer Cooperative A7 B7 V. Description of Invention (157) ci On, CDC13): 9.71 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 and 3. 6 Hz), 4.60 (d, 1H, -, J = 2.4 Hz), 4.31 (dd, 1H, H-3 ', J = 4.2 and 6.0 Hz), 3.98 (d, 1H, 8aCH2, J = 9.3 Hz), 3.94 (dd, 1H, H-2, J = 2.4 and 4_2 Hz), 3.88 (dd, 1H, H-41, J = 6_0 and 9.3 Hz), 3.65 (d, 1H, 8aCH2, J = 9.3 Hz), 3.50 (t, 1H, CH20, J = 7.2 Hz), 3.50-3.40 (m, 1H, H-5 '), 2.69 (t, 1H, Hl, J = 3.9 Hz); d (13C, CDCI3): 204.5 (CHO), 176.2 (C02H), 148.2 (C-3), 130.6 (C-2), 109.8 (C-2 &amp;quot;), 98.8 (C-l '), 76.7 (C-4') , 75.7 (C-2 '), 73.8 (8aCH2), 71.2 (C-2'), 68.8 (C-5 '), 68.4 (C H20), 65.6 (C8a), 58.9 (C-4), 58.5 (CH3)  Example 5 [1R- (1 a, 3a / ?, 4, 4a / 9, 7 Lu, 7aa, 8ay5)] 8a -[(6-Deoxy-3,4--cyclopentylidene- 0-D-azorpiperanosyloxy) methyl] _4_carboxamyl_4,4a, 5,6,7 , 7a, 8,8a-octahydro-7_methyl  3- (1-methylethyl) -1,4-methylene-s--sap-3a (lH) -carboxylic acid at 10 0 /  Palladium / carbon (50 mg) in a suspension of ethyl acetate (1 () mL) was added a solution of Intermediate 5 (232 mg) in ethyl acetate. Inch 2 hydrogenated under hydrogen pressure for 5 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash chromatography on silica gel, and washed away with methane: methanol (30: 1) to obtain the title compound (67 mg). ^ CDC13): 9.71 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.3Hz), 4.59 (d, lH, H-l ', J = 2.1Hz), 4.17 (dd, lH, H-3 ', J = 3.6 and 5.4 Hz), 4.54 (d, 1H, 8aCH2, J = 9.3 Hz), 3.97 ________- 160-_ This paper is suitable for gj housekeeping standards ( CNS) A4 ^ (21GX297 public and public) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 ____B7 15S) (dd1H, H-2'J=2.1 3.6 Hz)3.81 (dd1HH-4'J=5.4 9.0 Hz), 3.70 (d, 1H, 8aCH2, J=9.3 Hz), 3.44 (dq, 1H, H-5', Jd=9.0 Hz, Jq=6.3 Hz), 2.69 (t, 1H, H-l, J=3.3 Hz)  6 [1R-(1 a3a/?4/?4a77aa8ay9 )]8a-[(6--3,4 0-4--/5 -D -]_4__ 4,4&amp;amp;5,6,7,73,8,8&amp;amp;--7--3-(1-_14_ -s--3a(lH)- 7(1.26 1 0 %/600 40/21  25 : 1) 0.79  (^, CDC13) 9.81 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J1.2&amp;amp;3.3Hz)4.63(ddlH,H-l,,J=2.4&amp;amp;8.4Hz),4.38(dt 1H, H-3', Jd=3.0 Hz, Jt-5.1 Hz), 4.29 (d, 1H, 8aCH2, J=9.3</span>Du7 A7 ____B7 for consumer cooperation of the Central Department of Economic Affairs of the Ministry of Economic Affairs 5. Invention description (15S) (dd, 1H, H-2 ', J = 2.1 and 3.6 Hz), 3.81 (dd, 1H, H-4', J = 5.4 and 9.0 Hz), 3.70 (d, 1H, 8aCH2, J = 9.3 Hz), 3.44 (dq, 1H, H-5 ', Jd = 9.0 Hz, Jq = 6.3 Hz), 2.69 (t, 1H, Hl, J = 3.3 Hz)  Example 6 [1R- (1 a, 3a / ?, 4 / ?, 4a, 7 Lu, 7aa, 8ay9)] 8a-[(6-deoxy-3,4  0 -4-Isopropylidene- / 5-D-perpiperanosyloxy) methyl] _4_formyl_4,4 &amp;amp;, 5,6,7,73,8,8 &amp;amp; -octahydro -7-methyl-3- (1-methylethyl) _1,4-methylene-s-pyridine-3a (lH) -carboxylic acid in intermediate 7 (1.2 g) in ethyl acetate (6 To the solution in 0 ml), 10% palladium on carbon (600 mg) was added in portions under nitrogen. This mixture was shaken in a Parr apparatus at 40 psi hydrogen pressure for 1 hour at room temperature. The catalyst was filtered off and washed with more ethyl acetate. The solvent was evaporated to dryness. The residue was analyzed by flash chromatography on silica gel and washed away with methane: methanol (25: 1) to obtain the title compound (0.79 g).  (^, CDC13): 9.81 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J1.2 &amp;amp; 3.3Hz), 4.63 (dd, lH, Hl ,, J = 2.4 &amp;amp; 8.4 Hz), 4.38 (dt, 1H, H-3 ', Jd = 3.0 Hz, Jt-5.1 Hz), 4.29 (d, 1H, 8aCH2, J = 9.3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)3.64 (dd1H, H_4J=5.1 9.3 Hz), 4.43 (dq1H, H-5</span>Hz), 3.64 (dd, 1H, H_4 , J = 5.1 and 9.3 Hz), 4.43 (dq, 1H, H-5 ,,</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Jd=9.3 Hz, Jq=6.0 Hz), 3.40 (d, 1H, 8aCH2, J=9.3 Hz), 2.53 (t, 1H, H-l, J=3.9 Hz); tf(13C, CDC13): 204.7 (CHO), 174.6 (C02H), 148.2 (C-3), 130.6 (C-2), 108.9 (C(CH3)2), 98.3 (C-l'), 76.6 (C-4'), 73.7 (8aCH2), 72.5 (C-3'), 71.7 (C-5'), 67.0 (C8a), 65.2, 59.0 (C-4) 7 ______-161_-__ CNS ) A4210X297 (} u</span>Jd = 9.3 Hz, Jq = 6.0 Hz), 3.40 (d, 1H, 8aCH2, J = 9.3 Hz), 2.53 (t, 1H, Hl, J = 3.9 Hz); tf (13C, CDC13): 204.7 (CHO) , 174.6 (C02H), 148.2 (C-3), 130.6 (C-2), 108.9 (C (CH3) 2), 98.3 (C-l '), 76.6 (C-4'), 73.7 (8aCH2), 72.5 (C-3 '), 71.7 (C-5'), 67.0 (C8a), 65.2, 59.0 (C-4). Example 7 ______- 161 _-__ The paper size is applicable to China National Standard (CNS) A4 (210X297mm) (please read the precautions on the back before filling this page) u</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 15 [1R-(1 a ,3a/5 ,4/? ,4a57 7aor8a/? )]8a-[(2,6 - _ 3.4- 0-(4--2-_D ]_4 --4,43,5,6,7,78,8&amp;amp;--7_-3-(1- -1,4 --s-_3a(1H) 10%/3001 8(2461 45/2i  3 : 1) 1824 : 1  OH, CDC13)9.81 (s, 1HCHO), 6.06 (dd, lHH-2J=1.5A3.6Hz)4.62(dlHH-l'J=2.7&amp;amp;8.1Hz) 4.41 (dt, 1H, H-3', Jd=3.3 Hz, Jt=2.5 Hz), 4.24 (d, 1H, 8aCH2, J=9.0 Hz), 3.68 (dd, 1H, H-4J=5.79.0 Hz), 3.50 (t, 2H, CH2, J=7.5 Hz), 3.46-3.38 (in, 1H, H-5'), 3.33 (s, 3H, CH30), 2.54 (t, 1H, H-l, J=4.2 Hz); (13C, CDC13): 204.5 (CHO), 175.1 (C02H), 148.2 (C-3), 130.7 (C-2), 109.4 (C-2&amp;quot;), 98.3 (C-l')5 76.4 (C-4'), 73.6 (8aCH2), 71.9 (C-3'), 71.4 (C-5'), 68.6 (CH20), 65.2 (C8a), 58.9 (C-4), 58.6 (CH30) &amp;lt;= 8 [1R-(1 a3a/?44a/37y57aa8ayS )]8a-[(2,6-- 3.4- 0 ---D-]_4_ -4,4&amp;amp;5,6,7,7&amp;amp;8,83--7--3-(1-- 1.4- -s--3a(lH)- -162 CNS ) A4210X297 () &amp;lt;</span> 1T Ministry of Economic Affairs Central Bureau of Precision Industry Beigong Consumer Cooperative Printed A7 V. Description of invention (15 bows [1R- (1 a, 3a / 5, 4 /?, 4a; 5,7 cold, 7aor, 8a /?) ] 8a-[(2,6 -dideoxy_ 3.4- 0- (4-methoxy-2-butylidene_D  piperanyloxy) methyl] _4 -methylacyl-4, 43,5,6,7,7,8,8 &amp;amp; -octahydro-7_methyl-3- (1-methylethyl) -1,4-methylene-s-indap province_3a (1H)  A solution of Intermediate 8 (246 mg) in ethyl acetate (10 mL) was added to a suspension of carboxylic acid in 10% palladium / carbon (300 mg) in ethyl acetate (10 mL). The mixture was hydrogenated at 45 psig hydrogen pressure for 1 hour at room temperature. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash chromatography on silica gel using methane and methane. : Methanol (30: 1) was washed away to obtain the title compound (182 mg) as a white foam with an epimer ratio of 4: 1.  OH, CDC13) Main component signal: 9.81 (s, 1H, CHO ), 6.06 (dd, lH, H-2, J = 1.5A3.6Hz), 4.62 (d, lH, H-l ', J = 2.7 &amp;amp; 8.1Hz), 4.41 (dt, 1H, H-3' , Jd = 3.3 Hz, Jt = 2.5 Hz), 4.24 (d, 1H, 8aCH2, J = 9.0 Hz) , 3.68 (dd, 1H, H-4 ', J = 5.7 and 9.0 Hz), 3.50 (t, 2H, CH2, J = 7.5 Hz), 3.46-3.38 (in, 1H, H-5'), 3.33 ( s, 3H, CH30), 2.54 (t, 1H, Hl, J = 4.2 Hz); (13C, CDC13): 204.5 (CHO), 175.1 (C02H), 148.2 (C-3), 130.7 (C-2) , 109.4 (C-2 &amp;quot;), 98.3 (C-l ') 5 76.4 (C-4'), 73.6 (8aCH2), 71.9 (C-3 '), 71.4 (C-5'), 68.6 (CH20) , 65.2 (C8a), 58.9 (C-4), 58.6 (CH30) &amp;lt; = Example 8 [1R- (1 a, 3a / ?, 4 points, 4a / 3, 7y5, 7aa, 8ayS)] 8a- [ (2,6-dideoxy-3.4- 0 -isopropylidene--D-dezopiperanosyloxy) methyl] _4_carboxyl-4,4 &amp;amp;, 5,6,7 , 7 &amp;, 8,83-octaamino-7-methyl-3- (1-methylethyl)-1.4-methylene-s-indida-3a (lH) -carboxylic acid, sodium salt- 162 The standard size of this paper is Chinese National Standard (CNS) A4 (210X297mm) (Please read the precautions on the back before filling this page) &amp;lt;</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  321644 A7 _ B7 160) 637635 1.503 392 ^ (^, CDC13): 9.84 (s, 1H, CHO), 5.94 (dd, 1H, H-2, J=1.55.3.6 Hz), 4.52 (dd, 1H, -, J=2.4A9.0 Hz), 4.41-4.37 (m, 1H, H-3'), 4.02 (d, 1H, 8aCH2, J=9.6 Hz), 3.74 (d, 1H8aCH2, J=9.6 Hz), 3.57 (dd1HH-4'J=5.4 10.0 Hz), 3.42 (dq, 1H, H-5', Jd=6.3 Hz, Jq=6.3 Hz), 2.56 (t, 1H, H-l, J=3.6 Hz) 9 [1R-(1 3a/9 ,4 04ay?77aa8a/5 )]8a-[(6--3,4- --D-4_-4,4a5,6,7,7a8,8a--7-3-(l--l4--s --3 a (1 )- 2%2 9(0.2205 0C12 X 20  40 : 120 : 1) 0.1 d (:, CDC13): 9.68 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)4.94(ddlH,H-3J=3.9&amp;amp;7.2Hz)4.62(m, 2HH-liH-41)4.14 (dd1HH-2, J=2.1 3_9 Hz)4.00 (d, 1H, 8aCH2Jab=9.3 Hz), 3.72 (d, 1H8aCH2, JAB=9.3 Hz), -163- ACNS ) A4L210X297 ()</span> 1T Printed by 321644 A7 _ B7, Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economy V. Description of the invention (160) Dissolve the compound of Example 6 (376 mg) in dioxane (3 ml) and add 0.5 equivalent of carbonic acid Sodium hydrogen (1.50 ml). The resulting solution was stirred at room temperature for 30 minutes and then lyophilized to prepare the title compound (392 mg). ^ (^, CDC13): 9.84 (s, 1H, CHO), 5.94 (dd, 1H, H-2, J = 1.55.3.6 Hz), 4.52 (dd, 1H, -, J = 2.4A9.0 Hz), 4.41-4.37 (m, 1H, H-3 '), 4.02 (d, 1H, 8aCH2, J = 9.6 Hz), 3.74 (d, 1H, 8aCH2, J = 9.6 Hz), 3.57 (dd, 1H , H-4 ', J = 5.4 and 10.0 Hz), 3.42 (dq, 1H, H-5', Jd = 6.3 Hz, Jq = 6.3 Hz), 2.56 (t, 1H, Hl, J = 3.6 Hz). Example 9 [1R- (1 , 3a / 9, 4 0, 4ay ?, 7, 7aa, 8a / 5)] 8a-[(6-deoxy-3,4--thiocarbonyl-D-Azhuo Piperanosyloxy) methyl bu 4_methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7methyl-3- (l-methylethyl)- l, 4-Methylene-s-indap-3a (1 ) -tetanoic acid 2% trifluoroacetic acid in difluoromethane solution (20 mL) was added to intermediate 9: (0.220 g) in a solution of methane (5 ml). The reaction mixture was stirred at 0  C for 1 hour, then washed with water (2 X 20 mL) and dried (magnesium sulfate). The solvent was evaporated to obtain a residue, which was analyzed by flash chromatography on a silica gel column, and washed away with methane: methanol (40: 1 to 20: 1) to obtain the title compound (0.1 g) . d (: , CDC13): 9.68 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.94 (dd, lH, H-3, J = 3.9 &amp;amp; 7.2Hz), 4.62 (m, 2H, H-li and H-41), 4.14 (dd, 1H, H-2, J = 2.1 and 3_9 Hz), 4.00 (d, 1H, 8aCH2, Jab = 9.3 Hz), 3.72 (d, 1H, 8aCH2, JAB = 9.3 Hz), -163- This paper uses the Chinese National Standard (CNS) A4 L grid (210X297mm) for A degree (Please read the precautions on the back first (Fill in this page again)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 B7 s2l644 161) 3.68 (m, 1H, H-5'), 2.71 (m, 1H, H-l) i(13C, CDC13) 204.4 (CHO), 190.2 (CS), 176.4 (C02H), 148.4 (C-3), 130.6 (C_2),98.2(C-r)82.3&amp;amp;80.1(C-3iC-4')74.5(8aCH2), 71.7 (C-3a), 69.266.4 (C-2'&amp;amp;C-565.5(C-8a)58.8(C-4)46.0 (C-l) 1 0 [1R-(1 a3a44a77aa8a]8a-[(2,6-_ 3,4-0--/?-0-]_4_-4,4&amp;amp;5,6,7,78,8&amp;amp;--7--3-(1--14--s-- 3a(lH)- 10(12515 ( TLC (20013xilx 1 1 X 100  152/2 10%/5 1T L C 1 : 15) 5 0Rf0.5  (^, CDC13): 9.70 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.23.3 Hz), 4.93 (m, 1H, H-34.63 (dd1H, H-l J=2.47.8 Hz), 4.24 (dd1H, H-4, J=6.69.3 Hz)4.05 -164- CNS ) A4210X297) ---------(&amp;lt;------------^ ()   3^t644 A7 B7 162) 3.57 (2d2H8aCH2, JAB=9 Hz), 3.63 (m, 1HH-5')2.66 (t 1H, H-l, J=3.9 Hz); d(l3C, CDC13): 204.6 (COH), 176.0 (COOH), 154.0 (OCO), 148.2 (C-3), 130.7 (C-2), 97.5 (C-l')s 76_6 (Q-4)74.7 (y)69.9 (g-5)31.7 (Q-2 1 1 [1R-(1 a3ay544a/?77aor8a/? )]8a-[(2,6-. 3,4-0----]-4-_ 4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1--14 -s-i-3a(lH)- 11(1305 0C2502 (502 X 100 TLC :1 : 15)68Rf0.5  s (!H, CDC13): 9.70 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J=1.23.3 Hz), 5.08 (m1H, H-3')4.63 (dd1H, - J=2.7&amp;amp;8.4Hz)4.45(ddlHH-4J=6.6&amp;amp;9.0Hz)4.03&amp;amp; 3.59 (2d, 2H8aCH2, JAB=9.3 Hz), 3.64 (m1HH-51)2.67 (t, 1H, H-l, J=3.0 Hz); S3C, CDC13): 204.5 (COH), 190.9 (CS), 176.3 (COOH), 148.2 (C-3), 130.7 (C-2), 97.5 (C-l'), 80.3 (-4)79.6 (-3)69.5 (y)31.3 (y) 1 2 [1R-(1 a3a54/?4a57y57aa8a/? )]8a-[(2,6-- -165- (}</span> 1T  A7 B7 s2l644 V. Description of invention (161) 3.68 (m, 1H, H-5 '), 2.71 (m, 1H, Hl); i (13C, CDC13): 204.4 (CHO), 190.2 (CS) , 176.4 (C02H), 148.4 (C-3), 130.6 (C_2), 98.2 (Cr), 82.3 &amp;amp; 80.1 (C-3iC-4 '), 74.5 (8aCH2), 71.7 (C-3a), 69.2 and 66.4 (C-2 '&amp;amp; C-5'), 65.5 (C-8a), 58.8 (C-4), 46.0 (Cl). Example 1 0 [1R- (1 a, 3a point, 4 Lu, 4a point, 7 point, 7aa, 8a)] 8a-[(2,6-dideoxy_ 3,4-0-carbonyl- /? -0-epiperanosyloxy) methyl] _4_carboxamide-4,4 &amp;amp;, 5,6,7,7,8,8 &amp; -octahydro-7-methyl-3- ( 1-methylethyl) -1,4-methylene-s-pyridine-3a (lH) -carboxylic acid in intermediate 10 (125 mg) in refluxing anhydrous toluene (15 ml) Add a small amount of excess carbonyldiimidazole under nitrogen. After the reaction was completed (controlled by TLC), the solvent was removed under reduced pressure, and the crude mixture was dissolved in dichloromethane (200 mL), using 1 equivalent of hydrochloric acid (3 x 100 mL), brine (lx 100 mL) and water ( 1 X 100 ml), then dried over magnesium sulfate, and concentrated to dryness to obtain an oil body, which can be used further without purification. Dissolve this oil in ethyl acetate (15 mL), in a Parr device under 20 psi hydrogen pressure, and shake at room temperature in the presence of 10% palladium / carbon (50 mg) 1 hour. The catalyst was filtered off and the solvent was removed to obtain a slurry, which was then purified by preparation using TLC (silica gel, methanol: methane 1:15) to obtain the title compound (50 mg), which was obtained from Rf0.5.  (^, CDC13): 9.70 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.93 (m, 1H, H-3,), 4.63 (dd, 1H, Hl ,, J = 2.4 and 7.8 Hz), 4.24 (dd, 1H, H-4, J = 6.6 and 9.3 Hz), 4.05 and -164- The paper size is free to use China National Standard (CNS) A4 specification (210X297mm) --------- (:  &amp;lt; ------ order ------ ^ (please read the notes on the back before filling in this page) Central Standard of the Ministry of Economic Affairs Bureau of Industry and Consumers Cooperative Printing Agency Central Central Bureau of Economics of the Ministry of Economic Affairs-Industry and Consumers Cooperative Printing 3 ^ t644 A7 B7 V. Description of Invention (162) 3.57 (2d, 2H, 8aCH2, JAB = 9 Hz), 3.63 (m, 1H , H-5 '), 2.66 (t, 1H, Hl, J = 3.9 Hz); d (l3C, CDC13): 204.6 (COH), 176.0 (COOH), 154.0 (OCO), 148.2 (C-3), 130.7 (C-2), 97.5 (C-l ') s 76_6 (Q-4,), 74.7 (y), 69.9 (g-5,), 31.7 (Q-2,). Example 1 1 [1R- (1 a, 3ay5, 4 Lu, 4a / ?, 7 Lu, 7aor, 8a /?)] 8a-[(2,6-dideoxy. 3,4-0-thiocarbonyl-luo--pipera Furanosyloxy) methyl] -4-carboxamide_ 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methyl) Ethyl) -1,4  methylidene-s-, i province-3a (lH) -A solution of carboxylic acid in intermediate 11 (130 mg) in anhydrous difluoromethane (5 ml) was added trifluoroacetic acid (250 ml) at 0  C. After 2 hours the solution was replaced by difluoromethane (50 ml ) Dilute, wash with water (2 X 100 ml), dry over magnesium sulfate, and concentrate to dryness to obtain an oil body for preparation by TLC purification (silica gel, methanol: difluoromethane 1: 15) to prepare the title compound (68g), obtained from Rf0.5. S (! H, CDC13): 9.70 (s, 1H, CHO), 6.07 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5.08 (m , 1H, H-3 '), 4.63 (dd, 1H, -, J = 2.7 &amp;amp; 8.4Hz), 4.45 (dd, lH, H-4, J = 6.6 &amp;amp; 9.0Hz), 4.03 &amp;amp; 3.59 (2d, 2H, 8aCH2, JAB = 9.3 Hz), 3.64 (m, 1H, H-51), 2.67 (t, 1H, Hl, J = 3.0 Hz); S3C, CDC13): 204.5 (COH) , 190.9 (CS), 176.3 (COOH), 148.2 (C-3), 130.7 (C-2), 97.5 (C-l '), 80.3 ( -4,), 79.6 ( -3'), 69.5 (y), 31.3 (y). Example 1 2 [1R- (1 a, 3a; 5, 4 / ?, 4a; 5, 7y5, 7aa, 8a /?)] 8a-[(2,6-dideoxy- -165- (please read first Note on the back then fill out this page}</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T CNS ) 210X297 A7 B7 163) 3.4- 0-_-1)_]_4_-44a5,6,7,7a8,8a--7_ -3-(1--1,4- -s -_ 3 a (1 )- 10(45010 4 5  % 1001 211 1001 (1X100 15 20/21  1 : 1 )1 : 5) 130 (lR, CDC13) 9.80 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.23.3 Hz)512486 (2m, 2H, 0CH20)4.60 (dd, 1H H-lJ=2.48.7 Hz)4.203.44 (2d, 2H8aCH2, Jab=9,3</span> 1T The size of this paper is applicable to China National Standard (CNS) grid (210X297mm) A7 B7 V. Description of the invention (163) 3.4- 0-methylene_10,000-1) _piperanosyloxy) methyl] _4_    -4'4a, 5,6,7,7a, 8,8a-octahydro-7_methyl-3- (1-methylethyl) -1,4-methylene- s-    _ 3 a (1 ) -carboxylic acid in Zhongli Li 10 (450 mg) in anhydrous digas methane (10 ml) was added under strong stirring tetrabutylammonium bromide (4 mg) and 50% aqueous sodium hydroxide solution (100 ml). After 12 hours, add 1 equivalent of hydrochloric acid (100 mL) to stop the reaction 'and extract with methane (100 mL). The organic layer was washed with 1 equivalent of hydrochloric acid (1X100 mL), dried over magnesium sulfate, and concentrated to dryness to obtain a white solid, which can be used further without purification. This solid was dissolved in ethyl acetate (15 mL) and shaken in a Parr device at 20 psi hydrogen pressure for 1 hour at room temperature. The catalyst was filtered off, the solvent was removed, and the residue of the oil body was subjected to flash layer analysis on silica gel, and washed away with acetone: hexane (1: 1) and (1: 5) to obtain the title compound (130 mg ) Is an oil body. (lR, CDC13): 9.80 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 5.12 and 4.86 (2m, 2H, 0CH20), 4.60 ( dd, 1H, Hl ,, J = 2.4 and 8.7 Hz), 4.20 and 3.44 (2d, 2H, 8aCH2, Jab = 9,3</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz),4.13(mlHH-3'),3.67(ddlHH-4'J=5.1&amp;amp;8.7Hz)  () 3.38 (m, 1H, H-5'), 2.58 (t, 1H, H-l, J=3.9 Hz); i(13C, CDCI3): 2046 (CH), 174.8 (COOH), 148.3 (C-3), 130.6 (C-2), 98.1 (C-l'), 94.9 (0CH20), 75.4 (C-4'), 73.9 (C-3')s 70.3 (y)32_3 (y) 1 3 [1R-(1 a3a54/? ,4 a/?7/S7aa8ay5 )]8a-[(2,6 - _ 3.4- 0 ---D -]-4 -_ -166- CNS ) A421&amp;gt;&amp;lt;297 ^21644 A7 B7  1, 4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;__7_.3_(1_14_ -S--3a(lH)- 122005 0.1063.983 5 209 ci H, CD3OD) 9.87 (s, 1H, CHO), 6.54 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)5,l(^4.82(2m2HOCH20)4.51(ddlH H-rJ=2.4&amp;amp;8.7Hz)4.12(mlHH-3l),4.03&amp;amp;3.73(2d2H, 8aCH2, Jab=9.9 Hz), 3.61 (m, 1H, H-4'), 3.35 (m, 1H, H-5'), 2.56 (t, 1H, H-l)  3C, CD3OD): 200.2 (COH), 169.0 (COOH), 142.9 (C-2), 120.6 (C-2), 90.3 (C-l'), 86.4 (0H20)67.5 (y), 66.2 (-3)61.8 (-5 1 4 (a) [lR-(l ,3a^ ,4/5 ,4a^ ,1  ,laa ,8a/? ) ] 8 a-[ [ 1 S , 3 R, 7R9R]-2,5,8--3,7---[4.4.0]--9---]-4 --4,4a5,6,7,7a8,8a--7--3-(l--l4--s--3a(lH)-  (b) [lR-(l ,3a/? , ,4ay9 ,  ,laa ,8a/? ) ] 8 a - [ [ 1 S, 3 S, 7R9R]-2,5,8-3,7---[4.4.0]--9---]-4 --4,4a56,7,7a,8,8a--7-- 3- (1--14--s-- 3a(lH) -  -167- CNS ) A4210X 297 ()  _   A7 B7 165) 1514(120 20/21  /1 : 10)1 : 7)1 : 5) a)(35Rf=0.5_4 : 1 b)(40Rf=0.44 : 1  (a)  (^, CDC13) 9.80 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz)4.62(ddlHH-9'J=2.1&amp;amp;9.9Hz)4.20(m 2H, 8aCH2+H-7'), 3.97 (m, 1H, H-l'), 3.73 (m, 1H, OCHCH3), 3.40 (m, 2H, 8aCH2+OCH2), 3.27 (d, 1H, OCH2, JAB = 10.8 Hz)3.18 (dd1HH-6J=3.3 10.2 Hz); d(13C CDCI3): 204.6 (COH), 174.6 (COOH), 148.3 (C-3), 130.6 (C-2), 97.9 (C-9'), 73.5 (OCH2), 73.2 (C-6'), 72.1 (C-l'), 71.9 (OCHCH3), 654 (C-7'), 31.9 (C-10'), 22.7 (OCHCH3) o (b)  (!, CDC13): 9.79 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.536 Hz)4.73 (dd1HH-91J=3.06.3 Hz)4.26 (m, 1H, -), 4.15 (m, 2H, 8aCH2+H-7')5 3.98 (m, 1H, OCHCH3), 3.79 (dd, 1H, 0CH2,J=3.1J5L11.4 Hz), 3.41 (d, 1H, 8aCH2, J=9.6 Hz), 3.35 (m, 1H, OCH2, J=3.1 6.3 Hz), 3.27 (ddlH,H-6J=5.7&amp;amp;11.7Hz)2.55(tlHH-l);e(13C CDCI3): 204.6 (COH), 174.6 (COOH), 148.3 (C-3), 130.6 (C-2), 99.2 (C-9'), 74.7 (OCHCH3), 73.6 (OCH2), 69.3 (C- -168- CNS ) A4210X297 ()   A7 B7 16e) 6)66.3 (-)654 (Q-71)31.9 (g-l')22.6 (OCH[H3) 1 5 [1R-(1  ,3a/? , ,4a/? ,1  ,7a  ,8a/5 ) ] 8 a-[ [ 1 S, 7R, 9R]-2,5,8 --3,3,7 ---[4.4.0]-_9-- -]-4-_4,45,6,7,78,8&amp;amp;--7--3-(1--l4--s-?-3a(lH)- 15(20015 10 %/50 20/21  1:10)1:15) 140 ^ CDC13): 9.81 (s, 1H, CHO), 6.03 (dd, 1H, H-2, J=l.5 Hz), 4.62 (dd1H, -J=2.1 9.6 Hz)4.35-4.15 (m 3H8aCH2, H-7'-)3.40 (m2H8aCH2 &amp;amp;OCH2)3.25-3.15 (m2H, H-6OCH2)2.52 (t1H, H-l)1.33 1.13 (2s 2CH3); c? (13C, CDCI3): 204.7 (COH), 174.1 (COOH), 148.3 (C-3), 130.6 (C-2), 98.0 (C-9'), 73.4 (CH2), 73.3 (C-6'), 65.1 (1)64.7 (g-7), 31.9 (-10)21.1 (2H3) 1 6 [lR-(lor ,3a/?   ,  ,7aa ) ] 8 a-[ [ 1 S , 4 S , 6 R, 8R]-2,7-4,6---[3.4.0]--8-- -]_4 -- 4,4a5,6,7,7a,8,8a --7--3-(1--1,4--s -_3a(lH)- -169- CNS ) A4210X2S7 ()  </span>Hz), 4.13 (m, lH, H-3 '), 3.67 (dd, lH, H-4', J = 5.1 &amp;amp; 8.7Hz), Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please first Read the notes on the back and fill in this page) 3.38 (m, 1H, H-5 '), 2.58 (t, 1H, Hl, J = 3.9 Hz); i (13C, CDCI3): 204  6 (CH ), 174.8 (COOH), 148.3 (C-3), 130.6 (C-2), 98.1 (C-l '), 94.9 (0CH20), 75.4 (C-4'), 73.9 (C-3 ') s 70.3 (y), 32_3 (y). Example 1 3 [1R- (1 a, 3a; 5, 4 / ?, 4 a / ?, 7 / S, 7aa, 8ay5)] 8a-[(2,6 -dideoxy_ 3.4- 0 -methylene --D-piperanosyloxy) methyl] -4-formyl-_166- This paper scale is free to use the Chinese National Standard Rate (CNS) A4 specification (21 &amp;lt; 297 g ^) 21644 A7 B7 Printed by the Central Bureau of Economic Affairs of the Ministry of Economic Affairs Beigong Consumer Cooperatives V. Invention Instructions (1, 4, 4 &amp;, 5, 6, 7, 7 &amp;amp;, 8,8 &amp;amp; _   _7_ A solution of 3_ (1_methylethyl) 14_methylene-S-pyda-3a (lH) -carboxylic acid, bell salt in the compound of Example 12 (200 mg) in meme (5 ml) A 0.106 equivalent of aqueous sodium hydroxide solution (3.98 ml) was added dropwise. After 30 minutes, the solvent was removed under reduced pressure, and the residue was dissolved in dioxane (5 ml) and frozen to obtain the title compound (209 mg). ci H, CD3OD): 9.87 (s, 1H, CHO), 6.54 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 5,1 (^ 4.82 (2m, 2H, OCH20), 4.51 (dd, lH, Hr, J = 2.4 &amp;amp; 8.7Hz), 4.12 (m, lH, H-3l), 4.03 &amp;amp; 3.73 (2d, 2H, 8aCH2, Jab = 9.9 Hz), 3.61 (m, 1H, H-4 '), 3.35 (m, 1H, H-5'), 2.56 (t, 1H, Hl);  3C, C D3OD): 200.2 (COH), 169.0 (COOH), 142.9 (C-2), 120.6 (C-2), 90.3 (C-l '), 86.4 (0  H20), 67.5 (y), 66.2 ( -3,), 61.8 ( -5,). Example 1 4 (a) [lR- (l , 3a ^, 4/5, 4a ^, 1 , laa, 8a /?)] 8 a- [[1 S, 3 R, 7R, 9R] -2 , 5,8-tris-3,7-dimethyl-cis-bicyclo [4.4.0] -dec-9-yl-oxy-methyl] -4 -carboxamide-4,4a, 5 , 6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylidene-s-indap-3a (lH) -carboxy Acid (b) [lR- (l , 3a /?, , 4ay9,  , laa, 8a /?)] 8 a-[[1 S, 3 S, 7R, 9R] -2,5,8  Trihum-3,7-dimethyl-cis-bicyclo [4.4.0] -dec-9-yl-oxy-methyl] -4-carboxamide-4,4a, 5,6,7 , 7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-indjian- 3a (lH) -etacid-167- The standard size of this paper is Chinese National Standard (CNS) A4 (210X 297mm) (please read the notes on the back before filling out this page)  _ Order A7 B7 printed by Bei Gong Consumer Cooperatives 5. Description of the invention (165) Intermediate 14 (120 mg) in ethyl acetate (15 ml) is shaken in a Parr device at 20 psi hydrogen pressure and room temperature for 1 hour. The catalyst was filtered off, the solvent was evaporated under reduced pressure to obtain a slurry, and the material was analyzed on the silica gel for flash layer analysis. Wash with acetone / hexane (1:10), (1: 7) and (1: 5) Separating agent to prepare the title compound (a) (35 mg, Rf = 0.5, in hexane: propane 4: 1) and the title compound (b) (40 mg, Rf = 0.4, in hexane: propionate 4 : Within 1), both are colorless oil bodies. (a)  (^, CDC13): 9.80 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.62 (dd, lH, H-9 ', J = 2.1 &amp;amp; 9.9Hz), 4.20 (m, 2H, 8aCH2 + H-7 '), 3.97 (m, 1H, H-l'), 3.73 (m, 1H, OCHCH3), 3.40 (m, 2H, 8aCH2 + OCH2), 3.27 (d, 1H, OCH2, JAB = 10.8 Hz), 3.18 (dd, 1H, H-6 ', J = 3.3 and 10.2 Hz); d (13C, CDCI3): 204.6 (COH), 174.6 (COOH), 148.3 (C-3), 130.6 (C-2), 97.9 (C-9 '), 73.5 (OCH2), 73.2 (C-6'), 72.1 (C-l '), 71.9 (OCHCH3 ), 65.4 (C-7 '), 31.9 (C-10'), 22.7 (OCHCH3) o (b)  (! , CDC13): 9.79 (s, 1H, CHO), 6.05 (dd, 1H , H-2, J = 1.5 and 3'6 Hz), 4.73 (dd, 1H, H-91, J = 3.0 and 6.3 Hz), 4.26 (m, 1H, -), 4.15 (m, 2H, 8aCH2 + H-7 ') 5 3.98 (m, 1H, OCHCH3), 3.79 (dd, 1H, 0CH2, J = 3.1J5L11.4 Hz), 3.41 (d, 1H, 8aCH2, J = 9.6 Hz), 3.35 ( m, 1H, OCH2, J = 3.1 and 6.3 Hz), 3.27 (dd, lH, H-6 ,, J = 5.7 &amp;amp; 11.7Hz), 2.55 (t, lH, Hl); e (13C, CDCI3): 204.6 (COH), 174.6 (COOH), 148.3 (C-3), 130.6 (C-2), 99.2 (C-9 '), 74.7 (OCHCH3), 73.6 (OCH2), 69.3 (C- -168- The paper standard is applicable to the Chinese National Standard (C NS) A4 specification (210X297mm) (please read the notes on the back before filling in this page) Order the A7 B7 printed by the Consumer Cooperative of the Central Standards Bureau of the Ministry of Economy V. Invention Instructions (16e) 6,), 66.3 (Zhu- ), 65  4 (Q-71), 31.9 (gl '), 22.6 (OCH [H3). Example 1 5 [1R- (1 , 3a /?, , 4a /?, 1 , 7a, 8a / 5)] 8 a- [[1 S, 7R, 9R] -2,5,8- Trimethyl-3,3,7-trimethyl-cis-bicyclo [4.4.0] -dec-9-yl-oxy-methyl] -4-carboxyl_4,4 lines, 5,6 , 7,7,8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-,? da province-3a (lH) -A solution of carboxylic acid in intermediate 15 (200 mg) in ethyl acetate (15 ml) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device at 20 psi hydrogen pressure at room temperature for 1 hour. The catalyst was filtered off, and the solvent was evaporated under reduced pressure to obtain a residue. This residue was analyzed by flash layer on silica gel, washed away with acetone: hexane (1:10), and (1:15) to prepare the title The compound (140 mg) is a white foam. ^ CDC13): 9.81 (s, 1H, CHO), 6.03 (dd, 1H, H-2, J = 1.5 Hz), 4.62 (dd, 1H, -, J = 2.1 and 9.6 Hz), 4.35 -4.15 (m, 3H, 8aCH2, H-7 'and -), 3.40 (m, 2H, 8aCH2 &amp; OCH2), 3.25-3.15 (m, 2H, H-6' and OCH2), 2.52 (t , 1H, Hl), 1.33 and 1.13 (2s, 2CH3); c? (13C, CDCI3): 204.7 (COH), 174.1 (COOH), 148.3 (C-3), 130.6 (C-2), 98.0 (C -9 '), 73.4 (CH2), 73.3 (C-6'), 65.1 (  1,), 64.7 (g-7), 31.9 ( -10 ), 21.1 (2  H3). Example 1 6 [lR- (lor, 3a /?  ,  , 7aa)] 8 a- [[1 S, 4 S, 6 R, 8R] -2,7  diox-4,6-di Methyl-cis-bicyclo [3.4.0] -non-8-yl-oxy-methyl] _4 -carboxamide- 4,4a, 5,6,7,7a, 8,8a -octahydro- 7-Methyl-3- (1-methylethyl) -1,4-methylidene-s-Tida province_3a (lH) -carboxylic acid-169 ) A4 specification (210X2S7mm) (Please read the precautions on the back before filling this page)  </span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">-1T  ^21644 A7 B7  20(a)( 6801 10%/2 25/22  49 : 1)450  ^ On, CDC13): 9.86 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J^l.5^3.6 Hz), 4.57 (dd, 1H, H-8', J=2.4^L9.3 Hz), 4.40 (d, 1H, 8a-CH2, J=9.6 Hz), 4.08 (m, 2H, -CH2-3' (1H)) 3-27 (m, 3H, H-6', CH2-3' (1H), 8a-CH2 (1H)), 2.47 (t, 1H, H-l, J=3.9 Hz), 1.02 (d, 3H, 4'-CH3, J=6.6 Hz); ^(13C, CDCI3): 204.7 (CHO), 173.8 (COOH), 148.4 (C-3), 130.5 (C-2), 98.5 (C-8'), 75.2 (C-l'), 74.3 (8a-CH2), 73.3 (C-3')s 71.9 (C-6'), 51.2 (C-5'), 36.0 (C-4'), 32.9 (C-9'), 19.4 (4'-CH3) o 1 7 [lR-(la ,3a^  ^ ,  , ,8ay5 ) ] 8 a-[ [ 1 S , 4 S, 6 R, 8R]-2,7--4,6---[3.4.]--8-- -]-4--4,43,5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1--1,4 -- s-_3a(lH)_ 164501 0.099N9.5 80470  -170- CNS ) A4210X297 ()   A7 B7_ 168)  (iH, CD3OD): 9.86 (s, 1H, CHO), 5.94 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)4.43(dd,lHH-8J=2.1&amp;amp;9.3Hz)4.13- 4.02 (m, 3H8a-CH2(lH)-CH2-3' (1H))3.74 (d1H, 8a-CH2, J=9.9 Hz), 3.34-3.23 (m, 2H, CH2-3' (1H), H-6'), 2.56 (t, 1H, H-l, J=3.9 Hz), 2.34 (m, 1H, H-4'), 0.99 (d, 3H, 4'-CH3, J=6.9 Hz); ^(13C, CD3OD): 209.7 (CHO), 178.4 (COO'Na + ), 152.4 (C-3), 130.1 (C-2), 100.1 (C-8'), 77.2 ('), 77.0 (C-3'), 75.3 (8a-CH2), 73.0 (C-6'), 52.8 (C-5')s 37.2 (C-4)34_5 (C-9)19.6 (4CH3) 1 8 [1R-(1^ ,3a^ ,4a/? ,7/3 ,7aa ,8a/? ) ] 8 a-[ [ 1 S , 4 R, 6 R, 8R]-2,7--4,6--|3.4.]--8- -]-4 --4,4a,5,6,77a,8,8a--7 --3-(1--l4--s-_3a(lH)_ 20(b)(18060 10%/100 25/22  49 : 1)4 : 1) 9 0 cy (^, CDC13) 11.5 (bs, 1H, COOH), 9.87 (s, 1H, CHO), 6.04 (dd, 1HH-2, J=1.23.3 Hz)4.53 (dd, 1H, H-8'J=2.4 &amp;amp;9.9Hz)4.45&amp;amp;3.26(2d,2H8a-CH2,J=9.3Hz)4.19(q 1H, H-l', J=3.3 Hz), 3.96 (t, 1H, CH2-3', J=8.4 Hz), 3.58 (m, ___ -171 - CNS ) A4210X297 ()  I 3^1644 A7 ___B7 169) 1H, H-6'), 3.43 (dd, 1H, CH2-3', J=10.2 Hz), 2.55 (m, 1H, H-4'); ci (13C, CDC13): 204.6 (CHO), 174.4 (COOH), 148.3 (C-3), 130.6 (C-2), 97.9 (C-8'), 78.7 (C-l'), 73.3 (C-3'), 72.9 (8a-CH2), 68.7 (C-6'), 46.1 (C-5'), 36.6 (C-4'), 34.02 (C-9'), 21.8 (6-CH3)13.6 (4-CH3) 1 9 [lR-(la ,3a/? ,4/5 ,4ay5 ,  ,7a ,8a^ ) ] 8 a-[ [ 1 S, 4 R, 7 R, 9R]-2,8--4,9---[3_4.]_7__ -]-4 --4,4a5,6,7,7a8,8a--7 --3-(1--1,4 --s-_3a(lH)- 23(a)(15015 10 %/50 20/2  1 : 3 )100   (!, CDC13): 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.23.3 Hz)4.63 (dd, 1HH-71J=3.36.6 Hz)4.37 (d lH8aCH2JAB=9.6Hz)3.98&amp;amp;3.67(2dd2HH-3'J=6.6 8.1 Hz), 3.40-3.20 (m3H, 8aCH2, H-9,-)2_46 (t 1H, H-l, J=3.9 Hz), 1.04 (d, 3H, CH3CH)  2 0 [lR-(lor ,3ayS ,  Aa/3 ,/3 ,7aa ,8a^ ) ] 8 a-[ [ 1 S ,4R, 7R, 9R]-2,8 -4,9__[no7__- _ -172- CNS ) A4g ( 21297) ()</span>-, 1T Printed by Beigong Consumer Cooperative of Central Bureau of Standards, Ministry of Economic Affairs ^ 21644 A7 B7 V. Description of the invention (in the solution of intermediate 20 (a) (680 mg) in ethyl acetate (100 mL) under nitrogen Next, 10% palladium / carbon (200 mg) was added. The mixture was shaken in a Parr device at 25 psi hydrogen pressure and room temperature for 2 hours. The catalyst was filtered off, and the solvent was evaporated to dryness. The residue It was purified by flash chromatography and washed away with methane  methanol (49: 1) to obtain the title compound (450 mg) as white foam  ^ On, CDC13): 9.86 (s, 1H, CHO ), 6.04 (dd, 1H, H-2, J ^ l.5 ^ 3.6 Hz), 4.57 (dd, 1H, H-8 ', J = 2.4 ^ L9.3 Hz), 4.40 (d, 1H, 8a -CH2, J = 9.6 Hz), 4.08 (m, 2H, - and CH2-3 '(1H)), 3-27 (m, 3H, H-6', CH2-3 '(1H), 8a -CH2 (1H)), 2.47 (t, 1H, Hl, J = 3.9 Hz), 1.02 (d, 3H, 4'-CH3, J = 6.6 Hz); ^ (13C, CDCI3): 204.7 (CHO), 173.8 (COOH), 148.4 (C-3), 130.5 (C-2), 98.5 (C-8 '), 75.2 (C-l'), 74.3 (8a-CH2), 73.3 (C-3 ') s 71.9 (C-6 '), 51.2 (C-5'), 36.0 (C-4 '), 32.9 (C-9'), 19.4 (4'-CH3) o Example 1 7 [lR- (la, 3a ^   ^ ,  ,  , 8ay5)] 8 a- [[1 S, 4 S, 6 R, 8R] -2,7-dioxo-4,6-dimethyl-cis-bicyclo [3.4.] -Non-8 -Yl-oxy-methyl] -4-carboxamide-4,43,5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl Group) -1,4-methylene-s-, Yinda province_3a (lH) _carboxylic acid, sodium salt was added dropwise to a solution of the compound of Example 16 (450 mg) in methanol (100 mL) Sodium hydroxide aqueous solution (0.099N, 9.5 ml). The solvent was removed under reduced pressure, the residue was dissolved in water (80 ml), and the crystals were frozen to prepare the title compound (470 mg). -170- This paper standard uses the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back and then fill out this page). Ordered by the Ministry of Economic Affairs Central Bureau of Industry and Commerce Co., Ltd. Du Printing A7 B7_ 5. Description of the invention (168)  (iH, CD3OD): 9.86 (s, 1H, CHO), 5.94 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.43 (dd, lH, H- 8 ', J = 2.1 &amp;amp; 9.3Hz), 4.13-4.02 (m, 3H, 8a-CH2 (lH), -, CH2-3' (1H)), 3.74 (d, 1H, 8a-CH2, J = 9.9 Hz), 3.34-3.23 (m, 2H, CH2-3 '(1H), H-6'), 2.56 (t, 1H, Hl, J = 3.9 Hz), 2.34 (m, 1H, H- 4 '), 0.99 (d, 3H, 4'-CH3, J = 6.9 Hz); ^ (13C, CD3OD): 209.7 (CHO), 178.4 (COO'Na +), 152.4 (C-3), 130.1 ( C-2), 100.1 (C-8 '), 77.2 ('), 77.0 (C-3 '), 75.3 (8a-CH2), 73.0 (C-6'), 52.8 (C-5 ') s 37.2 (C-4,), 34_5 (C-9,), 19.6 (4, CH3). Example 1 8 [1R- (1 ^, 3a ^, 4a /?, 7/3, 7aa, 8a /?)] 8 a- [[1 S, 4 R, 6 R, 8R] -2,7-II Oxygen-4,6-dimethyl cis-bicyclo |; 3.4.] -non-8-yl  oxy-methyl] -4-carboxamide-4,4a, 5,6,7,7a , 8,8a-octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-s--soda_3a (lH) _carboxylic acid in intermediate 20 (b) (180 mg) in ethyl acetate (60 ml) was added 10% palladium / carbon (100 mg) under nitrogen. This suspension was shaken in a Parr device at 25 psi hydrogen pressure at room temperature for 2 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was subjected to secondary flash layer analysis on silica gel, using methane: methanol (49: 1) and hexane: acetone (4: 1) as the eluent, to obtain the title compound (90 mg ) Is a white foam. cy (^, CDC13): 11.5 (bs, 1H, COOH), 9.87 (s, 1H, CHO), 6.04 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.53 (dd, 1H, H -8 ', J = 2.4 &amp;amp; 9.9Hz), 4.45 &amp;amp; 3.26 (2d, 2H, 8a-CH2, J = 9.3Hz), 4.19 (q, 1H, H-l', J = 3.3 Hz), 3.96 (t, 1H, CH2-3 ', J = 8.4 Hz), 3.58 (m, ___ -171-This paper scale is applicable to China National Standards (CNS) A4 specification (210X297 public daughter) (please read the note on the back first  Item and then fill out this page) Order the printed bag of the Central Industrial Development Bureau of the Ministry of Economic Affairs, I Industrial and Consumer Cooperatives 3 ^ 1644 A7 ___B7 V. Description of the invention (169) 1H, H-6 '), 3.43 (dd, 1H, CH2-3', J = 10.2 Hz), 2.55 (m, 1H, H-4 '); ci (13C, CDC13): 204.6 (CHO), 174.4 (COOH), 148.3 (C-3), 130.6 (C-2), 97.9 (C-8 '), 78.7 (C-l'), 73.3 (C-3 '), 72.9 (8a-CH2), 68.7 (C-6'), 46.1 (C-5 '), 36.6 (C- 4 '), 34.02 (C-9'), 21.8 (6, -CH3), 13.6 (4'-CH3). Example 1 9 [lR- (la, 3a /?, 4/5, 4ay5,  , 7a , 8a ^)] 8 a- [[1 S, 4 R, 7 R, 9R] -2,8- Dioxo-4,9-dimethyl-cis-bicyclo [3_4.]  non_7_yl_oxy-methyl] -4-carboxamide-4,4a, 5,6,7, 7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-pyridine_3a (lH) -carboxylic acid in intermediate 23 (a) (150 mg) in ethyl acetate (15 mL) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device at 20 psi hydrogen pressure at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified by flash chromatography, successively washed away with acetone: hexane (1: 3) to obtain the title compound (100 mg) as a crystalline solid  (! , CDC13): 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.63 (dd, 1H, H-71, J = 3.3 and 6.6 Hz), 4.37 (d, lH, 8aCH2, JAB = 9.6 Hz), 3.98 &amp;amp; 3.67 (2dd, 2H, H-3 ', J = 6.6 and 8.1 Hz), 3.40-3.20 (m, 3H, 8aCH2, H-9, and -), 2_46 (t, 1H , Hl, J = 3.9 Hz), 1.04 (d, 3H, CH3CH)  Example 2 0 [lR- (lor, 3ayS,   Aa / 3,  / 3, 7aa, 8a ^)] 8 a- [[ 1 S, 4R, 7R, 9R] -2,8 -Dioxy  4,9_dimethyl_cis  Bicyclo [no  7_  _oxy- _ -172- This paper scale is used in the country of China Sample Standard (CNS) A4g (21  297 Public Director) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 17) ]-4--4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;-_7--3-(1- -1,4 -- s-- 3a(lH) - 191005 /0.106N_883 3 104 3 dHCD3OD): 9.88 (s1HCHO)5.93 (dd, 1HH-2, J-1.2^3.3Hz)4.49(mlHH-7')4.02(m2H,H-3{ 8aCH2), 3.72 (d, 1H, 8aCH2, JAB=9 3 hz)2.56 (t1H, 1 J-3.6 Hz);  (13C, CD3OD): 209.7 (CHO), 178.4 (COOH), 152.4 (C-3), 130.1 (C-2), 99.9 (C-7'), 82.1 (C-l')5 76.5 (8aCH2)72.2 (C-9')37.5 (C-5)15.2 (^H3-CH) 2 1 [lR-(lar3a&amp;gt;54/54a/?7y?7ar8a5 )]8a-[[lS4S7R, 9R]-2,8 --4,9 ---[34]__7_- -]-4 --4,4a5,6,7,7a8,8a--7_ -3_ (1--l4 -_s -_3a(lH)_ 23(b)(26015) 10 %/50 20/21 TLC 1 : 20)185 Rf=0.6  CDC13): 9.85 (s5 1H, CHO), 6.04 (dd, 1H, H-2, -173- CNSA4210X297 ()</span>A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Affairs of the Ministry of Economic Affairs V. Description of the invention (17) Methyl] -4-methylbenzene-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-    -3a (lH) -tetanoic acid, sodium salt in Example 19 compound ( 100 mg) in a solution of methanol (5 ml) was added dropwise hydrogen emulsified sodium / valley solution (0.106N water drop, _88 ml). After 30 minutes, the solvent was removed under reduced pressure, and the residue was dissolved in water (3 ml); Tojing, the title compound (104 mg) was prepared. 3 dH, CD3OD): 9.88 (s, 1H, CHO), 5.93 (dd, 1H, H-2, J-1.2; ^ 3.3Hz), 4.49 (m, lH, H-7 '), 4.02 (m, 2H, H-3 {8aCH2), 3.72 (d, 1H, 8aCH2, JAB = 9 3 hz), 2.56 (t, 1H,   1, J-3.6 Hz);  (13C, CD3OD): 209.7 (CHO ), 178.4 (COOH), 152.4 (C-3), 130.1 (C-2), 99.9 (C-7 '), 82.1 (C-l') 5 76.5 (8aCH2), 72.2 (C-9 '), 37.5 (C-5 '), 15.2 (^ H3-CH). Example 2 1 [lR- (lar, 3a&gt; 5, 4/5, 4a / ?, 7y ?, 7ar, 8a; 5)] 8a-[[lS, 4S, 7R, 9R] -2,8- Dioxo-4,9-dimethyl-cis-bicyclo [34] _non_7_yl-oxy-methyl] -4-methylacyl-4,4a, 5,6,7,7a , 8,8a-octahydro-7_ methyl-3_ (1-methylethyl) -l, 4-methylene_s-indida_3a (lH) _carboxylic acid in intermediate 23 (b) (260 mg) in a solution of ethyl acetate (15 ml) was added 10% carbon / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device at 20 psi hydrogen pressure at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was purified by preparative TLC (silica dioxide, methanol: methane 1:20) to obtain the title compound (185 mg) as an oil body at Rf = 0.6.  CDC13): 9.85 (s5 1H, CHO), 6.04 (dd, 1H, H-2, -173- This paper scale adopts the Chinese National Standard (CNS&gt; A4 specification (210X297 mm) (please read the notes on the back (Fill in this page again)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 ___B7__ 171) J=1.5&amp;amp;3.6Hz),4.88(tlHH-72.7Hz)4.27&amp;amp;3.28(2d 2H8aCH2JAB=9.9Hz)3.85&amp;amp;3.73(2m,2HOCH2)3.60 (m1H, H-9')3.37 (dd, 1HH-lJ=7_28.4 Hz)2.47 (m, 3H, H-5'+CHCH3+Hl); d(13C, CDC13): 204.4 (CHO), 173.7 (COOH), 148.2 (C-3), 130.5 (C-2), 98.7 (C-7'), 81.2 (C-), 72.8 (8aCH2 + OCH2), 69.9 (C-9'), 25.4 (C-6'), 12.4(CH3CH) o 2 2 [1R-(1  ,3ay5 ,4^ ,4ay3 ,1  ,7a or ,8a^ ) ] 8a-[ [ 1 S ,7R,9R]- 2.8 -- 4,4,9 ---[3.4.0]-7-- -]-4--4,4a5,6,7,7a8,8a--7--3-(l--l4--s_3a(lH)- 24(10045 10 %/50 25/22 1 5 % 15 % 40  ()</span> 1T  A7 ___B7__ V. Description of the invention (171) J = 1.5 &amp;amp; 3.6Hz), 4.88 (t, lH, H-7 , 2.7Hz), 4.27 &amp;amp; 3.28 (2d, 2H, 8aCH2, JAB = 9.9 Hz), 3.85 &amp;amp; 3.73 (2m, 2H, OCH2), 3.60 (m, 1H, H-9 '), 3.37 (dd, 1H, Hl ,, J = 7_2 and 8.4 Hz), 2.47 (m, 3H, H-5 '+ CHCH3 + Hl); d (13C, CDC13): 204.4 (CHO), 173.7 (COOH), 148.2 (C-3), 130.5 (C-2), 98.7 (C-7'), 81.2 (C-), 72.8 (8aCH2 + OCH2), 69.9 (C-9 '), 25.4 (C-6'), 12.4 (CH3CH) o Example 2 2 [1R- (1 , 3ay5, 4 ^, 4ay3 , 1 , 7a or, 8a ^)] 8a- [[1 S, 7R, 9R]-2.8 -dioxa-4,4,9 -trimethyl-cis-bicyclo [3.4.0]  non- 7-yl-oxy-methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl ) -L, 4-methylene-s  indap province_3a (lH) -carboxylic acid in a solution of intermediate 24 (100 mg) in ethyl acetate (45 ml) was added 10% palladium under nitrogen / Carbon (50 mg). This mixture was shaken in a Parr device at 25 psi hydrogen pressure at room temperature for 2 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was subjected to secondary flash chromatography, using methanol in 1.5% two-gas methane and acetone in 15% hexane as the eluent, to obtain the title compound (40 mg) as a white foam. Printed bags of the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">On, CDC13): 9.85 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.2&amp;amp;3.6Hz)4.84(t,lHH-7,,J=3Hz)4.23&amp;amp;3.29(2d 2H, 8a-CH2, J=9.6 Hz), 3.81 (t, 1H, -, J=8.7 Hz), 3.52 (dq1H, H-9', J=9.36.3 Hz), 3.503.42 (2d, 2H, CH2-3' JU Hz)248 (t1HH-lJ=4.2 Hz)1.090.98 (2s, 6H, H-CH3); ^(13C, CDCI3) 204.5 (CHO), 174.0 (COOH), ____-174- ACNS ) 210X297  A7 B7 172) 148.2 (C-3), 130.5 (C-2), 98.7 (C-7'), 81.01 (C-1'), 78.8 (C-3'), 72.7 (8a-CH2), 70.2 (C-9'), 41.3 (C-4'), 40.4 (C-5'), 27.3 (4-CH3), 26.5 (C-622.8 (4-(3) 2 3 [1R-(1 a3a4y54a77aa8ay9 )]8a-[(6--3,4- O--D -]_4__ 44a, 5,6,7,7a8,8a --7--3-(1--1,4--s--3a(lH)- 27(1252 5 1 0 %/100i 5 /21.5 0C10.51 10% 4: 1) :20 : 1)62 cJ (lK, CDC13): 9.73 (s, 1H, CHO), 6.10 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz),4.51(t,lHH-2'J=4.5Hz)4.48(dlHH-lJ=7.5Hz),3.65&amp;amp;4.07(2d2H8aCH2J=9.3Hz)3.78 (dd1HH-41J=95.1 Hz), 3.69 (dd1HH-3'J=7.55.1 Hz), 350 (m1H, H-5J=69 Hz)2.59 (t1HH-lJ=3.9 Hz), 2.32 (m, 1H, CHMe2); tf(13C, CDC13 ): 204.6 (CHO), 176_1 (C02H)148.2 (C-3)130.8 (C-2), 110.4 (C 100.9 (C-)78.34 (C-475.1 (C-274.7 (8aCH2) 72.5 (C-4a), 71.7 (C-3'), 69.3 (C-5'), 65.6 (C-8a), 58.9 (C- -175- CNS ) A4210X297 (  ,  A7 _________B7 173) 4')46.3(C-1) 2 4 [1-(13&amp;amp;44&amp;amp;;5,7/?7&amp;amp;8&amp;amp;]8&amp;amp;-[(2--3,4- --6-0 ---D-]-4 - -4,4a5,6,7,7a8,8a--7 --3-(1--14--8_,5_3&amp;amp;(111)- 30(505 1200 24 5 : 1 8 ^ (lU, CDC13): 9.80 (s, 1H, CHO), 5.98 (dd, 1H, H-2, J=1.23.3 Hz)4.64 (dd1H-J=2.78.1 Hz)4.42 (m, 1HH-3')3.684.01 (2d2H, 8aCH2, J=9 Hz), 3.90 (m, 1H H-4')3.45-3.65 (m3HH-5'&amp;amp;2H-6')3.22(s3H6-CH3)2.60 (m1H-), 1.34 1.35 (2s, 6H S);e(13CCDCl3):206.3 (CHO)175.7(CO2H)149.7(C- 3)129.7 (C-2), 108.9 ((98.2(0174.8((-3a), 74.8 (C-4), 74.4 (8aCH2), 72.6 (C-3'), 71.3 (C-5'), 65.1 (C-8a), 61.1 (C-6')5 58.4 (C-4), 48.4 (6'-OMe), 46.1 (C-l), 32.8 (C-2') 2 5 [1R-(1^ ,3ay5 ,4y5 ,4a^ ,1  ,laa ,8a/? ) ] 8 a-[ [ 1 S , 4 R, 7 R, 9R]-2,8 --4 --9 ---[3_4_0] --7- ____-176-__ CNS ) A4210X297 () </span>On, CDC13): 9.85 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 4.84 (t, lH, H-7 ,, J = 3Hz), 4.23 &amp;amp; 3.29 (2d, 2H, 8a-CH2, J = 9.6 Hz), 3.81 (t, 1H, -, J = 8.7 Hz), 3.52 (dq, 1H, H-9 ', J = 9.3 and 6.3 Hz), 3.50 and 3.42 (2d, 2H, CH2-3 ', JU Hz), 2.48 (t, 1H, Hl, J = 4.2 Hz), 1.09 and 0.98 (2s, 6H, H-CH3); ^ (13C, CDCI3): 204.5 (CHO), 174.0 (COOH), ____- 174- This paper is printed on the Chinese National Gradient (CNS) grid (210X297 mm) for the A-degree use of this paper A7 B7 5. Description of the invention (172) 148.2 (C-3), 130.5 (C-2), 98.7 (C-7 '), 81.01 (C-1'), 78.8 (C-3 '), 72.7 (8a -CH2), 70.2 (C-9 '), 41.3 (C-4'), 40.4 (C-5 '), 27.3 (4-CH3), 26.5 (C-6,), 22.8 (4'-(: 3). Example 2 3 [1R- (1a, 3a, 4y5, 4a, 7 Lu, 7aa, 8ay9)] 8a-[(6-deoxy-3,4-O-isopropylidene-D -Allopyranosyloxy) methyl] _4_carboxamide_ 4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl Group) -1,4-methylene-s-indap-3a (lH) -carboxylic acid dissolved in intermediate 27 (125 mg) in methanol (25 mL) 10% palladium / carbon (100 mg) was added under nitrogen. The mixture was shaken in a Parr device at 1.5 psi hydrogen pressure at room temperature for 1.5 hours. The catalyst was filtered off and the filtrate was filtered at 0  C Added to 1 equivalent of hydrochloric acid (0.5 ml). After stirring for 1 hour, the mixture was neutralized with 10% sodium bicarbonate. The solvent was evaporated to dryness, and the oily residue was purified by flash chromatography, using hexane: acetic acid Ethyl ester (4: 1) and dimethane: methanol (20: 1) were washed away to obtain the title compound (62 mg). CJ (lK, CDC13): 9.73 (s, 1H, CHO), 6.10 (dd , 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.51 (t, lH, H-2 ', J = 4.5Hz), 4.48 (d, lH, Hl ,, J = 7.5Hz), 3.65 &amp;amp;; 4.07 (2d, 2H, 8aCH2, J = 9.3Hz), 3.78 (dd, 1H, H-41, J = 9 and 5.1 Hz), 3.69 (dd, 1H, H-3 ', J = 7.5 and 5.1 Hz ), 3  50 (m, 1H, H-5 ', J = 6 and 9 Hz), 2.59 (t, 1H, Hl, J = 3.9 Hz), 2.32 (m, 1H, CHMe2); tf (13C, CDC13): 204.6 (CHO), 176_1 (C02H), 148.2 (C-3), 130.8 (C-2), 110.4 (quaternary C isopropylidene), 100.9 (C-), 78.34 (C-4 '), 75.1 (C-2,), 74.7 (8aCH2), 72.5 (C-4a), 71.7 (C-3'), 69.3 (C -5 '), 65.6 (C-8a), 58.9 (C-175- This paper size is applicable to China National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page),  A7 _________B7 printed by the Employees Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs V. Description of Invention (173) 4 '), 46.3 (C-1). Example 2 4 [1 ruler- (1 , 3 &amp;amp; Lu, 4, 4 &amp;amp;; 5,7 / ?, 7 &amp;amp;", 8 &amp;amp; Lu)] 8 &amp;amp;-[(2-deoxy-3,4- -Isopropylidene-6-0-methyl--D-allyloranosyloxy) methyl] -4-methylbromo-4,4a, 5,6,7,7a, 8, 8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-8_, 5 ~ da province_3 &amp; (111) -carboxylic acid intermediate 30 (50 Mg) solution in tetrahydrofuran (5 mL) was treated with tetrabutylammonium fluoride (1.0 M in tetrahydrofuran solution, 200 l) at room temperature. After 24 hours, the reaction mixture was concentrated to dryness and became The yellow oil was purified by flash column chromatography and washed away with dioxane: methanol ( 5: ) to obtain the title compound (18 mg). ^ (LU, CDC13): 9.80 (s, 1H, CHO), 5.98 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.64 (dd, 1H, -, J = 2.7 and 8.1 Hz), 4.42 (m, 1H, H-3 '), 3.68 and 4.01 (2d, 2H, 8aCH2, J = 9 Hz), 3.90 (m, 1H, H-4'), 3.45-3.65 (m, 3H, H-5 '&amp;amp; 2H-6') , 3.22 (s, 3H, 6, -CH3), 2.60 (m, 1H, -), 1.34 and 1.35 (2s, 6H, propylene propylene); e (13C, CDCl3): 206.3 ( CHO) 175.7 (CO2H), 149.7 (C-3), 129.7 (C-2), 108.9 (Propylene grade four (:), 98.2 (01,), 74.8 ((: -3a), 74.8 (C-4 ), 74.4 (8aCH2), 72.6 (C-3 '), 71.3 (C-5'), 65.1 (C-8a), 61.1 (C-6 ') 5 58.4 (C-4), 48.4 (6'- OMe), 46.1 (Cl), 32.8 (C-2 '). Example 2 5 [1R- (1 ^, 3ay5, 4y5, 4a ^, 1 , laa, 8a /?)] 8 a- [[1 S , 4 R, 7 R, 9R] -2,8 -dioxo-4 -ethyl-9 -methyl-cis-bicyclo [3_4_0] -non-7-yl ____- 176 -__ Use the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)  </span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 B7_____ 174) --]-4 --4,4a,56,7,7a,8,8a--7 - -3-U --1,4--s--3 a(lH)- 3 7(20040 10%/50 30/22  98 : 2)125)  ^ (^, CDC13) 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.5&amp;amp;3.3Hz),4.66(ddlHH-7J=3.0&amp;amp;6.0Hz),4.32&amp;amp; 3.29 (2d, 2H, 8a-CH2, J=9.6 Hz), 4.02 (dd, 1H, CH2-3', (1H), J=7.2&amp;amp;8.4Hz)3.67(ddlHH-rJ=7.8&amp;amp;9.3Hz)3.41-3.22 (m2HH-9CH2-3' (1H))2.48 (t1HH_lJ=3.9 Hz), 0.92 (t, 3H, CH3CH2, J=7.5 Hz); ^ (13C, CDC13): 204.5 (CHO), 174.2 (COOH), 148.3 (C-3), 130.5 (C-2), 98.5 (C-780.3 (C-)73.073.0 (8a_gC-370.9 (C-9 2 6 [lR-(la3a44a7/57aa ,8a/? )]8a_[[lS4R7R 9R]-2,8--4 --9---[3.4.0]--7- --]-4 --4,4a,5,6,7,7a8,8a --7- -3-(1--1,4-- s-_3a(lH)_  25881 0.0991.8 -177- CNS &amp;gt; A4210x297 ---------f II ()</span> 1T Printed and printed by the employee consumer cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs A7 B7_____ V. Description of the invention (174) -Oxy-methyl] -4 -Methyl-4,4a, 5,6,7,7a, 8, 8a-octahydro-7-methyl-3-U-methylethyl) -1,4-methylene-s--pyridin-3 a (lH) -carboxylic acid in intermediate 37 (200 mg ) To a solution in ethyl acetate (40 ml) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device at 30 psi hydrogen pressure at room temperature for 2 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash layer on silica gel, using methane gas: methanol (98: 2) as the eluent to obtain the title compound (125 mg). ^^^^, CDC13): 9.86 (s, 1H , CHO), 6.05 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.3Hz), 4.66 (dd, lH, H-7 ', J = 3.0 &amp;amp; 6.0Hz), 4.32 &amp;amp; 3.29 (2d, 2H, 8a-CH2, J = 9.6 Hz), 4.02 (dd, 1H, CH2-3 ', (1H), J = 7.2 &amp;amp; 8.4Hz), 3.67 (dd, lH, Hr, J = 7.8 &amp;amp; 9.3 Hz), 3.41-3.22 (m, 2H, H-9 'and CH2-3' (1H)), 2.48 (t, 1H, H_l, J = 3.9 Hz), 0.92 (t, 3H, CH3CH2, J = 7.5 Hz); ^ (13C, CDC13): 204.5 (CHO), 174.2 (COOH), 148.3 (C-3), 130.5 (C-2), 98.5 (C-7,), 80.3 (C-), 73.0 And 73.0 (8a_g and C-3,), 70.9 (C-9,). Example 2 6 [lR- (la, 3a Lu, 4 o'clock, 4a Lu, 7/5, 7aa, 8a /?)] 8a _ [[lS, 4R, 7R, 9R] -2,8-diox-4- Ethyl-9-methyl-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-methylbromo-4,4a, 5,6,7,7a, 8 , 8a -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylidene-s-    _3a (lH) _trait acid, sodium salt in Example 25 To a solution of the compound (88 mg) in methanol (10 mL), 0.099 equivalent of aqueous sodium hydroxide solution (1.8 mL) was added dropwise. Removal of solvent under reduced pressure-177- This paper scale uses the Chinese National Standard (CNS &amp;gt; A4 specification (210x297mm) --------- f  II (Please read the precautions on the back before filling this page )</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T 4 A7 B7 17 5  (92 d DMSO-d6) 9.77 (s, 1H, CHO), 5.78 (m, 1H, H-2), 4-4 (brdd, 1H, H-7'), 3.92 (m, 1H, H-3'), 3.87 (d, 1H, 8a-CH2 (1H), J=9.6 Hz), 3.50 (m, 2H8a-CH2 (1H)-) 3-38-3.21 (m2HH-3H-9 2 7 [lR-(lflr ,3a^ , ,4ay5 ,1  ,^  ) ] 8 a-[ [ 1 S, 4 S , 7 R, 9R]-2,8--4 --9 ---[3.4_0]--7- --]-4 --44a,5,6,7,7a,8,8a--7 - -3_(1--l4--s-M- 3a(lH)-  38(42080 10//100 3 0/2h5  98 : 2)280  d (!H, CDC13) 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, CH2, J=9.9 Hz), 3.90 (dd1HH-3J=7.58.7 Hz), 375 (m 1H-), 3.64 (m1H, H-93.43 (t1H, H_3IJ=8 7 Hz) 2.46 (t1HH-lJ=3.6 Hz)0.93 (t, 3H, J=7.2</span>, 1T 4 A7 B7 V. Description of the invention (17 Jin 'The residue was dissolved in water (50 mL), frozen crystals to obtain the title compound (92 mg). D DMSO-d6): 9.77 (s, 1H, CHO), 5.78 (m, 1H, H-2), 4-4 (brdd, 1H, H-7 '), 3.92 (m, 1H, H-3'), 3.87 (d, 1H, 8a-CH2 (1H), J = 9.6 Hz), 3.50 (m, 2H, 8a-CH2 (1H) and -), 3-38-3.21 (m, 2H, H-3 'and H-9,). Example 2 7 [lR- (lflr, 3a ^, , 4ay5, 1,  ^  )] 8 a-[[1 S, 4 S, 7 R, 9R] -2,8-diox-4 -Ethyl-9-methyl-cis-bicyclo [3.4_0] -non-7-yl-oxy-methyl] -4-methyl-4,4a, 5,6,7,7a, 8 , 8a-octahydro-7-methyl-3_ (1-methylethyl) -l, 4-methylidene-sM-da-3a (lH) -carboxylic acid, sodium salt in intermediate 38 (420 Mg) in a solution of ethyl acetate (80 ml), add 10  / under nitrogen milk. Put / carbon (100 mg). This mixture was shaken in a Parr device at 30 psi hydrogen pressure for 5 hours at room temperature. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed by flash layer on silica gel, using methane gas: methanol (98: 2) as the eluent to obtain the title compound (280 mg). Od (! H, CDC13): 9.86 (s, 1H, CHO), 6.05 (dd, 1H, H-2, CH2, J = 9.9 Hz), 3.90 (dd, 1H, H-3 ', J = 7.5 and 8.7 Hz), 3.75 (m, 1H, -), 3.64 (m, 1H, H-9 '), 3.43 (t, 1H, H_3I, J = 8 7 Hz), 2.46 (t, 1H, Hl, J = 3.6 Hz), 0.93 (t, 3H, J = 7.2</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz); (i(13C, CDC13): 204.4 (CHO), 173.7 (COOH), 148.2 __-178- CNS ) A421x 297 () -    A7 _______ 17 (C-3),130.5(C-2)98.8(C-781.3(C-l')72.8&amp;amp;70.9(8a-&amp;amp;C-369.8 (C-9') 2 8 [lR-(la3ay944a/?77aa8a]8a-[[lS4S7R 9R]-2,8 --4--9 ---[3.4.0] --7- --]-4 --44a5,6,7,7a8,8a --7- -3-(1--l4--S-W- 3a(lH)-  2726220 0.0995.3^ 1 (272 (y On, DMSO-d6): 9.77 (s, 1H, CHO), 5.79 (dd, 1H, H-2, J=1.2&amp;amp;3.6Hz)4.57(mlHH_7,)3.83&amp;amp;3.45(2d2H8a-CH2J=9.6Hz)3.76&amp;amp;3.33(2m2HCH2-3l)3.52(m2H -H-9 2 9 [lR-(la ,3 , ,4ay3 ,1  ,7a  ) ] 8 a - [ [ 1 S , 4 R, 7 R, 9R]-2,8--4-(1--9 ---[3.4.0 ] --7---]-4 -- 4,4a,5,6,7,7a8,8a_ -7 --3-(1--1,4--S--3a(lH) 39(28015 /10 % )(50 __-179-_ CNS ) A4210X 297 (}</span>Hz); (i (13C, CDC13): 204.4 (CHO), 173.7 (COOH), 148.2 __- 178- This paper scale is applicable to the Chinese National Frame Rate (CNS) A4 specification (21x 297 public) (please first Read the precautions on the back and fill out this page),- D Printed by the Ministry of Economic Affairs, Central Bureau of Economic Affairs, Beigong Consumer Cooperatives Printed by the Ministry of Economic Affairs, Central Bureau of Economics, Beigong Consumer Cooperatives A7  _______ V. Description of invention (17 (C-3 ), 130.5 (C-2), 98.8 (C-7,), 81.3 (C-l '), 72.8 &amp;amp; 70.9 (8a- &amp;amp; and C-3'), 69.8 (C-9 '). Examples 2 8 [lR- (la, 3ay9, 4 Lu, 4a / ?, 7 points, 7aa, 8a Lu)] 8a-[[lS, 4S, 7R, 9R] -2,8-diox-4-ethyl -9 -methyl-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -Octahydro-7-methyl-3- (1-methylethyl) -l, 4-methylene-SW pyridine-3a (lH) -carboxylic acid, sodium salt of the compound of Example 27 (262 mg) To a solution in methanol (20 mL), was added dropwise 0.099 equivalent of sodium hydroxide aqueous solution (5.3 mL). The solvent was removed under reduced pressure, the residue was dissolved in water (100 mL), and the crystal was frozen to prepare The title compound (272 mg "(y On, DMSO-d6): 9.77 (s, 1H, CHO), 5.79 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 4.57 (m, lH, H_7,), 3.83 &amp;amp; 3.45 (2d, 2H, 8a-CH2, J = 9.6Hz), 3.76 &amp;amp; 3.33 (2m, 2H, CH2-3l), 3.52 (m, 2H, - and H-9 ... Example 2 9 [lR- (la, 3, , 4ay3, 1 , 7a )] 8 a-[[1 S, 4 R, 7 R, 9R] -2,8-dioxo-4- (1-methylethyl) -9 -Methyl-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-carboxamide- 4,4a, 5,6,7,7a, 8,8a_octa Hydrogen-7-methyl-3- (1-methylethyl) -1,4-methylene-S-indazole-3a (lH)  carboxylic acid in intermediate 39 (280 mg) in ethyl acetate Palladium / carbon (10%) (50 mg) is added to the solution in the ester (15 ml) under nitrogen. This mixture is in the Parr device __- 179-_ This paper size is applicable to China National Standards (CNS) A4 Specifications (210X 297mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7  7) (PH2 20/*2)  /10 : 15 : 1)180 8 4 %) ^ (lHCDC13) 12-11 (b, in, COOH), 9.88 (s, 1H, CHO), 6.053 (dd, 1H, H2, J=1.5^3.6 Hz), 4.77 (m, 1H, H-7'), 4.37 (d, 1H, 8aCH2, J=9.3 Hz), 3.95 (dd, 1H, H3's J-7.2^8.7 Hz), 3.67 (dd, 1HHlJ=8.79 Hz), 3.5-3.36 (m, 2H3+9') 3.23 (d, 1H, 8aCH2, J=9.3 Hz), 2.43 (t, 1H, HI, J=3.9 Hz)  3 0 [1R-(1 ,3a^ , ,4a/? ,   ^aJ3 ) ] 8 a-[ [ 1 S , 4R, 7 R, 9R]-2,8--4(1__9__[3 4  ] --7---]_4_  __4,4&amp;amp;5,677&amp;amp;8,83_ -7 --3-(1-__s__ 3a(lH)- 2917015 0.09563 45 3 U, DMSO-d6): 9.78 (s, 1H, CHO), 5.80 (dd, 1H, H2, J=1.23.6 Hz)4.46 (dd1H, H7J=2.75.1 Hz), 3.9-3.8 (m2HH3+8aCH2)3.54 (dd1HJ=8.1 9 Hz), 3.47 (d, 1H, 8aCH2, J=9.3 Hz) ;  (13C, DMSO-d6): 206.4 (CHO), 174.3 (COO'), 151.3 (C3), 127.6 (C2), 97.1 (C7'), 80.7 (Cl') -180- CNS ) A4210X297 ()</span>A7 B7 Printed by Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of the invention (mouth 7) (PH2 20 pieces / call * 2) Shake at room temperature for 1 hour. The catalyst was filtered off, and the solvent was evaporated to obtain a residue, which was then subjected to flash chromatography analysis and purification (dioxide crushed rubber, acetone, acetone, and distillate / valley 10: 1 and 5: 1) to obtain the title compound (180 mg) as Oil body (yield rate 84%). ^ (lH, CDC13): 12-11 (b, in, COOH), 9.88 (s, 1H, CHO), 6.053 (dd, 1H, H2, J = 1.5 ^ 3.6 Hz), 4.77 (m, 1H, H -7 '), 4.37 (d, 1H, 8aCH2, J = 9.3 Hz), 3.95 (dd, 1H, H3's J-7.2 ^ 8.7 Hz), 3.67 (dd, 1H, Hl', J = 8.7 and 9 Hz) , 3.5-3.36 (m, 2H, 3, + 9 '), 3.23 (d, 1H, 8aCH2, J = 9.3 Hz), 2.43 (t, 1H, HI, J = 3.9 Hz) Example 3 0 [1R- (1 , 3a ^, , 4a /?,    ^ aJ3)] 8 a- [[1 S, 4R, 7 R, 9R] -2,8-dioxo-4  (1_methyl Ethyl) _9_methyl_cis-bicyclo [3 4 ] -non-7-yl-oxy-methyl] _4_methyl_yl_4,4 &amp;amp;, 5,677 &amp;amp;, 8,83_octahydro- 7-methyl-3- (1-methylethyl) _ , lamethylene_s_indap province_3a (lH) -carboxylic acid, sodium salt of the compound of Example 29 (170 mg) in methanol ( 15 mL), add 0.0956 equivalent of sodium hydroxide aqueous solution (3 45 mL). After removing it for 1 hour, remove the solvent to dryness, dissolve the obtained solid in 3 ml of water and dry. U, DMSO-d6): 9.78 (s, 1H, CHO), 5.80 (dd, 1H, H2, J = 1.2 and 3.6 Hz), 4.46 (dd, 1H, H7 ', J = 2.7 and 5.1 Hz), 3.9-3.8 (m, 2H, H3 '+ 8aCH2), 3.54 (dd, 1H, H, J = 8.1 and 9 Hz), 3.47 (d, 1H, 8aCH2, J = 9.3 Hz);  (13C, DMSO- d6): 206.4 (CHO), 174.3 (COO '), 151.3 (C3), 127.6 (C2), 97.1 (C7'), 80.7 (Cl '). -180- The private paper standard is used in China National Standard (CNS) A4 specification (210X297mm) (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">,1T  321644 A7 ___B7  3 1 [lR_(la3a/?4yS4ay377aor8a]8a-[[lS,4S,7R, 9R]-2,8--4-(1-_9__[3 4  ] --7---]_4-_4,4&amp;amp;5,6,7,7&amp;amp;8,83_ -7-- 3-(1-_s__ 3a(lH)- 40(28015 /10%)(50 (PH2 = 2 0/2)  :/10 : 15 : 1)190 8 9 %)  (!, CDC13): 9.88 (s, 1H, CHO), 6.05 (dd, 1H, H2, J=1.5 &amp;amp;3.3Hz),4.92(t,lHH7,J=2.7Hz4.33(dlH8aCH2 J=10.2 Hz), 3.94 (t, 1H, H3', J=8.1 Hz), 3.8-3.7 (m, 2H, Hl'+H93.47 (dd1H, H3'J=8.4 10.8 Hz)3.29 (d1H, 8aCH2, J=10_5 Hz) 3 2  () [1R-(1^ ,3a^ , ^ ,1  ,laa ,8a/3 ) ] 8 a-[ [ 1 S , 4 S , 7R, 9R]-2,8--4-(1-9_--[3.4.0 ] --7---]-4 --4,4a56,7,7a,8,8a - -7-- 3- (1--1,4-- S-p5l-3a(lH)- 3116515 -181 - CNSA421X 297  A7 17^ ~ --- 0.09563 35 13 ^ ('H, CDC13) 9.77 (s, 1H, CHO), 5.79 (dd, 1H, H2, J=0.9 33 Hz), 4.58 (bs, 1HH7)3.85-3.72 (m2H H3+8aCH2)3.71-3.56 (m2HH9+H13.45 (d1H 8aCH2, J=9.9 Hz); d (^c, CDC13): 206.3 (CHO), 174.3 (COO)151.4 (3)127.5 96 7 (C7,)8 8 (cr) 3 3 [1R-(1  ,3a^ ,4^ ,4ay5 ,7,7a a ,8a/? ) ] 8 a-[ [ 1 S , 7R, 9R]- 2,8--9- .-4__-[3 4 ]_7- --]-4 -_4,4&amp;amp;,5,6,7,7&amp;amp;8,83--7_ -3-(1-_1,4__8_,5_3&amp;amp;(111)_ 41(3304 0.22 1501  98 : 2) 1RP_18 6 7 5 % )  (^, CDC13): 9.87 (s, 1H, CHO), 6.04 (d, 1H, H-2, J=3.3 8.4 Hz)4.48-4.29 (m3HCH2-38a-CH2(lH))3.76 (dd1HH-lJ=7.29.3 Hz), 3.27 (m1H, H-9)3.02 (m 1H, H-5'), 2.45 (m, 1H, H-l);  (13C, CDC13): 205.1 (CHO), -182- CNS ) A42I0X297 ()</span>, 1T people! 321644 A7 ___B7 5. Description of the invention (Example 3 1 [lR_ (la, 3a / ?, 4yS, 4ay3, 7 cold, 7aor, 8a point)] 8a-[[lS, 4S, 7R, 9R] -2, 8- Dioxo-4- (1-methylethyl) _9methyl_cis_bicyclo [3 4 ] -non-7-yl-oxy-methyl] _4-carboxamide_4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,83_octahydro-7-methyl-3- (1-methylethylmethylene_s_indap province_ 3a (lH) -carboxylic acid in intermediate A solution of 40 (280 mg) in ethyl acetate (15 ml) was added with carbon / carbon (10%) (50 mg) under nitrogen. This mixture was in a Parr device (PH2 = 20 lb / in2) Shake at room temperature for 1 hour. Filter off the catalyst, evaporate the solvent to obtain a residue, and then purify by flash chromatography (silica gel, hexane: acetone volume / volume 10: 1 and 5: 1) to obtain the title compound (190 mg) as an oil body (yield rate 8 9%).  (! , CDC13): 9.88 (s, 1H, CHO), 6.05 (dd, 1H, H2, J = 1.5 &amp;amp; 3.3Hz) , 4.92 (t, lH, H7 ,, J = 2.7Hz, 4.33 (d, lH, 8aCH2, J = 10.2 Hz), 3.94 (t, 1H, H3 ', J = 8.1 Hz), 3.8-3.7 (m, 2H, Hl '+ H9'), 3.47 (dd, 1H, H3 ', J = 8.4 and 10.8 Hz), 3.29 (d, 1H, 8aCH2, J = 10_5 Hz) Example 3 2 Printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please read the precautions on the back before filling in this page) [1R- (1 ^, 3a ^,   ^ , 1 , laa, 8a / 3)] 8 a- [[1 S, 4 S, 7R, 9R] -2,8-dioxo-4- (1-methylethyl)  9_methyl-cis-bicyclo [3.4.0 ] -Non-7-yl-oxy-methyl] -4 -carboxyl-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1- Methylethyl) -1,4-methylene-S-p5l Gap-3a (lH) -carboxylic acid, sodium salt in a solution of the compound of Example 31 (165 mg) in methanol (15 ml), -181-This paper scale is applicable to the Chinese National Standard (CNS&gt; A4 specification (21X 297 mm). The A7 is printed by the Beigong Consumer Cooperative of the Central Standard Rating Bureau of the Ministry of Economic Affairs. 5. Description of the invention (17 ^ ~ --- plus 0.0956 An equivalent of aqueous sodium hydroxide solution (3 35 ml). After stirring for 1 hour, the solvent was removed to dryness, and the resulting solid was dissolved in 3 ml of water and lyophilized. ^ ('H, CDC13): 9.77 (s, 1H, CHO), 5.79 (dd, 1H, H2, J = 0.9 and 3.3 Hz), 4.58 (bs, 1H, H7,), 3.85-3.72 (m , 2H, H3 '+ 8aCH2), 3.71-3.56 (m, 2H, H9, + H1,), 3.45 (d, 1H, 8aCH2, J = 9.9 Hz); d (^ c, CDC13): 206.3 (CHO) , 174.3 (COO ), 151.4 ( 3), 127.5 (iv), 96 7 (C7,), 88 (cr). Example 3 3 [1R- (1 , 3a ^, 4 ^, 4ay5, 7,7a a, 8a /?)] 8 a- [[1 S, 7R, 9R]-2,8-dioxo-9- .Methyl-4_methylene_cis-bicyclo [3 4 ] non_7-yl-oxy-methyl] -4 -methylacyl_4,4 &amp;amp;, 5,6,7,7 &amp;amp;;, 8,83-octahydro-7_methyl-3- (1-methylethyl) _1,4_methylene_8_, 5  Province_3 &amp; (111) _carboxylic acid in intermediate To a solution of 41 (330 mg) in methane (4 ml) was added trifluoroacetic acid (0.2 ml). This mixture is 0.  Stir for 20 minutes, then dilute with two gas methane (150 ml), wash three times with water (100 ml). The organic layer was dried over magnesium sulfate and concentrated to dryness to obtain an oil body, which was then subjected to a flash layer analysis on silica. Dioxane: methanol (98: 2) was used as the washing away agent. The appropriate portion was collected under moderate pressure (approximately 10 bar) for RP_18 chromatographic analysis, using linear gradient water in acetonitrile (60 to 75%) to prepare the title compound.  (^, CDC13): 9.87 (s, 1H, CHO), 6.04 (d, 1H, H-2, J = 3.3 and 8.4 Hz), 4.48-4.29 (m, 3H, CH2-3 'and 8a-CH2 (lH)), 3.76 (dd, 1H, H-l ', J = 7.2 and 9.3 Hz), 3.27 (m, 1H, H-9 ), 3.02 (m, 1H, H-5'), 2.45 ( m, 1H, Hl);  (13C, CDC13): 205.1 (CHO), -182- This paper uses the Chinese national standard (CNS) A4 specification (2I0X297mm) (Please read the precautions on the back first Fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 180) 176.0 (COOH), 148.6 (C-3), 130.4 (C-2), 104.2 (CH2=), 98.2 (780.1((-1')73.470.6(8&amp;amp;-^12(-369.8((-9  3 4 [1R-(1  ,3a^ ,4^ ,4a^ ,7 ^ ,7a a ,8a^ ) ] 8 a - [ [ 1 S , 7 R, 9 R]- 2.8- -9--4---[3.4.0]--7---]-4--4,4a5,6,7,7a8,8a--7--3-(l--l4--S--3a(lH)-  3314015 0.9453.06 6 0 (145 , DMSO-d6): 9.76 (s, 1H, CHO), 5.76 (d, 1H, H-2, J= 3.3 Hz), 5.04 (m, 2H, H2C=), 4.34-4.20 (m3HH-7'CH2_ 33_84&amp;amp;3.50(2d2H8a-CH2J=9.9Hz)3.62(dd,lH,H-J=7.59.3 Hz), 3.15 (m, 1HH-92.89 (m1HH-51) 3 5 [1R-(1 a3a/5 ,44a77aa8a]8a-[[ls,7R9R]_ 2.8- -9 --4--3--[34]_ -7--]_4 --4,4a5,6,7,7a8,8a-- 7--3-(l--l4--S-_3a(1H)_  42(621_1 ___ - 183- CNS ) A4210X297) ' ---- ()</span>A7 B7 printed by Beigong Consumer Cooperative of Central Bureau of Standards of the Ministry of Economy V. Description of Invention (180) 176.0 (COOH), 148.6 (C-3), 130.4 (C-2), 104.2 (CH2 =), 98.2 (7 ' ), 80.1 ((: -1 '), 73.4 and 70.6 (8 &amp;amp;-^ 12 and (: -3,), 69.8 ((: -9,)) Example 3 4 [1R- (1 , 3a ^, 4 ^, 4a ^, 7 ^, 7a a, 8a ^)] 8 a-[[1 S, 7 R, 9 R]-2.8-dioxo-9-methyl-4-methylene-cis- Bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl- 3- (l-methylethyl) -l, 4-methylene-S-pyridine-3a (lH) -carboxylic acid, sodium salt of Example 33 compound (140 mg) in methanol (15 ml) To the solution in the solution, 0.945 equivalent of aqueous sodium hydroxide solution (3.06 ml) was added dropwise. The solvent was removed under reduced pressure, and the residue was dissolved in water (60 ml) and frozen to obtain the title compound (145 mg). , DMSO-d6): 9.76 (s, 1H, CHO), 5.76 (d, 1H, H-2, J = 3.3 Hz), 5.04 (m, 2H, H2C =), 4.34-4.20 (m, 3H, H-7 'and CH2_3'), 3_84 &amp; 3.50 (2d, 2H, 8a-CH2, J = 9.9Hz), 3.62 (dd, lH, H-, J = 7.5 and 9.3 Hz), 3.15 (m, 1H, H-9 ') , 2.89 (m, 1H, H-51). Example 3 5 [1R- (1 a, 3a / 5, 4, 4a Lu, 70,000, 7aa, 8a)] 8a-[[ls, 7R, 9R ] _ 2.8-Dioxo-9 -methyl-4-methylene-3-oxycis-bicyclo [34] _non-7-yl-oxy  methyl] _4 -carboxamide-4 , 4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -l, 4-methylene-S-indap province_3a ( 1H) _ Carboxylic acid is added to a solution of intermediate 42 (62 mg) in methane (1_1 ml) ___-183- This paper scale is applicable to China National Standard (CNS) A4 specification (210X297mm) ---- (please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T W A7 B7 181) 0.05C20 503X25  98 : 2) 2 5 d(1H,CDCl3):9.75(s,lH,CHO),6.35&amp;amp;5,63(2d,2H l^OCJ=3.3 Hz)6.04 (dd1HH-2, J=1.23.3 Hz)4.52 (tlHH-7J=4.8Hz)4.24(tlHH-4J=8.7Hz)4.09&amp;amp; 3.46 (2d, 2H, 8a-CH2, J=9.3 Hz), 3.38 (m, 1H, H-5'), 3.30 (m, 1H, H-9'), 2.59 (t, 1H, H-l, J=3.9 Hz); ^ (13C, CDC13) 204.5 (CHO), 175.3 (COOH), 169.7 (C-3'), 148.2 (C-3), 136.8 (C-4'), 130.6 (C-2), 122.4 (C=CH2), 97.7 (C-7'), 77.8 (C-)71_2 (C-9 3 6 [lR-(la,3a/5,4y5,4a7/5,7aa,8a^)]8a-[[lS7R9R]-28--9 --4--3---[3.4.0]- -7---]-4 -- 4,4a5,6,7,7a8,8a--7--3-(l--l,4--S--3a(lH)- 352510 0.9450.53 25 (26 ci(1HDMSO-d6):9.75(slHCHO)6.15&amp;amp;5.82(2d,2H -184- CNS ) A4210X297 ()   A7 B7 182) 1^0=0, J=3.3 Hz), 5.76 (brd, 1H, H-2), 4.31 (dd, 1H, H-7', J=2.4&amp;amp;7.8Hz)4.24(tlHH-rJ=8.7Hz)3.84&amp;amp;3.52(2d, 2H, 8a-CH2, J=9.9 Hz), 3.38 (m5 1H, H-5'), 3.21 (m, 1H, H-9') 3 7 [1R-(1  ,3ay5 , ,4a^ ,1  ,1^  )]8a-[[lS,7R,9R]-2,8--9--4---[3.4.]__7__ -]-4 --4,4a56,7,7a8,8a--7 --3-U --14 -_s -- 3a(lH) - 43(4515 10%/25 25/2  65 : 35) (25 ^ (^, CDC13): 9.77 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J=1.53.6 Hz), 4.17 (m, 4HH-3,1H), 8a-CH2 (1H)H-7 CH2 (1H)J=9 Hz), 3.31 (m, 1HH-92.85 (m1HH-5 2-58 (t, 1H, H-3, J=3.9 Hz); i (13C, CDC13): 214.4 (C-4), 204.8 (H0), 148.3 (C-3), 130.6 (C-2)98.9 (C-7)78.6 70.3 (C-C-973.669.1 (C8a-gC-3 3 8_ [lR-(la3a/5 ,4/34a/57y37aa8a^ )]8a-[[lS4S6S, -185- CNS ) A4210X 297 ()</span>1. Printed by the 1T Ministry of Economic Affairs, Central Bureau of Standards, W Industrial and Consumer Cooperatives A7 B7 5. Description of the invention (181) Trifluoroacetic acid (0.05 ml). The mixture was stirred at 0  C for 20 minutes, then diluted with methane (50 ml) and washed with water (3  25 ml). The organic layer was dried over sodium sulfate and concentrated to obtain an oil body, which was then analyzed as a flash layer on silicon dioxide twice, using dichloromethane: methanol (98: 2) as the washing agent. The title compound (25 mg) was obtained as a pale yellow foam. d (1H, CDCl3): 9.75 (s, lH, CHO), 6.35 &amp;amp; 5,63 (2d, 2H, l ^ OC, J = 3.3 Hz), 6.04 (dd, 1H, H-2, J = 1.2 And 3.3 Hz), 4.52 (t, lH, H-7, J = 4.8Hz), 4.24 (t, lH, H-4 ', J = 8.7Hz), 4.09 &amp;amp; 3.46 (2d, 2H, 8a- CH2, J = 9.3 Hz), 3.38 (m, 1H, H-5 '), 3.30 (m, 1H, H-9'), 2.59 (t, 1H, Hl, J = 3.9 Hz); ^ (13C, CDC13): 204.5 (CHO), 175.3 (COOH), 169.7 (C-3 '), 148.2 (C-3), 136.8 (C-4'), 130.6 (C-2), 122.4 (C = CH2), 97.7 (C-7 '), 77.8 (C-) and 71_2 (C-9,). Example 3 6 [lR- (la, 3a / 5,4y5,4a, 7 / 5,7aa, 8a ^)] 8a-[[lS, 7R, 9R] -2,8-dioxo-9-methyl -4-Methylidene-3-oxy-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-methylacyl-4,4a, 5,6,7 , 7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl) -1,4-methylene-S-pyridine-3a (; lH) -carboxylic acid, sodium To a solution of the compound of Example 35 (25 mg) in methanol (10 ml), add 0.945 equivalent of aqueous sodium hydroxide solution (0.53 ml). The solvent was removed under reduced pressure, and the residue was dissolved in water (25 ml) and frozen to obtain the title compound (26 mg). ci (1H, DMSO-d6): 9.75 (s, lH, CHO), 6.15 &amp;amp; 5.82 (2d, 2H, -184- This paper size is applicable to China National Standard (CNS) A4 specification (210X297mm) (please first Read the precautions on the back and fill out this page) Order A7 B7 Printed by the Ministry of Economy Central Bureau of Industry and Commerce-Industrial and Consumer Cooperatives V. Description of Invention (182) 1 ^ 0 = 0, J = 3.3 Hz), 5.76 (brd, 1H, H-2), 4.31 (dd, 1H, H-7 ', J = 2.4 &amp;amp; 7.8Hz), 4.24 (t, lH, Hr, J = 8.7Hz), 3.84 &amp;amp; 3.52 (2d, 2H, 8a- CH2, J = 9.9 Hz), 3.38 (m5 1H, H-5 '), 3.21 (m, 1H, H-9'). Example 3 7 [1R- (1 , 3ay5, A, 4a ^, 1 , 1 ^  )] 8a-[[lS, 7R, 9R] -2,8-dioxo-9-methyl-4 -Oxy-cis-bicyclo [3.4.] _non_7_yl_oxy-methyl] -4-methylacyl-4,4a, 5,6,7,7a, 8,8a-octa Hydrogen-7-methyl-3-U-methylethyl) -1,4-methylene_s-indap-3a (lH) -carboxylic acid in intermediate 43 (45 mg) in ethyl acetate To the solution (15 ml) was added 10% palladium / carbon (25 mg) under nitrogen. This mixture was shaken in a Parr device under 25 psi hydrogen pressure at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified on silica gel as a flash layer, using ethyl acetate: ethyl acetate (65:35) as the eluent to obtain the title compound (25 mg). ^ (^, CDC13): 9.77 (s, 1H, CHO), 6.05 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 4.17 (m, 4H, H-3, (1H), 8a- CH2 (1H), H-7, CH2 (1H), J = 9 Hz), 3.31 (m, 1H, H-9,), 2.85 (m, 1H, H-5,), 2-58 (t, 1H, H-3, J = 3.9 Hz); i (13C, CDC13): 214.4 (C-4), 204.8 ( H0), 148.3 (C-3), 130.6 (C-2), 98.9 (C- 7,), 78.6 and 70.3 (C-factory and C-9,), 73.6 and 69.1 (C8a-g and C-3,). Example 3 8_ [lR- (la, 3a / 5, 4/3, 4a / 5, 7y3, 7aa, 8a ^)] 8a-[[lS, 4S, 6S, -185- This paper size is applicable to the Chinese national standard (CNS) A4 specification (210X 297mm) (Please read the note  on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">3^1644 A7 B7</span>3 ^ 1644 A7 B7</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">183) 7R9R]-2,8--4 --6--9--- () [340]--7--]-4--4,4a5,6,7, 7a8,8a--7--3-(1--i4--S-4 -3a(lH)- 45(12350 10 %/6515/2 1  19 : 1)18  2)90  (^, CDC13): 9.67 (s, 1H, CHO), 6.07 (d, 1H, H-2, J=3.3 Hz), 4.64 (d, 1H, H-7',J=3.6 Hz), 4.02 (d, 1H, 8aCHa, J=9.9</span>5. Description of the invention (183) 7R, 9R] -2,8-dioxo-4 -ethyl-6-hydroxy-9-methyl-cis-bicyclo (please read the precautions on the back before filling this page) [3  4  0] -Non-7-yl-oxy  methyl] -4-methyl-2,4a, 5,6,7, 7a, 8,8a-octahydro-7-methyl -3- (1-methylethyl) -i, 4-methylene-S-4 pyridine-3a (lH) -carboxylic acid in intermediate 45 (123 mg) in ethyl acetate (50 ml) To the solution was added 10% palladium / carbon (65 mg) under nitrogen. This mixture was hydrogenated at room temperature for 1 hour under a hydrogen pressure of 15 psi. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified by flash layer on silica gel, and washed away with methane: methanol (19: 1) and (18  2). The title compound (90 mg) was prepared.  (^, CDC13): 9.67 (s, 1H, CHO), 6.07 (d, 1H, H-2, J = 3.3 Hz), 4.64 (d, 1H, H-7 ', J = 3.6 Hz), 4.02 (d, 1H, 8aCHa, J = 9.9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.89 (dd, 1H, Ha-3J=6.99 Hz), 3.85-3.7 (m, 3H, H-6'-H-93.68-3.5 (m2H, Hb-3,8a-CHb)2.65 (t  1H, H-l, J=3.6 Hz); c^(13C5 CDC13): 204.9 (CHO), 176.3 (C02H), 148.9 (C-3), 130.1 (C-2), 99.2 (C-7'), 80.5, 70.1^ 65.5(C-6C-HC-9.)73.7l71.0(8a-QH2&amp;amp;C-313.4 (CH2-H3) 3 9  [lR-(la3ay54y54ay57y?7aa8a/5 )]8a-[[lS4R6S 7R9R]-2,8 --4--6--9--- [3_4.0]--7---]_4-_4,4&amp;amp;,5,6,7, 7a, 8,8a--7 --3-(1--1,4--S-p1 -3a(lH)- 46(10225 -186- CNS)42297 A7 B7 184) 10 %/6015/*2 1  26 : 1)75 ci CDC13) 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.23.6 Hz), 4.53 (d1HH-7'J=1.8 Hz), 4.05 (dd1H Ha-3', J=7.28.4 Hz)4.02 (d, 1H, 8aCHa, J=9.3 Hz) 3 83 (dd, 1H, H-lJ=7.28.7 Hz), 3.72 (dd1HH-6J=2.1 </span>Hz), 3.89 (dd, 1H, Ha-3, J = 6.9 and 9 Hz), 3.85-3.7 (m, 3H, H-6 ', - and H-9,), 3.68-3.5 (m , 2H, Hb-3, and 8a-CHb), 2.65 (t,  1H, Hl, J = 3.6 Hz); c ^ (13C5 CDC13): 204.9 (CHO), 176.3 (C02H), 148.9 (C-3 ), 130.1 (C-2), 99.2 (C-7 '), 80.5, 70.1 ^ 65.5 (C-6 ,, C-HC-9.), 73.7l71.0 (8a-QH2 &amp;amp; C-3,) , 13.4 (CH2-  H3). Example 3 9 Printed by the Beigong Consumer Cooperative of the Central Prototype Bureau of the Ministry of Economic Affairs [lR- (la, 3ay5, 4y5, 4ay5, 7y ?, 7aa, 8a / 5)] 8a-[[lS, 4R, 6S, 7R, 9R ] -2,8 -Dioxo-4-ethyl-6-hydroxy-9-methyl-cis-bicyclo [3_4.0] -non-7-yl-oxy-methyl] _4-carboxamide Base_4,4 &amp;amp;, 5,6,7, 7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-Sp bow 1 Province-3a (lH) -carboxylic acid in a solution of intermediate 46 (102 mg) in ethyl acetate (25 ml) at -186- This paper scale is applicable to China National Standards (CNS) A4 specifications (2297 Mm) A7 B7 5. Description of the invention (184) Add 10% carbon / carbon (60 mg) under nitrogen. This mixture was hydrogenated at room temperature for 1 hour at 15 min / * 2 nitrogen pressure. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified by flash chromatography on the crushed silica, and washed away with difluoromethane: methanol (26: 1). The title compound (75 mg) was prepared. ci CDC13): 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 and 3.6 Hz), 4.53 (d, 1H, H-7 ', J = 1.8 Hz), 4.05 ( dd, 1H Ha-3 ', J = 7.2 and 8.4 Hz), 4.02 (d, 1H, 8aCHa, J = 9.3 Hz) 3 83 (dd, 1H, H-l', J = 7.2 and 8.7 Hz), 3.72 (dd, 1H, H-6, J = 2.1 and</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">4.8 Hz), 3.64 (d, 1H, 8a-CHb, J=9.3 Hz), 3.54-3.36 (m, 2H H-91 &amp;amp;Hb-3)2.68(tlHH-lJ=3.9Hz),.96(t3HCl-CH2, J=7.5 Hz); tf(13CCDC13): 204.7 (CHO)176.1 (C02H), 148.5 (C-3)130.5 (C-2)98.8 (C-7)79.2, 7.7 69.1((-6'-1(-973.772.7(8&amp;amp;-2(-312.7 (CH2-H3) 4 0</span>4.8 Hz), 3.64 (d, 1H, 8a-CHb, J = 9.3 Hz), 3.54-3.36 (m, 2H H-91 &amp;amp; Hb-3 '), 2.68 (t, lH, Hl, J = 3.9Hz ), .96 (t, 3H, Cl-CH2, J = 7.5 Hz); tf (13C, CDC13): 204.7 (CHO), 176.1 (C02H), 148.5 (C-3), 130.5 (C-2) , 98.8 (C-7,), 79.2, 70.7 and 69.1 ((: -6 ', (: -1, and (: -9,), 73.7 and 72.7 (8 &amp;amp;-4 2 and (:- 3,), 12.7 (CH2-  H3). Example 4 0</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1^ ,3&amp;amp;/3 , ^ ,1  ,7a ) ] 8 a-[ [ 1 S , 4R, 6 S  {) r ! 7R9R]-2,8 --4--6-_9___ [3.4.0]--7---]-4- _4,4a5,6,7 7a8,8a --7-- 3- (1-_s_p -3a(lH)- 394905 0.09513 1 0 475 -187 - CNS ) A4210X297 A7 A7  B7 185) ^ On, (CD3)2SO): 9.77 (s, 1H, CHO), 5.8 (d, 1H, H-2, ^=2.4 Hz), 4.41 (bs, 1H, -OH), 4.31 (d, 1H, H-7', J=2.1 Hz), 394-3_82 (m2H, 8aCHa&amp;amp;Ha-33.66 (t1HH-lJ=8.1</span>[1R- (1 ^, 3 &amp;amp; / 3,   ^ , 1 , 7a )] 8 a- [[1 S, 4R, 6 S Printed by Beigong Consumer Cooperative of Central Bureau of Economics of the Ministry of Economic Affairs {please Read the precautions on the back before filling in this page) r! 7R  9R] -2,8 -Dioxy-4-ethyl-6-keto_9_methyl_cis_bicyclo [3.4.0]- Non-7-yl-oxy-methyl] -4-carboxamide_4,4a, 5,6,7 7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl Radical) methylene_s_p Yinda province-3a (lH) -carboxylic acid, sodium salt in a solution of the compound of Example 39 (490 mg) in methanol (50 mL), and 0.095 equivalent of aqueous sodium hydroxide 10 ml). After 30 minutes, the solvent was removed under reduced pressure. The residue was dissolved in water (10 ml) and crystallized by freezing to obtain the title compound (475 mg). -187-This paper scale uses the Chinese National Gradient (CNS) A4 specification (210X297 mm) A7 A7 Central Standard Rating Bureau of the Ministry of Economic Affairs, Beigong Consumer Cooperative Printed B7. Invention Description (185) ^ On, (CD3) 2SO): 9.77 (s, 1H, CHO), 5.8 (d, 1H, H-2, ^ = 2.4 Hz), 4.41 (bs, 1H, -OH), 4.31 (d, 1H, H-7 ', J = 2.1 Hz), 3  94-3_82 (m, 2H, 8aCHa &amp; Ha-3,), 3.66 (t, 1H, Hl ,, J = 8.1</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.54-3.34 (m, 3H, 8aCHb, H-6'^LH-9'), 3.24 (t, 1H, Hb-3J=8.1 Hz), 2.55 (t, 1H, H-lJ=3.6 Hz) 4 1 [1R-(la,3a^,4^,4ay5,7y5,7aar,8a^)]8a-[[lS,7R,9R]-28-9--4--[3.4.0] --7-- -]-4 --4,4a56,7,7a88a--7 --3-U --14 -- S-5- 3a(lH) - 43(35015 10%/50 (PH2=15/2)1  /100 : 170 : 150 : 1)200 10.0947  4.54 (1 5 ^ (^, DMSO-d6): 9.76 (s, 1H, CHO), 5.80 (dd, 1H, H2, J=.9&amp;amp;3.3Hz)4.20-3.95 (m,4HH7+Hr+H3')3.89(d 1H, 8aCH2, J=9.6 Hz), 3.47 (d, 1H, 8aCH2, J=9.6 Hz), 2.92 (m, 1HH5 4 2 [HUa3a^4/?4a/?77aa8a0 )]8a-[(ls4R,7R, -188- CNS ) A421&amp;gt;&amp;lt; 297) ()</span>Hz), 3.54-3.34 (m, 3H, 8aCHb, H-6 '^ LH-9'), 3.24 (t, 1H, Hb-3 ', J = 8.1 Hz), 2.55 (t, 1H, Hl, J = 3.6 Hz). Example 4 1 [1R- (la, 3a ^, 4 ^, 4ay5,7y5,7aar, 8a ^)] 8a-[[lS, 7R, 9R] -2,8  diox-9-methyl-4  Oxy-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydrogen -7-Methyl-3-U-Methylethyl) -1,4-Methylene-S-5  Province-3a (lH) -carboxylic acid, sodium salt in intermediate 43 (350 mg) To a solution in ethyl acetate (15 ml) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was hydrogenated at room temperature for 1 hour in a Parr device (PH2 = 15 psi). The catalyst was filtered off, the solvent was evaporated to obtain the residue, and then the flash layer analysis was carried out (silica dioxide, methane gas: methanol volume / volume 100: 1, 70: 1 and 50: 1) to prepare 200 mg of bubble gum. The foam was redissolved in methanol (10 mL), treated with 0.0947  of sodium hydroxide (4.54 mL), the solvent was removed in vacuo, and the resulting solid was dissolved in water (15 mL) and lyophilized. ^ (^, DMSO-d6): 9.76 (s, 1H, CHO), 5.80 (dd, 1H, H2, J = .9 &amp;amp; 3.3Hz), 4.20-3.95 (m, 4H, H7 '+ Hr + H3 '), 3.89 (d, 1H, 8aCH2, J = 9.6 Hz), 3.47 (d, 1H, 8aCH2, J = 9.6 Hz), 2.92 (m, 1H, H5'). Example 4 2 [HUa, 3a ^, 4 / ?, 4a / ?, 7, 7aa, 8a0)] 8a-[(ls, 4R, 7R, -188- This paper scale is applicable to China National Standard (CNS) A4 Specifications (21 &amp;lt; 297mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T  A7 B7 186) 9R)-2,8--4 --9---[3.4.0]--7_ --]-4--4,4&amp;amp;5,6,7,7&amp;amp;8,8-7- - 3- (1-_4-- S- H_3a(lH) -  82(25015 10 %/50 (PH2=15/2)1  /100: 170 : 150 : 1)120 150.0947  2.5115  ci (lR, DMSO-d6): 9.77 (s, 1H, CHO), 5.80 (dd, 1H, H2, 1=1.2^3.3 Hz), 4.47 (t, 1H, H7', J=3.9 Hz), 3.96-3.84 (m, 2H, H3'+8aCH2,), 3.80 (m, 1H, H4'), 3.65-3.40 (m, 4H, H9-+8aCH2+H3'+Hl'), 3.23 (s, 3H, OCH3), 2.46-2.2 (m, 4H, H1+H6'+H5'+CH(CH3)2);&amp;gt; (13C&amp;gt; DMSO-d6): 206.4 (CHO), 174.4 (COO-), 151.3 (C3), 127.6 (C2), 96.9 (C7&amp;quot;), 84.1 (4')56.6 (03) 4 3 [1R-(1 a ,3ay5 ,  ,4ay3 ,1  a ,8ay5 )]8a-[(lS,7R,9R)-2,8--9---[3.4.]__4_-7___ ]-4 --4,4a5,6,7,7a, 8,8a --7-- 3- (1--1,4--S-M- 3a(lH)- -189- CNS ) 4210X297 ()  ! A7 B7 187) 87(1202 0C15 1001001  /2 : 115 151  TLC1 : 3) 6273%)  CDC13): 9.79 (s, 1H, CHO), 6.06 (dd, 1H, H2, J-1.2 3.3 Hz), 5.56 (m, 1HH44.65-4.65 (m, 2HH3'), - (m, 3H H7+8aCH2+Hl 3.50 (d 1H, 8aCH2, J=9 Hz) 3.18 (dq1HH91J=6.39Hz), 2.72 (m, 1H, H6')2.62 (t, 1H, HI, J=3 Hz);  (13C, CDC13) 204.6 (CHO), 175.2 (COOH), 148.3 (C3), 136.3 (C5'), 130.6 (C2), 119.15 (C-4')5 101.5 (C7)86.5 (Cl 44  () [lR-(l,3a^ , ,4ay5,7^)7a,8a/5)]8a-[(lS,7R,9R)-2,8--9---[3.4.0]--4--7---]-4 --4,4a5,677a8,8a --7-- 3-(1--14-S-- 3a(lH) - 43505 0.09661.0915 1 -190- CNS ) A4210X297  A7 B7 18) 475 ^ (, DMS0-d6): 9.78 (s, 1H, CHO), 5.80 (bd, 1H, H2, J=3.6 Hz), 5.64 (bs, 1H, H4'), 4.6-4.4 (m, 2H, H3'), 4.1 (dd, 1HH7'J=2.79.3 Hz)4.05-3.90 (m2HHl'+8aCH2) 3.56 (d1H, 8aCH2, J=9.6 Hz)306 (dq1HH9J=6.3 8.7 Hz);  (13C, DMSO-d6): 215.9 (CHO), 183.9 (COO'), 160.9 (C3), 146.1 (C5'), 137.2(C2), 128.3 (C4'), 110.9 (Cl'), 95.7 (Cl) 4 5 [1R-(1 ,3a5 ,4/? ,4a&amp;gt;5 ,7/? ,7a or ,8ay5 )] 8a-[(1 S ,7R,9R)- 2,8--9---[340]--7-- ]-4 --4,4 a5,6,7,7a, 8,8a --7--3-(1- -1,4--S--3a(lH)- 87(10015 1 0 %/5 0 (PH2 = 20/2)1 / 2 : 11515 11  TLC/3 : 1)2 3  /0) CDC13): 9_86 (s, 1HCHO), 6.05 (dd1H, H2, J=l.5 3_6 Hz), 4.07 (dd1HH7J=35.4 Hz), 433 (d1H -191 - CNSA4&amp;quot;(210X297 '  ()</span> 1T Printed by the Ministry of Economic Affairs Central Bureau of Precision Industry Beigong Consumer Cooperative A7 B7 V. Description of the invention (186) 9R) -2,8-dioxo-4 -methoxy-9-methyl-cis-bicyclo [3.4 .0] -non-7-yl-oxy-methyl] -4-methyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8-octahydro-7-methyl-3- (1-Methylethyl) _, 4-methylene-S-H  Jianjian_3a (lH) -tetanoic acid, sodium salt in intermediate 82 (250 mg) in ethyl acetate (15 mL) To the solution was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was hydrogenated in a Parr device (PH2 = 15 psi) at room temperature for 1 hour. The catalyst was filtered off, and the solvent was evaporated to obtain a residue, which was then subjected to flash chromatography (silica dioxide, methane gas: methanol volume / volume 100: 1, 70: 1, and 50: 1) to obtain 120 mg of the body. The slurry was redissolved in methanol (15 ml), treated with 0.0947 M sodium hydroxide (2.51 ml), and the solvent was removed to obtain a semi-solid, dissolved in water (15 ml) and lyophilized. ci (lR, DMSO-d6): 9.77 (s, 1H, CHO), 5.80 (dd, 1H, H2, 1 = 1.2 ^ 3.3 Hz), 4.47 (t, 1H, H7 ', J = 3.9 Hz), 3.96 -3.84 (m, 2H, H3 '+ 8aCH2,), 3.80 (m, 1H, H4'), 3.65-3.40 (m, 4H, H9- + 8aCH2 + H3 '+ Hl'), 3.23 (s, 3H, OCH3), 2.46-2.2 (m, 4H, H1 + H6 '+ H5' + CH (CH3) 2); &amp;gt; (13C &amp;gt; DMSO-d6): 206.4 (CHO), 174.4 (COO-), 151.3 (C3 ), 127.6 (C2), 96.9 (C7 &amp;quot;), 84.1 ( 4 '), 56.6 (0 inverse 3). Example 4 3 [1R- (1 a, 3ay5, A , 4ay3, 1  a, 8ay5)] 8a-[(lS, 7R, 9R) -2,8-dioxo-9-methyl-cis- Bicyclo [3.4.] _non_4_  -7_yl_oxy_methyl] -4 -methylbromo-4,4a, 5,6,7,7a, 8,8a -octahydro-7 -Methyl- 3- (1-methylethyl) -1,4-methylene-SM-Province- 3a (lH) -carboxylic acid-189- Chinese paper standard for standard use of this paper (CNS) 4 Specifications (210X297mm) (Please read the precautions on the back before filling in this page) Order! A7 B7 5. Description of the invention (187) In the intermediate 87 (120 mg) in anhydrous digas methane (20 ml) To the solution was added difluoroacetic acid (100 l) under nitrogen at 0C. After 5 minutes, the mixture was diluted with methane (100 mL), washed with water (100 mL) and brine (100 mL), then dried over magnesium sulfate and concentrated to give the crude product, which was then dissolved in tetrahydrofuran: methanol ( The volume / volume 2: 1, 15 ml) mixture was treated with 1 equivalent of hydrochloric acid (5 ml). After the reaction was completed, it was diluted with water (100 ml) and extracted twice with one-shot methane. The organic layer was dried on sulfuric acid by mistake to obtain an oil body, which was then purified by TLC (silica dioxide, acetone: hexane 1: 3) to prepare 62 mg of the title compound (yield 73%) as a white foam.  CDC13): 9.79 (s, 1H, CHO), 6.06 (dd, 1H, H2, J-1.2 and 3.3 Hz), 5.56 (m, 1H, H4 '), 4.65-4.65 (m, 2H, H3') , - (m, 3H, H7 '+ 8aCH2 + Hl,), 3.50 (d, 1H, 8aCH2, J = 9 Hz), 3.18 (dq, 1H, H91, J = 6.3 and 9Hz), 2.72 (m , 1H, H6 '), 2.62 (t, 1H, HI, J = 3 Hz);  (13C, CDC13): 204.6 (CHO), 175.2 (COOH), 148.3 (C3), 136.3 (C5'), 130.6 (C2), 119.15 (C-4 ') 5 101.5 (C7,), 86.5 (Cl,). Example 44 The policy of the Ministry of Economic Affairs, Central Bureau of Accreditation and Unemployment Consumer Cooperative (please read the note  on the back and then fill in this page) 5)] 8a-[(lS, 7R, 9R) -2,8-dioxo-9-methyl-cis-bicyclo [3.4.0] -non-4-ene-7-yl-oxy-methyl Radical] -4 -carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methylethyl) -1,4  methylene Base-S-indjian-3a (lH) -tetanoic acid, sodium salt in a solution of the compound of Example 43 (50 mg) in methanol (5 mL) was added 0.0966 equivalent of sodium hydroxide (1.09 mL). The mixture was stirred for 15 minutes and the solvent was removed to dryness. The residue is dissolved in water (1 ml) and frozen crystals, the standard -190- This paper size is suitable for China National Standard (CNS) A4 specifications (210X297 mm) Printed by the Consumer Labor Cooperative of the Central Bureau of Standards A7 B7 V. Description of the invention (18) The title compound (475 mg). ^ (, DMS0-d6): 9.78 (s, 1H, CHO), 5.80 (bd, 1H, H2, J = 3.6 Hz), 5.64 (bs, 1H, H4 '), 4.6-4.4 (m, 2H, H3 '), 4.1 (dd, 1H, H7', J = 2.7 and 9.3 Hz), 4.05-3.90 (m, 2H, Hl '+ 8aCH2), 3.56 (d, 1H, 8aCH2, J = 9.6 Hz), 3 06 (dq, 1H, H9 , J = 6.3 and 8.7 Hz);  (13C, DMSO-d6): 215.9 (CHO), 183.9 (COO '), 160.9 (C3), 146.1 (C5'), 137.2 (C2), 128.3 (C4 '), 110.9 (Cl'), 95.7 (Cl ). Example 4 5 [1R- (1, 3a; 5, 4 /?, 4a &amp;gt; 5, 7 /?, 7a or, 8ay5)] 8a-[(1 S, 7R, 9R)-2,8-dioxo- 9-Methyl-cis-bicyclo [3  4  0] -non-7-yl-oxy-methyl] -4-methylacyl-4,4 a, 5,6,7,7a, 8 , 8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-S-indap-3a (lH) -carboxylic acid in intermediate 87 (100 mg ) To a solution in ethyl acetate (15 mL) was added 10% palladium / carbon (50 mg) under nitrogen. This mixture was shaken in a Parr device (PH2 = 20 psi) at room temperature for 1 hour. The catalyst was filtered off, and the solvent was evaporated to obtain a residue. The residue was redissolved in a mixture of tetrahydrofuran: methanol (volume / volume 2: 1, 15 ml) and treated with 1 equivalent of hydrochloric acid (5 ml). After the reaction was complete, dimethane (100 ml) and water (100 ml) were added to separate the two layers. The organic layer was dried over magnesium sulfate, concentrated to prepare an oil body, and then purified by TLC for preparation (hexane: acetone volume / volume 3: 1) to obtain 20 mg of the title compound as a transparent oil body (yield rate) 3  / 0). CDC13): 9_86 (s, 1H, CHO), 6.05 (dd, 1H, H2, J = 1.5 and 3_6 Hz), 4.07 (dd, 1H, H7, J = 3 and 5.4 Hz), 4.33 (d, 1H, -191-This paper scale is applicable to Chinese national standard (CNS&gt; A4 specification &amp;quot; (210X297mm) ' (please read the notes on the back and fill in this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T A7 B7  189) 8aCH2, J=9.6 Hz), 3.90 (m, 1H, H3'), 3.69 (m, 1H, H3'), 3.61 (dd, 1H, , J=8.1 9 Hz), 3.39 (dq, 1H, H9J=69</span>, 1T, A7, B7, Ministry of Economic Affairs, Central Standards Bureau, BeiH Consumer Cooperative Institution V. Invention Instructions (189) 8aCH2, J = 9.6 Hz), 3.90 (m, 1H, H3 '), 3.69 (m, 1H, H3'), 3.61 (dd, 1H, , J = 8.1 and 9 Hz), 3.39 (dq, 1H, H9 ,, J = 6 and 9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.28 (d, 1H, 8aCH2, J=9.6 Hz), 2.6-2.4 (m, 2H, H5'+H1), 2.32 (m, 1H, CH(CH3)2)  4 6 [1R-(1 ,3a^ ,4/3  ,  ,7a^  ) ] 8 a-[ (1 S , 4R, 6 S , 7R9R)-2,8 --4,9 --6---[340 ] --7---]_4__4,4&amp;amp;5,6,7,7&amp;amp;88&amp;amp;- -7--3-(1-_14-_s__ 3a(lH)- 89b(9025 10%/604/2 4 5  :10 : 1)6 ^ (^, CDC13): 9.74 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J-1.53.6 Hz)4.53 (d1H, H-7', J=2.1 Hz)4.09 (d, 1H, 8a-CHaJ=9.6HZ)4.02(ddlHHa-3J=7.5&amp;amp;8.4HZ), 3.84 (dd, 1H, H-l'J=7.89 Hz), 3.74 (dd1H, H-6, J=2.1 5.1 Hz), 3.60 (d, 1H, 8a-CHb, J=9.3 Hz), 3.42 (dq, 1H, H_ 9', J=6^9 Hz), 3.34 (t, 1H, Hb-3's J=8.7 Hz), 2.66 (t, 1H, H-13_9 Hz) 4 7 [lR-(la ,3a^ AP ,4a/5 ,1  ,laa ,8ay9 ) ] 8 a-[ (1 S , 4R, 6 S , -192- CNS ) A4210X297 () 11 A7 B7  190) 7R9R)-2,8--4,9-6_--[3.4.0 ] --7---]-4 -_4,4&amp;amp;5,6,7,78,8- -7--3-(1-4-S-_ 3a(lH)- 4625820 0.1034.981 5 1  250  (^, (CD3)2SO) 9.77 (s, 1H, CHO), 5.79 (d, 1H, H-2, J=3.6 Hz), 4.29 (d, 1H, H-7', J=1.8 Hz), 3.94-3.8 (m, 2H, 8a-CHaHa-3'), 3.67 (t1H, H-l1J=8.4 Hz)3.55-3.25 (m, 3H, 8a-CHb, H-6', H-9'), 3.14 (t, 1H, Hb-3', J=8.4 Hz), 2.54 (t1HH-l, J = 3.6 Hz)  4 8 [1R-(1 a3a44a77aa ,8aA )]8a-(((2,3,6- -3 --3-N4-0--b-D-]_ 4 --4,43,5,6,7,73,8,83--7_-3-(1- -14 --S- 3a(lH) - 96(18015 10%/30 (PH2 = 2 0/2)2  1:1)GM23339X (7  193- tACNS ) A4210X297 (} 11  A7 B7_____ 191)  GHCDC13): 9.76 (s, 1H, C0)6.05 (dd1HH-2, J=3.0 1.2 Hz), 4.64 (dd1H, -J=5_733 Hz), 4.11 (m 2H, H-3', H-4'), 4.04 (d, 1H, H-8a, J=9.3 Hz), 3.62 (dq, 1H, H-5', J=8.4J5L6.0 Hz), 3.51 (d, 1H, H-8a, J=9.3 Hz), 3.49 (m, 1HC^-CH3.13 (m, 1H, Cii2-CH3),2.62 (t1HH-l, J=3.6 Hz), 2.32 (m, 1H, CH(CH3)2), 1.15 (t, 3H, , J=7.2 Hz); (J (13C, CDC13): 204.4 (CHO), 175.7 (COOH), 157.6 (N-COO), 148.3 (C-3), 130.5 (C-2), 97.2 (C-l'), 74.2 (C-41)73.4 (8a-QH2)69.4 (C-5'), 51.2 (-N) 49 [1R-(1 a3ay34y54ay57/?7aa8ay5 )]83-[(2,3--6--4-0 ---D-]-4- -44a5,6,7,7a8,8a --7- 3- (1--1,4--s--3a(lH)- 50(14020 10%/100 15/21 . 5 : 1)20 : 1) 85 ^ (^, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz),4.74(slHH-l')3.63&amp;amp;4.13(2d2H 8aCH2, J=9.3 Hz)3.48 (m4HH-44-OMe)2.26 (d, 1H H-2', J=3.9 Hz), 3.19 (m, 1H, H-5'), 3.13 (d, 1H, H-3', J=3.9 ____ -194-  ( CNS ) A4 210X297) ' ' ()</span>Hz), 3.28 (d, 1H, 8aCH2, J = 9.6 Hz), 2.6-2.4 (m, 2H, H5 '+ H1), 2.32 (m, 1H, CH (CH3) 2) Example 4 6 (1R- (1 , 3a ^, 4/3 ,  , 7a ^ )] 8 a- [(1 S, 4R, 6 S, 7R, 9R) -2,8 -diox-4,9 -di Methyl-6-benzyl-cis-bicyclo [340] -non-7-yl-oxy-methyl] _4_methanyl_4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8, 8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) _1,4-methylene_s_pyda province_ 3a (lH) -carboxylic acid in intermediate 89b (90 mg) To a solution in ethyl acetate (25 ml) was added 10% palladium / carbon (60 mg) under nitrogen. This mixture was hydrogenated at room temperature under a hydrogen pressure of 40 psi / p 2 for 45 minutes. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was analyzed by flash layer on silica gel and washed away with methane: ethyl acetate (10: 1). The title compound (60 mg) was prepared. ^ (^, CDC13): 9.74 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J-1.5 and 3.6 Hz), 4.53 (d, 1H, H-7 ', J = 2.1 Hz) , 4.09 (d, 1H, 8a-CHa, J = 9.6HZ), 4.02 (dd, lH, Ha-3 ,, J = 7.5 &amp;amp; 8.4HZ), 3.84 (dd, 1H, H-l ', J = 7.8 and 9 Hz), 3.74 (dd, 1H, H-6 , J = 2.1 and 5.1 Hz), 3.60 (d, 1H, 8a-CHb, J = 9.3 Hz), 3.42 (dq, 1H, H_ 9 ' , J = 6 ^ 9 Hz), 3.34 (t, 1H, Hb-3's J = 8.7 Hz), 2.66 (t, 1H, H-1, Bu 3_9 Hz). Example 4 7 [lR- (la, 3a ^ AP, 4a / 5, 1 , laa, 8ay9)] 8 a- [(1 S, 4R, 6 S, -192- This paper size is suitable for Chinese national standards ( CNS) A4 specification (210X297mm) (please read the precautions on the back before filling in this page), 11 A7 B7 Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economy V. Invention Instructions (190) 7R, 9R)- 2,8-dioxa-4,9-dimethyl  6_hydroxy-cis-bicyclo [3.4.0] -non-7-yl-lactyl-methyl] -4-methanyl_4, 4 &amp;amp;, 5,6,7,7 Jiang, 8,8-octahydro-7-methyl-3- (1-methylethyl) 4  methylene-S-indap province_ 3a (lH ) -Carboxylic acid, sodium salt In a solution of the compound of Example 46 (258 mg) in methanol (20 mL), 0.103 equivalent of aqueous sodium hydroxide solution (4.98 mL) was added dropwise. After 15 minutes, the solvent was removed under reduced pressure. The residue was dissolved in water (10 ml) and frozen to obtain the title compound (250 mg).  (^, (CD3) 2SO): 9.77 (s, 1H, CHO), 5.79 (d, 1H, H-2, J = 3.6 Hz), 4.29 (d, 1H, H-7 ', J = 1.8 Hz ), 3.94-3.8 (m, 2H, 8a-CHa and Ha-3 '), 3.67 (t, 1H, H-l1, J = 8.4 Hz), 3.55-3.25 (m, 3H, 8a-CHb, H- 6 ', H-9'), 3.14 (t, 1H, Hb-3 ', J = 8.4 Hz), 2.54 (t, 1H, Hl, J = 3.6 Hz) Example 4 8 [1R- (1 a, 3a point, 40,000, 4a point, 7 Lu, 7aa, 8aA)] 8a-(((2,3,6-trideoxy-3-ethylamino-3-N, 4-0-carbonyl-bD- Isopiperosyloxy) methyl] _ 4 -carboxamide-4,43,5,6,7,73,8,83-octahydro-7_methyl-3- (1-methylethyl Radical) -1,4-methylene-S  Qiaoda province-3a (lH) -carboxylic acid in a solution of intermediate 96 (180 mg) in ethyl acetate (15 ml) was added 10% under nitrogen wind Palladium / carbon (30 mg). The mixture was shaken in a Parr device (PH2 = 20 bricks / inch 2) at room temperature for 2 hours. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was on silica gel For flash layer analysis, wash off with hexane: ethyl acetate (1: 1) to prepare pure GM23339X (70 mg). 193-t paper A degree is applicable to China National Frame Rate (CNS) A4 specification ( 210X297mm) (Please read first Please pay attention to this page and fill out this page}, 11 Printed by the Ministry of Economic Affairs, Central Bureau of Economic Development, Beigong Consumer Cooperative A7 B7_____ 5. Description of Invention (191)  GH, CDC13): 9.76 (s, 1H, C Ting 0), 6.05 (dd, 1H, H-2, J = 3.0 and 1.2 Hz), 4.64 (dd, 1H, -, J = 5_7 and 3.3 Hz), 4.11 (m, 2H, H-3 ', H- 4 '), 4.04 (d, 1H, H-8a, J = 9.3 Hz), 3.62 (dq, 1H, H-5', J = 8.4J5L6.0 Hz), 3.51 (d, 1H, H-8a, J = 9.3 Hz), 3.49 (m, 1H, C ^ -CH), 3.13 (m, 1H, Cii2-CH3), 2.62 (t, 1H, Hl, J = 3.6 Hz), 2.32 (m, 1H, CH (CH3) 2), 1.15 (t, 3H,, J = 7.2 Hz); (J (13C, CDC13): 204.4 (CHO), 175.7 (COOH), 157.6 (N-COO), 148.3 (C-3 ), 130.5 (C-2), 97.2 (C-l '), 74.2 (C-41), 73.4 (8a-QH2), 69.4 (C-5'), 51.2 ( -N). Example 49 [1R- (1 a, 3ay3, 4y5, 4ay5, 7 / ?, 7aa, 8ay5)] 83-[(2,3-anhydro-6-deoxy-4-0-methyl--D- Pipermannosyloxy) methyl] -4-methylacetate-4,4a, 5,6,7,7a, 8,8a -octahydro-7  methyl-3- (1-methylethyl Radical) -1,4-methylene-s-pyda-3a (lH) -carboxylic acid in a solution of intermediate 50 (140 mg) in ethyl acetate (20 ml) was added 10% under nitrogen Palladium / carbon (100 mg). This mixture was shaken at room temperature under a pressure of 15 psi for 1 hour in a Parr device. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was separated on silica gel as a flash layer. 'Use ethyl acetate: ethyl acetate (5: 1) and two gas tiger: methanol (20: 1) was washed away to obtain the title compound (85 mg ) Is a bubble. ^ (^, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.74 (s, lH, H-l '), 3.63 &amp;amp; 4.13 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.48 (m, 4H, H-4 'and 4-OMe), 2.26 (d, 1H, H-2', J = 3.9 Hz), 3.19 (m , 1H, H-5 '), 3.13 (d, 1H, H-3', J = 3.9 ____ -194- This paper size is suitable for financial solutions (CNS) A4 Na (210X297 Gongmai) '' (please (Read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 A7  B7____ 192)</span>A7 A7 Printed by Bei H Consumer Cooperative, Central Bureau of Standards, Ministry of Economic Affairs B7____ V. Description of Invention (192)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.06 (d, 1H, H-4', J=8.7 Hz), 2.74 (t, 1H, H-l, J=3.6 Hz); S3C, CDC13): 204.8 (CHO), 175.6 (C02H), 148.2 (C-3), 130.8 (C-2), 98.0 (C-), 76.5 (C-4'), 74.3 (8aCH2), 74.4 (C-3a), 72.5 (C-5')s 65.6 (C-8a), 59.0 (C-4), 58.2 (4'-OMe)53.6 (C-250.3 (C-346.4 (C-l) 5 0 [1R-(1 a3a/3 ,4y54a70 ,7aa8aA )]8a-[(2,3--6- -4-0 -]-4- -4,4a,5,6,7,7a8,8a--7--3-(-1,4--s--3a(lH)- 4931010 0.0976N669 22 324  (JH, CDCI3) 9.87 (s, 1H, CHO), 5.98 (dd, 1H, H-2, J=1.53_6 Hz)4.69 (s1H, H-l3.854.07 (2d2H 8aCH2, J=9.6 Hz), 3.47 (s, 3H, 4'-OMe), 3.26 (d, 1H, H-2', J=3.9 Hz), 3.19 (dq, 1HH-5J=5.7&amp;amp;9Hz),3.12(dlHH-3'J=3.9 Hz)2.97 (dd1HH-4'J=0.68.7 Hz)2.66 (t 1H, H-l, J=3.6 Hz); cJ(13C, CDCI3): 209.6 (CHO), 178.6 (C02H), 152.4 (C-3), 130.2 (C-2), 100.1 (C-l'), 78.2 (C-4'), 77.9 (8aCH2), 73.8 (C-3a), 73.9 (C-5'), 65.6 (C-8a), 59.2 (C-4), 58.2 (4'-OMe), 54.6 (C-2'), 51.9 (C-3'), 46.4 (C-l)  5 1  __ -195- _ CNS ) A4210X 297 ()</span>Hz), 3.06 (d, 1H, H-4 ', J = 8.7 Hz), 2.74 (t, 1H, Hl, J = 3.6 Hz); S3C, CDC13): 204.8 (CHO), 175.6 (C02H) , 148.2 (C-3), 130.8 (C-2), 98.0 (C-), 76.5 (C-4 '), 74.3 (8aCH2), 74.4 (C-3a), 72.5 (C-5') s 65.6 (C-8a), 59.0 (C-4), 58.2 (4'-OMe), 53.6 (C-2 '), 50.3 (C-3,), 46.4 (Cl). Example 5 0 [1R- (1 a, 3a / 3, 4y5, 4a, 70, 7aa, 8aA)] 8a-[(2,3-anhydro-6-deoxy-4-0-methyl piperan mannose Glycosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (bumethylethyl) -1,4 -Methylene-s-zhaoda-3a (lH) -carboxylic acid, sodium salt in a solution of the compound of Example 49 (310 mg) in methanol (10 mL), and a solution of sodium hydroxide (0.0976N, 6.69 ml). This mixture was stirred at room temperature for 2 hours. The solvent was removed, and the residue was dissolved in water (2 ml) and frozen to obtain the title compound (324 mg) as a white solid.  (JH, CDCI3): 9.87 (s, 1H, CHO), 5.98 (dd, 1H, H-2, J = 1.5 and 3_6 Hz), 4.69 (s, 1H, Hl,), 3.85 and 4.07 (2d, 2H, 8aCH2, J = 9.6 Hz), 3.47 (s, 3H, 4'-OMe), 3.26 (d, 1H, H-2 ', J = 3.9 Hz), 3.19 (dq, 1H, H-5', J = 5.7 &amp;amp; 9Hz), 3.12 (d, lH, H-3 ', J = 3.9 Hz), 2.97 (dd, 1H, H-4', J = 0.6 and 8.7 Hz), 2.66 (t, 1H, Hl, J = 3.6 Hz); cJ (13C, CDCI3): 209.6 (CHO), 178.6 (C02H), 152.4 (C-3), 130.2 (C-2), 100.1 (C-l '), 78.2 (C -4 '), 77.9 (8aCH2), 73.8 (C-3a), 73.9 (C-5'), 65.6 (C-8a), 59.2 (C-4), 58.2 (4'-OMe), 54.6 (C -2 '), 51.9 (C-3'), 46.4 (Cl)  Example 5 1, __ -195- _ This paper size applies to China National Standard (CNS) A4 specification (210X 297mm) (please read first (Notes on the back then fill this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ~--- 193) [1R-(1 or3a44a/577a8a/S )]8a-[(2,3_ _4_  --2,3,6--_D_]_4_ -4,4a5,6,7,7a8,8a-_7_-3-(1- -1,4 --5-4_3a(iH) - 52(0.675,5__2__2_ -13,2-3.374.02) 51t48  3  : 180 ^ R, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz)495(dlHH-l'J=l.8Hz)4.15&amp;amp;3.65 (d,d, 1H, 8a-CH2, J=9.3 Hz), 3.33 (d, 1H, H-4', J=8.7 Hz), 3.18 (m1H, H-51)3_14 (m2H, H-2'H-32.70 (m1H H-l), 2.30 (m, 1H, CH(CH3)2) ^(13C, CDC13): 204.7 (CHO), 175.6 (C02H), 148.3 (C-3), 130.7 (C-2), 98.5 (C-l')5 79.1 (C-4'), 74.1 (8a-CH2), 73.5 (C-5'), 46.6 (C-l), 35.6 (C-2)35.2 (C-3)27.5 (H(CH3)2) 1 R.S. Edmundson; Tetrahedron, 2J_, 2379 (1965)  5 2 [1R-(1 a3a/34y5 ,4a7/?7aa ,8a0 )]8a-[(2,3--6--4-0 ---D-]-4 - -4,4a,5,6,7,7a,8,8a--7--3-(1--1,4--s-- 3a(lH)- -196- CNS ) A4210X297 ($)</span>Printed by the Employee Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs ~ --- V. Description of the Invention (193) [1R- (1 or, 3a, 4 o'clock, 4a / 5, 7na, 7a , 8a / S) ] 8a-[(2,3_Episulfo_4_ -methyl-2,3,6-trideoxy-Lu_D_piperanmannosyloxy) methyl] _4_carboxamide-4, 4a, 5,6,7,7a, 8,8a-octahydro_7_methyl-3- (1-methylethyl) -1,4-methylene-5-4 ~ da province_3a ( iH) -carboxylic acid intermediate 52 (0.67 mmol), 5,5_dimethyl_2_thiol_2_thio-1,3,2-dioxane (3.37 mmol) ) And triethylamine (4.02 mmol) in dimethylformamide (5 mL) in water, heated at 100 t for 48 hours. After cooling, the mixture was poured into water ether. The organic phase was evaporated, and the residue was subjected to flash chromatography analysis and purification using methane gas: methanol (30: ) as the eluent to obtain the title compound (180 mg). ^ R, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4'95 (d, lH, H-l ', J = l.8Hz), 4.15 &amp;amp; 3.65 (d, d, 1H, 8a-CH2, J = 9.3 Hz), 3.33 (d, 1H, H-4 ', J = 8.7 Hz), 3.18 (m, 1H, H -51), 3_14 (m, 2H, H-2 'and H-3'), 2.70 (m, 1H, Hl), 2.30 (m, 1H, CH (CH3) 2); ^ (13C, CDC13): 204.7 (CHO), 175.6 (C02H), 148.3 (C-3), 130.7 (C-2), 98.5 (C-l ') 5 79.1 (C-4'), 74.1 (8a-CH2), 73.5 (C -5 '), 46.6 (Cl), 35.6 (C-2,), 35.2 (C-3,), 27.5 ( H (CH3) 2). 1 RS Edmundson; Tetrahedron, 2J_, 2379 (1965). Example 5 2 [1R- (1 a, 3a / 3, 4y5, 4a point, 7 / ?, 7aa, 8a0)] 8a-[(2,3-dehydration -6-deoxy-4-0-propyl-lu-D-piperanmannosyloxy) methyl] -4-methyl-4,4a, 5,6,7,7a, 8,8a -Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-indida province- 3a (lH) -carboxylic acid-196 National Standard (CNS) A4 specification (210X297mm) (Please read the note $ item on the back and then fill in this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7 194) 65(400100 10 %/2 20/21  25 : 1) 300  (^, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.5^3.6 Hz), 4.72 (s, 1H, -), 4.13^13.65 (2d, 2H, 8a-CH2, J=9 Hz), 3.67 (m, 1H, H-5'), 3.44 (m, 1H, H-4'), 3.25 3.12 (2d, 2H, H-2', H-3J=4.2 Hz)3.20 (m2H, OC^CI^CHs)2.74 (t, 1H, H-l, J=3.9 Hz); d(13C, CDC13): 204.8 (CHO), 175.8 (C2H), 130.8 (C-2), 148.2 (C-3), 98.0 (C-l')5 74.9 (C-4'), 74.3 (C-8a-CH2), 72.6 (C-5'), 72.4 (OC^CI^CHs en C-41)65.6 (C-8a), 59.0 (C-3), 54.2 (C-2')50.3 (C-3')18.6 (C-6') 5 3 [1R-(1 3a/54/54a3757aa8ay5 )]8a-[(2,3--6 -4-0 -_0_D_]_4  ( -4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1-_14_ -s-M-3a(lH)- 524003 0.09768_ 15 11_ 15417 -197- CNS ) A4210X297 A7 A7  B7 195)  ci (lR, CDC13): 9.89 (s, 1H, CHO), 5.97 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)4.70(slHH-l,)4.09&amp;amp;3.86(2d2H8a- CH2, J=9.7 Hz), 3.70 (m, 1H, H-5'), 3.44 (m, 1H, H-4'), 3.24 &amp;amp;3.12(2d2HH-2H3J=4Hz)3.20(m2H, OCCH2CH3)2.65 (t, 1H, H-lJ=3.9 Hz); d(13C, CDCI3) 209.6 (CHO), 178.38 (C02Na), 152.4 (C-3), 130.1 (C-2), 100.1 (C-l'), 77.9 (OCH2CH2CH3 en C-4'), 76.6 (C- 4 )73.5 (C-5 )73.1 (C-8a-^_H2)66.6 (C-3'), 18.9 (C-6 5 4 [1R-(1 a3a44a7/57aa8a0 )]8a-[(2,3--4_  --6-- /3-D -]_4_ -44&amp;amp;,5,6,7,7&amp;amp;8,8&amp;amp;--7_-3-(1-_1,4_ -s --3 a (1 )- 225 63(2007) i 3  5 : 1) 35 : 1)15   (1 HCDC13): 986 (s1HCHO)7.3 1 (m5HPhCH2) 6.08 (dd1HH-2, J=l_23.3 Hz)4.75 (d, 1H, OC^Ph -198- CNS ) A4210X297 ()</span>A7 B7 5. Description of the invention (194) To a solution of intermediate 65 (400 mg) in ethyl acetate (100 ml), add 10% palladium / carbon (200 mg) under nitrogen. This mixture was shaken in a Parr device under hydrogen pressure of 20 psi at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was subjected to flash chromatography on a silica gel flash column and washed away with methane and methane: methanol (25: 1) to obtain the title compound (300 mg) as a white foam.  (^, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 ^ 3.6 Hz), 4.72 (s, 1H, -), 4.13 ^ 13.65 (2d , 2H, 8a-CH2, J = 9 Hz), 3.67 (m, 1H, H-5 '), 3.44 (m, 1H, H-4'), 3.25 and 3.12 (2d, 2H, H-2 ', H-3 ,, J = 4.2 Hz), 3.20 (m, 2H, OC ^ CI ^ CHs), 2.74 (t, 1H, Hl, J = 3.9 Hz); d (13C, CDC13): 204.8 (CHO), 175.8 (C2H), 130.8 (C-2), 148.2 (C-3), 98.0 (C-l ') 5 74.9 (C-4'), 74.3 (C-8a-CH2), 72.6 (C- 5 '), 72.4 (OC ^ CI ^ CHs en C-41), 65.6 (C-8a), 59.0 (C-3), 54.2 (C-2'), 50.3 (C-3 '), 18.6 (C -6 '). Example 5 3 [1R- (1 , 3a / 5, 4/5, 4a; 3, 7; 5, 7aa, 8ay5)] 8a-[(2,3-anhydro-6  deoxy-4-0- Propyl_0_D_piperanmannosyloxy) methyl] _4  Printed by the Staff Consumer Cooperative of the Central Standards Bureau of the Ministry of Economics (Please read the precautions on the back before filling out this page) -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) _1,4_methylidene-sM ~ da province-3a (lH) -treason Acid, sodium salt in a solution of the compound of Example 52 (400 mg) in methanol (30 mL) was added dropwise 0.0976 equivalent of aqueous sodium hydroxide solution (8-15 mL). The mixture was stirred for 1 hour. The solvent was removed to dryness , Dissolve the solid residue in the minimum amount of water (10-15 ml). Freeze the crystals of this solution to prepare the title compound (417 mg), -197- This paper size is applicable to China National Standard (CNS) A4 (210X297 mm) A7 A7 Printed B7 by the Beigong Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 5. The description of invention (195) is a white solid. Ci (lR, CDC13): 9.89 (s, 1H, CHO), 5.97 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.70 (s, lH, Hl,), 4.09 &amp;amp; 3.86 (2d , 2H, 8a- CH2, J = 9.7 Hz), 3.70 (m, 1H, H-5 '), 3.44 (m, 1H, H-4'), 3.24 &amp;amp; 3.12 (2d, 2H, H-2H3, , J = 4Hz), 3.20 (m, 2H, OC CH2CH3), 2.65 (t, 1H, Hl, J = 3.9 Hz); d (13C, CDCI3): 209.6 (CHO), 178.38 (C02Na), 152.4 ( C-3), 130.1 (C-2), 100.1 (C-l '), 77.9 (OCH2CH2CH3 en C-4'), 76.6 (C- 4), 73.5 (C-5), 73.1 (C-8a- ^ _H2), 66.6 (C-3 '), 18.9 (C-6'). Example 5 4 [1R- (1 a, 3a point, 4, 4a, 7/5, 7aa, 8a0)] 8a- [ (2,3-anhydro-4_ -benzyl-6-deoxy- / 3-D-piperanmannosyloxy) methyl] _4_    -4'4 &amp;amp;, 5,6,7 , 7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl-3- (1-methylethyl) _1,4_methylene-s-indap-3a (1 ) -carboxylic acid in To a suspension of sodium hydride (22 mg) in anhydrous dimethylformamide (5 ml) was added dropwise a solution of intermediate 63 (200 mg) in anhydrous dimethylformamide (7 ml). The mixture was stirred at room temperature for 1 hour. The reaction mixture was neutralized with i-equivalent hydrochloric acid, ethyl acetate (30 mL of organic layer was washed with water and brine, dried over anhydrous magnesium sulfate, filtered and evaporated to dryness. The residue flashed on a silica gel flash column Layer analysis, using two gas methane burning: methanol (50: 1) and (35: 1) as the eluent to prepare the title compound (15 mg), as white foam Zhu.  (1 H, CDC13): 9.86 (s, 1H, CHO), 7.31 (m, 5H, PhCH2), 6.08 (dd, 1H, H-2, J = l_2 and 3.3 Hz), 4.75 (d, 1H, OC ^ Ph, -198- The size of this paper is applicable to China National Standard (CNS) A4 (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">IT A7 B7  196) J=11.4 Hz), 4.73 (s, 1H, -), 4.56 (d, 1H, OCi^Ph, J=11.4</span>IT A7 B7 Printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Invention description (196) J = 11.4 Hz), 4.73 (s, 1H, -), 4.56 (d, 1H, OCi ^ Ph, J = 11.4</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)4.17&amp;amp;3.62(2d2H8a-C^J=9_0Hz),3.32&amp;amp;3.14(2d, 2HH-3'H-2' J=3.7 Hz), 3.30 (m, 2HH-4H-5)2.71 (t 1H, H-l); i(13C, CDC13): 204.9 (CHO), 175.8 (COOH), 137.2, 128.14, 128.1 1 (6C-Ph), 148.3 (C-3), 130.8 (C-2), 98.0 (C-l'), 74.4 (C8a-CH2), 74.3 (C-4'), 72.6 (OCH2Ph), 72.5 (C-5'), 65.5 (C-8a), 54.0 (C-2'), 50.3 (C-3'), 18.6 (C-6') o 5 5 [1R-(1 a3a44a/?7/? ,7aa8ay5 )]8a-[(2,3--6- -D-]_4_ 4,4&amp;amp;5,6,7,7&amp;amp;8,83--7--3-(1--14. -s --3 a (1 )- 755 66(500 53 0.5pH6.5-7 11  2X20  4 : 1)17 2 ^ (^, CDC13): 9.76 (s, 1H, CHO), 6.09 (dd, 1H, H-12, J=1.5&amp;amp;3.6Hz)4.77(s,lHH-r),3.6^4.21(2d2H, ()</span>Hz), 4.17 &amp;amp; 3.62 (2d, 2H, 8a-C ^, J = 9_0Hz), 3.32 &amp;amp; 3.14 (2d, 2H, H-3 'and H-2' J = 3.7 Hz), 3.30 (m, 2H, H-4 ,, H-5 '), 2.71 (t, 1H, Hl); i (13C, CDC13): 204.9 (CHO), 175.8 (COOH), 137.2, 128.14, 128.1 1 (6C-Ph) , 148.3 (C-3), 130.8 (C-2), 98.0 (C-l '), 74.4 (C8a-CH2), 74.3 (C-4'), 72.6 (OCH2Ph), 72.5 (C-5 ') , 65.5 (C-8a), 54.0 (C-2 '), 50.3 (C-3'), 18.6 (C-6 ') o Example 5 5 [1R- (1 a, 3a Lu, 4 points, 4a / ?, 7 /?, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-D-piperanmannosyloxy) methyl] _4  methanyl_4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,83-octahydro-7-methyl-3- (1-methylethyl) -1,4. Methylene-s-pyda-3a (1 ) -carboxylic acid in a suspension of anhydrous sodium hydride (75 mg) in anhydrous dimethylformamide (5 mL) was added intermediate 66 (500 mg) in anhydrous dimethylformamide under nitrogen ( 5 ml). The mixture was stirred under nitrogen for 3 hours. Then, water was added to stop the reaction, and the pH was neutralized to 6.5-7 with 0.5M hydrochloric acid. The concentrated 'residue of this mixture was separated in water: ethyl acetate (: 1,100 ml). The aqueous phase was extracted with ethyl acetate (2  20 ml), the combined organic phases were treated with brine, dried over magnesium sulfate, filtered and concentrated in vacuo to a slurry. Then, flash column chromatography was performed on the silica gel, and washed away with methane: methanol (40: 1) to obtain the title compound (172 mg) as a white foam. ^ (^, CDC13): 9.76 (s, 1H, CHO), 6.09 (dd, 1H, H-12, J = 1.5 &amp;amp; 3.6Hz), 4.77 (s, lH, Hr), 3.6 ^ 4.21 (2d, 2H, (Please read the notes on the back before filling this page)</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">1T f 199  A7 B7 197) 8aCH2, J=9 Hz), 3.60 (d, 1H, H-4', J-8.7 Hz), 3.21 (dq, 1H, H-5', J=9^6 Hz), 3.165.3.27 (2d, 2H, H-2'^LH-3', J=3.6 Hz), 2.70 (t, 1H, H-l); ^ (13C, CDC13): 205.5 (CHO), 174.6 (C02H), 148.4 (C-3), 130.8 (C-2), 97.8 (C-l'), 74.1 (8aCH2), 73.9 (C-4'), 73.7 (C-3a), 67.2 (C-5'), 65.5 (C-8a), 59.0 (C-4), 56.5 (C-250.4 (C-31)46.5 (C-l) 5 6 [1R-(1 3a44a/57yS ,7aa8a0 )]8&amp;amp;-[(2,3--46--4-]-4 - -4,43,5,6,7,7&amp;amp;8,8--7--3-(1--14 -_S-,5_3a(iH)_ 68(13030 10%/1 1 /21  4 : 1)&amp;gt;2^ : 1) 8 2 ^ Ob., CDC13): 9.79 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2&amp;amp;3.6Hz)5.13(slHH-l,)4.75&amp;amp;4.58(2dqlH,H-5J5F=48.3HzJ=6.6HzJ=3.9Hz)4.18&amp;amp;4.11(2dlH H-4'J=3.9Hz&amp;amp;J4,F=23.1Hz)4.07&amp;amp;3.61(2d,2H8aCH2, J=9.3 Hz), 3.77 (m, 2H, H-2'^H-3'), 2.67 (t, 1H, H-l); ^ (13C, CDC13) 204.6 (CHO), 175.3 (C02H), 148.2 (C-3), 130.7 (C-2), 101.7 (C-1'), 90.2 (d, C-4', JC4,.F-157 Hz), -200- CNS ) A4210X297 () -* 7  7 7 198) 80.3 (d, C-5', JC5--f=21.4 Hz)574.3 (C-8aCH2), 73.4 (C-3a), 65.4 (C-8a), 58.9 (C-4)55.9 (C-2')55.1 (d, C-3'JC3_F =6.3 Hz)16.4 (dC-6', JC6,_F=21 Hz) 5 7 [1R-(1 3a404a7aa8a/? )]8a-[(2,3--6- -4-0-(2 -_y?-D-] -4 -_4,4a5,6,7,7a, 8,8a--7 --3-(1- -14--s-_3a( 1H)- 69(14050 10 %/70 2 0/21  4 : 74  cy Cn, CDC13): 9.78 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2&amp;amp;3.3Hz)4.74(slHH-r)4.23&amp;amp;3.60(2d2H8a- CH2, J=9 Hz), 3.86-3.50 (m, 4H, OCl^ C  C H 3 ), 3.38 (s, 3HC|i3CH2CH20),3.3(m3.13(2d,2HH-2m-3 J=3.9 Hz), 3.26-3.22 (m2H, H-4,H-52.68 (t1HH-l J=3.7 Hz); (13C, CDCI3): 204.8 (CHO), 175.2 (COOH), 148.3 (C-3), 130.8 (C-2), 97.9 (C-l')s 74.2 (C-8aCH2), 72.4 (C-51), 717 69.9 (0H2^H20CH3)54.1 (C-2SOCKS) 46.5 (QH3OCH2CH2) 18.5 (C-6')  5 8 ___-201 -___ CMS ) A4210X297~ ()</span> 1T f  199 A7 B7 printed by Beigong Consumer Cooperative of Central Bureau of Economics and Development, Ministry of Economic Affairs 5. Description of Invention (197) 8aCH2, J = 9 Hz), 3.60 (d, 1H, H-4 ', J-8.7 Hz) , 3.21 (dq, 1H, H-5 ', J = 9 ^ 6 Hz), 3.165.3.27 (2d, 2H, H-2' ^ LH-3 ', J = 3.6 Hz), 2.70 (t, 1H, Hl); ^ (13C, CDC13): 205.5 (CHO), 174.6 (C02H), 148.4 (C-3), 130.8 (C-2), 97.8 (C-l '), 74.1 (8aCH2), 73.9 (C -4 '), 73.7 (C-3a), 67.2 (C-5'), 65.5 (C-8a), 59.0 (C-4), 56.5 (C-2 '), 50.4 (C-31), 46.5 (Cl). Example 5 6 [1R- (1 , 3a, 4 cold, 4a / 5, 7yS, 7aa, 8a0)) 8 &amp;amp;-[(2,3-anhydro-4,6-dideoxy-4-fluoropiper Furanosyloxy) methyl] -4 -carboxamide-4,43,5,6,7,7 &amp;, 8,8hexane-octahydro-7-methyl-3- (1-methyl Ethyl) -1,4-methylene_S-, 5 | dida_3a (iH) _carboxylic acid in a solution of intermediate 68 (130 mg) in ethyl acetate (30 ml) under nitrogen Add 10% palladium on carbon (100 mg). This mixture was shaken at room temperature for 1 hour under a pressure of 10 bricks / inch 2 in a Parr device. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was analyzed by flash chromatography on a silica gel flash column, and washed away with hexane: ethyl acetate (4: 1) and difluoromethane: methanol &amp;gt; 2 ^: 1) to prepare the title compound (8 2 Mg) as a white foam. ^ Ob., CDC13): 9.79 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.6Hz), 5.13 (s, lH, Hl,), 4.75 &amp;amp; 4.58 ( 2dq, lH, H-5 ', J5'F = 48.3Hz, J = 6.6Hz, J = 3.9Hz), 4.18 &amp;amp; 4.11 (2d, lH, H-4', J = 3.9Hz &amp;amp; J4, F = 23.1Hz), 4.07 &amp;amp; 3.61 (2d, 2H, 8aCH2, J = 9.3 Hz), 3.77 (m, 2H, H-2 '^ H-3'), 2.67 (t, 1H, Hl); ^ (13C , CDC13): 204.6 (CHO), 175.3 (C02H), 148.2 (C-3), 130.7 (C-2), 101.7 (C-1 '), 90.2 (d, C-4', JC4, .F- 157 Hz), -200- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297 commonweed) (please read the notes on the back and then fill out this page)-* 7 Printed by the Employees Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs Install 7 7 5. Description of the invention (198) 80.3 (d, C-5 ', JC5--f = 21.4 Hz) 574.3 (C-8aCH2), 73.4 (C-3a), 65.4 (C-8a), 58.9 ( C-4), 55.9 (C-2 '), 55.1 (d, C-3', JC3, _F = 6.3 Hz), 16.4 (d, C-6 ', JC6, _F = 21 Hz). Example 5 7 [1R- (1 , 3a Lu, 40, 4a point, 7aa, 8a /?)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2-methoxy Ethyl) _y? -D-piperanmannosyloxy) methyl] -4 -methylbrenyl_4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl -3- (1-Methylethyl) -1,4-methylene-s-indap_3a (1H) -carboxylic acid in intermediate 69 (140 mg) in ethyl acetate (50 ml) To the solution was added 10% palladium / carbon (70 mg) under nitrogen. This mixture was shaken in a Parr apparatus under hydrogen pressure of 20 psi at room temperature for 1 hour. The catalyst was filtered off and the solvent was evaporated to dryness. The resulting residue was purified on a silica gel flash column, using methane and methane: methanol (40: washed away, the title compound (74 g) was obtained as a white foam. Cy Cn, CDC13) : 9.78 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 &amp;amp; 3.3Hz), 4.74 (s, lH, Hr), 4.23 &amp;amp; 3.60 (2d, 2H, 8a-CH2 , J = 9 Hz), 3.86-3.50 (m, 4H, OCl  ^ C CH 3), 3.38 (s, 3H, C3iCH2CH20), 3.3 (m3.13 (2d, 2H, H-2m -3 ,, J = 3.9 Hz), 3.26-3.22 (m, 2H, H-4, and H-5 '), 2.68 (t, 1H, Hl, J = 3.7 Hz); (13C, CDCI3): 204.8 (CHO), 175.2 (COOH), 148.3 (C-3), 130.8 (C-2), 97.9 (C-l ') s 74.2 (C-8aCH2), 72.4 (C-51), 717 and 69.9 (0  H2 ^ H20CH3), 54.1 (C-2,), SOCKS '), 46.5 (QH3OCH2CH2), 18.5 (C-6'). Example 5 8 ___- 201 -___ The paper size is applicable to the Chinese National Standard (CMS) A4 specification (210X297 ~ (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 199) [lR-(l3a/?4y54ay57/?7a8a)]8a-[(2,3--6- -4-0-(2-__D_] -4 -_4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7__3-(1- -1,4 --s__3a(iH)_ 70(0.143 10 %/50 25/23  40 : 1)49)   (!HCDC13): 9.76 (s1H, CHO)6.09 (dd1HH-2 J=1.2^3.3 Hz), 4.73 (s, 1H, H-l'), 4.12^13.65 (2d, 2H, 8a- CH2, J=9.3 Hz)3.49 (m1H, H-53.22 (m3HH-21  CH2-0), 3.13 (m2HH-31 H-4')2.75 (t1HH-l, J=3.9</span>A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs 5. Description of the invention (199) [lR- (l , 3a / ?, 4y5, 4ay5, 7 / ?, 7a, 8a)] 8a-[(2 , 3-anhydro-6-deoxy-4-0- (2-methoxypropyl) _cold_D_piperannomannosyloxy) methyl] -4 -methylacetyl_4,4 &amp;amp; , 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7_methyl_3- (1-methylethyl) -1,4-methylene-s_indap province_3a ( iH) _carboxylic acid in a solution of intermediate 70 (0.14 mmol) in ethyl acetate (30 mL) was added 10% palladium on carbon (50 mg) under nitrogen. This mixture was shaken at room temperature for 30 minutes under 25 psi hydrogen pressure in a Parr device. The catalyst was filtered off and the solvent was evaporated to dryness. The obtained residue was analyzed and purified by flash chromatography, using two gas tigers: methanol (40: 1) as the eluent to obtain the title compound (49 mg)  (! H, CDC13): 9.76 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J = 1.2 ^ 3.3 Hz), 4.73 (s, 1H, H-l '), 4.12 ^ 13.65 (2d, 2H, 8a- CH2, J = 9.3 Hz) , 3.49 (m, 1H, H-5 '), 3.22 (m, 3H, H-21 and CH2-0), 3.13 (m, 2H, H-31 and H-4'), 2.75 (t, 1H, Hl, J = 3.9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 2.33 (m, 1H, CH(CH3)2) ^(13C, CDC13 ): 204.8 (CHO), 176.0 (C02H), 148.2 (C-3), 130.8 (C-2), 98.0 (C-l')s 77.6 (C-l&amp;quot;), 75.2 (C-4'), 74.3 (8a-CH2), 72.9 (C-3a), 72.6 (C-5'), 65.6 (C-8a), 59.0 (C-4), 54.1 (C-2'), 50.4 (C-3'), 46.4 (C-l), 41.7 (C-4a)41_3 (C-7a) 5 9 [1R-(1 a3a/?4y54a/?7/?7aa ,8a]8a-[(2,3 --6- -4-0-(1---D_ ]-4 --4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1- -1,4 --s -- 3a(lH) - -202- ()  CNS ) A4210X297 3^1644  A7 B7 2q&amp;gt; 71(14020 10%/120 20/23  4 : 1)20 : 1) 13 ^ n, CDC13): 9.74 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J=1.5^3.6 Hz), 4.78 (s, 1H, H-l'), 4.66 (d, 1H, H-4', J=9</span>Hz), 2.33 (m, 1H, CH (CH3) 2); ^ (13C, CDC13): 204.8 (CHO), 176.0 (C02H), 148.2 (C-3), 130.8 (C-2), 98.0 (C -l ') s 77.6 (C-l &amp;quot;), 75.2 (C-4'), 74.3 (8a-CH2), 72.9 (C-3a), 72.6 (C-5 '), 65.6 (C-8a), 59.0 (C-4), 54.1 (C-2 '), 50.4 (C-3'), 46.4 (Cl), 41.7 (C-4a), 41_3 (C-7a). Example 5 9 [1R- (1 a, 3a / ?, 4y5, 4a / ?, 7 / ?, 7aa, 8a)] 8a-[(2,3 -anhydro-6-deoxy-4-0- ( 1-methylethyl) carbonyl-dot-D-piperanmannosyloxy) methyl] -4-carboxyl-4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp;- Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s-indap-3a (lH) -carboxylic acid-202- (please read the notes on the back first Please fill in this page again) Dingben's paper standard uses the Chinese National Standard (CNS) A4 specification (210X297 mm) 3 ^ 1644 Printed by the Ministry of Economic Affairs Central Standards Bureau Employee Consumer Cooperative A7 B7 V. Invention description (2q &amp;gt; To a solution of intermediate 71 (140 mg) in ethyl acetate (20 mL) was added 10% palladium / carbon (120 mg) under nitrogen. This mixture was placed in a Parr device under 20 psi hydrogen pressure Shake at room temperature for 30 minutes. Filter off the catalyst and evaporate the solvent to dryness. Purify the resulting residue on silica gel by flash column chromatography, using hexane: ethyl acetate (4: 1) and methane gas : Methanol (20: 1) was used as the eluent to obtain the title compound (103 mg) as a white foam. ^ n, CDC13): 9.74 (s, 1H, CHO), 6.09 (dd, 1H, H-2, J = 1.5 ^ 3.6 Hz), 4.78 (s, 1H, H-l '), 4.66 (d, 1H, H-4', J = 9</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)4.1(^3.60(2d,2H8aCH2J=9Hz)3.42(dq,lHH-5' J=93 Hz)3.15 (s2HH-2,H-32.78 (m1HH-l) 2.58 (m, 1H, 4'-OCOCHMe2); ci(13C, CDC13): 204.9 (CHO), 176.1, 175.9 (C2H4OCOR)148,2 (C-3)130.9 (C-2) 97.9 (C-l')5 74.5 (C-8aCH2), 72.6 (C-3a), 71.4 (C-4'), 67.8 (C-5)66.0 (C-8a), 59.0 (C-4)18.5 18.8 (2CH3 of 4-OCOCHMe-,) 60 [1R-(1 a3a44a77aor ,8a/3 )]8a-[(2,3--6--4-0-(2,2--0-1)-) ]-4 - _4,4 a, 5,6,7,7a8,8a--7 --3-(1--l4 --s-- 3a(lH)- 72(0.216 10 %/50 20/23  _ -203- CNS )421297 ()   A7 __B7 21) :20 : 1)101 S (!, CDC13) 9.75 (s, 1H, CHO), 6.10 (dd, 1H, H-2, J=1.23.3 Hz)4.80 (s, 1H, -)4.64 (d, 1HH-4'J=9 Hz)4.11&amp;amp;3.70(2d2H8a-CH2,J=9.3Hz),3.43(mlH H-53.13 (m2HH-2,H-3')2.78 (t1HH-lJ = 3.9 Hz), 2.34 (m, 1H, CH(CH3)2); &amp;lt;S(l3C, CDC13): 204.9 (CHO), 177.3&amp;amp;176_5(2xCO2)148.2(C-3)130.9(C-2)98.0(C-)74.5 (8a-CH2)72.6 (C-2)71.3 (C-5)67.9 (C-4)65.7 (C-8a), 59.0 (C-4), 54.3 (C-2'), 50.1 (C-3'), 46.3 (C-l), 41.8 (C-4a), 41.3 (C-8), 38.8 (C^Bu), 32.0 (C-5), 30.9 (C-7), 18.5 (tBu) 6 1 [1R-(1 a3a044ay57/5 ,7aa8a9 )]8a-[(2,3- --6---D- ]-4- -4,4a5,6,7,7a8,8a --7 -- 3- (1--14 --s-p- 3a(lH)- 73(0 .2210 0C0.1  40 : 1)6  ^ U, CDC13) 9.74 (s, 1H, CHO), .31 (m, 5H, Ph), 6.09 (dd1H, H-2, J=1.53.6 Hz)5.20 (m2HC^Ph)475 (s, 1H-)4.55 (d, 1HH-4'J=9 Hz), 4.083.70 (2d2H, _ - 204 - &amp;amp;CNS ) A4210X297 ()</span>Hz), 4.1 (^ 3.60 (2d, 2H, 8aCH2, J = 9Hz), 3.42 (dq, lH, H-5 ', J = 9 and 3 Hz), 3.15 (s, 2H, H-2, and H -3,), 2.78 (m, 1H, Hl), 2.58 (m, 1H, 4'-OCOCHMe2); ci (13C, CDC13): 204.9 (CHO), 176.1, 175.9 (C2H and 4OCOR), 148 , 2 (C-3), 130.9 (C-2), 97.9 (C-l ') 5 74.5 (C-8aCH2), 72.6 (C-3a), 71.4 (C-4'), 67.8 (C-5 '), 66.0 (C-8a), 59.0 (C-4), 18.5 and 18.8 (2CH3 of 4, -OCOCHMe-,). Example 60 [1R- (1 a, 3a ten thousand, 4 lu, 4 a lu, 7 Lu, 7aor, 8a / 3)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2,2-dimethylpropionyl) -0-1) -pipermannose Yloxy) methyl] -4 -carboxamide_4,4 a, 5,6,7,7a, 8,8a-octahydro-7 -methyl-3- (1-methylethyl)- l, 4-Methylene-s-pyridine-3a (lH) -carboxylic acid in a solution of intermediate 72 (0.21 mmol) in ethyl acetate (60 mL) was added 10% under nitrogen Palladium / carbon (50 mg). This mixture was shaken at room temperature for 30 minutes in a Parr device under 20 psi hydrogen pressure. The catalyst was filtered off and the solvent was evaporated to dryness. The residue is analyzed and purified by flash chromatography, using difluoromethane _ -203- The paper size is applicable to the Chinese National Standard (CNS) 84 specifications (21 297 mm) (please read the note  on the back before filling in this Page) A7 __B7 printed by the Beigong Consumer Cooperative of the Ministry of Economic Affairs of the Central Customs Bureau. V. Description of the Invention (21): Methanol (20: 1) as the eluent to obtain the title compound (101 mg). S (! , CDC13): 9.75 (s, 1H, CHO), 6.10 (dd, 1H, H-2, J = 1.2 and 3.3 Hz), 4.80 (s, 1H, -), 4.64 (d, 1H, H-4 ', J = 9 Hz), 4.11 &amp; 3.70 (2d, 2H, 8a-CH2, J = 9.3Hz), 3.43 (m, lH, H-5'), 3.13 (m, 2H, H-2, and H-3 '), 2.78 (t, 1H, Hl, J = 3.9 Hz), 2.34 (m, 1H, CH (CH3) 2); &amp;lt; S (l3C, CDC13): 204.9 (CHO ), 177.3 &amp;amp; 176_5 (2xCO2), 148.2 (C-3), 130.9 (C-2), 98.0 (C-), 74.5 (8a-CH2), 72.6 (C-2), 71.3 (C-5 ,), 67.9 (C-4 ), 65.7 (C-8a), 59.0 (C-4), 54.3 (C-2 '), 50.1 (C-3'), 46.3 (Cl), 41.8 (C- 4a), 41.3 (C-8), 38.8 (C ^ Bu), 32.0 (C-5), 30.9 (C-7), 18.5 (tBu). Example 6 1 [1R- (1 a, 3a0, 4 Lu, 4ay5, 7/5, 7aa, 8a; 9)] 8a-[(2,3-anhydrol-benzyloxycarbonyl-6-deoxy-Lu- D-piperanmannosyloxy) methyl] -4-carboxamide-4,4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3- (1-methyl Ethyl) -1,4-methylidene-sp indica-3a (lH) -chiric acid solution of intermediate 73 (0.22 millimoles) in methane (10 ml) in 0  C with trifluoroacetic acid (0.1 ml). After two hours, the mixture was washed with water and the organic phase was evaporated to dryness. The residue was analyzed and purified by flash chromatography, using methane gas: methanol (40: 1) as the eluent, to obtain the title compound (60 mg)  ^ U, CDC13): 9.74 (s, 1H, CHO) , .31 (m, 5H, Ph), 6.09 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 5.20 (m, 2H, C ^ Ph), 4.75 (s, 1H,  -), 4.55 (d, 1H, H-4 ', J = 9 Hz), 4.08 and 3.70 (2d, 2H, _-204-This &amp;amp; Zhang scale applies to China National Standards (CNS) A4 specification (210X297 Mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 202) 8a-CH2, J=9 Hz)3.47 (m1HH-5')3.283.16 (d, d, 1H 1HH-2,H-3', J=3.6 Hz), 2.79 (t1HH-l, J=3.9 Hz)2.33 (m, 1H, CH(CH3)2); i(13C, CDC13): 204.8 (CHO), 176.4 (C02H), 154.1 (C03), 148.1 (C-3), 134.6 (Cipso), 130.9 (C- 2), 128.8, 128.7, 128.5, 128.4 (Ph), 97.8 (C-l')5 74.5 (8a-CH2), 72.5 (C-3a), 71.6 (C-51), 71.1 (C-4'), 70.3 (CH2Ph), 65.7 (C-8a), 58.9 (C-4), 53.9 (C-2'), 50.0 (C-3')s 46.2 (C-l), 41.7 (C-4a), 41.3 (C-7a) 62 [1R-(1 a3ay544ay57 0 ,7aa8ay5 )]8a-[(2,3--6--4-- -D -]_4__ 4,4a5,6,7,7a8,8a-_7--3-(l--l,4--s --3 a (1 )- 74(0.2630 10//50 25/215  :20 : 1) 3 8 ^ (^, CDC13): 9.72 (s, 1H, CHO), 6.12 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)4.87(slHH-r)4.1(^3.76(2d2H 8aCH2, J=9 Hz)3.83 (q1HH-5'J=6.6 Hz)3.603.38 (d d1H1H32'J=3.9 Hz), 2.82 (t, 1HH-lJ:3.6 Hz) 2.36 (m, 1H, CH(CH3)2) s (13C, CDC13): 204.9 (CHO), _____-205- CNS ) A421x297) ()</span>A7 B7 printed by the Consumer Labor Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of Invention (202) 8a-CH2, J = 9 Hz), 3.47 (m, 1H, H-5 '), 3.28 and 3.16 (d, d, 1H, 1H, H-2, and H-3 ', J = 3.6 Hz), 2.79 (t, 1H, Hl, J = 3.9 Hz), 2.33 (m, 1H, CH (CH3) 2); i (13C , CDC13): 204.8 (CHO), 176.4 (C02H), 154.1 (C03), 148.1 (C-3), 134.6 (Cipso), 130.9 (C-2), 128.8, 128.7, 128.5, 128.4 (Ph), 97.8 (C-l ') 5 74.5 (8a-CH2), 72.5 (C-3a), 71.6 (C-51), 71.1 (C-4'), 70.3 (CH2Ph), 65.7 (C-8a), 58.9 ( C-4), 53.9 (C-2 '), 50.0 (C-3') s 46.2 (Cl), 41.7 (C-4a), 41.3 (C-7a). Example 62 [1R- (1 a, 3ay5,4, 4ay5,7 0, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-4-oxy--D-piran Mannosyloxy) methyl] _4_formyl_4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l-methylethyl)- l, 4-Methylene-s-indap-3a (1 ) -carboxylic acid in a solution of intermediate 74 (0.26 mmol) in ethyl acetate (30 mL) was added 10 under nitrogen  /. Palladium / carbon (50 mg). This mixture was shaken at room temperature for 15 hours at 25 psig hydrogen pressure in a Parr device. The catalyst was filtered off and the solvent was evaporated to dryness. The residue was analyzed and purified by flash chromatography, using methane: methanol (20: 1) as the eluent. The appropriate fraction was collected and evaporated to obtain the title compound (38 mg). ^ (^, CDC13): 9.72 (s, 1H, CHO), 6.12 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.87 (s, lH, Hr), 4.1 (^ 3.76 (2d , 2H, 8aCH2, J = 9 Hz), 3.83 (q, 1H, H-5 ', J = 6.6 Hz), 3.60 and 3.38 (d, d, 1H, 1H, 3' and 2 ', J = 3.9 Hz ), 2.82 (t, 1H, Hl, J: 3.6 Hz), 2.36 (m, 1H, CH (CH3) 2); s (13C, CDC13): 204.9 (CHO), _____- 205- This paper size applies to China National Standard (CNS) A4 specification (21x297 public director) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 ____B7 203) 202.9 (CO-4'), 176.2 (C02H), 148.2 (C-3), 130.9 (C-2), 96.1 (C-), 76.6 (C-5'), 74.7 (8aCH2), 72.1 (C-3a), 65.7 (C-8a), 58.9 (C-4), 54.253.5 (C-2,C-3')46.1 (C-l), 41.8 (C-4a), 41.3 (C_7a) 6 3 [1R-(1 a3a04/?4ay?7/?7aa8ay5 )]8a-[(2,3--4,6--4--b-D--4 - -4,4a5,6,7,7a8,8a--7--3-(l--l4-s'*5-3a(lH)- 101(0.1715 0C0.151 151 1.5C2 20 : 1 24 ( CDC13) 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.2.3Hz)5.2(^5.10(sslHlHCH2=C)4.82(d 1HH-lJ=2.1 Hz)4_42 (m2HH-51 H-4193.56 (d d, 1H, 1H, 8a-CH2, J=9.6 Hz), 3.65 (m, 1H, H-2'), 2.63 (t, 1H, H-l, J=3.9 Hz), 2.36 (m, 1H, CH(CH3)2);  CDCI3): 204.7 (CHO), 175.0 (C02H), 148.5 (C-3), 145,6 (C-4-), 130.5 (C-2), 112.1 (CH2=C), 99.5 (C-l'), 74.0 (8a-CH2), 73.0 (C-572.8 (C-3a)72.271.6 (C-2'C-3 6 4 -206- CNS ) A4210X297 ()</span>Printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economic Affairs A7 ____B7 V. Description of Invention (203) 202.9 (CO-4 '), 176.2 (C02H), 148.2 (C-3), 130.9 (C-2), 96.1 (C -), 76.6 (C-5 '), 74.7 (8aCH2), 72.1 (C-3a), 65.7 (C-8a), 58.9 (C-4), 54.2 and 53.5 (C-2, and C-3 '), 46.1 (Cl), 41.8 (C-4a), 41.3 (C_7a). Example 6 3 [1R- (1 a, 3a0, 4 / ?, 4ay ?, 7 / ?, 7aa, 8ay5)] 8a-[(2,3-anhydro-4,6-dideoxy-4-methylene -BD-piperanmannosyloxy) methyl-4-methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (l- Methylethyl) -l, 4  methylene-s  '* 5 ~ 3a (lH) -carboxylic acid, intermediate 101 (0.17 mmol) in methane (15 ml) The solution was treated with trifluoroacetic acid (0.15 ml) at 0  C. After two hours, treat with water (10 mL). The organic phase was evaporated and the residue was dissolved in ethanol (15 ml) and 1 equivalent of hydrochloric acid (1.5 ml) and stirred at 0  C for 2 hours. The solvent was removed, and the residue was purified using dichloromethane: methanol 20: 1 as the eluent. Evaporate the appropriate fraction to obtain the title compound (24 mg). ( CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.2 .3Hz), 5.2 (^ 5.10 (s, s, lH, lH, CH2 = C), 4.82 (d, 1H, Hl, J = 2.1 Hz), 4_42 (m, 2H, H-51 and H-approximate, 4.19 and 3.56 (dd, 1H, 1H, 8a-CH2, J = 9.6 Hz), 3.65 (m, 1H, H-2 '), 2.63 (t, 1H, Hl, J = 3.9 Hz), 2.36 (m, 1H, CH (CH3) 2);  CDCI3): 204.7 (CHO), 175.0 ( C02H), 148.5 (C-3), 145,6 (C-4-), 130.5 (C-2), 112.1 (CH2 = C), 99.5 (C-l '), 74.0 (8a-CH2), 73.0 (C-5 '), 72.8 (C-3a), 72.2 and 71.6 (C-2' and C-3,). Example 6 4 -206- This paper scale is easy to use China National Standard (CNS) A4 specification ( 210X297mm) (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7 B7 ^^1644 24) [1R-(1 a3a44aA77aa8a/? )]8a-(2,3- --6--b-D-   4_ -4,4a5,6,7,7a,8,8a--7 --3-(1- -1,4 -- s-4- 3a(lH) - 103(0.12 3901 :1 (3 0 40 : 132  ^ (!H, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=1.5&amp;amp;3.6Hz)4.75(dd,lHH-4,J=3.6&amp;amp;4.8Hz),4.68(s, 1H, -), 4.17 (d, 1H, 8a-CHa, J=9.3 Hz), 3.66 (m, 2H, 8a- CHbH-5')3.57 (t, 1H, H-3'J=4.2 Hz), 3_17 (d1HH-2', J=3.6 Hz), 2.73 (t, 1H, H-l, J=3.9 Hz), 2.33 (m, 1H, cll(CH3)2);(y(13CCDCl3 ):204.8(CHO)m.5&amp;amp;175.7(2 XC02), 148.3 (C-3), 130.8 (C-2), 97.9 (C-l'), 74.1 (8a-CH2), 73.0 (C-3a), 71.5 (C-5'), 66.0 (C-4'&amp;gt;, 65.6 (C-8a), 59.0 (C-4), 51_3 (C-2-), 50.7 (C-3 6 5 .</span>A7 B7 ^^ 1644 V. Description of the invention (24) [1R- (1 a, 3a cold, 4 cold, 4aA, 7 Lu, 7aa, 8a /?)] 8a- (2,3-dehydrated - Grade butyl benzyl-6-deoxy-bD-pyrantalosyloxy) methyl  4_ carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7 -Methyl-3- (1-methylethyl) -1,4-methylene-s-4pyridine-3a (lH) -carboxylic acid Intermediate 103 (0.1 mmol) in water (2 Ml) in the solution. Treat with trifluoroacid (3 ml). After 90 minutes, the mixture was poured into ether: water 1: 1 (30 ml). The organic phase was evaporated and the residue was chromatographed and purified using one gas methane: methanol 40: 1 as the eluent to obtain the title compound (32 mg). ^ (! H, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 &amp;amp; 3.6Hz), 4.75 (dd, lH, H-4 ,, J = 3.6 &amp;amp; 4.8Hz), 4.68 (s, 1H, -), 4.17 (d, 1H, 8a-CHa, J = 9.3 Hz), 3.66 (m, 2H, 8a-CHb and H-5 '), 3.57 (t, 1H, H-3 ', J = 4.2 Hz), 3_17 (d, 1H, H-2', J = 3.6 Hz), 2.73 (t, 1H, Hl, J = 3.9 Hz), 2.33 (m , 1H, cll (CH3) 2); (y (13C, CDCl3): 204.8 (CHO), m.5 &amp; 175.7 (2 XC02), 148.3 (C-3), 130.8 (C-2), 97.9 (C -l '), 74.1 (8a-CH2), 73.0 (C-3a), 71.5 (C-5'), 66.0 (C-4 '&amp;gt;, 65.6 (C-8a), 59.0 (C-4), 51_3 (C-2-), 50.7 (C-3,) Example 6 5.</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">[1R-(1 a3a/?4/?4ay577aa8ay5 )]8a-{[2,3 -- 4_ -(-2--6 --b-D-} -4 --4,4a56,7,7a8,8a--7 -- 3-(1- -1,4--s-4-3a(lH)- 47(1035 -207- CNS ) A4210X297 () 11-  A7 B7 205) 100 5050   (2 : 1)1 : 1)50 ( n, CDC13) 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J=l.53.6 Hz), 5.82-5.68 (m1H, C|i=CH)5.62-5.48 (m 1H, CH=CH), 4.72 (s, 1H, -), 4.2-4.1 (m, 2H, O-CHa-C=C8a-CHa), 4.02-3.92 (m, 1H, OCHb-C=C)3.63 (d1H 8a-CHbJ=9.3 Hz), 3.3-3.15 (m3HH-3H-4tU)3.12 (d, 1H, H-2', J-3.9 Hz), 2.73 (t, 1H, H-l, J=3.9 Hz), 1.72 (dd, 3H, H3C-C=C, J=1.26.6 Hz); d(13C, CDC13): 204.8 (CHO)175.6 (C02H)148.2 (C-3), 130.8 (C-2), 131.1  126.6 (0-CH2-C=C-CH3), 97.9 (C-l'), 74.2(8a-CH2), 71.2 (0-H2-C=C-CH3)73.5&amp;amp;72.5(C-4H5') 6 6 WC () [1R-(1 a3ay94y54a77aa8a0 )]8a-(2,3--6-- 4- 0--b-D --4 -_ 4,4&amp;amp;5,6,7,78,8&amp;amp;--7--3-(1-_14--s--3a(lH)- 104 ( 1500.2150 101N1 10 %/30 (pH2 = 3 5/2)3.5 -208- CNS ) A4210X297 321644 26)  : 16 ^ On, CDC13): 9.83 (s, 1H, CHO), 6.06 (dd, 1H, H-2, J-1.2^3.6 Hz), 4.75 (s, 1H, H-l'), 4.44A3.42 (dd, 2H, 8a- CH2, J=9.3 Hz)4.37 (t1HH-31J=2.7 Hz)4.10 (m1H, H-4'), 3.74-3.65 (m, 2H, CH20), 3.91 (m, 1H, H-5'), 3.19 (m, 1H, H 2 ), 2.51 (t, 1H, H-l, J=3.6 Hz);  (13C, CDC13) (CHO), 174.9 (C02H), 148.6 (C-3), 130.4 (-2), 97.9 (C-r)78.7 (C-473.9(8a-CH2)73.3 (CH2)69.8 (c_5 69.3 (C-365.3 (C-8a)59.0 (C-4)54.6 (C-2')47.0 (c-l) o 67 3a44a77aa8ay5 )]8^(2,3_-4--4,6 -_b-D-_4_  4,4a,5,6,7,7a8,8a -.-7--3-(l__ 14 -_s -_3a(1H)_ 106(0.065  c702  3 : 112 ^ CDCI3): 9.73 (s, 1H, CHO), 6.09 (d, 1H, H-2, J&amp;quot;36</span>[1R- (1 a, 3a / ?, 4 / ?, 4ay5, 7 Lu, 7aa, 8ay5)] 8a-{[2,3 -thiazin-4_ - (trans-2-butenyl)- 6 -deoxy-bD-mannanosyloxy)  Feng} -4 -Methyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3 -(1-Methylethyl) -1,4-methylene-s-4, Provincial-3a (lH) -carboxylic acid, and intermediate 47 (103 mg) in methane (5 mL) Solution in . -207- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the notes on the back before filling out this page), 11- A7 printed by the Employee Consumer Cooperative of the Central Standard Falcon Bureau of the Ministry of Economic Affairs B7 5. Description of the invention (205) Treat with trifluoroacetic acid (100 microliters). After one hour, the mixture was separated between ethyl acetate (50 ml) and saturated aqueous sodium sulfate (50 ml). The organic layer was washed with saturated aqueous sodium sulfate, water and brine, then dried and evaporated. The residue was chromatographed twice on silica gel and washed away with hexane: ethyl acetate (2: 1) to (1: 1) to obtain the title compound (50 mg). ( n, CDC13): 9.76 (s, 1H, CHO), 6.08 (dd, 1H, H-2, J = 1.5 and 3.6 Hz), 5.82-5.68 (m, 1H, C | i = CH ), 5.62-5.48 (m, 1H, CH = CH), 4.72 (s, 1H, -), 4.2-4.1 (m, 2H, O-CHa-C = C and 8a-CHa), 4.02-3.92 (m, 1H, OCHb-C = C), 3.63 (d, 1H, 8a-CHb, J = 9.3 Hz), 3.3-3.15 (m, 3H, H-3 ', H-4' and tU), 3.12 (d, 1H, H-2 ', J-3.9 Hz), 2.73 (t, 1H, Hl, J = 3.9 Hz), 1.72 (dd, 3H, H3C-C = C, J = 1.2 and 6.6 Hz); d (13C, CDC13): 204.8 (CHO), 175.6 (C02H), 148.2 (C-3), 130.8 (C-2), 131.1 and 126.6 (0-CH2-C = C-CH3), 97.9 (C- l '), 74.2 (8a-CH2), 71.2 (0-  H2-C = C-CH3), 73.5 &amp;amp; 72.5 (C-4H5'). Example 6 6 Printed by the WC Industrial Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs (please read the note  on the back before filling in this page) [1R- (1 a, 3ay9, 4y5, 4a, 70,000, 7aa, 8a0) ] 8a- (2,3-anhydro-6-deoxy-4-O-propyl-bD-piperanmannosyloxy) methyl-4-carboxyl_4,4 &amp;amp;, 5,6, 7,7 strong, 8,8 &amp;amp; -octaqi-7-methyl-3- (1-methylethyl) _1,4-methylidene-s-pyridine-3a (lH) -carboxylic acid Intermediate 104 (150 mg, 0.21 mmol) in ethanol (50 ml), ethyl acetate (10 ml) and 1N hydrochloric acid (1 ml) was added 10% palladium / carbon (30 mg) under nitrogen ). This mixture was shaken at room temperature for 3.5 hours in a Parr device (pH 2 = 35 psi). Filter out the catalyst and evaporate -208- This paper scale applies the Chinese National Standard (CNS) A4 specification (210X297mm) 321644 V. Description of the invention (26) Remove the solvent to dryness. The residue was chromatographed and purified using two-gas methane: methanol: 1 as the eluent to obtain the title compound (60 mg). ^ On, CDC13): 9.83 (s, 1H, CHO), 6.06 (dd, 1H, H-2, J-1.2 ^ 3.6 Hz), 4.75 (s, 1H, H-l '), 4.44A3.42 ( dd, 2H, 8a- CH2, J = 9.3 Hz), 4.37 (t, 1H, H-31, J = 2.7 Hz), 4.10 (m, 1H, H-4 '), 3.74-3.65 (m, 2H, CH20), 3.91 (m, 1H, H-5 '), 3.19 (m, 1H, H 2), 2.51 (t, 1H, Hl, J = 3.6 Hz);  (13C, CDC13) (CHO), 174.9 (C02H), 148.6 (C-3), 130.4 (-2), 97.9 (Cr), 78.7 (C-4,), 73.9 (8a-CH2), 73.3 (CH2), 69.8 (c_5,) , 69.3 (C-3 '), 65.3 (C-8a), 59.0 (C-4), 54.6 (C-2'), 47.0 (cl) o Example 67 , 30 million, 40 thousand, 4a points, 7 Point, 7aa, 8ay5)] 8 ^ (2,3_anhydro-4-azido-4,6 -dideoxy_bD-pyranomannosyloxy) methyl_4_carboxamyl 4, 4a, 5,6,7,7a, 8,8a -octa-nitrogen-7-methyl-3- (l_methylethyl) _ 1,4-methylene_s-indap province_3a ( 1H) _carboxylic acid A solution of intermediate 106 (0.06 mmol) in methane (5 ml) was treated with trifluoroacetic acid (70 l) at 0 c. After 2 hours, wash with water and medicine. The solvent was evaporated, and the residue was purified by chromatographic analysis, using dichloromethane: Tingting 30: 1 as the eluent to obtain the title compound (12 mg). ^ CDCI3): 9.73 (s, 1H, CHO), 6.09 (d, 1H, H-2, J &amp;quot; 3  6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz)4.73 (s1H, H-l')4.123.67 (dd1H, 1H8a-CH2 93.39((111111-49 112)3.333.17((111 1HH-2'H-3J=3.6 Hz)3.22 (m, 1HH-5)2.76 (t, l11 -209 CNS ) A4210X 297 ()   !  A7 B7 27) H-l, J=3.6 Hz), 2.34 (m, 1H, CH(CH3)2); ^(13C, CDC13): 205.1 (CHO), 175.3 (C02H), 148.4 (C-3), 130.8 (C-2), 97.8 (C-l'), 74.6(8a-CH2), 72.7 (C-5'), 68.0 (C-3a), 65.7 (C-8a), 59.0 (C-4), 58.7 (C-4'), 54.4 (C-2'), 50.1 (C-3'), 46.3 (C-l) o 6 8 [1R-(1 a3a44ay5 ,7y5 ,7aa8a5 )]8a-[(4-0--2,3 --6-- b- D-&amp;gt;-]-4 - 4,4a5,6,7,7a8,8a--7--3(l--l4--s-II5-3a(lH)- 107(250100.2 C4 5 0 : 1 140 e GhCDC13): 9.77 (s1HCHO)6.08 (dd1HH-12 J=1.23.3 Hz)5.90 (m, 1H, CH=CH2)5.28 (m, 2H, CH=CH2), 4.75 (s, 1H, H-l'), 4.28 (m, 1H, H-5'), 4.21 (d,  () 1H, H-19a, J=9.6 Hz), 4.05 (m, 1H, H-4'), 4.05 (m, 1H, H-4'), 3.60 (d, 1H, H-19b, J=9.6 Hz), 3.27, 3.14 (d, d, 1H, 1H, H-2', H-3J=3.9 Hz)3.25 (m2H, Cii2-CH=CH2)2.68 (t, 1H H-ll, J=4.2 Hz); c^(13C, CDC13): 205.07 (CHO), 174.6 (C2H), 148.4 (C-13), 133.7 (CH=CH2), 129.7 (C-12), 118.0 (CH2=CH), 97.8 (C-), 74.17 (C-19), 74.04 (C-4'), 72.5 (C-5'), 71.0 (0-CH2-CH=CH2), 54.1 (C-2'), 50.2 (C-3'), -210- CNS ) A4210X297  A7 B7 28) 27.5 (C-14), 22.7 (C-20), 21.2 (C-15), 18.6 (C-6'), 17.4 (C-17) 69 [111-(1^3&amp;amp;44379,7&amp;amp;8&amp;amp;/?)]8&amp;amp;-[(2,3--6--4-0--b-D-- ]-4_ -4,45,6,7,7&amp;amp;8,83--7--3-(1- -1,4 -- s- _3a(iH) - 21(20015THF (30C3 260 3  5 : 1 140  (]H, CDC13): 9.74 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J=l_53_9 Hz), 4_74 (s, 1H, H-l1)4.21 (dd1H, H-4J=3.6 &amp;amp;6.0Hz),4.16(dlHH-19aJ=9Hz),4.12(s2HC||2 C02C(CH3)3), 3.63 (d, 1H, H-19b, J=9 Hz), 3.36, 3.14 (d, d, 1H, 1H, H-2', H-3', J=3.9 Hz), 3.30 (m, 1H, H-5'), 2.71 (t, 1H, H-ll, J=3.9 Hz); S (13C, CDC13): 205.7 (CHO), 174.9 (C02C(CH3)3), 168.8 (C02H), 148.4 (C-13), 130.8 (C-12), 97.8 (C-), 82.2 (C(CH3)3), 75.6(C-4'), 72.4 (C-5'), 68.2 (OCH2-CO), 59.0 (C-3), 53.9 (C-2'), 50.3 (C-3'), 27.5 (C- 14)22.7 (C-20)21.2 (C-15), 18.6 (C-6')17.4 (C-17) 211 - CNS ) A4210X297 ()   A7 B7 29) 70 [1R-(1 a3a4 04a7y9,7aQ^,8a/3)]8a-[(2,3--6_ _4-0--b-D-_]_4_ -4,4&amp;amp;5,6,7,7&amp;amp;8,8--7_-3_(1--14--s-M_3a(lH)- 21(2905 0C25 30116 1   50 : 1180 .   ^ (lU, CDC13): 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-l2 J=3.3 Hz), 4.73 (s, 1H, H-l'), 4.16 (d, 1H, H-19a, J=9 3.78, 3.54 (mm, 1H1H0-Cii2-CH3)3.63 (s;HH l9: J=9.3 Hz), 3.25, 3.13 (d, d, 1H, 1H, H-2', H-3', j=3 9 3.19 (m2HH-4H-52.71 (t1HH-llj=3 3 h HZ) (13CCDC13): 201.8 (CHO)175.0 (C02H)148.2 (^i3^ 130.7 (C-12)97.9 (C-l74.6(C-474.3 (C_19)72 5  5'), 54.3 (C-2'), 50.3 (C-3'), 27.5 (C-14), 22.7 (0-20^2 (C-15), 18.6 (C-6')17.4 (C-17)   7 1 [1R-(1  ,3&amp;amp; ,4 ,4a^ ,1  ,7a or ,8ay3 ) 1 8 a -  r ?  L3 --6 - 212- CNS ) A4210X297 (1f)</span>Hz), 4.73 (s, 1H, H-l '), 4.12 and 3.67 (d, d, 1H, 1H, 8a-CH2, Bu 9 called, 3.39 ((1, 111, 11-4, Bu 9 112 ), 3.33 and 3.17 ((1,  1, 1 , 1H, H-2 'and H-3', J = 3.6 Hz), 3.22 (m, 1H, H-5 '), 2.76 (t, l11 , -209 The private paper size is free to use the Chinese National Standard (CNS) A4 specification (210X 297mm) (please read the notes on the back before filling this page) Order nine! Printed by the Beigong Consumer Cooperative of the Ministry of Economic Affairs A7 B7 5. Description of the invention (27) Hl, J = 3.6 Hz), 2.34 (m, 1H, CH (CH3) 2); ^ (13C, CDC13): 205.1 (CHO), 175.3 (C02H), 148.4 (C-3), 130.8 (C-2), 97.8 (C-l '), 74.6 (8a-CH2), 72.7 (C-5'), 68.0 (C-3a), 65.7 (C-8a), 59.0 (C-4), 58.7 (C-4 '), 54.4 (C-2'), 50.1 (C-3 '), 46.3 (Cl) o Example 6 8 [1R- (1 a, 3a, 4 Point, 4ay5, 7y5, 7aa, 8a; 5)] 8a-[(4-0-allyl-2,3-dehydrate-6-deoxy-b-D- &amp;gt; mannan glycosyl) oxygen -Methyl] -4  methylamino-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3  (l-methylethyl) -1,4 -Methylene-s-II5-da-3a (lH) -carboxylic acid, intermediate 107 (250 mg) in 10 ml di The solution in a mixture of methane and 0.2 ml of trifluoroacetic acid was stirred at 0  C for 4 hours. The crude material was evaporated to dryness, and the residue was purified by flash chromatography. It was washed away with methane: methanol 50: 1. Preparation, to obtain 140 mg of the title compound as a white foam. E Gh, CDC13): 9.77 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J = 1.2 and 3.3 Hz), 5.90 (m, 1H, CH = CH2), 5.28 (m, 2H, CH = CH2), 4.75 (s, 1H, H-l '), 4.28 (m, 1H, H-5'), 4.21 (d, Ministry of Economic Affairs Central Standard Printed by Bureau Cooper Consumer Cooperative (please read the notes on the back before filling in this page) 1H, H-19a, J = 9.6 Hz), 4.05 (m, 1H, H-4 '), 4.05 (m, 1H, H-4 '), 3.60 (d, 1H, H-19b, J = 9.6 Hz), 3.27, 3.14 (d, d, 1H, 1H, H-2', H-3, J = 3.9 Hz), 3.25 (m, 2H, Cii2-CH = CH2), 2.68 (t, 1H, H-ll, J = 4.2 Hz); c ^ (13C, CDC13): 205.07 (CHO), 174.6 (C2H), 148.4 (C-13), 133.7 (CH = CH2), 129.7 (C-12), 118.0 (CH2 = CH), 97.8 (C-), 74.17 (C-19), 74.04 (C-4 '), 72.5 (C-5 '), 71.0 (0-CH2-CH = CH2), 54.1 (C-2'), 50.2 (C-3 '), -210- This paper scale uses the Chinese National Standard (CNS) A4 specifications (210 X297 mm) A7 B7 printed by the Beigong Consumer Cooperative of the Central Bureau of Standards of the Ministry of Economy V. Description of Invention (28) 27.5 (C-14), 22.7 (C-20), 21.2 (C-15), 18.6 (C -6 '), 17.4 (C-17). Example 69 [111- (1  ^, 3 &amp;amp; Lu, 4, 43 Lu, 7; 9,7 &amp;amp; , 8 &amp;amp; /?)] 8 &amp;amp;-[(2,3-anhydro-6-deoxy- 4-0-tertiary butoxycarbonylmethyl-bD-piperanmannosyl) oxy-methyl] -4_carboxyl-4,4 also, 5,6,7,7 &amp;amp;, 8,83- Octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-s--soda_3a (iH) -carboxylic acid in intermediate 21 (200 mg) in To a solution in 15 ml of anhydrous THF at 0  (: add 30 mg of sodium hydride. This mixture was stirred at 0  C under nitrogen for 30 minutes. Then 260 l of tertiary butyl bromoacetate was added and this mixture was added at Stir at room temperature for 3 days under nitrogen. The crude material is treated with equivalent vaporized ammonium and ethyl acetate. The organic layer is washed with water and brine and evaporated to dryness. The residue is hydrogenated by standard methods and the crude material is purified by flash chromatography , Using two gas methane: methanol 50: 1 as the eluent, to obtain 140 mg of the title compound as a white foam.  (] H, CDC13): 9.74 (s, 1H, CHO), 6.08 (dd, 1H , H-12, J = l_5 and 3_9 Hz), 4_74 (s, 1H, H-l1), 4.21 (dd, 1H, H-4 ,, J = 3.6 &amp; 6.0 Hz), 4.16 (d, lH, H-19a, J = 9Hz), 4.12 (s, 2H, C | | 2  C02C (CH3) 3), 3.63 (d, 1H, H-19b, J = 9 Hz), 3.36, 3.14 (d, d, 1H, 1H, H-2 ', H-3', J = 3.9 Hz), 3.30 (m, 1H, H-5 '), 2.71 (t, 1H, H-ll, J = 3.9 Hz); S (13C, CDC13): 205.7 (CHO), 174.9 (C02C (CH3) 3), 168.8 (C02H), 148.4 (C-13), 130.8 (C-12), 97.8 (C-), 82.2 (C (CH3) 3), 75.6 (C-4 '), 72.4 (C- 5 '), 68.2 (OCH2-CO), 59.0 (C-3), 53.9 (C-2'), 50.3 (C-3 '), 27.5 (C-14), 22.7 (C-20), 21.2 ( C-15), 18.6 (C-6 '), 17.4 (C-17).  211-This paper size is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the notes on the back before filling in This page) Order the A7 B7 printed bag of the Beigong Consumer Cooperative of the Central Kneading Bureau of the Ministry of Economy V. Description of the invention (29) Example 70 [1R- (1 a, 3a point, 4 0, 4a, 7y9, 7aQ ^, 8a / 3)] 8a-[(2,3-anhydro-6_deoxy_4-0-ethyl-bD-piperanmannosyl) oxy_methyl] _4_carmidyl-4,4 &amp;amp; , 5,6,7,7 &amp;amp;, 8,8-octahydro-7_methyl-3_ (1-methylethyl) -1,4-methylene-sM Shuda province_3a (lH) -Add a few acids to a solution of intermediate 21 (290 mg) in 5 ml of anhydrous dimethylformamide at 0C under nitrogen and add 2 5 mg sodium hydride. Place this mixture at 0. After stirring for 30 minutes, 1 millimolar ethyl iodide was added. The reaction was complete after stirring at room temperature for 16 hours. The crude product was treated with 1 equivalent of gasified ammonium and ethyl acetate. The organic layer was washed with water and brine, and evaporated to dryness on anhydrous magnesium sulfate. The residue was hydrogenated by standard methods, and the crude product was further purified by flash chromatography. Using dimethanol 50: 1 as the eluent, 180 mg of the title compound was obtained. Horse white foam. ^ (lU, CDC13): 9.73 (s, 1H, CHO), 6.08 (dd, 1H, H-l2 J = 3.3 Hz), 4.73 (s, 1H, H-l '), 4.16 (d, 1H, H -19a, J = 9 3.78, 3.54 (m, m, 1H, 1H, 0-Cii2-CH3), 3.63 (s ,; H, H l9 :, J = 9.3 Hz), 3.25, 3.13 (d, d, 1H, 1H, H-2 ', H-3', j = 3 9 3.19 (m, 2H, H-4 ,, H-5,), 2.71 (t, 1H, H-ll, j = 3 3 h HZ) '(13C, CDC13): 201.8 (CHO), 175.0 (C02H), 148.2 (^' i3 ^ 130.7 (C-12), 97.9 (C-l '), 74.6 (C-4,), 74.3 ( C_19), 72 5, 5 '), 54.3 (C-2'), 50.3 (C-3 '), 27.5 (C-14), 22.7 (0-20 ^ 2 (C-15), 18.6 (C- 6 '), 17.4 (C-17).' Example 7 1 [1R- (1 , 3 &amp;amp; , 4, 4a ^, 1 , 7a or, 8ay3) 1 8 a- r? L3- Dewatering-6-212- Apparel paper size applies to China National Standard (CNS) A4 specification (210X297mm) (please read note 1f on the back before filling in this education)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> ^21644 at B7 2 - 4- 0- (2,3 --b-D -_ ]]4 --44a,5,6,7,7a,8,8a--7 --3-( -1,4--s-_3a(lH)- 108(7001 10%/350 (pH2 = 25/2)i  25 : 1)425 50 : 50 CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J=1.2&amp;amp;3.6Hz)4.73(slHH-r)3.98(dlHH-19aJ=9.6</span>Printed by Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs ^ 21644 at B7 5. Description of the invention (2, deoxy-4-0- (2,3-dihydroxypropyl) -bD-pipermannosyl) oxy Yl_methyl]]  4-methylformyl-4,4a, 5,6,7,7a, 8,8a-octahydro-7-methyl-3- (p-methylethyl) -1,4-methylene To a solution of methyl-s--da provincial_3a (lH) -carboxylic acid in intermediate 108 (700 mg) in ethanol (100 mL) was added 10% palladium / carbon (350 mg) under nitrogen . This mixture was shaken at room temperature for 1 hour in a Parr device (pH 2 = 25 psi). The catalyst was filtered off and the solvent was evaporated to dryness. The residue was purified on a silica gel column, using methane and methane: methanol (25: 1) as the eluent to prepare 425 mg of the title compound (50:50 isomer mixture) as a white powder. CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J = 1.2 &amp;amp; 3.6Hz), 4.73 (s, lH, Hr), 3.98 (d, lH, H-19a, J = 9.6</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Hz), 3.81 (d, 1H, H-19b, J=9.6 Hz), 3.81-3.68 (m, 2H,-OCi^-CHOH in C-4'), 3.55-3.31 (m, 3H, -CHOH-CI^OH in C-4'), 3.30-3.11 (m, 4H, H-2', H-3', H-4', H-5'), 2.76 (t, 1H, H-ll, J=3.6 Hz); d(13C, CDC13): 207.70 (CHO), 178.2 (C02H)150.49 (C-13)131.44 (C-12)99.81 (C-l1)77.07 76.96 (CH-CH2OH in C-4'), 76.57 (C-19), 73.55 (C-4'), 72.8672_69 (O-C^-CHOH in C-472.24 (C-555.01 (C-31), 51.89 (C-21), 23.2 (C-20), 21.6 (C-15), 19.4 (C-61), 17.9 (C-17) 72 [1R-(1 a3a/? ,44a/? ,7y5 ,7aa8a]8a-[(2,3--6--4-0-(2,3--b-D--]-4 --4,4a,5,6,7,7a8,8a--7--3-(l- -213- CNS ) A4210X297 (</span>Hz), 3.81 (d, 1H, H-19b, J = 9.6 Hz), 3.81-3.68 (m, 2H, -OCi ^ -CHOH in C-4 '), 3.55-3.31 (m, 3H, -CHOH- CI ^ OH in C-4 '), 3.30-3.11 (m, 4H, H-2', H-3 ', H-4', H-5 '), 2.76 (t, 1H, H-ll, J = 3.6 Hz); d (13C, CDC13): 207.70 (CHO), 178.2 (C02H), 150.49 (C-13), 131.44 (C-12), 99.81 (C-l1), 77.07 and 76.96 (CH-CH2OH) in C-4 '), 76.57 (C-19), 73.55 (C-4'), 72.86 and 72_69 (OC ^ -CHOH in C-4,), 72.24 (C-5,), 55.01 (C-31 ), 51.89 (C-21), 23.2 (C-20), 21.6 (C-15), 19.4 (C-61), 17.9 (C-17). Example 72 [1R- (1 a, 3a / ?, 4, 4a / ?, 7y5, 7aa, 8a)] 8a-[(2,3-anhydro-6-deoxy-4-0- (2, 3-dimethoxypropyl) -bD-piperanmannosyl) oxy-methyl] -4-carboxyl-4,4a, 5,6,7,7a, 8,8a-octahydro- 7-Methyl-3- (l- -213- This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (210X297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 __B7_ 211) -14--s-- 3a(lH)- 108 (350THF(20 0C4030 0.5 21  50 : 50 225 (lU, CDC13) 9.75 (s, 1H, CHO), 6.08 (d, 1H, H-12, J=3.3 Hz), 4.73 (d, 1H, H-l', J=1.5 Hz), 4.18 (d, 1H, H-19b, J=9 Hz)3.62 (d1H, H-19b, J=9 Hz)3.483.47 (s, s3H 3HCH2OMe, CHOMe), 3.36-3.20 (m, 4H, H-2', H-3', H-4', H-5'), 2.70 (t, 1H, H-ll, J=3.6 Hz); S3C, CDC13 ): 205.2 (CHO), 174.7 (C02H), 148.4 (C-ll), 130.7 (C-12), 97.9 (C- ), 79.0 (QHOMe in C4')75.675.7 (C-4)72.4 (C-5') 71.6&amp;amp;71.5(gH2-CHOMeinC_4i),70.1&amp;amp;69.8(-H2OMe in C-4)59.2, 57.957.8 (_CHOMe-CH7OMe in C-4) 53.950.2 (C-21 &amp;amp;C-322.7(C-20)21.2(C-15)18.6(C-6-)17.4 (C-17) 7 3 [1R-(1 a3a^44a 707aa,8ay5 )]8a-[(2,3--6--4-0-[(2,3-0--2,3-]-b-D- -]-4 --4,4a56,7,7a,8,8a--7--3-(1--1,4--s-- ___-214-__ CNS ) A4210X297 ()</span>A7 __B7_ printed by the Beigong Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economic Affairs 5. Description of the invention (211) Methyl ethyl) -1,4-methylene-s-indap province- 3a (lH) -carboxylic acid in the middle To a solution of 108 (350 mg) in anhydrous THF (20 ml) was added sodium hydride (40 mg) at 0  C under nitrogen, and the mixture was stirred for 30 minutes. Then methyl iodide (0.5 ml) was added, and the mixture was stirred at room temperature for 2 days to react. The crude product was treated with 1 equivalent of gasified ammonium and ethyl acetate. The organic layer was washed with water and brine, and evaporated to dryness. The residue was hydrogenated by standard methods, and the title compound (50:50 isomer mixture) was obtained as a white foam (225 mg) without purification as before. (lU, CDC13): 9.75 (s, 1H, CHO), 6.08 (d, 1H, H-12, J = 3.3 Hz), 4.73 (d, 1H, H-l ', J = 1.5 Hz), 4.18 ( d, 1H, H-19b, J = 9 Hz), 3.62 (d, 1H, H-19b, J = 9 Hz), 3.48 and 3.47 (s, s, 3H, 3H, CH2OMe, CHOMe), 3.36-3.20 (m, 4H, H-2 ', H-3', H-4 ', H-5'), 2.70 (t, 1H, H-ll, J = 3.6 Hz); S3C, CDC13): 205.2 (CHO), 174.7 (C02H), 148.4 (C-ll), 130.7 (C-12), 97.9 (C-), 79.0 (QHOMe in C, 4 '), 75.6 and 75.7 (C-4,), 72.4 (C-5 '), 71.6 &amp;amp; 71.5 (gH2-CHOMeinC_4i), 70.1 &amp;amp; 69.8 (- H2OMe in C-4,), 59.2, 57.9 and 57.8 (_CHOMe and -CH7OMe in C-4,) , 53.9 and 50.2 (C-21 &amp; C-3,), 22.7 (C-20), 21.2 (C-15), 18.6 (C-6-), 17.4 (C-17). Example 7 3 [1R- (1 a, 3a ^, 4 Lu, 4a Lu, 70, 7aa, 8ay5)] 8a-[(2,3-anhydro-6-deoxy-4-0-[(2,3 -0-isopropylidene) -2,3-dihydroxypropyl] -bD-piperanylmannosyl) oxy-methyl] -4-methylacyl-4,4a, 5,6,7, 7a, 8,8a-octahydro-7-methyl-3- (1-methylethyl) -1,4-methylidene-s-indap-___- 214 -__ This paper size applies to China Standard (CNS) A4 specification (210X297mm) (Please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">A7</span>A7</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> 3a(lH)- 109(25050 10%/1 pH2 20/2)i  1 : 15: 1 5 0 : 5 015  (!11, CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J=l.53.6 Hz)4.71 (d1H-J=.9 Hz)4.29-4.24 (m 1H, CHOH in 4'), 4.15-4.01 (m, 3H, H-19a^-OCH2), 3.82- 3.49 (m, 4HH-19bOC^-CHOH-C^O), 3.293.13 (dd 1H1HH-2H-3J=3.9 Hz)3.27-3.18 (m2HH-4iH_ 5')2.74 (t1HH-llJ=3.6 Hz)1.41  1.35 (d, d3H, 3H, CH3)2C); (J(13C, CDC13): 204.8 (CHO)165.7 (CO2H)148.2(C-ll)130.8(C-12)97.9(C-l75.7&amp;amp;75.6 (-gHO-CH2OinC-474.4(C-472.8&amp;amp;72.4(C-5')72.0&amp;amp; 71.6 (0-H2-0 in C-41)54.053.8 (C-350.3 (C-21)22.6 (C-20), 21.1 (C-15)18.6 (C-61)17.4 (C-17) 74 IMI 362184 IMI 362184 ATCC 36386, NRRL 3196) N----N- IMI 362184 1162,027NRRL 3196IMI 362184 -215- 4^210297 ()</span>The Ministry of Economic Affairs Central Bureau of Samples and Services Zhengong Consumer Cooperative printed 3a (lH) -carboxylic acid in a solution of intermediate 109 (250 mg) in ethyl acetate (50 mL) and added 10% palladium / carbon ( 100 mg of this mixture was shaken at room temperature for 1 hour in a Parr device (pH 2 20 hours / pair 2). The catalyst was filtered off and the solvent was evaporated to dryness. The residue was purified by flash chromatography analysis using n-hexane: acetic acid Ethyl acetate 1: 1 and methane gas: methanol 50: 1 as the eluent to prepare the title compound (50:50 isomer mixture) (15 mg) as a white foam.  (! 11 , CDC13): 9.75 (s, 1H, CHO), 6.08 (dd, 1H, H-12, J = 1.5 and 3.6 Hz), 4.71 (d, 1H, -, J = 0.9 Hz) , 4.29-4.24 (m, 1H, CHOH in 4 '), 4.15-4.01 (m, 3H, H-19a ^ -OCH2), 3.82- 3.49 (m, 4H, H-19b, OC ^ -CHOH-C ^ O), 3.29 and 3.13 (d, d, 1H, 1H, H-2 'and H-3', J = 3.9 Hz), 3.27-3.18 (m, 2H, H-4iH_5 '), 2.74 (t, 1H, H-ll, J = 3.6 Hz), 1.41 and 1.35 (d, d, 3H, 3H, isopropylidene (CH3) 2C); (J (13C, CDC13): 204.8 (CHO), 165.7 ( CO2H), 148.2 (C-ll), 130.8 (C-12), 97.9 (C-l ' , 75.7 &amp;amp; 75.6 (-gHO-CH2OinC-4 '), 74.4 (C-4'), 72.8 &amp;amp; 72.4 (C-5 '), 72.0 &amp;amp; 71.6 (0-  H2-0 in C-41) , 54.0 and 53.8 (C-3,), 50.3 (C-21), 22.6 (C-20), 21.1 (C-15), 18.6 (C-61), 17.4 (C-17). Example 74 IMI 362184 Characteristic IMI 362184 is a variant of D. arachnidus (ATCC 36386, NRRL 3196), and the ascospores of this strain are isolated after N-methyl-'-nitro-N-nitrosoguanidine. IMI The characteristics of 362184 are basically similar to the description of British Patent No. 1,162,027 on NRRL 3196, except that IMI 362184-215- The paper size is applicable to the Chinese National Standard ( Can) 8 4 ^ Luo (210 to 297 mm) ( (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> A7 B7 213) NRRL 3196 4- 7 5 IMI 362947 IMI 362947ATCC 36386, NRRL 3 196) N--N--N- IMI 362947 1162,027NRRL3196IMI 362947 NRRL 3196 NRRL 3 196 7 6 NCIMB 40675 NCIMB 40675 ' 28 C2 %(/ 4 8 .5_1 37C45C &amp;amp; &amp;amp; _ D_D_p -D_\ D - D- ^ NCIMB 406752,6 -216- CNS ) A4^2I0X297 () - 321644 A7 B7 214)  12 - 14 -14 - - - -ncimb 40675 Curtobacterium NCIMB 4067516S rRNA 110024 NCIMB 40675 Curtobacterium   CurtobacteriumrRNA  1    ()   Crosscarmellose sodium  .  100' 160' 20 ' 5 \ crosscarmellose sodium^^ -217- CNS ) A420X297  ^1644</span>Printed by the Beigong Consumer Cooperative of the Central Standardization Bureau of the Ministry of Economic Affairs A7 B7 V. Description of Invention (213) Compared with NRRL 3196, it produced more 4-demethyl sodarin for the production of sodaline under the same conditions. Example 7 5 Features of IMI 362947 IMI 362947 is a variant of D. arachnidus (ATCC 36386, NRRL 3 196), the ascospores of this strain are N-methyl-N, -nitro-N-nitrosoguanidine mutagenized It is separated afterwards. The characteristics of IMI 362947 are basically similar to those described in British Patent No. 1,162,027 for NRRL3196, except that IMI 362947 does not produce ascospores on agar. This strain differs from NRRL 3196 in that it produces more sodaline than NRRL 3 196 under the same conditions. Example 7 6 NCIMB 40675   NCIMB 40675 is aerobic 'Gram-positive, immobile irregular rods' in 28  C in 2% (weight / volume) yeast trypsin soybean At 48 hours of agar, lemon yellow, translucent, round, complete, raised, 0.5 mm in diameter colonies were produced. This microorganism grows well up to 37C, but it does not grow better than this strain at 45  C. There are no metachromatic particles, but it is catalase-positive, oxidative, and cannot metabolize glucose by fermentation. This strain can use the following carbon sources: _D_glucose, D_fruit sugar, p-hydroxyphenylacetic acid, D_mannose, methyl \ pyruvate, lactamide, D-trehalose and sucrose . This microorganism can only use a little D-gluconate, pyruvate, and salicin as the main carbon source. The colony and microscope morphology are similar to Corynebacterium ^ The difference with Corynebacterium is that the peptidoglycan of NCIMB 40675 contains ornithine instead of 2,6  diaminopimelic acid or -216- This paper size is applicable Chinese National Standard (CNS) A4 ^ grid (2I0X297mm) (Please read the precautions on the back before filling in this page), - 321644 A7 B7 V. Description of the invention (214) The racemic difference of monoaminobutyric acid Structure. Moreover, this microbial-containing complex mixture of fat and acid is also different from that contained in coryneform bacteria, namely 12-methyltetradecanoic acid, 14-methylhexadecanoic acid and 14-methylpentadecanoic acid. No alpha-branched-A-hydroxylated fatty acids were also detected. Based on these results, ncimb 40675 is closest to the following species of Actinomyces: Aureobacillus, Curtobacterium, or Cellulomonas. To clarify the taxonomic position of NCIMB 40675, the 1100 base pair portion of the 16S rRNA gene is compared with 24 other species representing Actinobacteria and related genera. The results of this analysis show that NCIMB 40675 is more closely related to the genus Staphylococcus aureus and Curtobacterium, but farther away from the genus Cellulomonas and the genus Corynebacterium. For more accurate confirmation of this strain, in addition to more chemical taxonomy and physiology tests, phylogenetic analysis can be performed to compare the rRNA genes of various regions of Chrysanthemum aureus and Curtobacterium. Example of traditional medicine 1  Traditional oral lozenge medicinal ingredients (please read the precautions on the back before filling in this page) The Ministry of Economic Affairs Central Standards Bureau Beigong Consumer Cooperatives printed microcrystalline cellulose Crosscarmellose sodium magnesium stearate. Crystalline cellulose. Magnesium fatty acid is blended and then pelletized. 100'160mg ', 20mg' 5mg \ crosscarmellose sodium ^^ -217- This paper is based on the Chinese National Standard (CNS) A4 specification (2  0X297mm) Beicong consumption of the Central Standard Rating Bureau of the Ministry of Economic Affairs Cooperative printing ^ 1644</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">215) 2    100  865  5  10  15  at        100   150   1   2   10   5   800      5  pHS  ()</span>V. Description of the invention (215) 2  Chewable oral tablet medicinal ingredients 100 mg xylitol 865 mg peppermint flavoring agent 5 mg asparagine methyl ester 10 mg polyethylene bispyridine 15 mg stearic acid Magnesium at blends the pharmaceutical ingredients' xylitol, aspartame and polyvinylpyrrolidine together, granulates with water, and then dries. The granules are mixed with peppermint flavor and magnesium stearate and then beaten into tablets. Oral water solution medicinal ingredients 100 mg hydroxypropyl methylcellulose 150 mg sodium hydroxypropyl benzoate 1 mg sodium hydroxybenzoate 2 mg ritual and bridge flavor 10 mg sodium saccharin 5 mg sucrose 800 mg suitable buffer appropriate amount of purified water is added to Dissolve the pharmaceutical ingredients and all excipients in most purified water in 5 ml and mix. Make the required volume and mix. A suitable buffer can be added to control the pHS maximum stability. (Please read the notes on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">321644 A7 B7 21)   100   50   25   800   10   5   5_   200  9800   (^^)   6.   4 0        0  pH -219- CNS ) 4( 210X297</span>321644 A7 B7 V. Description of the invention (21) Non-aqueous oral suspension medicinal ingredients 100 mg propyl methyl cellulose 50 mg grape flavoring agent 25 mg mannitol 800 mg colloidal silica 10 mg surplus coconut oil 5 Milliliters disperse the drug ingredients and mannitol in most coconut oil by high shear mixing method. Add remaining ingredients and mix. Also add coconut oil to the required volume and mix. 5_ ointment medicinal ingredients 200 mg white soft paraffin 9800 mg melted white soft stone, add medicinal ingredients and mix. Continue mixing until it forms a paste. (Please read the note ^^ on the back and then fill out this page)  Printed by the Employee Consumer Cooperative of the Central Standards Bureau of the Ministry of Economic Affairs 6. Injectable medicinal ingredients 40 mg suitable buffer appropriate amount suitable antioxidant appropriate amount suitable chelating agent appropriate amount water for injection plus To 0 Beijing will dissolve the drug ingredients in most of the water for injection. An appropriate buffer can be added to control the pH within the appropriate stability range. Appropriate antioxidants and chelate can be added -219- This paper scale is applicable to China National Standard (CNS) 4 specification (210X297mm</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">V  321644 A? B7 217)    -220- CNS ) A4210X 297 ()</span>V Printed by the Staff Consumer Cooperative of the Central Bureau of Economic Development of the Ministry of Economy 321644 A? B7 V. Description of the invention (217) Mixture to increase the stability of the injection. Add to the required amount with water for injection. Fill into ampoules or vials and autoclave. Alternatively, filter sterilize and put it in an antelope or vial under aseptic conditions. -220- This paper scale is applicable to China National Standard (CNS) A4 specification (210X 297mm) (please read the precautions on the back before filling this page)</span>
  </p>
  <span class="patent-image-not-available style-scope patent-text"></span>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">321644</span>321644</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Sord. NT</span>Sord. NT</span>
  </p>
  <p class="style-scope patent-text">
    <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">Attondsnsn 2867E 2376E 12375E I2371 12808 14711  2402E 2005 1208E   &amp;gt;125 3T.OO ' 31.00 0.060 1.000 0,250 j 0.500 0,120 0.500   8.00 3LOO 31.00 0.004  0.004 0.008 0,001 0.008 03  0.500 8.00 8.00 0.008 0.120 0.015 0.015 0.008 0.015   31.00 16.00 8.00 1 0.060 16.00 | 0.030 0.060 0.015 0.030   1.00 B.00 . &amp;lt;0.001 0.008 0.001 0.001 0,001 0.001   0.250 0.500 0.500 0.004 1  | 0.008 ' 1 1_ I &amp;lt;0.001 &amp;lt;0.001 &amp;lt;0.001 &amp;lt;0.001   '&amp;lt;0.250 I j 1.000 I 1.000 &amp;lt;0-001 0,150  00 0.001 0,001 U)  &amp;lt;0.250 1 6.00 4.00 0.060 0.500 0.030 0.060 | 0.001 j 0.060   2_001 4.00 | 4,00 &amp;lt;0.001 0.500 0.001 j 0.001 ' I | 0.001 0.001   &amp;gt;125 16.00 1G.00 I 0.008 0.500 1_ I 0.120 0.120 0.030 0.120   1.00 B.00 8.00 0.001 0.030 I _J | 0.004 0.008 0.001 0.004 Cn ro  2,00 8.00 3.00 &amp;lt;0.01 &amp;lt;.| &amp;lt;0.001 ^ .001 &amp;lt;0.001    Mol  16.0 6.0 0.015 0.015 0.002 0.008 001 0.015   g 31.00 1 31.00 I 0.015 0.250 0.030 0.002 0.050 0.060 CD 03  &amp;gt;125 &amp;gt;125  &amp;gt;125  cn   CP  Sord. 841122594_+^^^_(85  125g/mlj</span>Attondsnsn Cryptococcus neoformans 2867E Candida group 2376E 1 Candida group 2375E I Candida pseudotropicalis 2371E 1 Candida tropicalis 2808E 1 Candida albicans 4711 Candida albicans 2402E Candida albicans 2005E Candida albicans 1208E microorganisms&gt; 125 3T. OO '31.00 0.060 1.000 0,250 j 0.500' 0,120 0.500 8.00 3LOO 31.00 0.004 0.004 0.008 0,001 0.008 03 0.500 8.00 8.00 0.008 0.120 0.015 0.015 0.008 0.015 31.00 16.00 8.00 1 0.060 16.00 | 0.030 0.060 0.015 0.030 1.00 B.00 . &amp;lt; 0.001 0.008 0.001 0.001 0,001 0.001 0.250 0.500 0.500 0.004 1 | 0.008 '1 1_ I &amp;lt; 0.001 &amp;lt; 0.001 &amp;lt; 0.001 &amp;lt; 0.001 ' &amp;lt; 0.250 I j 1.000 I 1.000 &amp;lt; 0-001 0,150 00 0.001 0,001 U) &amp;lt; 0.250 1 6.00 4.00 0.060 0.500 0.030 0.060 | 0.001 j 0.060 2_001 4.00 | 4,00 &amp;lt; 0.001 0.500 0.001 j 0.001 'I | 0.001 0.001 &amp;gt; 125 16.00 1G.00 I 0.008 0.500 1_ I 0.120 0.120 0.030 0.120  1.00 B .00 8.00 0.001 0.030 I  _J | 0.004 0.008 0.001 0.004 Cn ro 2,00 8.00 3.00 &amp;lt; 0.01 &amp;lt; . | &amp;lt; 0.001 ^  .001 &amp;lt; 0.001  Mol 16.0 6.0 0.015 0.015 0.002 0.008 level 001 0.015 g 31.00 1 31.00 I 0.015 0.250 0.030 0.002 0.050 0.060 CD 03 &amp;gt; 125 &amp;gt; 125  &amp;gt; 125  cn CP  Sord. 84112259 4 wa odd ball _ + ^  ^ fresh ^ _ (85 book 125g / ml malformation j  </span>
  </p>
</description>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
            <div class="flex flex-width style-scope patent-result">
              <section id="claims" class="style-scope patent-result">
                <h3 class="style-scope patent-result">
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result">Claims <span class="style-scope patent-result">(1)</span></div>
                    <div class="collapse style-scope patent-result">
                      Hide Dependent <iron-icon style="height: 15px; width: 15px;" icon="expand-less" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M12 8l-6 6 1.41 1.41L12 10.83l4.59 4.58L18 14z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon><template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </div>
                  </div>
                  <div class="layout horizontal style-scope patent-result">
                    <div class="flex style-scope patent-result"></div>
                    <div class="righthead style-scope patent-result">translated from Chinese</div>
                  </div>
                </h3>
                <patent-text name="claims" enable-text-selection="" class="style-scope patent-result" style="padding-top: 0px;">
    
    
    <template is="dom-if" restamp="" class="style-scope patent-text"></template>
    <overlay-tooltip id="tooltip" class="style-scope patent-text" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      
    </div>
  </overlay-tooltip>
    <div class="layout horizontal style-scope patent-text">
      <section id="text" class="flex style-scope patent-text"><claims mxw-id="PCLM107007585" lang="EN" load-source="google" class="style-scope patent-text">
  <claim num="1" class="style-scope patent-text">
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">f  3   (867  A8 B8 C8 D8    1. I)</span>Printed by the Central Bureau of Standards of the Ministry of Economic Affairs, printed by the Cooperative Society of the 3rd Class Patent No. Patent Application Scope of Amendment (July 86) A8 B8 C8 D8 Patent Application Siege 1. A compound of formula (I)</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(I)  Z  RZ ft</span>(I) wherein Z is a tetrahydropiperanyl group selected from the formula RZ ft</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">w  R .&amp;lt; 7(b).  R1Ci_4R2R3CuCb4C_4  L:\EXTA41\41881.DOC  CNS ) A421X297  ()  *1T  S31644   8 88S ABCD    R2R3C = c = s C3.8 RCH^R7(R7c]_4 0C0R8^^5_6_   1 - 6 Ci_6c^4 R5R6 1 ; XCR9R10(R9Rl  Cb6 Cb4Ci-4^-4 R9R10C = c = Sc3 8C^CHR11Rii^ XY-Y_cr2r3_x_cr2r3 -N = CR3 -- NR12-CR2R3-( CR2  R3  C = 0R12Ci_4 COR13R13c 1 - 6YXCH  R15Cl_6 1212 C3_6OCOR18r18ci4 Cb1()Ci_6 C1-4R!6RI5r16 C = 0C = CH2 ;  L:\EXTA41\41881.DOC  CNS ) A421297  ()  -11    A8 B8 C8 D8  R]7CH2R19r19 w a) .1   ;  I)Z  </span>w R . &amp;lt; 7 (b). And its pharmaceutically acceptable salts and solvates (such as hydrates), where R1 represents hydrogen, pixel, hydroxyl, Ci_4 alkoxy or acetyloxy; R2 and R3 may Each independent representative hydrogen, Cu alkyl or Cb4 alkoxy C  _4 L: \ EXTA41 \ 41881.DOC This paper scale is applicable to the Chinese National Standard (CNS) A4 specification (21X: 297 mm) (please read first (Notes on the back and then fill out this page) * 1T S31644 VI. Patent application range 8 88S ABCD The Ministry of Economic Affairs Central Consortium Bureau Consumer Cooperative printed the environmental base, or R2 and R3 together with the associated carbon atom representative C = , c = s or C3.8 cycloalkyl; R stands for lice or CH ^ R7 (where R7 is , several groups, c] _4 alkoxy group bite 0C0R8 group, where ^ is ^ -alkyl, or phenyl Or a 5- or 6-membered heteroaromatic ring (which contains one or more heteroatoms selected from nitrogen, oxygen, or sulfur), each of which is unsubstituted, or one or more selected from halogen, hydroxyl,  1 -6 present groups, atom or group substitution of Ci_6 alkoxy or c ^ 4 alkoxycarbonyl); R5 and R6 may independently represent hydrogen;  represents zero or 1; X and  may independently represent oxygen or CR9R10 ( Here R9 and Rl can independently represent hydrogen 'Cb6 alkyl' Cb4 alkoxy or Ci-4 alkoxy ^ ^ -4 alkyl, or R9 and R10 together with the carbon atoms associated with it represents C = , c = S , C3 8 cycloalkyl or C ^ CHR11, where Rii represents hydrogen or ^  alkyl); or when X or Y is milk and  is zero, -Y_cr2r3 or _x_cr2r3 may represent -N = CR3-or -NR12-CR2R3- (where CR2 and R3 are C = 0, and R12 is Ci_4 alkyl 'COR13 acetyl, where R13 is c 1-6 alkyl) or when Y is oxygen and  is zero, X May represent CH group, this group is connected to the ring with a double bond; R15 represents hydrogen, halogen, azido, hydroxy, Cl_6 alkoxy (if necessary from 1 or 2 hydroxyl or ketal or 1 or 2 alkoxy substitutions), C3_6 alkenoxy, OCOR18 group (where r18 is aryl ci4 alkoxy, alkyl or Cb1 () alkyl with one or two double bonds) or Ci_6 alkoxycarbonyl C1-4 alkoxy, and R! 6 represents hydrogen or RI5 and r16 together with the associated carbon atom represents C = 0 or C = CH2; L: \ EXTA41 \ 41881.DOC This paper size is applicable to Chinese national standards ( CNS) A4 specification (21297 and public) (Please read the notes on the back first (Fill in this page)-, 11 Patent scope A8 B8 C8 D8 R] 7 represents CH2R19, where r19 is hydrogen w represents oxygen or sulfur atom; and the dotted line of group (a) indicates that sometimes there are additional bonds. .According to the base of the first patent application; and the compound of formula (I) in the item, where Z is as follows</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text"> '  R</span>Or ' R</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">CH-CH i   FT  {W)  xCR9Rl0  321)    421)X R2R3Ci  5_21) CR9r1  651)R9  C_4Rl(119111c C = CHRU  7.121)X    8_i2R i  .:\HXT\41\41881.DOC  1    JULiis uCNS ) 210^7  321644  C8  _______ D8    R4  91)</span>CHCH 2 i  FT (please read the precautions on the back before filling this page) where x or -is oxygen, and the other is oxygen or CR9Rl0 group. 3. According to the scope of the patent application! Or a compound of formula (1) in item 2, wherein  is zero. 4. According to the formula (1) compound of the first or second patent application scope, wherein X and  are both oxygen and R2 and R3 independently represent hydrogen or Ci "alkyl. 5_ According to the formula of the patent application scope item 1 or 2 (1) Compounds in which one of them is oxygen and the other is a CR9r10 group. 6. A compound of formula (1) according to item 5 of the patent application scope, in which R9 represents hydrogen or C] _4 burning group and Rl stands for hydrogen or (: 119111 group stands for c group, or C = CHRU. 7. The compound of formula (1) according to item 1 or 2 of the patent application scope, where X is oxygen. 8_ According to the patent application scope The compound of formula i or item 2, wherein R i is.: \ HXT \ 41 \ 41881.DOC, 1 Printed paper of Juli Choi Susu Household Materials (CNS) 210 ~ ^ 7 Public reply 321644 C8 _______ D8 6. The scope of patent application is hydrogen or hydroxy and R4 is methyl. 9. According to the compound of formula (1) in item 1 of the scope of patent application, where</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">W  102[R_ ( i  ^,3a^ ,4^ ,4a/? ,7^ ,7a^s8a/?)]8a-[[lS, 7R,9R]-2,8-  -9 --4 ---[3.4.0]__7_--]-4--4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;--7--3-(1--14 --S-- 3a-(lH) -   1[R_  (1 3a/?4 4ay57 /?7a or8a]8a-[(2,6 --    3,4-0 --D_]_4_ -4,4a56,7,7a8,8a --7-- 3_(1- -1,4--s-_3a(iH)_  [1R-(1 a3a4 4a/?77a a8a]8a-[[l S,4R 7911]-2,8--4,9---[3.4.0]--7---]-4 --4,4a,56,7,7a8,8a--7-  -3-(1-4,4--s-p_3a(lH)-   L:\EXTVUVn881.DOC _ 4 -  CNS ) M^ ( ?  ^21644  A8 B8 C8 D8    6R?Rl(-2a73.a^4/?4a^7^7aflr8a/5)38a'[[1S54S5  4,6---[3.4.0]--8---]-4-.4,4a5,6,7,7a8,8a_M_7_  .-_(1'14--s-3a(lH)-  [1R (1 ar,3a/?54/?54a^,7^,7aa58a/?)]8a_[(253  4  -_^_D_]_4_ 4,4&amp;amp;5,6,7,7&amp;amp;8,8&amp;amp;-^_-3_(1. ]_3a(iH)  a3a44a77&amp;amp;8&amp;amp;]8&amp;amp;_[(2 3_ 6-4__--D -]-4-  -4,4a5,6,7,7a8,8a--7--3-(1-  14-_s_3&amp;amp;(1)_    12'1I)   )II)  ()          XH</span>Where W is oxygen. 10. The compound of formula () according to item 2 of the patent application scope, which is [ R_ (i ^, 3a ^, 4 ^, 4a /?, 7 ^, 7a ^ s8a /?)] 8a-[[lS , 7R, 9R] -2,8-dioxo-9-methyl-4-methylidene-cis-bicyclo [3.4.0] _non_7_yl-oxy-methyl] -4-carboxamide -4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro-7-methyl-3- (1-methylethyl) -1,4-methylene-S- Indah-3a- (lH) -carboxylic acid; and its pharmaceutically acceptable salts. According to the formula () compound of the first item of the patent application scope, it is selected from [ R_ (1 , 3a / ?, 4, 4ay5, 7 / ?, 7a or, 8a)] 8a-[(2, 6 -Dideoxy-printed by 3,4-0 -isopropylidene-D_bezopiperanosyloxy) methyl] _4_methanyl-4, 4a, 5,6,7,7a, 8,8a -octahydro-7-methyl-3_ (1-methylethyl) -1,4-methylene-s-indap province_3a (iH) _Carboxylic acid; [1R- (1 a, 3a point, 4 point, 4a / ?, 7, 7a a, 8a point)] 8a-[[l S, 4R, 7 Han, 911] -2,8- Dioxo-4,9-dimethyl-cis-bicyclo [3.4.0] -non-7-yl-oxy-methyl] -4-methyl-4,4a, 5,6,7,7a , 8,8a-octahydro-7-methyl-3- (1-methylethyl) 4,4-methylene-sp lead-free_3a (lH) -carboxylic acid; L: \ EXTVUVn881.DOC _ 4-This paper is from China National Standard (CNS) M class ^ (plus  ? Mm) ^ 21644 A8 B8 C8 D8 Patent scope 6R? Rl (-2a73.a ^ 4 / ?, 4a ^, 7 ^, 7aflr, 8a / 5) 38a '[[1S54S5 its dagger, -oxy  4,6-dimethyl-cis-bicyclo [3.4.0] -non-8--lactyl-methyl] -4-methyl Brewer. 4,4a, 5,6,7,7a, 8,8a_M_7_ acid .-_ (1'Methylethyl 1,4-methylene -s "  -3a (lH)-defect [1R (1 ar, 3a /? 54 /? 54a ^, 7 ^, 7aa, 58a /?)] 8a _ [(253 oxy4 -propyl _ ^ _ D _Piperanmannosyloxy) methyl] _4_carbofuran 4,4 &amp;amp;, 5,6,7,7 &amp;amp;, 8,8 &amp;amp; -octahydro ^ _methyl-3_ (1.methylethyl )], Renmethylene decapentan province _3a (iH) citric acid; a, 3a is, 40,000, 4a, 7, 7 &amp;amp; , 8 &amp;amp; million)] 8 &amp;amp; _ [(2 3_ Dehydrated 6-deoxy-4__methyl-cold-D-piperanmannosyloxy) methyl] -4-methylacetate-4,4a, 5,6,7,7a, 8,8a- Octahydro-7-methyl-3- (1-methylethyl)  1,4-methylene_s called  Da province_3 &amp; (1) _carboxylic acid; and its pharmaceutically acceptable salts . 12 'methods for preparing the compound of formula (I) according to item 1 of the patent application, which includes ) compound of formula (II) (please read the precautions on the back before filling in this page) XH printed by the quasi-bureau employee consumer cooperative</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">YH (II)  L:\EXT\41\41881.DOC  CNS ) A*2  297  A8 B8 C8 D8    (R1R4I)Rp XYI)X/  C R9 R1 )    (b)Za)R2&amp;amp;R3 XCHI)VII)  ()</span>YH (II) L: \ EXT \ 41 \ 41881.DOC This paper scale is applicable to China s national frame rate (CNS) A * specifications (2   297 hectares) A8 B8 C8 D8 Patent application scope (where R1 and R4 are as above As defined in formula (I), Rp is a carboxyl protecting group, and X and Y are as defined in formula (I) above, except that X and / or  cannot represent CR 9 R1)) The reaction forms the desired ring system, Then remove the carboxyl protecting group; (b) When preparing the compound of formula (I) where Z is (a) group,  is oxygen,  is zero, R2 &amp;amp; R3 is hydrogen, and X is CH, use formula (VII) Compound (please read the notes on the back before filling this page)</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">(VII)      R21CHORp*   (c)Zb)WI) VIII)  L:\EXT\41\41881.DOC   t ^ ( CNS ) A(  </span>(VII) Printed by the Employee Consumer Cooperative of the Central Bureau of Preservation of the Ministry of Economy where R21 is the CHO group or its protected derivative, Rp * protected carboxyl group, and reacts with dialkylbisazomethylphosphonate (c) When the compound of formula (I) where Z is (b) group and W is oxygen, it is the cyclized compound of formula (VIII) L: \ EXT \ 41 \ 41881.DOC This paper uses t Guanjia; ^ ( CNS) A video (Scope of patent application</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">R 15 R J7a 16a (VIII) ( R15aR16a&amp;amp;Rl7aI)tRl5r16r17  Rp L-r2 2  R  (d)WI))  ()  </span>R 15  R J7a 16a (VIII) (wherein R15a, R16a &amp;amp; Rl7a are as defined in formula (I) tRl5, r16 and r17 above) or their protected derivatives, Rp is hydrogen or carboxyl protecting group, L is suitable In the leaving group such as alkyl- or arylsulfonyloxy, and r2 2 is nitrogen or R group as defined in B), if necessary, remove any existing protecting groups: (d) Preparation W is For the sulfur compound of formula (I), it is the compound of formula () (please read the precautions on the back before filling out this page). Printed by the Employee Consumer Cooperative of the Central Standardization Bureau</span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text">
        <span class="google-src-text style-scope patent-text">
          <span class="patent-image-not-available style-scope patent-text"></span>
        </span>
        <span class="patent-image-not-available style-scope patent-text"></span>
      </span>
    </claim-text>
    <claim-text class="style-scope patent-text">
      <span class="notranslate style-scope patent-text"> <span class="google-src-text style-scope patent-text">,15 R16 ,17 (IX)  r:R15R16H17)  (i)    CNS )421&amp;gt;&amp;lt;297  321644 as    C8  __ D8    (ii) I) I)  (iii) I)  13_   12I)   ()    8   -    \/ S  C /IV _  I - - I      7 9 2</span>, 15 R16, 17 (IX) r: R15, R16H17 as defined in the above formula (1), if necessary or desired, do one or more of the following steps: (i) remove any protecting groups; sulfur donor at the paper size Use the Chinese National Standard (CNS) VIII 4 specifications (21 &amp;gt; &amp;lt; 297mm 321644 as  C8 __ D8 VI. Scope of patent application (ii) A compound of formula (I) or its protected derivatives Conversion into another compound of formula (I); (iii) Isolation of compound of formula (I) in the form of its pharmaceutically acceptable salt. 13_  A pharmaceutical composition for the treatment of anti-mycobacterial infections, which contains The compound of formula (I) according to item 1 or 2 and mixed with one or more physiologically acceptable carriers or excipients. (Please read the precautions on the back before filling out this page) Central Standard Falcon, Ministry of Economic Affairs Bureau Staff Consumer Cooperative Printed 8 Yi Lai-Paper  \  / S  C / IV _   I -- I      7 7 2</span>
    </claim-text>
  </claim>
</claims>
  </section>
      <div id="margin" class="style-scope patent-text">
        <div id="createHighlight" style="top: 0px;" class="style-scope patent-text" hidden="">
          <iron-icon id="comment" icon="editor:insert-comment" class="style-scope patent-text x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M20 2H4c-1.1 0-2 .9-2 2v12c0 1.1.9 2 2 2h14l4 4V4c0-1.1-.9-2-2-2zm-2 12H6v-2h12v2zm0-3H6V9h12v2zm0-3H6V6h12v2z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon>
        </div>
      </div>
    </div>
  </patent-text>
              </section>
            </div>
          </div>

          <div class="footer style-scope patent-result">

            
            <h3 id="patentCitations" class="scroll-target style-scope patent-result">
              Patent Citations (4)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CH465771A/en"><a id="link" href="#" class="style-scope state-modifier">CH465771A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1965-12-06</span>
                    <span class="td style-scope patent-result">1968-11-30</span>
                    <span class="td style-scope patent-result">Sandoz Ag</span>
                    <span class="td style-scope patent-result">
  Process for the manufacture of a new antibiotic
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH0615555B2/en"><a id="link" href="#" class="style-scope state-modifier">JPH0615555B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1985-08-14</span>
                    <span class="td style-scope patent-result">1994-03-02</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">
  Antibiotic Zofimarin
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP3189443B2/en"><a id="link" href="#" class="style-scope state-modifier">JP3189443B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-11-20</span>
                    <span class="td style-scope patent-result">2001-07-16</span>
                    <span class="td style-scope patent-result"></span>
                    <span class="td style-scope patent-result">
  Antifungal substance BE-31405
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EA002469B1/en"><a id="link" href="#" class="style-scope state-modifier">EA002469B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-12</span>
                    <span class="td style-scope patent-result">2002-06-27</span>
                    <span class="td style-scope patent-result">  ., .</span>
                    <span class="td style-scope patent-result">Method for treating fungal infections 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                </div>
              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="citedBy" class="scroll-target style-scope patent-result">
              Cited By (25)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication number</span>
                    <span class="th style-scope patent-result">Priority date</span>
                    <span class="th style-scope patent-result">Publication date</span>
                    <span class="th style-scope patent-result">Assignee</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  <template is="dom-repeat" class="style-scope patent-result"></template>

                  <div class="tr style-scope patent-result">
                    <span class="td famheader style-scope patent-result">Family To Family Citations</span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                    <span class="td famheader style-scope patent-result"></span>
                  </div>

                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0901493A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0901493A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-08</span>
                    <span class="td style-scope patent-result">1999-03-17</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome S.A.</span>
                    <span class="td style-scope patent-result">Process for the preparation of an indacene compound 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6436395B1/en"><a id="link" href="#" class="style-scope state-modifier">US6436395B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-09-18</span>
                    <span class="td style-scope patent-result">2002-08-20</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Rosellinia subiculata ATCC 74386 and fungus ATCC 74387 for producing sordarin compounds for fungi control 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6040463A/en"><a id="link" href="#" class="style-scope state-modifier">US6040463A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-10-07</span>
                    <span class="td style-scope patent-result">2000-03-21</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6096511A/en"><a id="link" href="#" class="style-scope state-modifier">US6096511A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-06-10</span>
                    <span class="td style-scope patent-result">2000-08-01</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Protein elongation factor 2 as a target for antifungal and antiparasitic agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5965612A/en"><a id="link" href="#" class="style-scope state-modifier">US5965612A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">1999-10-12</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordaricin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US5972996A/en"><a id="link" href="#" class="style-scope state-modifier">US5972996A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">1999-10-26</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2300407C/en"><a id="link" href="#" class="style-scope state-modifier">CA2300407C</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-08-22</span>
                    <span class="td style-scope patent-result">2010-01-26</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">4-cyano-4-deformylsordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6136853A/en"><a id="link" href="#" class="style-scope state-modifier">US6136853A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-10-03</span>
                    <span class="td style-scope patent-result">2000-10-24</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/FI974385A0/en"><a id="link" href="#" class="style-scope state-modifier">FI974385A0</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-01</span>
                    <span class="td style-scope patent-result">1997-12-01</span>
                    <span class="td style-scope patent-result">Xyrofin Oy</span>
                    <span class="td style-scope patent-result">
  Preparation of xylitol For the purpose of pharmaceutical treatment and xylitol preparations For the manufacture of xylitol
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7070965B1/en"><a id="link" href="#" class="style-scope state-modifier">US7070965B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-04-14</span>
                    <span class="td style-scope patent-result">2006-07-04</span>
                    <span class="td style-scope patent-result">Zhenhua Yang</span>
                    <span class="td style-scope patent-result">Small molecule anticancer compounds and related production process 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/MA26628A1/en"><a id="link" href="#" class="style-scope state-modifier">MA26628A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-05-11</span>
                    <span class="td style-scope patent-result">2004-12-20</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome Sa</span>
                    <span class="td style-scope patent-result">
  MORPHOLINO ETHERS
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2000024728A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2000024728A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1998-10-26</span>
                    <span class="td style-scope patent-result">2000-05-04</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Microbial transformation product 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2003501488A/en"><a id="link" href="#" class="style-scope state-modifier">JP2003501488A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-06-11</span>
                    <span class="td style-scope patent-result">2003-01-14</span>
                    <span class="td style-scope patent-result">  </span>
                    <span class="td style-scope patent-result">
  High-dose radionuclide complexes for bone marrow suppression
 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7094885B2/en"><a id="link" href="#" class="style-scope state-modifier">US7094885B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-07-11</span>
                    <span class="td style-scope patent-result">2006-08-22</span>
                    <span class="td style-scope patent-result">Neorx Corporation</span>
                    <span class="td style-scope patent-result">Skeletal-targeted radiation to treat bone-associated pathologies 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6645960B1/en"><a id="link" href="#" class="style-scope state-modifier">US6645960B1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1999-11-11</span>
                    <span class="td style-scope patent-result">2003-11-11</span>
                    <span class="td style-scope patent-result">Glaxo Wellcome S.A.</span>
                    <span class="td style-scope patent-result">Antifungal sordaricin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2001289063A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2001289063A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-09-15</span>
                    <span class="td style-scope patent-result">2002-03-26</span>
                    <span class="td style-scope patent-result">Bristol-Myers Squibb Company</span>
                    <span class="td style-scope patent-result">Novel thio derivatives of sordarin as antifungal agents 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002249935A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002249935A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-01-08</span>
                    <span class="td style-scope patent-result">2002-08-19</span>
                    <span class="td style-scope patent-result">Neorx Corporation</span>
                    <span class="td style-scope patent-result">Radioactively labelled conjugates of phosphonates 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2003007878A2/en"><a id="link" href="#" class="style-scope state-modifier">WO2003007878A2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-18</span>
                    <span class="td style-scope patent-result">2003-01-30</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">Antifungal agents of sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US7045116B2/en"><a id="link" href="#" class="style-scope state-modifier">US7045116B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-13</span>
                    <span class="td style-scope patent-result">2006-05-16</span>
                    <span class="td style-scope patent-result">Dow Global Technologies Inc.</span>
                    <span class="td style-scope patent-result">Treatment of osteomyelitis with radiopharmaceuticals 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU2002351340A1/en"><a id="link" href="#" class="style-scope state-modifier">AU2002351340A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-12-14</span>
                    <span class="td style-scope patent-result">2003-06-30</span>
                    <span class="td style-scope patent-result">Merck &amp; Co., Inc.</span>
                    <span class="td style-scope patent-result">A novel sordarin derivative isolated from culture fermentations and functions as an antifungal agent 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JP2006513235A/en"><a id="link" href="#" class="style-scope state-modifier">JP2006513235A</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-12-31</span>
                    <span class="td style-scope patent-result">2006-04-20</span>
                    <span class="td style-scope patent-result">  </span>
                    <span class="td style-scope patent-result">
  Aerosolizable pharmaceutical formulation for fungal infection therapy
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US9314524B2/en"><a id="link" href="#" class="style-scope state-modifier">US9314524B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-12-31</span>
                    <span class="td style-scope patent-result">2016-04-19</span>
                    <span class="td style-scope patent-result">Calla Therapeutics Llc</span>
                    <span class="td style-scope patent-result">Topical formulations of Flucytosine 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US8419948B2/en"><a id="link" href="#" class="style-scope state-modifier">US8419948B2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2009-11-22</span>
                    <span class="td style-scope patent-result">2013-04-16</span>
                    <span class="td style-scope patent-result">United Laboratories International, Llc</span>
                    <span class="td style-scope patent-result">Wastewater treatment 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2012033427A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2012033427A1</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2010-09-08</span>
                    <span class="td style-scope patent-result">2012-03-15</span>
                    <span class="td style-scope patent-result">Dalin Mikhail Viktorovich</span>
                    <span class="td style-scope patent-result">Method for treating mycotic infections and drug for carrying out said method 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                      <template is="dom-if" class="style-scope patent-result"></template>
                      
                      <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/RU2630403C2/en"><a id="link" href="#" class="style-scope state-modifier">RU2630403C2</a></state-modifier>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      *<template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2016-02-25</span>
                    <span class="td style-scope patent-result">2017-09-07</span>
                    <span class="td style-scope patent-result">  </span>
                    <span class="td style-scope patent-result">Abrasive mass for manufacturing tool with high structure numbers 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>

              </div>
            </div>
            <div style="padding: 10px 12px; font-size: 11px;" class="style-scope patent-result">* Cited by examiner,  Cited by third party,  Family to family citation</div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="similarDocuments" class="scroll-target style-scope patent-result">
              Similar Documents
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Publication</span>
                    <span class="th style-scope patent-result">Publication Date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/TW321644B/en"><a id="link" href="#" class="style-scope state-modifier">TW321644B</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-01</span>
                    <span class="td style-scope patent-result"></span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH06505472A/en"><a id="link" href="#" class="style-scope state-modifier">JPH06505472A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-06-23</span>
                    <span class="td style-scope patent-result">
  Bridged cyclic ketal derivatives
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6054478A/en"><a id="link" href="#" class="style-scope state-modifier">US6054478A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2000-04-25</span>
                    <span class="td style-scope patent-result">Antifungal sordaridin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/IE920056A1/en"><a id="link" href="#" class="style-scope state-modifier">IE920056A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-07-15</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992016530A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992016530A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-10-01</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1992012157A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1992012157A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1992-07-23</span>
                    <span class="td style-scope patent-result">Bridged cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP1296989B1/en"><a id="link" href="#" class="style-scope state-modifier">EP1296989B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2007-05-23</span>
                    <span class="td style-scope patent-result">Polycyclic xanthones as antibiotics 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2803670A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2803670A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2012-01-12</span>
                    <span class="td style-scope patent-result">Novel antibacterial compounds, methods of making them, and uses thereof 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP3445741A1/en"><a id="link" href="#" class="style-scope state-modifier">EP3445741A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2019-02-27</span>
                    <span class="td style-scope patent-result">Antimicrobial agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0711784A1/en"><a id="link" href="#" class="style-scope state-modifier">EP0711784A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1996-05-15</span>
                    <span class="td style-scope patent-result">Antifungal Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/AU653446B2/en"><a id="link" href="#" class="style-scope state-modifier">AU653446B2</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-09-29</span>
                    <span class="td style-scope patent-result">Novel alkaloids and processes for their production 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2257422A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2257422A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-12-18</span>
                    <span class="td style-scope patent-result">Dibenzo-oxazepine and -dioxepine derivatives and their use as anti-tumor agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US6255339B1/en"><a id="link" href="#" class="style-scope state-modifier">US6255339B1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2001-07-03</span>
                    <span class="td style-scope patent-result">Tetrahydronaphthofuranone derivatives and process for producing the same 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/KR20020037730A/en"><a id="link" href="#" class="style-scope state-modifier">KR20020037730A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2002-05-22</span>
                    <span class="td style-scope patent-result">New iodolocarbazole alkaloids from a marine actinomycete 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/US20220177484A1/en"><a id="link" href="#" class="style-scope state-modifier">US20220177484A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2022-06-09</span>
                    <span class="td style-scope patent-result">Macrocycles with antioxidant and neuroprotective activities 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH0959275A/en"><a id="link" href="#" class="style-scope state-modifier">JPH0959275A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-03-04</span>
                    <span class="td style-scope patent-result">New substance tryprostatin, its production, cell period inhibitor and antitumor agent 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH07504421A/en"><a id="link" href="#" class="style-scope state-modifier">JPH07504421A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1995-05-18</span>
                    <span class="td style-scope patent-result">
  Cyclic ketal derivative
 
     </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO1993007151A1/en"><a id="link" href="#" class="style-scope state-modifier">WO1993007151A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-04-15</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/WO2015145152A1/en"><a id="link" href="#" class="style-scope state-modifier">WO2015145152A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">2015-10-01</span>
                    <span class="td style-scope patent-result">Antimicrobial agents 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/CA2131010A1/en"><a id="link" href="#" class="style-scope state-modifier">CA2131010A1</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1993-09-16</span>
                    <span class="td style-scope patent-result">Cyclic ketal derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH06206884A/en"><a id="link" href="#" class="style-scope state-modifier">JPH06206884A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1994-07-26</span>
                    <span class="td style-scope patent-result">Production of new compound thiomarinol b 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td style-scope patent-result">
                      
                        <template is="dom-if" class="style-scope patent-result"></template>
                        
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/JPH09255680A/en"><a id="link" href="#" class="style-scope state-modifier">JPH09255680A</a></state-modifier>
                        <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                      <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td style-scope patent-result">1997-09-30</span>
                    <span class="td style-scope patent-result">Spirotryprostatin, its production, cell cycle inhibitor and antitumor agent 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="relatedApplications" class="scroll-target style-scope patent-result">Priority And Related Applications</h3>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            
            <h3 id="appsClaimingPriority" class="scroll-target style-scope patent-result">
              Applications Claiming Priority (2)
              <a href="#title" class="style-scope patent-result"><iron-icon icon="arrow-drop-up" class="style-scope patent-result x-scope iron-icon-0"><svg viewBox="0 0 24 24" preserveAspectRatio="xMidYMid meet" focusable="false" style="pointer-events: none; display: block; width: 100%; height: 100%;" class="style-scope iron-icon"><g class="style-scope iron-icon"><path d="M7 14l5-5 5 5z" class="style-scope iron-icon"></path></g></svg>
    
  </iron-icon></a>
            </h3>
            <div class="responsive-table style-scope patent-result">
              <div class="table style-scope patent-result">
                <div class="thead style-scope patent-result">
                  <div class="tr style-scope patent-result">
                    <span class="th style-scope patent-result">Application</span>
                    <span class="th style-scope patent-result">Filing date</span>
                    <span class="th style-scope patent-result">Title</span>
                  </div>
                </div>
                <div class="tbody style-scope patent-result">
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0712859A1/en"><a id="link" href="#" class="style-scope state-modifier">EP94500173A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result">Antifungal Sordarin derivatives 
       </span>
                  </div>
                  
                  <div class="tr style-scope patent-result">
                    <span class="td nowrap style-scope patent-result">
                        <state-modifier act="{&quot;type&quot;: &quot;OPEN_RESULT&quot;, &quot;result&quot;: &quot;$result&quot;}" class="style-scope patent-result" data-result="patent/EP0711784A1/en"><a id="link" href="#" class="style-scope state-modifier">EP94500175A</a></state-modifier><template is="dom-if" class="style-scope patent-result"></template>
                        <template is="dom-if" class="style-scope patent-result"></template>
                    </span>
                    <span class="td nowrap style-scope patent-result">1994-11-08</span>
                    <span class="td style-scope patent-result">Antifungal Sordarin derivatives 
       </span>
                  </div>
                  <template is="dom-repeat" class="style-scope patent-result"></template>
                </div>
              </div>
            </div>
            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <template is="dom-if" class="style-scope patent-result"></template>

            <div id="notices" class="vertical layout center style-scope patent-result">
              
                <span class="style-scope patent-result">Data provided by IFI CLAIMS Patent Services</span>
              <template is="dom-if" class="style-scope patent-result"></template>
            </div>
          </div>
          <div class="bottombar style-scope patent-result">
            <bottom-bar class="style-scope patent-result"><template is="dom-if" class="style-scope bottom-bar"></template>
</bottom-bar>
          </div>
        </div>
      </div>
      <template is="dom-if" class="style-scope patent-result"></template>
    </div>
  </patent-result>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
    <template is="dom-if" restamp="" class="style-scope result-container"></template>
  </result-container>
        </div>
      </div>
    
        </div>
      </div>
      <search-footer class="style-scope search-ui">
    
    

    <div id="footer" class="vertical layout center style-scope search-footer">
        <span class="links style-scope search-footer">
          <overlay-tooltip positioning-target="#footerAbout" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Learn more about data coverage, search syntax and other features.
    </div>
  </overlay-tooltip>
          <a id="footerAbout" data-proto="ABOUT" href="https://support.google.com/faqs/answer/6390996" target="_blank" class="style-scope search-footer">About</a>
          <overlay-tooltip positioning-target="#footerFeedback" direction="top" class="style-scope search-footer" style="display: none;">
    
    <div id="arrow" class="style-scope overlay-tooltip" hidden=""></div>
    <div class="style-scope overlay-tooltip">
      Send feedback about technical issues or feature requests for Google Patents.
    </div>
  </overlay-tooltip>
          <a id="footerFeedback" data-proto="SEND_FEEDBACK" href="#" onclick="sendFeedback();" class="style-scope search-footer">Send Feedback</a>
          <a data-proto="PUBLIC_DATASETS" href="https://console.cloud.google.com/marketplace/product/google_patents_public_datasets/google-patents-public-data" target="_blank" class="style-scope search-footer">Public Datasets</a>
          <a data-proto="TERMS" href="https://www.google.com/policies/terms/" target="_blank" class="style-scope search-footer">Terms</a>
          <a data-proto="PRIVACY_POLICY" href="https://www.google.com/privacy/privacy-policy.html" target="blank" class="style-scope search-footer">Privacy Policy</a>
          <a data-proto="SEARCH_HELP" href="https://support.google.com/websearch/" target="_blank" class="style-scope search-footer">Help</a>
        </span>
    </div>
  </search-footer>
    </div>

  </search-ui>
  </search-result>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <template is="dom-if" restamp="" class="style-scope search-app"></template>
    <paper-toast id="toast" duration="3000" class="style-scope search-app x-scope paper-toast-0" aria-hidden="true" style="outline: none; display: none;">
    

    <span id="label" class="style-scope paper-toast"></span>
    
      <div id="noticeContent" class="style-scope search-app"></div>
    
  </paper-toast>
  </search-app>
    <script type="text/javascript" src="//www.gstatic.com/feedback/api.js"></script>
    <script type="text/javascript" src="//www.gstatic.com/feedback/js/help/prod/service/lazy.min.js"></script>
    <script type="text/javascript">
      if (window.help && window.help.service) {
        helpApi = window.help.service.Lazy.create(0, {apiKey: 'AIzaSyDTEI_0tLX4varJ7bwK8aT-eOI5qr3BmyI', locale: 'en-US'});
        window.requestedSurveys = new Set();
        window.requestSurvey = function(triggerId) {
          if (window.requestedSurveys.has(triggerId)) {
            return;
          }
          window.requestedSurveys.add(triggerId);
          helpApi.requestSurvey({
            triggerId: triggerId,
            enableTestingMode: false,
            callback: (requestSurveyCallbackParam) => {
              if (!requestSurveyCallbackParam.surveyData) {
                return;
              }
              helpApi.presentSurvey({
                productData: {
                  productVersion: window.version,
                  customData: {
                    "experiments": "",
                  },
                },
                surveyData: requestSurveyCallbackParam.surveyData,
                colorScheme: 1,
                customZIndex: 10000,
              });
            }
          });
        };

        window.requestSurvey('YXTwAsvoW0kedxbuTdH0RArc9VhT');
      }
    </script>
    <script src="/sw/null_loader.js"></script>
  

<iframe id="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.56922999" name="apiproxyddf475d63cd8173a637a287407211e3c7614fb050.56922999" style="width: 1px; height: 1px; position: absolute; top: -100px; display: none;" src="https://scone-pa.clients6.google.com/static/proxy.html?usegapi=1&amp;jsh=m%3B%2F_%2Fscs%2Fabc-static%2F_%2Fjs%2Fk%3Dgapi.lb.en.IKZeRvoAYNY.O%2Fam%3DAAAQ%2Fd%3D1%2Frs%3DAHpOoo-SMWTzMRJrTty6iE5dL_aWGYOnuw%2Fm%3D__features__#parent=https%3A%2F%2Fpatents.google.com&amp;rpctoken=334204779" tabindex="-1" aria-hidden="true"></iframe><iron-a11y-announcer>
    
    <div class="style-scope iron-a11y-announcer" aria-live="polite"></div>
  </iron-a11y-announcer></body></html>